data_2ln7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ln7 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 tttp . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.844 0.354 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.443 ' HG3' ' CD1' ' A' ' 32' ' ' TRP . 2.3 mp0 -59.85 137.87 57.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.356 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.29 9.17 70.34 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -115.49 141.25 48.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.839 0.352 . . . . 0.0 110.429 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 84.3 tttt -67.82 113.6 5.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.228 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.3 m -111.8 -37.22 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.028 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.36 158.33 44.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.665 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 44.9 ttp -118.05 138.42 52.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.415 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.42 121.9 43.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.077 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -122.46 135.29 54.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.119 0.485 . . . . 0.0 111.07 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.489 HG21 ' H ' ' A' ' 24' ' ' LEU . 3.8 mt -110.82 118.01 49.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.291 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.58 -48.5 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.832 2.355 . . . . 0.0 112.728 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -60.21 -44.93 94.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.627 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.8 mm? -96.53 3.03 52.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.618 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.41 38.96 1.95 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.719 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.445 ' HA ' ' HZ3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -112.22 145.06 40.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.356 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.37 144.06 50.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -140.23 141.88 35.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.661 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 p -86.68 121.21 28.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.712 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.559 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.1 mp -103.63 120.66 54.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.549 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 32.2 m-85 -106.2 150.31 25.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.727 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.443 ' CD1' ' HG3' ' A' ' 12' ' ' GLU . 33.2 t-105 -60.12 128.63 37.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.696 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.29 160.51 12.3 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.405 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.586 179.597 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.591 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.766 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -96.57 134.82 39.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.728 0.299 . . . . 0.0 110.576 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.766 ' N ' ' SD ' ' A' ' 45' ' ' MET . 1.9 t80 -64.02 132.55 50.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.712 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.416 ' H ' HG11 ' A' ' 47' ' ' VAL . 2.2 p -121.56 120.24 61.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.558 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.594 ' OG ' ' OG1' ' A' ' 51' ' ' THR . 43.2 p -160.69 169.66 22.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.498 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.554 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 47.8 t0 -62.45 -10.67 12.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.625 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 3.5 m -112.11 -34.25 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.71 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.594 ' OG1' ' OG ' ' A' ' 48' ' ' SER . 65.7 p -85.14 138.27 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.582 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.3 t -139.83 174.23 10.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.565 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.38 158.28 46.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.38 83.69 1.98 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.664 2.243 . . . . 0.0 112.694 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.9 p -118.83 -2.1 10.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.79 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.21 86.2 0.06 OUTLIER Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.59 101.55 0.01 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.513 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -178.42 165.32 34.52 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.713 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 16.2 t-160 -83.7 110.21 18.11 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.4 m -105.82 120.9 42.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.844 0.354 . . . . 0.0 110.426 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.453 HG11 ' CD1' ' A' ' 109' ' ' ILE . 61.9 t -117.7 131.56 70.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.195 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.506 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.8 mm? -111.25 139.44 46.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.596 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 t -122.59 129.4 51.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.733 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.639 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.531 1.041 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.548 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -68.83 -44.09 74.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.697 0.284 . . . . 0.0 110.656 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.3 mt -90.82 92.95 9.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.952 0.406 . . . . 0.0 110.352 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.482 ' HG3' ' H ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -174.73 147.67 1.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.06 -11.72 60.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.755 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.482 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 3.8 mtpt -84.13 -15.61 46.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.382 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.66 157.28 28.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 p -137.02 149.87 47.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.969 0.414 . . . . 0.0 109.992 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.9 mt -118.8 120.07 36.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.224 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 14.9 t -102.76 124.57 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.949 0.404 . . . . 0.0 110.642 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 3.2 mm? -113.0 133.16 55.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.127 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -106.09 119.33 38.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.542 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 1.1 t80 -143.2 127.05 17.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.266 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 57.08 44.32 22.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.854 0.359 . . . . 0.0 111.194 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 64.32 15.62 9.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.486 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 6.4 mtmp? -116.4 140.85 48.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.185 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.65 124.46 50.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 15.8 m-85 -104.06 129.68 51.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 117.75 35.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 111.127 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 89.7 m-85 -112.34 163.83 13.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.593 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -139.04 133.86 32.21 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.824 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' A' ' 77' ' ' LYS . 0.9 OUTLIER -65.52 123.78 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.201 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -99.89 -47.93 4.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.996 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -153.32 139.28 18.16 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.099 0.476 . . . . 0.0 110.532 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mt -116.51 130.58 71.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.539 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.475 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 20.0 p90 -151.62 -175.88 5.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.471 HG12 ' CD1' ' A' ' 135' ' ' TYR . 6.9 mt -129.31 135.21 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.498 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.501 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 6.5 t -134.86 171.23 14.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.77 158.11 35.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.459 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.462 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . . . -69.53 -11.44 60.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.701 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.554 ' C ' ' OD1' ' A' ' 104' ' ' ASP . 12.4 p30 -100.82 15.51 28.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.694 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.501 ' OD2' ' OG1' ' A' ' 101' ' ' THR . 39.8 t0 -79.15 94.28 5.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.973 0.416 . . . . 0.0 110.594 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 110' ' ' ILE . 52.3 ptt85 -74.82 -20.51 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.524 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.563 ' O ' ' CD1' ' A' ' 110' ' ' ILE . 5.9 p -60.08 -26.28 66.06 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.313 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.82 -4.83 10.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 42.5 mm -118.78 14.05 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.03 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.713 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.7 OUTLIER -79.61 -160.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.71 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -99.24 149.64 22.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.378 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.475 ' N ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -129.73 126.24 37.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -76.6 7.65 4.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.028 0.442 . . . . 0.0 110.117 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.14 164.08 43.14 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.542 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.513 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 44.6 Cg_endo -76.33 87.81 1.4 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.961 2.44 . . . . 0.0 111.888 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.5 mm -119.1 130.47 73.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.968 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.551 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 6.0 tt -103.56 118.57 37.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.149 0.5 . . . . 0.0 110.884 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 96.9 m -117.78 124.31 48.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.228 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.576 ' C ' ' CD1' ' A' ' 119' ' ' LEU . 0.5 OUTLIER -106.44 122.7 46.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.493 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.503 ' N ' ' CD1' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -121.08 120.48 35.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.236 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.639 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.4 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.158 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.779 0.323 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.462 ' NE ' ' HA ' ' A' ' 103' ' ' ALA . 10.6 ptp180 -101.31 144.42 30.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.785 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.471 ' CD1' HG12 ' A' ' 100' ' ' ILE . 4.5 t80 -76.42 135.04 39.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.872 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 mm -120.14 124.15 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.426 ' CD1' ' CD2' ' A' ' 135' ' ' TYR . 1.2 mp -112.91 109.5 28.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.475 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 22.7 tp10 -94.19 136.78 34.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.143 0.497 . . . . 0.0 110.89 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.59 148.98 31.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.973 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 79.2 tttt -116.2 155.23 28.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.06 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.459 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 11.8 tp -78.86 122.53 26.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.009 0.433 . . . . 0.0 110.478 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.66 -38.13 6.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.782 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -143.29 159.67 27.51 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.9 p -144.61 149.51 35.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.764 0.316 . . . . 0.0 110.457 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -128.97 153.8 47.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.598 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 77.4 p -146.86 126.99 13.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.729 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.591 179.995 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.611 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 64.1 tttt . . . . . 0 N--CA 1.461 0.114 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -91.61 149.39 21.68 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 89.71 10.23 65.37 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.611 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -113.64 133.95 55.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.843 0.354 . . . . 0.0 110.412 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.48 106.24 0.52 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.289 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.5 m -109.28 -40.53 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.971 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.17 160.32 32.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.7 ttp -123.7 147.1 47.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.189 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.8 tp -112.56 123.39 50.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.68 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.5 HD22 ' CD ' ' A' ' 27' ' ' LYS . 3.3 t-20 -118.02 128.38 54.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.963 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.1 mt -106.42 106.34 57.15 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD2' ' O ' ' A' ' 81' ' ' THR . 55.6 Cg_endo -76.33 -40.39 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.82 2.347 . . . . 0.0 112.851 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -58.48 -43.55 89.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.614 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.0 mm? -99.58 -0.03 41.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.569 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.25 49.49 17.07 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.593 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -127.66 165.42 20.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.402 . . . . 0.0 110.839 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.5 ' CD ' HD22 ' A' ' 20' ' ' ASN . 15.4 mtmt -140.59 145.82 37.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.103 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -142.6 145.47 33.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.861 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -90.01 129.18 36.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.188 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.23 119.58 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.004 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -102.36 142.71 33.13 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.967 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.5 ' CZ2' ' HB ' ' A' ' 47' ' ' VAL . 46.0 t-105 -60.63 119.36 7.96 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.855 0.36 . . . . 0.0 110.611 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 83.08 159.53 27.54 Favored Glycine 0 C--N 1.332 0.307 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.579 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.729 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.555 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.401 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 35.0 ttm -108.19 128.19 54.49 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.59 128.67 36.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.884 0.373 . . . . 0.0 110.565 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.628 ' C ' ' HG ' ' A' ' 48' ' ' SER . 1.1 m -109.35 133.67 53.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.71 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.696 ' N ' ' OG1' ' A' ' 51' ' ' THR . 12.9 m -161.5 177.17 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.576 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.559 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 46.5 t0 -67.7 -10.2 50.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.43 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 4.6 m -118.1 -28.52 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.816 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.696 ' OG1' ' N ' ' A' ' 48' ' ' SER . 39.1 p -83.07 141.11 32.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.584 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.406 ' HG1' ' H ' ' A' ' 53' ' ' THR . 2.8 t -142.71 177.2 8.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.723 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.415 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.2 OUTLIER -96.8 160.43 29.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.649 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -77.53 83.1 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.863 2.375 . . . . 0.0 112.39 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.7 p -120.95 -1.51 9.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.25 90.96 0.15 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.72 86.85 0.04 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.04 155.62 27.04 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.699 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 17.5 t-160 -79.43 112.17 16.41 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 m -104.28 127.0 51.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.1 t -119.19 128.97 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 0.0 110.249 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.455 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.6 mm? -111.19 142.84 42.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.608 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.5 t -127.29 136.24 51.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.615 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.526 0.764 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.594 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -66.24 -40.36 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.694 0.283 . . . . 0.0 110.963 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.67 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 2.9 pp -100.52 108.71 20.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.186 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 14.7 ptmt 173.77 145.04 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.374 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -72.78 -14.06 61.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -83.0 -15.72 50.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.891 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.17 160.99 20.07 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.922 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.443 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -150.01 119.99 7.17 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.026 0.441 . . . . 0.0 109.973 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.5 131.77 43.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.074 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 43.8 t -112.94 130.32 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.015 0.436 . . . . 0.0 110.458 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.0 mt -113.01 126.47 55.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.53 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -104.45 116.49 32.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.442 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -149.09 131.4 15.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.852 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.4 t70 60.78 42.44 13.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.352 . . . . 0.0 111.241 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.2 m120 61.34 15.69 6.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.021 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -115.2 146.97 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.496 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -115.74 123.35 48.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.936 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.426 ' HB3' ' CD1' ' A' ' 141' ' ' LEU . 20.2 m-85 -106.28 137.09 44.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.682 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.99 120.22 41.68 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.035 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 71.4 m-85 -112.91 155.65 24.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.729 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -130.3 138.73 50.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.59 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.428 HD11 HG23 ' A' ' 95' ' ' ILE . 9.2 mm -63.63 121.41 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.23 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -98.55 -52.8 3.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.933 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -150.46 141.49 23.0 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.465 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.412 HD12 HG23 ' A' ' 98' ' ' ILE . 76.3 mt -121.7 130.82 74.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.835 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -153.08 -176.15 5.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 110.854 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.5 mt -128.25 131.71 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.5 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.71 169.46 17.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 110.895 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.41 148.39 45.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.985 0.421 . . . . 0.0 110.452 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.13 -19.48 64.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.629 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -88.96 11.8 17.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -84.9 88.4 7.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.375 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.601 ' O ' ' N ' ' A' ' 109' ' ' ILE . 6.9 ptp85 -60.42 -31.82 70.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.485 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.496 ' HG1' HG23 ' A' ' 108' ' ' VAL . 5.7 p -44.52 -14.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.25 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.55 ' H ' ' C ' ' A' ' 106' ' ' ARG . 4.8 t -108.12 -16.43 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.044 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.601 ' N ' ' O ' ' A' ' 106' ' ' ARG . 47.3 mm -107.51 12.16 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.048 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.699 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -79.42 -175.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.93 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -81.57 142.45 32.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.145 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.461 ' HB2' ' CG ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -116.09 130.59 56.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.949 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -78.15 16.77 0.7 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.056 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -160.23 167.14 14.42 Favored Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.771 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -73.21 101.9 1.4 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.678 2.252 . . . . 0.0 111.414 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 116' ' ' ILE . 50.6 mm -131.13 136.42 57.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.357 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.521 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 6.3 tt -108.65 119.65 40.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.358 0.599 . . . . 0.0 110.681 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.431 HG21 ' CG1' ' A' ' 108' ' ' VAL . 61.7 m -118.2 125.11 49.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.202 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.565 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 6.2 tt -112.97 124.9 53.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.388 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.467 ' N ' HD21 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -120.54 116.47 25.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.503 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.634 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.356 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.829 0.347 . . . . 0.0 110.748 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -104.16 143.98 32.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.055 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 120' ' ' THR . 2.8 t80 -69.13 124.97 25.22 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.881 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 2.6 mm -111.01 112.16 39.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.486 ' O ' ' CG2' ' A' ' 137' ' ' ILE . 0.9 OUTLIER -100.37 112.22 32.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.233 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -95.51 140.29 30.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.389 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.85 138.76 21.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.966 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -110.47 150.86 28.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.242 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 91' ' ' TYR . 5.4 tp -72.46 122.59 21.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.355 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.94 -41.06 5.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.738 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.23 175.39 20.16 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 94.3 p -155.85 160.85 40.54 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.65 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' THR . 92.9 m-85 -147.87 152.47 37.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.582 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.1 p -147.57 132.66 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.759 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.604 ' O ' ' OE1' ' A' ' 14' ' ' GLU . 54.6 mmtt . . . . . 0 C--O 1.225 -0.205 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.545 ' C ' ' OE2' ' A' ' 14' ' ' GLU . 97.6 mt-10 -107.31 123.86 48.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.377 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.577 ' N ' ' OE2' ' A' ' 14' ' ' GLU . . . 114.42 1.78 23.18 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.604 ' OE1' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -115.34 139.79 49.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.859 0.362 . . . . 0.0 110.278 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.472 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 89.0 tttt -58.67 120.74 9.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.642 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.1 m -116.23 -18.05 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.84 158.63 39.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.539 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.2 ttp -120.76 133.14 55.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.392 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -99.19 129.74 45.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.352 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.466 ' N ' HD12 ' A' ' 19' ' ' LEU . 27.4 t-20 -125.69 124.01 40.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.988 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.415 HD13 ' NE2' ' A' ' 75' ' ' GLN . 6.9 mt -105.9 109.74 63.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.855 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 81' ' ' THR . 57.2 Cg_endo -75.89 -42.92 0.36 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.577 2.185 . . . . 0.0 112.6 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HE2' ' NZ ' ' A' ' 77' ' ' LYS . 8.1 tmtm? -60.57 -40.12 90.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.253 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.474 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.7 mm? -98.53 -2.35 38.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 0.0 110.489 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 54.46 42.66 31.23 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.689 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HE3' ' CZ ' ' A' ' 28' ' ' PHE . 4.2 mtpp -124.03 163.01 22.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.093 0.473 . . . . 0.0 110.636 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -141.89 143.37 33.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.007 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.464 ' CZ ' ' HE3' ' A' ' 26' ' ' LYS . 89.4 m-85 -137.71 152.23 49.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.805 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.642 ' OG ' ' CE1' ' A' ' 31' ' ' TYR . 4.9 t -97.15 124.82 41.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.772 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.4 mm -92.56 126.2 45.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.556 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.642 ' CE1' ' OG ' ' A' ' 29' ' ' SER . 89.1 m-85 -114.16 138.47 50.4 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.957 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.49 ' CE2' HG23 ' A' ' 47' ' ' VAL . 41.5 t-105 -60.74 126.85 28.92 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.604 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 84.28 169.79 45.96 Favored Glycine 0 C--N 1.331 0.289 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.51 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.783 179.607 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.513 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 40.1 ttm -103.8 144.48 31.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.484 ' CE2' HG21 ' A' ' 109' ' ' ILE . 21.0 t80 -73.54 143.95 46.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.516 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.49 HG23 ' CE2' ' A' ' 32' ' ' TRP . 78.8 t -115.87 129.81 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.367 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.4 p -166.83 -173.92 2.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.65 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -89.28 -23.75 22.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 5.8 m -92.13 -38.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.687 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 63.6 p -78.53 153.23 31.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.556 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 t -150.24 172.09 15.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.459 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.415 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -84.91 153.92 60.68 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.701 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.44 80.65 2.69 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.546 2.164 . . . . 0.0 112.34 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.5 p -107.48 -13.39 15.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.755 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.62 88.99 0.08 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.42 80.23 0.51 Allowed Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.466 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -165.97 158.42 31.32 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.695 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 15.3 t-160 -81.75 121.73 26.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.8 m -116.17 129.48 56.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.274 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.426 HG12 ' CD1' ' A' ' 109' ' ' ILE . 58.3 t -116.35 126.1 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.221 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 62' ' ' LEU . 2.4 mm? -108.47 138.89 44.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.125 0.488 . . . . 0.0 110.529 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.3 t -121.63 138.67 54.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.876 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.531 1.037 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' A' ' 77' ' ' LYS . . . . . . . . 0 CA--C 1.523 0.557 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.415 ' NE2' HD13 ' A' ' 21' ' ' ILE . 92.5 mm-40 -68.41 -41.22 80.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.78 0.324 . . . . 0.0 110.696 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.434 HD12 ' CZ ' ' A' ' 135' ' ' TYR . 8.2 mt -93.85 89.42 6.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.491 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 74' ' ' GLY . 6.3 ptpt -176.25 145.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.427 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -69.8 -21.99 63.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.739 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -76.39 -14.63 60.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.152 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.68 154.93 39.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.789 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.402 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -137.92 133.17 33.45 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.4 mt -109.23 124.68 51.27 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.785 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.37 116.65 50.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.981 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 8.1 mp -98.54 127.04 44.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.031 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -106.54 117.3 33.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.244 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -148.23 131.95 16.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.846 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 59.32 49.33 9.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.514 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 56.91 13.28 1.43 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.049 0.452 . . . . 0.0 110.259 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -114.9 144.81 42.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.61 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -114.08 123.31 49.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.673 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 14.6 m-85 -104.38 145.14 30.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.453 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.56 114.66 28.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.315 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.479 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 78.3 m-85 -113.03 151.46 30.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.609 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -128.83 141.65 51.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.786 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.5 mm -64.38 119.2 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.362 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.17 -62.92 1.41 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.024 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -145.87 150.92 37.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.307 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.0 mt -122.62 134.35 66.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.059 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.422 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 15.8 p90 -161.87 -179.74 7.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.034 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 100' ' ' ILE . 1.3 mp -128.69 129.25 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.257 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.672 ' HG1' ' H ' ' A' ' 102' ' ' HIS . 7.6 t -127.16 173.5 9.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.006 0.432 . . . . 0.0 110.68 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.672 ' H ' ' HG1' ' A' ' 101' ' ' THR . 0.3 OUTLIER -70.79 161.55 30.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.526 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.08 -11.74 60.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.761 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -101.71 22.69 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.628 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.597 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 50.1 t0 -92.04 100.83 13.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.594 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 109' ' ' ILE . 2.7 ptt180 -79.71 -20.06 47.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.372 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.597 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 20.0 p -48.39 -16.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.615 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.405 ' N ' ' C ' ' A' ' 106' ' ' ARG . 8.8 m -109.4 -6.56 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.233 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.542 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 47.8 mm -113.44 7.76 7.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.937 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.695 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -79.52 -171.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.462 ' N ' ' HB ' ' A' ' 50' ' ' VAL . 19.5 ttpt -102.5 141.59 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.938 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.408 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 87.0 mttt -124.89 151.91 44.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.574 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -92.41 7.26 43.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.204 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -130.94 159.59 70.68 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.762 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.466 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 43.6 Cg_endo -74.58 94.88 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.978 2.452 . . . . 0.0 111.894 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.2 mm -126.41 134.77 65.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.137 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.532 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 6.1 tt -108.92 118.48 36.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.251 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 92.1 m -115.14 119.69 37.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.369 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.49 ' C ' ' CD1' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -105.86 124.97 50.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.361 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.632 ' OG1' ' NE ' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -121.57 124.37 44.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.932 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.513 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.3 t . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.305 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.8 t0 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.706 0.289 . . . . 0.0 110.396 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.632 ' NE ' ' OG1' ' A' ' 120' ' ' THR . 5.6 ptm180 -98.42 138.55 35.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.094 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 120' ' ' THR . 4.5 t80 -69.92 136.53 50.69 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.827 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.402 ' CG2' ' CZ2' ' A' ' 99' ' ' TRP . 9.3 mm -120.84 115.68 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.421 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.6 mm -106.99 107.32 22.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -94.24 140.32 29.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.197 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.75 142.92 27.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.132 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 67.2 tttt -117.44 152.78 34.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.996 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.479 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 7.2 tp -73.23 124.19 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.455 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.19 -43.65 5.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.343 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.27 -178.97 16.34 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 34.9 p -153.78 160.29 42.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.708 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 90' ' ' THR . 59.7 m-85 -149.06 156.03 41.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.535 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 64.6 p -147.26 130.94 16.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.594 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.9 pttt . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.526 179.906 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.613 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 70.6 mmtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.115 0.484 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.64 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 52.9 mp0 -90.72 151.89 21.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.387 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.79 18.11 64.27 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.613 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -121.97 133.73 54.83 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.537 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.571 ' HZ3' ' CB ' ' A' ' 29' ' ' SER . 64.4 tttp -60.08 112.03 1.74 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.344 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.5 m -114.07 -26.38 3.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.965 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -144.08 158.02 43.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.598 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.1 ttp -120.6 140.59 51.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.343 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.4 tp -108.96 125.66 52.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.577 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -121.25 133.88 55.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.0 mt -119.59 111.24 36.39 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.02 -36.94 1.74 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.735 2.29 . . . . 0.0 112.843 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -61.1 -36.83 80.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.582 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.5 mm? -103.61 -0.51 29.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.642 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.59 50.72 16.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.247 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.22 175.7 9.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.036 0.446 . . . . 0.0 110.287 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.76 157.47 31.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.707 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -144.05 159.73 42.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.826 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.571 ' CB ' ' HZ3' ' A' ' 15' ' ' LYS . 4.3 m -99.83 116.14 31.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.012 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 17' ' ' ALA . 35.3 mm -80.39 126.67 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.247 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.485 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 70.8 m-85 -111.03 137.79 48.23 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.988 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.485 ' CE2' HG21 ' A' ' 47' ' ' VAL . 41.5 t-105 -60.14 117.31 4.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.695 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.575 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 94.24 166.3 36.76 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.703 179.585 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.615 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.575 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 13.4 tpt -95.3 138.1 33.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.714 0.292 . . . . 0.0 110.713 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -77.69 137.56 38.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.982 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 32' ' ' TRP . 86.9 t -119.34 114.81 45.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.242 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.54 ' N ' ' OG1' ' A' ' 51' ' ' THR . 6.1 m -163.28 169.35 19.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.686 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.575 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 65.1 t0 -70.85 -8.84 55.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.432 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 3.2 m -110.42 -22.95 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.645 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.54 ' OG1' ' N ' ' A' ' 48' ' ' SER . 37.0 p -85.58 138.21 32.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.398 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -131.0 168.17 17.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.22 161.0 28.57 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.594 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -81.29 73.65 5.83 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.635 2.224 . . . . 0.0 112.365 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.6 p -115.76 -6.33 12.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.754 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.01 91.98 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.47 79.22 0.16 Allowed Glycine 0 CA--C 1.53 1.028 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.471 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -155.29 150.83 22.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.666 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 16.7 t-160 -77.58 104.99 8.44 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.3 m -100.19 122.43 43.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.433 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.471 ' H ' ' HE1' ' A' ' 45' ' ' MET . 54.1 t -114.77 127.44 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 0.0 110.276 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.7 mm? -112.36 147.13 37.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.684 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 120' ' ' THR . 32.6 t -128.99 142.29 50.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.619 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.531 1.076 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.464 ' OE1' ' N ' ' A' ' 75' ' ' GLN . 0.7 OUTLIER -64.37 -36.18 83.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 110.405 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.66 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 3.2 pp -136.13 112.56 9.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.324 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -179.99 144.68 0.19 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.348 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -79.52 -11.51 59.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.947 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -83.59 -13.95 53.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.898 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.683 ' OD1' ' N ' ' A' ' 81' ' ' THR . 23.4 t0 -81.06 158.04 25.21 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.215 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.683 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.6 p -138.48 135.44 35.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.7 mt -109.79 122.09 46.71 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.355 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.7 t -104.33 121.93 56.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.995 0.426 . . . . 0.0 110.263 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 8.0 mp -103.59 129.54 50.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.367 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -105.44 120.86 42.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.941 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.449 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 2.1 t80 -149.38 127.67 12.14 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.933 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 64.4 t0 54.02 52.68 12.38 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.827 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.474 ' N ' HD21 ' A' ' 88' ' ' ASN . 1.3 m-80 57.18 12.23 1.27 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.448 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 49.9 mtmt -112.72 141.63 46.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.956 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.466 ' HG1' ' HB2' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -113.65 126.08 54.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.339 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 10.5 m-85 -109.3 134.83 51.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.102 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.425 ' OG1' ' C ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -101.96 115.28 30.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.047 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -110.95 144.27 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.582 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -119.74 138.27 53.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.672 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.3 mm -66.2 115.95 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.411 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -86.63 -60.62 1.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.593 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -152.72 145.1 24.03 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.197 0.522 . . . . 0.0 110.26 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.466 HG23 ' CZ ' ' A' ' 135' ' ' TYR . 1.7 mp -119.56 131.45 72.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.541 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 26.5 p90 -149.61 -177.51 5.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.01 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.528 ' N ' ' CD1' ' A' ' 100' ' ' ILE . 0.9 OUTLIER -130.33 132.42 64.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.356 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.2 t -138.98 178.9 6.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.712 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -68.5 148.71 50.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.564 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.9 -34.31 75.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.363 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -82.8 16.69 2.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.724 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.63 90.52 5.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.571 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.682 ' O ' ' N ' ' A' ' 109' ' ' ILE . 17.0 ptp180 -63.57 -37.92 89.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.515 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.489 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 1.6 p -38.71 -18.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.522 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.655 ' N ' ' O ' ' A' ' 106' ' ' ARG . 11.1 t -111.18 -16.53 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.107 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 106' ' ' ARG . 49.3 mm -112.32 22.34 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.751 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -89.94 -163.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.837 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -102.69 148.31 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.686 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.427 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 98.1 mttt -132.9 150.46 52.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.635 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -94.94 8.98 41.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.401 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.27 163.9 46.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.767 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.471 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 50.2 Cg_endo -79.04 98.5 1.19 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.071 2.514 . . . . 0.0 111.624 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 117' ' ' LEU . 50.2 mm -128.84 138.29 54.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.439 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.541 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 6.5 tt -110.13 116.48 31.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.666 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 72.3 m -116.03 114.76 25.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.324 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.49 ' C ' ' CD1' ' A' ' 119' ' ' LEU . 0.9 OUTLIER -103.71 116.32 32.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.026 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.47 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -107.22 122.87 47.39 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.431 0.457 . . . . 0.0 110.403 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.632 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.4 t . . . . . 0 CA--C 1.513 -0.464 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.06 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.698 0.285 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 134' ' ' ARG . 7.7 ttp180 -113.07 142.46 45.7 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.809 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.486 ' CE2' HD12 ' A' ' 137' ' ' ILE . 7.9 t80 -81.9 123.28 28.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 1.6 mt -119.55 124.17 72.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 120.978 0.418 . . . . 0.0 111.959 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.486 HD12 ' CE2' ' A' ' 135' ' ' TYR . 1.4 mp -103.04 112.62 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.816 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 10.4 tt0 -90.11 142.72 27.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.868 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -152.86 149.72 28.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.822 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.451 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 66.7 tttt -123.45 153.4 40.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.451 ' N ' ' CG ' ' A' ' 140' ' ' LYS . 13.8 tp -71.7 126.6 30.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.435 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.68 -36.83 5.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.628 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.425 ' C ' ' OG1' ' A' ' 92' ' ' THR . . . -141.32 162.33 26.87 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.0 p -142.72 133.17 24.94 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.294 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.466 ' HB2' ' HG1' ' A' ' 90' ' ' THR . 62.8 m-85 -123.01 101.6 7.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.684 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.526 ' O ' ' O ' ' A' ' 147' ' ' LYS . 8.6 p -89.38 136.93 32.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.703 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.526 ' O ' ' O ' ' A' ' 146' ' ' SER . 22.0 mtpt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.554 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.556 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 27.4 ttmt . . . . . 0 N--CA 1.458 -0.038 0 CA-C-O 120.842 0.353 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -92.12 147.58 22.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.292 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.41 3.74 68.96 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.556 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.8 OUTLIER -109.7 137.5 47.41 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.878 0.371 . . . . 0.0 110.483 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -62.77 117.17 5.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.195 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.443 ' H ' HG22 ' A' ' 16' ' ' VAL . 16.1 m -116.31 -39.93 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.746 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.92 162.18 33.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.7 ttm -127.2 135.66 50.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.527 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tt -101.53 121.53 42.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.195 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 21' ' ' ILE . 3.8 t30 -116.79 136.07 53.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.419 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.504 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 3.4 mt -113.57 118.3 43.53 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.175 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.664 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.7 Cg_endo -76.55 -48.36 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.857 2.371 . . . . 0.0 112.674 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.484 ' HE3' ' HZ1' ' A' ' 77' ' ' LYS . 27.1 tptp -61.57 -39.4 91.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.1 mm? -99.49 0.68 42.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.768 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt 45.61 38.74 4.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.909 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 21' ' ' ILE . 2.9 mtpt -117.18 157.59 25.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.841 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -137.57 136.35 37.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.725 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -126.27 120.96 31.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.414 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.8 m -67.32 119.42 12.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.916 0.389 . . . . 0.0 110.646 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.495 HG22 HD13 ' A' ' 30' ' ' ILE . 40.0 mm -95.73 120.68 45.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.542 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -106.71 147.97 28.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.641 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.768 ' CZ3' ' SD ' ' A' ' 45' ' ' MET . 46.4 t-105 -60.8 117.73 5.77 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.861 0.362 . . . . 0.0 110.454 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.94 153.67 22.37 Favored Glycine 0 C--N 1.332 0.311 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HB2' ' HG ' ' A' ' 63' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.662 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.554 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.768 ' SD ' ' CZ3' ' A' ' 32' ' ' TRP . 1.5 tmt? -93.68 146.97 23.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.94 0.4 . . . . 0.0 110.965 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.562 ' O ' ' SD ' ' A' ' 45' ' ' MET . 57.8 t80 -76.72 130.29 37.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.371 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.5 t -96.62 125.96 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.429 . . . . 0.0 110.669 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.644 ' HG ' ' H ' ' A' ' 51' ' ' THR . 38.5 p -160.45 176.25 11.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.575 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.586 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 65.9 t0 -82.7 -7.14 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.542 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 9.0 m -115.45 -32.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.599 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.644 ' H ' ' HG ' ' A' ' 48' ' ' SER . 72.8 p -78.9 145.35 34.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.78 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -145.24 171.18 14.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.535 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.468 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -90.04 154.39 47.31 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.848 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HD3' ' HG1' ' A' ' 60' ' ' THR . 59.9 Cg_endo -75.78 84.25 1.8 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.689 2.259 . . . . 0.0 112.415 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -117.02 -4.49 11.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.828 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.15 88.98 0.07 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.13 91.23 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.465 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.96 165.34 38.67 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.506 ' CD2' ' HD2' ' A' ' 112' ' ' LYS . 13.2 t-160 -84.24 111.87 19.77 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.427 ' HG1' ' HD3' ' A' ' 54' ' ' PRO . 61.2 m -105.61 123.22 47.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.352 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.9 t -116.57 126.87 74.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.549 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 62' ' ' LEU . 2.5 mm? -114.16 143.97 43.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.819 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.435 ' HG ' ' HB2' ' A' ' 34' ' ' ALA . 4.9 p -132.86 147.5 52.3 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.56 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.225 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.7 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.668 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -61.49 -41.15 96.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.716 0.293 . . . . 0.0 110.792 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.612 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 3.0 pp -97.11 109.3 22.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.44 . . . . 0.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.484 ' HZ1' ' HE3' ' A' ' 23' ' ' LYS . 2.3 ptpt 172.2 143.32 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.445 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.63 -14.83 63.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.721 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -82.07 -14.32 56.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.239 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.23 158.91 34.98 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.06 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.664 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -147.67 111.05 4.91 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.235 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.0 mt -87.77 131.24 34.58 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.224 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 2.8 t -112.61 122.39 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.204 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.521 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 3.2 mm? -107.98 133.24 52.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.343 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.25 118.04 35.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.373 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.468 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 1.0 OUTLIER -146.87 125.81 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.764 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 89' ' ' LYS . 96.7 m-20 60.14 51.65 5.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.156 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 56.53 11.39 0.85 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.445 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 45.0 mtpt -112.01 145.05 40.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.612 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -113.71 117.2 30.86 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.344 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 8.6 m-85 -95.17 136.23 35.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.412 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -105.91 113.79 27.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.659 -179.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.413 ' HH ' ' HB3' ' A' ' 54' ' ' PRO . 87.7 m-85 -110.9 147.23 35.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.525 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -123.67 138.9 54.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.432 ' CD1' HG22 ' A' ' 137' ' ' ILE . 8.0 mm -65.89 118.98 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.038 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -95.94 -62.01 1.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.485 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -139.77 135.27 32.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.407 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.9 mt -114.18 127.86 71.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.205 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.473 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 21.4 p90 -151.14 -176.35 5.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.73 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.428 HG12 ' CD1' ' A' ' 135' ' ' TYR . 8.0 mt -129.34 138.85 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.46 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.463 ' HG1' ' H ' ' A' ' 102' ' ' HIS . 2.2 t -137.55 170.43 16.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.093 0.473 . . . . 0.0 110.776 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.594 ' C ' ' H ' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -73.57 154.72 39.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.555 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.55 8.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.67 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.594 ' H ' ' C ' ' A' ' 102' ' ' HIS . 57.8 t0 -131.53 36.53 3.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.556 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.445 ' H ' HH21 ' A' ' 134' ' ' ARG . 21.7 t0 -96.44 94.78 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.69 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -62.45 -35.52 79.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.463 179.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 p -44.91 -13.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.354 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.573 ' N ' ' O ' ' A' ' 106' ' ' ARG . 15.7 t -113.46 -12.67 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.116 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.578 ' N ' ' O ' ' A' ' 106' ' ' ARG . 50.9 mm -117.68 22.2 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.164 0.507 . . . . 0.0 111.064 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.765 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -87.28 -161.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.706 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -104.45 147.07 27.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.506 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 98.6 mttt -142.82 136.27 28.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.305 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.15 16.23 8.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.465 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -125.93 151.47 71.4 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.784 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.465 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 37.0 Cg_endo -72.33 80.84 1.57 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.995 2.464 . . . . 0.0 111.275 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.4 mm -115.5 132.85 63.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.287 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.537 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 5.7 tt -106.13 118.79 37.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.178 0.513 . . . . 0.0 110.739 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.445 ' CG2' ' CG1' ' A' ' 108' ' ' VAL . 90.8 m -112.78 120.88 43.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.162 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 120' ' ' THR . 0.4 OUTLIER -108.26 119.68 40.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.414 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.503 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -111.17 115.63 29.71 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.81 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 135' ' ' TYR . 3.6 p . . . . . 0 CA--C 1.513 -0.455 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 40.1 p-10 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.717 0.294 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.445 HH21 ' H ' ' A' ' 105' ' ' ASP . 29.6 ptt180 -98.76 141.83 31.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.733 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.502 ' N ' ' O ' ' A' ' 121' ' ' THR . 3.1 t80 -75.57 130.85 39.48 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.3 mm -118.96 116.98 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.195 0.521 . . . . 0.0 112.076 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.464 ' CD1' ' CD2' ' A' ' 135' ' ' TYR . 1.2 mp -106.77 110.32 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.543 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.473 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 48.4 tt0 -90.18 134.91 33.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.034 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -144.35 142.81 30.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.006 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 59.5 tttt -114.65 153.32 30.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.181 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.442 ' N ' ' CG ' ' A' ' 140' ' ' LYS . 27.8 tp -74.62 116.94 15.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.12 -33.87 10.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -154.74 158.66 28.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 38.3 p -138.42 151.62 47.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 0.0 110.384 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.4 ' N ' ' O ' ' A' ' 90' ' ' THR . 90.2 m-85 -130.04 145.08 51.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.458 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 147' ' ' LYS . 5.2 p -136.68 129.07 30.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.553 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 146' ' ' SER . 13.8 mttm . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.339 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.3 tptp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.646 0.26 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.02 141.01 55.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.94 0.4 . . . . 0.0 110.335 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.5 14.06 66.57 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -119.38 141.54 48.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.328 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -62.31 112.25 2.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.257 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.405 HG21 ' N ' ' A' ' 17' ' ' ALA . 16.5 m -112.94 -43.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.721 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.405 ' N ' HG21 ' A' ' 16' ' ' VAL . . . -129.53 162.27 28.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.76 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.434 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 50.8 ttm -125.84 143.0 51.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.51 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.1 tp -107.01 127.75 53.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.409 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.433 HD21 ' N ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -124.88 125.88 44.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.04 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 24' ' ' LEU . 4.8 mt -105.01 119.68 52.43 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.934 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 81' ' ' THR . 59.5 Cg_endo -76.66 -48.18 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.637 2.225 . . . . 0.0 112.918 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.476 ' HG2' ' HZ1' ' A' ' 77' ' ' LYS . 16.7 tptp -59.34 -43.87 92.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.985 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.603 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.7 mm? -96.93 -0.57 47.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.362 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.15 37.69 8.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.622 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -107.65 157.21 18.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.533 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -140.06 145.6 37.9 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.683 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -143.73 150.75 39.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.876 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.2 m -99.06 116.26 30.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.76 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 30' ' ' ILE . 1.7 mp -86.13 122.54 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.42 139.02 34.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.714 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.455 ' CZ3' HG22 ' A' ' 53' ' ' THR . 42.6 t-105 -60.43 127.73 33.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 110.654 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.409 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 77.64 175.28 43.32 Favored Glycine 0 C--N 1.329 0.188 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.639 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.889 179.306 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.758 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -100.91 131.35 46.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.758 ' N ' ' SD ' ' A' ' 45' ' ' MET . 1.5 t80 -65.59 132.97 50.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.682 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.431 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 1.8 p -122.47 114.97 44.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.351 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.665 ' N ' ' OG1' ' A' ' 51' ' ' THR . 16.0 p -157.96 173.13 17.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.6 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.21 -14.8 11.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.6 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 5.3 m -110.57 -38.61 3.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.784 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.665 ' OG1' ' N ' ' A' ' 48' ' ' SER . 62.5 p -77.45 140.39 39.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.606 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.481 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -144.9 167.05 23.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.245 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.455 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -85.5 157.02 58.97 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.73 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.52 83.98 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.529 2.153 . . . . 0.0 112.343 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 p -115.16 -2.92 12.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.688 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.19 91.12 0.18 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.34 81.68 0.14 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.468 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -163.38 162.19 34.67 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.607 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 20.0 t-160 -83.22 118.59 23.73 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.4 m -117.21 126.5 52.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.051 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.667 ' O ' ' SD ' ' A' ' 45' ' ' MET . 70.4 t -116.58 132.34 66.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 110.038 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 62' ' ' LEU . 2.7 mm? -112.63 135.39 53.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.724 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.8 t -117.7 132.81 56.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.603 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.955 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.311 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -139.74 -15.86 1.03 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.221 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.45 ' N ' HD21 ' A' ' 76' ' ' LEU . 2.3 mt -90.8 60.72 4.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.91 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.519 ' HE2' ' N ' ' A' ' 80' ' ' ASP . 23.3 pttm -164.29 143.66 7.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.211 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.67 -19.3 59.24 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.228 0.537 . . . . 0.0 110.164 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -71.14 -15.51 62.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.817 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.686 ' OD1' ' N ' ' A' ' 81' ' ' THR . 6.0 t0 -68.86 152.34 45.43 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.175 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.686 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -141.22 121.95 14.34 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.128 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.0 mt -99.65 117.49 34.13 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.606 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.2 t -100.47 121.89 51.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.969 0.414 . . . . 0.0 110.097 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 4.0 mm? -109.36 131.62 54.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.296 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 85' ' ' GLU . 54.9 mp0 -102.5 123.47 46.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.83 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 5.3 t80 -143.62 119.19 10.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.87 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 57.35 51.1 10.41 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.745 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 62.34 7.7 2.42 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.675 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 56.9 mtmt -107.57 142.85 36.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.808 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -113.29 123.95 51.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.688 -179.372 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.402 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 22.1 m-85 -106.69 128.66 54.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.144 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.04 115.46 29.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.219 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.471 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 86.5 m-85 -109.97 153.47 24.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.639 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -126.88 139.29 53.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.64 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.406 HG23 HD12 ' A' ' 95' ' ' ILE . 9.1 mm -61.86 119.89 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.181 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -88.53 -67.15 0.85 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.553 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -148.97 136.37 20.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.295 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.2 mp -108.04 135.12 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.149 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.427 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 15.0 p90 -160.71 -178.86 7.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.268 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.588 ' N ' ' CD1' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -126.2 132.82 70.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.316 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -136.11 175.66 9.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 110.894 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -76.31 151.21 36.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.85 -18.47 65.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.788 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -94.28 17.31 13.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.048 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.628 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 21.4 t0 -91.89 100.42 13.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.837 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.699 ' O ' ' N ' ' A' ' 109' ' ' ILE . 3.0 ptp85 -69.17 -32.57 71.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.268 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.628 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 6.3 p -37.85 -20.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.356 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' A' ' 106' ' ' ARG . 18.5 t -105.26 -19.4 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.013 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.699 ' N ' ' O ' ' A' ' 106' ' ' ARG . 45.4 mm -113.19 27.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.801 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.701 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -91.18 -168.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.425 ' N ' ' HB ' ' A' ' 50' ' ' VAL . 33.9 ttmt -97.1 147.87 23.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.577 ' HZ1' ' CG2' ' A' ' 116' ' ' ILE . 99.3 mttt -130.82 155.55 46.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 110.588 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -102.26 13.39 34.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.329 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.98 169.2 10.75 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.971 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.468 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 47.6 Cg_endo -79.66 95.4 1.04 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 123.284 2.656 . . . . 0.0 112.438 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.577 ' CG2' ' HZ1' ' A' ' 112' ' ' LYS . 49.7 mm -126.16 128.54 71.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.568 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.506 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 4.7 tt -104.52 121.01 42.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.903 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.2 m -115.65 126.64 54.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.343 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 120' ' ' THR . 2.5 tp -111.98 127.85 55.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.056 0.455 . . . . 0.0 111.671 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.501 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -122.05 129.19 52.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.039 178.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 65.7 p . . . . . 0 CA--C 1.506 -0.744 0 CA-C-O 121.244 0.545 . . . . 0.0 111.768 -179.695 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.877 0.37 . . . . 0.0 110.55 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -119.16 134.33 55.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.29 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 120' ' ' THR . 6.6 t80 -68.53 133.01 47.93 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.969 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.405 HG23 ' CZ2' ' A' ' 99' ' ' TRP . 37.8 mm -118.76 115.15 47.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.086 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.1 mm -107.96 108.53 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -91.4 146.65 23.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.02 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -153.05 142.96 22.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.428 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -115.64 150.46 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.146 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.471 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 6.5 tp -77.48 123.24 26.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.353 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.03 -40.36 5.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.826 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -136.99 164.23 25.26 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.0 p -151.1 152.44 33.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.826 0.346 . . . . 0.0 110.386 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 90' ' ' THR . 87.1 m-85 -136.44 155.04 50.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.487 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.1 p -143.27 125.62 15.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.583 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.1 tttt . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.562 -179.85 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.882 0.373 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -70.18 123.89 22.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.025 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 109.43 11.74 20.97 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -118.48 134.43 55.08 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.333 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.537 ' N ' ' CD2' ' A' ' 31' ' ' TYR . 40.3 tttm -57.97 112.69 1.58 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.352 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 m -114.2 -38.22 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.877 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.79 154.97 49.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.541 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.413 ' CE ' ' OE1' ' A' ' 85' ' ' GLU . 16.2 ttp -118.74 137.94 53.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.2 tp -106.1 119.26 38.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.145 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.57 HD21 ' N ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -118.87 127.14 53.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 111.328 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.614 ' CD1' HE22 ' A' ' 75' ' ' GLN . 4.5 mt -109.82 116.95 53.25 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.516 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.03 -45.74 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.529 2.153 . . . . 0.0 113.036 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HG2' ' NZ ' ' A' ' 77' ' ' LYS . 19.1 tptm -62.52 -38.6 90.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.2 mm? -96.4 4.62 52.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.999 0.428 . . . . 0.0 110.442 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 41.9 49.09 4.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.127 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -135.33 157.7 46.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.963 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -138.92 140.18 38.26 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.47 142.38 47.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.457 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 m -90.73 123.76 34.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.28 123.19 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.453 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.537 ' CD2' ' N ' ' A' ' 15' ' ' LYS . 42.1 m-85 -103.11 145.06 30.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.787 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.599 ' O ' ' N ' ' A' ' 13' ' ' GLY . 41.1 t-105 -59.1 130.05 45.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.974 0.416 . . . . 0.0 110.521 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 82.59 141.07 3.82 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB3' ' HG ' ' A' ' 63' ' ' SER . . . . . . . . 0 C--N 1.325 -0.476 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.925 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.495 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.692 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -93.41 125.58 38.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.692 ' N ' ' SD ' ' A' ' 45' ' ' MET . 16.7 t80 -66.84 140.87 57.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.26 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.505 HG21 ' CE2' ' A' ' 32' ' ' TRP . 54.4 t -114.58 129.46 70.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.633 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.628 ' N ' ' OG1' ' A' ' 51' ' ' THR . 11.6 t -163.21 166.42 23.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.59 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 36.8 t0 -68.94 -11.48 60.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.433 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 6.1 m -109.01 -14.55 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.528 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 48' ' ' SER . 25.5 p -85.73 149.1 25.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.554 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.521 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.8 OUTLIER -140.74 164.85 29.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.951 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.439 HG23 ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -95.38 151.93 38.98 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.216 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.89 54.23 3.99 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.757 2.305 . . . . 0.0 112.634 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.2 p -102.4 -7.69 21.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.264 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.07 81.17 0.04 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.78 103.15 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.557 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.7 160.41 34.0 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.738 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 22.1 t-160 -81.42 99.37 8.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.8 m -94.02 126.54 39.29 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.677 ' O ' ' SD ' ' A' ' 45' ' ' MET . 71.8 t -116.52 128.93 73.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.077 0.465 . . . . 0.0 110.232 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 62' ' ' LEU . 2.7 mm? -114.58 141.55 47.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.73 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.401 ' HG ' ' HB3' ' A' ' 34' ' ' ALA . 4.8 p -128.4 146.61 50.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.707 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.66 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.531 1.05 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.438 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.614 HE22 ' CD1' ' A' ' 21' ' ' ILE . 91.8 mm-40 -63.82 -39.42 94.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.688 0.28 . . . . 0.0 110.669 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.668 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 2.6 pp -91.25 102.45 15.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.39 0.614 . . . . 0.0 111.333 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.476 ' HG3' ' H ' ' A' ' 80' ' ' ASP . 20.6 pttm 176.83 152.56 0.19 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.221 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.32 -31.73 70.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.359 0.599 . . . . 0.0 110.727 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 mmtt -69.78 -14.15 62.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.501 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.67 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 1.2 t70 -82.67 152.95 25.62 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.566 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 p -138.85 149.55 45.02 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 41.1 mt -121.58 123.66 42.5 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.8 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.74 116.96 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.535 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 2.7 mm? -105.69 132.35 51.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.53 -178.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.413 ' OE1' ' CE ' ' A' ' 18' ' ' MET . 28.6 mt-10 -108.75 123.53 49.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.55 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.587 ' O ' ' N ' ' A' ' 89' ' ' LYS . 12.2 t80 -144.48 145.22 31.75 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.034 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.417 ' N ' ' CD1' ' A' ' 86' ' ' TYR . 34.8 t70 36.95 51.29 0.96 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.759 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.0 m120 59.32 25.12 13.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.961 0.41 . . . . 0.0 110.598 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 86' ' ' TYR . 54.5 mtmt -124.07 144.34 49.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.107 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.69 126.92 55.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.565 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -112.47 131.86 55.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.278 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.64 ' HG1' ' C ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -102.59 106.24 16.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.343 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.551 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 53.1 m-85 -97.08 161.49 13.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.354 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.67 ' OE1' ' O ' ' A' ' 80' ' ' ASP . 2.8 tp10 -136.85 137.23 39.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.514 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.599 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 1.9 mm -65.54 124.2 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.554 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -98.72 -62.89 1.18 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.544 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -141.14 138.9 33.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.319 0.58 . . . . 0.0 109.786 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 77' ' ' LYS . 46.6 mt -120.36 127.62 75.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.833 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.452 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 22.4 p90 -152.72 -177.59 6.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.816 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.441 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 2.4 mp -125.68 132.82 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.757 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.429 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 2.0 t -143.32 166.45 24.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -65.9 147.83 52.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.236 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.44 80.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.64 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' ARG . 46.7 t0 -63.91 -33.34 75.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.611 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.456 ' CG ' ' HG1' ' A' ' 107' ' ' THR . 14.6 t70 -40.13 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.447 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 109' ' ' ILE . 11.1 ptp85 -68.96 -26.09 64.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.531 ' O ' ' CD1' ' A' ' 110' ' ' ILE . 10.9 p -49.1 -21.93 0.83 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.587 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.8 t -97.77 -13.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.166 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.543 ' N ' ' O ' ' A' ' 106' ' ' ARG . 48.1 mm -114.83 18.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.273 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.738 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.4 OUTLIER -79.1 -156.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.889 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -107.76 148.18 29.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HG2' ' CG ' ' A' ' 59' ' ' HIS . 71.9 mmtt -125.15 141.66 51.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.906 0.384 . . . . 0.0 110.257 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.578 ' O ' ' OE2' ' A' ' 114' ' ' GLU . 51.4 mm-40 -89.62 10.78 21.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.722 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.578 ' OE2' ' O ' ' A' ' 113' ' ' GLU . 44.0 mm-40 -143.11 152.65 58.67 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.557 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 12.0 Cg_endo -62.15 84.49 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.642 2.228 . . . . 0.0 110.771 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.49 HG21 HD12 ' A' ' 116' ' ' ILE . 50.6 mm -115.65 132.11 66.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.787 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.511 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 5.5 tt -107.54 119.77 40.33 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.277 0.56 . . . . 0.0 109.923 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.448 ' OG1' ' OE1' ' A' ' 138' ' ' GLU . 73.1 m -116.15 117.44 30.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.742 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.478 HD11 ' N ' ' A' ' 120' ' ' THR . 1.0 OUTLIER -107.54 124.69 50.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.85 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.478 ' N ' HD11 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -119.03 122.74 42.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.578 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.66 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.3 t . . . . . 0 CA--C 1.513 -0.48 0 CA-C-O 121.224 0.535 . . . . 0.0 111.989 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.441 ' OD2' ' CG2' ' A' ' 100' ' ' ILE . 4.8 t0 . . . . . 0 CA--C 1.522 -0.096 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -99.02 144.11 28.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.235 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.477 ' N ' ' O ' ' A' ' 121' ' ' THR . 4.6 t80 -75.57 132.57 40.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.452 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 15.8 mm -110.88 110.94 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.49 HD11 HG22 ' A' ' 137' ' ' ILE . 51.2 mm -101.28 108.89 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.448 ' OE1' ' OG1' ' A' ' 118' ' ' THR . 3.6 tp10 -96.76 142.2 29.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.31 0.576 . . . . 0.0 111.407 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -153.54 146.98 24.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.04 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -116.57 157.47 25.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.901 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.551 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 2.6 tm? -87.77 118.41 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.119 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.721 ' HG1' ' N ' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -108.44 -65.03 1.16 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.441 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.721 ' N ' ' HG1' ' A' ' 142' ' ' THR . . . -93.16 156.9 23.04 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.0 p -152.6 152.1 31.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.518 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -142.87 132.82 24.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.411 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.3 t -121.63 131.94 54.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.998 0.428 . . . . 0.0 110.434 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.622 -179.27 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 tptm . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -64.99 130.4 43.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.914 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 95.54 21.38 24.41 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -128.45 146.35 50.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.994 0.426 . . . . 0.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -64.26 119.8 10.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.065 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 m -119.59 -46.12 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.22 169.54 14.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.457 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.7 tpp -127.75 139.72 52.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.399 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 tp -108.18 124.49 50.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.338 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 26' ' ' LYS . 21.5 t-20 -118.33 129.3 55.36 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.0 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 mt -114.73 111.87 45.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.202 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.8 -37.65 1.13 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.647 2.231 . . . . 0.0 112.993 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.808 ' NZ ' ' HZ2' ' A' ' 77' ' ' LYS . 2.1 tptm -62.33 -37.24 84.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.701 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.559 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.3 mm? -98.95 -3.34 35.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.402 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 54.62 65.8 1.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.339 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.431 ' C ' ' CG ' ' A' ' 27' ' ' LYS . 16.0 ptmt -165.72 -175.19 3.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.077 0.465 . . . . 0.0 111.26 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' CG ' ' C ' ' A' ' 26' ' ' LYS . 4.1 mtpt -155.32 155.75 34.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.292 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.417 ' CZ ' ' HE2' ' A' ' 26' ' ' LYS . 78.9 m-85 -135.82 146.48 47.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.449 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.7 m -87.18 118.45 26.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.956 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.1 mm -85.1 113.92 24.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -99.22 135.53 40.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.848 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.535 ' O ' ' N ' ' A' ' 13' ' ' GLY . 28.3 t-105 -60.62 122.18 14.06 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.015 0.436 . . . . 0.0 110.829 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 86.97 156.77 29.84 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.449 179.806 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.555 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.674 ' SD ' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -104.27 129.97 52.08 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.674 ' N ' ' SD ' ' A' ' 45' ' ' MET . 5.5 t80 -63.06 145.95 54.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.983 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.468 HG22 ' CE2' ' A' ' 32' ' ' TRP . 46.1 t -118.55 128.01 75.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.796 ' HG ' ' H ' ' A' ' 51' ' ' THR . 59.8 p -167.1 173.85 8.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.435 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.91 -6.73 53.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.768 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 3.5 m -114.1 -23.04 4.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.664 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.796 ' H ' ' HG ' ' A' ' 48' ' ' SER . 23.7 p -87.21 159.05 18.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.531 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.49 171.61 19.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.187 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.436 HG21 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -91.16 156.49 43.85 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.413 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.81 83.13 2.0 Allowed 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.687 2.258 . . . . 0.0 112.444 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.8 p -115.3 -4.72 12.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.719 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.82 89.66 0.08 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.78 87.12 0.04 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.449 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -162.32 168.47 37.31 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.493 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 16.8 t-160 -89.16 116.93 27.77 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.9 m -111.97 127.22 55.8 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.073 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.674 ' O ' ' SD ' ' A' ' 45' ' ' MET . 58.6 t -119.35 126.14 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.994 0.426 . . . . 0.0 110.787 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.445 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.3 mm? -116.23 145.78 42.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.629 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 93.7 p -137.93 154.33 49.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.825 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.751 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.616 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.658 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -28.1 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.586 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.85 91.57 3.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.018 0.437 . . . . 0.0 110.88 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.808 ' HZ2' ' NZ ' ' A' ' 23' ' ' LYS . 60.0 pttt -177.95 147.4 0.46 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.977 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.6 -18.12 61.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.921 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -77.35 -15.54 59.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.595 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.468 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 3.7 t70 -76.76 154.57 33.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.927 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.441 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.9 p -139.45 139.89 37.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.0 mt -118.67 129.75 55.46 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.755 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.62 118.29 57.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 7.6 mp -99.3 130.87 45.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.57 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -114.9 115.11 26.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.55 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -147.61 130.25 15.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.698 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 61.9 t0 64.01 40.37 7.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.668 0.27 . . . . 0.0 111.325 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 63.17 11.0 4.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.793 ' HZ2' ' HH ' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -107.64 143.18 36.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.962 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.575 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -111.66 124.8 53.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.32 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.793 ' HH ' ' HZ2' ' A' ' 89' ' ' LYS . 5.6 m-85 -113.6 137.49 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.907 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.684 ' HG1' ' CA ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -105.86 118.76 37.42 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.478 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 64.7 m-85 -113.27 161.46 17.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.983 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -141.12 140.2 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.246 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -66.92 124.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.57 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -96.11 -60.24 1.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.184 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -144.4 143.81 31.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.25 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.476 HG23 ' HH ' ' A' ' 135' ' ' TYR . 1.8 mt -117.38 133.43 64.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.483 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.45 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 18.4 p90 -153.0 -175.63 5.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.004 0.43 . . . . 0.0 111.433 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 mt -125.52 133.06 70.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.536 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.558 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 1.7 t -133.71 168.32 18.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.132 0.491 . . . . 0.0 110.906 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.524 ' CD2' ' N ' ' A' ' 102' ' ' HIS . 1.5 m170 -76.65 157.05 32.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.48 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.53 -9.23 40.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.661 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.559 ' O ' ' OD1' ' A' ' 104' ' ' ASP . 57.7 t0 -109.26 23.75 14.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.881 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.622 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 67.2 t0 -88.95 92.67 9.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.645 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 109' ' ' ILE . 12.2 ptp85 -65.27 -34.76 79.1 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.161 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.622 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 10.2 p -42.29 -17.02 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.472 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' A' ' 106' ' ' ARG . 58.9 t -102.79 -20.89 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.046 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.634 ' N ' ' O ' ' A' ' 106' ' ' ARG . 48.4 mm -110.31 21.99 5.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.992 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.594 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.0 OUTLIER -82.73 -172.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.146 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -87.27 142.52 27.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.888 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.487 ' HE2' ' CD2' ' A' ' 59' ' ' HIS . 2.5 tppt? -121.42 147.26 45.97 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.934 0.397 . . . . 0.0 110.57 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 113' ' ' GLU . 1.6 mp0 -101.47 15.72 27.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.031 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.11 171.81 6.21 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.29 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.449 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 54.7 Cg_endo -80.06 95.43 1.01 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 123.014 2.476 . . . . 0.0 111.668 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.49 HD13 HG23 ' A' ' 116' ' ' ILE . 49.2 mm -127.66 139.05 52.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.625 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.498 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 5.5 tt -112.44 120.11 40.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.35 0.595 . . . . 0.0 110.195 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.423 HG21 ' CG1' ' A' ' 108' ' ' VAL . 85.7 m -111.95 116.61 30.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.099 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.548 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 3.7 tt -108.97 122.4 47.15 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.412 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.504 ' N ' HD22 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -106.29 124.33 49.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.055 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.755 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 . . . . . 0 N--CA 1.456 -0.141 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -110.45 131.56 54.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.099 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.476 ' HH ' HG23 ' A' ' 98' ' ' ILE . 2.0 t80 -64.42 141.86 58.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.538 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.9 mm -128.4 116.71 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.3 mp -105.32 112.11 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.45 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 45.4 tt0 -93.96 139.34 31.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.9 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.52 148.77 33.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.205 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.9 tttm -122.03 148.41 44.88 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.992 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.516 ' CD2' ' C ' ' A' ' 141' ' ' LEU . 8.2 tt -73.14 115.33 12.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.162 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.8 -43.38 11.29 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.912 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.684 ' CA ' ' HG1' ' A' ' 92' ' ' THR . . . -134.9 160.51 24.31 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 62.5 p -136.23 142.74 44.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.588 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.575 ' N ' ' O ' ' A' ' 90' ' ' THR . 92.6 m-85 -130.53 154.96 47.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.464 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.55 ' O ' ' OXT' ' A' ' 147' ' ' LYS . 20.2 p -141.77 121.19 13.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.299 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.55 ' OXT' ' O ' ' A' ' 146' ' ' SER . 18.5 ttmt . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.621 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.5 tptt . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.751 0.31 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.61 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 1.0 OUTLIER -68.14 148.6 50.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.374 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.24 0.76 76.5 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -115.33 131.97 56.76 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.333 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . 60.7 tttm -57.38 125.35 22.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.064 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 m -117.06 -37.98 2.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.135 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' A' ' 86' ' ' TYR . . . -140.92 167.37 22.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.865 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.447 ' SD ' ' HA ' ' A' ' 29' ' ' SER . 4.5 tpp -121.0 147.64 45.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.452 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 18' ' ' MET . 51.1 tp -114.76 115.47 27.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.003 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.435 HD21 ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -105.24 135.94 45.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.302 179.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 25' ' ' LYS . 8.3 mt -113.34 90.67 17.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.125 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -55.5 -42.68 65.5 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 123.178 2.585 . . . . 0.0 112.746 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.451 ' HD3' ' NZ ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -60.31 -42.75 96.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.715 -178.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.614 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.8 mm? -100.41 2.65 42.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.147 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 21' ' ' ILE . 75.3 mmtt 50.34 36.02 12.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.432 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -113.6 173.09 6.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.377 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.408 ' CD ' ' OD1' ' A' ' 20' ' ' ASN . 30.9 mtmm -148.57 142.18 25.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.98 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -134.07 152.55 51.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.851 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.447 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -95.11 120.52 35.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.578 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.496 HG23 HD12 ' A' ' 30' ' ' ILE . 48.9 mm -88.76 117.29 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.236 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.443 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 87.3 m-85 -102.37 135.81 43.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.113 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.524 ' CE2' HG21 ' A' ' 47' ' ' VAL . 53.4 t-105 -59.66 125.55 24.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 74.35 173.65 30.14 Favored Glycine 0 C--N 1.331 0.266 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.57 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.642 179.617 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.628 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.432 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 2.3 ttp -97.9 129.38 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.12 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -63.73 143.28 57.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.524 HG21 ' CE2' ' A' ' 32' ' ' TRP . 55.4 t -122.85 128.55 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.77 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.664 ' N ' ' OG1' ' A' ' 51' ' ' THR . 7.3 p -164.18 168.96 18.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.507 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -64.03 -35.29 80.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 4.4 m -87.62 -25.34 6.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.802 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.664 ' OG1' ' N ' ' A' ' 48' ' ' SER . 43.5 p -77.23 140.38 40.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.737 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.682 ' HG1' ' N ' ' A' ' 59' ' ' HIS . 1.3 p -131.75 171.31 13.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.847 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.12 155.87 36.08 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.948 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.429 ' CB ' HD11 ' A' ' 84' ' ' LEU . 65.4 Cg_endo -77.77 62.89 7.97 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.723 2.282 . . . . 0.0 112.325 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.415 ' O ' ' OH ' ' A' ' 91' ' ' TYR . 86.7 p -112.63 -3.8 14.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.77 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.52 91.24 0.08 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.09 88.35 0.01 OUTLIER Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.481 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -161.04 152.32 22.91 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.682 ' N ' ' HG1' ' A' ' 52' ' ' THR . 19.8 t-160 -78.69 106.18 10.5 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.3 m -101.8 124.44 47.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.231 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.402 HG12 ' CD1' ' A' ' 109' ' ' ILE . 74.3 t -117.62 129.46 74.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.465 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 3.0 mm? -108.04 144.36 35.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.167 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.2 t -128.1 136.54 51.33 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.755 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.088 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.57 -179.913 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.885 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -66.07 -35.81 81.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.631 0.253 . . . . 0.0 111.246 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.508 ' CD2' ' OH ' ' A' ' 135' ' ' TYR . 11.3 mt -88.37 83.29 6.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.845 0.355 . . . . 0.0 111.005 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.451 ' NZ ' ' HD3' ' A' ' 23' ' ' LYS . 14.2 ptmt -177.8 134.6 0.17 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.837 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.65 -10.63 59.89 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.394 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -82.92 -14.9 53.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.064 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -64.21 155.16 32.7 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.637 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.25 140.29 47.41 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.033 0.445 . . . . 0.0 110.067 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 21.2 mt -119.8 120.58 36.92 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.485 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.403 ' CG1' HG21 ' A' ' 90' ' ' THR . 2.9 t -107.13 130.32 59.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.045 0.45 . . . . 0.0 110.492 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.429 HD11 ' CB ' ' A' ' 54' ' ' PRO . 27.1 mt -113.79 128.83 56.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.474 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -104.46 118.27 36.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.564 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.509 ' CD2' ' HB1' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -153.19 129.38 10.45 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.869 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.435 ' C ' ' N ' ' A' ' 89' ' ' LYS . 58.2 m-20 61.24 54.29 3.28 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.844 0.354 . . . . 0.0 111.338 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 51.59 15.31 0.34 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.699 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.435 ' N ' ' C ' ' A' ' 87' ' ' ASP . 20.6 mtpt -119.33 143.23 47.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.37 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.403 HG21 ' CG1' ' A' ' 83' ' ' VAL . 4.6 m -115.14 120.55 40.14 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.346 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.415 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 13.6 m-85 -99.62 136.06 40.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.177 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -108.27 119.01 38.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.218 -178.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -113.1 165.13 12.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.62 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -143.44 139.89 30.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.942 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mt -69.01 121.63 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.804 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -97.04 -42.19 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.587 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -158.25 140.08 13.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.692 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.5 mt -118.25 126.59 75.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.256 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.8 p90 -149.37 -179.23 6.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.459 HD13 ' N ' ' A' ' 100' ' ' ILE . 1.3 mp -125.21 126.89 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.047 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.7 t -129.11 173.38 10.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.711 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.487 ' ND1' ' N ' ' A' ' 102' ' ' HIS . 1.0 OUTLIER -73.16 152.73 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.649 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.82 -18.51 65.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.743 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -92.58 4.53 53.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.696 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 107' ' ' THR . 41.9 t0 -75.3 60.55 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.373 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 109' ' ' ILE . 28.1 ptt85 -38.53 -23.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.747 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 105' ' ' ASP . 65.5 p -46.5 -16.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.599 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 106' ' ' ARG . 3.9 m -106.25 -13.03 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 120.952 0.406 . . . . 0.0 110.339 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.613 ' N ' ' O ' ' A' ' 106' ' ' ARG . 41.6 mm -112.89 21.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.549 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.635 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -88.95 -163.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.862 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -104.07 140.56 37.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.632 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -131.4 140.41 49.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.566 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -87.74 11.44 15.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.058 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.93 160.33 69.05 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.845 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.481 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 39.6 Cg_endo -77.32 99.37 1.29 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.895 2.397 . . . . 0.0 111.563 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.477 HG23 HD11 ' A' ' 116' ' ' ILE . 49.8 mm -130.36 133.27 64.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.179 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.41 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 6.5 tt -107.94 117.85 35.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.249 0.547 . . . . 0.0 110.249 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 61.2 m -118.27 123.02 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.971 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.615 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 1.0 OUTLIER -109.23 131.53 54.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.93 0.395 . . . . 0.0 111.043 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 135' ' ' TYR . 0.2 OUTLIER -126.32 121.65 33.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.895 179.469 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 69.5 p . . . . . 0 CA--C 1.511 -0.531 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.586 -179.626 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.766 0.317 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 62.5 mmt-85 -103.59 136.6 43.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.508 ' OH ' ' CD2' ' A' ' 76' ' ' LEU . 5.0 t80 -68.13 130.6 43.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.674 -0.411 . . . . 0.0 109.903 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.6 mm -120.58 118.91 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.501 ' CD1' ' CD2' ' A' ' 135' ' ' TYR . 1.2 mp -108.1 109.02 26.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -91.13 140.05 30.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.906 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.13 137.3 18.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.955 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 69.2 tttt -112.54 158.53 19.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.022 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.537 ' N ' ' CG ' ' A' ' 140' ' ' LYS . 10.6 tp -77.06 122.68 25.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.449 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.25 -38.19 6.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.515 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.562 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -148.7 149.68 21.73 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.5 p -135.6 152.96 51.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.379 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -128.54 147.66 50.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.779 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.8 t -133.37 136.93 45.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 110.526 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.8 tptp . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.563 -179.665 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.405 ' HD3' ' N ' ' A' ' 12' ' ' GLU . 9.9 tmtt? . . . . . 0 CA--C 1.527 0.068 0 CA-C-O 120.806 0.336 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.669 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 1.8 mp0 -67.58 151.09 47.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.358 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.39 9.8 81.1 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -121.47 135.68 55.02 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.343 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HZ3' ' HB3' ' A' ' 29' ' ' SER . 1.3 tttp -61.86 122.83 16.39 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.948 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.427 ' H ' HG21 ' A' ' 16' ' ' VAL . 14.3 m -117.29 -40.72 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.137 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.44 165.6 27.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.648 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.1 ttp -130.45 137.25 49.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.633 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.5 tp -99.11 127.69 45.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.486 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.57 HD22 ' NZ ' ' A' ' 27' ' ' LYS . 16.7 t-20 -117.4 125.91 51.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.205 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.9 mt -103.24 108.37 58.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.445 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -75.41 -40.1 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.435 2.09 . . . . 0.0 112.392 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -60.64 -42.99 98.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.626 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.7 mm? -99.13 3.4 46.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.562 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.86 51.3 16.19 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.474 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -132.1 173.13 11.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.989 0.424 . . . . 0.0 110.974 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.57 ' NZ ' HD22 ' A' ' 20' ' ' ASN . 2.7 mtpp -143.67 152.3 41.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.203 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -146.63 130.49 17.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.939 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.446 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 13.3 m -83.01 112.77 20.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.413 ' N ' HD13 ' A' ' 30' ' ' ILE . 1.5 mp -83.14 124.75 39.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.446 ' CE1' ' O ' ' A' ' 29' ' ' SER . 83.9 m-85 -110.1 140.6 44.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.858 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -60.69 118.35 6.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.963 0.411 . . . . 0.0 110.693 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 92.85 158.56 34.41 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.51 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.887 179.713 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.554 ' SD ' ' CG2' ' A' ' 60' ' ' THR . 3.3 tpp -90.52 132.89 35.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.53 121.58 18.09 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.383 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.2 t -91.95 127.69 44.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.665 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.698 ' N ' ' OG1' ' A' ' 51' ' ' THR . 7.2 t -164.13 165.18 22.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.495 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -64.07 -34.26 77.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.675 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 2.8 m -89.58 -12.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.957 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.698 ' OG1' ' N ' ' A' ' 48' ' ' SER . 24.9 p -84.95 144.2 28.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.019 0.438 . . . . 0.0 110.866 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.489 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.7 OUTLIER -134.92 174.55 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.934 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.94 159.87 27.97 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.801 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.5 66.2 8.62 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.606 2.204 . . . . 0.0 112.522 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.1 p -112.89 -6.32 13.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.541 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.0 92.68 0.09 OUTLIER Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.545 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.5 85.01 0.04 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.499 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -156.87 155.06 26.05 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.489 ' N ' ' OG1' ' A' ' 52' ' ' THR . 19.9 t-160 -80.08 104.65 10.79 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.554 ' CG2' ' SD ' ' A' ' 45' ' ' MET . 26.0 m -101.08 122.45 43.6 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.888 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.9 t -111.91 124.81 68.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.157 0.503 . . . . 0.0 110.423 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.461 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.6 mm? -113.01 139.5 48.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.382 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.0 m -140.87 153.61 45.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.072 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.802 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.725 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.758 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -72.93 -39.52 66.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.999 0.428 . . . . 0.0 110.446 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.43 ' H ' HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -109.12 103.65 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.137 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -179.07 150.44 0.46 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -78.93 -13.37 59.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.523 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -86.87 -13.7 44.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.117 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 81' ' ' THR . 2.5 t0 -75.25 153.61 37.92 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.704 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.638 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -137.98 143.3 40.6 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.5 mt -118.3 129.89 55.71 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.927 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 2.8 t -115.46 121.6 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.547 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.408 ' N ' HD13 ' A' ' 84' ' ' LEU . 10.2 mp -101.06 133.2 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.224 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -107.98 120.7 43.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.209 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.442 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 1.5 t80 -147.23 137.3 23.19 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.083 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 50.59 42.03 26.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 0.0 111.043 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.6 m120 63.41 26.78 15.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.295 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 40.4 mttm -116.26 170.84 8.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.973 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.25 111.84 7.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.684 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.439 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 7.9 m-85 -96.27 136.92 36.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.203 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -104.86 113.12 26.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.802 0.334 . . . . 0.0 111.452 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.463 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 85.1 m-85 -110.2 151.68 27.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.554 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -128.04 140.2 52.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.408 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 mm -68.99 118.49 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.033 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -94.44 -59.23 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -144.84 140.05 28.13 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.27 0.557 . . . . 0.0 110.59 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 mp -119.67 127.93 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.78 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.457 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 23.1 p90 -144.06 -175.78 4.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.569 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.482 HG13 ' CD1' ' A' ' 135' ' ' TYR . 4.2 mp -126.32 132.45 70.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.471 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.711 ' HG1' ' CB ' ' A' ' 105' ' ' ASP . 2.3 t -134.51 165.3 25.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 110.73 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -73.95 149.42 41.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.331 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.1 -10.91 3.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.648 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -108.28 24.6 12.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.131 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.711 ' CB ' ' HG1' ' A' ' 101' ' ' THR . 20.4 t0 -90.18 102.01 14.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.944 0.402 . . . . 0.0 110.585 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -70.91 -35.91 72.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.606 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 p -42.06 -18.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.586 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 106' ' ' ARG . 4.0 t -104.68 -15.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.012 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.657 ' N ' ' O ' ' A' ' 106' ' ' ARG . 52.1 mm -114.44 20.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.187 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.658 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -82.68 -173.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -92.53 146.1 23.94 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.846 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.471 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.6 mttt -133.46 177.21 7.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.294 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -129.86 17.05 5.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.913 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -135.43 158.76 73.78 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.499 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 37.2 Cg_endo -74.59 86.65 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 123.186 2.59 . . . . 0.0 110.693 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.8 mm -121.78 133.4 68.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.1 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.532 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 6.2 tt -108.1 119.78 40.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.216 0.531 . . . . 0.0 110.335 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.2 m -114.89 117.88 31.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.394 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.558 HD11 ' N ' ' A' ' 120' ' ' THR . 5.6 tp -105.98 128.38 53.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.28 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.558 ' N ' HD11 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -113.89 114.16 25.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.284 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.414 ' OG1' ' HB3' ' A' ' 135' ' ' TYR . 1.2 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.985 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 . . . . . 0 C--O 1.232 0.148 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -123.52 119.42 29.9 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.135 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.482 ' CD1' HG13 ' A' ' 100' ' ' ILE . 4.6 t80 -69.18 137.94 53.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.961 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 6.8 mm -122.63 122.13 65.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.17 112.03 38.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 38.4 tt0 -95.59 134.06 38.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.942 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.74 145.23 34.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.18 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -117.37 145.83 43.8 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.215 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.463 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 16.9 tp -69.8 123.26 20.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.491 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.2 p -99.33 -43.66 6.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.224 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.582 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -145.89 165.9 28.0 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 35.4 p -139.55 142.28 37.19 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.708 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -124.53 143.57 50.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.3 p -133.51 127.31 32.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.442 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.4 tttp . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.724 179.779 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.79 0.328 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 59.9 mp0 -68.96 137.45 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.279 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 94.84 12.98 54.85 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -120.35 134.92 55.18 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.801 0.334 . . . . 0.0 110.498 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' NZ ' ' SD ' ' A' ' 18' ' ' MET . 88.3 tttt -57.99 120.06 7.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.349 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.14 -31.95 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.78 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.45 161.94 36.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.673 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.564 ' SD ' ' OG ' ' A' ' 29' ' ' SER . 1.0 OUTLIER -123.45 133.88 54.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.432 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.543 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 2.0 tt -104.1 122.56 45.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.622 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.401 HD21 ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -115.29 126.12 54.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.85 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.401 ' N ' HD21 ' A' ' 20' ' ' ASN . 7.9 mt -102.86 114.82 65.02 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.322 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 81' ' ' THR . 60.8 Cg_endo -77.68 -43.9 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.812 2.341 . . . . 0.0 112.527 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.464 ' CE ' ' HZ2' ' A' ' 77' ' ' LYS . 24.2 tptp -60.37 -41.72 94.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.569 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.638 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.8 mm? -98.31 0.24 45.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.812 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 49.79 42.07 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.68 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -119.96 162.65 18.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.9 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -135.38 145.06 46.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.765 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 19' ' ' LEU . 61.8 m-85 -141.0 150.45 43.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.584 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.564 ' OG ' ' SD ' ' A' ' 18' ' ' MET . 9.9 m -103.27 119.65 39.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.801 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 19' ' ' LEU . 4.6 mp -83.8 124.18 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.259 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 42.1 m-85 -107.17 135.04 49.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.989 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.499 ' O ' ' N ' ' A' ' 13' ' ' GLY . 26.2 t-105 -60.42 127.75 33.27 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.6 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.468 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 75.05 144.67 1.09 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.758 0.313 . . . . 0.0 110.685 179.881 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.637 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -96.21 127.92 42.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.747 0.308 . . . . 0.0 110.655 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.507 ' O ' ' SD ' ' A' ' 45' ' ' MET . 9.5 t80 -69.1 131.8 45.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.527 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.454 HG21 ' CE2' ' A' ' 32' ' ' TRP . 33.6 t -111.26 128.87 67.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.567 ' N ' ' OG1' ' A' ' 51' ' ' THR . 33.0 p -161.99 171.8 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.584 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 39.4 t0 -74.98 10.1 1.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.464 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 3.7 m -132.27 -15.58 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.665 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 48' ' ' SER . 2.6 p -87.8 139.7 30.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.611 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.802 ' HG1' ' N ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -131.04 169.52 15.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.633 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.64 154.71 38.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.466 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.403 ' CB ' HD11 ' A' ' 84' ' ' LEU . 59.3 Cg_endo -78.97 61.08 8.03 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.835 2.357 . . . . 0.0 112.214 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.48 ' C ' ' HH ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -107.33 -5.36 17.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.64 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.99 91.94 0.09 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.92 92.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.441 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.27 155.18 26.02 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.802 ' N ' ' HG1' ' A' ' 52' ' ' THR . 21.7 t-160 -79.59 112.59 17.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.932 0.396 . . . . 0.0 110.1 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.3 m -105.48 123.39 47.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.348 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 63.5 t -116.7 127.42 74.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.476 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.2 mm? -109.76 145.51 36.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.616 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.1 t -130.3 144.13 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.591 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.592 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.528 0.883 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.586 ' O ' ' CG ' ' A' ' 77' ' ' LYS . . . . . . . . 0 CA--C 1.526 0.722 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -71.24 -36.36 71.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.757 0.313 . . . . 0.0 110.817 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -88.85 73.69 8.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.642 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.586 ' CG ' ' O ' ' A' ' 74' ' ' GLY . 10.5 ptpt -169.38 129.86 1.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.436 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -74.75 -10.46 59.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.582 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -79.95 -16.36 55.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.361 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.686 ' OD1' ' N ' ' A' ' 81' ' ' THR . 34.5 t0 -71.38 154.38 41.61 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.586 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.686 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.6 OUTLIER -141.3 117.7 10.81 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.916 0.389 . . . . 0.0 110.803 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 51.8 mt -90.7 128.96 36.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.642 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.23 127.08 60.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.383 . . . . 0.0 110.239 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.403 HD11 ' CB ' ' A' ' 54' ' ' PRO . 33.4 mt -111.07 122.89 49.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.96 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -99.59 119.35 37.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.69 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -150.06 129.39 12.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.995 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 56.46 43.98 25.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.996 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.509 ' OD1' ' C ' ' A' ' 147' ' ' LYS . 6.3 t-20 61.82 15.4 7.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.645 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -114.99 137.13 52.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.202 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.3 OUTLIER -107.67 124.04 49.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.755 -178.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.48 ' HH ' ' C ' ' A' ' 55' ' ' SER . 63.8 m-85 -108.89 125.56 52.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.096 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.428 ' OG1' ' C ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -94.95 107.09 19.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.143 -179.383 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 141' ' ' LEU . 40.2 m-85 -95.09 156.92 16.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.577 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.5 134.1 45.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.55 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mm -65.7 114.59 3.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.246 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -83.57 -66.18 0.92 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.842 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 98' ' ' ILE . 29.1 tptp -150.36 146.91 27.01 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.506 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.509 ' O ' ' NZ ' ' A' ' 97' ' ' LYS . 5.2 mm -114.16 135.36 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.482 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 14.3 p90 -155.43 178.68 9.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.683 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 mt -127.47 128.83 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.151 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.521 ' HG1' ' H ' ' A' ' 102' ' ' HIS . 3.0 t -131.05 172.87 11.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.521 ' H ' ' HG1' ' A' ' 101' ' ' THR . 25.1 t60 -62.92 171.95 1.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.551 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.36 -20.47 28.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.555 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.55 19.32 17.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.449 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.525 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 28.9 t0 -83.17 92.4 7.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.71 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.702 ' O ' ' N ' ' A' ' 108' ' ' VAL . 36.6 ptt180 -63.52 -37.84 88.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.234 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.525 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 9.4 p -37.0 -18.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.258 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.702 ' N ' ' O ' ' A' ' 106' ' ' ARG . 10.9 t -108.86 -21.3 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.711 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.701 ' N ' ' O ' ' A' ' 106' ' ' ARG . 33.5 mm -109.71 28.13 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.774 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -93.07 -165.71 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.329 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -99.57 141.5 32.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.647 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.48 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.1 mttt -128.21 135.46 49.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.206 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -81.63 7.98 10.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.499 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.52 160.18 69.34 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.441 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 41.1 Cg_endo -74.69 101.23 1.42 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.936 2.424 . . . . 0.0 111.972 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.2 mm -131.33 135.11 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.788 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.408 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 9.4 tt -106.32 118.58 37.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.794 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.414 HG22 ' CG1' ' A' ' 108' ' ' VAL . 53.6 m -122.75 121.35 36.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.364 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.595 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 5.8 tt -109.26 124.71 51.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.015 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 135' ' ' TYR . 0.2 OUTLIER -116.51 124.54 50.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.376 178.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.592 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.7 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.848 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.798 0.332 . . . . 0.0 110.394 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -115.72 138.25 51.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.659 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.499 ' CD2' ' CD1' ' A' ' 137' ' ' ILE . 4.5 t80 -73.23 123.94 24.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.024 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.4 mm -115.8 118.67 59.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.883 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.499 ' CD1' ' CD2' ' A' ' 135' ' ' TYR . 1.2 mp -105.24 107.22 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.482 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 46.3 tt0 -88.3 134.95 33.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.308 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.84 138.96 21.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.482 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.534 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 31.6 ttpt -109.27 161.28 15.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 2.6 tm? -91.77 115.89 28.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.241 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.526 ' N ' HD21 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -110.94 -66.01 1.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.898 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.466 ' N ' ' OG1' ' A' ' 142' ' ' THR . . . -83.32 165.53 43.04 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' SER . . . . . 0.415 ' O ' ' CG ' ' A' ' 145' ' ' TYR . 12.4 p -158.15 158.08 33.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.799 0.333 . . . . 0.0 110.582 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 90' ' ' THR . 79.4 m-85 -153.99 104.8 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.523 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.5 p -98.99 122.28 42.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.637 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.509 ' C ' ' OD1' ' A' ' 88' ' ' ASN . 68.6 mttm . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.429 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 tttt . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -80.79 151.02 28.98 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.59 15.25 71.42 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -118.07 132.1 56.39 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.044 0.45 . . . . 0.0 110.456 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 61.9 tttm -58.24 106.09 0.34 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.601 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.47 HG23 ' N ' ' A' ' 17' ' ' ALA . 14.5 m -110.55 -38.81 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.47 ' N ' HG23 ' A' ' 16' ' ' VAL . . . -131.38 155.64 46.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.607 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.7 ttp -121.29 131.54 54.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.84 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.8 tp -93.95 123.67 37.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.425 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -119.5 124.3 46.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.0 mt -106.64 111.61 63.89 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.242 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.618 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.9 Cg_endo -78.9 -42.78 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 123.057 2.505 . . . . 0.0 112.615 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -63.01 -39.05 93.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.0 mm? -99.54 5.81 45.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.907 0.384 . . . . 0.0 110.522 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 44.71 56.91 4.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.42 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -141.37 158.71 43.51 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.667 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -141.26 140.46 33.9 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.612 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -133.81 155.41 49.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.5 m -95.92 118.37 32.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.442 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -95.31 123.84 47.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.243 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.485 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 52.4 m-85 -103.76 142.92 33.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.515 ' CZ2' ' HB ' ' A' ' 47' ' ' VAL . 40.9 t-105 -61.54 130.92 48.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.952 0.406 . . . . 0.0 110.659 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 84.51 171.39 48.01 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.521 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.906 179.697 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.416 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.477 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 2.8 tpp -103.14 142.88 33.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -75.97 140.27 41.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.402 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.515 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.1 p -123.37 124.3 69.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.465 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 51' ' ' THR . 21.1 t -168.76 169.67 9.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.531 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -62.99 -37.39 86.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.29 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 3.0 m -83.98 -26.6 7.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.843 0.354 . . . . 0.0 110.552 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 48' ' ' SER . 64.8 p -99.05 142.58 30.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.823 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -143.83 175.45 9.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.654 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.624 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -91.36 155.07 44.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.731 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.59 84.29 2.0 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.746 2.298 . . . . 0.0 112.431 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.3 p -115.22 -7.64 12.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.727 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.08 89.29 0.07 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.68 84.65 0.07 OUTLIER Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.477 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -166.4 158.87 32.0 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.659 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 19.1 t-160 -78.71 121.9 25.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 88.9 m -119.2 128.39 54.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.564 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.448 HG12 ' CD1' ' A' ' 109' ' ' ILE . 55.0 t -119.5 132.84 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.099 0.476 . . . . 0.0 110.238 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.462 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.8 mm? -113.18 140.56 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.625 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.9 t -118.84 136.69 53.88 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.427 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.163 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.929 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.63 -39.9 84.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 110.391 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -95.54 101.72 13.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.98 -179.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.439 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 11.2 ptpt 175.84 145.95 0.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.567 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.68 -14.61 60.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.128 0.489 . . . . 0.0 110.698 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -79.67 -15.25 57.93 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.725 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.12 154.3 29.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.762 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.618 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -141.37 115.26 9.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.418 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.2 mt -89.19 131.43 35.32 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.236 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.8 t -111.53 122.42 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.054 0.454 . . . . 0.0 109.852 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.463 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 3.4 mm? -112.67 132.47 55.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.696 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -104.7 119.54 39.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.42 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.624 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 9.1 t80 -140.49 137.3 33.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.022 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.433 ' O ' ' CG ' ' A' ' 87' ' ' ASP . 50.1 t0 50.98 41.12 26.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.158 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 65.86 16.77 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.264 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -117.82 149.77 40.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.4 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -110.96 125.85 54.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.532 -179.136 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -110.15 125.76 53.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.455 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.625 ' N ' ' O ' ' A' ' 143' ' ' GLY . 0.3 OUTLIER -97.81 108.18 20.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.697 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.571 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 62.9 m-85 -98.98 151.91 20.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.704 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -124.41 132.69 53.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.759 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 77' ' ' LYS . 1.2 mm -65.86 119.62 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.059 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -89.84 -57.79 2.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.951 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -153.35 151.48 30.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.295 0.569 . . . . 0.0 109.934 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.0 mm -122.41 132.15 71.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.25 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.467 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 11.2 p90 -150.21 178.87 8.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.192 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.9 mt -125.87 138.65 53.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.664 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.4 t -138.68 169.14 18.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.268 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.478 ' ND1' ' OD1' ' A' ' 133' ' ' ASP . 68.5 m-70 -68.86 168.23 13.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.672 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.489 ' HA ' ' HE ' ' A' ' 134' ' ' ARG . . . -76.08 -9.51 58.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -105.35 20.06 19.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.062 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.561 ' OD2' ' OG1' ' A' ' 107' ' ' THR . 24.4 t70 -87.28 95.01 9.83 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.705 0.288 . . . . 0.0 110.761 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -73.33 -20.21 60.84 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.122 0.487 . . . . 0.0 110.615 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.561 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 20.9 p -44.87 -14.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.445 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 106' ' ' ARG . 11.0 m -112.37 -12.16 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.406 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.591 ' N ' ' O ' ' A' ' 106' ' ' ARG . 49.0 mm -109.48 13.49 8.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.663 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -92.61 -170.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.83 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -95.12 155.22 16.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.446 ' HZ2' HG23 ' A' ' 116' ' ' ILE . 97.0 mttt -131.73 -174.47 3.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.871 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -125.48 10.14 7.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.132 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.75 168.13 11.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.971 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.477 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 38.1 Cg_endo -75.76 97.55 1.11 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.084 2.522 . . . . 0.0 111.929 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.446 HG23 ' HZ2' ' A' ' 112' ' ' LYS . 51.2 mm -127.6 132.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.709 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 tt -106.14 123.85 48.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.245 0.545 . . . . 0.0 109.827 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 96.7 m -115.69 126.67 54.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.458 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 120' ' ' THR . 0.6 OUTLIER -112.35 126.35 55.18 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.198 -179.398 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.503 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -122.89 117.45 25.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.078 179.239 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.9 p . . . . . 0 CA--C 1.51 -0.573 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.528 -179.218 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.478 ' OD1' ' ND1' ' A' ' 102' ' ' HIS . 95.1 m-20 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.758 0.313 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.489 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 85.7 mtm180 -98.27 142.24 30.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.29 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -72.92 132.49 43.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.34 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.7 mm -118.05 120.12 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.5 mm -105.68 111.53 35.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.747 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.458 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 39.4 tt0 -99.03 129.18 45.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.083 0.468 . . . . 0.0 110.946 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -135.46 150.63 49.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.412 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.462 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 53.4 tptt -115.75 140.99 48.68 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 2.6 tm? -80.22 117.2 20.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -108.34 -61.23 1.62 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.68 -179.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -104.72 151.99 17.38 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.7 m -150.43 148.94 29.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.952 0.406 . . . . 0.0 110.222 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 90' ' ' THR . 81.8 m-85 -132.2 156.92 45.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.404 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.9 p -137.09 125.13 22.86 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.315 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.449 ' O ' ' CD ' ' A' ' 147' ' ' LYS . 5.9 tmtt? . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.576 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.5 tptt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.917 0.389 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.489 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 56.4 mp0 -65.5 145.76 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.941 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.17 10.76 68.23 Favored Glycine 0 CA--C 1.517 0.214 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -119.47 136.15 54.44 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.079 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.91 117.9 5.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.829 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.415 HG21 ' N ' ' A' ' 17' ' ' ALA . 16.0 m -117.35 -43.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' N ' HG21 ' A' ' 16' ' ' VAL . . . -129.19 161.48 30.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.951 0.405 . . . . 0.0 110.723 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.4 ttt -125.89 131.09 52.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 51.0 tp -95.76 123.55 39.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.51 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -120.24 128.17 53.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.146 0.498 . . . . 0.0 110.687 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.404 HD11 HG23 ' A' ' 21' ' ' ILE . 2.0 mt -106.77 115.65 60.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.294 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 81' ' ' THR . 57.6 Cg_endo -77.88 -49.97 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.077 2.518 . . . . 0.0 112.526 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HG2' ' HZ3' ' A' ' 77' ' ' LYS . 1.9 tptt -63.16 -37.06 85.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.074 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.7 mm? -96.77 5.81 49.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.977 0.418 . . . . 0.0 110.377 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 24' ' ' LEU . 12.9 mttt 40.21 53.96 2.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.463 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -136.73 159.47 41.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.068 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 2.2 mtmt -137.78 154.49 49.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.944 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.423 ' CG ' ' O ' ' A' ' 27' ' ' LYS . 76.8 m-85 -154.23 150.61 28.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.949 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.0 m -99.87 119.33 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.541 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 30' ' ' ILE . 1.7 mp -93.07 122.16 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.611 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -97.89 141.14 31.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.748 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.454 ' CZ3' HG21 ' A' ' 53' ' ' THR . 48.2 t-105 -60.51 130.3 45.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.778 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.85 156.54 32.53 Favored Glycine 0 C--N 1.33 0.22 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.609 179.392 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.6 tpp -96.38 127.88 42.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -64.27 142.34 58.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.606 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.452 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.0 p -124.26 125.87 71.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.743 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.642 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.2 OUTLIER -161.8 169.86 20.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.238 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -61.35 -38.97 88.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.183 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 11.9 m -85.17 -31.79 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 48' ' ' SER . 67.3 p -82.61 155.35 24.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.633 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.19 170.85 21.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.375 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.454 HG21 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -87.77 152.93 52.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.641 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.17 83.03 1.91 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.712 2.275 . . . . 0.0 112.463 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.603 ' C ' ' HH ' ' A' ' 91' ' ' TYR . 5.0 p -117.88 -1.45 11.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.35 89.49 0.08 OUTLIER Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.02 90.2 0.02 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.5 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -165.84 163.33 36.65 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.552 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 17.2 t-160 -87.33 106.27 17.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.9 m -101.01 124.15 46.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.354 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.46 HG12 ' CD1' ' A' ' 109' ' ' ILE . 54.3 t -117.87 129.98 73.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.5 . . . . 0.0 110.081 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 118' ' ' THR . 2.2 mm? -115.18 146.46 41.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.877 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 p -138.25 150.76 47.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.81 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.879 179.632 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.651 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -67.05 -40.33 87.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.204 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.459 ' N ' HD21 ' A' ' 76' ' ' LEU . 5.9 mt -90.4 86.33 6.43 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.906 0.384 . . . . 0.0 111.186 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.529 ' HZ3' ' HG2' ' A' ' 23' ' ' LYS . 56.7 pttt -178.84 155.58 0.79 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.932 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.13 -11.75 59.72 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.206 0.527 . . . . 0.0 110.731 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -79.86 -15.48 57.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.821 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.19 157.57 29.31 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.821 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.531 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -144.22 118.3 9.46 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.128 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 93' ' ' TYR . 35.4 mt -96.03 134.96 38.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.697 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.31 126.22 74.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.437 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.504 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 4.0 mm? -112.75 134.6 54.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.537 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.94 125.1 50.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.013 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 1.0 OUTLIER -148.27 133.18 18.08 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.312 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 51.94 51.96 15.42 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.965 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 55.69 27.08 10.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.105 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.431 ' HG2' ' CB ' ' A' ' 146' ' ' SER . 39.0 mtpt -129.92 140.83 50.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.042 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.06 125.46 52.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.9 0.381 . . . . 0.0 110.379 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.603 ' HH ' ' C ' ' A' ' 55' ' ' SER . 17.0 m-85 -104.32 135.26 46.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.164 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.593 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -102.88 113.81 27.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.087 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 82' ' ' LEU . 82.8 m-85 -111.81 147.16 36.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.681 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.494 ' HG3' HE21 ' A' ' 96' ' ' GLN . 15.0 pt-20 -127.92 145.06 51.08 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.389 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.471 ' CD1' HG21 ' A' ' 137' ' ' ILE . 10.0 mm -67.04 120.39 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.318 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.494 HE21 ' HG3' ' A' ' 94' ' ' GLU . 96.3 mm-40 -94.49 -61.15 1.56 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.614 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -148.74 140.99 24.06 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.32 0.581 . . . . 0.0 110.595 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.435 HG21 ' CZ ' ' A' ' 135' ' ' TYR . 6.6 mm -117.33 136.75 53.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.026 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.459 ' C ' ' CD1' ' A' ' 99' ' ' TRP . 12.4 p90 -154.59 178.98 9.48 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.379 -0.529 . . . . 0.0 111.395 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.527 ' N ' ' CD1' ' A' ' 100' ' ' ILE . 1.2 mp -128.46 133.52 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.674 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.449 HG23 ' HE1' ' A' ' 99' ' ' TRP . 6.3 t -145.11 160.33 41.58 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.633 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -61.62 150.85 35.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.366 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.79 -4.97 2.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.669 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.548 ' C ' ' OD1' ' A' ' 104' ' ' ASP . 2.1 p30 -99.56 13.52 33.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.849 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.593 ' OD2' ' OG1' ' A' ' 107' ' ' THR . 17.7 t0 -82.71 96.72 8.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.393 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.432 ' O ' HG13 ' A' ' 110' ' ' ILE . 8.7 ptm180 -66.49 -18.4 65.34 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.589 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.593 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 15.5 p -58.56 -16.56 16.19 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.719 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.6 t -100.46 -14.44 7.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.399 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.539 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 48.4 mm -117.02 23.51 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.956 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.552 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.7 OUTLIER -83.61 -162.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.877 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -106.28 134.51 49.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.358 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -115.5 126.61 54.5 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.754 -0.378 . . . . 0.0 109.982 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 113' ' ' GLU . 56.2 mp0 -77.72 15.17 0.88 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.105 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -147.36 171.1 6.73 Favored Pre-proline 0 C--N 1.332 -0.163 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.954 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.5 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 56.7 Cg_endo -80.24 90.37 1.25 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.326 2.684 . . . . 0.0 111.949 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.22 133.54 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.725 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.563 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 5.4 tt -106.88 124.02 49.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.492 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 62' ' ' LEU . 31.8 m -119.32 126.99 52.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.362 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.543 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 5.5 tt -120.11 125.42 48.21 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.315 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.484 ' N ' HD22 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -109.66 126.6 53.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 0.0 110.319 179.065 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.4 HG23 ' CD2' ' A' ' 119' ' ' LEU . 1.2 p . . . . . 0 C--O 1.237 0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.519 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 10.1 p-10 . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 42.3 mtt85 -103.44 140.59 37.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.069 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.497 ' CD1' HG13 ' A' ' 100' ' ' ILE . 8.1 t80 -84.71 128.87 34.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.556 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 1.3 mt -123.05 128.07 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.471 HG21 ' CD1' ' A' ' 95' ' ' ILE . 1.5 mp -106.39 114.85 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.578 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.412 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 6.0 tt0 -94.43 138.0 32.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.761 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -148.57 148.03 29.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -116.1 160.43 20.35 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.866 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -77.31 123.12 26.05 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.824 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.0 p -98.78 -40.15 8.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.355 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.593 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -145.36 162.99 28.21 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.5 p -139.39 142.87 37.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.874 0.369 . . . . 0.0 110.433 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -129.73 141.22 50.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.37 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.431 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 23.2 t -137.23 141.97 42.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.184 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.0 tptp . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.465 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.822 0.344 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -68.99 151.4 46.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.179 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.35 11.25 80.84 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -118.16 135.01 54.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.4 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -59.01 118.2 5.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.217 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.438 HG23 ' H ' ' A' ' 17' ' ' ALA . 17.1 m -117.48 -34.99 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.118 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.438 ' H ' HG23 ' A' ' 16' ' ' VAL . . . -139.2 163.25 32.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.763 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.617 ' SD ' ' O ' ' A' ' 28' ' ' PHE . 7.6 tpp -121.94 142.56 50.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.527 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.6 tp -106.14 123.29 47.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.242 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -120.36 128.24 53.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.162 0.506 . . . . 0.0 111.003 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.482 HG23 ' H ' ' A' ' 24' ' ' LEU . 3.3 mt -105.88 116.76 59.21 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.213 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.615 ' CD ' ' O ' ' A' ' 81' ' ' THR . 59.3 Cg_endo -76.92 -50.09 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.79 2.327 . . . . 0.0 112.903 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -60.43 -38.85 85.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.598 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.0 mm? -100.44 3.99 43.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.875 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.7 mptt 43.22 39.31 1.94 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.622 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 21' ' ' ILE . 6.8 mmmt -115.53 150.62 36.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.434 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -131.93 147.88 52.49 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.849 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.617 ' O ' ' SD ' ' A' ' 18' ' ' MET . 85.3 m-85 -141.83 162.47 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.691 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.461 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 8.7 p -103.54 122.27 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.929 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.47 HG22 HD13 ' A' ' 30' ' ' ILE . 38.3 mm -95.37 124.51 47.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.286 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -108.11 142.51 38.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.496 ' CZ2' ' HB ' ' A' ' 47' ' ' VAL . 51.3 t-105 -65.29 132.82 50.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.849 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.549 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 76.35 159.01 8.67 Favored Glycine 0 N--CA 1.46 0.293 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.408 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.414 179.614 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.571 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.549 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 1.2 ttp -91.4 138.04 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.504 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.448 ' CD1' HG22 ' A' ' 51' ' ' THR . 3.0 t80 -76.26 143.12 41.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.954 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.496 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.0 p -130.83 120.33 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.483 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.7 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.6 OUTLIER -170.9 174.98 4.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.577 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -62.92 -38.88 92.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.513 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 2.0 m -85.12 -23.45 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.78 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.7 ' OG1' ' N ' ' A' ' 48' ' ' SER . 71.1 p -93.67 144.35 25.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.471 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 1.7 p -138.38 172.41 12.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.929 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.45 149.16 36.43 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.491 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.18 83.02 1.5 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.757 2.305 . . . . 0.0 112.647 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -127.46 -1.76 6.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.585 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.74 63.3 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.76 104.32 0.47 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.54 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -178.89 155.12 15.41 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.572 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 22.2 t-160 -78.65 103.24 8.46 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.5 m -99.11 114.97 27.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.434 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.414 HG11 ' CD1' ' A' ' 109' ' ' ILE . 48.1 t -111.26 128.36 67.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.84 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.7 mt -118.1 154.51 31.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.997 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 120' ' ' THR . 13.7 t -137.52 148.81 46.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.365 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.602 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.529 0.918 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.442 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.425 ' O ' ' HD2' ' A' ' 77' ' ' LYS . . . . . . . . 0 CA--C 1.527 0.788 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -71.93 -40.74 68.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.791 0.329 . . . . 0.0 110.797 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.438 ' CD2' ' OH ' ' A' ' 135' ' ' TYR . 16.5 mt -89.83 91.49 8.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 74' ' ' GLY . 11.1 ptmt -179.21 135.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.386 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -71.68 -12.18 61.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.618 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -81.28 -15.9 54.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.104 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.55 ' C ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -67.55 153.36 43.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.487 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.615 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -141.36 116.5 9.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.062 0.458 . . . . 0.0 110.279 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.7 mt -93.28 129.47 39.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.777 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 2.5 t -111.22 122.71 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.011 0.434 . . . . 0.0 110.361 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 3.3 mm? -109.69 136.67 48.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.43 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -102.29 123.91 46.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.179 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 89' ' ' LYS . 7.0 t80 -145.03 143.15 30.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.618 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.49 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 65.3 t0 36.85 53.05 1.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.871 0.367 . . . . 0.0 111.406 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 56.4 25.77 9.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.335 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 86' ' ' TYR . 30.8 mtpt -125.11 145.42 49.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.491 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -108.21 124.17 49.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.48 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 12.4 m-85 -105.04 131.83 52.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.097 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.591 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -101.68 113.79 27.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.467 ' CZ ' HD12 ' A' ' 141' ' ' LEU . 83.2 m-85 -110.03 152.29 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.624 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -126.32 137.77 53.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.489 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mm -67.38 119.01 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.582 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -88.27 -64.87 1.08 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.826 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -147.26 143.24 27.97 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.055 0.455 . . . . 0.0 110.349 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mp -118.46 131.52 70.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -154.17 -174.55 5.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.5 mt -132.05 132.24 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.193 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.613 ' HG1' ' H ' ' A' ' 102' ' ' HIS . 5.0 t -131.92 174.49 10.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.613 ' H ' ' HG1' ' A' ' 101' ' ' THR . 16.9 t-80 -75.74 153.06 37.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.84 -25.54 68.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.608 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -85.87 10.2 14.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.556 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -82.09 90.6 6.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.396 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.536 ' C ' ' H ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -68.8 -21.62 64.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.29 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.5 p -48.51 -11.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.384 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.536 ' H ' ' C ' ' A' ' 106' ' ' ARG . 45.7 t -111.54 -11.03 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.035 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.534 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 50.1 mm -111.9 10.14 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.015 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.705 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -80.78 -165.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.722 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -97.13 158.94 15.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.052 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.476 ' HG3' ' CD2' ' A' ' 59' ' ' HIS . 66.9 mmtt -126.37 -168.02 1.8 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.263 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.442 ' C ' ' CG ' ' A' ' 114' ' ' GLU . 4.9 mm-40 -138.34 16.5 2.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.425 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.443 ' CB ' ' HD2' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -162.23 169.62 9.05 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.523 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.54 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 32.7 Cg_endo -70.06 90.21 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.174 2.583 . . . . 0.0 111.829 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.2 mm -122.27 133.09 69.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.029 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.1 tt -108.38 123.69 49.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.734 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.44 HG21 ' CG1' ' A' ' 108' ' ' VAL . 94.5 m -122.68 128.4 50.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.38 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.487 HD21 ' N ' ' A' ' 120' ' ' THR . 5.1 tt -111.61 127.18 55.66 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.953 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.487 ' N ' HD21 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -121.52 108.83 14.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.262 0.553 . . . . 0.0 110.524 179.323 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.602 ' OG1' ' O ' ' A' ' 64' ' ' GLY . 1.2 t . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.101 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.626 0.25 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -114.1 140.75 48.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.672 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.502 ' CD2' HD11 ' A' ' 137' ' ' ILE . 3.8 t80 -74.73 128.29 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 136' ' ' ILE . 18.4 mm -112.81 117.62 55.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.761 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.502 HD11 ' CD2' ' A' ' 135' ' ' TYR . 15.9 mm -107.45 107.09 21.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -92.79 133.22 36.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.135 0.493 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.1 145.42 30.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 50.7 tttm -117.31 152.53 34.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.467 HD12 ' CZ ' ' A' ' 93' ' ' TYR . 11.0 tp -78.68 122.26 25.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.075 0.464 . . . . 0.0 110.35 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.27 -41.75 5.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.841 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.591 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -136.23 156.88 23.22 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 82.2 p -138.51 151.02 46.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.805 0.336 . . . . 0.0 110.597 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' THR . 94.4 m-85 -134.54 151.16 50.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.607 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 60.3 p -140.96 134.13 29.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.555 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.4 mttt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.51 -179.92 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.898 0.38 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.48 124.93 24.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.936 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 113.15 -8.44 25.01 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -94.52 133.46 38.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.888 0.375 . . . . 0.0 110.26 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 89.0 tttt -57.93 122.04 12.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.323 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.29 -34.69 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.976 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.18 156.68 45.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.514 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.2 ttp -120.97 140.42 51.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.311 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 20' ' ' ASN . 22.4 tp -105.84 129.45 54.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.62 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.691 HD22 ' HZ2' ' A' ' 27' ' ' LYS . 57.1 t-20 -121.52 133.62 55.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.993 0.425 . . . . 0.0 110.815 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.501 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 3.5 mt -114.69 112.62 45.32 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.527 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.418 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 56.8 Cg_endo -77.16 -42.91 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.579 2.186 . . . . 0.0 112.412 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.77 ' HZ1' ' HZ2' ' A' ' 77' ' ' LYS . 19.9 tptm -62.26 -38.44 89.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.803 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.606 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.9 mm? -101.74 4.04 40.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.945 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 22' ' ' PRO . 7.0 mptt 43.85 48.75 7.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.562 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -134.25 152.16 51.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.931 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.691 ' HZ2' HD22 ' A' ' 20' ' ' ASN . 8.6 mttp -130.43 143.04 50.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.675 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -130.88 145.66 52.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.743 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.3 p -95.06 113.83 25.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.644 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.501 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.2 mp -89.26 124.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.386 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 86.1 m-85 -106.06 149.66 26.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' A' ' 13' ' ' GLY . 24.0 t-105 -59.18 132.7 54.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.967 0.413 . . . . 0.0 110.824 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 75.04 162.41 9.83 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.592 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.277 179.237 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.614 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.492 ' CE ' ' H ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -94.99 140.04 30.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.684 0.278 . . . . 0.0 110.321 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -66.95 136.09 54.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.475 HG23 ' CE2' ' A' ' 32' ' ' TRP . 77.8 t -115.63 116.17 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.467 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.589 ' OG ' ' OG1' ' A' ' 51' ' ' THR . 50.1 p -161.88 166.74 25.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.549 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 42.0 t0 -66.75 -2.68 5.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.52 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 3.0 m -118.96 -30.06 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.81 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.589 ' OG1' ' OG ' ' A' ' 48' ' ' SER . 27.8 p -80.47 142.72 33.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.736 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 59' ' ' HIS . 1.1 t -146.82 167.8 23.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.293 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.678 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -89.87 158.99 44.0 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.979 0.418 . . . . 0.0 110.601 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.84 83.16 1.83 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.755 2.303 . . . . 0.0 112.367 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.6 p -112.38 -3.78 14.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.679 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.83 91.9 0.24 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.18 77.44 0.28 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.16 162.94 32.6 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.681 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 18.6 t-160 -82.91 116.96 22.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.9 m -111.31 124.39 52.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.299 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.492 ' H ' ' CE ' ' A' ' 45' ' ' MET . 97.6 t -118.01 129.08 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.006 0.431 . . . . 0.0 110.354 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.457 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.3 mm? -110.48 139.27 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.3 t -121.93 134.16 54.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.05 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.832 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.63 -42.11 95.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.754 0.311 . . . . 0.0 110.957 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.647 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 2.7 pp -92.18 101.73 14.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.988 0.423 . . . . 0.0 111.017 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.77 ' HZ2' ' HZ1' ' A' ' 23' ' ' LYS . 8.6 ptpt 170.96 135.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.472 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -67.57 -15.39 63.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.269 0.557 . . . . 0.0 110.536 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -80.62 -14.94 57.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.871 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -79.96 157.24 26.9 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.9 p -137.57 147.17 44.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.1 mt -122.76 126.6 47.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.917 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 2.7 t -112.55 124.76 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.997 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 3.7 mm? -110.73 137.78 47.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.44 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -106.72 115.72 30.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.332 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.678 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 16.4 t80 -142.16 124.92 15.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.863 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.9 t70 61.19 44.24 10.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.733 0.302 . . . . 0.0 111.256 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 64.19 7.87 3.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.51 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -108.69 145.87 34.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.37 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -111.48 120.71 43.06 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.481 -179.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.419 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 7.4 m-85 -98.98 143.3 29.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.372 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.87 110.61 21.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.843 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 82.9 m-85 -108.49 155.77 20.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.641 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -132.35 140.67 48.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.68 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mm -67.81 120.26 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.341 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.26 -65.03 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -144.53 137.88 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.309 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.89 130.93 65.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.015 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 19.2 p90 -152.83 -177.29 6.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.51 HG12 ' CD1' ' A' ' 135' ' ' TYR . 54.8 mt -125.72 132.74 70.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.253 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 t -133.7 166.62 22.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.928 0.395 . . . . 0.0 110.874 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -68.62 158.42 34.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.588 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.21 -15.59 62.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.697 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -97.47 8.49 44.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.697 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.4 87.7 4.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.986 0.422 . . . . 0.0 110.322 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 109' ' ' ILE . 10.9 ptp85 -65.63 -32.28 73.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.368 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.46 ' HG1' HG23 ' A' ' 108' ' ' VAL . 6.9 p -42.94 -17.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.375 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 106' ' ' ARG . 48.4 t -106.42 -16.78 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.002 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.627 ' N ' ' O ' ' A' ' 106' ' ' ARG . 45.4 mm -110.08 20.19 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.163 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.711 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -86.92 -165.36 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.941 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -97.02 151.37 19.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HZ1' HG21 ' A' ' 116' ' ' ILE . 98.4 mttt -135.99 134.99 39.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.571 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -83.7 14.21 4.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.084 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.15 159.61 70.25 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.992 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.93 92.9 1.09 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 123.126 2.551 . . . . 0.0 112.031 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.478 HG21 ' HZ1' ' A' ' 112' ' ' LYS . 50.4 mm -124.73 137.34 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.189 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.473 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 6.8 tt -109.78 118.0 35.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.203 0.525 . . . . 0.0 110.436 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 68.3 m -114.16 123.0 48.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.825 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.552 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 4.0 tt -107.79 120.77 43.18 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.558 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.513 ' N ' HD21 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -115.87 114.68 25.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.154 0.502 . . . . 0.0 110.523 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.631 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.172 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.562 ' OD1' ' O ' ' A' ' 133' ' ' ASP . 27.3 p30 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.657 0.265 . . . . 0.0 110.486 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -100.89 139.43 36.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.951 0.405 . . . . 0.0 110.341 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.51 ' CD1' HG12 ' A' ' 100' ' ' ILE . 1.9 t80 -76.42 136.22 39.44 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.172 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.9 mm -122.55 113.54 38.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.696 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -107.18 112.88 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.422 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 44.7 tt0 -93.63 139.81 30.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.508 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.58 148.77 31.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.974 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.1 tttm -119.12 152.22 36.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.384 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 18.0 tp -77.45 119.21 20.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.25 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.2 p -95.43 -41.55 8.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.673 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -144.78 179.93 21.6 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.1 p -154.03 161.42 41.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.731 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 90' ' ' THR . 94.5 m-85 -144.03 159.37 42.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.773 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.8 p -144.57 128.17 17.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.654 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.3 tttp . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.967 -1.015 . . . . 0.0 110.579 179.92 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.133 0.492 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.433 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 58.3 mp0 -69.24 142.18 54.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.341 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.57 15.8 63.13 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -119.61 137.01 54.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.014 0.435 . . . . 0.0 110.375 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HZ1' ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -62.05 106.81 0.77 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.46 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.9 m -109.81 -40.53 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.971 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.09 164.56 27.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.695 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.429 ' HB2' ' HZ1' ' A' ' 15' ' ' LYS . 3.0 ttt -131.75 128.21 38.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.635 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 tt -98.11 116.79 31.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.069 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.487 ' ND2' ' HE3' ' A' ' 27' ' ' LYS . 48.5 t-20 -110.76 137.33 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.022 0.439 . . . . 0.0 111.235 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.3 mt -116.67 115.87 39.03 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.286 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.94 -39.0 0.69 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.677 2.251 . . . . 0.0 112.847 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -64.1 -35.62 81.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.007 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.4 mm? -101.9 7.14 41.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 40.78 59.35 2.21 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.131 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.429 ' HD3' ' CE2' ' A' ' 28' ' ' PHE . 15.3 ptpt -150.33 166.52 29.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.668 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.487 ' HE3' ' ND2' ' A' ' 20' ' ' ASN . 27.6 mtpt -139.82 146.49 39.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.144 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.429 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 49.4 m-85 -132.13 138.68 48.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.717 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 p -89.57 112.24 23.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.544 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.9 mm -84.09 120.72 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.395 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -100.69 140.37 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.024 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.49 ' CE2' HG21 ' A' ' 47' ' ' VAL . 58.6 t-105 -59.46 132.1 52.96 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.276 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 76.55 140.2 1.03 Allowed Glycine 0 N--CA 1.463 0.445 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.602 ' CB ' ' HG ' ' A' ' 63' ' ' SER . . . . . . . . 0 N--CA 1.448 -0.538 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.857 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.588 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.52 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 2.4 tpp -87.93 145.65 25.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.705 0.288 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.472 ' CD1' HG22 ' A' ' 51' ' ' THR . 2.4 t80 -77.13 139.13 39.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.49 HG21 ' CE2' ' A' ' 32' ' ' TRP . 94.2 t -117.24 120.76 65.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.401 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.751 ' HG ' ' H ' ' A' ' 50' ' ' VAL . 4.9 p -170.64 176.3 4.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.54 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.98 -18.76 61.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.751 ' H ' ' HG ' ' A' ' 48' ' ' SER . 2.3 m -107.9 -21.28 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.9 0.381 . . . . 0.0 110.843 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 48' ' ' SER . 17.3 p -89.49 127.95 35.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.288 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 59' ' ' HIS . 1.3 t -136.02 166.83 22.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.64 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.4 OUTLIER -86.56 157.75 55.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.684 -179.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.87 80.68 2.89 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.589 2.193 . . . . 0.0 112.528 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.4 p -113.02 -5.33 13.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.946 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.46 91.48 0.1 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.69 91.36 0.01 OUTLIER Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.491 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -170.25 162.43 35.65 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.66 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 17.0 t-160 -83.35 117.19 22.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.6 m -112.77 108.02 16.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.4 t -106.24 129.03 60.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 110.011 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.45 HD21 ' SD ' ' A' ' 45' ' ' MET . 27.1 mt -120.53 158.63 26.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.939 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.602 ' HG ' ' CB ' ' A' ' 34' ' ' ALA . 7.8 p -139.0 150.58 46.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.261 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -78.72 -41.91 29.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.832 0.348 . . . . 0.0 111.035 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.425 ' CD2' ' OH ' ' A' ' 135' ' ' TYR . 20.8 mt -89.83 80.92 6.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.085 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.443 ' HB3' ' HZ3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -172.69 142.38 1.18 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.462 179.587 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -77.83 -16.5 58.27 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.596 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -79.2 -15.19 58.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.143 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.423 ' OD1' ' C ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -70.57 153.67 42.65 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 p -136.08 142.42 44.33 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.044 0.45 . . . . 0.0 110.002 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.1 mt -119.12 123.54 44.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.878 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.12 124.73 63.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.35 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 3.4 mm? -110.39 129.61 55.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.377 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -101.0 124.25 46.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.216 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.64 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 1.8 t80 -149.8 130.37 13.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.992 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 55.46 43.29 28.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.136 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 65.27 8.17 4.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.458 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 52.1 mtmt -107.02 150.98 25.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.383 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.29 121.97 42.64 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.798 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -104.12 130.53 51.84 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.522 ' H ' ' HG1' ' A' ' 92' ' ' THR . 0.2 OUTLIER -99.75 114.98 28.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.13 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.434 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 81.7 m-85 -110.69 155.49 22.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.725 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -130.73 140.13 50.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.156 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.38 119.69 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.203 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.68 -64.1 1.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.885 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -146.98 133.01 19.21 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.172 0.51 . . . . 0.0 110.452 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.474 HG21 ' CZ ' ' A' ' 135' ' ' TYR . 1.6 mp -111.04 131.13 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.608 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.402 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 18.9 p90 -153.72 -178.16 6.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.092 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.42 HG12 ' CD1' ' A' ' 135' ' ' TYR . 2.7 mt -127.13 134.08 66.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.258 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.9 t -146.06 172.49 13.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.91 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -61.77 156.48 20.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.48 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.5 -25.97 59.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.831 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -89.46 2.17 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.565 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -65.36 90.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.526 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 109' ' ' ILE . 22.9 ptt85 -56.11 -35.91 67.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.51 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.5 p -40.64 -17.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.536 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 106' ' ' ARG . 6.5 t -110.61 -15.58 9.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.005 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.654 ' N ' ' O ' ' A' ' 106' ' ' ARG . 48.2 mm -113.74 21.91 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.036 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.731 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -88.19 -169.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.858 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -94.03 147.44 23.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.4 mttt -133.22 147.95 52.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.449 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -97.58 11.66 36.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.847 0.356 . . . . 0.0 110.067 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -133.66 159.48 72.34 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.73 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.491 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 46.7 Cg_endo -76.02 89.79 1.21 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.043 2.495 . . . . 0.0 111.959 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.46 134.99 63.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.437 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.2 tt -109.34 120.85 43.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.653 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.411 HG21 ' CG1' ' A' ' 108' ' ' VAL . 71.7 m -116.36 119.78 36.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.109 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.574 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -110.67 114.65 28.2 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.462 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.527 ' N ' HD21 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -106.63 127.86 53.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.462 . . . . 0.0 110.762 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.4 p . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 121.129 0.49 . . . . 0.0 111.56 -179.818 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.164 0 CA-C-O 120.699 0.285 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 134' ' ' ARG . 0.0 OUTLIER -126.4 137.96 53.49 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 110.95 -179.62 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.474 ' CZ ' HG21 ' A' ' 98' ' ' ILE . 5.2 t80 -79.57 126.39 30.82 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 1.1 mt -122.02 126.51 74.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-O 121.218 0.532 . . . . 0.0 111.943 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.423 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp -108.17 112.76 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.287 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -95.4 136.65 35.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.548 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.87 153.53 47.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.546 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 8.4 tptt -116.55 146.72 42.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.948 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.546 ' H ' ' HD2' ' A' ' 140' ' ' LYS . 16.4 tp -69.69 124.09 23.08 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.107 0.479 . . . . 0.0 110.109 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.734 ' HG1' ' N ' ' A' ' 143' ' ' GLY . 4.9 p -99.04 -47.94 5.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.629 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.734 ' N ' ' HG1' ' A' ' 142' ' ' THR . . . -141.97 172.05 24.26 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.2 p -144.9 134.76 23.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.614 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -122.93 146.29 47.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.196 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 97.9 p -134.14 123.99 25.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.485 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.419 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.0 tptt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.732 0.301 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -58.22 135.87 57.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.073 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.39 2.68 61.77 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -115.32 140.45 49.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.793 0.33 . . . . 0.0 110.512 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -63.1 121.52 13.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.216 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.55 -39.47 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.96 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.3 156.95 43.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.628 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ttm -119.68 141.77 49.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.161 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.0 tp -108.4 121.81 45.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.644 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -118.38 127.8 54.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.902 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.477 HG23 ' H ' ' A' ' 24' ' ' LEU . 6.0 mt -104.56 115.53 62.62 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.389 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.62 ' CD ' ' O ' ' A' ' 81' ' ' THR . 56.9 Cg_endo -77.11 -45.78 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.846 2.364 . . . . 0.0 112.52 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.3 -40.25 89.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.489 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.607 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.9 mm? -102.56 8.97 39.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.562 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 40.42 40.21 0.83 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.519 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.07 157.91 20.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.519 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -138.71 139.89 38.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.584 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -137.06 159.09 42.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.855 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 m -101.99 122.38 43.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.001 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.441 HG21 HD12 ' A' ' 30' ' ' ILE . 39.4 mm -94.08 118.71 40.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.319 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -101.16 136.76 40.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.323 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.574 ' CZ3' ' SD ' ' A' ' 45' ' ' MET . 55.8 t-105 -60.41 133.05 55.72 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.616 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.556 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 77.62 163.98 21.63 Favored Glycine 0 C--N 1.331 0.258 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.868 179.26 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.582 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.673 ' SD ' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -95.46 134.45 38.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.627 0.251 . . . . 0.0 110.325 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.673 ' O ' ' SD ' ' A' ' 45' ' ' MET . 18.6 t80 -75.43 139.45 42.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.535 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.47 HG23 ' CE2' ' A' ' 32' ' ' TRP . 40.2 t -111.02 124.58 67.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.962 0.41 . . . . 0.0 110.433 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.538 ' OG ' ' CE2' ' A' ' 46' ' ' PHE . 18.8 m -160.92 165.38 30.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.604 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -69.0 -24.22 64.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.704 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.465 ' O ' ' HB3' ' A' ' 111' ' ' LYS . 4.6 m -94.18 -40.52 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.161 0.505 . . . . 0.0 110.742 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.464 ' H ' HG21 ' A' ' 50' ' ' VAL . 81.7 p -76.18 155.56 34.44 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.716 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -148.97 171.6 16.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.606 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.41 156.75 53.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.754 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -80.03 83.46 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.581 2.188 . . . . 0.0 112.445 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.0 p -113.85 -9.47 13.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.569 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.73 90.41 0.08 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.85 85.75 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.501 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.22 160.64 34.37 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.702 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 13.6 t-160 -83.65 116.66 22.74 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.7 m -111.81 127.19 55.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.234 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.651 ' H ' ' CE ' ' A' ' 45' ' ' MET . 54.6 t -117.29 129.75 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.354 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.452 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 1.9 mm? -112.7 145.49 40.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.632 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 120' ' ' THR . 47.2 t -126.73 144.12 51.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.086 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.47 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.527 0.834 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.531 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -40.35 94.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.918 0.39 . . . . 0.0 110.165 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.33 111.4 17.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.409 ' HZ2' ' HB3' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -174.23 141.12 0.71 Allowed 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -77.84 -12.36 59.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.052 0.454 . . . . 0.0 110.507 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -84.95 -15.51 44.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.137 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -69.5 152.76 44.45 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.62 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -142.04 115.01 8.7 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.304 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 93' ' ' TYR . 67.2 mt -90.47 132.21 35.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.629 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 2.1 t -109.85 115.54 49.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.994 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.486 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 6.0 mp -94.98 123.47 38.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.196 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -99.73 117.61 34.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.374 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -149.6 133.26 16.8 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.936 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 56.23 43.67 26.21 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.321 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.5 9.31 2.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.337 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -107.44 150.21 27.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.518 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -118.03 123.85 46.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.709 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 15.4 m-85 -107.31 132.63 52.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.271 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.18 112.37 24.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 111.634 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.468 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 75.6 m-85 -109.85 147.58 33.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.775 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.645 ' OE2' ' NE2' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -124.71 139.83 53.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 179.682 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.583 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 1.3 mm -63.5 117.13 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.286 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.645 ' NE2' ' OE2' ' A' ' 94' ' ' GLU . 55.9 mm-40 -84.27 -67.97 0.75 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.844 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -145.83 139.66 26.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.109 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.4 mt -112.81 127.78 69.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.61 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.45 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 25.8 p90 -150.89 -177.98 6.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.777 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 100' ' ' ILE . 3.6 mp -127.25 131.52 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.641 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.6 t -132.31 165.95 23.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.673 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -70.6 153.8 42.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.408 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.56 -13.32 61.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.697 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -92.67 8.02 40.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.76 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.599 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 68.1 t0 -85.98 89.91 7.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.581 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 108' ' ' VAL . 11.5 ptm180 -70.15 -24.19 63.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.429 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.599 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 12.9 p -49.56 -12.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.357 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.49 ' H ' ' C ' ' A' ' 106' ' ' ARG . 43.9 t -111.02 -8.77 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.992 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.569 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 29.9 mm -111.91 7.03 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 0.0 111.022 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.702 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -79.03 -161.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.629 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 14.1 ptpt -109.89 155.25 21.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.784 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.445 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.3 mttt -138.54 144.06 39.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.451 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -85.74 10.88 12.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.999 0.428 . . . . 0.0 110.051 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.04 156.72 73.89 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.135 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.501 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 51.4 Cg_endo -76.89 88.48 1.39 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.975 2.45 . . . . 0.0 111.609 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.4 mm -124.07 131.43 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.916 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.552 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 5.3 tt -105.28 122.41 45.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.201 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.8 m -118.99 126.08 50.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.134 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 120' ' ' THR . 3.2 tt -107.7 124.55 50.17 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.599 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.513 ' N ' HD22 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -120.99 113.97 20.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.448 0.642 . . . . 0.0 110.719 179.04 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 64' ' ' GLY . 1.7 t . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.229 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.861 0.362 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -105.26 136.23 45.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.556 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.463 ' CD2' HD13 ' A' ' 137' ' ' ILE . 3.6 t80 -74.58 130.68 40.01 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.78 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.3 mm -115.21 117.22 54.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.936 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.472 ' CG2' ' CD1' ' A' ' 95' ' ' ILE . 12.8 mm -107.04 109.97 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.45 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 41.8 tt0 -92.06 137.0 32.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.054 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -138.65 149.03 44.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.199 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.489 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 26.6 tptt -123.44 142.1 51.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.489 ' H ' ' HD2' ' A' ' 140' ' ' LYS . 21.3 tp -69.5 122.88 19.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.382 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.4 p -99.06 -46.82 5.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.734 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -142.04 -177.67 17.37 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.9 p -151.05 152.4 33.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.945 0.403 . . . . 0.0 110.713 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 90' ' ' THR . 90.5 m-85 -140.02 149.56 43.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.427 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.1 p -139.18 119.39 13.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.334 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.8 tttm . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.484 -179.835 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.985 0.421 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -78.6 154.35 30.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.88 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 76.7 18.79 78.62 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -125.75 147.6 49.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 120.835 0.35 . . . . 0.0 110.548 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -63.21 119.52 9.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.236 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.421 HG21 ' N ' ' A' ' 32' ' ' TRP . 4.6 m -119.64 -20.94 4.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.226 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.19 161.38 42.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.709 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.5 ttt -116.51 141.23 48.45 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.627 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 tp -109.81 121.86 46.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.567 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -117.76 129.67 55.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.706 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.3 mt -113.84 109.17 50.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.2 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -77.92 -41.72 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.679 2.253 . . . . 0.0 113.208 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.6 tptp -58.78 -43.98 90.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.175 -178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.502 ' N ' HD21 ' A' ' 24' ' ' LEU . 1.4 mm? -101.24 2.93 40.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.022 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 mttt 50.4 56.75 7.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.953 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -134.44 155.23 50.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.788 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.04 138.86 42.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.772 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -137.92 157.8 45.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.762 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 t -99.86 134.03 43.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.831 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.4 mm -99.24 127.28 52.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.331 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -106.37 139.51 40.74 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.222 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.502 ' O ' ' N ' ' A' ' 13' ' ' GLY . 41.6 t-105 -70.29 131.78 44.69 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 71.57 173.24 17.1 Favored Glycine 0 C--O 1.23 -0.122 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.836 179.408 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.55 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.449 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 30.6 ttm -90.92 128.64 36.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -70.97 132.48 45.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.494 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 p -115.46 109.88 29.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.171 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 t -150.5 172.06 16.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.471 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -63.49 -37.62 88.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.537 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 51' ' ' THR . 13.0 m -83.92 -38.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.898 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.481 ' H ' HG23 ' A' ' 50' ' ' VAL . 30.6 p -85.89 158.08 20.02 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.459 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 t -160.08 173.56 15.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.6 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.52 158.46 60.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.736 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -82.65 83.62 1.95 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.501 2.134 . . . . 0.0 112.654 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 p -119.7 -5.65 10.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.735 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.24 87.4 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.6 96.49 0.02 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.528 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -172.65 150.74 12.96 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.626 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 22.3 t-160 -76.4 102.47 5.97 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -96.36 125.1 40.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.013 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.468 HG12 ' CD1' ' A' ' 109' ' ' ILE . 55.2 t -117.75 130.54 72.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.042 0.449 . . . . 0.0 109.975 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 62' ' ' LEU . 2.1 mm? -114.18 139.65 49.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.16 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.8 t -112.89 134.11 54.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.846 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 120' ' ' THR . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.461 ' HA2' ' HZ3' ' A' ' 77' ' ' LYS . . . . . . . . 0 CA--C 1.525 0.662 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.624 ' OE1' ' N ' ' A' ' 75' ' ' GLN . 0.1 OUTLIER -69.99 -42.52 72.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.462 -179.264 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.662 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 2.9 pp -92.56 108.64 20.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.21 0.529 . . . . 0.0 110.88 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.574 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 16.6 ptpt 177.15 150.38 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.284 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -80.02 -12.4 59.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.497 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -87.98 -14.84 38.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.572 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.512 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 3.5 t70 -66.96 153.3 43.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.862 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.486 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.3 p -141.49 135.7 30.48 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.147 0.499 . . . . 0.0 109.69 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.2 mt -114.42 128.1 56.17 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.714 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.77 121.47 59.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.954 0.407 . . . . 0.0 110.249 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.525 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 6.1 mp -105.1 121.59 44.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.208 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -101.71 113.7 27.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.108 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -147.86 132.76 18.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.843 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 t0 60.35 40.39 17.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.833 0.349 . . . . 0.0 111.404 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 63.71 11.13 5.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.178 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.673 ' NZ ' ' OH ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -110.61 149.66 30.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.566 179.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -115.18 113.31 23.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.747 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.673 ' OH ' ' NZ ' ' A' ' 89' ' ' LYS . 9.4 m-85 -100.77 129.01 46.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.551 ' N ' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -100.86 119.95 39.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.045 0.45 . . . . 0.0 111.637 -178.154 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -111.55 158.16 19.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.248 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -133.79 139.69 46.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.262 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.574 ' CG2' ' O ' ' A' ' 77' ' ' LYS . 7.0 mm -67.64 120.72 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.13 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.458 ' NE2' ' HB2' ' A' ' 140' ' ' LYS . 44.5 mt-30 -90.89 -62.68 1.4 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.613 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -148.98 143.35 26.07 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.143 0.497 . . . . 0.0 110.247 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.8 mm -117.67 129.72 73.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.792 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.424 ' CZ2' HG22 ' A' ' 136' ' ' ILE . 19.7 p90 -150.35 -176.71 5.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.031 0.443 . . . . 0.0 111.352 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.04 132.63 70.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.4 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.594 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 3.1 t -131.84 171.32 13.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.839 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.502 ' CD2' ' OD1' ' A' ' 133' ' ' ASP . 26.7 m170 -72.97 162.1 29.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.728 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.13 -11.37 60.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.62 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -104.14 16.6 25.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.621 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 31.6 t0 -86.31 101.42 13.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 110.377 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 109' ' ' ILE . 33.7 ptt180 -72.62 -21.32 61.13 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.799 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.621 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 21.3 p -45.73 -20.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.884 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.411 ' N ' ' C ' ' A' ' 106' ' ' ARG . 10.6 m -101.42 -17.2 6.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.047 0.451 . . . . 0.0 110.291 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.613 ' N ' ' O ' ' A' ' 106' ' ' ARG . 47.8 mm -109.89 23.36 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.626 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -89.01 -162.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.428 ' H ' ' HB ' ' A' ' 110' ' ' ILE . 7.7 ttmm -111.46 143.15 42.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.724 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -131.07 145.39 52.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.575 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -87.48 12.62 11.83 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.109 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.75 165.72 26.33 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.966 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.528 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 52.6 Cg_endo -78.87 98.52 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.854 2.369 . . . . 0.0 111.605 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.446 HG22 HD11 ' A' ' 116' ' ' ILE . 50.3 mm -126.02 131.66 71.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.331 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.6 tt -102.4 121.3 42.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.368 0.604 . . . . 0.0 110.203 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.8 m -117.52 106.18 12.88 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.491 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.539 ' C ' ' CD1' ' A' ' 119' ' ' LEU . 0.1 OUTLIER -100.85 127.41 47.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.046 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.481 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -119.69 137.35 53.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.451 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.046 -179.756 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.502 ' OD1' ' CD2' ' A' ' 102' ' ' HIS . 78.0 m-20 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.757 0.313 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -117.36 133.11 56.35 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 120' ' ' THR . 2.8 t80 -70.12 135.41 49.15 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.2 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.508 HD13 HG23 ' A' ' 136' ' ' ILE . 43.5 mm -121.84 116.03 48.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.455 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.4 mm -101.76 108.42 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -97.65 138.36 35.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.107 0.479 . . . . 0.0 111.1 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.45 28.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.862 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.536 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 28.2 ttpt -121.97 157.59 30.95 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.024 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.536 ' N ' ' CG ' ' A' ' 140' ' ' LYS . 3.9 tt -81.67 122.09 27.19 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.64 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.47 ' N ' HD21 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -98.47 -40.37 8.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.709 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -150.76 155.13 26.01 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.14 158.19 45.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 111.277 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' THR . 95.2 m-85 -135.07 146.47 48.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.688 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.577 ' O ' ' O ' ' A' ' 147' ' ' LYS . 96.2 p -129.57 114.37 15.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.19 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.577 ' O ' ' O ' ' A' ' 146' ' ' SER . 55.0 tttt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.592 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.694 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER . . . . . 0 CA--C 1.526 0.053 0 CA-C-O 120.83 0.348 . . . . 0.0 110.565 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 54.1 mp0 -86.61 147.01 26.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.83 18.69 55.86 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.694 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 1.0 OUTLIER -123.65 131.13 53.54 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.842 0.354 . . . . 0.0 110.449 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.585 ' N ' ' CD2' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.4 100.97 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.023 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.0 m -100.34 -30.49 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.092 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.4 158.34 43.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.723 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.9 ttm -119.47 139.61 51.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.448 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 tp -105.53 113.84 27.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.475 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -107.13 126.04 51.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.245 0.545 . . . . 0.0 110.726 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.417 ' N ' ' O ' ' A' ' 26' ' ' LYS . 10.3 mt -103.95 114.08 64.82 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.138 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.511 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.4 Cg_endo -77.33 -47.51 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.984 2.456 . . . . 0.0 112.871 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -59.47 -40.51 87.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.574 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.617 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.8 mm? -98.43 -3.57 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.582 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 52.87 39.77 29.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.972 0.415 . . . . 0.0 110.642 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -119.83 152.44 37.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.832 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -128.96 142.31 50.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.853 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -135.67 150.41 49.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.801 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.1 m -98.96 115.78 29.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.583 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.48 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.3 mp -93.14 127.03 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.63 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 15' ' ' LYS . 33.6 m-85 -107.55 143.1 36.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.869 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.494 ' CD1' ' HG3' ' A' ' 12' ' ' GLU . 47.3 t-105 -61.84 127.29 30.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.736 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 89.1 168.21 43.59 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.915 179.499 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.766 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -104.27 139.25 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.72 0.295 . . . . 0.0 110.587 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.766 ' N ' ' SD ' ' A' ' 45' ' ' MET . 40.5 t80 -76.7 120.59 22.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.127 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.461 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.2 p -97.53 120.37 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.661 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.21 166.53 32.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.414 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.51 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 41.0 t0 -64.07 -33.98 77.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.548 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.499 HG22 ' H ' ' A' ' 51' ' ' THR . 4.1 m -84.82 -41.62 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 110.863 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.499 ' H ' HG22 ' A' ' 50' ' ' VAL . 44.2 p -77.5 161.47 27.9 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.724 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.508 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -156.22 169.75 23.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.905 0.383 . . . . 0.0 110.587 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.89 153.86 49.73 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.587 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.23 85.56 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.874 2.383 . . . . 0.0 112.314 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -118.95 4.41 11.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.62 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.94 89.95 0.26 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.5 85.58 0.05 OUTLIER Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.44 161.91 35.31 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.714 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 12.3 t-160 -81.36 121.03 25.7 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.2 m -114.9 122.9 47.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.188 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.467 ' H ' ' HE3' ' A' ' 45' ' ' MET . 39.9 t -115.98 128.61 73.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.338 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 1.9 mm? -113.82 145.64 41.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.232 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.7 t -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.647 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.651 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.868 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -70.06 -39.44 75.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.935 0.398 . . . . 0.0 110.792 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.439 ' N ' HD21 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -101.44 98.02 8.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.772 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.509 ' HZ3' ' HB2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 178.01 148.71 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.116 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -78.13 -13.83 59.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.54 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.509 ' HB2' ' HZ3' ' A' ' 77' ' ' LYS . 52.2 mtpt -83.17 -15.69 49.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.414 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.55 153.16 41.44 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.652 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.511 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -141.95 121.53 13.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.088 0.471 . . . . 0.0 109.8 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.2 mt -98.39 133.34 42.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.545 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 t -111.92 122.62 66.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.927 0.394 . . . . 0.0 110.25 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.443 ' N ' ' CD1' ' A' ' 84' ' ' LEU . 8.5 mp -102.33 124.45 47.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.105 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -101.22 115.22 29.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.093 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.632 ' O ' ' N ' ' A' ' 89' ' ' LYS . 5.6 t80 -144.55 143.07 30.64 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.812 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 89' ' ' LYS . 38.9 t70 38.05 52.64 1.57 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.738 0.304 . . . . 0.0 111.407 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 58.1 9.87 1.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.395 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.632 ' N ' ' O ' ' A' ' 86' ' ' TYR . 53.4 mtmt -104.57 143.72 32.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.55 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.85 122.56 44.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.844 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -109.88 127.95 55.04 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.533 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -96.47 109.25 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.393 -179.65 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 52.9 m-85 -99.06 155.15 17.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.991 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -131.38 130.02 42.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.194 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.526 ' CD1' ' CG2' ' A' ' 137' ' ' ILE . 4.9 mm -61.11 119.32 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.648 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -89.79 -65.8 0.98 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.757 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -147.16 138.15 23.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.454 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.497 HG21 ' CZ ' ' A' ' 135' ' ' TYR . 1.3 mp -113.62 133.27 60.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.404 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 18.6 p90 -153.48 -178.68 7.16 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.929 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 100' ' ' ILE . 1.8 mp -125.27 129.67 73.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.491 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.8 t -128.85 172.94 10.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.673 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -73.9 153.41 39.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.69 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 105' ' ' ASP . . . -61.95 -34.51 76.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.524 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -78.98 18.75 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.677 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.617 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 9.9 t70 -89.22 99.09 12.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.326 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.475 ' O ' ' CG2' ' A' ' 110' ' ' ILE . 23.1 ptt85 -80.15 -19.42 47.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.779 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.617 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 6.8 p -48.1 -18.25 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.957 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.1 m -110.52 -9.35 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.287 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.512 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 39.2 mm -104.95 1.33 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.033 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.714 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -77.72 -167.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.464 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 12.6 ptmt -99.88 151.66 21.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.774 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.528 ' H ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -125.45 134.94 51.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.303 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -78.31 6.96 7.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.221 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.09 164.16 33.4 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -71.41 96.17 0.72 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.192 2.595 . . . . 0.0 112.155 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.9 mm -128.98 133.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.46 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.562 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 5.7 tt -106.69 120.36 41.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.161 0.505 . . . . 0.0 110.316 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 91.1 m -118.34 119.09 33.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.158 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.521 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 5.6 tt -105.73 127.81 53.31 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.609 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.499 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -120.83 117.76 28.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.817 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.651 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.7 t . . . . . 0 CA--C 1.514 -0.423 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.729 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.737 0.303 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.448 ' HD3' ' HG1' ' A' ' 120' ' ' THR . 4.9 ttt180 -117.22 132.87 56.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.922 0.391 . . . . 0.0 110.411 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.497 ' CZ ' HG21 ' A' ' 98' ' ' ILE . 5.3 t80 -75.79 125.96 30.08 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.915 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.2 mm -112.91 118.59 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.91 0.386 . . . . 0.0 111.94 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.705 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 1.3 mp -110.42 107.04 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -90.98 136.58 32.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.382 0.611 . . . . 0.0 111.344 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.2 36.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.911 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.534 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 50.9 tptt -111.69 139.85 46.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.352 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.549 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 2.2 tm? -75.5 114.87 14.55 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.707 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.615 ' HG1' ' H ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -97.74 -65.39 0.97 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.273 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.615 ' H ' ' HG1' ' A' ' 142' ' ' THR . . . -101.41 151.19 18.66 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.257 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 89.9 p -137.35 126.91 25.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.93 0.395 . . . . 0.0 110.428 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -118.74 146.48 44.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.677 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.2 p -133.94 130.1 37.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.574 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.609 -179.962 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.607 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 12.5 tmtt? . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.839 0.352 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.467 ' OE2' ' NE1' ' A' ' 32' ' ' TRP . 9.0 mp0 -81.38 109.28 15.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.141 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 129.05 24.69 1.04 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.607 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -127.29 131.8 50.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.801 0.334 . . . . 0.0 110.458 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 96.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.986 0.422 . . . . 0.0 110.285 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 m -100.71 -38.31 6.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.921 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.95 157.85 45.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 32.0 ttm -125.35 136.16 53.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.441 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 tt -101.72 119.05 38.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.19 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -111.89 137.73 49.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.367 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -119.26 112.96 35.59 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.892 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.477 ' O ' ' CD ' ' A' ' 25' ' ' LYS . 56.3 Cg_endo -75.16 -40.26 0.91 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.882 2.388 . . . . 0.0 112.929 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HE3' ' HZ1' ' A' ' 77' ' ' LYS . 4.5 tmtt? -65.06 -37.57 88.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.716 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.7 mm? -96.24 3.02 53.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.738 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.536 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER 45.69 57.12 5.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.433 ' HD3' ' CE2' ' A' ' 28' ' ' PHE . 18.1 ptpt -157.26 173.91 16.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.969 0.414 . . . . 0.0 110.629 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.01 158.09 43.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.619 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.433 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 87.7 m-85 -133.37 154.22 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.738 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.1 m -95.21 112.48 24.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.835 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.546 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.2 mp -93.79 122.04 44.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.425 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -102.71 146.1 28.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TRP . . . . . 0.469 ' O ' ' N ' ' A' ' 13' ' ' GLY . 51.6 t-105 -62.56 125.08 22.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.557 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.67 142.98 4.58 Favored Glycine 0 N--CA 1.46 0.291 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.376 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.623 179.791 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.574 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 2.1 ttp -98.74 129.09 45.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 109' ' ' ILE . 19.3 t80 -65.12 131.12 45.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.393 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.467 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.0 p -113.7 124.18 70.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.667 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.744 ' HG ' ' H ' ' A' ' 49' ' ' ASP . 36.3 t -158.02 174.31 15.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.563 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.744 ' H ' ' HG ' ' A' ' 48' ' ' SER . 44.1 t0 -67.65 -13.75 62.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.602 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 3.5 m -111.17 -14.1 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.892 0.377 . . . . 0.0 110.556 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.65 ' OG1' ' N ' ' A' ' 48' ' ' SER . 29.3 p -104.32 141.22 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -142.18 167.48 22.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.473 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.415 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -83.11 162.65 53.81 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.917 -179.515 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -82.58 83.08 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.681 2.254 . . . . 0.0 112.437 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.459 ' HA ' ' HH ' ' A' ' 91' ' ' TYR . 0.9 OUTLIER -117.77 7.71 12.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.654 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.16 87.28 0.36 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.76 92.64 0.04 OUTLIER Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.526 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -170.25 160.09 32.78 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.707 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 19.2 t-160 -82.61 114.2 20.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.6 m -111.47 120.87 43.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.253 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.407 ' O ' ' HG2' ' A' ' 45' ' ' MET . 65.2 t -114.6 125.66 71.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 109.806 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.551 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.7 mm? -108.55 143.26 37.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.567 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.3 t -126.87 138.28 53.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.712 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.53 1.014 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.626 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -87.17 -43.42 12.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 110.68 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.654 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 2.6 pp -108.47 103.99 13.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 111.218 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . 0.497 ' HG3' ' H ' ' A' ' 80' ' ' ASP . 2.3 ptmt 177.91 137.02 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.246 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.31 -17.62 62.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.058 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -79.49 -13.94 59.23 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.367 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.657 ' OD1' ' N ' ' A' ' 81' ' ' THR . 1.0 OUTLIER -70.65 155.35 40.85 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.935 -179.609 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.657 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -142.64 119.16 10.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.025 0.441 . . . . 0.0 109.981 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.9 mt -95.66 129.05 42.98 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.837 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.43 118.1 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.033 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.458 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 4.1 mm? -105.45 135.36 46.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.458 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -106.48 123.73 48.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.946 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 21.9 t80 -143.4 131.03 21.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.261 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.419 ' HB2' ' CD1' ' A' ' 86' ' ' TYR . 8.6 t0 49.45 49.02 20.54 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.315 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 97.7 m-20 63.43 11.27 5.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.471 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 44.3 mtmt -109.94 145.24 37.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.987 0.423 . . . . 0.0 110.288 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.33 123.64 50.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.909 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.459 ' HH ' ' HA ' ' A' ' 55' ' ' SER . 26.6 m-85 -104.48 132.87 50.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.295 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.97 111.1 23.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.164 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TYR . . . . . 0.471 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 80.4 m-85 -109.6 150.36 28.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.48 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -131.18 140.38 49.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.827 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.446 HD12 ' CG2' ' A' ' 137' ' ' ILE . 14.4 mm -60.76 122.23 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.557 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -104.02 -50.48 3.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.859 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 15.3 tptm -154.27 132.51 11.86 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.192 0.52 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 76' ' ' LEU . 71.9 mt -122.04 132.84 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.475 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 30.2 p90 -153.73 -176.06 5.66 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.797 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.501 ' N ' ' CD1' ' A' ' 100' ' ' ILE . 1.8 mp -127.75 129.61 70.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.604 ' HG1' ' H ' ' A' ' 102' ' ' HIS . 9.4 t -134.39 -171.12 2.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.694 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' HIS . . . . . 0.604 ' H ' ' HG1' ' A' ' 101' ' ' THR . 93.2 m-70 -78.31 153.89 31.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.14 -30.8 71.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.609 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -88.63 14.22 10.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.731 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.608 ' OD2' ' OG1' ' A' ' 107' ' ' THR . 3.8 t70 -75.58 94.34 3.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.039 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.728 ' O ' ' N ' ' A' ' 109' ' ' ILE . 30.6 ptt-85 -64.78 -34.28 77.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.664 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.608 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 3.1 p -35.63 -25.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.93 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.582 ' N ' ' O ' ' A' ' 106' ' ' ARG . 28.6 m -98.15 -24.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 110.801 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.728 ' N ' ' O ' ' A' ' 106' ' ' ARG . 8.1 mm -104.89 27.34 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.637 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.707 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.8 OUTLIER -90.85 -162.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.408 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -107.39 137.9 44.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.769 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.498 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.2 mttt -126.36 143.4 51.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.18 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.6 ' N ' ' OE2' ' A' ' 114' ' ' GLU . 15.0 mt-10 -90.97 11.4 22.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.569 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.6 ' OE2' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -136.7 168.68 15.91 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 110.589 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PRO . . . . . 0.526 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 51.7 Cg_endo -78.44 90.46 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.164 2.576 . . . . 0.0 112.251 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.493 HG21 ' HZ3' ' A' ' 112' ' ' LYS . 50.8 mm -122.57 129.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.757 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.535 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 6.5 tt -104.08 122.26 44.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.71 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.6 m -114.27 113.61 24.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.13 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.529 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 1.8 tt -104.27 116.23 31.8 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.699 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.486 ' N ' HD22 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -112.52 129.29 56.4 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.42 0.45 . . . . 0.0 110.196 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' A' ' 64' ' ' GLY . 71.4 p . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.397 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.82 0.343 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -123.53 134.61 53.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.209 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.488 ' CD1' HG13 ' A' ' 100' ' ' ILE . 4.2 t80 -87.43 125.14 34.1 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -122.16 128.52 75.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.016 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.446 ' CG2' HD12 ' A' ' 95' ' ' ILE . 7.2 mm -106.87 111.76 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.036 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 97' ' ' LYS . 67.5 tt0 -94.27 138.48 32.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.507 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -148.75 149.02 30.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.655 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -114.43 152.66 31.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.188 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' LEU . . . . . 0.471 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 11.2 tp -77.07 115.61 17.01 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.702 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.63 -42.18 12.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.123 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -142.73 171.6 24.74 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 56.4 p -147.08 151.39 36.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 110.41 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -136.58 160.75 37.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.688 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.588 ' O ' ' C ' ' A' ' 147' ' ' LYS . 7.9 p -150.74 125.56 9.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.45 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.588 ' C ' ' O ' ' A' ' 146' ' ' SER . 17.4 tttm . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.471 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.9 p -108.94 9.48 26.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.684 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -54.73 -39.22 68.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.698 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.3 mtp -79.01 141.12 37.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.567 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.3 m -130.15 155.02 46.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.446 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.1 t -125.48 139.75 53.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.636 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.53 ' C ' ' OG1' ' A' ' 8' ' ' THR . 65.2 tt0 -151.73 93.6 1.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.594 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.53 ' OG1' ' C ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER 172.93 -37.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.56 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.679 ' OE1' ' CE1' ' A' ' 10' ' ' HIS . 9.2 mm-40 -97.84 153.41 18.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.486 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.679 ' CE1' ' OE1' ' A' ' 9' ' ' GLU . 1.2 p-80 -48.39 109.97 0.29 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.616 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -134.37 143.24 47.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.443 ' HG3' ' CD1' ' A' ' 32' ' ' TRP . 2.3 mp0 -59.85 137.87 57.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.356 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.29 9.17 70.34 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -115.49 141.25 48.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.839 0.352 . . . . 0.0 110.429 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 84.3 tttt -67.82 113.6 5.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.228 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.3 m -111.8 -37.22 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.028 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -141.36 158.33 44.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.665 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 44.9 ttp -118.05 138.42 52.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.415 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.42 121.9 43.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.077 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -122.46 135.29 54.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.119 0.485 . . . . 0.0 111.07 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.489 HG21 ' H ' ' A' ' 24' ' ' LEU . 3.8 mt -110.82 118.01 49.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.291 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -75.58 -48.5 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.832 2.355 . . . . 0.0 112.728 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -60.21 -44.93 94.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.627 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.8 mm? -96.53 3.03 52.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.618 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.41 38.96 1.95 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.719 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.445 ' HA ' ' HZ3' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -112.22 145.06 40.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.356 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.37 144.06 50.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -140.23 141.88 35.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.661 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 p -86.68 121.21 28.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.712 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.559 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.1 mp -103.63 120.66 54.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.549 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 32.2 m-85 -106.2 150.31 25.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.727 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.443 ' CD1' ' HG3' ' A' ' 12' ' ' GLU . 33.2 t-105 -60.12 128.63 37.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.696 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.29 160.51 12.3 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.28 86.12 2.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.586 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -78.37 113.44 16.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.894 0.378 . . . . 0.0 110.592 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 67.2 t0 -84.46 -16.56 42.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.528 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.82 92.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.469 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.734 ' HG1' ' H ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -109.68 140.31 43.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.605 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.629 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 2.8 mm? -93.58 13.04 23.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.542 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.734 ' H ' ' HG1' ' A' ' 38' ' ' THR . 61.1 mttp -55.4 -58.4 7.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.044 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -79.86 169.21 18.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.691 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.47 -53.07 0.57 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.49 131.21 73.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.166 0.507 . . . . 0.0 110.724 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.78 155.65 21.71 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.766 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -96.57 134.82 39.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.728 0.299 . . . . 0.0 110.576 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.766 ' N ' ' SD ' ' A' ' 45' ' ' MET . 1.9 t80 -64.02 132.55 50.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.712 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.416 ' H ' HG11 ' A' ' 47' ' ' VAL . 2.2 p -121.56 120.24 61.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.558 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.594 ' OG ' ' OG1' ' A' ' 51' ' ' THR . 43.2 p -160.69 169.66 22.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.498 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.554 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 47.8 t0 -62.45 -10.67 12.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.625 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 3.5 m -112.11 -34.25 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.71 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.594 ' OG1' ' OG ' ' A' ' 48' ' ' SER . 65.7 p -85.14 138.27 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.582 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.3 t -139.83 174.23 10.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.565 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.38 158.28 46.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.38 83.69 1.98 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.664 2.243 . . . . 0.0 112.694 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.9 p -118.83 -2.1 10.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.79 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.21 86.2 0.06 OUTLIER Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.59 101.55 0.01 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.513 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -178.42 165.32 34.52 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.713 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 16.2 t-160 -83.7 110.21 18.11 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.4 m -105.82 120.9 42.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.844 0.354 . . . . 0.0 110.426 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.453 HG11 ' CD1' ' A' ' 109' ' ' ILE . 61.9 t -117.7 131.56 70.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.195 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.506 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.8 mm? -111.25 139.44 46.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.596 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 t -122.59 129.4 51.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.733 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.639 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -154.59 176.49 32.35 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -126.29 159.89 31.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.783 0.325 . . . . 0.0 110.717 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.445 ' NH1' HG22 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -105.42 127.99 53.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.423 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -108.95 -66.27 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.714 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 69' ' ' VAL . 0.4 OUTLIER -129.83 177.15 7.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.597 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.445 HG22 ' NH1' ' A' ' 66' ' ' ARG . 53.0 t -110.25 127.79 66.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.281 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -143.07 -67.94 0.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.529 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 19.5 p -113.38 20.49 16.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.438 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.645 ' OD1' ' N ' ' A' ' 73' ' ' LEU . 41.8 p-10 -58.21 -28.4 64.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.397 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.645 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 10.3 tt -62.9 -39.64 95.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.865 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.24 -20.08 55.74 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -68.83 -44.09 74.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.697 0.284 . . . . 0.0 110.656 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 72' ' ' ASP . 5.3 mt -90.82 92.95 9.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.952 0.406 . . . . 0.0 110.352 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.482 ' HG3' ' H ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -174.73 147.67 1.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.06 -11.72 60.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.755 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.482 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 3.8 mtpt -84.13 -15.61 46.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.382 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.66 157.28 28.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.8 p -137.02 149.87 47.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.969 0.414 . . . . 0.0 109.992 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.9 mt -118.8 120.07 36.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.224 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 14.9 t -102.76 124.57 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.949 0.404 . . . . 0.0 110.642 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.512 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 3.2 mm? -113.0 133.16 55.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.127 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -106.09 119.33 38.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.542 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.431 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 1.1 t80 -143.2 127.05 17.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.266 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 57.08 44.32 22.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.854 0.359 . . . . 0.0 111.194 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 64.32 15.62 9.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.486 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 6.4 mtmp? -116.4 140.85 48.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.185 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.65 124.46 50.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 15.8 m-85 -104.06 129.68 51.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 117.75 35.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 111.127 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.459 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 89.7 m-85 -112.34 163.83 13.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.593 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -139.04 133.86 32.21 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.824 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.409 ' HB ' ' O ' ' A' ' 77' ' ' LYS . 0.9 OUTLIER -65.52 123.78 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.201 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -99.89 -47.93 4.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.996 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -153.32 139.28 18.16 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.099 0.476 . . . . 0.0 110.532 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mt -116.51 130.58 71.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.539 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.475 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 20.0 p90 -151.62 -175.88 5.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.471 HG12 ' CD1' ' A' ' 135' ' ' TYR . 6.9 mt -129.31 135.21 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.498 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.501 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 6.5 t -134.86 171.23 14.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.675 ' ND1' ' O ' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -73.77 158.11 35.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.459 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.462 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . . . -69.53 -11.44 60.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.701 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.554 ' C ' ' OD1' ' A' ' 104' ' ' ASP . 12.4 p30 -100.82 15.51 28.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.694 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.501 ' OD2' ' OG1' ' A' ' 101' ' ' THR . 39.8 t0 -79.15 94.28 5.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.973 0.416 . . . . 0.0 110.594 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 110' ' ' ILE . 52.3 ptt85 -74.82 -20.51 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.524 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.563 ' O ' ' CD1' ' A' ' 110' ' ' ILE . 5.9 p -60.08 -26.28 66.06 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.313 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.82 -4.83 10.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.571 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 42.5 mm -118.78 14.05 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.03 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.713 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.7 OUTLIER -79.61 -160.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.71 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.1 ttmt -99.24 149.64 22.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.378 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.475 ' N ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -129.73 126.24 37.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -76.6 7.65 4.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.028 0.442 . . . . 0.0 110.117 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.14 164.08 43.14 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.542 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.513 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 44.6 Cg_endo -76.33 87.81 1.4 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.961 2.44 . . . . 0.0 111.888 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.5 mm -119.1 130.47 73.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.968 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.551 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 6.0 tt -103.56 118.57 37.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.149 0.5 . . . . 0.0 110.884 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 96.9 m -117.78 124.31 48.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.228 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.576 ' C ' ' CD1' ' A' ' 119' ' ' LEU . 0.5 OUTLIER -106.44 122.7 46.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.493 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.503 ' N ' ' CD1' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -121.08 120.48 35.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.236 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.639 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.4 t -150.75 -179.11 6.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.158 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.617 ' SG ' ' C ' ' A' ' 121' ' ' THR . 1.2 p 157.25 -77.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.926 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.575 ' C ' ' O ' ' A' ' 122' ' ' CYS . 10.2 m-85 20.68 70.01 0.26 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.815 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.427 ' O ' ' O ' ' A' ' 127' ' ' TYR . 57.7 Cg_endo -76.67 153.6 34.17 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.913 2.408 . . . . 0.0 112.172 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.558 ' CE2' ' OD1' ' A' ' 126' ' ' ASP . 24.2 p90 -59.32 -32.67 70.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.445 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.558 ' OD1' ' CE2' ' A' ' 125' ' ' PHE . 38.6 m-20 -59.78 -44.13 94.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.472 ' CE1' ' O ' ' A' ' 128' ' ' ILE . 40.7 t80 -102.88 138.6 39.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.592 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.472 ' O ' ' CE1' ' A' ' 127' ' ' TYR . 96.6 mt -100.25 128.36 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.311 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.6 -141.95 15.88 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -89.36 101.77 14.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.509 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -48.0 150.92 1.84 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.56 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.675 ' O ' ' ND1' ' A' ' 102' ' ' HIS . 25.9 Cg_endo -61.51 -49.98 6.42 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.922 2.415 . . . . 0.0 111.996 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -109.56 116.03 31.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.434 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.502 ' CB ' ' HG ' ' A' ' 122' ' ' CYS . 10.6 ptp180 -101.31 144.42 30.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.785 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.471 ' CD1' HG12 ' A' ' 100' ' ' ILE . 4.5 t80 -76.42 135.04 39.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.872 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.1 mm -120.14 124.15 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.426 ' CD1' ' CD2' ' A' ' 135' ' ' TYR . 1.2 mp -112.91 109.5 28.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.475 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 22.7 tp10 -94.19 136.78 34.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.143 0.497 . . . . 0.0 110.89 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.59 148.98 31.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.973 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 79.2 tttt -116.2 155.23 28.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.06 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.459 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 11.8 tp -78.86 122.53 26.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.009 0.433 . . . . 0.0 110.478 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.66 -38.13 6.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.782 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -143.29 159.67 27.51 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.9 p -144.61 149.51 35.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.764 0.316 . . . . 0.0 110.457 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -128.97 153.8 47.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.598 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 77.4 p -146.86 126.99 13.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.729 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.591 179.995 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.478 ' C ' ' ND1' ' A' ' 3' ' ' HIS . 38.5 m -154.03 168.01 27.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 0.0 110.54 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.478 ' ND1' ' C ' ' A' ' 2' ' ' SER . 12.6 m80 72.68 85.34 0.12 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.458 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 30.6 ttm -80.33 147.96 30.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.488 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.591 ' H ' ' NZ ' ' A' ' 11' ' ' LYS . 10.7 t 63.95 -82.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.533 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.518 ' O ' ' C ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER 63.2 -1.32 0.54 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.516 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.659 ' CG ' ' H ' ' A' ' 8' ' ' THR . 2.5 tp60 29.31 -144.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.574 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.659 ' H ' ' CG ' ' A' ' 7' ' ' GLN . 75.3 p 51.8 -163.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.468 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.547 ' C ' ' O ' ' A' ' 8' ' ' THR . 44.9 mm-40 27.38 -98.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.005 0.431 . . . . 0.0 110.685 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.575 ' O ' ' OE1' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -154.45 -116.88 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.389 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.611 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 64.1 tttt 87.55 159.06 0.07 Allowed 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -91.61 149.39 21.68 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 89.71 10.23 65.37 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.611 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -113.64 133.95 55.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.843 0.354 . . . . 0.0 110.412 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.48 106.24 0.52 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.289 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.5 m -109.28 -40.53 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.971 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.17 160.32 32.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.7 ttp -123.7 147.1 47.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.189 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.8 tp -112.56 123.39 50.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.68 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.5 HD22 ' CD ' ' A' ' 27' ' ' LYS . 3.3 t-20 -118.02 128.38 54.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.963 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.1 mt -106.42 106.34 57.15 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.443 ' HD2' ' O ' ' A' ' 81' ' ' THR . 55.6 Cg_endo -76.33 -40.39 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.82 2.347 . . . . 0.0 112.851 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -58.48 -43.55 89.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.614 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.0 mm? -99.58 -0.03 41.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.569 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.25 49.49 17.07 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.593 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -127.66 165.42 20.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.402 . . . . 0.0 110.839 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' CD ' HD22 ' A' ' 20' ' ' ASN . 15.4 mtmt -140.59 145.82 37.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.103 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -142.6 145.47 33.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.861 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -90.01 129.18 36.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.188 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.23 119.58 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.004 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -102.36 142.71 33.13 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.967 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.5 ' CZ2' ' HB ' ' A' ' 47' ' ' VAL . 46.0 t-105 -60.63 119.36 7.96 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.855 0.36 . . . . 0.0 110.611 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 83.08 159.53 27.54 Favored Glycine 0 C--N 1.332 0.307 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.14 97.92 7.45 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.729 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -94.42 110.29 22.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.895 0.379 . . . . 0.0 111.02 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -78.67 -20.06 51.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.589 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.51 -29.97 68.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.525 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.487 ' H ' ' HG1' ' A' ' 38' ' ' THR . 1.4 p -104.36 128.29 52.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.395 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.538 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 3.1 mm? -83.9 -3.1 57.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.371 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 41' ' ' LYS . 27.1 tttt -71.64 133.44 45.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.134 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.633 ' C ' ' H ' ' A' ' 43' ' ' VAL . 68.7 mttm 24.78 85.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.599 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.27 13.57 0.16 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.633 ' H ' ' C ' ' A' ' 41' ' ' LYS . 2.5 t -90.92 99.52 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.385 0.612 . . . . 0.0 110.294 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.68 168.77 21.03 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.401 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 35.0 ttm -108.19 128.19 54.49 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.59 128.67 36.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.884 0.373 . . . . 0.0 110.565 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.628 ' C ' ' HG ' ' A' ' 48' ' ' SER . 1.1 m -109.35 133.67 53.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.71 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.696 ' N ' ' OG1' ' A' ' 51' ' ' THR . 12.9 m -161.5 177.17 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.576 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.559 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 46.5 t0 -67.7 -10.2 50.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.43 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 4.6 m -118.1 -28.52 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.816 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.696 ' OG1' ' N ' ' A' ' 48' ' ' SER . 39.1 p -83.07 141.11 32.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.584 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.406 ' HG1' ' H ' ' A' ' 53' ' ' THR . 2.8 t -142.71 177.2 8.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.723 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.415 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.2 OUTLIER -96.8 160.43 29.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.649 -179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -77.53 83.1 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.863 2.375 . . . . 0.0 112.39 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.7 p -120.95 -1.51 9.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.25 90.96 0.15 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.72 86.85 0.04 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.04 155.62 27.04 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.699 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 17.5 t-160 -79.43 112.17 16.41 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 m -104.28 127.0 51.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 71.1 t -119.19 128.97 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 0.0 110.249 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.455 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.6 mm? -111.19 142.84 42.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.608 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.5 t -127.29 136.24 51.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.615 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -150.13 95.87 0.16 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.686 ' CG ' ' OD2' ' A' ' 126' ' ' ASP . 0.3 OUTLIER -70.66 139.13 51.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.625 ' CB ' ' O ' ' A' ' 65' ' ' HIS . 47.2 ttt-85 94.12 151.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.565 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 68' ' ' THR . 50.2 t0 -64.66 155.08 34.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.568 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 39.8 p -74.11 168.97 18.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.34 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.528 ' O ' ' O ' ' A' ' 70' ' ' PHE . 8.3 p -99.49 114.38 37.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.502 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.528 ' O ' ' O ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER 33.19 -156.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.658 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 p 42.27 34.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.507 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.63 -42.38 99.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.602 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.452 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -62.63 -39.71 94.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.409 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.73 -40.64 97.57 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.516 HE22 ' CB ' ' A' ' 68' ' ' THR . 52.7 mt-30 -66.24 -40.36 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.694 0.283 . . . . 0.0 110.963 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.67 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 2.9 pp -100.52 108.71 20.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.186 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 14.7 ptmt 173.77 145.04 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.374 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -72.78 -14.06 61.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -83.0 -15.72 50.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.891 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.17 160.99 20.07 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.922 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.443 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -150.01 119.99 7.17 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.026 0.441 . . . . 0.0 109.973 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.5 131.77 43.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.074 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 43.8 t -112.94 130.32 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.015 0.436 . . . . 0.0 110.458 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.0 mt -113.01 126.47 55.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.53 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -104.45 116.49 32.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.442 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -149.09 131.4 15.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.852 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.4 t70 60.78 42.44 13.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.352 . . . . 0.0 111.241 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.2 m120 61.34 15.69 6.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.021 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -115.2 146.97 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.496 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -115.74 123.35 48.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.936 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.426 ' HB3' ' CD1' ' A' ' 141' ' ' LEU . 20.2 m-85 -106.28 137.09 44.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.682 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.99 120.22 41.68 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.035 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.404 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 71.4 m-85 -112.91 155.65 24.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.729 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -130.3 138.73 50.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.59 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.428 HD11 HG23 ' A' ' 95' ' ' ILE . 9.2 mm -63.63 121.41 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.23 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -98.55 -52.8 3.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.933 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -150.46 141.49 23.0 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.465 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.412 HD12 HG23 ' A' ' 98' ' ' ILE . 76.3 mt -121.7 130.82 74.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.835 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -153.08 -176.15 5.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 110.854 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.5 mt -128.25 131.71 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.5 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.71 169.46 17.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 110.895 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.41 148.39 45.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.985 0.421 . . . . 0.0 110.452 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -63.13 -19.48 64.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.629 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -88.96 11.8 17.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -84.9 88.4 7.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.375 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.601 ' O ' ' N ' ' A' ' 109' ' ' ILE . 6.9 ptp85 -60.42 -31.82 70.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.485 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.496 ' HG1' HG23 ' A' ' 108' ' ' VAL . 5.7 p -44.52 -14.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.25 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.55 ' H ' ' C ' ' A' ' 106' ' ' ARG . 4.8 t -108.12 -16.43 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.044 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.601 ' N ' ' O ' ' A' ' 106' ' ' ARG . 47.3 mm -107.51 12.16 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.048 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.699 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -79.42 -175.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.93 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -81.57 142.45 32.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.145 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.461 ' HB2' ' CG ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -116.09 130.59 56.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.949 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -78.15 16.77 0.7 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.056 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.45 ' H ' ' C ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -160.23 167.14 14.42 Favored Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.771 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -73.21 101.9 1.4 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.678 2.252 . . . . 0.0 111.414 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.462 HD11 HG22 ' A' ' 116' ' ' ILE . 50.6 mm -131.13 136.42 57.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.357 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.521 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 6.3 tt -108.65 119.65 40.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.358 0.599 . . . . 0.0 110.681 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.431 HG21 ' CG1' ' A' ' 108' ' ' VAL . 61.7 m -118.2 125.11 49.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.202 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.565 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 6.2 tt -112.97 124.9 53.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.388 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.467 ' N ' HD21 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -120.54 116.47 25.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.503 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.646 ' OG1' ' N ' ' A' ' 122' ' ' CYS . 0.1 OUTLIER -136.29 -168.57 2.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.356 -179.183 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.646 ' N ' ' OG1' ' A' ' 121' ' ' THR . 3.6 t 94.62 -77.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.53 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.504 ' H ' ' HG3' ' A' ' 134' ' ' ARG . 51.4 m-85 58.97 134.87 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.278 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.75 -48.92 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.8 2.333 . . . . 0.0 112.833 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.414 ' CG ' ' N ' ' A' ' 126' ' ' ASP . 4.1 p90 -63.43 -33.47 75.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.618 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.686 ' OD2' ' CG ' ' A' ' 65' ' ' HIS . 40.0 t0 -80.27 -55.39 4.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.826 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.509 ' CZ ' ' O ' ' A' ' 128' ' ' ILE . 40.3 t80 -68.02 142.13 56.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.509 ' O ' ' CZ ' ' A' ' 127' ' ' TYR . 50.8 mm -90.38 121.08 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.012 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.437 ' O ' ' OD1' ' A' ' 130' ' ' ASP . . . 128.82 -121.26 3.54 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 129' ' ' GLY . 99.2 m-20 -139.6 101.46 4.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 110.548 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.19 67.51 80.65 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.171 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.08 -37.83 69.32 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.764 2.309 . . . . 0.0 112.411 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -106.68 161.77 14.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.748 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.504 ' HG3' ' H ' ' A' ' 123' ' ' TYR . 7.3 mpt_? -104.16 143.98 32.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.055 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 120' ' ' THR . 2.8 t80 -69.13 124.97 25.22 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.881 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 2.6 mm -111.01 112.16 39.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.486 ' O ' ' CG2' ' A' ' 137' ' ' ILE . 0.9 OUTLIER -100.37 112.22 32.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.233 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -95.51 140.29 30.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.389 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.85 138.76 21.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.966 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -110.47 150.86 28.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.242 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.426 ' CD1' ' HB3' ' A' ' 91' ' ' TYR . 5.4 tp -72.46 122.59 21.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.355 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.94 -41.06 5.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.738 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.23 175.39 20.16 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 94.3 p -155.85 160.85 40.54 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.65 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' THR . 92.9 m-85 -147.87 152.47 37.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.582 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.1 p -147.57 132.66 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.759 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.4 p -64.62 154.97 34.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.808 0.337 . . . . 0.0 110.44 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.5 m170 -116.05 142.4 46.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.559 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.8 mtt -88.8 137.84 31.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.635 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.1 t -87.31 -64.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.679 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.8 m -144.61 -126.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.558 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -59.89 142.99 52.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.473 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 73.4 p -112.85 164.45 13.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.82 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.62 ' C ' ' H ' ' A' ' 11' ' ' LYS . 95.7 mt-10 -151.87 134.19 15.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.016 0.436 . . . . 0.0 110.296 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.2 m80 57.81 -3.35 0.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.776 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.62 ' H ' ' C ' ' A' ' 9' ' ' GLU . 54.6 mmtt -61.14 162.5 7.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.31 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.545 ' C ' ' OE2' ' A' ' 14' ' ' GLU . 97.6 mt-10 -107.31 123.86 48.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.377 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.577 ' N ' ' OE2' ' A' ' 14' ' ' GLU . . . 114.42 1.78 23.18 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.604 ' OE1' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -115.34 139.79 49.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.859 0.362 . . . . 0.0 110.278 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.472 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 89.0 tttt -58.67 120.74 9.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.642 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.1 m -116.23 -18.05 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.84 158.63 39.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.539 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.2 ttp -120.76 133.14 55.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.392 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -99.19 129.74 45.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.352 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.466 ' N ' HD12 ' A' ' 19' ' ' LEU . 27.4 t-20 -125.69 124.01 40.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.988 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.415 HD13 ' NE2' ' A' ' 75' ' ' GLN . 6.9 mt -105.9 109.74 63.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.855 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' A' ' 81' ' ' THR . 57.2 Cg_endo -75.89 -42.92 0.36 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.577 2.185 . . . . 0.0 112.6 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HE2' ' NZ ' ' A' ' 77' ' ' LYS . 8.1 tmtm? -60.57 -40.12 90.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.253 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.474 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.7 mm? -98.53 -2.35 38.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 0.0 110.489 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 54.46 42.66 31.23 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.689 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.464 ' HE3' ' CZ ' ' A' ' 28' ' ' PHE . 4.2 mtpp -124.03 163.01 22.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.093 0.473 . . . . 0.0 110.636 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.9 mtmt -141.89 143.37 33.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.007 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.464 ' CZ ' ' HE3' ' A' ' 26' ' ' LYS . 89.4 m-85 -137.71 152.23 49.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.805 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.642 ' OG ' ' CE1' ' A' ' 31' ' ' TYR . 4.9 t -97.15 124.82 41.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.772 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.4 mm -92.56 126.2 45.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.556 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.642 ' CE1' ' OG ' ' A' ' 29' ' ' SER . 89.1 m-85 -114.16 138.47 50.4 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.957 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.49 ' CE2' HG23 ' A' ' 47' ' ' VAL . 41.5 t-105 -60.74 126.85 28.92 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.604 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.513 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 84.28 169.79 45.96 Favored Glycine 0 C--N 1.331 0.289 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.77 99.3 3.51 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.783 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -101.11 114.72 28.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.837 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -73.54 -23.69 60.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.759 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.47 90.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.709 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 m -69.76 131.35 44.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.435 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.6 mt -92.82 -1.63 56.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.472 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.0 mtmt -106.19 33.28 3.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.941 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -126.12 141.46 51.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.58 -31.5 0.46 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.453 ' CG2' ' O ' ' A' ' 29' ' ' SER . 0.0 OUTLIER -136.38 105.18 4.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.064 0.459 . . . . 0.0 110.827 179.781 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.54 154.32 16.93 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.513 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 40.1 ttm -103.8 144.48 31.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.484 ' CE2' HG21 ' A' ' 109' ' ' ILE . 21.0 t80 -73.54 143.95 46.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.516 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.49 HG23 ' CE2' ' A' ' 32' ' ' TRP . 78.8 t -115.87 129.81 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.367 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.4 p -166.83 -173.92 2.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.65 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -89.28 -23.75 22.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 5.8 m -92.13 -38.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.687 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.4 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 63.6 p -78.53 153.23 31.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.556 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 t -150.24 172.09 15.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.459 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.415 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -84.91 153.92 60.68 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.701 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.44 80.65 2.69 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.546 2.164 . . . . 0.0 112.34 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.5 p -107.48 -13.39 15.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.755 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.62 88.99 0.08 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.42 80.23 0.51 Allowed Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.466 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -165.97 158.42 31.32 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.695 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 15.3 t-160 -81.75 121.73 26.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.8 m -116.17 129.48 56.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.274 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.426 HG12 ' CD1' ' A' ' 109' ' ' ILE . 58.3 t -116.35 126.1 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.221 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.45 HD23 ' N ' ' A' ' 62' ' ' LEU . 2.4 mm? -108.47 138.89 44.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.125 0.488 . . . . 0.0 110.529 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.3 t -121.63 138.67 54.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.876 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -152.5 155.27 26.03 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.516 ' O ' ' O ' ' A' ' 66' ' ' ARG . 3.1 m80 -98.7 132.18 44.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.864 0.364 . . . . 0.0 110.677 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.516 ' O ' ' O ' ' A' ' 65' ' ' HIS . 27.9 ttm180 56.7 127.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.393 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 67' ' ' ASP . 26.0 p-10 -66.83 -26.16 66.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.687 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.5 m -42.47 97.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.474 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 71' ' ' THR . 11.6 m -122.75 31.72 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.62 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 1.9 m-85 67.78 -55.32 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.691 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.432 ' N ' ' O ' ' A' ' 69' ' ' VAL . 0.6 OUTLIER -108.78 74.19 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.759 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.408 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 4.8 t70 -65.86 -38.48 88.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.538 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 96.6 mt -73.6 -15.65 61.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.905 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' A' ' 77' ' ' LYS . . . -91.91 -44.99 4.02 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.415 ' NE2' HD13 ' A' ' 21' ' ' ILE . 92.5 mm-40 -68.41 -41.22 80.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.78 0.324 . . . . 0.0 110.696 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.434 HD12 ' CZ ' ' A' ' 135' ' ' TYR . 8.2 mt -93.85 89.42 6.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.491 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 74' ' ' GLY . 6.3 ptpt -176.25 145.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.427 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -69.8 -21.99 63.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.739 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -76.39 -14.63 60.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.152 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.68 154.93 39.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.789 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.402 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -137.92 133.17 33.45 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.4 mt -109.23 124.68 51.27 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.785 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 40.0 t -106.37 116.65 50.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.981 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 8.1 mp -98.54 127.04 44.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.031 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -106.54 117.3 33.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.244 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -148.23 131.95 16.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.846 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 59.32 49.33 9.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.514 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 56.91 13.28 1.43 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.049 0.452 . . . . 0.0 110.259 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -114.9 144.81 42.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.61 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.411 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -114.08 123.31 49.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.673 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 14.6 m-85 -104.38 145.14 30.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.453 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -109.56 114.66 28.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.315 -179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.479 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 78.3 m-85 -113.03 151.46 30.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.609 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -128.83 141.65 51.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.786 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.5 mm -64.38 119.2 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.362 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.17 -62.92 1.41 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.024 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -145.87 150.92 37.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.307 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 12.0 mt -122.62 134.35 66.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.059 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.422 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 15.8 p90 -161.87 -179.74 7.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.034 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 100' ' ' ILE . 1.3 mp -128.69 129.25 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.257 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.672 ' HG1' ' H ' ' A' ' 102' ' ' HIS . 7.6 t -127.16 173.5 9.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.006 0.432 . . . . 0.0 110.68 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.672 ' H ' ' HG1' ' A' ' 101' ' ' THR . 0.3 OUTLIER -70.79 161.55 30.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.526 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.08 -11.74 60.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.761 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -101.71 22.69 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.628 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.597 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 50.1 t0 -92.04 100.83 13.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.594 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.462 ' O ' ' N ' ' A' ' 109' ' ' ILE . 2.7 ptt180 -79.71 -20.06 47.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.372 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.597 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 20.0 p -48.39 -16.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.615 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.405 ' N ' ' C ' ' A' ' 106' ' ' ARG . 8.8 m -109.4 -6.56 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.233 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.542 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 47.8 mm -113.44 7.76 7.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.937 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.695 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -79.52 -171.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.462 ' N ' ' HB ' ' A' ' 50' ' ' VAL . 19.5 ttpt -102.5 141.59 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.938 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.408 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 87.0 mttt -124.89 151.91 44.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.574 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -92.41 7.26 43.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.204 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -130.94 159.59 70.68 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.762 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.466 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 43.6 Cg_endo -74.58 94.88 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.978 2.452 . . . . 0.0 111.894 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 48.2 mm -126.41 134.77 65.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.137 -179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.532 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 6.1 tt -108.92 118.48 36.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.251 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 92.1 m -115.14 119.69 37.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.369 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.49 ' C ' ' CD1' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -105.86 124.97 50.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.361 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.632 ' OG1' ' NE ' ' A' ' 134' ' ' ARG . 0.1 OUTLIER -121.57 124.37 44.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.932 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.537 ' O ' ' CB ' ' A' ' 122' ' ' CYS . 1.3 t -152.17 170.45 19.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.305 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 121' ' ' THR . 1.7 p 158.19 -66.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.871 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.534 ' N ' ' HD3' ' A' ' 124' ' ' PRO . 17.1 m-85 38.54 60.76 5.03 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.646 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.534 ' HD3' ' N ' ' A' ' 123' ' ' TYR . 11.3 Cg_exo -70.81 160.81 48.2 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 123.291 2.661 . . . . 0.0 112.125 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -51.75 -25.34 7.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.362 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.603 ' O ' ' N ' ' A' ' 128' ' ' ILE . 38.2 t70 -94.63 5.55 51.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.549 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.581 ' O ' ' C ' ' A' ' 128' ' ' ILE . 2.2 t80 -43.11 -14.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.578 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.603 ' N ' ' O ' ' A' ' 126' ' ' ASP . 38.8 mm -19.99 92.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.589 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 127' ' ' TYR . . . 80.56 -102.2 2.08 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -104.04 118.93 37.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.688 0.28 . . . . 0.0 110.868 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -53.7 141.91 44.54 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.578 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.12 -27.93 56.89 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.623 2.215 . . . . 0.0 111.819 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -163.2 115.67 1.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.396 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.632 ' NE ' ' OG1' ' A' ' 120' ' ' THR . 5.6 ptm180 -98.42 138.55 35.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.094 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.47 ' O ' ' HA ' ' A' ' 120' ' ' THR . 4.5 t80 -69.92 136.53 50.69 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.827 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.402 ' CG2' ' CZ2' ' A' ' 99' ' ' TRP . 9.3 mm -120.84 115.68 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.421 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.6 mm -106.99 107.32 22.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -94.24 140.32 29.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.197 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.75 142.92 27.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.132 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 67.2 tttt -117.44 152.78 34.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.996 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.479 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 7.2 tp -73.23 124.19 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.455 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.19 -43.65 5.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.343 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.27 -178.97 16.34 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 34.9 p -153.78 160.29 42.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.708 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.411 ' N ' ' O ' ' A' ' 90' ' ' THR . 59.7 m-85 -149.06 156.03 41.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.535 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 64.6 p -147.26 130.94 16.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.594 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.9 pttt . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.526 179.906 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.459 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 2.2 t 77.68 -127.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.352 . . . . 0.0 110.727 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -66.73 -40.0 88.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.428 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.423 ' O ' ' O ' ' A' ' 1' ' ' GLY . 3.0 tpt -151.46 -161.08 1.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.572 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.5 m -70.42 153.21 43.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.562 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.631 ' HG ' ' N ' ' A' ' 7' ' ' GLN . 2.3 t -65.62 -83.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.775 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.631 ' N ' ' HG ' ' A' ' 6' ' ' SER . 87.3 mt-30 -106.14 134.87 48.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.543 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 3.1 p -153.06 -114.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.715 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -97.79 -115.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.535 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -107.51 39.3 1.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.68 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.613 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 70.6 mmtt -65.52 151.23 46.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.799 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.64 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 52.9 mp0 -90.72 151.89 21.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.387 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.79 18.11 64.27 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.613 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -121.97 133.73 54.83 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.537 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.571 ' HZ3' ' CB ' ' A' ' 29' ' ' SER . 64.4 tttp -60.08 112.03 1.74 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.344 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.5 m -114.07 -26.38 3.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.965 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -144.08 158.02 43.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.598 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.1 ttp -120.6 140.59 51.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.343 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 55.4 tp -108.96 125.66 52.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.577 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -121.25 133.88 55.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.0 mt -119.59 111.24 36.39 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -76.02 -36.94 1.74 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.735 2.29 . . . . 0.0 112.843 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -61.1 -36.83 80.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.582 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.5 mm? -103.61 -0.51 29.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.642 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.59 50.72 16.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.247 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.22 175.7 9.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.036 0.446 . . . . 0.0 110.287 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.76 157.47 31.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.707 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -144.05 159.73 42.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.826 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.571 ' CB ' ' HZ3' ' A' ' 15' ' ' LYS . 4.3 m -99.83 116.14 31.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.012 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 17' ' ' ALA . 35.3 mm -80.39 126.67 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.247 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.552 ' HH ' ' HZ1' ' A' ' 41' ' ' LYS . 70.8 m-85 -111.03 137.79 48.23 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.988 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.485 ' CE2' HG21 ' A' ' 47' ' ' VAL . 41.5 t-105 -60.14 117.31 4.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.695 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.575 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 94.24 166.3 36.76 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.31 101.28 2.2 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.703 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -84.5 113.86 21.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.882 0.372 . . . . 0.0 110.808 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -62.13 -45.31 94.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.574 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.75 -48.88 75.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.553 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.484 ' O ' ' OG1' ' A' ' 38' ' ' THR . 2.9 p -110.52 92.96 4.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.194 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.97 108.38 16.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.809 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.77 -53.59 6.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.497 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.552 ' HZ1' ' HH ' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -131.11 148.47 52.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.736 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.34 -16.63 21.58 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 m -116.6 94.92 3.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.379 0.609 . . . . 0.0 111.155 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.17 142.65 15.99 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.575 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 13.4 tpt -95.3 138.1 33.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.714 0.292 . . . . 0.0 110.713 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -77.69 137.56 38.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.982 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.485 HG21 ' CE2' ' A' ' 32' ' ' TRP . 86.9 t -119.34 114.81 45.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.242 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.54 ' N ' ' OG1' ' A' ' 51' ' ' THR . 6.1 m -163.28 169.35 19.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.686 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.575 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 65.1 t0 -70.85 -8.84 55.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.432 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.497 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 3.2 m -110.42 -22.95 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.645 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.54 ' OG1' ' N ' ' A' ' 48' ' ' SER . 37.0 p -85.58 138.21 32.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.398 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -131.0 168.17 17.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.22 161.0 28.57 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.594 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -81.29 73.65 5.83 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.635 2.224 . . . . 0.0 112.365 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.6 p -115.76 -6.33 12.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.754 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.01 91.98 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.47 79.22 0.16 Allowed Glycine 0 CA--C 1.53 1.028 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.471 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -155.29 150.83 22.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.666 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 16.7 t-160 -77.58 104.99 8.44 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 38.3 m -100.19 122.43 43.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.433 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.471 ' H ' ' HE1' ' A' ' 45' ' ' MET . 54.1 t -114.77 127.44 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 0.0 110.276 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.488 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.7 mm? -112.36 147.13 37.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.684 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 120' ' ' THR . 32.6 t -128.99 142.29 50.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.619 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -165.82 169.87 40.34 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.584 ' N ' ' ND1' ' A' ' 65' ' ' HIS . 0.1 OUTLIER -123.5 146.33 48.16 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.497 -0.414 . . . . 0.0 110.716 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 66' ' ' ARG . 51.5 mtt-85 -63.44 109.91 1.77 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.732 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -77.3 -72.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.708 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 88.7 m -136.24 139.57 42.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.683 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.1 m -82.34 96.6 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.335 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -134.02 -73.29 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.632 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.595 ' O ' ' NE2' ' A' ' 75' ' ' GLN . 0.8 OUTLIER -93.48 72.1 4.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.064 0.459 . . . . 0.0 110.652 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -64.61 -33.93 77.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.241 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.0 mt -61.23 -45.55 94.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.809 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.42 -37.38 93.74 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.595 ' NE2' ' O ' ' A' ' 71' ' ' THR . 0.7 OUTLIER -64.37 -36.18 83.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 110.405 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.66 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 3.2 pp -136.13 112.56 9.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.324 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.8 ptpt -179.99 144.68 0.19 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.348 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -79.52 -11.51 59.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.947 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -83.59 -13.95 53.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.898 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.683 ' OD1' ' N ' ' A' ' 81' ' ' THR . 23.4 t0 -81.06 158.04 25.21 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.215 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.683 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.6 p -138.48 135.44 35.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.7 mt -109.79 122.09 46.71 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.355 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.7 t -104.33 121.93 56.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.995 0.426 . . . . 0.0 110.263 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 8.0 mp -103.59 129.54 50.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.367 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -105.44 120.86 42.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.941 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.449 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 2.1 t80 -149.38 127.67 12.14 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.933 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 64.4 t0 54.02 52.68 12.38 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.827 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.474 ' N ' HD21 ' A' ' 88' ' ' ASN . 1.3 m-80 57.18 12.23 1.27 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.448 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 49.9 mtmt -112.72 141.63 46.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.956 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.466 ' HG1' ' HB2' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -113.65 126.08 54.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.339 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 10.5 m-85 -109.3 134.83 51.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.102 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.425 ' OG1' ' C ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -101.96 115.28 30.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.047 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -110.95 144.27 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.582 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -119.74 138.27 53.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.672 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.3 mm -66.2 115.95 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.411 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -86.63 -60.62 1.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.593 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -152.72 145.1 24.03 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.197 0.522 . . . . 0.0 110.26 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.466 HG23 ' CZ ' ' A' ' 135' ' ' TYR . 1.7 mp -119.56 131.45 72.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.541 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.471 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 26.5 p90 -149.61 -177.51 5.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.01 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.528 ' N ' ' CD1' ' A' ' 100' ' ' ILE . 0.9 OUTLIER -130.33 132.42 64.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.356 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.2 t -138.98 178.9 6.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.712 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -68.5 148.71 50.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.564 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.9 -34.31 75.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.363 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -82.8 16.69 2.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.724 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.63 90.52 5.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.571 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.682 ' O ' ' N ' ' A' ' 109' ' ' ILE . 17.0 ptp180 -63.57 -37.92 89.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.515 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.489 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 1.6 p -38.71 -18.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.522 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.655 ' N ' ' O ' ' A' ' 106' ' ' ARG . 11.1 t -111.18 -16.53 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.107 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.682 ' N ' ' O ' ' A' ' 106' ' ' ARG . 49.3 mm -112.32 22.34 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.751 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -89.94 -163.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.837 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -102.69 148.31 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.686 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.427 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 98.1 mttt -132.9 150.46 52.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.635 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -94.94 8.98 41.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.401 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.27 163.9 46.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.767 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.471 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 50.2 Cg_endo -79.04 98.5 1.19 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.071 2.514 . . . . 0.0 111.624 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.433 HG22 ' N ' ' A' ' 117' ' ' LEU . 50.2 mm -128.84 138.29 54.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.439 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.541 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 6.5 tt -110.13 116.48 31.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.666 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 72.3 m -116.03 114.76 25.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.324 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.49 ' C ' ' CD1' ' A' ' 119' ' ' LEU . 0.9 OUTLIER -103.71 116.32 32.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.026 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.47 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -107.22 122.87 47.39 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.431 0.457 . . . . 0.0 110.403 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.632 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.4 t -156.08 178.9 9.76 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.06 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 121' ' ' THR . 1.6 p 158.54 -75.14 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.791 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 47.88 67.01 4.9 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.027 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.4 160.82 32.06 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 123.08 2.52 . . . . 0.0 112.237 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.562 ' CE1' ' OD2' ' A' ' 126' ' ' ASP . 8.9 p90 -51.99 -17.19 0.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.978 0.418 . . . . 0.0 110.314 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.562 ' OD2' ' CE1' ' A' ' 125' ' ' PHE . 1.3 p30 -108.44 26.63 10.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.637 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.677 ' O ' ' O ' ' A' ' 129' ' ' GLY . 14.7 t80 -56.6 -49.36 75.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.632 ' C ' ' O ' ' A' ' 127' ' ' TYR . 21.6 mt 9.52 78.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 O-C-N 123.732 0.645 . . . . 0.0 110.739 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.677 ' O ' ' O ' ' A' ' 127' ' ' TYR . . . 87.98 157.2 31.54 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.558 ' C ' ' O ' ' A' ' 129' ' ' GLY . 10.0 p30 -27.39 99.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.896 0.379 . . . . 0.0 110.681 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 129' ' ' GLY . . . -47.69 130.41 11.08 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.623 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.64 -41.4 37.63 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.484 2.122 . . . . 0.0 111.876 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -124.5 125.94 45.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.418 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.455 ' HG3' ' SG ' ' A' ' 122' ' ' CYS . 7.7 ttp180 -113.07 142.46 45.7 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.809 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.486 ' CE2' HD12 ' A' ' 137' ' ' ILE . 7.9 t80 -81.9 123.28 28.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 1.6 mt -119.55 124.17 72.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 120.978 0.418 . . . . 0.0 111.959 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.486 HD12 ' CE2' ' A' ' 135' ' ' TYR . 1.4 mp -103.04 112.62 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.816 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.471 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 10.4 tt0 -90.11 142.72 27.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.868 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -152.86 149.72 28.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.822 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.451 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 66.7 tttt -123.45 153.4 40.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.451 ' N ' ' CG ' ' A' ' 140' ' ' LYS . 13.8 tp -71.7 126.6 30.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.435 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.68 -36.83 5.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.628 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.425 ' C ' ' OG1' ' A' ' 92' ' ' THR . . . -141.32 162.33 26.87 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.0 p -142.72 133.17 24.94 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.294 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.466 ' HB2' ' HG1' ' A' ' 90' ' ' THR . 62.8 m-85 -123.01 101.6 7.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.684 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.526 ' O ' ' O ' ' A' ' 147' ' ' LYS . 8.6 p -89.38 136.93 32.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.703 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.526 ' O ' ' O ' ' A' ' 146' ' ' SER . 22.0 mtpt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.554 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.684 ' O ' ' ND1' ' A' ' 3' ' ' HIS . 16.1 p -77.37 170.09 17.17 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.684 ' ND1' ' O ' ' A' ' 2' ' ' SER . 6.8 m80 83.91 129.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 42.8 mtm -96.02 140.15 31.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.621 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.5 t -93.83 35.45 1.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.656 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.0 t -74.39 153.74 39.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.82 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -103.49 44.06 1.04 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.495 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.43 ' H ' ' HG1' ' A' ' 8' ' ' THR . 0.7 OUTLIER -79.08 -48.73 13.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.034 -179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.631 ' O ' ' N ' ' A' ' 11' ' ' LYS . 2.7 tm-20 -128.94 165.05 21.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.654 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.655 ' CD2' ' H ' ' A' ' 10' ' ' HIS . 0.5 OUTLIER -51.38 79.26 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.573 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.631 ' N ' ' O ' ' A' ' 9' ' ' GLU . 27.4 ttmt -105.12 157.57 17.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.645 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -92.12 147.58 22.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.292 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.41 3.74 68.96 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.556 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.8 OUTLIER -109.7 137.5 47.41 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.878 0.371 . . . . 0.0 110.483 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -62.77 117.17 5.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.195 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.443 ' H ' HG22 ' A' ' 16' ' ' VAL . 16.1 m -116.31 -39.93 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.746 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.92 162.18 33.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.7 ttm -127.2 135.66 50.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.527 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tt -101.53 121.53 42.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.195 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 21' ' ' ILE . 3.8 t30 -116.79 136.07 53.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.419 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.504 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 3.4 mt -113.57 118.3 43.53 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.175 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.664 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.7 Cg_endo -76.55 -48.36 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.857 2.371 . . . . 0.0 112.674 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.484 ' HE3' ' HZ1' ' A' ' 77' ' ' LYS . 27.1 tptp -61.57 -39.4 91.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.1 mm? -99.49 0.68 42.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.768 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt 45.61 38.74 4.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.909 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 21' ' ' ILE . 2.9 mtpt -117.18 157.59 25.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.841 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -137.57 136.35 37.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.725 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -126.27 120.96 31.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.414 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.8 m -67.32 119.42 12.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.916 0.389 . . . . 0.0 110.646 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.495 HG22 HD13 ' A' ' 30' ' ' ILE . 40.0 mm -95.73 120.68 45.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.542 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -106.71 147.97 28.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.641 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.768 ' CZ3' ' SD ' ' A' ' 45' ' ' MET . 46.4 t-105 -60.8 117.73 5.77 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.861 0.362 . . . . 0.0 110.454 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 85.94 153.67 22.37 Favored Glycine 0 C--N 1.332 0.311 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.435 ' HB2' ' HG ' ' A' ' 63' ' ' SER . . . -124.25 78.99 1.7 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.662 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -101.85 133.41 46.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.648 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -88.2 -3.89 58.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.554 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.38 -25.96 67.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.546 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.507 ' OG1' ' N ' ' A' ' 39' ' ' LEU . 6.9 t -64.9 -153.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.517 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 39' ' ' LEU . 7.6 mp -72.62 -124.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.684 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -92.67 -48.03 6.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.697 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -61.92 131.6 50.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.473 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.5 39.65 1.51 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.93 126.32 49.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.467 0.651 . . . . 0.0 110.781 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.22 -172.8 42.16 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.768 ' SD ' ' CZ3' ' A' ' 32' ' ' TRP . 1.5 tmt? -93.68 146.97 23.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.94 0.4 . . . . 0.0 110.965 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.562 ' O ' ' SD ' ' A' ' 45' ' ' MET . 57.8 t80 -76.72 130.29 37.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.371 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.5 t -96.62 125.96 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.429 . . . . 0.0 110.669 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.644 ' HG ' ' H ' ' A' ' 51' ' ' THR . 38.5 p -160.45 176.25 11.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.575 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.586 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 65.9 t0 -82.7 -7.14 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.542 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 9.0 m -115.45 -32.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.599 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.644 ' H ' ' HG ' ' A' ' 48' ' ' SER . 72.8 p -78.9 145.35 34.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.78 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -145.24 171.18 14.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.535 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.468 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -90.04 154.39 47.31 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.848 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.427 ' HD3' ' HG1' ' A' ' 60' ' ' THR . 59.9 Cg_endo -75.78 84.25 1.8 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.689 2.259 . . . . 0.0 112.415 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -117.02 -4.49 11.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.828 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.15 88.98 0.07 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.13 91.23 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.465 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.96 165.34 38.67 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.506 ' CD2' ' HD2' ' A' ' 112' ' ' LYS . 13.2 t-160 -84.24 111.87 19.77 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.427 ' HG1' ' HD3' ' A' ' 54' ' ' PRO . 61.2 m -105.61 123.22 47.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.352 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 44.9 t -116.57 126.87 74.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.549 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 62' ' ' LEU . 2.5 mm? -114.16 143.97 43.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.819 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.435 ' HG ' ' HB2' ' A' ' 34' ' ' ALA . 4.9 p -132.86 147.5 52.3 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.56 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -169.43 161.94 35.47 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.713 ' ND1' ' CG ' ' A' ' 123' ' ' TYR . 90.6 m-70 -110.62 145.41 37.93 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.639 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 47.07 -79.62 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.718 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 65' ' ' HIS . 20.2 t0 59.92 148.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.6 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.468 HG22 ' N ' ' A' ' 72' ' ' ASP . 8.1 m 61.43 148.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.624 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.4 t -113.78 -49.4 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.719 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -138.19 -12.68 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.606 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 57.1 p -87.7 25.46 1.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.33 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.468 ' N ' HG22 ' A' ' 68' ' ' THR . 2.6 m-20 -62.75 -36.02 81.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.657 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.425 ' O ' ' CD1' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -61.8 -42.4 98.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.417 -179.638 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -68.51 -34.59 79.49 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.7 mm-40 -61.49 -41.15 96.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.716 0.293 . . . . 0.0 110.792 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.612 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 3.0 pp -97.11 109.3 22.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.44 . . . . 0.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.484 ' HZ1' ' HE3' ' A' ' 23' ' ' LYS . 2.3 ptpt 172.2 143.32 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.445 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.63 -14.83 63.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.721 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -82.07 -14.32 56.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.239 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.23 158.91 34.98 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.06 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.664 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -147.67 111.05 4.91 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.235 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.0 mt -87.77 131.24 34.58 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.224 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 2.8 t -112.61 122.39 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.204 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.521 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 3.2 mm? -107.98 133.24 52.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.343 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -104.25 118.04 35.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.373 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.468 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 1.0 OUTLIER -146.87 125.81 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.764 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 89' ' ' LYS . 96.7 m-20 60.14 51.65 5.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.156 179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 56.53 11.39 0.85 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.445 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 45.0 mtpt -112.01 145.05 40.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.612 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.4 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -113.71 117.2 30.86 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.344 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 8.6 m-85 -95.17 136.23 35.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.412 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.469 ' N ' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -105.91 113.79 27.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.659 -179.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.413 ' HH ' ' HB3' ' A' ' 54' ' ' PRO . 87.7 m-85 -110.9 147.23 35.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.525 179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -123.67 138.9 54.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.432 ' CD1' HG22 ' A' ' 137' ' ' ILE . 8.0 mm -65.89 118.98 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.038 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -95.94 -62.01 1.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.485 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -139.77 135.27 32.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.407 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.9 mt -114.18 127.86 71.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.205 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.473 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 21.4 p90 -151.14 -176.35 5.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.73 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.428 HG12 ' CD1' ' A' ' 135' ' ' TYR . 8.0 mt -129.34 138.85 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.46 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.463 ' HG1' ' H ' ' A' ' 102' ' ' HIS . 2.2 t -137.55 170.43 16.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.093 0.473 . . . . 0.0 110.776 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.594 ' C ' ' H ' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -73.57 154.72 39.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.555 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.55 8.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.67 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.594 ' H ' ' C ' ' A' ' 102' ' ' HIS . 57.8 t0 -131.53 36.53 3.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.556 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.445 ' H ' HH21 ' A' ' 134' ' ' ARG . 21.7 t0 -96.44 94.78 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.69 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.578 ' O ' ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -62.45 -35.52 79.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.463 179.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 1.2 p -44.91 -13.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.354 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.573 ' N ' ' O ' ' A' ' 106' ' ' ARG . 15.7 t -113.46 -12.67 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.116 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.578 ' N ' ' O ' ' A' ' 106' ' ' ARG . 50.9 mm -117.68 22.2 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.164 0.507 . . . . 0.0 111.064 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.765 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -87.28 -161.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.706 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -104.45 147.07 27.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.506 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 98.6 mttt -142.82 136.27 28.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.305 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.15 16.23 8.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.465 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -125.93 151.47 71.4 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.784 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.465 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 37.0 Cg_endo -72.33 80.84 1.57 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.995 2.464 . . . . 0.0 111.275 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.4 mm -115.5 132.85 63.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.287 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.537 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 5.7 tt -106.13 118.79 37.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.178 0.513 . . . . 0.0 110.739 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.445 ' CG2' ' CG1' ' A' ' 108' ' ' VAL . 90.8 m -112.78 120.88 43.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.162 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 120' ' ' THR . 0.4 OUTLIER -108.26 119.68 40.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.414 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.503 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -111.17 115.63 29.71 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.81 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 135' ' ' TYR . 3.6 p -141.27 158.6 43.68 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.652 ' O ' ' C ' ' A' ' 123' ' ' TYR . 13.9 t 171.76 -80.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.78 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.733 ' N ' ' CD1' ' A' ' 123' ' ' TYR . 0.0 OUTLIER 0.24 72.81 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.388 0 O-C-N 123.954 0.784 . . . . 0.0 110.546 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.559 ' N ' ' O ' ' A' ' 122' ' ' CYS . 60.1 Cg_endo -81.08 169.02 16.59 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 123.175 2.583 . . . . 0.0 112.277 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -63.28 -29.02 70.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.389 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -61.35 -45.88 92.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.583 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -107.29 126.25 52.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.603 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.8 mm -98.46 129.19 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.231 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.72 -118.95 5.93 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 130' ' ' ASP . 0.6 OUTLIER -116.63 105.03 11.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.337 . . . . 0.0 110.57 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.85 152.05 21.43 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.509 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.21 -28.8 85.59 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.958 2.439 . . . . 0.0 111.975 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 40.1 p-10 -138.53 126.64 22.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.613 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.445 HH21 ' H ' ' A' ' 105' ' ' ASP . 29.6 ptt180 -98.76 141.83 31.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.733 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.579 ' H ' ' HB2' ' A' ' 122' ' ' CYS . 3.1 t80 -75.57 130.85 39.48 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.3 mm -118.96 116.98 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.195 0.521 . . . . 0.0 112.076 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.464 ' CD1' ' CD2' ' A' ' 135' ' ' TYR . 1.2 mp -106.77 110.32 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.543 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.473 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 48.4 tt0 -90.18 134.91 33.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.034 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -144.35 142.81 30.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.006 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 59.5 tttt -114.65 153.32 30.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.181 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.442 ' N ' ' CG ' ' A' ' 140' ' ' LYS . 27.8 tp -74.62 116.94 15.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.12 -33.87 10.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -154.74 158.66 28.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 38.3 p -138.42 151.62 47.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 0.0 110.384 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.4 ' N ' ' O ' ' A' ' 90' ' ' THR . 90.2 m-85 -130.04 145.08 51.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.458 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 147' ' ' LYS . 5.2 p -136.68 129.07 30.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.553 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 146' ' ' SER . 13.8 mttm . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.339 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.571 ' O ' ' CB ' ' A' ' 3' ' ' HIS . 86.6 p -61.47 -35.02 76.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.399 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.679 ' C ' ' H ' ' A' ' 5' ' ' SER . 4.3 t60 86.65 71.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.181 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.585 ' O ' ' O ' ' A' ' 5' ' ' SER . 78.4 mtm 47.98 4.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.691 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.679 ' H ' ' C ' ' A' ' 3' ' ' HIS . 3.5 m 40.42 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.771 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.2 t -73.36 146.07 45.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.477 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -122.38 168.12 12.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.433 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 29.9 m 65.69 5.08 3.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.686 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.655 ' C ' ' H ' ' A' ' 11' ' ' LYS . 83.3 tt0 -93.72 162.2 14.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.578 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.478 ' N ' ' HG2' ' A' ' 9' ' ' GLU . 97.7 m-70 -64.85 33.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.632 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.655 ' H ' ' C ' ' A' ' 9' ' ' GLU . 22.3 tptp -72.81 144.92 47.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.481 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.02 141.01 55.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.94 0.4 . . . . 0.0 110.335 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.5 14.06 66.57 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -119.38 141.54 48.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.328 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -62.31 112.25 2.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.257 179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.405 HG21 ' N ' ' A' ' 17' ' ' ALA . 16.5 m -112.94 -43.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.721 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.405 ' N ' HG21 ' A' ' 16' ' ' VAL . . . -129.53 162.27 28.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.76 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.434 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 50.8 ttm -125.84 143.0 51.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.51 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 21.1 tp -107.01 127.75 53.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.409 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.433 HD21 ' N ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -124.88 125.88 44.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.04 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 24' ' ' LEU . 4.8 mt -105.01 119.68 52.43 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.934 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 81' ' ' THR . 59.5 Cg_endo -76.66 -48.18 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.637 2.225 . . . . 0.0 112.918 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.476 ' HG2' ' HZ1' ' A' ' 77' ' ' LYS . 16.7 tptp -59.34 -43.87 92.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.985 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.603 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.7 mm? -96.93 -0.57 47.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.362 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.15 37.69 8.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.622 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -107.65 157.21 18.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.533 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -140.06 145.6 37.9 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.683 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -143.73 150.75 39.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.876 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.2 m -99.06 116.26 30.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.76 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 30' ' ' ILE . 1.7 mp -86.13 122.54 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.42 139.02 34.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.714 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.455 ' CZ3' HG22 ' A' ' 53' ' ' THR . 42.6 t-105 -60.43 127.73 33.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 110.654 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.409 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 77.64 175.28 43.32 Favored Glycine 0 C--N 1.329 0.188 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.62 108.92 3.58 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.889 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -93.72 114.74 27.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.767 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -77.22 -8.6 57.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.543 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.56 -36.18 82.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.507 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.1 t -109.07 127.27 53.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.456 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.9 mp -84.23 -8.99 58.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.464 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.496 ' HD3' ' H ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -63.59 -41.41 98.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.441 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.67 132.29 38.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.51 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 63' ' ' SER . . . -123.65 -41.59 0.41 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.19 93.49 2.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.101 0.476 . . . . 0.0 111.069 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.18 155.46 22.45 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.758 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -100.91 131.35 46.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.758 ' N ' ' SD ' ' A' ' 45' ' ' MET . 1.5 t80 -65.59 132.97 50.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.682 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.431 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 1.8 p -122.47 114.97 44.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.351 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.665 ' N ' ' OG1' ' A' ' 51' ' ' THR . 16.0 p -157.96 173.13 17.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.6 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.21 -14.8 11.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.6 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.496 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 5.3 m -110.57 -38.61 3.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.784 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.665 ' OG1' ' N ' ' A' ' 48' ' ' SER . 62.5 p -77.45 140.39 39.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.606 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.481 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -144.9 167.05 23.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.245 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.455 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -85.5 157.02 58.97 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.73 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.52 83.98 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.529 2.153 . . . . 0.0 112.343 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 p -115.16 -2.92 12.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.688 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.19 91.12 0.18 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.34 81.68 0.14 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.468 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -163.38 162.19 34.67 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.607 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 20.0 t-160 -83.22 118.59 23.73 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.4 m -117.21 126.5 52.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.051 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.667 ' O ' ' SD ' ' A' ' 45' ' ' MET . 70.4 t -116.58 132.34 66.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 110.038 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.459 HD23 ' N ' ' A' ' 62' ' ' LEU . 2.7 mm? -112.63 135.39 53.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.724 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.605 ' O ' ' O ' ' A' ' 42' ' ' GLY . 26.8 t -117.7 132.81 56.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.603 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.94 131.47 5.74 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.477 ' HA ' ' CD1' ' A' ' 123' ' ' TYR . 23.6 t60 -73.81 128.45 35.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.728 0.299 . . . . 0.0 110.403 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.475 ' H ' ' HB2' ' A' ' 123' ' ' TYR . 4.2 ptt180 79.09 138.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.424 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.576 ' O ' ' C ' ' A' ' 68' ' ' THR . 14.5 p-10 -112.15 -59.65 1.97 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.266 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.576 ' C ' ' O ' ' A' ' 67' ' ' ASP . 9.9 p 20.26 52.06 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.726 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 67' ' ' ASP . 12.2 m -67.9 94.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.58 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -99.45 -11.78 20.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.455 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 74' ' ' GLY . 2.6 m -97.38 91.34 5.44 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.315 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -57.73 -47.84 81.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.213 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.55 ' N ' ' CD1' ' A' ' 73' ' ' LEU . 6.2 mp -78.02 -13.37 59.9 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.547 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.493 ' N ' HG23 ' A' ' 71' ' ' THR . . . -64.18 -50.53 59.64 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -139.74 -15.86 1.03 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.221 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.45 ' N ' HD21 ' A' ' 76' ' ' LEU . 2.3 mt -90.8 60.72 4.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.91 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.541 ' NZ ' ' O ' ' A' ' 73' ' ' LEU . 23.3 pttm -164.29 143.66 7.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.211 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.67 -19.3 59.24 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.228 0.537 . . . . 0.0 110.164 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -71.14 -15.51 62.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.817 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.686 ' OD1' ' N ' ' A' ' 81' ' ' THR . 6.0 t0 -68.86 152.34 45.43 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.175 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.686 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -141.22 121.95 14.34 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.128 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.0 mt -99.65 117.49 34.13 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.606 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 45.2 t -100.47 121.89 51.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.969 0.414 . . . . 0.0 110.097 -179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 4.0 mm? -109.36 131.62 54.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.296 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.498 ' OE1' ' N ' ' A' ' 85' ' ' GLU . 54.9 mp0 -102.5 123.47 46.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.83 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.421 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 5.3 t80 -143.62 119.19 10.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.87 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 57.35 51.1 10.41 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.745 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 62.34 7.7 2.42 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.675 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 56.9 mtmt -107.57 142.85 36.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.808 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.417 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -113.29 123.95 51.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.688 -179.372 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.402 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 22.1 m-85 -106.69 128.66 54.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.144 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.04 115.46 29.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.219 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.471 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 86.5 m-85 -109.97 153.47 24.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.639 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -126.88 139.29 53.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.64 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.406 HG23 HD12 ' A' ' 95' ' ' ILE . 9.1 mm -61.86 119.89 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.181 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -88.53 -67.15 0.85 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.553 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -148.97 136.37 20.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.295 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.2 mp -108.04 135.12 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.149 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.427 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 15.0 p90 -160.71 -178.86 7.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.268 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.588 ' N ' ' CD1' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -126.2 132.82 70.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.316 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -136.11 175.66 9.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 110.894 -179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 67.2 m80 -76.31 151.21 36.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.9 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.85 -18.47 65.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.788 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -94.28 17.31 13.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.048 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.628 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 21.4 t0 -91.89 100.42 13.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.837 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.699 ' O ' ' N ' ' A' ' 109' ' ' ILE . 3.0 ptp85 -69.17 -32.57 71.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.268 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.628 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 6.3 p -37.85 -20.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.356 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' A' ' 106' ' ' ARG . 18.5 t -105.26 -19.4 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.013 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.699 ' N ' ' O ' ' A' ' 106' ' ' ARG . 45.4 mm -113.19 27.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.801 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.701 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -91.18 -168.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.425 ' N ' ' HB ' ' A' ' 50' ' ' VAL . 33.9 ttmt -97.1 147.87 23.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.577 ' HZ1' ' CG2' ' A' ' 116' ' ' ILE . 99.3 mttt -130.82 155.55 46.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 110.588 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -102.26 13.39 34.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.329 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.98 169.2 10.75 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.971 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.468 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 47.6 Cg_endo -79.66 95.4 1.04 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 123.284 2.656 . . . . 0.0 112.438 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.577 ' CG2' ' HZ1' ' A' ' 112' ' ' LYS . 49.7 mm -126.16 128.54 71.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.568 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.506 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 4.7 tt -104.52 121.01 42.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.903 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.2 m -115.65 126.64 54.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.343 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.501 HD12 ' N ' ' A' ' 120' ' ' THR . 2.5 tp -111.98 127.85 55.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.056 0.455 . . . . 0.0 111.671 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.501 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -122.05 129.19 52.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.039 178.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.631 ' O ' ' CB ' ' A' ' 122' ' ' CYS . 65.7 p -134.9 164.54 27.35 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.244 0.545 . . . . 0.0 111.768 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.631 ' CB ' ' O ' ' A' ' 121' ' ' THR . 0.5 OUTLIER 150.38 -76.16 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.935 179.202 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.62 ' O ' ' N ' ' A' ' 125' ' ' PHE . 26.1 m-85 48.5 159.81 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.011 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.94 62.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.268 1.979 . . . . 0.0 112.641 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.661 ' CD1' ' N ' ' A' ' 126' ' ' ASP . 1.7 p90 -79.9 -42.61 23.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.945 0.402 . . . . 0.0 110.715 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.661 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 25.4 t70 -126.82 -24.5 3.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.385 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.691 ' CE2' ' O ' ' A' ' 128' ' ' ILE . 60.4 t80 -105.73 132.49 51.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.553 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.691 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 88.7 mt -72.22 125.57 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.02 -154.24 25.34 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -73.25 108.23 6.01 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.293 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.586 ' CB ' ' SG ' ' A' ' 122' ' ' CYS . . . -45.41 148.58 1.15 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.895 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.542 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 52.1 Cg_exo -49.16 -37.04 38.09 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.28 1.987 . . . . 0.0 111.937 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.542 ' OD1' ' O ' ' A' ' 132' ' ' PRO . 97.0 m-20 -145.06 157.47 44.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.55 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -119.16 134.33 55.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.29 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 120' ' ' THR . 6.6 t80 -68.53 133.01 47.93 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.969 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.405 HG23 ' CZ2' ' A' ' 99' ' ' TRP . 37.8 mm -118.76 115.15 47.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.086 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.1 mm -107.96 108.53 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -91.4 146.65 23.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.02 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -153.05 142.96 22.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.428 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -115.64 150.46 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.146 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.471 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 6.5 tp -77.48 123.24 26.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.353 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.03 -40.36 5.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.826 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -136.99 164.23 25.26 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.0 p -151.1 152.44 33.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.826 0.346 . . . . 0.0 110.386 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 90' ' ' THR . 87.1 m-85 -136.44 155.04 50.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.487 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.1 p -143.27 125.62 15.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.583 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.1 tttt . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.562 -179.85 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.0 t -118.46 131.83 56.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 110.697 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -82.42 -162.15 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.56 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.9 ttm -69.3 137.45 53.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.638 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.1 -10.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.621 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 m -74.23 148.29 41.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 51.9 18.2 0.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.66 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.569 ' O ' ' O ' ' A' ' 9' ' ' GLU . 95.5 m -134.85 138.53 44.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.002 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.569 ' O ' ' O ' ' A' ' 8' ' ' THR . 50.1 tp10 52.6 155.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.46 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.483 ' N ' ' HG3' ' A' ' 9' ' ' GLU . 53.3 m80 -68.4 113.21 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.928 0.394 . . . . 0.0 110.554 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -135.4 140.67 45.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.401 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -70.18 123.89 22.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.025 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 109.43 11.74 20.97 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -118.48 134.43 55.08 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.333 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.537 ' N ' ' CD2' ' A' ' 31' ' ' TYR . 40.3 tttm -57.97 112.69 1.58 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.352 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 m -114.2 -38.22 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.877 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.79 154.97 49.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.541 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.413 ' CE ' ' OE1' ' A' ' 85' ' ' GLU . 16.2 ttp -118.74 137.94 53.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.2 tp -106.1 119.26 38.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.145 179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.57 HD21 ' N ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -118.87 127.14 53.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 111.328 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.614 ' CD1' HE22 ' A' ' 75' ' ' GLN . 4.5 mt -109.82 116.95 53.25 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.516 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.03 -45.74 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.529 2.153 . . . . 0.0 113.036 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HG2' ' NZ ' ' A' ' 77' ' ' LYS . 19.1 tptm -62.52 -38.6 90.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.2 mm? -96.4 4.62 52.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.999 0.428 . . . . 0.0 110.442 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 41.9 49.09 4.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.127 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.544 ' HZ2' ' CG2' ' A' ' 71' ' ' THR . 13.7 mtmt -135.33 157.7 46.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.963 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -138.92 140.18 38.26 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.47 142.38 47.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.457 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 m -90.73 123.76 34.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 1.7 mp -96.28 123.19 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.453 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.537 ' CD2' ' N ' ' A' ' 15' ' ' LYS . 42.1 m-85 -103.11 145.06 30.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.787 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.599 ' O ' ' N ' ' A' ' 13' ' ' GLY . 41.1 t-105 -59.1 130.05 45.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.974 0.416 . . . . 0.0 110.521 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 82.59 141.07 3.82 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB3' ' HG ' ' A' ' 63' ' ' SER . . . -118.96 81.33 1.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.925 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -101.66 108.94 20.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.496 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -85.58 -7.98 58.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.624 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.64 -13.63 48.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.633 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.45 -147.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.693 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.9 mt -38.37 -63.05 0.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.783 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 87.6 tttt 62.14 111.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.053 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -112.84 -4.84 13.92 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.802 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.53 -31.99 7.9 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.46 92.39 2.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.96 0.409 . . . . 0.0 110.527 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.34 141.79 14.42 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.692 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -93.41 125.58 38.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.692 ' N ' ' SD ' ' A' ' 45' ' ' MET . 16.7 t80 -66.84 140.87 57.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.26 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.505 HG21 ' CE2' ' A' ' 32' ' ' TRP . 54.4 t -114.58 129.46 70.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.633 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.628 ' N ' ' OG1' ' A' ' 51' ' ' THR . 11.6 t -163.21 166.42 23.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.59 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 36.8 t0 -68.94 -11.48 60.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.433 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 6.1 m -109.01 -14.55 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.528 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 48' ' ' SER . 25.5 p -85.73 149.1 25.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.554 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.521 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.8 OUTLIER -140.74 164.85 29.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.951 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.439 HG23 ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -95.38 151.93 38.98 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.216 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.89 54.23 3.99 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.757 2.305 . . . . 0.0 112.634 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.2 p -102.4 -7.69 21.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.264 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.07 81.17 0.04 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.78 103.15 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.557 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.7 160.41 34.0 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.738 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 22.1 t-160 -81.42 99.37 8.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.8 m -94.02 126.54 39.29 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.677 ' O ' ' SD ' ' A' ' 45' ' ' MET . 71.8 t -116.52 128.93 73.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.077 0.465 . . . . 0.0 110.232 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 62' ' ' LEU . 2.7 mm? -114.58 141.55 47.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.73 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.401 ' HG ' ' HB3' ' A' ' 34' ' ' ALA . 4.8 p -128.4 146.61 50.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.707 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.66 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -176.91 -179.44 47.31 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -115.92 160.01 20.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.901 0.382 . . . . 0.0 110.534 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -54.08 137.43 40.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.6 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -84.57 -108.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.576 ' OG1' ' OG1' ' A' ' 71' ' ' THR . 4.5 p -128.36 -178.44 4.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.465 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 72.8 t -60.34 -46.09 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.79 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.99 70.63 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.683 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.576 ' OG1' ' OG1' ' A' ' 68' ' ' THR . 0.0 OUTLIER -164.62 -67.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 0.0 110.541 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.515 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 26.8 t0 -63.36 -27.82 69.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.498 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.0 tp -60.91 -42.88 98.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.199 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.438 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . . . -80.7 -28.09 48.31 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.614 HE22 ' CD1' ' A' ' 21' ' ' ILE . 91.8 mm-40 -63.82 -39.42 94.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.688 0.28 . . . . 0.0 110.669 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.668 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 2.6 pp -91.25 102.45 15.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.39 0.614 . . . . 0.0 111.333 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.476 ' HG3' ' H ' ' A' ' 80' ' ' ASP . 20.6 pttm 176.83 152.56 0.19 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.221 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.32 -31.73 70.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.359 0.599 . . . . 0.0 110.727 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 mmtt -69.78 -14.15 62.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.501 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.67 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 1.2 t70 -82.67 152.95 25.62 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.566 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 p -138.85 149.55 45.02 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 41.1 mt -121.58 123.66 42.5 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.8 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.7 t -103.74 116.96 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.535 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 2.7 mm? -105.69 132.35 51.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.53 -178.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.413 ' OE1' ' CE ' ' A' ' 18' ' ' MET . 28.6 mt-10 -108.75 123.53 49.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.55 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.587 ' O ' ' N ' ' A' ' 89' ' ' LYS . 12.2 t80 -144.48 145.22 31.75 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.034 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.417 ' N ' ' CD1' ' A' ' 86' ' ' TYR . 34.8 t70 36.95 51.29 0.96 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.759 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.0 m120 59.32 25.12 13.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.961 0.41 . . . . 0.0 110.598 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 86' ' ' TYR . 54.5 mtmt -124.07 144.34 49.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.107 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.69 126.92 55.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.565 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -112.47 131.86 55.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.278 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.64 ' HG1' ' C ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -102.59 106.24 16.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.343 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.551 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 53.1 m-85 -97.08 161.49 13.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.354 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.67 ' OE1' ' O ' ' A' ' 80' ' ' ASP . 2.8 tp10 -136.85 137.23 39.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.514 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.599 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 1.9 mm -65.54 124.2 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.554 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -98.72 -62.89 1.18 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.544 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -141.14 138.9 33.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.319 0.58 . . . . 0.0 109.786 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.452 HD12 ' N ' ' A' ' 77' ' ' LYS . 46.6 mt -120.36 127.62 75.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.833 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.452 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 22.4 p90 -152.72 -177.59 6.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.816 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.441 ' CG2' ' OD2' ' A' ' 133' ' ' ASP . 2.4 mp -125.68 132.82 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.757 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.429 ' C ' ' OD1' ' A' ' 133' ' ' ASP . 2.0 t -143.32 166.45 24.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -65.9 147.83 52.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.236 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.44 80.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.64 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' ARG . 46.7 t0 -63.91 -33.34 75.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.611 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.456 ' CG ' ' HG1' ' A' ' 107' ' ' THR . 14.6 t70 -40.13 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.447 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 109' ' ' ILE . 11.1 ptp85 -68.96 -26.09 64.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.531 ' O ' ' CD1' ' A' ' 110' ' ' ILE . 10.9 p -49.1 -21.93 0.83 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.587 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.8 t -97.77 -13.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.166 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.543 ' N ' ' O ' ' A' ' 106' ' ' ARG . 48.1 mm -114.83 18.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.273 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.738 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.4 OUTLIER -79.1 -156.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.889 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -107.76 148.18 29.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HG2' ' CG ' ' A' ' 59' ' ' HIS . 71.9 mmtt -125.15 141.66 51.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.906 0.384 . . . . 0.0 110.257 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.578 ' O ' ' OE2' ' A' ' 114' ' ' GLU . 51.4 mm-40 -89.62 10.78 21.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.722 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.578 ' OE2' ' O ' ' A' ' 113' ' ' GLU . 44.0 mm-40 -143.11 152.65 58.67 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.557 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 12.0 Cg_endo -62.15 84.49 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.642 2.228 . . . . 0.0 110.771 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.49 HG21 HD12 ' A' ' 116' ' ' ILE . 50.6 mm -115.65 132.11 66.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.787 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.511 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 5.5 tt -107.54 119.77 40.33 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.277 0.56 . . . . 0.0 109.923 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.448 ' OG1' ' OE1' ' A' ' 138' ' ' GLU . 73.1 m -116.15 117.44 30.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.742 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.478 HD11 ' N ' ' A' ' 120' ' ' THR . 1.0 OUTLIER -107.54 124.69 50.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.85 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.478 ' N ' HD11 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -119.03 122.74 42.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.578 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.66 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.3 t -161.02 176.15 11.69 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.224 0.535 . . . . 0.0 111.989 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.658 ' N ' ' HG1' ' A' ' 121' ' ' THR . 0.1 OUTLIER 152.07 -66.09 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.192 179.595 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.722 ' O ' ' CG ' ' A' ' 123' ' ' TYR . 5.8 p90 -31.01 95.53 0.08 OUTLIER Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.711 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.476 ' N ' ' O ' ' A' ' 122' ' ' CYS . 60.9 Cg_endo -81.64 -168.24 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.518 2.146 . . . . 0.0 111.863 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -65.15 -20.08 66.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.397 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.465 ' C ' ' OD1' ' A' ' 126' ' ' ASP . 43.8 t0 -63.11 -65.44 0.69 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.159 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.593 ' CE2' ' O ' ' A' ' 130' ' ' ASP . 43.5 t80 -71.38 128.74 36.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.199 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.6 mt -91.71 90.55 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 125.87 -128.15 6.38 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.596 ' CB ' HH21 ' A' ' 134' ' ' ARG . 52.9 p-10 -105.15 114.91 29.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.747 0.308 . . . . 0.0 110.621 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.74 157.19 15.3 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.69 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -49.8 -37.92 46.13 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.338 2.025 . . . . 0.0 112.356 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.441 ' OD2' ' CG2' ' A' ' 100' ' ' ILE . 4.8 t0 -140.08 133.11 29.45 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.596 HH21 ' CB ' ' A' ' 130' ' ' ASP . 92.6 mtt180 -99.02 144.11 28.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.235 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.477 ' N ' ' O ' ' A' ' 121' ' ' THR . 4.6 t80 -75.57 132.57 40.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.452 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 15.8 mm -110.88 110.94 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.49 HD11 HG22 ' A' ' 137' ' ' ILE . 51.2 mm -101.28 108.89 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.448 ' OE1' ' OG1' ' A' ' 118' ' ' THR . 3.6 tp10 -96.76 142.2 29.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.31 0.576 . . . . 0.0 111.407 -178.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -153.54 146.98 24.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.04 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -116.57 157.47 25.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.901 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.551 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 2.6 tm? -87.77 118.41 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.119 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.721 ' HG1' ' N ' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -108.44 -65.03 1.16 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.441 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.721 ' N ' ' HG1' ' A' ' 142' ' ' THR . . . -93.16 156.9 23.04 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.0 p -152.6 152.1 31.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.518 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -142.87 132.82 24.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.411 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.3 t -121.63 131.94 54.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.998 0.428 . . . . 0.0 110.434 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.622 -179.27 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 3' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -75.38 13.32 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 110.562 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.44 ' H ' ' C ' ' A' ' 1' ' ' GLY . 99.3 m-70 -89.67 127.64 35.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.611 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 73.0 mtp -121.61 -174.93 2.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.412 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.38 35.24 4.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.562 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.5 p -136.29 -175.23 3.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.597 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -88.33 124.8 34.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.015 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.432 ' CG2' ' H ' ' A' ' 9' ' ' GLU . 20.8 m -119.0 -118.63 0.31 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.388 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.467 ' O ' ' CB ' ' A' ' 10' ' ' HIS . 21.7 tt0 -166.17 121.75 1.24 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.018 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.497 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 0.2 OUTLIER 79.64 11.52 1.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.533 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -68.07 131.69 45.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.846 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -64.99 130.4 43.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.914 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 95.54 21.38 24.41 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -128.45 146.35 50.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.994 0.426 . . . . 0.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -64.26 119.8 10.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.065 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.0 m -119.59 -46.12 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -128.22 169.54 14.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.457 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.7 tpp -127.75 139.72 52.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.399 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 tp -108.18 124.49 50.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.338 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 26' ' ' LYS . 21.5 t-20 -118.33 129.3 55.36 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.0 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 24.5 mt -114.73 111.87 45.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.202 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.8 -37.65 1.13 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.647 2.231 . . . . 0.0 112.993 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.808 ' NZ ' ' HZ2' ' A' ' 77' ' ' LYS . 2.1 tptm -62.33 -37.24 84.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.701 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.559 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.3 mm? -98.95 -3.34 35.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.402 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 54.62 65.8 1.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.339 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.431 ' C ' ' CG ' ' A' ' 27' ' ' LYS . 16.0 ptmt -165.72 -175.19 3.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.077 0.465 . . . . 0.0 111.26 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' CG ' ' C ' ' A' ' 26' ' ' LYS . 4.1 mtpt -155.32 155.75 34.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.292 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.417 ' CZ ' ' HE2' ' A' ' 26' ' ' LYS . 78.9 m-85 -135.82 146.48 47.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.449 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.7 m -87.18 118.45 26.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.956 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.1 mm -85.1 113.92 24.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -99.22 135.53 40.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.848 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.535 ' O ' ' N ' ' A' ' 13' ' ' GLY . 28.3 t-105 -60.62 122.18 14.06 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.015 0.436 . . . . 0.0 110.829 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 86.97 156.77 29.84 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.01 84.96 2.26 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.449 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -96.85 98.63 10.28 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.507 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' C ' ' OD1' ' A' ' 36' ' ' ASP . 47.5 p30 -82.84 -6.24 59.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.221 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.42 ' N ' ' OD1' ' A' ' 36' ' ' ASP . . . -68.42 -43.29 77.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.5 p -84.79 165.8 17.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.547 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.39 69.41 9.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.336 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -104.52 -176.18 3.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.432 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -76.31 150.19 36.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.663 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -75.83 55.52 3.03 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 p -159.63 92.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.372 0.606 . . . . 0.0 110.529 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.48 160.83 24.12 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.674 ' SD ' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -104.27 129.97 52.08 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.674 ' N ' ' SD ' ' A' ' 45' ' ' MET . 5.5 t80 -63.06 145.95 54.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.983 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.468 HG22 ' CE2' ' A' ' 32' ' ' TRP . 46.1 t -118.55 128.01 75.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.796 ' HG ' ' H ' ' A' ' 51' ' ' THR . 59.8 p -167.1 173.85 8.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.435 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.91 -6.73 53.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.768 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 3.5 m -114.1 -23.04 4.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.664 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.796 ' H ' ' HG ' ' A' ' 48' ' ' SER . 23.7 p -87.21 159.05 18.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.531 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.49 171.61 19.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.187 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.436 HG21 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -91.16 156.49 43.85 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.413 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -75.81 83.13 2.0 Allowed 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.687 2.258 . . . . 0.0 112.444 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.8 p -115.3 -4.72 12.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.719 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.82 89.66 0.08 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.78 87.12 0.04 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.449 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -162.32 168.47 37.31 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.493 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 16.8 t-160 -89.16 116.93 27.77 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.9 m -111.97 127.22 55.8 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.073 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.674 ' O ' ' SD ' ' A' ' 45' ' ' MET . 58.6 t -119.35 126.14 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.994 0.426 . . . . 0.0 110.787 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.445 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.3 mm? -116.23 145.78 42.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.629 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 93.7 p -137.93 154.33 49.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.825 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.39 156.74 27.12 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.755 ' O ' ' N ' ' A' ' 67' ' ' ASP . 65.1 t-80 -140.91 142.71 34.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.412 0.149 . . . . 0.0 110.609 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.477 ' C ' ' O ' ' A' ' 65' ' ' HIS . 8.6 ttt180 26.18 -76.5 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.573 0.546 . . . . 0.0 111.434 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.755 ' N ' ' O ' ' A' ' 65' ' ' HIS . 0.2 OUTLIER 40.48 -165.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.772 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.2 m -124.7 89.52 3.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.131 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 32.1 m -131.17 129.58 62.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.713 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -117.52 12.61 14.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.958 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 71' ' ' THR . 0.1 OUTLIER -107.46 46.59 0.93 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.177 0.513 . . . . 0.0 110.335 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.605 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 55.1 m-20 -63.3 -39.27 94.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.674 ' CD2' ' H ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -59.36 -37.13 77.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.883 -179.318 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.33 -16.11 67.48 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -28.1 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.586 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.605 ' CD2' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -120.85 91.57 3.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.018 0.437 . . . . 0.0 110.88 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.808 ' HZ2' ' NZ ' ' A' ' 23' ' ' LYS . 60.0 pttt -177.95 147.4 0.46 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.977 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.6 -18.12 61.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.921 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -77.35 -15.54 59.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.595 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.468 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 3.7 t70 -76.76 154.57 33.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.927 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.441 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.9 p -139.45 139.89 37.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.0 mt -118.67 129.75 55.46 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.755 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.62 118.29 57.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.504 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 7.6 mp -99.3 130.87 45.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.57 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -114.9 115.11 26.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.55 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -147.61 130.25 15.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.698 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 61.9 t0 64.01 40.37 7.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.668 0.27 . . . . 0.0 111.325 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 63.17 11.0 4.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.793 ' HZ2' ' HH ' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -107.64 143.18 36.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.962 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.575 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -111.66 124.8 53.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.32 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.793 ' HH ' ' HZ2' ' A' ' 89' ' ' LYS . 5.6 m-85 -113.6 137.49 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.907 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.684 ' HG1' ' CA ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -105.86 118.76 37.42 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.478 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 64.7 m-85 -113.27 161.46 17.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.983 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -141.12 140.2 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.246 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.474 HD13 ' H ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -66.92 124.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.57 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -96.11 -60.24 1.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.184 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -144.4 143.81 31.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.25 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.476 HG23 ' HH ' ' A' ' 135' ' ' TYR . 1.8 mt -117.38 133.43 64.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.483 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.45 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 18.4 p90 -153.0 -175.63 5.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.004 0.43 . . . . 0.0 111.433 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 mt -125.52 133.06 70.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.536 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.558 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 1.7 t -133.71 168.32 18.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.132 0.491 . . . . 0.0 110.906 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.524 ' CD2' ' N ' ' A' ' 102' ' ' HIS . 1.5 m170 -76.65 157.05 32.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.48 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.53 -9.23 40.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.661 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.559 ' O ' ' OD1' ' A' ' 104' ' ' ASP . 57.7 t0 -109.26 23.75 14.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.881 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.622 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 67.2 t0 -88.95 92.67 9.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.645 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.634 ' O ' ' N ' ' A' ' 109' ' ' ILE . 12.2 ptp85 -65.27 -34.76 79.1 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.161 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.622 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 10.2 p -42.29 -17.02 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.472 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.568 ' N ' ' O ' ' A' ' 106' ' ' ARG . 58.9 t -102.79 -20.89 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.046 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.634 ' N ' ' O ' ' A' ' 106' ' ' ARG . 48.4 mm -110.31 21.99 5.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.992 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.594 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.0 OUTLIER -82.73 -172.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.146 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -87.27 142.52 27.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.888 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.487 ' HE2' ' CD2' ' A' ' 59' ' ' HIS . 2.5 tppt? -121.42 147.26 45.97 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.934 0.397 . . . . 0.0 110.57 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 113' ' ' GLU . 1.6 mp0 -101.47 15.72 27.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.031 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.11 171.81 6.21 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.29 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.449 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 54.7 Cg_endo -80.06 95.43 1.01 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 123.014 2.476 . . . . 0.0 111.668 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.49 HD13 HG23 ' A' ' 116' ' ' ILE . 49.2 mm -127.66 139.05 52.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.625 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.498 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 5.5 tt -112.44 120.11 40.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.35 0.595 . . . . 0.0 110.195 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.423 HG21 ' CG1' ' A' ' 108' ' ' VAL . 85.7 m -111.95 116.61 30.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.099 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.548 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 3.7 tt -108.97 122.4 47.15 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.412 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.504 ' N ' HD22 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -106.29 124.33 49.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.055 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.11 127.42 52.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.755 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.5 ' C ' ' CD1' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -118.21 80.34 1.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.856 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 123' ' ' TYR . 2.4 m-85 -131.03 120.82 18.48 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.317 -178.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.604 ' CB ' ' H ' ' A' ' 129' ' ' GLY . 69.1 Cg_endo -77.81 76.18 4.44 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.327 2.018 . . . . 0.0 112.081 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -72.09 -28.28 63.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.481 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -131.92 -36.13 1.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.706 ' CE2' ' O ' ' A' ' 130' ' ' ASP . 72.3 t80 -61.29 -36.64 80.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.413 ' HB ' ' O ' ' A' ' 127' ' ' TYR . 69.6 mt 68.1 85.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.427 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.604 ' H ' ' CB ' ' A' ' 124' ' ' PRO . . . 120.21 -116.47 3.26 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.706 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 21.5 t70 -101.87 101.07 11.46 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.714 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.435 ' HA ' ' CG ' ' A' ' 127' ' ' TYR . . . -63.7 148.9 93.69 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.593 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.479 ' HD3' ' CD1' ' A' ' 127' ' ' TYR . 29.8 Cg_endo -64.85 -60.11 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.673 2.249 . . . . 0.0 112.178 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -98.15 158.14 15.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.156 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -110.45 131.56 54.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.099 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.476 ' HH ' HG23 ' A' ' 98' ' ' ILE . 2.0 t80 -64.42 141.86 58.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.538 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.9 mm -128.4 116.71 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.3 mp -105.32 112.11 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.45 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 45.4 tt0 -93.96 139.34 31.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.9 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.52 148.77 33.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.205 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.9 tttm -122.03 148.41 44.88 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.992 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.516 ' CD2' ' C ' ' A' ' 141' ' ' LEU . 8.2 tt -73.14 115.33 12.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.162 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.8 -43.38 11.29 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.912 179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.684 ' CA ' ' HG1' ' A' ' 92' ' ' THR . . . -134.9 160.51 24.31 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 62.5 p -136.23 142.74 44.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.588 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.575 ' N ' ' O ' ' A' ' 90' ' ' THR . 92.6 m-85 -130.53 154.96 47.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.464 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.55 ' O ' ' OXT' ' A' ' 147' ' ' LYS . 20.2 p -141.77 121.19 13.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.299 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.55 ' OXT' ' O ' ' A' ' 146' ' ' SER . 18.5 ttmt . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.621 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.4 p -75.16 159.92 31.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.524 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.49 122.71 12.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.395 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.632 ' O ' ' SD ' ' A' ' 4' ' ' MET . 0.3 OUTLIER -136.2 157.24 47.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.744 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 6' ' ' SER . 9.4 m -153.42 74.14 1.0 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.347 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 5' ' ' SER . 0.6 OUTLIER 44.39 104.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.621 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 6' ' ' SER . 97.9 mm-40 42.45 96.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.75 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.443 ' CG2' ' H ' ' A' ' 5' ' ' SER . 2.7 t -156.85 166.91 32.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.817 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 60.53 165.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.651 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -91.06 104.55 17.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.556 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -129.8 127.16 39.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.24 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.61 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 1.0 OUTLIER -68.14 148.6 50.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.374 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.24 0.76 76.5 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -115.33 131.97 56.76 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.333 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . 60.7 tttm -57.38 125.35 22.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.064 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 m -117.06 -37.98 2.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.135 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.509 ' HB1' ' CD2' ' A' ' 86' ' ' TYR . . . -140.92 167.37 22.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.865 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.447 ' SD ' ' HA ' ' A' ' 29' ' ' SER . 4.5 tpp -121.0 147.64 45.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.452 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.421 ' N ' ' HG3' ' A' ' 18' ' ' MET . 51.1 tp -114.76 115.47 27.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.003 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.435 HD21 ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -105.24 135.94 45.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.302 179.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 25' ' ' LYS . 8.3 mt -113.34 90.67 17.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.125 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -55.5 -42.68 65.5 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 123.178 2.585 . . . . 0.0 112.746 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' HD3' ' NZ ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -60.31 -42.75 96.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.715 -178.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.614 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.8 mm? -100.41 2.65 42.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.147 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 21' ' ' ILE . 75.3 mmtt 50.34 36.02 12.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.432 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -113.6 173.09 6.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.377 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.408 ' CD ' ' OD1' ' A' ' 20' ' ' ASN . 30.9 mtmm -148.57 142.18 25.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.98 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -134.07 152.55 51.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.851 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.447 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -95.11 120.52 35.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.578 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.496 HG23 HD12 ' A' ' 30' ' ' ILE . 48.9 mm -88.76 117.29 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.236 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.443 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 87.3 m-85 -102.37 135.81 43.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.113 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.524 ' CE2' HG21 ' A' ' 47' ' ' VAL . 53.4 t-105 -59.66 125.55 24.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.432 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 74.35 173.65 30.14 Favored Glycine 0 C--N 1.331 0.266 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.96 135.42 46.57 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.642 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -93.01 95.51 9.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.698 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 37' ' ' ALA . 50.2 p-10 -67.92 -31.36 71.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.359 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.555 ' N ' ' OD1' ' A' ' 36' ' ' ASP . . . -74.8 -63.69 1.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.078 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.2 p -83.28 165.38 19.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.461 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.54 142.25 40.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.41 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.636 ' NZ ' ' OG1' ' A' ' 68' ' ' THR . 22.2 pttp -83.75 149.95 26.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.923 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -63.77 -44.86 92.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.968 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.534 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . . . -162.94 -55.45 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.09 135.44 37.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -118.42 139.09 14.29 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.432 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 2.3 ttp -97.9 129.38 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.12 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -63.73 143.28 57.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.524 HG21 ' CE2' ' A' ' 32' ' ' TRP . 55.4 t -122.85 128.55 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.77 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.664 ' N ' ' OG1' ' A' ' 51' ' ' THR . 7.3 p -164.18 168.96 18.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.507 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -64.03 -35.29 80.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 4.4 m -87.62 -25.34 6.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.802 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.664 ' OG1' ' N ' ' A' ' 48' ' ' SER . 43.5 p -77.23 140.38 40.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.737 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.682 ' HG1' ' N ' ' A' ' 59' ' ' HIS . 1.3 p -131.75 171.31 13.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.847 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.12 155.87 36.08 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.948 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.429 ' CB ' HD11 ' A' ' 84' ' ' LEU . 65.4 Cg_endo -77.77 62.89 7.97 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.723 2.282 . . . . 0.0 112.325 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.415 ' O ' ' OH ' ' A' ' 91' ' ' TYR . 86.7 p -112.63 -3.8 14.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.77 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.52 91.24 0.08 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.09 88.35 0.01 OUTLIER Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.481 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -161.04 152.32 22.91 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.682 ' N ' ' HG1' ' A' ' 52' ' ' THR . 19.8 t-160 -78.69 106.18 10.5 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.3 m -101.8 124.44 47.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.231 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.402 HG12 ' CD1' ' A' ' 109' ' ' ILE . 74.3 t -117.62 129.46 74.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.465 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 3.0 mm? -108.04 144.36 35.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.167 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.2 t -128.1 136.54 51.33 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.755 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.21 139.49 6.95 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.57 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.757 ' NE2' ' CZ ' ' A' ' 123' ' ' TYR . 16.2 m170 -81.97 144.9 30.58 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.492 -0.417 . . . . 0.0 110.482 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.86 -15.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.47 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.474 ' N ' ' C ' ' A' ' 65' ' ' HIS . 25.0 t70 -63.23 -39.96 96.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.636 ' OG1' ' NZ ' ' A' ' 40' ' ' LYS . 13.9 m -72.8 101.63 3.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.703 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.81 126.39 54.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.344 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.495 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -135.26 -96.73 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.79 0.328 . . . . 0.0 110.548 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.423 ' H ' ' HG1' ' A' ' 71' ' ' THR . 17.0 p -94.98 76.14 3.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.366 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.415 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 46.3 m-20 -62.86 -40.19 96.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.489 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.408 ' HG ' ' H ' ' A' ' 74' ' ' GLY . 1.2 pp -63.55 -35.9 82.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.59 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.408 ' H ' ' HG ' ' A' ' 73' ' ' LEU . . . -78.96 -33.54 36.53 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -66.07 -35.81 81.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.631 0.253 . . . . 0.0 111.246 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.508 ' CD2' ' OH ' ' A' ' 135' ' ' TYR . 11.3 mt -88.37 83.29 6.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.845 0.355 . . . . 0.0 111.005 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.451 ' NZ ' ' HD3' ' A' ' 23' ' ' LYS . 14.2 ptmt -177.8 134.6 0.17 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.837 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.65 -10.63 59.89 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.394 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -82.92 -14.9 53.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.064 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -64.21 155.16 32.7 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.637 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -133.25 140.29 47.41 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.033 0.445 . . . . 0.0 110.067 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 21.2 mt -119.8 120.58 36.92 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.485 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.403 ' CG1' HG21 ' A' ' 90' ' ' THR . 2.9 t -107.13 130.32 59.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.045 0.45 . . . . 0.0 110.492 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.429 HD11 ' CB ' ' A' ' 54' ' ' PRO . 27.1 mt -113.79 128.83 56.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.474 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -104.46 118.27 36.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.564 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.509 ' CD2' ' HB1' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -153.19 129.38 10.45 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.869 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.435 ' C ' ' N ' ' A' ' 89' ' ' LYS . 58.2 m-20 61.24 54.29 3.28 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.844 0.354 . . . . 0.0 111.338 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 51.59 15.31 0.34 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.699 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.435 ' N ' ' C ' ' A' ' 87' ' ' ASP . 20.6 mtpt -119.33 143.23 47.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.37 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.403 HG21 ' CG1' ' A' ' 83' ' ' VAL . 4.6 m -115.14 120.55 40.14 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.346 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.415 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 13.6 m-85 -99.62 136.06 40.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.177 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -108.27 119.01 38.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.218 -178.496 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -113.1 165.13 12.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.62 179.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -143.44 139.89 30.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.942 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mt -69.01 121.63 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.804 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -97.04 -42.19 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.587 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -158.25 140.08 13.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.692 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.5 mt -118.25 126.59 75.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.256 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.8 p90 -149.37 -179.23 6.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.459 HD13 ' N ' ' A' ' 100' ' ' ILE . 1.3 mp -125.21 126.89 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.047 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.7 t -129.11 173.38 10.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.711 -179.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.487 ' ND1' ' N ' ' A' ' 102' ' ' HIS . 1.0 OUTLIER -73.16 152.73 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.649 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.82 -18.51 65.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.743 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -92.58 4.53 53.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.696 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.575 ' O ' ' N ' ' A' ' 107' ' ' THR . 41.9 t0 -75.3 60.55 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.373 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 109' ' ' ILE . 28.1 ptt85 -38.53 -23.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.747 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 105' ' ' ASP . 65.5 p -46.5 -16.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.599 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.457 ' N ' ' O ' ' A' ' 106' ' ' ARG . 3.9 m -106.25 -13.03 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 120.952 0.406 . . . . 0.0 110.339 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.613 ' N ' ' O ' ' A' ' 106' ' ' ARG . 41.6 mm -112.89 21.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.549 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.635 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -88.95 -163.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.862 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -104.07 140.56 37.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.632 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -131.4 140.41 49.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.566 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -87.74 11.44 15.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.058 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.93 160.33 69.05 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.845 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.481 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 39.6 Cg_endo -77.32 99.37 1.29 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.895 2.397 . . . . 0.0 111.563 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.477 HG23 HD11 ' A' ' 116' ' ' ILE . 49.8 mm -130.36 133.27 64.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.179 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.41 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 6.5 tt -107.94 117.85 35.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.249 0.547 . . . . 0.0 110.249 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 61.2 m -118.27 123.02 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.971 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.615 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 1.0 OUTLIER -109.23 131.53 54.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.93 0.395 . . . . 0.0 111.043 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 135' ' ' TYR . 0.2 OUTLIER -126.32 121.65 33.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.895 179.469 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.68 ' O ' ' SG ' ' A' ' 122' ' ' CYS . 69.5 p -136.57 159.33 42.12 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.586 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.68 ' SG ' ' O ' ' A' ' 121' ' ' THR . 1.3 m 152.58 -66.79 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.794 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.757 ' CZ ' ' NE2' ' A' ' 65' ' ' HIS . 19.7 m-85 55.36 109.42 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.338 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -46.37 -72.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.821 2.348 . . . . 0.0 113.496 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 0.5 OUTLIER -53.39 -49.51 67.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.005 -178.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -56.53 -41.11 76.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.987 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.462 ' O ' ' N ' ' A' ' 129' ' ' GLY . 14.1 t80 -71.66 139.54 49.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.733 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.9 mm -53.08 90.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.158 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 127' ' ' TYR . . . 104.3 -114.33 4.69 Favored Glycine 0 CA--C 1.517 0.216 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -137.79 136.52 37.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.911 0.386 . . . . 0.0 110.372 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.733 ' O ' ' NH1' ' A' ' 134' ' ' ARG . . . -112.24 83.97 5.58 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.271 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -50.55 -37.68 52.94 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.781 2.321 . . . . 0.0 112.282 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -115.8 149.17 38.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.429 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.733 ' NH1' ' O ' ' A' ' 131' ' ' ALA . 62.5 mmt-85 -103.59 136.6 43.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.508 ' OH ' ' CD2' ' A' ' 76' ' ' LEU . 5.0 t80 -68.13 130.6 43.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.674 -0.411 . . . . 0.0 109.903 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.6 mm -120.58 118.91 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.501 ' CD1' ' CD2' ' A' ' 135' ' ' TYR . 1.2 mp -108.1 109.02 26.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -91.13 140.05 30.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.906 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.13 137.3 18.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.955 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 69.2 tttt -112.54 158.53 19.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.022 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.537 ' N ' ' CG ' ' A' ' 140' ' ' LYS . 10.6 tp -77.06 122.68 25.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.449 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.25 -38.19 6.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.515 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.562 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -148.7 149.68 21.73 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.5 p -135.6 152.96 51.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.379 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -128.54 147.66 50.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.779 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.8 t -133.37 136.93 45.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 110.526 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.8 tptp . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.563 -179.665 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.2 p -120.27 136.17 54.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.825 0.345 . . . . 0.0 110.576 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -156.08 155.95 33.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.673 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 98.5 mmm -41.43 146.25 0.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.416 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 t -151.73 168.55 24.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.431 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.2 p -76.68 166.38 23.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.697 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.428 ' O ' ' CB ' ' A' ' 11' ' ' LYS . 12.7 mm-40 -83.49 127.9 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.706 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 26.4 m -113.47 -1.37 14.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.425 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.5 -96.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.358 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.515 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 1.5 m80 -97.6 14.09 27.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.339 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 7' ' ' GLN . 9.9 tmtt? -70.39 125.94 28.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.113 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.669 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 1.8 mp0 -67.58 151.09 47.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.358 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.39 9.8 81.1 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -121.47 135.68 55.02 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.343 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.43 ' HZ3' ' HB3' ' A' ' 29' ' ' SER . 1.3 tttp -61.86 122.83 16.39 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.948 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.427 ' H ' HG21 ' A' ' 16' ' ' VAL . 14.3 m -117.29 -40.72 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.137 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.44 165.6 27.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.648 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.1 ttp -130.45 137.25 49.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.633 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.5 tp -99.11 127.69 45.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.486 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.57 HD22 ' NZ ' ' A' ' 27' ' ' LYS . 16.7 t-20 -117.4 125.91 51.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.205 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.9 mt -103.24 108.37 58.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.445 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -75.41 -40.1 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.435 2.09 . . . . 0.0 112.392 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -60.64 -42.99 98.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.626 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.7 mm? -99.13 3.4 46.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.562 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.86 51.3 16.19 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.474 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -132.1 173.13 11.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.989 0.424 . . . . 0.0 110.974 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.57 ' NZ ' HD22 ' A' ' 20' ' ' ASN . 2.7 mtpp -143.67 152.3 41.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.203 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -146.63 130.49 17.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.939 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.446 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 13.3 m -83.01 112.77 20.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.413 ' N ' HD13 ' A' ' 30' ' ' ILE . 1.5 mp -83.14 124.75 39.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.446 ' CE1' ' O ' ' A' ' 29' ' ' SER . 83.9 m-85 -110.1 140.6 44.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.858 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.515 ' CD1' ' O ' ' A' ' 10' ' ' HIS . 37.3 t-105 -60.69 118.35 6.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.963 0.411 . . . . 0.0 110.693 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.414 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 92.85 158.56 34.41 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.72 103.4 6.09 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.887 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -101.55 139.55 37.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.845 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.405 ' OD1' ' CE1' ' A' ' 65' ' ' HIS . 38.6 m-20 -83.37 -23.27 32.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.494 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.76 -40.1 84.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.821 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.443 ' HG1' ' HE2' ' A' ' 40' ' ' LYS . 41.3 p -72.76 134.8 45.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.625 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -98.39 -0.78 42.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.615 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.619 ' O ' ' C ' ' A' ' 41' ' ' LYS . 61.4 pttt -37.73 166.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.191 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.619 ' C ' ' O ' ' A' ' 40' ' ' LYS . 95.3 mttt -12.35 -77.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.432 0.458 . . . . 0.0 111.277 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.45 ' O ' ' OD2' ' A' ' 67' ' ' ASP . . . 137.78 59.74 0.05 OUTLIER Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.2 p -166.49 101.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 121.056 0.455 . . . . 0.0 110.773 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.65 154.49 19.2 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.554 ' SD ' ' CG2' ' A' ' 60' ' ' THR . 3.3 tpp -90.52 132.89 35.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.53 121.58 18.09 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.383 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.2 t -91.95 127.69 44.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.665 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.698 ' N ' ' OG1' ' A' ' 51' ' ' THR . 7.2 t -164.13 165.18 22.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.495 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -64.07 -34.26 77.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.675 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 2.8 m -89.58 -12.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.957 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.698 ' OG1' ' N ' ' A' ' 48' ' ' SER . 24.9 p -84.95 144.2 28.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.019 0.438 . . . . 0.0 110.866 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.489 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.7 OUTLIER -134.92 174.55 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.934 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.94 159.87 27.97 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.801 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -81.5 66.2 8.62 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.606 2.204 . . . . 0.0 112.522 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.1 p -112.89 -6.32 13.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.541 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.0 92.68 0.09 OUTLIER Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.545 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.5 85.01 0.04 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.499 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -156.87 155.06 26.05 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.489 ' N ' ' OG1' ' A' ' 52' ' ' THR . 19.9 t-160 -80.08 104.65 10.79 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.554 ' CG2' ' SD ' ' A' ' 45' ' ' MET . 26.0 m -101.08 122.45 43.6 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.888 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 54.9 t -111.91 124.81 68.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.157 0.503 . . . . 0.0 110.423 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.461 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.6 mm? -113.01 139.5 48.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.382 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.0 m -140.87 153.61 45.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.072 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.75 143.52 11.81 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.405 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 79.0 m80 -115.73 129.24 56.39 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.306 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.564 ' O ' ' O ' ' A' ' 67' ' ' ASP . 43.9 mtp180 59.73 -95.88 0.06 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.631 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 66' ' ' ARG . 59.8 m-20 51.92 119.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.752 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 68' ' ' THR . 4.3 p -97.46 79.93 2.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.395 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.7 t -123.11 130.45 74.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.677 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.681 ' O ' ' N ' ' A' ' 72' ' ' ASP . 41.2 t80 -81.72 -114.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.384 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.531 ' C ' ' O ' ' A' ' 70' ' ' PHE . 41.1 p 28.11 33.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.673 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.681 ' N ' ' O ' ' A' ' 70' ' ' PHE . 55.1 m-20 -62.16 -36.89 83.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.168 0.509 . . . . 0.0 110.924 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.547 ' CD2' ' N ' ' A' ' 73' ' ' LEU . 3.6 mm? -62.72 -32.17 73.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.44 -18.21 59.16 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.429 ' OE1' ' OD1' ' A' ' 72' ' ' ASP . 85.4 mt-30 -72.93 -39.52 66.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.999 0.428 . . . . 0.0 110.446 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.55 ' CD1' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -109.12 103.65 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.137 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.6 ptpt -179.07 150.44 0.46 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -78.93 -13.37 59.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.523 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -86.87 -13.7 44.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.117 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 81' ' ' THR . 2.5 t0 -75.25 153.61 37.92 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.704 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.638 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -137.98 143.3 40.6 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.5 mt -118.3 129.89 55.71 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.927 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.439 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 2.8 t -115.46 121.6 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.547 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.408 ' N ' HD13 ' A' ' 84' ' ' LEU . 10.2 mp -101.06 133.2 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.224 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 85.1 mt-10 -107.98 120.7 43.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.209 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.442 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 1.5 t80 -147.23 137.3 23.19 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.083 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 50.59 42.03 26.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 0.0 111.043 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.6 m120 63.41 26.78 15.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.295 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 40.4 mttm -116.26 170.84 8.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.973 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.25 111.84 7.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.684 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.439 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 7.9 m-85 -96.27 136.92 36.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.203 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -104.86 113.12 26.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.802 0.334 . . . . 0.0 111.452 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.463 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 85.1 m-85 -110.2 151.68 27.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.554 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -128.04 140.2 52.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.408 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 2.4 mm -68.99 118.49 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.033 -179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -94.44 -59.23 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -144.84 140.05 28.13 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.27 0.557 . . . . 0.0 110.59 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 mp -119.67 127.93 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.78 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.457 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 23.1 p90 -144.06 -175.78 4.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.569 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.482 HG13 ' CD1' ' A' ' 135' ' ' TYR . 4.2 mp -126.32 132.45 70.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.471 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.711 ' HG1' ' CB ' ' A' ' 105' ' ' ASP . 2.3 t -134.51 165.3 25.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 110.73 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -73.95 149.42 41.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.331 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.1 -10.91 3.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.648 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -108.28 24.6 12.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.131 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.711 ' CB ' ' HG1' ' A' ' 101' ' ' THR . 20.4 t0 -90.18 102.01 14.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.944 0.402 . . . . 0.0 110.585 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.657 ' O ' ' N ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -70.91 -35.91 72.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.606 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.2 p -42.06 -18.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.586 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.535 ' N ' ' O ' ' A' ' 106' ' ' ARG . 4.0 t -104.68 -15.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.012 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.657 ' N ' ' O ' ' A' ' 106' ' ' ARG . 52.1 mm -114.44 20.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.187 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.658 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -82.68 -173.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -92.53 146.1 23.94 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.846 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.471 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.6 mttt -133.46 177.21 7.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.294 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -129.86 17.05 5.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.913 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -135.43 158.76 73.78 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.499 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 37.2 Cg_endo -74.59 86.65 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 123.186 2.59 . . . . 0.0 110.693 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.8 mm -121.78 133.4 68.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.1 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.532 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 6.2 tt -108.1 119.78 40.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.216 0.531 . . . . 0.0 110.335 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 88.2 m -114.89 117.88 31.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.394 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.558 HD11 ' N ' ' A' ' 120' ' ' THR . 5.6 tp -105.98 128.38 53.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.28 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.558 ' N ' HD11 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -113.89 114.16 25.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.284 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.506 ' HB ' ' CZ ' ' A' ' 123' ' ' TYR . 1.2 p -94.47 136.65 34.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.985 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 17.6 t -134.36 61.64 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.145 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.604 ' N ' ' CD1' ' A' ' 123' ' ' TYR . 0.5 OUTLIER -102.95 137.29 19.23 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.092 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.86 51.43 2.34 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.53 2.153 . . . . 0.0 112.126 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.65 ' CG ' ' N ' ' A' ' 126' ' ' ASP . 3.1 p90 -59.38 -48.5 81.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.446 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.65 ' N ' ' CG ' ' A' ' 125' ' ' PHE . 25.4 t70 -113.37 -31.32 6.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.515 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 128' ' ' ILE . 87.1 t80 -89.59 161.11 16.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.499 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.711 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 88.0 mt -104.69 115.17 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.769 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.97 -118.35 5.13 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.473 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 43.1 t0 -86.12 100.71 12.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.341 . . . . 0.0 110.567 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.49 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . . . -60.01 113.05 6.35 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.122 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -48.57 -43.3 33.86 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.224 1.95 . . . . 0.0 112.149 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -85.91 148.15 25.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.237 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 35.5 ttp180 -123.52 119.42 29.9 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.135 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.482 ' CD1' HG13 ' A' ' 100' ' ' ILE . 4.6 t80 -69.18 137.94 53.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.961 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 6.8 mm -122.63 122.13 65.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.17 112.03 38.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.457 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 38.4 tt0 -95.59 134.06 38.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.942 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.74 145.23 34.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.18 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -117.37 145.83 43.8 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.215 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.463 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 16.9 tp -69.8 123.26 20.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.491 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.2 p -99.33 -43.66 6.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.224 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.582 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -145.89 165.9 28.0 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 35.4 p -139.55 142.28 37.19 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.708 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -124.53 143.57 50.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.3 p -133.51 127.31 32.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.442 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.4 tttp . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.724 179.779 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.553 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.578 ' O ' ' O ' ' A' ' 3' ' ' HIS . 14.8 m 26.08 76.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.777 0.322 . . . . 0.0 110.505 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.578 ' O ' ' O ' ' A' ' 2' ' ' SER . 84.7 t60 54.72 140.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.476 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.2 mtt -101.01 115.88 31.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.346 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.562 ' O ' ' OG ' ' A' ' 6' ' ' SER . 10.2 p -140.23 143.05 35.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.544 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.562 ' OG ' ' O ' ' A' ' 5' ' ' SER . 16.0 m -171.9 83.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.63 151.25 38.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.533 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m -65.24 118.82 9.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.51 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.634 ' C ' ' CG ' ' A' ' 10' ' ' HIS . 96.8 mt-10 -149.63 6.08 0.62 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.559 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.634 ' CG ' ' C ' ' A' ' 9' ' ' GLU . 1.7 m-70 86.65 9.79 0.21 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.498 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -75.5 137.46 40.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.606 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.442 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 59.9 mp0 -68.96 137.45 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.279 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 94.84 12.98 54.85 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -120.35 134.92 55.18 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.801 0.334 . . . . 0.0 110.498 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' NZ ' ' SD ' ' A' ' 18' ' ' MET . 88.3 tttt -57.99 120.06 7.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.349 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.14 -31.95 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.78 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.45 161.94 36.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.673 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.564 ' SD ' ' OG ' ' A' ' 29' ' ' SER . 1.0 OUTLIER -123.45 133.88 54.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.432 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.543 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 2.0 tt -104.1 122.56 45.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.622 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.401 HD21 ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -115.29 126.12 54.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.85 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.401 ' N ' HD21 ' A' ' 20' ' ' ASN . 7.9 mt -102.86 114.82 65.02 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.322 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 81' ' ' THR . 60.8 Cg_endo -77.68 -43.9 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.812 2.341 . . . . 0.0 112.527 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.464 ' CE ' ' HZ2' ' A' ' 77' ' ' LYS . 24.2 tptp -60.37 -41.72 94.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.569 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.638 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.8 mm? -98.31 0.24 45.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.812 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 49.79 42.07 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.68 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -119.96 162.65 18.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.9 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -135.38 145.06 46.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.765 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 19' ' ' LEU . 61.8 m-85 -141.0 150.45 43.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.584 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.564 ' OG ' ' SD ' ' A' ' 18' ' ' MET . 9.9 m -103.27 119.65 39.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.801 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.543 ' CD1' ' N ' ' A' ' 19' ' ' LEU . 4.6 mp -83.8 124.18 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.259 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.415 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 42.1 m-85 -107.17 135.04 49.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.989 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.499 ' O ' ' N ' ' A' ' 13' ' ' GLY . 26.2 t-105 -60.42 127.75 33.27 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.6 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.468 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 75.05 144.67 1.09 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -110.5 81.44 1.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.758 0.313 . . . . 0.0 110.685 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -77.16 131.38 38.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.482 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -89.49 -1.81 58.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.543 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.31 85.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.743 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 m -83.15 154.28 24.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.65 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.643 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 2.9 mm? -76.89 144.11 39.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.506 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.561 ' C ' ' O ' ' A' ' 39' ' ' LEU . 7.3 mtmm -25.87 104.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.484 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.25 -52.81 4.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.06 -56.25 0.08 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 43' ' ' VAL . 2.3 p -173.31 122.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.095 0.474 . . . . 0.0 110.566 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.44 150.5 16.84 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -96.21 127.92 42.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.747 0.308 . . . . 0.0 110.655 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.507 ' O ' ' SD ' ' A' ' 45' ' ' MET . 9.5 t80 -69.1 131.8 45.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.527 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.454 HG21 ' CE2' ' A' ' 32' ' ' TRP . 33.6 t -111.26 128.87 67.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.567 ' N ' ' OG1' ' A' ' 51' ' ' THR . 33.0 p -161.99 171.8 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.584 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 39.4 t0 -74.98 10.1 1.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.464 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 3.7 m -132.27 -15.58 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.665 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 48' ' ' SER . 2.6 p -87.8 139.7 30.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.611 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.802 ' HG1' ' N ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -131.04 169.52 15.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.633 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.64 154.71 38.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.466 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' CB ' HD11 ' A' ' 84' ' ' LEU . 59.3 Cg_endo -78.97 61.08 8.03 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.835 2.357 . . . . 0.0 112.214 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.48 ' C ' ' HH ' ' A' ' 91' ' ' TYR . 0.1 OUTLIER -107.33 -5.36 17.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.64 179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.99 91.94 0.09 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.92 92.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.441 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.27 155.18 26.02 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.802 ' N ' ' HG1' ' A' ' 52' ' ' THR . 21.7 t-160 -79.59 112.59 17.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.932 0.396 . . . . 0.0 110.1 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.3 m -105.48 123.39 47.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.348 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 63.5 t -116.7 127.42 74.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.476 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.2 mm? -109.76 145.51 36.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.616 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 44.1 t -130.3 144.13 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.591 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.592 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -171.84 178.72 43.94 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.613 ' ND1' ' CD1' ' A' ' 123' ' ' TYR . 28.3 m-70 -119.85 150.72 39.99 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 122.636 -0.332 . . . . 0.0 110.625 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -55.36 117.14 3.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.473 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.599 ' O ' ' C ' ' A' ' 68' ' ' THR . 96.8 m-20 -103.67 115.69 30.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.817 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.599 ' C ' ' O ' ' A' ' 67' ' ' ASP . 7.5 m 18.77 -125.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.455 0.472 . . . . 0.0 110.694 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.473 ' H ' ' CG2' ' A' ' 68' ' ' THR . 6.9 m -120.39 -148.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.54 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.72 ' C ' ' H ' ' A' ' 72' ' ' ASP . 89.4 t80 57.67 158.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.438 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.414 ' N ' ' CG ' ' A' ' 70' ' ' PHE . 25.2 m 62.26 -28.05 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.521 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.72 ' H ' ' C ' ' A' ' 70' ' ' PHE . 50.4 m-20 -59.66 -46.03 90.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.874 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -42.86 93.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.756 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.586 ' O ' ' CG ' ' A' ' 77' ' ' LYS . . . -67.83 -23.88 74.19 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -71.24 -36.36 71.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.757 0.313 . . . . 0.0 110.817 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -88.85 73.69 8.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.642 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.586 ' CG ' ' O ' ' A' ' 74' ' ' GLY . 10.5 ptpt -169.38 129.86 1.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.436 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -74.75 -10.46 59.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.582 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -79.95 -16.36 55.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.361 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.686 ' OD1' ' N ' ' A' ' 81' ' ' THR . 34.5 t0 -71.38 154.38 41.61 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.586 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.686 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.6 OUTLIER -141.3 117.7 10.81 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.916 0.389 . . . . 0.0 110.803 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 51.8 mt -90.7 128.96 36.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.642 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 t -105.23 127.08 60.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.383 . . . . 0.0 110.239 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.403 HD11 ' CB ' ' A' ' 54' ' ' PRO . 33.4 mt -111.07 122.89 49.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.96 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 84.2 mt-10 -99.59 119.35 37.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.69 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -150.06 129.39 12.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.995 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 56.46 43.98 25.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.996 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.509 ' OD1' ' C ' ' A' ' 147' ' ' LYS . 6.3 t-20 61.82 15.4 7.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.645 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -114.99 137.13 52.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.202 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.3 OUTLIER -107.67 124.04 49.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.755 -178.909 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.48 ' HH ' ' C ' ' A' ' 55' ' ' SER . 63.8 m-85 -108.89 125.56 52.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.096 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.428 ' OG1' ' C ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -94.95 107.09 19.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.143 -179.383 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.544 ' CZ ' ' HB2' ' A' ' 141' ' ' LEU . 40.2 m-85 -95.09 156.92 16.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.577 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.5 134.1 45.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.55 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mm -65.7 114.59 3.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.246 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -83.57 -66.18 0.92 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.842 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.509 ' NZ ' ' O ' ' A' ' 98' ' ' ILE . 29.1 tptp -150.36 146.91 27.01 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.506 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.509 ' O ' ' NZ ' ' A' ' 97' ' ' LYS . 5.2 mm -114.16 135.36 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.482 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 14.3 p90 -155.43 178.68 9.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.683 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 2.3 mt -127.47 128.83 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.151 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.521 ' HG1' ' H ' ' A' ' 102' ' ' HIS . 3.0 t -131.05 172.87 11.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.521 ' H ' ' HG1' ' A' ' 101' ' ' THR . 25.1 t60 -62.92 171.95 1.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.551 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.36 -20.47 28.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.555 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.55 19.32 17.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.449 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.525 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 28.9 t0 -83.17 92.4 7.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.71 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.702 ' O ' ' N ' ' A' ' 108' ' ' VAL . 36.6 ptt180 -63.52 -37.84 88.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.234 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.525 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 9.4 p -37.0 -18.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.258 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.702 ' N ' ' O ' ' A' ' 106' ' ' ARG . 10.9 t -108.86 -21.3 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.711 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.701 ' N ' ' O ' ' A' ' 106' ' ' ARG . 33.5 mm -109.71 28.13 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.774 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -93.07 -165.71 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.329 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -99.57 141.5 32.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.647 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.48 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.1 mttt -128.21 135.46 49.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.206 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -81.63 7.98 10.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.499 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.52 160.18 69.34 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.441 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 41.1 Cg_endo -74.69 101.23 1.42 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.936 2.424 . . . . 0.0 111.972 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.2 mm -131.33 135.11 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.788 -179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.408 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 9.4 tt -106.32 118.58 37.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.794 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.414 HG22 ' CG1' ' A' ' 108' ' ' VAL . 53.6 m -122.75 121.35 36.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.364 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.595 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 5.8 tt -109.26 124.71 51.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.015 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 135' ' ' TYR . 0.2 OUTLIER -116.51 124.54 50.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.376 178.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.673 ' O ' ' SG ' ' A' ' 122' ' ' CYS . 1.7 t -151.07 177.93 9.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.848 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.673 ' SG ' ' O ' ' A' ' 121' ' ' THR . 1.3 m 155.1 -75.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.507 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.613 ' CD1' ' ND1' ' A' ' 65' ' ' HIS . 21.1 m-85 25.84 67.68 0.46 Allowed Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.75 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -77.41 149.25 27.36 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.812 2.342 . . . . 0.0 111.953 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -66.65 -31.28 71.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.388 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -60.39 -48.68 80.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.518 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.413 ' CD1' ' HD3' ' A' ' 132' ' ' PRO . 35.4 t80 -85.79 135.43 33.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.402 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.8 mp -101.98 118.17 48.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.425 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.72 -104.37 1.86 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.482 ' HB3' HH12 ' A' ' 134' ' ' ARG . 0.2 OUTLIER -128.72 105.43 8.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 0.0 110.624 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -41.11 144.99 0.61 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.547 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.413 ' HD3' ' CD1' ' A' ' 127' ' ' TYR . 26.0 Cg_endo -62.12 -29.62 81.24 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.882 2.388 . . . . 0.0 112.212 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -128.89 140.28 51.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.394 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.482 HH12 ' HB3' ' A' ' 130' ' ' ASP . 1.3 mpt_? -115.72 138.25 51.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.659 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.499 ' CD2' ' CD1' ' A' ' 137' ' ' ILE . 4.5 t80 -73.23 123.94 24.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.024 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 2.4 mm -115.8 118.67 59.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.883 -178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.499 ' CD1' ' CD2' ' A' ' 135' ' ' TYR . 1.2 mp -105.24 107.22 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.482 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 46.3 tt0 -88.3 134.95 33.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.308 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.84 138.96 21.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.482 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.534 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 31.6 ttpt -109.27 161.28 15.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 93' ' ' TYR . 2.6 tm? -91.77 115.89 28.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.241 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.526 ' N ' HD21 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -110.94 -66.01 1.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.898 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.466 ' N ' ' OG1' ' A' ' 142' ' ' THR . . . -83.32 165.53 43.04 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.415 ' O ' ' CG ' ' A' ' 145' ' ' TYR . 12.4 p -158.15 158.08 33.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.799 0.333 . . . . 0.0 110.582 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 90' ' ' THR . 79.4 m-85 -153.99 104.8 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.523 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.5 p -98.99 122.28 42.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.637 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.509 ' C ' ' OD1' ' A' ' 88' ' ' ASN . 68.6 mttm . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.429 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.582 ' O ' ' O ' ' A' ' 1' ' ' GLY . 2.1 m 53.59 134.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 110.799 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -88.49 -18.41 28.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.604 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.485 ' HG2' ' H ' ' A' ' 5' ' ' SER . 4.5 ttt 67.55 -132.71 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.532 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.485 ' H ' ' HG2' ' A' ' 4' ' ' MET . 74.5 m -68.68 -68.5 0.39 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.775 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 7' ' ' GLN . 67.7 p -153.02 -163.41 1.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.517 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 6' ' ' SER . 18.3 mp0 56.61 115.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.513 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.487 ' OG1' ' N ' ' A' ' 9' ' ' GLU . 54.5 p -101.46 -77.78 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.569 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 10' ' ' HIS . 0.1 OUTLIER 165.88 -30.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.672 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.488 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 57.1 t-80 -98.37 -2.05 40.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.671 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -65.47 138.92 58.41 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.621 -0.432 . . . . 0.0 109.944 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -80.79 151.02 28.98 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.59 15.25 71.42 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -118.07 132.1 56.39 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.044 0.45 . . . . 0.0 110.456 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.485 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 61.9 tttm -58.24 106.09 0.34 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.601 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.47 HG23 ' N ' ' A' ' 17' ' ' ALA . 14.5 m -110.55 -38.81 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' N ' HG23 ' A' ' 16' ' ' VAL . . . -131.38 155.64 46.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.607 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.7 ttp -121.29 131.54 54.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.84 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.8 tp -93.95 123.67 37.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.425 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -119.5 124.3 46.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.0 mt -106.64 111.61 63.89 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.242 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.618 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.9 Cg_endo -78.9 -42.78 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 123.057 2.505 . . . . 0.0 112.615 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -63.01 -39.05 93.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.0 mm? -99.54 5.81 45.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.907 0.384 . . . . 0.0 110.522 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 44.71 56.91 4.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.42 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.55 ' HZ1' ' CG2' ' A' ' 71' ' ' THR . 19.2 mtmt -141.37 158.71 43.51 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.667 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -141.26 140.46 33.9 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.612 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -133.81 155.41 49.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.5 m -95.92 118.37 32.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.442 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -95.31 123.84 47.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.243 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.485 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 52.4 m-85 -103.76 142.92 33.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.515 ' CZ2' ' HB ' ' A' ' 47' ' ' VAL . 40.9 t-105 -61.54 130.92 48.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.952 0.406 . . . . 0.0 110.659 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 84.51 171.39 48.01 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.1 91.8 1.89 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.906 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -98.85 101.69 13.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.657 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 37' ' ' ALA . 42.1 p30 -70.97 -23.03 62.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.696 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.511 ' N ' ' OD1' ' A' ' 36' ' ' ASP . . . -56.48 -49.22 75.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.705 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.2 p -87.64 163.85 16.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.551 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.469 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 4.1 mm? -112.5 126.49 55.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.635 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -153.24 -80.44 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.358 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -138.57 154.61 48.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.921 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.04 39.16 3.14 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.12 92.21 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 120.943 0.401 . . . . 0.0 110.701 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.74 153.14 19.56 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.477 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 2.8 tpp -103.14 142.88 33.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -75.97 140.27 41.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.402 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.515 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.1 p -123.37 124.3 69.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.465 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 51' ' ' THR . 21.1 t -168.76 169.67 9.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.531 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -62.99 -37.39 86.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.29 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 3.0 m -83.98 -26.6 7.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.843 0.354 . . . . 0.0 110.552 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 48' ' ' SER . 64.8 p -99.05 142.58 30.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.823 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -143.83 175.45 9.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.654 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.624 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -91.36 155.07 44.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.731 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.59 84.29 2.0 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.746 2.298 . . . . 0.0 112.431 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.3 p -115.22 -7.64 12.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.727 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.08 89.29 0.07 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.68 84.65 0.07 OUTLIER Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.477 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -166.4 158.87 32.0 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.659 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 19.1 t-160 -78.71 121.9 25.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 88.9 m -119.2 128.39 54.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.564 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.448 HG12 ' CD1' ' A' ' 109' ' ' ILE . 55.0 t -119.5 132.84 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.099 0.476 . . . . 0.0 110.238 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.462 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.8 mm? -113.18 140.56 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.625 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.564 ' OG ' ' OH ' ' A' ' 123' ' ' TYR . 37.9 t -118.84 136.69 53.88 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.427 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.57 87.59 0.14 Allowed Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.562 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -66.31 135.02 53.8 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.583 -0.363 . . . . 0.0 110.026 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.562 ' O ' ' O ' ' A' ' 65' ' ' HIS . 77.7 ttt-85 54.88 133.38 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.559 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -119.6 -172.86 2.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.294 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.588 ' HG1' ' N ' ' A' ' 69' ' ' VAL . 69.6 p -97.42 -110.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.748 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.588 ' N ' ' HG1' ' A' ' 68' ' ' THR . 1.2 p -179.25 -14.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.513 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.544 ' CE2' ' NZ ' ' A' ' 26' ' ' LYS . 1.6 p90 -96.01 154.39 17.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.481 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.55 ' CG2' ' HZ1' ' A' ' 26' ' ' LYS . 22.6 p 52.4 8.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.66 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.517 ' H ' ' C ' ' A' ' 70' ' ' PHE . 51.9 t0 -61.14 -43.24 99.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.129 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -60.94 -41.3 95.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.039 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.79 -28.95 74.04 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.63 -39.9 84.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 110.391 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.464 HD22 ' N ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -95.54 101.72 13.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.98 -179.734 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.439 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 11.2 ptpt 175.84 145.95 0.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.567 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.68 -14.61 60.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.128 0.489 . . . . 0.0 110.698 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -79.67 -15.25 57.93 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.725 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.12 154.3 29.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.762 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.618 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -141.37 115.26 9.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.418 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.2 mt -89.19 131.43 35.32 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.236 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 48.8 t -111.53 122.42 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.054 0.454 . . . . 0.0 109.852 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.463 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 3.4 mm? -112.67 132.47 55.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.696 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -104.7 119.54 39.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.42 178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.624 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 9.1 t80 -140.49 137.3 33.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.022 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.433 ' O ' ' CG ' ' A' ' 87' ' ' ASP . 50.1 t0 50.98 41.12 26.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.158 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 65.86 16.77 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.264 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -117.82 149.77 40.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.4 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -110.96 125.85 54.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.532 -179.136 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -110.15 125.76 53.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.455 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.625 ' N ' ' O ' ' A' ' 143' ' ' GLY . 0.3 OUTLIER -97.81 108.18 20.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.697 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.571 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 62.9 m-85 -98.98 151.91 20.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.704 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -124.41 132.69 53.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.759 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 77' ' ' LYS . 1.2 mm -65.86 119.62 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.059 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -89.84 -57.79 2.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.951 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -153.35 151.48 30.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.295 0.569 . . . . 0.0 109.934 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 16.0 mm -122.41 132.15 71.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.25 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.467 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 11.2 p90 -150.21 178.87 8.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.192 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 7.9 mt -125.87 138.65 53.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.664 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.4 t -138.68 169.14 18.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.268 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.478 ' ND1' ' OD1' ' A' ' 133' ' ' ASP . 68.5 m-70 -68.86 168.23 13.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.672 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.489 ' HA ' ' HE ' ' A' ' 134' ' ' ARG . . . -76.08 -9.51 58.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -105.35 20.06 19.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.062 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.561 ' OD2' ' OG1' ' A' ' 107' ' ' THR . 24.4 t70 -87.28 95.01 9.83 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.705 0.288 . . . . 0.0 110.761 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.591 ' O ' ' N ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -73.33 -20.21 60.84 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.122 0.487 . . . . 0.0 110.615 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.561 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 20.9 p -44.87 -14.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.445 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 106' ' ' ARG . 11.0 m -112.37 -12.16 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.406 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.591 ' N ' ' O ' ' A' ' 106' ' ' ARG . 49.0 mm -109.48 13.49 8.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.663 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -92.61 -170.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.83 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -95.12 155.22 16.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.446 ' HZ2' HG23 ' A' ' 116' ' ' ILE . 97.0 mttt -131.73 -174.47 3.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.871 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -125.48 10.14 7.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.132 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.75 168.13 11.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.971 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.477 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 38.1 Cg_endo -75.76 97.55 1.11 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.084 2.522 . . . . 0.0 111.929 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.446 HG23 ' HZ2' ' A' ' 112' ' ' LYS . 51.2 mm -127.6 132.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.709 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 tt -106.14 123.85 48.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.245 0.545 . . . . 0.0 109.827 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 96.7 m -115.69 126.67 54.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.458 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 120' ' ' THR . 0.6 OUTLIER -112.35 126.35 55.18 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.198 -179.398 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.503 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -122.89 117.45 25.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.078 179.239 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.649 ' O ' ' CB ' ' A' ' 122' ' ' CYS . 42.9 p -131.27 176.29 8.4 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.528 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.649 ' CB ' ' O ' ' A' ' 121' ' ' THR . 5.1 t 97.77 -68.13 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.056 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.631 ' O ' ' O ' ' A' ' 124' ' ' PRO . 18.3 m-85 62.27 155.67 0.11 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.27 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.631 ' O ' ' O ' ' A' ' 123' ' ' TYR . 71.1 Cg_exo -41.85 -125.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.163 2.576 . . . . 0.0 113.157 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.585 ' O ' ' N ' ' A' ' 127' ' ' TYR . 47.5 p90 -58.35 -34.9 71.16 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.565 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 125' ' ' PHE . 81.3 m-20 -37.67 -24.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.411 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.665 ' CD1' ' N ' ' A' ' 128' ' ' ILE . 3.5 t80 -90.98 163.14 14.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.327 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.665 ' N ' ' CD1' ' A' ' 127' ' ' TYR . 2.0 mt -67.72 95.36 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.94 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.61 -128.18 8.66 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -133.88 114.94 13.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.762 0.315 . . . . 0.0 110.685 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.585 ' CB ' ' SG ' ' A' ' 122' ' ' CYS . . . -118.51 81.23 17.56 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.502 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -53.12 -38.25 80.58 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.699 2.266 . . . . 0.0 111.881 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.478 ' OD1' ' ND1' ' A' ' 102' ' ' HIS . 95.1 m-20 -107.86 144.27 35.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.607 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.489 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 85.7 mtm180 -98.27 142.24 30.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.29 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -72.92 132.49 43.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.34 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.7 mm -118.05 120.12 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.5 mm -105.68 111.53 35.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.747 177.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.458 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 39.4 tt0 -99.03 129.18 45.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.083 0.468 . . . . 0.0 110.946 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -135.46 150.63 49.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.412 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.462 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 53.4 tptt -115.75 140.99 48.68 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.571 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 2.6 tm? -80.22 117.2 20.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.447 ' OG1' ' N ' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -108.34 -61.23 1.62 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.68 -179.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.625 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -104.72 151.99 17.38 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.7 m -150.43 148.94 29.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.952 0.406 . . . . 0.0 110.222 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.418 ' N ' ' O ' ' A' ' 90' ' ' THR . 81.8 m-85 -132.2 156.92 45.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.404 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.9 p -137.09 125.13 22.86 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.315 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.449 ' O ' ' CD ' ' A' ' 147' ' ' LYS . 5.9 tmtt? . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.576 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 t -60.17 -48.46 81.65 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.818 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.423 ' CD2' ' HG ' ' A' ' 5' ' ' SER . 10.8 t60 -152.37 108.27 3.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.131 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 69.1 mmm -126.48 99.64 5.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.649 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.423 ' HG ' ' CD2' ' A' ' 3' ' ' HIS . 8.3 p -144.35 2.88 1.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.6 p -64.42 153.96 37.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.647 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.691 ' NE2' ' OE1' ' A' ' 14' ' ' GLU . 3.1 tp60 -97.97 -166.74 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.455 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.467 ' H ' ' HG3' ' A' ' 7' ' ' GLN . 0.2 OUTLIER 77.03 -17.61 0.55 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.44 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.458 ' H ' ' C ' ' A' ' 7' ' ' GLN . 98.7 mt-10 -67.98 -172.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.493 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -112.65 91.83 3.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.468 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -131.79 129.32 40.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.183 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.489 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 56.4 mp0 -65.5 145.76 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.941 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.17 10.76 68.23 Favored Glycine 0 CA--C 1.517 0.214 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.691 ' OE1' ' NE2' ' A' ' 7' ' ' GLN . 6.3 mt-10 -119.47 136.15 54.44 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.079 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.91 117.9 5.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.829 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.415 HG21 ' N ' ' A' ' 17' ' ' ALA . 16.0 m -117.35 -43.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' N ' HG21 ' A' ' 16' ' ' VAL . . . -129.19 161.48 30.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.951 0.405 . . . . 0.0 110.723 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.4 ttt -125.89 131.09 52.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 51.0 tp -95.76 123.55 39.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.51 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -120.24 128.17 53.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.146 0.498 . . . . 0.0 110.687 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.404 HD11 HG23 ' A' ' 21' ' ' ILE . 2.0 mt -106.77 115.65 60.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.294 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 81' ' ' THR . 57.6 Cg_endo -77.88 -49.97 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.077 2.518 . . . . 0.0 112.526 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HG2' ' HZ3' ' A' ' 77' ' ' LYS . 1.9 tptt -63.16 -37.06 85.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.074 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.488 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.7 mm? -96.77 5.81 49.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.977 0.418 . . . . 0.0 110.377 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 24' ' ' LEU . 12.9 mttt 40.21 53.96 2.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.463 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.442 ' NZ ' ' OG1' ' A' ' 71' ' ' THR . 19.6 mtmt -136.73 159.47 41.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.068 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 2.2 mtmt -137.78 154.49 49.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.944 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.423 ' CG ' ' O ' ' A' ' 27' ' ' LYS . 76.8 m-85 -154.23 150.61 28.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.949 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.0 m -99.87 119.33 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.541 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.496 ' N ' HD12 ' A' ' 30' ' ' ILE . 1.7 mp -93.07 122.16 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.611 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -97.89 141.14 31.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.748 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.454 ' CZ3' HG21 ' A' ' 53' ' ' THR . 48.2 t-105 -60.51 130.3 45.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.778 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.85 156.54 32.53 Favored Glycine 0 C--N 1.33 0.22 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.0 78.4 1.58 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.609 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -99.36 108.23 20.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.711 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -76.54 -21.46 55.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.511 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.53 -37.43 86.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.48 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.526 ' O ' ' O ' ' A' ' 39' ' ' LEU . 92.6 m -83.28 16.38 2.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.601 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.526 ' O ' ' O ' ' A' ' 38' ' ' THR . 1.2 pt? 30.79 -152.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.744 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' CB ' ' A' ' 41' ' ' LYS . 18.8 ttmt 54.38 172.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.617 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 76.08 158.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.363 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.3 -55.1 0.47 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.4 m -128.07 129.24 69.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.107 0.48 . . . . 0.0 111.049 179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.93 155.17 21.68 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 2.6 tpp -96.38 127.88 42.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -64.27 142.34 58.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.606 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.452 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.0 p -124.26 125.87 71.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.743 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.642 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.2 OUTLIER -161.8 169.86 20.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.238 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -61.35 -38.97 88.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.183 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 11.9 m -85.17 -31.79 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 48' ' ' SER . 67.3 p -82.61 155.35 24.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.633 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.19 170.85 21.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.375 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.454 HG21 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -87.77 152.93 52.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.641 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.17 83.03 1.91 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.712 2.275 . . . . 0.0 112.463 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.603 ' C ' ' HH ' ' A' ' 91' ' ' TYR . 5.0 p -117.88 -1.45 11.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.35 89.49 0.08 OUTLIER Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.02 90.2 0.02 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.5 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -165.84 163.33 36.65 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.552 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 17.2 t-160 -87.33 106.27 17.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.9 m -101.01 124.15 46.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.354 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.46 HG12 ' CD1' ' A' ' 109' ' ' ILE . 54.3 t -117.87 129.98 73.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.5 . . . . 0.0 110.081 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.502 ' N ' ' O ' ' A' ' 118' ' ' THR . 2.2 mm? -115.18 146.46 41.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.877 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 p -138.25 150.76 47.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.4 130.87 6.33 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.879 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.518 ' O ' ' O ' ' A' ' 66' ' ' ARG . 11.8 t-160 -107.49 114.3 28.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.717 0.294 . . . . 0.0 110.575 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.518 ' O ' ' O ' ' A' ' 65' ' ' HIS . 50.5 ttp85 35.9 99.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.174 0.512 . . . . 0.0 111.29 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 66' ' ' ARG . 91.8 m-20 -140.75 153.97 46.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.771 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.0 p -92.67 112.44 24.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.562 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 9.9 m -131.57 128.28 60.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.761 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -127.15 2.7 6.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.741 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.442 ' OG1' ' NZ ' ' A' ' 26' ' ' LYS . 70.7 p -110.51 20.8 17.33 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.244 0.545 . . . . 0.0 110.402 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.444 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 1.6 p30 -55.58 -24.82 34.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.374 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 tp -56.34 -36.21 68.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.385 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.38 -29.81 21.01 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -67.05 -40.33 87.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.204 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.459 ' N ' HD21 ' A' ' 76' ' ' LEU . 5.9 mt -90.4 86.33 6.43 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.906 0.384 . . . . 0.0 111.186 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.529 ' HZ3' ' HG2' ' A' ' 23' ' ' LYS . 56.7 pttt -178.84 155.58 0.79 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.932 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.13 -11.75 59.72 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.206 0.527 . . . . 0.0 110.731 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -79.86 -15.48 57.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.821 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.19 157.57 29.31 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.821 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.531 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -144.22 118.3 9.46 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.128 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 93' ' ' TYR . 35.4 mt -96.03 134.96 38.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.697 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.1 t -118.31 126.22 74.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.437 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.504 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 4.0 mm? -112.75 134.6 54.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.537 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.94 125.1 50.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.013 179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 1.0 OUTLIER -148.27 133.18 18.08 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.312 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 51.94 51.96 15.42 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.965 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 55.69 27.08 10.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.105 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.431 ' HG2' ' CB ' ' A' ' 146' ' ' SER . 39.0 mtpt -129.92 140.83 50.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.042 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.06 125.46 52.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.9 0.381 . . . . 0.0 110.379 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.603 ' HH ' ' C ' ' A' ' 55' ' ' SER . 17.0 m-85 -104.32 135.26 46.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.164 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.593 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -102.88 113.81 27.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.087 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 82' ' ' LEU . 82.8 m-85 -111.81 147.16 36.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.681 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.494 ' HG3' HE21 ' A' ' 96' ' ' GLN . 15.0 pt-20 -127.92 145.06 51.08 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.389 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.471 ' CD1' HG21 ' A' ' 137' ' ' ILE . 10.0 mm -67.04 120.39 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.318 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.494 HE21 ' HG3' ' A' ' 94' ' ' GLU . 96.3 mm-40 -94.49 -61.15 1.56 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.614 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -148.74 140.99 24.06 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.32 0.581 . . . . 0.0 110.595 -179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.435 HG21 ' CZ ' ' A' ' 135' ' ' TYR . 6.6 mm -117.33 136.75 53.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.026 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.459 ' C ' ' CD1' ' A' ' 99' ' ' TRP . 12.4 p90 -154.59 178.98 9.48 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.379 -0.529 . . . . 0.0 111.395 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.527 ' N ' ' CD1' ' A' ' 100' ' ' ILE . 1.2 mp -128.46 133.52 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.674 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.449 HG23 ' HE1' ' A' ' 99' ' ' TRP . 6.3 t -145.11 160.33 41.58 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.633 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -61.62 150.85 35.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.366 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.79 -4.97 2.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.669 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.548 ' C ' ' OD1' ' A' ' 104' ' ' ASP . 2.1 p30 -99.56 13.52 33.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.849 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.593 ' OD2' ' OG1' ' A' ' 107' ' ' THR . 17.7 t0 -82.71 96.72 8.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.393 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.432 ' O ' HG13 ' A' ' 110' ' ' ILE . 8.7 ptm180 -66.49 -18.4 65.34 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.589 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.593 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 15.5 p -58.56 -16.56 16.19 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.719 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.6 t -100.46 -14.44 7.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.399 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.539 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 48.4 mm -117.02 23.51 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.956 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.552 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.7 OUTLIER -83.61 -162.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.877 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -106.28 134.51 49.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.358 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.49 ' H ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -115.5 126.61 54.5 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.754 -0.378 . . . . 0.0 109.982 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 113' ' ' GLU . 56.2 mp0 -77.72 15.17 0.88 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.105 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -147.36 171.1 6.73 Favored Pre-proline 0 C--N 1.332 -0.163 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.954 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.5 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 56.7 Cg_endo -80.24 90.37 1.25 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.326 2.684 . . . . 0.0 111.949 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.22 133.54 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.725 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.563 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 5.4 tt -106.88 124.02 49.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.492 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.502 ' O ' ' N ' ' A' ' 62' ' ' LEU . 31.8 m -119.32 126.99 52.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.362 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.543 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 5.5 tt -120.11 125.42 48.21 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.315 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.484 ' N ' HD22 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -109.66 126.6 53.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 0.0 110.319 179.065 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.503 ' HB ' ' CE2' ' A' ' 123' ' ' TYR . 1.2 p -102.12 130.15 48.65 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.519 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.469 ' C ' ' CD1' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -137.63 72.85 1.42 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.345 0.593 . . . . 0.0 110.621 179.374 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.781 ' H ' ' CD ' ' A' ' 124' ' ' PRO . 0.1 OUTLIER -118.96 -25.84 0.08 OUTLIER Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.395 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.781 ' CD ' ' H ' ' A' ' 123' ' ' TYR . 73.3 Cg_exo -46.45 93.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.068 1.845 . . . . 0.0 112.614 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 127' ' ' TYR . 48.2 p90 -77.18 -26.67 53.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.382 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -40.26 -26.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.259 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.663 ' CE2' ' O ' ' A' ' 128' ' ' ILE . 41.7 t80 -81.7 161.43 23.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.652 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.663 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 48.1 mm -86.17 91.97 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.327 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.76 -126.55 8.95 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -89.54 114.27 25.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.831 0.348 . . . . 0.0 110.872 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -43.87 110.77 1.02 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.332 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.485 ' HD3' ' CE2' ' A' ' 127' ' ' TYR . 51.2 Cg_exo -49.75 -46.25 28.23 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.415 2.077 . . . . 0.0 112.253 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 10.1 p-10 -97.66 124.43 41.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.099 179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 42.3 mtt85 -103.44 140.59 37.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.069 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.497 ' CD1' HG13 ' A' ' 100' ' ' ILE . 8.1 t80 -84.71 128.87 34.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.556 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 1.3 mt -123.05 128.07 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.471 HG21 ' CD1' ' A' ' 95' ' ' ILE . 1.5 mp -106.39 114.85 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.578 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.412 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 6.0 tt0 -94.43 138.0 32.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.761 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -148.57 148.03 29.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -116.1 160.43 20.35 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.866 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -77.31 123.12 26.05 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.824 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.0 p -98.78 -40.15 8.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.355 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.593 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -145.36 162.99 28.21 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.5 p -139.39 142.87 37.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.874 0.369 . . . . 0.0 110.433 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -129.73 141.22 50.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.37 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.431 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 23.2 t -137.23 141.97 42.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.184 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.0 tptp . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.465 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 55.78 -169.09 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.331 . . . . 0.0 110.502 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -114.23 148.66 37.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.635 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.474 ' C ' ' H ' ' A' ' 6' ' ' SER . 3.6 ptm -85.65 -177.34 6.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.525 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.1 t -77.45 28.08 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.776 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.474 ' H ' ' C ' ' A' ' 4' ' ' MET . 80.7 p -62.57 -22.0 66.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.542 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -108.63 124.28 50.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.61 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.593 ' O ' ' O ' ' A' ' 9' ' ' GLU . 1.1 t -116.51 -6.13 11.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.574 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.593 ' O ' ' O ' ' A' ' 8' ' ' THR . 11.0 pt-20 -48.28 -116.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.702 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.531 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 8.2 m-70 -112.05 18.67 18.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.594 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.83 131.4 46.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.596 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -68.99 151.4 46.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.179 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.35 11.25 80.84 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -118.16 135.01 54.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.4 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -59.01 118.2 5.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.217 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.438 HG23 ' H ' ' A' ' 17' ' ' ALA . 17.1 m -117.48 -34.99 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.118 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.438 ' H ' HG23 ' A' ' 16' ' ' VAL . . . -139.2 163.25 32.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.763 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.617 ' SD ' ' O ' ' A' ' 28' ' ' PHE . 7.6 tpp -121.94 142.56 50.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.527 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 27.6 tp -106.14 123.29 47.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.242 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -120.36 128.24 53.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.162 0.506 . . . . 0.0 111.003 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.482 HG23 ' H ' ' A' ' 24' ' ' LEU . 3.3 mt -105.88 116.76 59.21 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.213 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.615 ' CD ' ' O ' ' A' ' 81' ' ' THR . 59.3 Cg_endo -76.92 -50.09 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.79 2.327 . . . . 0.0 112.903 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.1 tptp -60.43 -38.85 85.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.598 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.0 mm? -100.44 3.99 43.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.875 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.7 mptt 43.22 39.31 1.94 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.622 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.44 ' O ' ' N ' ' A' ' 21' ' ' ILE . 6.8 mmmt -115.53 150.62 36.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.434 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -131.93 147.88 52.49 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.849 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.617 ' O ' ' SD ' ' A' ' 18' ' ' MET . 85.3 m-85 -141.83 162.47 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.691 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.461 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 8.7 p -103.54 122.27 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.929 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.47 HG22 HD13 ' A' ' 30' ' ' ILE . 38.3 mm -95.37 124.51 47.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.286 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -108.11 142.51 38.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.531 ' CD1' ' O ' ' A' ' 10' ' ' HIS . 51.3 t-105 -65.29 132.82 50.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.849 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.549 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 76.35 159.01 8.67 Favored Glycine 0 N--CA 1.46 0.293 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.23 77.86 1.44 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.414 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -103.82 142.17 34.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.902 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.74 -9.13 53.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.508 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.61 81.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.578 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.1 p -67.2 104.02 1.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.458 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.81 -41.73 99.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.616 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -61.63 -41.14 97.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.547 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt 40.88 -143.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.553 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.54 -50.51 0.98 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -154.36 107.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.549 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.23 140.9 16.45 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.549 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 1.2 ttp -91.4 138.04 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.504 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.448 ' CD1' HG22 ' A' ' 51' ' ' THR . 3.0 t80 -76.26 143.12 41.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.954 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.496 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.0 p -130.83 120.33 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.483 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.7 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.6 OUTLIER -170.9 174.98 4.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.577 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -62.92 -38.88 92.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.513 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 2.0 m -85.12 -23.45 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.78 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.7 ' OG1' ' N ' ' A' ' 48' ' ' SER . 71.1 p -93.67 144.35 25.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.471 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 1.7 p -138.38 172.41 12.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.929 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.45 149.16 36.43 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.491 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.18 83.02 1.5 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.757 2.305 . . . . 0.0 112.647 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -127.46 -1.76 6.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.585 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.74 63.3 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.76 104.32 0.47 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.54 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -178.89 155.12 15.41 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.572 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 22.2 t-160 -78.65 103.24 8.46 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.5 m -99.11 114.97 27.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.434 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.414 HG11 ' CD1' ' A' ' 109' ' ' ILE . 48.1 t -111.26 128.36 67.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.84 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 25.7 mt -118.1 154.51 31.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.997 -179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 120' ' ' THR . 13.7 t -137.52 148.81 46.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.365 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.602 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -163.92 168.52 38.47 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.442 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.64 ' CD2' ' N ' ' A' ' 66' ' ' ARG . 2.4 t-160 -100.61 138.74 37.26 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.528 -0.395 . . . . 0.0 110.671 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.64 ' N ' ' CD2' ' A' ' 65' ' ' HIS . 54.4 ttt85 -58.13 130.44 46.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.389 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.13 -163.35 1.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.612 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.9 t -129.33 52.25 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.576 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.601 ' O ' ' CB ' ' A' ' 70' ' ' PHE . 9.7 t -63.93 -39.54 85.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.283 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.601 ' CB ' ' O ' ' A' ' 69' ' ' VAL . 5.3 t80 90.31 11.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.267 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.0 p -108.43 23.13 14.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.665 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -62.01 -33.29 74.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.457 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.4 mt -61.41 -33.83 74.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.714 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.425 ' O ' ' HD2' ' A' ' 77' ' ' LYS . . . -86.7 -24.81 37.37 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -71.93 -40.74 68.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.791 0.329 . . . . 0.0 110.797 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.438 ' CD2' ' OH ' ' A' ' 135' ' ' TYR . 16.5 mt -89.83 91.49 8.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.425 ' HD2' ' O ' ' A' ' 74' ' ' GLY . 11.1 ptmt -179.21 135.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.386 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -71.68 -12.18 61.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.618 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -81.28 -15.9 54.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.104 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.55 ' C ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -67.55 153.36 43.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.487 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.615 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -141.36 116.5 9.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.062 0.458 . . . . 0.0 110.279 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.7 mt -93.28 129.47 39.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.777 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 2.5 t -111.22 122.71 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.011 0.434 . . . . 0.0 110.361 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.52 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 3.3 mm? -109.69 136.67 48.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.43 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -102.29 123.91 46.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.179 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 89' ' ' LYS . 7.0 t80 -145.03 143.15 30.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.618 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.49 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 65.3 t0 36.85 53.05 1.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.871 0.367 . . . . 0.0 111.406 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 56.4 25.77 9.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.335 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 86' ' ' TYR . 30.8 mtpt -125.11 145.42 49.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.491 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -108.21 124.17 49.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.48 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 12.4 m-85 -105.04 131.83 52.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.097 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.591 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -101.68 113.79 27.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.467 ' CZ ' HD12 ' A' ' 141' ' ' LEU . 83.2 m-85 -110.03 152.29 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.624 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -126.32 137.77 53.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.489 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mm -67.38 119.01 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.582 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -88.27 -64.87 1.08 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.826 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -147.26 143.24 27.97 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.055 0.455 . . . . 0.0 110.349 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mp -118.46 131.52 70.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 29.1 p90 -154.17 -174.55 5.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.5 mt -132.05 132.24 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.193 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.613 ' HG1' ' H ' ' A' ' 102' ' ' HIS . 5.0 t -131.92 174.49 10.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.613 ' H ' ' HG1' ' A' ' 101' ' ' THR . 16.9 t-80 -75.74 153.06 37.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.84 -25.54 68.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.608 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -85.87 10.2 14.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.556 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -82.09 90.6 6.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.396 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.536 ' C ' ' H ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -68.8 -21.62 64.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.29 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 21.5 p -48.51 -11.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.384 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.536 ' H ' ' C ' ' A' ' 106' ' ' ARG . 45.7 t -111.54 -11.03 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.035 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.534 ' O ' ' CG2' ' A' ' 50' ' ' VAL . 50.1 mm -111.9 10.14 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.015 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.705 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -80.78 -165.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.722 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -97.13 158.94 15.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.052 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.476 ' HG3' ' CD2' ' A' ' 59' ' ' HIS . 66.9 mmtt -126.37 -168.02 1.8 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.263 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.442 ' C ' ' CG ' ' A' ' 114' ' ' GLU . 4.9 mm-40 -138.34 16.5 2.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.425 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.443 ' CB ' ' HD2' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -162.23 169.62 9.05 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.523 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.54 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 32.7 Cg_endo -70.06 90.21 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.174 2.583 . . . . 0.0 111.829 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.2 mm -122.27 133.09 69.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.029 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.1 tt -108.38 123.69 49.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.734 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.44 HG21 ' CG1' ' A' ' 108' ' ' VAL . 94.5 m -122.68 128.4 50.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.38 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.487 HD21 ' N ' ' A' ' 120' ' ' THR . 5.1 tt -111.61 127.18 55.66 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.953 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.487 ' N ' HD21 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -121.52 108.83 14.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.262 0.553 . . . . 0.0 110.524 179.323 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.63 ' HG1' ' N ' ' A' ' 122' ' ' CYS . 1.2 t -135.95 175.25 9.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.101 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.63 ' N ' ' HG1' ' A' ' 121' ' ' THR . 1.6 p 154.45 -71.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.702 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.545 ' C ' ' O ' ' A' ' 122' ' ' CYS . 74.7 m-85 26.34 66.85 0.49 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.809 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -84.73 -163.68 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 123.013 2.476 . . . . 0.0 112.186 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -64.22 -32.64 74.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.58 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -89.76 19.93 4.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.614 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.649 ' O ' ' C ' ' A' ' 128' ' ' ILE . 6.9 t80 -57.97 -47.29 83.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.649 ' C ' ' O ' ' A' ' 127' ' ' TYR . 2.6 mp 1.76 87.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 O-C-N 123.828 0.705 . . . . 0.0 110.676 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.584 ' O ' ' CE1' ' A' ' 127' ' ' TYR . . . 101.14 -90.67 0.88 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 131' ' ' ALA . 14.7 p-10 -140.51 110.33 6.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.744 0.306 . . . . 0.0 110.63 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 130' ' ' ASP . . . -38.13 119.13 0.99 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.615 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -48.25 -41.16 35.23 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.522 2.148 . . . . 0.0 111.996 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -127.08 126.05 42.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.331 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.473 ' HG2' ' SG ' ' A' ' 122' ' ' CYS . 29.4 mtm180 -114.1 140.75 48.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.672 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.502 ' CD2' HD11 ' A' ' 137' ' ' ILE . 3.8 t80 -74.73 128.29 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.415 HG22 HD11 ' A' ' 136' ' ' ILE . 18.4 mm -112.81 117.62 55.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.761 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.502 HD11 ' CD2' ' A' ' 135' ' ' TYR . 15.9 mm -107.45 107.09 21.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -92.79 133.22 36.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.135 0.493 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.1 145.42 30.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 50.7 tttm -117.31 152.53 34.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.467 HD12 ' CZ ' ' A' ' 93' ' ' TYR . 11.0 tp -78.68 122.26 25.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.075 0.464 . . . . 0.0 110.35 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.27 -41.75 5.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.841 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.591 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -136.23 156.88 23.22 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 82.2 p -138.51 151.02 46.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.805 0.336 . . . . 0.0 110.597 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' THR . 94.4 m-85 -134.54 151.16 50.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.607 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 60.3 p -140.96 134.13 29.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.555 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.4 mttt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.51 -179.92 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.566 ' O ' ' OG ' ' A' ' 5' ' ' SER . 1.3 t 84.26 133.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 110.525 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -70.0 -26.6 64.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.609 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.9 ttt -60.76 -38.47 85.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.379 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -60.36 159.5 10.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.745 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t -65.02 156.65 30.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.695 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -76.55 -77.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.655 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 70.6 p -139.41 152.02 46.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.528 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' A' ' 11' ' ' LYS . 83.2 mt-10 -156.84 152.91 27.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.941 0.401 . . . . 0.0 110.169 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 67.57 -9.59 0.42 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.702 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.536 ' H ' ' C ' ' A' ' 9' ' ' GLU . 23.6 mmtt -74.47 127.34 32.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.207 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.48 124.93 24.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.936 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 113.15 -8.44 25.01 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -94.52 133.46 38.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.888 0.375 . . . . 0.0 110.26 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 89.0 tttt -57.93 122.04 12.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.323 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.29 -34.69 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.976 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.18 156.68 45.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.514 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.2 ttp -120.97 140.42 51.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.311 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 20' ' ' ASN . 22.4 tp -105.84 129.45 54.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.62 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.691 HD22 ' HZ2' ' A' ' 27' ' ' LYS . 57.1 t-20 -121.52 133.62 55.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.993 0.425 . . . . 0.0 110.815 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.501 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 3.5 mt -114.69 112.62 45.32 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.527 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.418 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 56.8 Cg_endo -77.16 -42.91 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.579 2.186 . . . . 0.0 112.412 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.77 ' HZ1' ' HZ2' ' A' ' 77' ' ' LYS . 19.9 tptm -62.26 -38.44 89.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.803 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.606 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.9 mm? -101.74 4.04 40.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.945 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 22' ' ' PRO . 7.0 mptt 43.85 48.75 7.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.562 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.645 ' NZ ' ' OG1' ' A' ' 71' ' ' THR . 26.6 mtmt -134.25 152.16 51.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.931 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.691 ' HZ2' HD22 ' A' ' 20' ' ' ASN . 8.6 mttp -130.43 143.04 50.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.675 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -130.88 145.66 52.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.743 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.3 p -95.06 113.83 25.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.644 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.501 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.2 mp -89.26 124.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.386 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 86.1 m-85 -106.06 149.66 26.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' A' ' 13' ' ' GLY . 24.0 t-105 -59.18 132.7 54.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.967 0.413 . . . . 0.0 110.824 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.476 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 75.04 162.41 9.83 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.4 117.48 22.26 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.277 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -93.07 117.5 30.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.733 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -88.55 -2.97 58.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.619 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.46 -57.78 2.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.802 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.6 t -87.73 133.68 33.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.772 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 mt -98.15 0.84 46.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.551 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -62.13 -42.9 99.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.652 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -90.78 -72.45 0.58 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.543 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.64 -51.04 3.66 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -77.1 96.98 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.023 0.44 . . . . 0.0 110.53 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.16 158.16 24.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.492 ' CE ' ' H ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -94.99 140.04 30.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.684 0.278 . . . . 0.0 110.321 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -66.95 136.09 54.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.475 HG23 ' CE2' ' A' ' 32' ' ' TRP . 77.8 t -115.63 116.17 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.467 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.589 ' OG ' ' OG1' ' A' ' 51' ' ' THR . 50.1 p -161.88 166.74 25.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 42.0 t0 -66.75 -2.68 5.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.52 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 3.0 m -118.96 -30.06 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.81 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.589 ' OG1' ' OG ' ' A' ' 48' ' ' SER . 27.8 p -80.47 142.72 33.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.736 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 59' ' ' HIS . 1.1 t -146.82 167.8 23.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.293 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.678 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -89.87 158.99 44.0 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.979 0.418 . . . . 0.0 110.601 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.84 83.16 1.83 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.755 2.303 . . . . 0.0 112.367 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.6 p -112.38 -3.78 14.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.679 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.83 91.9 0.24 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.18 77.44 0.28 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.16 162.94 32.6 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.681 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 18.6 t-160 -82.91 116.96 22.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.9 m -111.31 124.39 52.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.299 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.492 ' H ' ' CE ' ' A' ' 45' ' ' MET . 97.6 t -118.01 129.08 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.006 0.431 . . . . 0.0 110.354 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.457 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.3 mm? -110.48 139.27 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.3 t -121.93 134.16 54.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.05 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -153.98 111.18 0.48 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.562 ' O ' ' C ' ' A' ' 66' ' ' ARG . 4.8 p-80 -61.85 151.53 34.22 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.259 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.562 ' C ' ' O ' ' A' ' 65' ' ' HIS . 19.2 tpt180 -25.59 101.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.72 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -108.42 110.25 21.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.605 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 46.2 p -99.36 109.6 22.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.38 . . . . 0.0 110.427 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.59 9.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.79 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 64.87 52.93 1.52 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.094 0.473 . . . . 0.0 110.644 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.645 ' OG1' ' NZ ' ' A' ' 26' ' ' LYS . 18.4 m -137.92 -0.79 2.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.671 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -62.49 -34.67 77.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.706 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.7 mt -61.23 -44.31 97.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.936 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.62 -31.01 57.26 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.63 -42.11 95.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.754 0.311 . . . . 0.0 110.957 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.647 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 2.7 pp -92.18 101.73 14.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.988 0.423 . . . . 0.0 111.017 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.77 ' HZ2' ' HZ1' ' A' ' 23' ' ' LYS . 8.6 ptpt 170.96 135.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.472 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -67.57 -15.39 63.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.269 0.557 . . . . 0.0 110.536 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -80.62 -14.94 57.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.871 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -79.96 157.24 26.9 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.9 p -137.57 147.17 44.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.1 mt -122.76 126.6 47.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.917 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 2.7 t -112.55 124.76 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.997 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 3.7 mm? -110.73 137.78 47.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.44 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -106.72 115.72 30.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.332 178.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.678 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 16.4 t80 -142.16 124.92 15.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.863 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.9 t70 61.19 44.24 10.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.733 0.302 . . . . 0.0 111.256 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 64.19 7.87 3.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.51 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -108.69 145.87 34.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.37 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -111.48 120.71 43.06 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.481 -179.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.419 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 7.4 m-85 -98.98 143.3 29.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.372 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.87 110.61 21.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.843 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 82.9 m-85 -108.49 155.77 20.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.641 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -132.35 140.67 48.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.68 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mm -67.81 120.26 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.341 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.26 -65.03 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -144.53 137.88 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.309 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.89 130.93 65.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.015 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.422 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 19.2 p90 -152.83 -177.29 6.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.51 HG12 ' CD1' ' A' ' 135' ' ' TYR . 54.8 mt -125.72 132.74 70.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.253 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.5 t -133.7 166.62 22.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.928 0.395 . . . . 0.0 110.874 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -68.62 158.42 34.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.588 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.416 ' CB ' ' H ' ' A' ' 131' ' ' ALA . . . -71.21 -15.59 62.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.697 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.543 ' OD1' ' CG ' ' A' ' 130' ' ' ASP . 75.2 m-20 -97.47 8.49 44.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.697 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.4 87.7 4.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.986 0.422 . . . . 0.0 110.322 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.627 ' O ' ' N ' ' A' ' 109' ' ' ILE . 10.9 ptp85 -65.63 -32.28 73.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.368 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.46 ' HG1' HG23 ' A' ' 108' ' ' VAL . 6.9 p -42.94 -17.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.375 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.532 ' N ' ' O ' ' A' ' 106' ' ' ARG . 48.4 t -106.42 -16.78 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.002 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.627 ' N ' ' O ' ' A' ' 106' ' ' ARG . 45.4 mm -110.08 20.19 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.163 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.711 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -86.92 -165.36 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.941 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -97.02 151.37 19.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.478 ' HZ1' HG21 ' A' ' 116' ' ' ILE . 98.4 mttt -135.99 134.99 39.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.571 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -83.7 14.21 4.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.084 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.15 159.61 70.25 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.992 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.93 92.9 1.09 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 123.126 2.551 . . . . 0.0 112.031 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.478 HG21 ' HZ1' ' A' ' 112' ' ' LYS . 50.4 mm -124.73 137.34 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.189 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.473 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 6.8 tt -109.78 118.0 35.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.203 0.525 . . . . 0.0 110.436 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 68.3 m -114.16 123.0 48.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.825 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.552 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 4.0 tt -107.79 120.77 43.18 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.558 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.513 ' N ' HD21 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -115.87 114.68 25.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.154 0.502 . . . . 0.0 110.523 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.68 ' OG1' ' N ' ' A' ' 122' ' ' CYS . 0.0 OUTLIER -133.43 -166.07 1.72 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.172 -178.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.68 ' N ' ' OG1' ' A' ' 121' ' ' THR . 3.5 t 94.42 -63.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.342 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.701 ' O ' ' CG ' ' A' ' 123' ' ' TYR . 9.1 p90 -32.58 96.27 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.43 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.479 ' N ' ' O ' ' A' ' 122' ' ' CYS . 58.5 Cg_endo -82.22 -100.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.618 2.212 . . . . 0.0 112.191 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -118.06 -8.9 10.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.566 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.536 ' C ' ' OD1' ' A' ' 126' ' ' ASP . 40.1 p30 -89.84 11.12 21.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.514 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.68 ' CZ ' ' O ' ' A' ' 129' ' ' GLY . 35.2 t80 -51.41 -39.87 58.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.694 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.589 ' C ' ' O ' ' A' ' 127' ' ' TYR . 84.4 mt 21.43 78.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.381 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.68 ' O ' ' CZ ' ' A' ' 127' ' ' TYR . . . 67.95 -46.97 0.34 Allowed Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.545 ' OD1' ' O ' ' A' ' 129' ' ' GLY . 85.8 m-20 -141.45 126.02 17.84 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.791 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.416 ' H ' ' CB ' ' A' ' 103' ' ' ALA . . . -77.42 135.19 65.56 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.45 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -44.66 -37.09 11.03 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.446 2.097 . . . . 0.0 111.784 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.562 ' OD1' ' O ' ' A' ' 133' ' ' ASP . 27.3 p30 -167.29 114.69 0.78 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.486 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -100.89 139.43 36.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.951 0.405 . . . . 0.0 110.341 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.51 ' CD1' HG12 ' A' ' 100' ' ' ILE . 1.9 t80 -76.42 136.22 39.44 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.172 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.9 mm -122.55 113.54 38.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.696 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -107.18 112.88 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.422 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 44.7 tt0 -93.63 139.81 30.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.508 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.58 148.77 31.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.974 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.1 tttm -119.12 152.22 36.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.384 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 18.0 tp -77.45 119.21 20.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.25 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.2 p -95.43 -41.55 8.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.673 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -144.78 179.93 21.6 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.1 p -154.03 161.42 41.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.731 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 90' ' ' THR . 94.5 m-85 -144.03 159.37 42.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.773 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.8 p -144.57 128.17 17.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.654 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.3 tttp . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.967 -1.015 . . . . 0.0 110.579 179.92 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.8 p -61.15 -36.34 79.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.748 0.309 . . . . 0.0 110.642 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' A' ' 4' ' ' MET . 96.9 m-70 -82.88 -149.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.327 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.444 ' O ' ' O ' ' A' ' 3' ' ' HIS . 92.0 mtp 59.13 123.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.463 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.444 ' O ' ' OG ' ' A' ' 5' ' ' SER . 10.8 t 60.23 44.12 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.36 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.4 t -133.88 151.32 51.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.607 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -109.79 178.63 4.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.041 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.493 ' O ' ' C ' ' A' ' 9' ' ' GLU . 74.3 m -62.3 -48.55 79.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.991 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 8' ' ' THR . 36.7 tt0 31.8 -116.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.488 ' N ' ' HG2' ' A' ' 9' ' ' GLU . 50.1 m-70 -136.23 26.53 3.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.53 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -79.55 142.6 35.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.133 0.492 . . . . 0.0 110.613 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.433 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 58.3 mp0 -69.24 142.18 54.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.341 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.57 15.8 63.13 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -119.61 137.01 54.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.014 0.435 . . . . 0.0 110.375 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HZ1' ' HB2' ' A' ' 18' ' ' MET . 0.0 OUTLIER -62.05 106.81 0.77 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.46 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.9 m -109.81 -40.53 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.971 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -135.09 164.56 27.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.695 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.429 ' HB2' ' HZ1' ' A' ' 15' ' ' LYS . 3.0 ttt -131.75 128.21 38.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.635 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 tt -98.11 116.79 31.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.069 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.487 ' ND2' ' HE3' ' A' ' 27' ' ' LYS . 48.5 t-20 -110.76 137.33 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.022 0.439 . . . . 0.0 111.235 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.3 mt -116.67 115.87 39.03 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.286 179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.94 -39.0 0.69 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.677 2.251 . . . . 0.0 112.847 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 47.5 tptt -64.1 -35.62 81.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.007 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.4 mm? -101.9 7.14 41.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 40.78 59.35 2.21 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.131 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.481 ' HZ2' HG22 ' A' ' 71' ' ' THR . 15.3 ptpt -150.33 166.52 29.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.668 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.487 ' HE3' ' ND2' ' A' ' 20' ' ' ASN . 27.6 mtpt -139.82 146.49 39.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.144 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.429 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 49.4 m-85 -132.13 138.68 48.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.717 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 p -89.57 112.24 23.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.544 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.9 mm -84.09 120.72 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.395 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -100.69 140.37 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.024 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.49 ' CE2' HG21 ' A' ' 47' ' ' VAL . 58.6 t-105 -59.46 132.1 52.96 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.276 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.52 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 76.55 140.2 1.03 Allowed Glycine 0 N--CA 1.463 0.445 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.602 ' CB ' ' HG ' ' A' ' 63' ' ' SER . . . -111.33 78.64 1.13 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.857 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -90.19 134.26 34.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.78 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.7 t0 -85.0 -8.09 58.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.494 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.63 -38.61 84.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.778 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.29 133.47 37.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.765 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.3 mt -101.76 6.19 41.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.318 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -62.34 -51.53 67.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.034 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -154.68 166.79 32.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.517 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 63' ' ' SER . . . -104.18 -12.22 29.89 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.38 98.31 5.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.314 0.578 . . . . 0.0 110.982 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.85 152.98 20.48 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.52 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 2.4 tpp -87.93 145.65 25.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.705 0.288 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.472 ' CD1' HG22 ' A' ' 51' ' ' THR . 2.4 t80 -77.13 139.13 39.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.49 HG21 ' CE2' ' A' ' 32' ' ' TRP . 94.2 t -117.24 120.76 65.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.401 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.751 ' HG ' ' H ' ' A' ' 50' ' ' VAL . 4.9 p -170.64 176.3 4.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.54 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.98 -18.76 61.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.751 ' H ' ' HG ' ' A' ' 48' ' ' SER . 2.3 m -107.9 -21.28 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.9 0.381 . . . . 0.0 110.843 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.506 ' OG1' ' N ' ' A' ' 48' ' ' SER . 17.3 p -89.49 127.95 35.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.288 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 59' ' ' HIS . 1.3 t -136.02 166.83 22.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.64 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.4 OUTLIER -86.56 157.75 55.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.684 -179.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.87 80.68 2.89 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.589 2.193 . . . . 0.0 112.528 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.4 p -113.02 -5.33 13.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.946 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.46 91.48 0.1 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.69 91.36 0.01 OUTLIER Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.491 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -170.25 162.43 35.65 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.66 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 17.0 t-160 -83.35 117.19 22.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.6 m -112.77 108.02 16.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.4 t -106.24 129.03 60.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 110.011 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.45 HD21 ' SD ' ' A' ' 45' ' ' MET . 27.1 mt -120.53 158.63 26.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.939 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.602 ' HG ' ' CB ' ' A' ' 34' ' ' ALA . 7.8 p -139.0 150.58 46.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.261 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.17 177.94 41.55 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.488 ' ND1' ' N ' ' A' ' 65' ' ' HIS . 3.2 p-80 -97.43 132.99 42.61 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.523 -0.398 . . . . 0.0 110.789 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.721 ' O ' ' CG ' ' A' ' 125' ' ' PHE . 60.6 ttt85 -84.83 77.25 10.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.159 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 68' ' ' THR . 1.0 OUTLIER -107.9 157.43 18.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.718 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.51 ' O ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER 57.15 128.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.642 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.451 ' CG1' ' O ' ' A' ' 69' ' ' VAL . 34.8 t -77.78 -10.53 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.627 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.495 ' C ' ' HG1' ' A' ' 71' ' ' THR . 44.5 t80 -72.17 159.83 33.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.441 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.495 ' HG1' ' C ' ' A' ' 70' ' ' PHE . 2.1 m 80.74 -11.98 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.546 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -62.54 -38.48 90.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.076 0.465 . . . . 0.0 110.429 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.637 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . 29.6 mt -62.07 -38.7 89.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.362 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.19 -29.26 37.92 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -78.72 -41.91 29.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.832 0.348 . . . . 0.0 111.035 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.425 ' CD2' ' OH ' ' A' ' 135' ' ' TYR . 20.8 mt -89.83 80.92 6.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.085 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.637 ' NZ ' ' O ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -172.69 142.38 1.18 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.462 179.587 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -77.83 -16.5 58.27 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.596 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -79.2 -15.19 58.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.143 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' OD1' ' C ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -70.57 153.67 42.65 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 p -136.08 142.42 44.33 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.044 0.45 . . . . 0.0 110.002 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.1 mt -119.12 123.54 44.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.878 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.2 t -107.12 124.73 63.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.35 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.522 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 3.4 mm? -110.39 129.61 55.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.377 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -101.0 124.25 46.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.216 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.64 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 1.8 t80 -149.8 130.37 13.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.992 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 55.46 43.29 28.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.136 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 65.27 8.17 4.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.458 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 52.1 mtmt -107.02 150.98 25.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.383 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.29 121.97 42.64 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.798 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -104.12 130.53 51.84 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.522 ' H ' ' HG1' ' A' ' 92' ' ' THR . 0.2 OUTLIER -99.75 114.98 28.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.13 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.434 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 81.7 m-85 -110.69 155.49 22.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.725 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -130.73 140.13 50.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.156 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mm -62.38 119.69 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.203 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.68 -64.1 1.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.885 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -146.98 133.01 19.21 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.172 0.51 . . . . 0.0 110.452 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.474 HG21 ' CZ ' ' A' ' 135' ' ' TYR . 1.6 mp -111.04 131.13 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.608 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.402 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 18.9 p90 -153.72 -178.16 6.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.092 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.42 HG12 ' CD1' ' A' ' 135' ' ' TYR . 2.7 mt -127.13 134.08 66.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.258 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.9 t -146.06 172.49 13.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.91 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -61.77 156.48 20.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.48 -179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -74.5 -25.97 59.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.831 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -89.46 2.17 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.565 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -65.36 90.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.526 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.654 ' O ' ' N ' ' A' ' 109' ' ' ILE . 22.9 ptt85 -56.11 -35.91 67.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.51 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 2.5 p -40.64 -17.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.536 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.619 ' N ' ' O ' ' A' ' 106' ' ' ARG . 6.5 t -110.61 -15.58 9.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.005 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.654 ' N ' ' O ' ' A' ' 106' ' ' ARG . 48.2 mm -113.74 21.91 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.036 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.731 ' H ' ' CD1' ' A' ' 110' ' ' ILE . 0.1 OUTLIER -88.19 -169.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.858 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -94.03 147.44 23.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.4 mttt -133.22 147.95 52.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.449 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -97.58 11.66 36.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.847 0.356 . . . . 0.0 110.067 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -133.66 159.48 72.34 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.73 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.491 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 46.7 Cg_endo -76.02 89.79 1.21 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.043 2.495 . . . . 0.0 111.959 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.46 134.99 63.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.437 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.2 tt -109.34 120.85 43.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.653 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.411 HG21 ' CG1' ' A' ' 108' ' ' VAL . 71.7 m -116.36 119.78 36.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.109 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.574 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -110.67 114.65 28.2 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.462 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.527 ' N ' HD21 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -106.63 127.86 53.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.462 . . . . 0.0 110.762 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.541 ' C ' ' SG ' ' A' ' 122' ' ' CYS . 27.4 p -135.76 162.39 32.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.129 0.49 . . . . 0.0 111.56 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.612 ' O ' ' O ' ' A' ' 123' ' ' TYR . 0.5 OUTLIER 179.61 -79.76 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.937 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.612 ' O ' ' O ' ' A' ' 122' ' ' CYS . 5.8 m-85 50.64 151.9 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.732 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.22 56.77 0.43 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.717 2.278 . . . . 0.0 112.244 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.721 ' CG ' ' O ' ' A' ' 66' ' ' ARG . 3.2 p90 -87.01 -31.49 20.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.575 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.703 ' OD2' ' CE2' ' A' ' 125' ' ' PHE . 62.1 m-20 -128.96 -17.56 3.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.757 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.687 ' CE2' ' O ' ' A' ' 128' ' ' ILE . 71.6 t80 -109.71 155.33 21.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.607 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.687 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 87.2 mt -93.44 119.71 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.237 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.89 -115.37 5.25 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -121.2 108.0 13.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.734 0.302 . . . . 0.0 110.682 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.577 ' O ' ' NH1' ' A' ' 134' ' ' ARG . . . -45.79 111.45 1.4 Allowed Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.695 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.85 -42.06 52.91 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.552 2.168 . . . . 0.0 112.022 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.82 150.42 24.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.25 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.577 ' NH1' ' O ' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -126.4 137.96 53.49 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 110.95 -179.62 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.474 ' CZ ' HG21 ' A' ' 98' ' ' ILE . 5.2 t80 -79.57 126.39 30.82 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 1.1 mt -122.02 126.51 74.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-O 121.218 0.532 . . . . 0.0 111.943 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.423 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp -108.17 112.76 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.287 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -95.4 136.65 35.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.548 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.87 153.53 47.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.546 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 8.4 tptt -116.55 146.72 42.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.948 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.546 ' H ' ' HD2' ' A' ' 140' ' ' LYS . 16.4 tp -69.69 124.09 23.08 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.107 0.479 . . . . 0.0 110.109 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.734 ' HG1' ' N ' ' A' ' 143' ' ' GLY . 4.9 p -99.04 -47.94 5.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.629 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.734 ' N ' ' HG1' ' A' ' 142' ' ' THR . . . -141.97 172.05 24.26 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.2 p -144.9 134.76 23.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.614 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -122.93 146.29 47.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.196 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 97.9 p -134.14 123.99 25.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.485 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.419 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.477 ' H2 ' ' H ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.477 ' H ' ' H2 ' ' A' ' 1' ' ' GLY . 0.7 OUTLIER 55.87 -165.17 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.79 0.329 . . . . 0.0 110.488 179.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.589 ' O ' ' OG ' ' A' ' 5' ' ' SER . 78.0 t60 -102.95 106.54 17.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.365 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.471 ' CG ' ' H ' ' A' ' 5' ' ' SER . 0.4 OUTLIER 42.81 -123.66 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.576 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.589 ' OG ' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER 52.86 77.53 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.615 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.586 ' O ' ' OE1' ' A' ' 14' ' ' GLU . 67.7 m -72.05 145.54 48.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.471 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -126.46 41.5 3.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.656 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.54 -41.77 2.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.572 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.63 158.12 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.612 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.625 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -82.54 18.28 1.54 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.568 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -55.28 145.58 21.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.208 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -58.22 135.87 57.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.073 -179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.39 2.68 61.77 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.586 ' OE1' ' O ' ' A' ' 6' ' ' SER . 76.2 mm-40 -115.32 140.45 49.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.793 0.33 . . . . 0.0 110.512 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -63.1 121.52 13.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.216 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.55 -39.47 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.96 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.3 156.95 43.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.628 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ttm -119.68 141.77 49.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.161 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 29.0 tp -108.4 121.81 45.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.644 -179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -118.38 127.8 54.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.902 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.477 HG23 ' H ' ' A' ' 24' ' ' LEU . 6.0 mt -104.56 115.53 62.62 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.389 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.62 ' CD ' ' O ' ' A' ' 81' ' ' THR . 56.9 Cg_endo -77.11 -45.78 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.846 2.364 . . . . 0.0 112.52 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.3 -40.25 89.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.489 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.607 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.9 mm? -102.56 8.97 39.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.562 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 40.42 40.21 0.83 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.519 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.07 157.91 20.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.519 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -138.71 139.89 38.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.584 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -137.06 159.09 42.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.855 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 m -101.99 122.38 43.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.001 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.441 HG21 HD12 ' A' ' 30' ' ' ILE . 39.4 mm -94.08 118.71 40.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.319 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -101.16 136.76 40.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.323 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 10' ' ' HIS . 55.8 t-105 -60.41 133.05 55.72 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.616 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.556 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 77.62 163.98 21.63 Favored Glycine 0 C--N 1.331 0.258 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -163.52 93.21 0.74 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.868 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -78.46 134.07 37.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.763 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -70.84 -40.39 72.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.642 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.77 64.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.557 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 48.5 p -101.86 144.16 30.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.542 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.0 mt -110.83 131.31 55.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.527 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -130.75 -160.55 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.624 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -61.65 -42.08 98.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.489 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.91 -4.59 4.65 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.77 92.45 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.398 . . . . 0.0 110.49 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.35 148.68 19.44 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.673 ' SD ' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -95.46 134.45 38.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.627 0.251 . . . . 0.0 110.325 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.673 ' O ' ' SD ' ' A' ' 45' ' ' MET . 18.6 t80 -75.43 139.45 42.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.535 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.47 HG23 ' CE2' ' A' ' 32' ' ' TRP . 40.2 t -111.02 124.58 67.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.962 0.41 . . . . 0.0 110.433 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.538 ' OG ' ' CE2' ' A' ' 46' ' ' PHE . 18.8 m -160.92 165.38 30.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.604 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -69.0 -24.22 64.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.704 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.465 ' O ' ' HB3' ' A' ' 111' ' ' LYS . 4.6 m -94.18 -40.52 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.161 0.505 . . . . 0.0 110.742 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.464 ' H ' HG21 ' A' ' 50' ' ' VAL . 81.7 p -76.18 155.56 34.44 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.716 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -148.97 171.6 16.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.606 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.41 156.75 53.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.754 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -80.03 83.46 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.581 2.188 . . . . 0.0 112.445 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.0 p -113.85 -9.47 13.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.569 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.73 90.41 0.08 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.85 85.75 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.501 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.22 160.64 34.37 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.702 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 13.6 t-160 -83.65 116.66 22.74 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.7 m -111.81 127.19 55.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.234 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.651 ' H ' ' CE ' ' A' ' 45' ' ' MET . 54.6 t -117.29 129.75 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.354 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.452 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 1.9 mm? -112.7 145.49 40.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.632 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 120' ' ' THR . 47.2 t -126.73 144.12 51.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.086 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.47 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -164.16 166.58 37.73 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.531 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.57 ' N ' ' ND1' ' A' ' 65' ' ' HIS . 0.5 OUTLIER -116.87 145.18 43.74 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.554 -0.38 . . . . 0.0 110.536 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.0 ttp180 -96.18 135.09 38.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.5 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -156.7 -50.74 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.621 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 t -127.47 129.32 47.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.495 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.92 135.69 52.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.647 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -122.35 -17.41 7.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.64 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -134.65 75.84 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.595 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -64.12 -40.67 96.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.58 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.668 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -62.48 -44.34 96.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.921 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.64 -32.46 83.21 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -40.35 94.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.918 0.39 . . . . 0.0 110.165 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.33 111.4 17.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.668 ' NZ ' ' O ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -174.23 141.12 0.71 Allowed 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -77.84 -12.36 59.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.052 0.454 . . . . 0.0 110.507 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -84.95 -15.51 44.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.137 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -69.5 152.76 44.45 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.62 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -142.04 115.01 8.7 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.304 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' A' ' 93' ' ' TYR . 67.2 mt -90.47 132.21 35.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.629 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 2.1 t -109.85 115.54 49.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.994 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.486 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 6.0 mp -94.98 123.47 38.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.196 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -99.73 117.61 34.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.374 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.524 ' HH ' ' CD2' ' A' ' 10' ' ' HIS . 1.4 t80 -149.6 133.26 16.8 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.936 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 56.23 43.67 26.21 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.321 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.5 9.31 2.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.337 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -107.44 150.21 27.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.518 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.508 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -118.03 123.85 46.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.709 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.428 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 15.4 m-85 -107.31 132.63 52.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.271 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.18 112.37 24.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 111.634 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.468 ' CZ ' HD13 ' A' ' 141' ' ' LEU . 75.6 m-85 -109.85 147.58 33.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.775 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.645 ' OE2' ' NE2' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -124.71 139.83 53.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 179.682 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.583 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 1.3 mm -63.5 117.13 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.286 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.645 ' NE2' ' OE2' ' A' ' 94' ' ' GLU . 55.9 mm-40 -84.27 -67.97 0.75 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.844 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -145.83 139.66 26.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.109 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.4 mt -112.81 127.78 69.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.61 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.45 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 25.8 p90 -150.89 -177.98 6.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.777 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 100' ' ' ILE . 3.6 mp -127.25 131.52 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.641 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.6 t -132.31 165.95 23.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.673 -179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -70.6 153.8 42.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.408 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.56 -13.32 61.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.697 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -92.67 8.02 40.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.76 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.599 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 68.1 t0 -85.98 89.91 7.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.581 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.49 ' C ' ' H ' ' A' ' 108' ' ' VAL . 11.5 ptm180 -70.15 -24.19 63.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.429 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.599 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 12.9 p -49.56 -12.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.357 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.49 ' H ' ' C ' ' A' ' 106' ' ' ARG . 43.9 t -111.02 -8.77 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.992 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.569 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 29.9 mm -111.91 7.03 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 0.0 111.022 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.702 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -79.03 -161.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.629 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.465 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 14.1 ptpt -109.89 155.25 21.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.784 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.445 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.3 mttt -138.54 144.06 39.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.451 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -85.74 10.88 12.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.999 0.428 . . . . 0.0 110.051 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.04 156.72 73.89 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.135 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.501 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 51.4 Cg_endo -76.89 88.48 1.39 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.975 2.45 . . . . 0.0 111.609 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.4 mm -124.07 131.43 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.916 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.552 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 5.3 tt -105.28 122.41 45.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.201 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 89.8 m -118.99 126.08 50.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.134 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.513 HD22 ' N ' ' A' ' 120' ' ' THR . 3.2 tt -107.7 124.55 50.17 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.599 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.513 ' N ' HD22 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -120.99 113.97 20.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.448 0.642 . . . . 0.0 110.719 179.04 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.682 ' O ' ' SG ' ' A' ' 122' ' ' CYS . 1.7 t -144.81 169.79 17.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.229 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.682 ' SG ' ' O ' ' A' ' 121' ' ' THR . 1.3 m 153.99 -71.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.503 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.503 ' C ' ' O ' ' A' ' 122' ' ' CYS . 51.5 m-85 28.6 70.77 0.5 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.896 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 127' ' ' TYR . 62.3 Cg_endo -77.79 160.36 31.01 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.889 2.392 . . . . 0.0 112.115 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.635 ' CE2' ' OD1' ' A' ' 126' ' ' ASP . 50.6 p90 -48.54 -13.71 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.872 0.368 . . . . 0.0 110.393 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.635 ' OD1' ' CE2' ' A' ' 125' ' ' PHE . 78.2 m-20 -102.7 12.11 36.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.861 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.659 ' CZ ' ' O ' ' A' ' 129' ' ' GLY . 39.3 t80 -51.3 -51.78 51.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.252 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.646 ' C ' ' O ' ' A' ' 127' ' ' TYR . 30.0 mm 9.92 94.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 O-C-N 123.508 0.505 . . . . 0.0 110.723 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.659 ' O ' ' CZ ' ' A' ' 127' ' ' TYR . . . 96.6 -95.52 1.77 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 131' ' ' ALA . 3.5 m-20 -132.82 113.17 12.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.634 0.254 . . . . 0.0 110.703 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' ASP . . . -37.26 140.49 0.47 Allowed Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.683 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.15 -20.12 56.57 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.693 2.262 . . . . 0.0 111.724 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -167.07 124.91 1.28 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.766 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -105.26 136.23 45.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.556 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.463 ' CD2' HD13 ' A' ' 137' ' ' ILE . 3.6 t80 -74.58 130.68 40.01 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.78 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 5.3 mm -115.21 117.22 54.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.936 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.472 ' CG2' ' CD1' ' A' ' 95' ' ' ILE . 12.8 mm -107.04 109.97 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.45 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 41.8 tt0 -92.06 137.0 32.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.054 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -138.65 149.03 44.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.199 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.489 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 26.6 tptt -123.44 142.1 51.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.489 ' H ' ' HD2' ' A' ' 140' ' ' LYS . 21.3 tp -69.5 122.88 19.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.382 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.4 p -99.06 -46.82 5.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.734 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -142.04 -177.67 17.37 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.9 p -151.05 152.4 33.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.945 0.403 . . . . 0.0 110.713 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 90' ' ' THR . 90.5 m-85 -140.02 149.56 43.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.427 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.1 p -139.18 119.39 13.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.334 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.8 tttm . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.484 -179.835 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 1' ' ' GLY . 4.4 p 36.25 -158.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 0.0 110.567 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -111.33 167.01 10.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.675 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 34.4 tpp -61.03 -85.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.641 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.665 ' O ' ' N ' ' A' ' 7' ' ' GLN . 77.3 p -165.98 128.41 1.98 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.528 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 47.26 -79.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.843 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.665 ' N ' ' O ' ' A' ' 5' ' ' SER . 93.2 mm-40 60.31 50.8 5.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.627 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.8 p -118.54 139.15 51.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.286 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 10' ' ' HIS . 36.5 tp10 -162.57 -118.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.446 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.429 ' N ' ' HG3' ' A' ' 9' ' ' GLU . 62.8 m170 -72.92 -12.39 60.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.414 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -62.29 127.4 31.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.26 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -78.6 154.35 30.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.88 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 76.7 18.79 78.62 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -125.75 147.6 49.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 120.835 0.35 . . . . 0.0 110.548 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -63.21 119.52 9.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.236 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.421 HG21 ' N ' ' A' ' 32' ' ' TRP . 4.6 m -119.64 -20.94 4.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.226 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -149.19 161.38 42.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.709 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.5 ttt -116.51 141.23 48.45 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.627 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 tp -109.81 121.86 46.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.567 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -117.76 129.67 55.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.706 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.3 mt -113.84 109.17 50.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.2 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -77.92 -41.72 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.679 2.253 . . . . 0.0 113.208 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.6 tptp -58.78 -43.98 90.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.175 -178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.502 ' N ' HD21 ' A' ' 24' ' ' LEU . 1.4 mm? -101.24 2.93 40.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.022 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 mttt 50.4 56.75 7.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.953 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -134.44 155.23 50.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.788 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.04 138.86 42.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.772 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -137.92 157.8 45.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.762 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 t -99.86 134.03 43.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.831 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.4 mm -99.24 127.28 52.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.331 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -106.37 139.51 40.74 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.222 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.502 ' O ' ' N ' ' A' ' 13' ' ' GLY . 41.6 t-105 -70.29 131.78 44.69 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 71.57 173.24 17.1 Favored Glycine 0 C--O 1.23 -0.122 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.65 78.89 1.37 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.836 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -94.74 149.19 21.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.757 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -72.26 -17.21 61.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.604 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.561 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.95 -38.0 89.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.685 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 31.9 m -62.53 133.77 55.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.607 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.561 ' CD2' ' O ' ' A' ' 37' ' ' ALA . 4.4 mm? -100.13 134.01 43.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.654 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.5 tttp 69.57 63.05 0.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.52 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 42' ' ' GLY . 4.3 tptm -89.82 -120.82 0.06 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.41 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.459 ' N ' ' HG3' ' A' ' 41' ' ' LYS . . . 122.79 -54.79 0.7 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.5 t -125.06 92.32 2.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 120.944 0.402 . . . . 0.0 110.661 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.96 143.07 17.83 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.449 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 30.6 ttm -90.92 128.64 36.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -70.97 132.48 45.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.494 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 p -115.46 109.88 29.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.171 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 t -150.5 172.06 16.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.471 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -63.49 -37.62 88.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.537 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 51' ' ' THR . 13.0 m -83.92 -38.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.898 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.481 ' H ' HG23 ' A' ' 50' ' ' VAL . 30.6 p -85.89 158.08 20.02 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.459 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 t -160.08 173.56 15.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.6 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.52 158.46 60.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.736 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -82.65 83.62 1.95 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.501 2.134 . . . . 0.0 112.654 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 p -119.7 -5.65 10.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.735 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.24 87.4 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.6 96.49 0.02 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.528 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -172.65 150.74 12.96 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.626 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 22.3 t-160 -76.4 102.47 5.97 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -96.36 125.1 40.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.013 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.468 HG12 ' CD1' ' A' ' 109' ' ' ILE . 55.2 t -117.75 130.54 72.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.042 0.449 . . . . 0.0 109.975 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.44 HD23 ' N ' ' A' ' 62' ' ' LEU . 2.1 mm? -114.18 139.65 49.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.16 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.8 t -112.89 134.11 54.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.846 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 120' ' ' THR . . . -131.35 71.77 0.49 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.559 ' H ' ' CD2' ' A' ' 65' ' ' HIS . 0.0 OUTLIER -54.12 137.24 40.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.602 0.239 . . . . 0.0 110.528 -179.668 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 mtm-85 71.97 174.49 0.29 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.941 0.401 . . . . 0.0 110.621 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -94.45 122.76 37.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.78 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.8 t -146.86 46.88 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.557 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.92 118.58 53.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.444 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -75.25 -61.91 1.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.73 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.42 ' O ' ' OE1' ' A' ' 75' ' ' GLN . 0.3 OUTLIER -113.72 98.62 7.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.937 179.729 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.4 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 26.2 m-20 -60.1 -42.3 94.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.569 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 46.0 mt -62.92 -41.55 99.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.587 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.461 ' HA2' ' HZ3' ' A' ' 77' ' ' LYS . . . -66.33 -42.51 93.97 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.624 ' OE1' ' N ' ' A' ' 75' ' ' GLN . 0.1 OUTLIER -69.99 -42.52 72.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.462 -179.264 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.662 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 2.9 pp -92.56 108.64 20.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.21 0.529 . . . . 0.0 110.88 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.574 ' O ' ' CG2' ' A' ' 95' ' ' ILE . 16.6 ptpt 177.15 150.38 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.284 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -80.02 -12.4 59.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.497 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -87.98 -14.84 38.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.572 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.512 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 3.5 t70 -66.96 153.3 43.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.862 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.486 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.3 p -141.49 135.7 30.48 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.147 0.499 . . . . 0.0 109.69 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.2 mt -114.42 128.1 56.17 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.714 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 t -106.77 121.47 59.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.954 0.407 . . . . 0.0 110.249 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.525 ' CD1' ' N ' ' A' ' 84' ' ' LEU . 6.1 mp -105.1 121.59 44.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.208 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -101.71 113.7 27.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.108 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -147.86 132.76 18.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.843 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 t0 60.35 40.39 17.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.833 0.349 . . . . 0.0 111.404 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 63.71 11.13 5.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.178 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.673 ' NZ ' ' OH ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -110.61 149.66 30.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.566 179.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -115.18 113.31 23.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.747 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.673 ' OH ' ' NZ ' ' A' ' 89' ' ' LYS . 9.4 m-85 -100.77 129.01 46.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.551 ' N ' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -100.86 119.95 39.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.045 0.45 . . . . 0.0 111.637 -178.154 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -111.55 158.16 19.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.248 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -133.79 139.69 46.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.262 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.574 ' CG2' ' O ' ' A' ' 77' ' ' LYS . 7.0 mm -67.64 120.72 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.13 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.458 ' NE2' ' HB2' ' A' ' 140' ' ' LYS . 44.5 mt-30 -90.89 -62.68 1.4 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.613 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -148.98 143.35 26.07 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.143 0.497 . . . . 0.0 110.247 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 14.8 mm -117.67 129.72 73.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.792 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.424 ' CZ2' HG22 ' A' ' 136' ' ' ILE . 19.7 p90 -150.35 -176.71 5.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.031 0.443 . . . . 0.0 111.352 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.9 mt -126.04 132.63 70.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.4 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.594 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 3.1 t -131.84 171.32 13.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.839 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.502 ' CD2' ' OD1' ' A' ' 133' ' ' ASP . 26.7 m170 -72.97 162.1 29.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.728 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.13 -11.37 60.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.62 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -104.14 16.6 25.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.621 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 31.6 t0 -86.31 101.42 13.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 110.377 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 109' ' ' ILE . 33.7 ptt180 -72.62 -21.32 61.13 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.799 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.621 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 21.3 p -45.73 -20.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.884 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.411 ' N ' ' C ' ' A' ' 106' ' ' ARG . 10.6 m -101.42 -17.2 6.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.047 0.451 . . . . 0.0 110.291 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.613 ' N ' ' O ' ' A' ' 106' ' ' ARG . 47.8 mm -109.89 23.36 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.626 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -89.01 -162.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.428 ' H ' ' HB ' ' A' ' 110' ' ' ILE . 7.7 ttmm -111.46 143.15 42.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.724 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -131.07 145.39 52.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.575 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -87.48 12.62 11.83 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.109 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.75 165.72 26.33 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.966 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.528 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 52.6 Cg_endo -78.87 98.52 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.854 2.369 . . . . 0.0 111.605 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.446 HG22 HD11 ' A' ' 116' ' ' ILE . 50.3 mm -126.02 131.66 71.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.331 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.6 tt -102.4 121.3 42.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.368 0.604 . . . . 0.0 110.203 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.8 m -117.52 106.18 12.88 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.491 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.539 ' C ' ' CD1' ' A' ' 119' ' ' LEU . 0.1 OUTLIER -100.85 127.41 47.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.046 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.481 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -119.69 137.35 53.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.451 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.687 ' O ' ' SG ' ' A' ' 122' ' ' CYS . 5.8 p -134.01 169.96 16.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.046 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.687 ' SG ' ' O ' ' A' ' 121' ' ' THR . 5.4 m 95.01 -73.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.337 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.631 ' CE2' ' CZ ' ' A' ' 134' ' ' ARG . 53.0 m-85 56.3 111.9 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.013 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.468 ' HA ' ' H ' ' A' ' 131' ' ' ALA . 50.2 Cg_exo -49.58 -43.11 40.62 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.368 2.046 . . . . 0.0 112.776 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.7 ' CG ' ' N ' ' A' ' 126' ' ' ASP . 0.8 OUTLIER -65.77 -50.77 63.53 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.993 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.7 ' N ' ' CG ' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -70.62 -43.76 68.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.208 -179.308 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.701 ' CE2' ' O ' ' A' ' 128' ' ' ILE . 17.7 t80 -55.15 141.63 34.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.555 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.701 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 8.8 mm -54.87 108.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.412 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.93 -113.76 4.25 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -141.54 106.38 4.92 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.615 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.468 ' H ' ' HA ' ' A' ' 124' ' ' PRO . . . -72.14 119.24 73.51 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.188 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.576 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 59.3 Cg_exo -47.49 -31.55 13.82 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.278 1.985 . . . . 0.0 111.909 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.576 ' OD1' ' O ' ' A' ' 132' ' ' PRO . 78.0 m-20 -155.84 178.53 10.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.502 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.631 ' CZ ' ' CE2' ' A' ' 123' ' ' TYR . 41.4 ttm180 -117.36 133.11 56.35 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.437 ' HB2' ' SG ' ' A' ' 122' ' ' CYS . 2.8 t80 -70.12 135.41 49.15 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.2 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.508 HD13 HG23 ' A' ' 136' ' ' ILE . 43.5 mm -121.84 116.03 48.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.455 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.4 mm -101.76 108.42 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -97.65 138.36 35.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.107 0.479 . . . . 0.0 111.1 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.45 28.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.862 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.536 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 28.2 ttpt -121.97 157.59 30.95 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.024 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.536 ' N ' ' CG ' ' A' ' 140' ' ' LYS . 3.9 tt -81.67 122.09 27.19 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.64 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.47 ' N ' HD21 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -98.47 -40.37 8.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.709 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.551 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -150.76 155.13 26.01 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.14 158.19 45.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 111.277 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' THR . 95.2 m-85 -135.07 146.47 48.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.688 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.577 ' O ' ' O ' ' A' ' 147' ' ' LYS . 96.2 p -129.57 114.37 15.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.19 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.577 ' O ' ' O ' ' A' ' 146' ' ' SER . 55.0 tttt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.592 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.563 ' O ' ' O ' ' A' ' 1' ' ' GLY . 1.4 p 29.96 99.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 0.0 110.558 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.557 ' O ' ' O ' ' A' ' 4' ' ' MET . 86.4 t60 32.97 90.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.496 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.557 ' O ' ' O ' ' A' ' 3' ' ' HIS . 77.2 mtm -30.2 151.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.3 p -72.02 158.99 34.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.505 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.6 p -132.43 147.77 52.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.512 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.457 ' NE2' ' HA ' ' A' ' 7' ' ' GLN . 8.0 mm100 -58.37 -113.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.535 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.46 116.06 29.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.346 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.452 ' O ' ' OE2' ' A' ' 14' ' ' GLU . 95.8 mt-10 -148.6 -160.75 1.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.523 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -91.15 1.24 57.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.512 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.694 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -70.18 150.88 46.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.565 -179.538 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 54.1 mp0 -86.61 147.01 26.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.83 18.69 55.86 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.694 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 1.0 OUTLIER -123.65 131.13 53.54 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.842 0.354 . . . . 0.0 110.449 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.585 ' N ' ' CD2' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.4 100.97 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.023 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 13.0 m -100.34 -30.49 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.092 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.4 158.34 43.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.723 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.9 ttm -119.47 139.61 51.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.448 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 tp -105.53 113.84 27.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.475 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -107.13 126.04 51.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.245 0.545 . . . . 0.0 110.726 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.417 ' N ' ' O ' ' A' ' 26' ' ' LYS . 10.3 mt -103.95 114.08 64.82 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.138 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.511 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.4 Cg_endo -77.33 -47.51 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.984 2.456 . . . . 0.0 112.871 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.5 tptt -59.47 -40.51 87.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.574 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.617 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 2.8 mm? -98.43 -3.57 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.582 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 52.87 39.77 29.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.972 0.415 . . . . 0.0 110.642 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -119.83 152.44 37.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.832 179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -128.96 142.31 50.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.853 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -135.67 150.41 49.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.801 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.1 m -98.96 115.78 29.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.583 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.48 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.3 mp -93.14 127.03 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.63 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 15' ' ' LYS . 33.6 m-85 -107.55 143.1 36.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.869 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.494 ' CD1' ' HG3' ' A' ' 12' ' ' GLU . 47.3 t-105 -61.84 127.29 30.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.736 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 89.1 168.21 43.59 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.17 110.85 0.93 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.915 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -101.8 125.77 48.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 0.0 110.716 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.472 ' C ' ' OD1' ' A' ' 36' ' ' ASP . 51.5 p30 -81.12 -3.83 53.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.511 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.94 -64.58 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.614 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.3 p -86.32 168.02 14.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.517 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.8 tp -98.36 86.53 3.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.413 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -80.96 -171.97 3.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.458 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -51.78 -28.63 16.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.371 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 63' ' ' SER . . . 108.52 -36.3 4.45 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.5 96.87 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.152 0.501 . . . . 0.0 110.355 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.04 161.02 23.79 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.766 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -104.27 139.25 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.72 0.295 . . . . 0.0 110.587 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.766 ' N ' ' SD ' ' A' ' 45' ' ' MET . 40.5 t80 -76.7 120.59 22.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.127 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.461 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.2 p -97.53 120.37 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.661 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.21 166.53 32.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.414 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.51 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 41.0 t0 -64.07 -33.98 77.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.548 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.499 HG22 ' H ' ' A' ' 51' ' ' THR . 4.1 m -84.82 -41.62 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 110.863 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.499 ' H ' HG22 ' A' ' 50' ' ' VAL . 44.2 p -77.5 161.47 27.9 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.724 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.508 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -156.22 169.75 23.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.905 0.383 . . . . 0.0 110.587 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.89 153.86 49.73 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.587 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -73.23 85.56 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.874 2.383 . . . . 0.0 112.314 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -118.95 4.41 11.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.62 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.94 89.95 0.26 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.5 85.58 0.05 OUTLIER Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.44 161.91 35.31 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.714 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 12.3 t-160 -81.36 121.03 25.7 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.2 m -114.9 122.9 47.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.188 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.467 ' H ' ' HE3' ' A' ' 45' ' ' MET . 39.9 t -115.98 128.61 73.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.338 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.439 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 1.9 mm? -113.82 145.64 41.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.232 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 42' ' ' GLY . 35.7 t -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.647 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.651 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -157.27 164.54 32.96 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.466 ' ND1' ' N ' ' A' ' 65' ' ' HIS . 0.0 OUTLIER -123.05 153.53 39.74 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.864 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 61.8 101.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.471 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -65.15 -31.68 72.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.214 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 70.63 107.03 0.06 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.592 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.5 m -45.15 -26.7 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.49 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.608 ' C ' ' H ' ' A' ' 72' ' ' ASP . 3.1 m-85 -73.93 143.57 45.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.669 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 53.8 p 50.33 6.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.479 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.608 ' H ' ' C ' ' A' ' 70' ' ' PHE . 25.5 t0 -59.36 -47.04 86.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.538 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.3 tp -60.64 -42.49 97.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.902 0.382 . . . . 0.0 110.814 -179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.26 -30.12 76.55 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -70.06 -39.44 75.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.935 0.398 . . . . 0.0 110.792 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.452 ' CD2' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -101.44 98.02 8.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.772 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.509 ' HZ3' ' HB2' ' A' ' 79' ' ' LYS . 0.0 OUTLIER 178.01 148.71 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.116 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -78.13 -13.83 59.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.54 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.509 ' HB2' ' HZ3' ' A' ' 77' ' ' LYS . 52.2 mtpt -83.17 -15.69 49.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.414 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.55 153.16 41.44 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.652 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.511 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -141.95 121.53 13.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.088 0.471 . . . . 0.0 109.8 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.2 mt -98.39 133.34 42.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.545 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.1 t -111.92 122.62 66.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.927 0.394 . . . . 0.0 110.25 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.443 ' N ' ' CD1' ' A' ' 84' ' ' LEU . 8.5 mp -102.33 124.45 47.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.105 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -101.22 115.22 29.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.093 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.632 ' O ' ' N ' ' A' ' 89' ' ' LYS . 5.6 t80 -144.55 143.07 30.64 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.812 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.414 ' C ' ' H ' ' A' ' 89' ' ' LYS . 38.9 t70 38.05 52.64 1.57 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.738 0.304 . . . . 0.0 111.407 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 58.1 9.87 1.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.395 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.632 ' N ' ' O ' ' A' ' 86' ' ' TYR . 53.4 mtmt -104.57 143.72 32.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.55 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.85 122.56 44.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.844 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -109.88 127.95 55.04 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.533 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -96.47 109.25 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.393 -179.65 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 52.9 m-85 -99.06 155.15 17.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.991 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -131.38 130.02 42.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.194 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.526 ' CD1' ' CG2' ' A' ' 137' ' ' ILE . 4.9 mm -61.11 119.32 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.648 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -89.79 -65.8 0.98 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.757 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -147.16 138.15 23.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.454 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.497 HG21 ' CZ ' ' A' ' 135' ' ' TYR . 1.3 mp -113.62 133.27 60.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.404 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 18.6 p90 -153.48 -178.68 7.16 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.929 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.449 ' N ' HD12 ' A' ' 100' ' ' ILE . 1.8 mp -125.27 129.67 73.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.491 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.8 t -128.85 172.94 10.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.673 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -73.9 153.41 39.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.69 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.421 ' C ' ' H ' ' A' ' 105' ' ' ASP . . . -61.95 -34.51 76.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.524 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -78.98 18.75 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.677 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.617 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 9.9 t70 -89.22 99.09 12.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.326 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.475 ' O ' ' CG2' ' A' ' 110' ' ' ILE . 23.1 ptt85 -80.15 -19.42 47.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.779 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.617 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 6.8 p -48.1 -18.25 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.957 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.1 m -110.52 -9.35 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.287 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.512 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 39.2 mm -104.95 1.33 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.033 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.714 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -77.72 -167.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.464 ' H ' ' HG2' ' A' ' 111' ' ' LYS . 12.6 ptmt -99.88 151.66 21.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.774 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.528 ' H ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -125.45 134.94 51.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.303 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -78.31 6.96 7.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.221 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.09 164.16 33.4 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -71.41 96.17 0.72 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.192 2.595 . . . . 0.0 112.155 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.9 mm -128.98 133.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.46 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.562 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 5.7 tt -106.69 120.36 41.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.161 0.505 . . . . 0.0 110.316 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 91.1 m -118.34 119.09 33.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.158 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.521 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 5.6 tt -105.73 127.81 53.31 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.609 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.499 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -120.83 117.76 28.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.817 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.651 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.7 t -151.5 -170.04 3.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.729 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.632 ' SG ' ' O ' ' A' ' 121' ' ' THR . 1.6 p 152.46 -85.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.593 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.487 ' N ' ' CD1' ' A' ' 123' ' ' TYR . 11.4 m-85 44.2 66.95 4.35 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.05 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -82.75 178.4 6.09 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 123.151 2.567 . . . . 0.0 112.304 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -54.09 -24.77 18.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.315 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.51 ' C ' ' OD1' ' A' ' 126' ' ' ASP . 2.0 p30 -93.64 13.11 23.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.556 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.681 ' CZ ' ' O ' ' A' ' 129' ' ' GLY . 53.0 t80 -58.47 -48.44 80.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.29 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.644 ' C ' ' O ' ' A' ' 127' ' ' TYR . 96.2 mt 4.03 78.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 O-C-N 123.918 0.761 . . . . 0.0 110.516 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.681 ' O ' ' CZ ' ' A' ' 127' ' ' TYR . . . 112.0 -100.69 1.19 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 131' ' ' ALA . 20.1 t70 -133.35 104.89 6.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.741 0.305 . . . . 0.0 110.574 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 130' ' ' ASP . . . -38.21 139.39 0.65 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.757 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.93 -21.34 37.61 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.797 2.332 . . . . 0.0 112.0 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -138.95 143.54 38.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.554 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.448 ' HD3' ' HG1' ' A' ' 120' ' ' THR . 4.9 ttt180 -117.22 132.87 56.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.922 0.391 . . . . 0.0 110.411 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.497 ' CZ ' HG21 ' A' ' 98' ' ' ILE . 5.3 t80 -75.79 125.96 30.08 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.915 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.2 mm -112.91 118.59 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.91 0.386 . . . . 0.0 111.94 -179.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.705 ' N ' ' CD1' ' A' ' 137' ' ' ILE . 1.3 mp -110.42 107.04 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -90.98 136.58 32.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.382 0.611 . . . . 0.0 111.344 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.2 36.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.911 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.534 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 50.9 tptt -111.69 139.85 46.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.352 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.549 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 2.2 tm? -75.5 114.87 14.55 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.707 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.615 ' HG1' ' H ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -97.74 -65.39 0.97 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.273 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.615 ' H ' ' HG1' ' A' ' 142' ' ' THR . . . -101.41 151.19 18.66 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.257 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 89.9 p -137.35 126.91 25.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.93 0.395 . . . . 0.0 110.428 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -118.74 146.48 44.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.677 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.2 p -133.94 130.1 37.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.574 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.609 -179.962 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.587 ' O ' ' O ' ' A' ' 1' ' ' GLY . 8.7 m 26.35 100.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.818 0.342 . . . . 0.0 110.592 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -98.26 -101.31 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.798 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.489 ' O ' ' CG ' ' A' ' 4' ' ' MET . 7.9 ptp -129.83 128.57 42.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.842 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 4' ' ' MET . 1.3 m -169.33 -152.12 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.469 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 71.43 84.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.598 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -128.38 8.08 5.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.492 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m 64.34 -129.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.531 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 52.6 -106.07 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.571 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.553 ' O ' ' OE2' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -127.55 43.93 3.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.694 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.607 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 12.5 tmtt? -68.43 127.28 32.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.531 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.553 ' OE2' ' O ' ' A' ' 10' ' ' HIS . 9.0 mp0 -81.38 109.28 15.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.141 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 129.05 24.69 1.04 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.607 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -127.29 131.8 50.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.801 0.334 . . . . 0.0 110.458 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 96.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.986 0.422 . . . . 0.0 110.285 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.6 m -100.71 -38.31 6.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.921 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.95 157.85 45.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 32.0 ttm -125.35 136.16 53.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.441 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.9 tt -101.72 119.05 38.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.19 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -111.89 137.73 49.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.367 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -119.26 112.96 35.59 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.892 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.477 ' O ' ' CD ' ' A' ' 25' ' ' LYS . 56.3 Cg_endo -75.16 -40.26 0.91 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.882 2.388 . . . . 0.0 112.929 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HE3' ' HZ1' ' A' ' 77' ' ' LYS . 4.5 tmtt? -65.06 -37.57 88.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.716 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.489 HD23 ' N ' ' A' ' 24' ' ' LEU . 3.7 mm? -96.24 3.02 53.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.738 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.536 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER 45.69 57.12 5.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.433 ' HD3' ' CE2' ' A' ' 28' ' ' PHE . 18.1 ptpt -157.26 173.91 16.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.969 0.414 . . . . 0.0 110.629 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.01 158.09 43.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.619 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.433 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 87.7 m-85 -133.37 154.22 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.738 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.1 m -95.21 112.48 24.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.835 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.546 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.2 mp -93.79 122.04 44.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.425 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.47 ' CG ' ' HE2' ' A' ' 41' ' ' LYS . 86.3 m-85 -102.71 146.1 28.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TRP . . . . . 0.469 ' O ' ' N ' ' A' ' 13' ' ' GLY . 51.6 t-105 -62.56 125.08 22.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.557 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.67 142.98 4.58 Favored Glycine 0 N--CA 1.46 0.291 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.74 94.36 3.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.623 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -99.38 108.09 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.861 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.22 -32.97 74.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.509 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.39 90.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.646 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.0 m -66.81 127.64 33.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.345 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.61 85.96 3.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.586 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt 175.63 -5.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.604 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.47 ' HE2' ' CG ' ' A' ' 31' ' ' TYR . 3.4 tptt -125.41 166.87 15.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.46 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.33 -51.72 0.03 OUTLIER Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.7 m -110.69 117.76 55.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.418 0.627 . . . . 0.0 110.546 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.99 167.28 31.68 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.114 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.407 ' HG2' ' O ' ' A' ' 61' ' ' VAL . 2.1 ttp -98.74 129.09 45.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 109' ' ' ILE . 19.3 t80 -65.12 131.12 45.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.393 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.467 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.0 p -113.7 124.18 70.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.667 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.744 ' HG ' ' H ' ' A' ' 49' ' ' ASP . 36.3 t -158.02 174.31 15.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.563 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.744 ' H ' ' HG ' ' A' ' 48' ' ' SER . 44.1 t0 -67.65 -13.75 62.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.602 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 3.5 m -111.17 -14.1 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.892 0.377 . . . . 0.0 110.556 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.65 ' OG1' ' N ' ' A' ' 48' ' ' SER . 29.3 p -104.32 141.22 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -142.18 167.48 22.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.473 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.415 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -83.11 162.65 53.81 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.917 -179.515 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -82.58 83.08 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.681 2.254 . . . . 0.0 112.437 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.459 ' HA ' ' HH ' ' A' ' 91' ' ' TYR . 0.9 OUTLIER -117.77 7.71 12.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.654 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.16 87.28 0.36 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.76 92.64 0.04 OUTLIER Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.526 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -170.25 160.09 32.78 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.707 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 19.2 t-160 -82.61 114.2 20.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.6 m -111.47 120.87 43.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.253 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.407 ' O ' ' HG2' ' A' ' 45' ' ' MET . 65.2 t -114.6 125.66 71.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 109.806 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.551 ' N ' ' CD2' ' A' ' 62' ' ' LEU . 2.7 mm? -108.55 143.26 37.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.567 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.3 t -126.87 138.28 53.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.712 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 123' ' ' TYR . . . -160.26 -179.0 34.75 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.68 ' O ' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -84.68 154.22 22.62 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.402 -0.469 . . . . 0.0 110.86 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.639 ' NH1' ' O ' ' A' ' 126' ' ' ASP . 29.0 ptt180 -36.41 -21.11 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.586 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 65' ' ' HIS . 23.1 t70 -25.84 97.95 0.01 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.539 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' ARG . 54.7 m -156.34 -23.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.528 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.44 -30.95 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.623 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -60.02 -44.06 94.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.626 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.5 p -135.33 51.47 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.532 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.432 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 30.3 p-10 -55.56 -44.41 76.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.452 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 73' ' ' LEU . 3.9 mm? -62.01 -41.95 98.63 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.079 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.55 -15.55 79.49 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -87.17 -43.42 12.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 110.68 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.654 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 2.6 pp -108.47 103.99 13.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 111.218 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.497 ' HG3' ' H ' ' A' ' 80' ' ' ASP . 2.3 ptmt 177.91 137.02 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.246 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.31 -17.62 62.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.058 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -79.49 -13.94 59.23 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.367 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.657 ' OD1' ' N ' ' A' ' 81' ' ' THR . 1.0 OUTLIER -70.65 155.35 40.85 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.935 -179.609 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.657 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -142.64 119.16 10.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.025 0.441 . . . . 0.0 109.981 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.9 mt -95.66 129.05 42.98 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.837 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.3 t -113.43 118.1 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.033 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.458 ' N ' ' CD2' ' A' ' 84' ' ' LEU . 4.1 mm? -105.45 135.36 46.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.458 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -106.48 123.73 48.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.946 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 21.9 t80 -143.4 131.03 21.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.261 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.419 ' HB2' ' CD1' ' A' ' 86' ' ' TYR . 8.6 t0 49.45 49.02 20.54 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.315 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 97.7 m-20 63.43 11.27 5.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.471 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 44.3 mtmt -109.94 145.24 37.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.987 0.423 . . . . 0.0 110.288 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.33 123.64 50.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.909 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.459 ' HH ' ' HA ' ' A' ' 55' ' ' SER . 26.6 m-85 -104.48 132.87 50.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.295 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.97 111.1 23.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.164 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TYR . . . . . 0.471 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 80.4 m-85 -109.6 150.36 28.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.48 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -131.18 140.38 49.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.827 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.446 HD12 ' CG2' ' A' ' 137' ' ' ILE . 14.4 mm -60.76 122.23 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.557 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -104.02 -50.48 3.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.859 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 15.3 tptm -154.27 132.51 11.86 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.192 0.52 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.434 ' CD1' ' HA ' ' A' ' 76' ' ' LEU . 71.9 mt -122.04 132.84 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.475 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 30.2 p90 -153.73 -176.06 5.66 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.797 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.501 ' N ' ' CD1' ' A' ' 100' ' ' ILE . 1.8 mp -127.75 129.61 70.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.604 ' HG1' ' H ' ' A' ' 102' ' ' HIS . 9.4 t -134.39 -171.12 2.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.694 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' HIS . . . . . 0.604 ' H ' ' HG1' ' A' ' 101' ' ' THR . 93.2 m-70 -78.31 153.89 31.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.14 -30.8 71.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.609 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -88.63 14.22 10.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.731 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.608 ' OD2' ' OG1' ' A' ' 107' ' ' THR . 3.8 t70 -75.58 94.34 3.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.039 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.728 ' O ' ' N ' ' A' ' 109' ' ' ILE . 30.6 ptt-85 -64.78 -34.28 77.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.664 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.608 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 3.1 p -35.63 -25.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.93 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.582 ' N ' ' O ' ' A' ' 106' ' ' ARG . 28.6 m -98.15 -24.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 110.801 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.728 ' N ' ' O ' ' A' ' 106' ' ' ARG . 8.1 mm -104.89 27.34 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.637 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.707 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.8 OUTLIER -90.85 -162.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.408 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -107.39 137.9 44.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.769 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.498 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.2 mttt -126.36 143.4 51.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.18 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.6 ' N ' ' OE2' ' A' ' 114' ' ' GLU . 15.0 mt-10 -90.97 11.4 22.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.569 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.6 ' OE2' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -136.7 168.68 15.91 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 110.589 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.526 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 51.7 Cg_endo -78.44 90.46 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.164 2.576 . . . . 0.0 112.251 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.493 HG21 ' HZ3' ' A' ' 112' ' ' LYS . 50.8 mm -122.57 129.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.757 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.535 ' CD2' ' C ' ' A' ' 117' ' ' LEU . 6.5 tt -104.08 122.26 44.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.71 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 19.6 m -114.27 113.61 24.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.13 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.529 ' CD2' ' C ' ' A' ' 119' ' ' LEU . 1.8 tt -104.27 116.23 31.8 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.699 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.486 ' N ' HD22 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -112.52 129.29 56.4 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.42 0.45 . . . . 0.0 110.196 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.546 ' O ' ' CB ' ' A' ' 122' ' ' CYS . 71.4 p -134.43 156.38 48.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.397 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' CYS . . . . . 0.548 ' O ' ' O ' ' A' ' 123' ' ' TYR . 1.0 OUTLIER 158.01 -62.15 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.676 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.548 ' O ' ' O ' ' A' ' 122' ' ' CYS . 8.2 m-85 54.46 144.59 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.757 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 127' ' ' TYR . 45.8 Cg_endo -71.54 -57.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.759 2.306 . . . . 0.0 112.475 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.639 ' CE2' ' OD2' ' A' ' 126' ' ' ASP . 1.6 p90 -56.99 -33.71 67.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.277 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.639 ' O ' ' NH1' ' A' ' 66' ' ' ARG . 4.0 m-20 -63.09 -37.73 88.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.444 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.609 ' O ' ' N ' ' A' ' 129' ' ' GLY . 4.0 t80 -110.7 118.55 36.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.445 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.505 ' C ' ' O ' ' A' ' 127' ' ' TYR . 88.1 mt -32.13 89.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.298 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 127' ' ' TYR . . . 104.2 -159.58 16.29 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -91.77 106.07 18.19 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.476 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -45.02 103.67 0.35 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.626 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.62 -40.92 63.46 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.695 2.264 . . . . 0.0 112.018 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -118.11 158.81 24.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.543 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.503 ' HA ' ' SG ' ' A' ' 122' ' ' CYS . 0.8 OUTLIER -123.53 134.61 53.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.209 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.488 ' CD1' HG13 ' A' ' 100' ' ' ILE . 4.2 t80 -87.43 125.14 34.1 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -122.16 128.52 75.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.016 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.446 ' CG2' HD12 ' A' ' 95' ' ' ILE . 7.2 mm -106.87 111.76 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.036 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . 0.4 ' HB3' ' O ' ' A' ' 97' ' ' LYS . 67.5 tt0 -94.27 138.48 32.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.507 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -148.75 149.02 30.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.655 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -114.43 152.66 31.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.188 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.471 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 11.2 tp -77.07 115.61 17.01 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.702 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.63 -42.18 12.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.123 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -142.73 171.6 24.74 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 56.4 p -147.08 151.39 36.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 110.41 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -136.58 160.75 37.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.688 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.588 ' O ' ' C ' ' A' ' 147' ' ' LYS . 7.9 p -150.74 125.56 9.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.45 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.588 ' C ' ' O ' ' A' ' 146' ' ' SER . 17.4 tttm . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.471 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 tttp . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.844 0.354 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.446 ' HG3' ' CD1' ' A' ' 32' ' ' TRP . 2.3 mp0 -59.85 137.87 57.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.356 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.29 9.17 70.34 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -115.49 141.25 48.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.839 0.352 . . . . 0.0 110.429 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 84.3 tttt -67.82 113.6 5.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.228 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.3 m -111.8 -37.22 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.028 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.494 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -141.36 158.33 44.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.665 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 44.9 ttp -118.05 138.42 52.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.415 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.487 HD12 HD11 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -102.42 121.9 43.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.077 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -122.46 135.29 54.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.119 0.485 . . . . 0.0 111.07 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.523 HG22 ' H ' ' A' ' 24' ' ' LEU . 3.8 mt -110.82 118.01 49.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.291 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD3' HG23 ' A' ' 83' ' ' VAL . 57.5 Cg_endo -75.58 -48.5 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.832 2.355 . . . . 0.0 112.728 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.54 ' C ' HD22 ' A' ' 24' ' ' LEU . 11.7 tptt -60.21 -44.93 94.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.815 HD22 ' N ' ' A' ' 24' ' ' LEU . 2.8 mm? -96.53 3.03 52.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.618 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.41 38.96 1.95 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.719 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HZ2' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -112.22 145.06 40.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.356 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.37 144.06 50.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -140.23 141.88 35.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.661 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.546 ' C ' HD12 ' A' ' 30' ' ' ILE . 5.0 p -86.68 121.21 28.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.712 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.559 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.1 mp -103.63 120.66 54.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.549 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 32.2 m-85 -106.2 150.31 25.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.727 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CD1' ' HG3' ' A' ' 12' ' ' GLU . 33.2 t-105 -60.12 128.63 37.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.696 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.29 160.51 12.3 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.405 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.586 179.597 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.591 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.766 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -96.57 134.82 39.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.728 0.299 . . . . 0.0 110.576 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.766 ' N ' ' SD ' ' A' ' 45' ' ' MET . 1.9 t80 -64.02 132.55 50.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.712 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.56 120.24 61.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.558 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.525 ' N ' ' OG1' ' A' ' 51' ' ' THR . 43.2 p -160.69 169.66 22.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.498 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.554 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 47.8 t0 -62.45 -10.67 12.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.625 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.5 m -112.11 -34.25 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.71 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' A' ' 48' ' ' SER . 65.7 p -85.14 138.27 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.582 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.3 t -139.83 174.23 10.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.565 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.416 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -89.38 158.28 46.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.38 83.69 1.98 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.664 2.243 . . . . 0.0 112.694 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.9 p -118.83 -2.1 10.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.79 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.21 86.2 0.06 OUTLIER Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.59 101.55 0.01 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.513 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -178.42 165.32 34.52 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.696 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 16.2 t-160 -83.7 110.21 18.11 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.4 m -105.82 120.9 42.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.844 0.354 . . . . 0.0 110.426 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.615 ' C ' HD22 ' A' ' 62' ' ' LEU . 61.9 t -117.7 131.56 70.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.195 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.615 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.8 mm? -111.25 139.44 46.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.596 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 t -122.59 129.4 51.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.733 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.639 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.531 1.041 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.548 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -68.83 -44.09 74.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.697 0.284 . . . . 0.0 110.656 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.555 HD22 ' HE2' ' A' ' 135' ' ' TYR . 5.3 mt -90.82 92.95 9.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.952 0.406 . . . . 0.0 110.352 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.534 ' HG3' ' H ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -174.73 147.67 1.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.06 -11.72 60.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.755 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.534 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 3.8 mtpt -84.13 -15.61 46.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.382 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.66 157.28 28.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.475 ' O ' HD23 ' A' ' 82' ' ' LEU . 1.8 p -137.02 149.87 47.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.969 0.414 . . . . 0.0 109.992 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 81' ' ' THR . 35.9 mt -118.8 120.07 36.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.224 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.65 ' C ' HD22 ' A' ' 84' ' ' LEU . 14.9 t -102.76 124.57 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.949 0.404 . . . . 0.0 110.642 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.65 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.2 mm? -113.0 133.16 55.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.127 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.531 ' HG2' HG23 ' A' ' 90' ' ' THR . 97.6 mt-10 -106.09 119.33 38.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.494 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.1 t80 -143.2 127.05 17.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.266 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 57.08 44.32 22.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.854 0.359 . . . . 0.0 111.194 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 64.32 15.62 9.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.486 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 6.4 mtmp? -116.4 140.85 48.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.185 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.65 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -108.65 124.46 50.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 15.8 m-85 -104.06 129.68 51.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 117.75 35.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 111.127 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.454 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 89.7 m-85 -112.34 163.83 13.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.593 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -139.04 133.86 32.21 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.824 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 77' ' ' LYS . 0.9 OUTLIER -65.52 123.78 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.201 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -99.89 -47.93 4.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.996 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -153.32 139.28 18.16 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.099 0.476 . . . . 0.0 110.532 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mt -116.51 130.58 71.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.539 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.499 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 20.0 p90 -151.62 -175.88 5.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.473 HG12 ' CD1' ' A' ' 135' ' ' TYR . 6.9 mt -129.31 135.21 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.498 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.539 HG22 HG13 ' A' ' 136' ' ' ILE . 6.5 t -134.86 171.23 14.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.77 158.11 35.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.459 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.465 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . . . -69.53 -11.44 60.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.701 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.554 ' OD1' ' C ' ' A' ' 104' ' ' ASP . 12.4 p30 -100.82 15.51 28.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.694 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.405 ' OD2' ' OG1' ' A' ' 101' ' ' THR . 39.8 t0 -79.15 94.28 5.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.973 0.416 . . . . 0.0 110.594 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.48 ' O ' HG13 ' A' ' 110' ' ' ILE . 52.3 ptt85 -74.82 -20.51 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.524 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.787 ' O ' HD11 ' A' ' 110' ' ' ILE . 5.9 p -60.08 -26.28 66.06 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.313 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.831 ' CG1' HG21 ' A' ' 118' ' ' THR . 21.5 t -95.82 -4.83 10.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.809 HG22 ' O ' ' A' ' 109' ' ' ILE . 42.5 mm -118.78 14.05 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.03 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.787 HD11 ' O ' ' A' ' 107' ' ' THR . 0.7 OUTLIER -79.61 -160.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.71 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.401 ' H ' ' HB ' ' A' ' 110' ' ' ILE . 24.1 ttmt -99.24 149.64 22.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.378 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.489 ' N ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -129.73 126.24 37.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 113' ' ' GLU . 68.8 tt0 -76.6 7.65 4.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.028 0.442 . . . . 0.0 110.117 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.14 164.08 43.14 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.542 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.513 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 44.6 Cg_endo -76.33 87.81 1.4 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.961 2.44 . . . . 0.0 111.888 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.5 mm -119.1 130.47 73.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.968 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.83 ' C ' HD23 ' A' ' 117' ' ' LEU . 6.0 tt -103.56 118.57 37.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.149 0.5 . . . . 0.0 110.884 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.831 HG21 ' CG1' ' A' ' 108' ' ' VAL . 96.9 m -117.78 124.31 48.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.228 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 1.009 HD12 ' N ' ' A' ' 120' ' ' THR . 0.5 OUTLIER -106.44 122.7 46.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.493 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . 1.009 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -121.08 120.48 35.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.236 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.639 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.4 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.158 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.779 0.323 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 103' ' ' ALA . 10.6 ptp180 -101.31 144.42 30.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.785 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.555 ' HE2' HD22 ' A' ' 76' ' ' LEU . 4.5 t80 -76.42 135.04 39.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.872 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.539 HG13 HG22 ' A' ' 101' ' ' THR . 5.1 mm -120.14 124.15 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 137' ' ' ILE . 1.2 mp -112.91 109.5 28.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.499 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 22.7 tp10 -94.19 136.78 34.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.143 0.497 . . . . 0.0 110.89 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.59 148.98 31.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.973 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 79.2 tttt -116.2 155.23 28.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.06 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.454 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 11.8 tp -78.86 122.53 26.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.009 0.433 . . . . 0.0 110.478 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.66 -38.13 6.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.782 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -143.29 159.67 27.51 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.9 p -144.61 149.51 35.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.764 0.316 . . . . 0.0 110.457 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 90' ' ' THR . 93.0 m-85 -128.97 153.8 47.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.598 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 77.4 p -146.86 126.99 13.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.729 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.591 179.995 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.611 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 64.1 tttt . . . . . 0 N--CA 1.461 0.114 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -91.61 149.39 21.68 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 89.71 10.23 65.37 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.611 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -113.64 133.95 55.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.843 0.354 . . . . 0.0 110.412 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.48 106.24 0.52 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.289 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.4 HG23 ' N ' ' A' ' 17' ' ' ALA . 17.5 m -109.28 -40.53 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.971 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.426 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -128.17 160.32 32.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.7 ttp -123.7 147.1 47.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.189 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.8 tp -112.56 123.39 50.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.68 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -118.02 128.38 54.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.963 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.1 mt -106.42 106.34 57.15 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 81' ' ' THR . 55.6 Cg_endo -76.33 -40.39 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.82 2.347 . . . . 0.0 112.851 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.564 ' C ' HD22 ' A' ' 24' ' ' LEU . 48.4 tptt -58.48 -43.55 89.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.614 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.799 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.0 mm? -99.58 -0.03 41.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.569 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.25 49.49 17.07 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.593 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -127.66 165.42 20.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.402 . . . . 0.0 110.839 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -140.59 145.82 37.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.103 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -142.6 145.47 33.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.861 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -90.01 129.18 36.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.188 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.421 HD12 ' CD1' ' A' ' 62' ' ' LEU . 37.0 mm -103.23 119.58 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.004 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -102.36 142.71 33.13 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.967 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.51 ' CZ2' ' HB ' ' A' ' 47' ' ' VAL . 46.0 t-105 -60.63 119.36 7.96 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.855 0.36 . . . . 0.0 110.611 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 83.08 159.53 27.54 Favored Glycine 0 C--N 1.332 0.307 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.579 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.729 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.555 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.401 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 35.0 ttm -108.19 128.19 54.49 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.59 128.67 36.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.884 0.373 . . . . 0.0 110.565 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.51 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 1.1 m -109.35 133.67 53.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.71 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.696 ' N ' ' OG1' ' A' ' 51' ' ' THR . 12.9 m -161.5 177.17 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.576 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.559 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 46.5 t0 -67.7 -10.2 50.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.43 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 109' ' ' ILE . 4.6 m -118.1 -28.52 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.816 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.696 ' OG1' ' N ' ' A' ' 48' ' ' SER . 39.1 p -83.07 141.11 32.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.584 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 t -142.71 177.2 8.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.723 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.8 160.43 29.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.649 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.717 ' HG3' HD13 ' A' ' 84' ' ' LEU . 64.9 Cg_endo -77.53 83.1 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.863 2.375 . . . . 0.0 112.39 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.7 p -120.95 -1.51 9.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.25 90.96 0.15 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.72 86.85 0.04 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 115' ' ' PRO . . . -163.04 155.62 27.04 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.686 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 17.5 t-160 -79.43 112.17 16.41 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 m -104.28 127.0 51.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.526 ' C ' HD22 ' A' ' 62' ' ' LEU . 71.1 t -119.19 128.97 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 0.0 110.249 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.526 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.6 mm? -111.19 142.84 42.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.608 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.5 t -127.29 136.24 51.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.615 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.526 0.764 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.594 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -66.24 -40.36 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.694 0.283 . . . . 0.0 110.963 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.86 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.9 pp -100.52 108.71 20.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.186 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 14.7 ptmt 173.77 145.04 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.374 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -72.78 -14.06 61.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -83.0 -15.72 50.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.891 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.17 160.99 20.07 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.922 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.472 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -150.01 119.99 7.17 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.026 0.441 . . . . 0.0 109.973 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.5 131.77 43.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.074 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 43.8 t -112.94 130.32 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.015 0.436 . . . . 0.0 110.458 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.87 HD11 HD12 ' A' ' 117' ' ' LEU . 39.0 mt -113.01 126.47 55.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.53 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -104.45 116.49 32.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.442 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.426 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.3 t80 -149.09 131.4 15.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.852 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.4 t70 60.78 42.44 13.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.352 . . . . 0.0 111.241 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 61.34 15.69 6.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.021 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -115.2 146.97 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.496 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -115.74 123.35 48.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.936 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.433 ' HB3' ' CD1' ' A' ' 141' ' ' LEU . 20.2 m-85 -106.28 137.09 44.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.682 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.99 120.22 41.68 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.035 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.533 ' CE1' HD12 ' A' ' 84' ' ' LEU . 71.4 m-85 -112.91 155.65 24.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.729 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -130.3 138.73 50.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.59 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.2 mm -63.63 121.41 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.23 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -98.55 -52.8 3.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.933 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -150.46 141.49 23.0 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.465 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.511 HG23 HD12 ' A' ' 137' ' ' ILE . 76.3 mt -121.7 130.82 74.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.835 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -153.08 -176.15 5.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 110.854 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.46 HG22 ' CB ' ' A' ' 133' ' ' ASP . 4.5 mt -128.25 131.71 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.5 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.71 169.46 17.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 110.895 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.41 148.39 45.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.985 0.421 . . . . 0.0 110.452 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 134' ' ' ARG . . . -63.13 -19.48 64.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.629 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -88.96 11.8 17.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -84.9 88.4 7.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.375 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.838 ' O ' HG23 ' A' ' 110' ' ' ILE . 6.9 ptp85 -60.42 -31.82 70.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.485 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.496 ' O ' HD12 ' A' ' 110' ' ' ILE . 5.7 p -44.52 -14.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.25 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.886 HG12 HG21 ' A' ' 118' ' ' THR . 4.8 t -108.12 -16.43 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.044 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.763 HG22 ' O ' ' A' ' 109' ' ' ILE . 47.3 mm -107.51 12.16 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.048 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.838 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -79.42 -175.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.93 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -81.57 142.45 32.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.145 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.493 ' HB2' ' CG ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -116.09 130.59 56.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.949 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 4.6 mt-10 -78.15 16.77 0.7 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.056 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -160.23 167.14 14.42 Favored Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.771 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.446 ' O ' HD13 ' A' ' 116' ' ' ILE . 37.3 Cg_endo -73.21 101.9 1.4 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.678 2.252 . . . . 0.0 111.414 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 115' ' ' PRO . 50.6 mm -131.13 136.42 57.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.357 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.87 HD12 HD11 ' A' ' 84' ' ' LEU . 6.3 tt -108.65 119.65 40.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.358 0.599 . . . . 0.0 110.681 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.886 HG21 HG12 ' A' ' 108' ' ' VAL . 61.7 m -118.2 125.11 49.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.202 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.83 HD23 ' C ' ' A' ' 119' ' ' LEU . 6.2 tt -112.97 124.9 53.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.388 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.757 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -120.54 116.47 25.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.503 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.634 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.356 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.46 ' CB ' HG22 ' A' ' 100' ' ' ILE . 97.9 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.829 0.347 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 103' ' ' ALA . 7.3 mpt_? -104.16 143.98 32.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.055 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 120' ' ' THR . 2.8 t80 -69.13 124.97 25.22 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.881 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 2.6 mm -111.01 112.16 39.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 137' ' ' ILE . 0.9 OUTLIER -100.37 112.22 32.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.233 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -95.51 140.29 30.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.389 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.85 138.76 21.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.966 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -110.47 150.86 28.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.242 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 91' ' ' TYR . 5.4 tp -72.46 122.59 21.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.355 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.94 -41.06 5.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.738 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.23 175.39 20.16 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 94.3 p -155.85 160.85 40.54 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.65 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' THR . 92.9 m-85 -147.87 152.47 37.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.582 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.1 p -147.57 132.66 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.759 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.604 ' O ' ' OE1' ' A' ' 14' ' ' GLU . 54.6 mmtt . . . . . 0 C--O 1.225 -0.205 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.558 ' OE2' HG11 ' A' ' 47' ' ' VAL . 97.6 mt-10 -107.31 123.86 48.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.377 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.577 ' N ' ' OE2' ' A' ' 14' ' ' GLU . . . 114.42 1.78 23.18 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.654 ' CD ' ' H ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -115.34 139.79 49.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.859 0.362 . . . . 0.0 110.278 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 89.0 tttt -58.67 120.74 9.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.642 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.408 HG11 ' HB2' ' A' ' 32' ' ' TRP . 24.1 m -116.23 -18.05 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.84 158.63 39.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.539 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.2 ttp -120.76 133.14 55.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.392 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.502 HD13 ' H ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -99.19 129.74 45.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.352 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.502 ' H ' HD13 ' A' ' 19' ' ' LEU . 27.4 t-20 -125.69 124.01 40.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.988 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.433 HG22 ' H ' ' A' ' 24' ' ' LEU . 6.9 mt -105.9 109.74 63.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.855 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 81' ' ' THR . 57.2 Cg_endo -75.89 -42.92 0.36 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.577 2.185 . . . . 0.0 112.6 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HB3' HD22 ' A' ' 24' ' ' LEU . 8.1 tmtm? -60.57 -40.12 90.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.253 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.668 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.7 mm? -98.53 -2.35 38.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 0.0 110.489 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 54.46 42.66 31.23 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.689 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.489 ' HE3' ' CZ ' ' A' ' 28' ' ' PHE . 4.2 mtpp -124.03 163.01 22.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.093 0.473 . . . . 0.0 110.636 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG2' ' CG ' ' A' ' 20' ' ' ASN . 34.9 mtmt -141.89 143.37 33.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.007 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.489 ' CZ ' ' HE3' ' A' ' 26' ' ' LYS . 89.4 m-85 -137.71 152.23 49.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.805 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.561 ' OG ' ' CE1' ' A' ' 31' ' ' TYR . 4.9 t -97.15 124.82 41.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.772 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.531 HD12 HD11 ' A' ' 62' ' ' LEU . 40.4 mm -92.56 126.2 45.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.556 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.561 ' CE1' ' OG ' ' A' ' 29' ' ' SER . 89.1 m-85 -114.16 138.47 50.4 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.957 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.646 ' CZ3' HG22 ' A' ' 53' ' ' THR . 41.5 t-105 -60.74 126.85 28.92 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.604 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.634 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 84.28 169.79 45.96 Favored Glycine 0 C--N 1.331 0.289 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.51 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.783 179.607 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.513 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 40.1 ttm -103.8 144.48 31.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.54 143.95 46.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.516 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' HA2' ' A' ' 33' ' ' GLY . 78.8 t -115.87 129.81 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.367 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.4 p -166.83 -173.92 2.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.65 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -89.28 -23.75 22.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 5.8 m -92.13 -38.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.687 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.459 ' N ' HG23 ' A' ' 50' ' ' VAL . 63.6 p -78.53 153.23 31.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.556 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 t -150.24 172.09 15.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.459 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.646 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -84.91 153.92 60.68 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.701 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.44 80.65 2.69 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.546 2.164 . . . . 0.0 112.34 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.5 p -107.48 -13.39 15.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.755 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.62 88.99 0.08 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.42 80.23 0.51 Allowed Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.455 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -165.97 158.42 31.32 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.695 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 15.3 t-160 -81.75 121.73 26.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.8 m -116.17 129.48 56.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.274 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.588 HG11 ' CD1' ' A' ' 109' ' ' ILE . 58.3 t -116.35 126.1 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.221 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.531 HD11 HD12 ' A' ' 30' ' ' ILE . 2.4 mm? -108.47 138.89 44.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.125 0.488 . . . . 0.0 110.529 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.3 t -121.63 138.67 54.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.876 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.531 1.037 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' A' ' 77' ' ' LYS . . . . . . . . 0 CA--C 1.523 0.557 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -68.41 -41.22 80.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.78 0.324 . . . . 0.0 110.696 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.574 HD22 ' HE2' ' A' ' 135' ' ' TYR . 8.2 mt -93.85 89.42 6.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.491 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 74' ' ' GLY . 6.3 ptpt -176.25 145.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.427 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -69.8 -21.99 63.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.739 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -76.39 -14.63 60.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.152 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.68 154.93 39.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.789 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.427 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -137.92 133.17 33.45 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.4 mt -109.23 124.68 51.27 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.785 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.625 ' CG1' HG22 ' A' ' 90' ' ' THR . 40.0 t -106.37 116.65 50.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.981 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.868 HD21 HD12 ' A' ' 117' ' ' LEU . 8.1 mp -98.54 127.04 44.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.031 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.695 ' HG2' HG23 ' A' ' 90' ' ' THR . 95.4 mt-10 -106.54 117.3 33.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.244 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -148.23 131.95 16.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.846 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 59.32 49.33 9.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.514 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 56.91 13.28 1.43 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.049 0.452 . . . . 0.0 110.259 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -114.9 144.81 42.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.61 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.695 HG23 ' HG2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -114.08 123.31 49.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.673 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 14.6 m-85 -104.38 145.14 30.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.453 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.585 ' HG1' ' HE2' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -109.56 114.66 28.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.315 -179.173 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.522 ' CE1' HD22 ' A' ' 84' ' ' LEU . 78.3 m-85 -113.03 151.46 30.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.609 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -128.83 141.65 51.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.786 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.571 ' CD1' HD12 ' A' ' 137' ' ' ILE . 1.5 mm -64.38 119.2 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.362 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.17 -62.92 1.41 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.024 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -145.87 150.92 37.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.307 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.415 HG12 HD13 ' A' ' 137' ' ' ILE . 12.0 mt -122.62 134.35 66.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.059 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.705 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 15.8 p90 -161.87 -179.74 7.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.034 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.645 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.3 mp -128.69 129.25 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.257 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.46 HG22 ' CG1' ' A' ' 136' ' ' ILE . 7.6 t -127.16 173.5 9.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.006 0.432 . . . . 0.0 110.68 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.79 161.55 30.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.526 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.08 -11.74 60.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.761 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -101.71 22.69 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.628 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.596 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 50.1 t0 -92.04 100.83 13.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.594 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.852 ' O ' HG23 ' A' ' 110' ' ' ILE . 2.7 ptt180 -79.71 -20.06 47.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.372 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.596 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 20.0 p -48.39 -16.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.615 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.555 ' HB ' HG21 ' A' ' 118' ' ' THR . 8.8 m -109.4 -6.56 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.233 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 109' ' ' ILE . 47.8 mm -113.44 7.76 7.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.937 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.852 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -79.52 -171.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.467 ' CB ' ' HB ' ' A' ' 50' ' ' VAL . 19.5 ttpt -102.5 141.59 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.938 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 87.0 mttt -124.89 151.91 44.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.574 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -92.41 7.26 43.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.204 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -130.94 159.59 70.68 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.762 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.455 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 43.6 Cg_endo -74.58 94.88 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.978 2.452 . . . . 0.0 111.894 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 115' ' ' PRO . 48.2 mm -126.41 134.77 65.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.137 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.868 HD12 HD21 ' A' ' 84' ' ' LEU . 6.1 tt -108.92 118.48 36.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.251 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.555 HG21 ' HB ' ' A' ' 108' ' ' VAL . 92.1 m -115.14 119.69 37.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.369 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.994 HD12 ' N ' ' A' ' 120' ' ' THR . 0.7 OUTLIER -105.86 124.97 50.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.361 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.994 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -121.57 124.37 44.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.932 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.513 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.3 t . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.305 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.605 ' OD1' HG22 ' A' ' 100' ' ' ILE . 6.8 t0 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.706 0.289 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.632 ' NE ' ' OG1' ' A' ' 120' ' ' THR . 5.6 ptm180 -98.42 138.55 35.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.094 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.574 ' HE2' HD22 ' A' ' 76' ' ' LEU . 4.5 t80 -69.92 136.53 50.69 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.827 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.705 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 9.3 mm -120.84 115.68 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.421 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.571 HD12 ' CD1' ' A' ' 95' ' ' ILE . 1.6 mm -106.99 107.32 22.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -94.24 140.32 29.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.197 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.75 142.92 27.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.132 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 67.2 tttt -117.44 152.78 34.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.996 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.479 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 7.2 tp -73.23 124.19 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.455 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.19 -43.65 5.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.343 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.27 -178.97 16.34 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 34.9 p -153.78 160.29 42.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.708 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.585 ' HE2' ' HG1' ' A' ' 92' ' ' THR . 59.7 m-85 -149.06 156.03 41.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.535 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 64.6 p -147.26 130.94 16.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.594 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.9 pttt . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.526 179.906 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.613 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 70.6 mmtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.115 0.484 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.64 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 52.9 mp0 -90.72 151.89 21.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.387 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 83.79 18.11 64.27 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.613 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -121.97 133.73 54.83 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.537 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 64.4 tttp -60.08 112.03 1.74 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.344 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 14' ' ' GLU . 24.5 m -114.07 -26.38 3.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.965 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -144.08 158.02 43.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.598 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.1 ttp -120.6 140.59 51.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.343 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.486 ' HB2' HD11 ' A' ' 30' ' ' ILE . 55.4 tp -108.96 125.66 52.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.577 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -121.25 133.88 55.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.432 HG22 ' H ' ' A' ' 24' ' ' LEU . 6.0 mt -119.59 111.24 36.39 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 81' ' ' THR . 56.8 Cg_endo -76.02 -36.94 1.74 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.735 2.29 . . . . 0.0 112.843 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.578 ' C ' HD22 ' A' ' 24' ' ' LEU . 39.8 tptt -61.1 -36.83 80.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.582 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.5 mm? -103.61 -0.51 29.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.642 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.59 50.72 16.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.247 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.22 175.7 9.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.036 0.446 . . . . 0.0 110.287 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.76 157.47 31.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.707 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -144.05 159.73 42.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.826 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.409 ' OG ' ' NZ ' ' A' ' 15' ' ' LYS . 4.3 m -99.83 116.14 31.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.012 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 62' ' ' LEU . 35.3 mm -80.39 126.67 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.247 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 70.8 m-85 -111.03 137.79 48.23 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.988 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 13' ' ' GLY . 41.5 t-105 -60.14 117.31 4.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.695 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.614 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 94.24 166.3 36.76 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.703 179.585 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.615 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.575 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 13.4 tpt -95.3 138.1 33.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.714 0.292 . . . . 0.0 110.713 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -77.69 137.56 38.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.982 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.614 HG23 ' HA2' ' A' ' 33' ' ' GLY . 86.9 t -119.34 114.81 45.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.242 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.54 ' N ' ' OG1' ' A' ' 51' ' ' THR . 6.1 m -163.28 169.35 19.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.686 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.575 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 65.1 t0 -70.85 -8.84 55.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.432 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.715 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.2 m -110.42 -22.95 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.645 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.54 ' OG1' ' N ' ' A' ' 48' ' ' SER . 37.0 p -85.58 138.21 32.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.398 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -131.0 168.17 17.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.22 161.0 28.57 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.594 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.522 ' HG3' HD23 ' A' ' 84' ' ' LEU . 66.7 Cg_endo -81.29 73.65 5.83 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.635 2.224 . . . . 0.0 112.365 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.6 p -115.76 -6.33 12.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.754 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.01 91.98 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.47 79.22 0.16 Allowed Glycine 0 CA--C 1.53 1.028 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.456 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -155.29 150.83 22.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.645 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 16.7 t-160 -77.58 104.99 8.44 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.46 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 38.3 m -100.19 122.43 43.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.433 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.599 ' C ' HD22 ' A' ' 62' ' ' LEU . 54.1 t -114.77 127.44 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 0.0 110.276 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.599 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.7 mm? -112.36 147.13 37.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.684 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 120' ' ' THR . 32.6 t -128.99 142.29 50.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.619 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.531 1.076 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.464 ' OE1' ' N ' ' A' ' 75' ' ' GLN . 0.7 OUTLIER -64.37 -36.18 83.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 110.405 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.849 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.2 pp -136.13 112.56 9.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.324 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.489 ' O ' HG21 ' A' ' 95' ' ' ILE . 7.8 ptpt -179.99 144.68 0.19 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.348 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -79.52 -11.51 59.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.947 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -83.59 -13.95 53.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.898 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.683 ' OD1' ' N ' ' A' ' 81' ' ' THR . 23.4 t0 -81.06 158.04 25.21 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.215 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.683 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.6 p -138.48 135.44 35.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.7 mt -109.79 122.09 46.71 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.355 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.486 ' C ' HD12 ' A' ' 84' ' ' LEU . 5.7 t -104.33 121.93 56.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.995 0.426 . . . . 0.0 110.263 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.811 HD21 HD12 ' A' ' 117' ' ' LEU . 8.0 mp -103.59 129.54 50.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.367 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -105.44 120.86 42.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.941 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 2.1 t80 -149.38 127.67 12.14 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.933 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.517 ' OD1' ' O ' ' A' ' 87' ' ' ASP . 64.4 t0 54.02 52.68 12.38 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.827 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.2 m120 57.18 12.23 1.27 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.448 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 49.9 mtmt -112.72 141.63 46.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.956 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.454 ' HG1' ' HB2' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -113.65 126.08 54.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.339 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 10.5 m-85 -109.3 134.83 51.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.102 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.44 ' HG1' ' HE2' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -101.96 115.28 30.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.047 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.497 ' CE1' HD22 ' A' ' 84' ' ' LEU . 75.7 m-85 -110.95 144.27 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.582 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -119.74 138.27 53.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.672 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.493 ' CD1' HG23 ' A' ' 137' ' ' ILE . 2.3 mm -66.2 115.95 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.411 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -86.63 -60.62 1.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.593 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -152.72 145.1 24.03 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.197 0.522 . . . . 0.0 110.26 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.56 131.45 72.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.541 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.496 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 26.5 p90 -149.61 -177.51 5.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.01 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.734 HD12 ' N ' ' A' ' 100' ' ' ILE . 0.9 OUTLIER -130.33 132.42 64.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.356 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.2 t -138.98 178.9 6.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.712 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -68.5 148.71 50.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.564 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.9 -34.31 75.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.363 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -82.8 16.69 2.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.724 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.644 ' OD2' HG23 ' A' ' 108' ' ' VAL . 28.5 t70 -79.63 90.52 5.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.571 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.98 ' O ' HG23 ' A' ' 110' ' ' ILE . 17.0 ptp180 -63.57 -37.92 89.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.515 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.507 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 1.6 p -38.71 -18.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.522 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.851 HG12 HG21 ' A' ' 118' ' ' THR . 11.1 t -111.18 -16.53 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.107 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 109' ' ' ILE . 49.3 mm -112.32 22.34 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.98 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -89.94 -163.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.837 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -102.69 148.31 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.686 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.421 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 98.1 mttt -132.9 150.46 52.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.635 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -94.94 8.98 41.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.401 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.27 163.9 46.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.767 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.456 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 50.2 Cg_endo -79.04 98.5 1.19 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.071 2.514 . . . . 0.0 111.624 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 115' ' ' PRO . 50.2 mm -128.84 138.29 54.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.439 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.824 ' C ' HD23 ' A' ' 117' ' ' LEU . 6.5 tt -110.13 116.48 31.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.666 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.851 HG21 HG12 ' A' ' 108' ' ' VAL . 72.3 m -116.03 114.76 25.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.324 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.843 HD12 ' N ' ' A' ' 120' ' ' THR . 0.9 OUTLIER -103.71 116.32 32.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.026 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.843 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -107.22 122.87 47.39 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.431 0.457 . . . . 0.0 110.403 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.632 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.4 t . . . . . 0 CA--C 1.513 -0.464 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.06 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.698 0.285 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 134' ' ' ARG . 7.7 ttp180 -113.07 142.46 45.7 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.809 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.685 ' CE2' HD11 ' A' ' 137' ' ' ILE . 7.9 t80 -81.9 123.28 28.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 1.6 mt -119.55 124.17 72.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 120.978 0.418 . . . . 0.0 111.959 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.685 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.4 mp -103.04 112.62 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.816 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.496 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 10.4 tt0 -90.11 142.72 27.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.868 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -152.86 149.72 28.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.822 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.451 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 66.7 tttt -123.45 153.4 40.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.451 ' N ' ' CG ' ' A' ' 140' ' ' LYS . 13.8 tp -71.7 126.6 30.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.435 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.68 -36.83 5.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.628 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.425 ' C ' ' OG1' ' A' ' 92' ' ' THR . . . -141.32 162.33 26.87 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.0 p -142.72 133.17 24.94 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.294 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.454 ' HB2' ' HG1' ' A' ' 90' ' ' THR . 62.8 m-85 -123.01 101.6 7.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.684 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.526 ' O ' ' O ' ' A' ' 147' ' ' LYS . 8.6 p -89.38 136.93 32.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.703 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.526 ' O ' ' O ' ' A' ' 146' ' ' SER . 22.0 mtpt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.554 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.556 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 27.4 ttmt . . . . . 0 N--CA 1.458 -0.038 0 CA-C-O 120.842 0.353 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -92.12 147.58 22.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.292 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.41 3.74 68.96 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.556 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.8 OUTLIER -109.7 137.5 47.41 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.878 0.371 . . . . 0.0 110.483 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -62.77 117.17 5.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.195 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.31 -39.93 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.746 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.92 162.18 33.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.7 ttm -127.2 135.66 50.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.527 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tt -101.53 121.53 42.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.195 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 21' ' ' ILE . 3.8 t30 -116.79 136.07 53.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.419 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.596 HD13 HE22 ' A' ' 75' ' ' GLN . 3.4 mt -113.57 118.3 43.53 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.175 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.664 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.7 Cg_endo -76.55 -48.36 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.857 2.371 . . . . 0.0 112.674 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.566 ' C ' HD22 ' A' ' 24' ' ' LEU . 27.1 tptp -61.57 -39.4 91.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.764 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.1 mm? -99.49 0.68 42.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.768 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt 45.61 38.74 4.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.909 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -117.18 157.59 25.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.841 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -137.57 136.35 37.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.725 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -126.27 120.96 31.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.414 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.8 m -67.32 119.42 12.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.916 0.389 . . . . 0.0 110.646 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.543 HD12 ' CD1' ' A' ' 62' ' ' LEU . 40.0 mm -95.73 120.68 45.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.542 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -106.71 147.97 28.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.641 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.768 ' CZ3' ' SD ' ' A' ' 45' ' ' MET . 46.4 t-105 -60.8 117.73 5.77 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.861 0.362 . . . . 0.0 110.454 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.666 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 85.94 153.67 22.37 Favored Glycine 0 C--N 1.332 0.311 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' CB ' ' OG ' ' A' ' 63' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.662 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.554 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.768 ' SD ' ' CZ3' ' A' ' 32' ' ' TRP . 1.5 tmt? -93.68 146.97 23.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.94 0.4 . . . . 0.0 110.965 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.562 ' O ' ' SD ' ' A' ' 45' ' ' MET . 57.8 t80 -76.72 130.29 37.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.371 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.666 HG23 ' HA2' ' A' ' 33' ' ' GLY . 63.5 t -96.62 125.96 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.429 . . . . 0.0 110.669 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.588 ' HG ' ' CB ' ' A' ' 51' ' ' THR . 38.5 p -160.45 176.25 11.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.575 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.586 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 65.9 t0 -82.7 -7.14 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.542 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.703 HG21 ' O ' ' A' ' 109' ' ' ILE . 9.0 m -115.45 -32.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.599 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.588 ' CB ' ' HG ' ' A' ' 48' ' ' SER . 72.8 p -78.9 145.35 34.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.78 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -145.24 171.18 14.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.535 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.467 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -90.04 154.39 47.31 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.848 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.78 84.25 1.8 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.689 2.259 . . . . 0.0 112.415 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -117.02 -4.49 11.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.828 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.15 88.98 0.07 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.13 91.23 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.471 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.96 165.34 38.67 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.502 ' CD2' ' HD2' ' A' ' 112' ' ' LYS . 13.2 t-160 -84.24 111.87 19.77 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.413 HG22 HD23 ' A' ' 62' ' ' LEU . 61.2 m -105.61 123.22 47.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.352 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.587 ' O ' HD22 ' A' ' 62' ' ' LEU . 44.9 t -116.57 126.87 74.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.549 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.587 HD22 ' O ' ' A' ' 61' ' ' VAL . 2.5 mm? -114.16 143.97 43.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.819 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 34' ' ' ALA . 4.9 p -132.86 147.5 52.3 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.56 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.469 ' O ' HG22 ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.534 1.225 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.415 ' HA3' HD11 ' A' ' 24' ' ' LEU . . . . . . . . 0 CA--C 1.525 0.668 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.596 HE22 HD13 ' A' ' 21' ' ' ILE . 52.7 mm-40 -61.49 -41.15 96.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.716 0.293 . . . . 0.0 110.792 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.84 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.0 pp -97.11 109.3 22.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.44 . . . . 0.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.42 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 2.3 ptpt 172.2 143.32 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.445 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.63 -14.83 63.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.721 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -82.07 -14.32 56.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.239 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.23 158.91 34.98 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.06 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.664 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -147.67 111.05 4.91 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.235 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.0 mt -87.77 131.24 34.58 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.224 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.679 HG12 HG22 ' A' ' 90' ' ' THR . 2.8 t -112.61 122.39 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.204 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.588 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.2 mm? -107.98 133.24 52.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.343 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.635 ' HG2' HG23 ' A' ' 90' ' ' THR . 96.5 mt-10 -104.25 118.04 35.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.373 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.467 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 1.0 OUTLIER -146.87 125.81 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.764 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 60.14 51.65 5.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.156 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 56.53 11.39 0.85 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.445 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.454 ' HG2' ' CB ' ' A' ' 146' ' ' SER . 45.0 mtpt -112.01 145.05 40.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.612 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.679 HG22 HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -113.71 117.2 30.86 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.344 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 8.6 m-85 -95.17 136.23 35.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.412 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.481 ' O ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -105.91 113.79 27.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.659 -179.447 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -110.9 147.23 35.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.525 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -123.67 138.9 54.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.651 ' CD1' HG23 ' A' ' 137' ' ' ILE . 8.0 mm -65.89 118.98 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.038 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -95.94 -62.01 1.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.485 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -139.77 135.27 32.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.407 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.9 mt -114.18 127.86 71.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.205 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 21.4 p90 -151.14 -176.35 5.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.73 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.435 HG12 ' CD1' ' A' ' 135' ' ' TYR . 8.0 mt -129.34 138.85 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.46 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.42 HG23 ' HE ' ' A' ' 134' ' ' ARG . 2.2 t -137.55 170.43 16.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.093 0.473 . . . . 0.0 110.776 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.56 ' C ' ' H ' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -73.57 154.72 39.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.555 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.55 8.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.67 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' A' ' 102' ' ' HIS . 57.8 t0 -131.53 36.53 3.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.556 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.541 ' H ' HH21 ' A' ' 134' ' ' ARG . 21.7 t0 -96.44 94.78 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.69 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.985 ' O ' HG23 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -62.45 -35.52 79.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.463 179.782 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.529 ' C ' HD12 ' A' ' 110' ' ' ILE . 1.2 p -44.91 -13.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.354 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.891 ' CG1' HG21 ' A' ' 118' ' ' THR . 15.7 t -113.46 -12.67 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.116 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 109' ' ' ILE . 50.9 mm -117.68 22.2 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.164 0.507 . . . . 0.0 111.064 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 1.016 HD13 ' H ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -87.28 -161.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.706 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -104.45 147.07 27.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 98.6 mttt -142.82 136.27 28.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.305 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.15 16.23 8.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.465 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -125.93 151.47 71.4 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.784 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.471 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 37.0 Cg_endo -72.33 80.84 1.57 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.995 2.464 . . . . 0.0 111.275 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.4 mm -115.5 132.85 63.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.287 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.812 ' C ' HD23 ' A' ' 117' ' ' LEU . 5.7 tt -106.13 118.79 37.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.178 0.513 . . . . 0.0 110.739 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.891 HG21 ' CG1' ' A' ' 108' ' ' VAL . 90.8 m -112.78 120.88 43.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.162 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.702 HD23 ' N ' ' A' ' 120' ' ' THR . 0.4 OUTLIER -108.26 119.68 40.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.414 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.702 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -111.17 115.63 29.71 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.81 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.509 HG23 ' CD2' ' A' ' 119' ' ' LEU . 3.6 p . . . . . 0 CA--C 1.513 -0.455 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 40.1 p-10 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.717 0.294 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.541 HH21 ' H ' ' A' ' 105' ' ' ASP . 29.6 ptt180 -98.76 141.83 31.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.733 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.578 ' CE2' HD11 ' A' ' 137' ' ' ILE . 3.1 t80 -75.57 130.85 39.48 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 101' ' ' THR . 3.3 mm -118.96 116.98 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.195 0.521 . . . . 0.0 112.076 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.651 HG23 ' CD1' ' A' ' 95' ' ' ILE . 1.2 mp -106.77 110.32 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.543 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.49 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 48.4 tt0 -90.18 134.91 33.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.034 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -144.35 142.81 30.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.006 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 59.5 tttt -114.65 153.32 30.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.181 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 92' ' ' THR . 27.8 tp -74.62 116.94 15.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.12 -33.87 10.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -154.74 158.66 28.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 38.3 p -138.42 151.62 47.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 0.0 110.384 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.494 ' N ' ' O ' ' A' ' 90' ' ' THR . 90.2 m-85 -130.04 145.08 51.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.458 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.454 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 5.2 p -136.68 129.07 30.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.553 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 146' ' ' SER . 13.8 mttm . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.339 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.3 tptp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.646 0.26 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.02 141.01 55.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.94 0.4 . . . . 0.0 110.335 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.5 14.06 66.57 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -119.38 141.54 48.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.328 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.403 ' NZ ' ' HB2' ' A' ' 18' ' ' MET . 12.4 tmtt? -62.31 112.25 2.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.257 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 32' ' ' TRP . 16.5 m -112.94 -43.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.721 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.472 ' N ' HG23 ' A' ' 16' ' ' VAL . . . -129.53 162.27 28.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.76 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.434 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 50.8 ttm -125.84 143.0 51.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.51 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.429 HD13 HD21 ' A' ' 84' ' ' LEU . 21.1 tp -107.01 127.75 53.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.409 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -124.88 125.88 44.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.04 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 24' ' ' LEU . 4.8 mt -105.01 119.68 52.43 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.934 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 81' ' ' THR . 59.5 Cg_endo -76.66 -48.18 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.637 2.225 . . . . 0.0 112.918 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.518 ' C ' HD22 ' A' ' 24' ' ' LEU . 16.7 tptp -59.34 -43.87 92.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.985 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.81 HD22 ' N ' ' A' ' 24' ' ' LEU . 2.7 mm? -96.93 -0.57 47.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.362 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.15 37.69 8.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.622 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -107.65 157.21 18.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.533 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -140.06 145.6 37.9 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.683 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -143.73 150.75 39.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.876 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.2 m -99.06 116.26 30.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.76 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.627 HG12 HD11 ' A' ' 62' ' ' LEU . 1.7 mp -86.13 122.54 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.42 139.02 34.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.714 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.484 ' HB2' HG11 ' A' ' 16' ' ' VAL . 42.6 t-105 -60.43 127.73 33.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 110.654 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.488 ' HA2' HG12 ' A' ' 47' ' ' VAL . . . 77.64 175.28 43.32 Favored Glycine 0 C--N 1.329 0.188 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.639 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.889 179.306 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.758 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -100.91 131.35 46.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.758 ' N ' ' SD ' ' A' ' 45' ' ' MET . 1.5 t80 -65.59 132.97 50.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.682 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.488 HG12 ' HA2' ' A' ' 33' ' ' GLY . 1.8 p -122.47 114.97 44.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.351 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.665 ' N ' ' OG1' ' A' ' 51' ' ' THR . 16.0 p -157.96 173.13 17.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.6 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.21 -14.8 11.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.6 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.787 HG21 ' O ' ' A' ' 109' ' ' ILE . 5.3 m -110.57 -38.61 3.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.784 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.665 ' OG1' ' N ' ' A' ' 48' ' ' SER . 62.5 p -77.45 140.39 39.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.606 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.481 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -144.9 167.05 23.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.245 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.478 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -85.5 157.02 58.97 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.73 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.52 83.98 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.529 2.153 . . . . 0.0 112.343 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 p -115.16 -2.92 12.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.688 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.19 91.12 0.18 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.34 81.68 0.14 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.456 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -163.38 162.19 34.67 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.607 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 20.0 t-160 -83.22 118.59 23.73 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.4 m -117.21 126.5 52.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.051 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.667 ' O ' ' SD ' ' A' ' 45' ' ' MET . 70.4 t -116.58 132.34 66.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 110.038 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.627 HD11 HG12 ' A' ' 30' ' ' ILE . 2.7 mm? -112.63 135.39 53.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.724 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.8 t -117.7 132.81 56.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.603 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.955 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.311 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -139.74 -15.86 1.03 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.221 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 76' ' ' LEU . 2.3 mt -90.8 60.72 4.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.91 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.516 ' HE2' ' N ' ' A' ' 80' ' ' ASP . 23.3 pttm -164.29 143.66 7.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.211 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.67 -19.3 59.24 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.228 0.537 . . . . 0.0 110.164 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -71.14 -15.51 62.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.817 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.686 ' OD1' ' N ' ' A' ' 81' ' ' THR . 6.0 t0 -68.86 152.34 45.43 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.175 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.686 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -141.22 121.95 14.34 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.128 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.0 mt -99.65 117.49 34.13 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.606 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.651 ' C ' HD22 ' A' ' 84' ' ' LEU . 45.2 t -100.47 121.89 51.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.969 0.414 . . . . 0.0 110.097 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 83' ' ' VAL . 4.0 mm? -109.36 131.62 54.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.296 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.581 ' HG3' HG23 ' A' ' 90' ' ' THR . 54.9 mp0 -102.5 123.47 46.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.83 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 5.3 t80 -143.62 119.19 10.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.87 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 57.35 51.1 10.41 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.745 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 62.34 7.7 2.42 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.675 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 56.9 mtmt -107.57 142.85 36.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.808 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.623 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -113.29 123.95 51.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.688 -179.372 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.402 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 22.1 m-85 -106.69 128.66 54.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.144 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.04 115.46 29.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.219 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 86.5 m-85 -109.97 153.47 24.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.639 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -126.88 139.29 53.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.64 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 95' ' ' ILE . 9.1 mm -61.86 119.89 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.181 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -88.53 -67.15 0.85 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.553 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -148.97 136.37 20.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.295 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.2 mp -108.04 135.12 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.149 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.607 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 15.0 p90 -160.71 -178.86 7.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.268 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.846 HD12 ' N ' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -126.2 132.82 70.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.316 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 102' ' ' HIS . 1.3 t -136.11 175.66 9.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 110.894 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.407 ' O ' HG23 ' A' ' 101' ' ' THR . 67.2 m80 -76.31 151.21 36.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.9 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.85 -18.47 65.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.788 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -94.28 17.31 13.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.048 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.628 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 21.4 t0 -91.89 100.42 13.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.837 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.911 ' O ' HG23 ' A' ' 110' ' ' ILE . 3.0 ptp85 -69.17 -32.57 71.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.268 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.628 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 6.3 p -37.85 -20.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.356 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.716 ' CG1' HG21 ' A' ' 118' ' ' THR . 18.5 t -105.26 -19.4 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.013 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.787 ' O ' HG21 ' A' ' 50' ' ' VAL . 45.4 mm -113.19 27.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.801 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.911 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -91.18 -168.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.433 ' N ' ' HB ' ' A' ' 50' ' ' VAL . 33.9 ttmt -97.1 147.87 23.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.538 ' HZ3' HG21 ' A' ' 116' ' ' ILE . 99.3 mttt -130.82 155.55 46.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 110.588 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -102.26 13.39 34.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.329 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.98 169.2 10.75 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.971 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.456 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 47.6 Cg_endo -79.66 95.4 1.04 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 123.284 2.656 . . . . 0.0 112.438 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.538 HG21 ' HZ3' ' A' ' 112' ' ' LYS . 49.7 mm -126.16 128.54 71.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.568 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.758 ' C ' HD23 ' A' ' 117' ' ' LEU . 4.7 tt -104.52 121.01 42.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.903 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.716 HG21 ' CG1' ' A' ' 108' ' ' VAL . 89.2 m -115.65 126.64 54.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.343 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.84 HD12 ' N ' ' A' ' 120' ' ' THR . 2.5 tp -111.98 127.85 55.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.056 0.455 . . . . 0.0 111.671 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.84 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -122.05 129.19 52.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.039 178.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.722 ' CG2' HD11 ' A' ' 119' ' ' LEU . 65.7 p . . . . . 0 CA--C 1.506 -0.744 0 CA-C-O 121.244 0.545 . . . . 0.0 111.768 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.494 ' HB3' HG22 ' A' ' 100' ' ' ILE . 97.0 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.877 0.37 . . . . 0.0 110.55 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -119.16 134.33 55.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.29 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 120' ' ' THR . 6.6 t80 -68.53 133.01 47.93 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.969 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.607 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 37.8 mm -118.76 115.15 47.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.086 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.424 HG23 ' CD1' ' A' ' 95' ' ' ILE . 2.1 mm -107.96 108.53 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -91.4 146.65 23.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.02 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -153.05 142.96 22.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.428 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -115.64 150.46 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.146 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 6.5 tp -77.48 123.24 26.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.353 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.03 -40.36 5.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.826 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -136.99 164.23 25.26 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.0 p -151.1 152.44 33.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.826 0.346 . . . . 0.0 110.386 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 90' ' ' THR . 87.1 m-85 -136.44 155.04 50.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.487 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.1 p -143.27 125.62 15.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.583 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.1 tttt . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.562 -179.85 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.882 0.373 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 12' ' ' GLU . 35.1 mp0 -70.18 123.89 22.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.025 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 109.43 11.74 20.97 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -118.48 134.43 55.08 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.333 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.537 ' N ' ' CD2' ' A' ' 31' ' ' TYR . 40.3 tttm -57.97 112.69 1.58 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.352 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 m -114.2 -38.22 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.877 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.79 154.97 49.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.541 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.413 ' CE ' ' OE1' ' A' ' 85' ' ' GLU . 16.2 ttp -118.74 137.94 53.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.436 ' CD1' HD21 ' A' ' 84' ' ' LEU . 46.2 tp -106.1 119.26 38.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.145 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -118.87 127.14 53.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 111.328 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.843 HD13 ' OE1' ' A' ' 75' ' ' GLN . 4.5 mt -109.82 116.95 53.25 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.516 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.03 -45.74 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.529 2.153 . . . . 0.0 113.036 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.511 ' C ' HD22 ' A' ' 24' ' ' LEU . 19.1 tptm -62.52 -38.6 90.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.773 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.2 mm? -96.4 4.62 52.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.999 0.428 . . . . 0.0 110.442 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 41.9 49.09 4.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.127 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -135.33 157.7 46.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.963 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -138.92 140.18 38.26 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.47 142.38 47.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.457 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 m -90.73 123.76 34.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.687 HG12 HD11 ' A' ' 62' ' ' LEU . 1.7 mp -96.28 123.19 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.453 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.537 ' CD2' ' N ' ' A' ' 15' ' ' LYS . 42.1 m-85 -103.11 145.06 30.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.787 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.599 ' O ' ' N ' ' A' ' 13' ' ' GLY . 41.1 t-105 -59.1 130.05 45.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.974 0.416 . . . . 0.0 110.521 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.573 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 82.59 141.07 3.82 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HB1' ' OG ' ' A' ' 63' ' ' SER . . . . . . . . 0 C--N 1.325 -0.476 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.925 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.495 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.692 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -93.41 125.58 38.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.692 ' N ' ' SD ' ' A' ' 45' ' ' MET . 16.7 t80 -66.84 140.87 57.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.26 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.573 HG23 ' HA2' ' A' ' 33' ' ' GLY . 54.4 t -114.58 129.46 70.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.633 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.628 ' N ' ' OG1' ' A' ' 51' ' ' THR . 11.6 t -163.21 166.42 23.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.59 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 36.8 t0 -68.94 -11.48 60.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.433 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.662 HG21 ' O ' ' A' ' 109' ' ' ILE . 6.1 m -109.01 -14.55 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.528 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 48' ' ' SER . 25.5 p -85.73 149.1 25.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.554 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.521 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.8 OUTLIER -140.74 164.85 29.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.951 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.44 HG22 ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -95.38 151.93 38.98 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.216 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.89 54.23 3.99 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.757 2.305 . . . . 0.0 112.634 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.2 p -102.4 -7.69 21.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.264 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.07 81.17 0.04 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.78 103.15 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.584 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.7 160.41 34.0 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.738 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 22.1 t-160 -81.42 99.37 8.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.8 m -94.02 126.54 39.29 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.677 ' O ' ' SD ' ' A' ' 45' ' ' MET . 71.8 t -116.52 128.93 73.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.077 0.465 . . . . 0.0 110.232 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.687 HD11 HG12 ' A' ' 30' ' ' ILE . 2.7 mm? -114.58 141.55 47.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.73 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.465 ' OG ' ' HB1' ' A' ' 34' ' ' ALA . 4.8 p -128.4 146.61 50.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.707 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.66 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.531 1.05 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.843 ' OE1' HD13 ' A' ' 21' ' ' ILE . 20.4 mm100 -63.82 -39.42 94.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.688 0.28 . . . . 0.0 110.669 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.859 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.6 pp -91.25 102.45 15.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.39 0.614 . . . . 0.0 111.333 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.529 ' HG3' ' H ' ' A' ' 80' ' ' ASP . 20.6 pttm 176.83 152.56 0.19 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.221 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.32 -31.73 70.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.359 0.599 . . . . 0.0 110.727 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 mmtt -69.78 -14.15 62.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.501 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.67 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 1.2 t70 -82.67 152.95 25.62 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.566 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.493 ' O ' HD23 ' A' ' 82' ' ' LEU . 2.6 p -138.85 149.55 45.02 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 81' ' ' THR . 41.1 mt -121.58 123.66 42.5 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.8 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.55 ' C ' HD22 ' A' ' 84' ' ' LEU . 10.7 t -103.74 116.96 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.55 HD22 ' C ' ' A' ' 83' ' ' VAL . 2.7 mm? -105.69 132.35 51.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.53 -178.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.499 ' HG2' HG23 ' A' ' 90' ' ' THR . 28.6 mt-10 -108.75 123.53 49.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.55 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.587 ' O ' ' N ' ' A' ' 89' ' ' LYS . 12.2 t80 -144.48 145.22 31.75 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.034 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.417 ' N ' ' CD1' ' A' ' 86' ' ' TYR . 34.8 t70 36.95 51.29 0.96 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.759 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.0 m120 59.32 25.12 13.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.961 0.41 . . . . 0.0 110.598 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 86' ' ' TYR . 54.5 mtmt -124.07 144.34 49.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.107 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.499 HG23 ' HG2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -111.69 126.92 55.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.565 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -112.47 131.86 55.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.278 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.431 ' O ' HD22 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -102.59 106.24 16.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.343 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 53.1 m-85 -97.08 161.49 13.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.354 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.67 ' OE1' ' O ' ' A' ' 80' ' ' ASP . 2.8 tp10 -136.85 137.23 39.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.514 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.599 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 1.9 mm -65.54 124.2 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.554 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -98.72 -62.89 1.18 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.544 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -141.14 138.9 33.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.319 0.58 . . . . 0.0 109.786 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.727 HG23 HD13 ' A' ' 137' ' ' ILE . 46.6 mt -120.36 127.62 75.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.833 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.599 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 22.4 p90 -152.72 -177.59 6.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.816 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.707 HG22 ' OD2' ' A' ' 133' ' ' ASP . 2.4 mp -125.68 132.82 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.757 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.623 HG21 HG21 ' A' ' 108' ' ' VAL . 2.0 t -143.32 166.45 24.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -65.9 147.83 52.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.236 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.44 80.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.64 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' ARG . 46.7 t0 -63.91 -33.34 75.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.611 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.447 ' OD2' ' OG1' ' A' ' 107' ' ' THR . 14.6 t70 -40.13 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.447 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 109' ' ' ILE . 11.1 ptp85 -68.96 -26.09 64.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.806 ' O ' HD11 ' A' ' 110' ' ' ILE . 10.9 p -49.1 -21.93 0.83 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.587 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.625 HG11 HD12 ' A' ' 136' ' ' ILE . 6.8 t -97.77 -13.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.166 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.791 HG22 ' O ' ' A' ' 109' ' ' ILE . 48.1 mm -114.83 18.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.273 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.806 HD11 ' O ' ' A' ' 107' ' ' THR . 0.4 OUTLIER -79.1 -156.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.889 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.421 ' H ' ' HB ' ' A' ' 110' ' ' ILE . 22.3 ttmt -107.76 148.18 29.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.524 ' HG2' ' CG ' ' A' ' 59' ' ' HIS . 71.9 mmtt -125.15 141.66 51.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.906 0.384 . . . . 0.0 110.257 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.578 ' O ' ' OE2' ' A' ' 114' ' ' GLU . 51.4 mm-40 -89.62 10.78 21.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.722 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.578 ' OE2' ' O ' ' A' ' 113' ' ' GLU . 44.0 mm-40 -143.11 152.65 58.67 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.584 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 12.0 Cg_endo -62.15 84.49 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.642 2.228 . . . . 0.0 110.771 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.65 132.11 66.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.787 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.785 ' C ' HD23 ' A' ' 117' ' ' LEU . 5.5 tt -107.54 119.77 40.33 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.277 0.56 . . . . 0.0 109.923 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.562 HG21 ' CG1' ' A' ' 108' ' ' VAL . 73.1 m -116.15 117.44 30.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.742 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.946 HD12 ' N ' ' A' ' 120' ' ' THR . 1.0 OUTLIER -107.54 124.69 50.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.85 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.946 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -119.03 122.74 42.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.578 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.66 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.3 t . . . . . 0 CA--C 1.513 -0.48 0 CA-C-O 121.224 0.535 . . . . 0.0 111.989 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.707 ' OD2' HG22 ' A' ' 100' ' ' ILE . 4.8 t0 . . . . . 0 CA--C 1.522 -0.096 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -99.02 144.11 28.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.235 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.484 ' CE2' HD11 ' A' ' 137' ' ' ILE . 4.6 t80 -75.57 132.57 40.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.625 HD12 HG11 ' A' ' 108' ' ' VAL . 15.8 mm -110.88 110.94 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.727 HD13 HG23 ' A' ' 98' ' ' ILE . 51.2 mm -101.28 108.89 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -96.76 142.2 29.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.31 0.576 . . . . 0.0 111.407 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -153.54 146.98 24.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.04 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -116.57 157.47 25.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.901 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.691 HD13 ' C ' ' A' ' 141' ' ' LEU . 2.6 tm? -87.77 118.41 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.119 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -108.44 -65.03 1.16 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.441 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.548 ' N ' ' OG1' ' A' ' 142' ' ' THR . . . -93.16 156.9 23.04 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.0 p -152.6 152.1 31.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.518 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -142.87 132.82 24.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.411 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.3 t -121.63 131.94 54.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.998 0.428 . . . . 0.0 110.434 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.622 -179.27 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 tptm . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.462 ' HG2' HG21 ' A' ' 47' ' ' VAL . 50.5 mt-10 -64.99 130.4 43.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.914 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 95.54 21.38 24.41 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -128.45 146.35 50.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.994 0.426 . . . . 0.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -64.26 119.8 10.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.065 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 17' ' ' ALA . 5.0 m -119.59 -46.12 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.626 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -128.22 169.54 14.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.457 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.7 tpp -127.75 139.72 52.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.399 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.719 ' HB2' HD11 ' A' ' 30' ' ' ILE . 5.6 tp -108.18 124.49 50.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.338 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 26' ' ' LYS . 21.5 t-20 -118.33 129.3 55.36 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.0 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.408 HG22 ' H ' ' A' ' 24' ' ' LEU . 24.5 mt -114.73 111.87 45.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.202 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.8 -37.65 1.13 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.647 2.231 . . . . 0.0 112.993 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.813 ' NZ ' ' HZ1' ' A' ' 77' ' ' LYS . 2.1 tptm -62.33 -37.24 84.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.701 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.715 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.3 mm? -98.95 -3.34 35.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.402 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 54.62 65.8 1.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.339 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.431 ' C ' ' CG ' ' A' ' 27' ' ' LYS . 16.0 ptmt -165.72 -175.19 3.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.077 0.465 . . . . 0.0 111.26 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' CG ' ' C ' ' A' ' 26' ' ' LYS . 4.1 mtpt -155.32 155.75 34.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.292 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.426 ' CZ ' ' HE2' ' A' ' 26' ' ' LYS . 78.9 m-85 -135.82 146.48 47.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.449 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.7 m -87.18 118.45 26.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.956 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.873 HD12 HD11 ' A' ' 62' ' ' LEU . 41.1 mm -85.1 113.92 24.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -99.22 135.53 40.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.848 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.535 ' O ' ' N ' ' A' ' 13' ' ' GLY . 28.3 t-105 -60.62 122.18 14.06 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.015 0.436 . . . . 0.0 110.829 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 86.97 156.77 29.84 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.449 179.806 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.555 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.674 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -104.27 129.97 52.08 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.674 ' N ' ' SD ' ' A' ' 45' ' ' MET . 5.5 t80 -63.06 145.95 54.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.983 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.479 HG22 ' CE2' ' A' ' 32' ' ' TRP . 46.1 t -118.55 128.01 75.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.483 ' HG ' ' CB ' ' A' ' 51' ' ' THR . 59.8 p -167.1 173.85 8.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.435 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.91 -6.73 53.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.768 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.704 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.5 m -114.1 -23.04 4.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.664 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.483 ' CB ' ' HG ' ' A' ' 48' ' ' SER . 23.7 p -87.21 159.05 18.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.531 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.49 171.61 19.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.187 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.505 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -91.16 156.49 43.85 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.413 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.772 ' HG3' HD23 ' A' ' 84' ' ' LEU . 70.8 Cg_endo -75.81 83.13 2.0 Allowed 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.687 2.258 . . . . 0.0 112.444 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.8 p -115.3 -4.72 12.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.719 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.82 89.66 0.08 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.78 87.12 0.04 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.442 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -162.32 168.47 37.31 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.517 ' CD2' ' HE2' ' A' ' 112' ' ' LYS . 16.8 t-160 -89.16 116.93 27.77 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.9 m -111.97 127.22 55.8 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.073 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.674 ' O ' ' SD ' ' A' ' 45' ' ' MET . 58.6 t -119.35 126.14 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.994 0.426 . . . . 0.0 110.787 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.873 HD11 HD12 ' A' ' 30' ' ' ILE . 2.3 mm? -116.23 145.78 42.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.629 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 93.7 p -137.93 154.33 49.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.825 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.751 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.616 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.658 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -28.1 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.586 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.85 91.57 3.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.018 0.437 . . . . 0.0 110.88 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.813 ' HZ1' ' NZ ' ' A' ' 23' ' ' LYS . 60.0 pttt -177.95 147.4 0.46 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.977 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.6 -18.12 61.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.921 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -77.35 -15.54 59.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.595 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.535 ' OD2' HD21 ' A' ' 82' ' ' LEU . 3.7 t70 -76.76 154.57 33.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.927 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.483 ' O ' HD23 ' A' ' 82' ' ' LEU . 1.9 p -139.45 139.89 37.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.535 HD21 ' OD2' ' A' ' 80' ' ' ASP . 13.0 mt -118.67 129.75 55.46 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.755 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.461 ' C ' HD12 ' A' ' 84' ' ' LEU . 2.3 t -111.62 118.29 57.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.772 HD23 ' HG3' ' A' ' 54' ' ' PRO . 7.6 mp -99.3 130.87 45.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.57 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -114.9 115.11 26.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.55 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.626 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.2 t80 -147.61 130.25 15.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 87' ' ' ASP . 61.9 t0 64.01 40.37 7.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.668 0.27 . . . . 0.0 111.325 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 63.17 11.0 4.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.449 ' HB3' ' CE1' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -107.64 143.18 36.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.962 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.575 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -111.66 124.8 53.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.32 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 5.6 m-85 -113.6 137.49 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.907 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.585 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -105.86 118.76 37.42 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.619 ' CE1' HD22 ' A' ' 84' ' ' LEU . 64.7 m-85 -113.27 161.46 17.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.983 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -141.12 140.2 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.246 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.533 HD12 ' H ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -66.92 124.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.57 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -96.11 -60.24 1.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.184 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -144.4 143.81 31.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.25 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.8 mt -117.38 133.43 64.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.483 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 18.4 p90 -153.0 -175.63 5.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.004 0.43 . . . . 0.0 111.433 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 mt -125.52 133.06 70.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.536 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.555 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 1.7 t -133.71 168.32 18.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.132 0.491 . . . . 0.0 110.906 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -76.65 157.05 32.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.48 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.53 -9.23 40.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.661 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.559 ' OD1' ' O ' ' A' ' 104' ' ' ASP . 57.7 t0 -109.26 23.75 14.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.881 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.621 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 67.2 t0 -88.95 92.67 9.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.645 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.736 ' O ' HG23 ' A' ' 110' ' ' ILE . 12.2 ptp85 -65.27 -34.76 79.1 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.161 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.621 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 10.2 p -42.29 -17.02 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.472 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.865 ' CG1' HG21 ' A' ' 118' ' ' THR . 58.9 t -102.79 -20.89 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.046 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.704 ' O ' HG21 ' A' ' 50' ' ' VAL . 48.4 mm -110.31 21.99 5.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.992 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.736 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -82.73 -172.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.146 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -87.27 142.52 27.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.888 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.517 ' HE2' ' CD2' ' A' ' 59' ' ' HIS . 2.5 tppt? -121.42 147.26 45.97 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.934 0.397 . . . . 0.0 110.57 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 113' ' ' GLU . 1.6 mp0 -101.47 15.72 27.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.031 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.11 171.81 6.21 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.29 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.442 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 54.7 Cg_endo -80.06 95.43 1.01 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 123.014 2.476 . . . . 0.0 111.668 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 116' ' ' ILE . 49.2 mm -127.66 139.05 52.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.625 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.771 ' C ' HD23 ' A' ' 117' ' ' LEU . 5.5 tt -112.44 120.11 40.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.35 0.595 . . . . 0.0 110.195 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.865 HG21 ' CG1' ' A' ' 108' ' ' VAL . 85.7 m -111.95 116.61 30.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.099 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.826 HD23 ' N ' ' A' ' 120' ' ' THR . 3.7 tt -108.97 122.4 47.15 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.412 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.826 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -106.29 124.33 49.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.055 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.505 HG22 HD22 ' A' ' 119' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.755 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 . . . . . 0 N--CA 1.456 -0.141 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -110.45 131.56 54.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.099 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.438 ' HB3' ' OG1' ' A' ' 121' ' ' THR . 2.0 t80 -64.42 141.86 58.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.538 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.462 ' CG1' HG22 ' A' ' 101' ' ' THR . 5.9 mm -128.4 116.71 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 137' ' ' ILE . 1.3 mp -105.32 112.11 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.469 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 45.4 tt0 -93.96 139.34 31.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.9 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.52 148.77 33.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.205 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.9 tttm -122.03 148.41 44.88 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.992 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.788 HD23 ' C ' ' A' ' 141' ' ' LEU . 8.2 tt -73.14 115.33 12.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.162 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.445 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.7 OUTLIER -88.8 -43.38 11.29 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.912 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.585 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -134.9 160.51 24.31 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 62.5 p -136.23 142.74 44.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.588 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.575 ' N ' ' O ' ' A' ' 90' ' ' THR . 92.6 m-85 -130.53 154.96 47.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.464 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.55 ' O ' ' OXT' ' A' ' 147' ' ' LYS . 20.2 p -141.77 121.19 13.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.299 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.55 ' OXT' ' O ' ' A' ' 146' ' ' SER . 18.5 ttmt . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.621 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.5 tptt . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.751 0.31 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.693 ' CD ' ' H ' ' A' ' 12' ' ' GLU . 1.0 OUTLIER -68.14 148.6 50.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.374 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.24 0.76 76.5 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -115.33 131.97 56.76 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.333 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . 60.7 tttm -57.38 125.35 22.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.064 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 m -117.06 -37.98 2.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.135 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -140.92 167.37 22.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.865 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.453 ' SD ' ' HA ' ' A' ' 29' ' ' SER . 4.5 tpp -121.0 147.64 45.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.452 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 83' ' ' VAL . 51.1 tp -114.76 115.47 27.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.003 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.471 HD22 ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -105.24 135.94 45.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.302 179.201 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 25' ' ' LYS . 8.3 mt -113.34 90.67 17.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.125 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 20' ' ' ASN . 31.6 Cg_exo -55.5 -42.68 65.5 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 123.178 2.585 . . . . 0.0 112.746 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.608 ' C ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -60.31 -42.75 96.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.715 -178.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.81 HD22 ' N ' ' A' ' 24' ' ' LEU . 2.8 mm? -100.41 2.65 42.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.147 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 21' ' ' ILE . 75.3 mmtt 50.34 36.02 12.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.432 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -113.6 173.09 6.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.377 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.408 ' CD ' ' OD1' ' A' ' 20' ' ' ASN . 30.9 mtmm -148.57 142.18 25.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.98 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -134.07 152.55 51.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.851 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.453 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -95.11 120.52 35.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.578 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.414 HD11 ' HB2' ' A' ' 19' ' ' LEU . 48.9 mm -88.76 117.29 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.236 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 87.3 m-85 -102.37 135.81 43.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.113 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -59.66 125.55 24.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.586 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 74.35 173.65 30.14 Favored Glycine 0 C--N 1.331 0.266 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.57 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.642 179.617 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.628 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.432 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 2.3 ttp -97.9 129.38 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.12 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -63.73 143.28 57.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.586 HG23 ' HA2' ' A' ' 33' ' ' GLY . 55.4 t -122.85 128.55 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.77 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.787 ' HG ' ' H ' ' A' ' 51' ' ' THR . 7.3 p -164.18 168.96 18.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.507 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -64.03 -35.29 80.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.698 HG21 ' O ' ' A' ' 109' ' ' ILE . 4.4 m -87.62 -25.34 6.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.802 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.787 ' H ' ' HG ' ' A' ' 48' ' ' SER . 43.5 p -77.23 140.38 40.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.737 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.616 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 1.3 p -131.75 171.31 13.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.847 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.12 155.87 36.08 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.948 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.685 ' HG3' HD13 ' A' ' 84' ' ' LEU . 65.4 Cg_endo -77.77 62.89 7.97 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.723 2.282 . . . . 0.0 112.325 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.415 ' O ' ' OH ' ' A' ' 91' ' ' TYR . 86.7 p -112.63 -3.8 14.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.77 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.52 91.24 0.08 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.09 88.35 0.01 OUTLIER Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.485 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -161.04 152.32 22.91 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.616 ' N ' ' OG1' ' A' ' 52' ' ' THR . 19.8 t-160 -78.69 106.18 10.5 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.3 m -101.8 124.44 47.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.231 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.639 HG11 ' CD1' ' A' ' 109' ' ' ILE . 74.3 t -117.62 129.46 74.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.521 HD22 ' C ' ' A' ' 61' ' ' VAL . 3.0 mm? -108.04 144.36 35.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.167 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.2 t -128.1 136.54 51.33 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.755 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.402 ' N ' HG22 ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.531 1.088 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.57 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' HD2' ' A' ' 77' ' ' LYS . . . . . . . . 0 CA--C 1.528 0.885 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -66.07 -35.81 81.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.631 0.253 . . . . 0.0 111.246 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.605 HD22 ' OH ' ' A' ' 135' ' ' TYR . 11.3 mt -88.37 83.29 6.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.845 0.355 . . . . 0.0 111.005 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.437 ' NZ ' ' HD3' ' A' ' 23' ' ' LYS . 14.2 ptmt -177.8 134.6 0.17 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.837 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.65 -10.63 59.89 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.394 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -82.92 -14.9 53.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.064 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.43 ' OD2' HD21 ' A' ' 82' ' ' LEU . 3.7 t70 -64.21 155.16 32.7 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.637 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.439 ' O ' HD23 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -133.25 140.29 47.41 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.033 0.445 . . . . 0.0 110.067 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 81' ' ' THR . 21.2 mt -119.8 120.58 36.92 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.485 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.508 ' O ' HD12 ' A' ' 19' ' ' LEU . 2.9 t -107.13 130.32 59.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.045 0.45 . . . . 0.0 110.492 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.752 HD11 HD12 ' A' ' 117' ' ' LEU . 27.1 mt -113.79 128.83 56.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.474 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HG2' HG23 ' A' ' 90' ' ' THR . 83.9 mt-10 -104.46 118.27 36.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.564 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.535 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -153.19 129.38 10.45 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.869 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.435 ' C ' ' N ' ' A' ' 89' ' ' LYS . 58.2 m-20 61.24 54.29 3.28 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.844 0.354 . . . . 0.0 111.338 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 51.59 15.31 0.34 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.699 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.435 ' N ' ' C ' ' A' ' 87' ' ' ASP . 20.6 mtpt -119.33 143.23 47.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.37 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.479 HG22 ' CG1' ' A' ' 83' ' ' VAL . 4.6 m -115.14 120.55 40.14 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.346 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.415 ' OH ' ' O ' ' A' ' 55' ' ' SER . 13.6 m-85 -99.62 136.06 40.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.177 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.561 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -108.27 119.01 38.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.218 -178.496 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.627 ' CE1' HD12 ' A' ' 84' ' ' LEU . 91.4 m-85 -113.1 165.13 12.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.62 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -143.44 139.89 30.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.942 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mt -69.01 121.63 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.804 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -97.04 -42.19 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.587 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -158.25 140.08 13.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.692 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.5 mt -118.25 126.59 75.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.256 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.8 p90 -149.37 -179.23 6.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.598 HG22 ' HB3' ' A' ' 133' ' ' ASP . 1.3 mp -125.21 126.89 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.047 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 102' ' ' HIS . 1.7 t -129.11 173.38 10.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.711 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.487 ' ND1' ' N ' ' A' ' 102' ' ' HIS . 1.0 OUTLIER -73.16 152.73 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.649 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.82 -18.51 65.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.743 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -92.58 4.53 53.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.696 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.852 ' O ' HG22 ' A' ' 108' ' ' VAL . 41.9 t0 -75.3 60.55 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.373 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 109' ' ' ILE . 28.1 ptt85 -38.53 -23.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.747 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 105' ' ' ASP . 65.5 p -46.5 -16.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.599 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.852 HG22 ' O ' ' A' ' 105' ' ' ASP . 3.9 m -106.25 -13.03 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 120.952 0.406 . . . . 0.0 110.339 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.755 HG22 ' O ' ' A' ' 109' ' ' ILE . 41.6 mm -112.89 21.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.549 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.573 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -88.95 -163.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.862 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -104.07 140.56 37.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.632 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -131.4 140.41 49.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.566 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -87.74 11.44 15.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.058 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.93 160.33 69.05 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.845 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.485 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 39.6 Cg_endo -77.32 99.37 1.29 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.895 2.397 . . . . 0.0 111.563 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.421 HD13 ' O ' ' A' ' 115' ' ' PRO . 49.8 mm -130.36 133.27 64.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.179 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.752 HD12 HD11 ' A' ' 84' ' ' LEU . 6.5 tt -107.94 117.85 35.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.249 0.547 . . . . 0.0 110.249 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 61.2 m -118.27 123.02 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.971 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.872 HD23 ' C ' ' A' ' 119' ' ' LEU . 1.0 OUTLIER -109.23 131.53 54.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.93 0.395 . . . . 0.0 111.043 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 135' ' ' TYR . 0.2 OUTLIER -126.32 121.65 33.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.895 179.469 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.604 HG23 HD21 ' A' ' 119' ' ' LEU . 69.5 p . . . . . 0 CA--C 1.511 -0.531 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.586 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.598 ' HB3' HG22 ' A' ' 100' ' ' ILE . 65.6 m-20 . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.766 0.317 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 62.5 mmt-85 -103.59 136.6 43.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.732 ' CE2' HD11 ' A' ' 137' ' ' ILE . 5.0 t80 -68.13 130.6 43.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.674 -0.411 . . . . 0.0 109.903 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.6 mm -120.58 118.91 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.732 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp -108.1 109.02 26.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -91.13 140.05 30.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.906 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.13 137.3 18.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.955 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 69.2 tttt -112.54 158.53 19.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.022 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.537 ' N ' ' CG ' ' A' ' 140' ' ' LYS . 10.6 tp -77.06 122.68 25.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.449 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.25 -38.19 6.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.515 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.561 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -148.7 149.68 21.73 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.5 p -135.6 152.96 51.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.379 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -128.54 147.66 50.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.779 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.8 t -133.37 136.93 45.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 110.526 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.8 tptp . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.563 -179.665 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.414 ' HD3' ' N ' ' A' ' 12' ' ' GLU . 9.9 tmtt? . . . . . 0 CA--C 1.527 0.068 0 CA-C-O 120.806 0.336 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.751 ' CD ' ' H ' ' A' ' 12' ' ' GLU . 1.8 mp0 -67.58 151.09 47.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.358 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.39 9.8 81.1 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -121.47 135.68 55.02 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.343 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -61.86 122.83 16.39 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.948 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 17' ' ' ALA . 14.3 m -117.29 -40.72 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.137 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.556 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -140.44 165.6 27.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.648 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.1 ttp -130.45 137.25 49.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.633 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.5 tp -99.11 127.69 45.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.486 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.488 ' ND2' ' HG2' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -117.4 125.91 51.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.205 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.431 HG22 ' H ' ' A' ' 24' ' ' LEU . 2.9 mt -103.24 108.37 58.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.445 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -75.41 -40.1 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.435 2.09 . . . . 0.0 112.392 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.612 ' C ' HD22 ' A' ' 24' ' ' LEU . 6.0 tptp -60.64 -42.99 98.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.803 HD22 ' N ' ' A' ' 24' ' ' LEU . 2.7 mm? -99.13 3.4 46.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.562 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.86 51.3 16.19 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.474 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -132.1 173.13 11.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.989 0.424 . . . . 0.0 110.974 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HG2' ' ND2' ' A' ' 20' ' ' ASN . 2.7 mtpp -143.67 152.3 41.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.203 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -146.63 130.49 17.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.939 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.446 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 13.3 m -83.01 112.77 20.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 30' ' ' ILE . 1.5 mp -83.14 124.75 39.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.446 ' CE1' ' O ' ' A' ' 29' ' ' SER . 83.9 m-85 -110.1 140.6 44.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.858 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -60.69 118.35 6.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.963 0.411 . . . . 0.0 110.693 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.644 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 92.85 158.56 34.41 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.51 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.887 179.713 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.579 ' SD ' HG23 ' A' ' 60' ' ' THR . 3.3 tpp -90.52 132.89 35.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.53 121.58 18.09 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.383 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.644 HG23 ' HA2' ' A' ' 33' ' ' GLY . 17.2 t -91.95 127.69 44.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.665 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.698 ' N ' ' OG1' ' A' ' 51' ' ' THR . 7.2 t -164.13 165.18 22.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.495 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -64.07 -34.26 77.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.675 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.718 HG21 ' O ' ' A' ' 109' ' ' ILE . 2.8 m -89.58 -12.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.957 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.698 ' OG1' ' N ' ' A' ' 48' ' ' SER . 24.9 p -84.95 144.2 28.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.019 0.438 . . . . 0.0 110.866 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.489 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.7 OUTLIER -134.92 174.55 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.934 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.94 159.87 27.97 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.801 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.647 ' HG3' HD23 ' A' ' 84' ' ' LEU . 72.4 Cg_endo -81.5 66.2 8.62 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.606 2.204 . . . . 0.0 112.522 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.1 p -112.89 -6.32 13.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.541 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.0 92.68 0.09 OUTLIER Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.545 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.5 85.01 0.04 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.499 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -156.87 155.06 26.05 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.489 ' N ' ' OG1' ' A' ' 52' ' ' THR . 19.9 t-160 -80.08 104.65 10.79 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.579 HG23 ' SD ' ' A' ' 45' ' ' MET . 26.0 m -101.08 122.45 43.6 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.888 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.572 ' C ' HD22 ' A' ' 62' ' ' LEU . 54.9 t -111.91 124.81 68.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.157 0.503 . . . . 0.0 110.423 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.599 ' O ' HG23 ' A' ' 120' ' ' THR . 2.6 mm? -113.01 139.5 48.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.382 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.0 m -140.87 153.61 45.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.072 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.802 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.725 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.758 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -72.93 -39.52 66.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.999 0.428 . . . . 0.0 110.446 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.454 ' H ' HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -109.12 103.65 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.137 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.492 ' O ' HG21 ' A' ' 95' ' ' ILE . 4.6 ptpt -179.07 150.44 0.46 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -78.93 -13.37 59.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.523 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -86.87 -13.7 44.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.117 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 81' ' ' THR . 2.5 t0 -75.25 153.61 37.92 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.704 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.638 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -137.98 143.3 40.6 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.5 mt -118.3 129.89 55.71 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.927 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 2.8 t -115.46 121.6 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.547 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.647 HD23 ' HG3' ' A' ' 54' ' ' PRO . 10.2 mp -101.06 133.2 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.224 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HG2' HG23 ' A' ' 90' ' ' THR . 85.1 mt-10 -107.98 120.7 43.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.209 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.556 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.5 t80 -147.23 137.3 23.19 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.083 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 50.59 42.03 26.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 0.0 111.043 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 63.41 26.78 15.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.295 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 40.4 mttm -116.26 170.84 8.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.973 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.427 HG23 ' HG2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -139.25 111.84 7.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.684 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.9 m-85 -96.27 136.92 36.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.203 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -104.86 113.12 26.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.802 0.334 . . . . 0.0 111.452 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 85.1 m-85 -110.2 151.68 27.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.554 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -128.04 140.2 52.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.408 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.492 HG21 ' O ' ' A' ' 77' ' ' LYS . 2.4 mm -68.99 118.49 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.033 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -94.44 -59.23 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -144.84 140.05 28.13 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.27 0.557 . . . . 0.0 110.59 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 mp -119.67 127.93 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.78 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.487 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 23.1 p90 -144.06 -175.78 4.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.569 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.514 HG13 ' CD1' ' A' ' 135' ' ' TYR . 4.2 mp -126.32 132.45 70.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.471 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.502 HG22 HD11 ' A' ' 136' ' ' ILE . 2.3 t -134.51 165.3 25.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 110.73 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -73.95 149.42 41.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.331 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.1 -10.91 3.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.648 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -108.28 24.6 12.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.131 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.512 ' OD2' HG23 ' A' ' 108' ' ' VAL . 20.4 t0 -90.18 102.01 14.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.944 0.402 . . . . 0.0 110.585 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.811 ' O ' HG23 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -70.91 -35.91 72.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.606 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.539 ' O ' HD12 ' A' ' 110' ' ' ILE . 2.2 p -42.06 -18.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.586 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.783 ' CG1' HG21 ' A' ' 118' ' ' THR . 4.0 t -104.68 -15.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.012 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 109' ' ' ILE . 52.1 mm -114.44 20.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.187 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.811 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -82.68 -173.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -92.53 146.1 23.94 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.846 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.469 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.6 mttt -133.46 177.21 7.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.294 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -129.86 17.05 5.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.913 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -135.43 158.76 73.78 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.499 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 37.2 Cg_endo -74.59 86.65 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 123.186 2.59 . . . . 0.0 110.693 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.8 mm -121.78 133.4 68.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.1 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.794 ' C ' HD23 ' A' ' 117' ' ' LEU . 6.2 tt -108.1 119.78 40.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.216 0.531 . . . . 0.0 110.335 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.783 HG21 ' CG1' ' A' ' 108' ' ' VAL . 88.2 m -114.89 117.88 31.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.394 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 120' ' ' THR . 5.6 tp -105.98 128.38 53.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.28 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.64 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -113.89 114.16 25.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.284 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 135' ' ' TYR . 1.2 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.985 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 . . . . . 0 C--O 1.232 0.148 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.41 ' NE ' ' HB ' ' A' ' 120' ' ' THR . 35.5 ttp180 -123.52 119.42 29.9 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.135 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.514 ' CD1' HG13 ' A' ' 100' ' ' ILE . 4.6 t80 -69.18 137.94 53.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.961 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 101' ' ' THR . 6.8 mm -122.63 122.13 65.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 137' ' ' ILE . 1.2 mp -107.17 112.03 38.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.487 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 38.4 tt0 -95.59 134.06 38.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.942 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.74 145.23 34.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.18 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -117.37 145.83 43.8 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.215 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 16.9 tp -69.8 123.26 20.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.491 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.2 p -99.33 -43.66 6.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.224 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.582 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -145.89 165.9 28.0 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 35.4 p -139.55 142.28 37.19 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.708 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -124.53 143.57 50.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.3 p -133.51 127.31 32.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.442 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.4 tttp . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.724 179.779 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.79 0.328 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.9 mp0 -68.96 137.45 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.279 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 94.84 12.98 54.85 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -120.35 134.92 55.18 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.801 0.334 . . . . 0.0 110.498 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' NZ ' ' SD ' ' A' ' 18' ' ' MET . 88.3 tttt -57.99 120.06 7.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.349 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.14 -31.95 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.78 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.45 161.94 36.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.673 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.502 ' SD ' ' OG ' ' A' ' 29' ' ' SER . 1.0 OUTLIER -123.45 133.88 54.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.432 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.852 ' HB2' HD11 ' A' ' 30' ' ' ILE . 2.0 tt -104.1 122.56 45.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.622 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.427 HD22 ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -115.29 126.12 54.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.85 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.427 ' N ' HD22 ' A' ' 20' ' ' ASN . 7.9 mt -102.86 114.82 65.02 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.322 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 81' ' ' THR . 60.8 Cg_endo -77.68 -43.9 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.812 2.341 . . . . 0.0 112.527 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.6 ' C ' HD22 ' A' ' 24' ' ' LEU . 24.2 tptp -60.37 -41.72 94.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.569 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.822 HD22 ' N ' ' A' ' 24' ' ' LEU . 2.8 mm? -98.31 0.24 45.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.812 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 49.79 42.07 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.68 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -119.96 162.65 18.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.9 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -135.38 145.06 46.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.765 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 19' ' ' LEU . 61.8 m-85 -141.0 150.45 43.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.584 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.502 ' OG ' ' SD ' ' A' ' 18' ' ' MET . 9.9 m -103.27 119.65 39.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.801 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.852 HD11 ' HB2' ' A' ' 19' ' ' LEU . 4.6 mp -83.8 124.18 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.259 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 42.1 m-85 -107.17 135.04 49.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.989 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.518 ' O ' ' N ' ' A' ' 13' ' ' GLY . 26.2 t-105 -60.42 127.75 33.27 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.6 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.468 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 75.05 144.67 1.09 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.758 0.313 . . . . 0.0 110.685 179.881 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.637 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -96.21 127.92 42.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.747 0.308 . . . . 0.0 110.655 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.507 ' O ' ' SD ' ' A' ' 45' ' ' MET . 9.5 t80 -69.1 131.8 45.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.527 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.6 t -111.26 128.87 67.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.567 ' N ' ' OG1' ' A' ' 51' ' ' THR . 33.0 p -161.99 171.8 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.584 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 39.4 t0 -74.98 10.1 1.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.464 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.782 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.7 m -132.27 -15.58 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.665 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 48' ' ' SER . 2.6 p -87.8 139.7 30.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.611 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.65 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -131.04 169.52 15.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.633 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.64 154.71 38.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.466 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.725 ' HG3' HD13 ' A' ' 84' ' ' LEU . 59.3 Cg_endo -78.97 61.08 8.03 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.835 2.357 . . . . 0.0 112.214 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.33 -5.36 17.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.64 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.99 91.94 0.09 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.92 92.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.428 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.27 155.18 26.02 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.65 ' N ' ' OG1' ' A' ' 52' ' ' THR . 21.7 t-160 -79.59 112.59 17.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.932 0.396 . . . . 0.0 110.1 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.3 m -105.48 123.39 47.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.348 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.585 ' C ' HD22 ' A' ' 62' ' ' LEU . 63.5 t -116.7 127.42 74.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.476 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.585 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.2 mm? -109.76 145.51 36.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.616 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 120' ' ' THR . 44.1 t -130.3 144.13 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.591 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.592 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.528 0.883 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.586 ' O ' ' CG ' ' A' ' 77' ' ' LYS . . . . . . . . 0 CA--C 1.526 0.722 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -71.24 -36.36 71.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.757 0.313 . . . . 0.0 110.817 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -88.85 73.69 8.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.642 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.586 ' CG ' ' O ' ' A' ' 74' ' ' GLY . 10.5 ptpt -169.38 129.86 1.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.436 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -74.75 -10.46 59.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.582 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -79.95 -16.36 55.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.361 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.686 ' OD1' ' N ' ' A' ' 81' ' ' THR . 34.5 t0 -71.38 154.38 41.61 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.586 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.686 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.6 OUTLIER -141.3 117.7 10.81 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.916 0.389 . . . . 0.0 110.803 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 51.8 mt -90.7 128.96 36.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.642 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.634 HG12 HG22 ' A' ' 90' ' ' THR . 2.3 t -105.23 127.08 60.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.383 . . . . 0.0 110.239 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.829 HD11 HD12 ' A' ' 117' ' ' LEU . 33.4 mt -111.07 122.89 49.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.96 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.41 ' HG2' HG23 ' A' ' 90' ' ' THR . 84.2 mt-10 -99.59 119.35 37.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.69 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -150.06 129.39 12.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.995 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 56.46 43.98 25.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.996 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASN . . . . . 0.509 ' OD1' ' C ' ' A' ' 147' ' ' LYS . 6.3 t-20 61.82 15.4 7.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.645 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -114.99 137.13 52.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.202 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.634 HG22 HG12 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -107.67 124.04 49.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.755 -178.909 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -108.89 125.56 52.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.096 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.428 ' OG1' ' C ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -94.95 107.09 19.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.143 -179.383 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.576 ' CE1' HD12 ' A' ' 84' ' ' LEU . 40.2 m-85 -95.09 156.92 16.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.577 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.5 134.1 45.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.55 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.695 HG23 HD11 ' A' ' 98' ' ' ILE . 1.1 mm -65.7 114.59 3.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.246 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -83.57 -66.18 0.92 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.842 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.552 ' C ' HD13 ' A' ' 98' ' ' ILE . 29.1 tptp -150.36 146.91 27.01 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.506 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.695 HD11 HG23 ' A' ' 95' ' ' ILE . 5.2 mm -114.16 135.36 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.51 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 14.3 p90 -155.43 178.68 9.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.683 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.427 HG22 ' HB3' ' A' ' 133' ' ' ASP . 2.3 mt -127.47 128.83 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.151 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 102' ' ' HIS . 3.0 t -131.05 172.87 11.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.497 ' O ' HG23 ' A' ' 101' ' ' THR . 5.0 t-80 -62.92 171.95 1.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.551 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.36 -20.47 28.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.555 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.55 19.32 17.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.449 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.524 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 28.9 t0 -83.17 92.4 7.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.71 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.966 ' O ' HG23 ' A' ' 110' ' ' ILE . 36.6 ptt180 -63.52 -37.84 88.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.234 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.524 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 9.4 p -37.0 -18.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.258 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.858 ' CG1' HG21 ' A' ' 118' ' ' THR . 10.9 t -108.86 -21.3 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.711 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.782 ' O ' HG21 ' A' ' 50' ' ' VAL . 33.5 mm -109.71 28.13 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.966 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -93.07 -165.71 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.329 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -99.57 141.5 32.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.647 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.474 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.1 mttt -128.21 135.46 49.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.206 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -81.63 7.98 10.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.499 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.52 160.18 69.34 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.431 ' O ' HD13 ' A' ' 116' ' ' ILE . 41.1 Cg_endo -74.69 101.23 1.42 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.936 2.424 . . . . 0.0 111.972 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 115' ' ' PRO . 49.2 mm -131.33 135.11 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.788 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.829 HD12 HD11 ' A' ' 84' ' ' LEU . 9.4 tt -106.32 118.58 37.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.794 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.858 HG21 ' CG1' ' A' ' 108' ' ' VAL . 53.6 m -122.75 121.35 36.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.364 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.861 HD23 ' C ' ' A' ' 119' ' ' LEU . 5.8 tt -109.26 124.71 51.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.015 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.743 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -116.51 124.54 50.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.376 178.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.592 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.7 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.848 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.427 ' HB3' HG22 ' A' ' 100' ' ' ILE . 96.0 m-20 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.798 0.332 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -115.72 138.25 51.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.659 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.751 ' CE2' HD11 ' A' ' 137' ' ' ILE . 4.5 t80 -73.23 123.94 24.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.024 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 2.4 mm -115.8 118.67 59.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.883 -178.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.751 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp -105.24 107.22 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 46.3 tt0 -88.3 134.95 33.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.308 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.84 138.96 21.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.482 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.534 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 31.6 ttpt -109.27 161.28 15.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.807 HD13 ' C ' ' A' ' 141' ' ' LEU . 2.6 tm? -91.77 115.89 28.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.241 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.564 ' N ' HD22 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -110.94 -66.01 1.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.898 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.553 ' O ' HD21 ' A' ' 141' ' ' LEU . . . -83.32 165.53 43.04 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' SER . . . . . 0.415 ' O ' ' CG ' ' A' ' 145' ' ' TYR . 12.4 p -158.15 158.08 33.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.799 0.333 . . . . 0.0 110.582 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 90' ' ' THR . 79.4 m-85 -153.99 104.8 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.523 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.5 p -98.99 122.28 42.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.637 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.509 ' C ' ' OD1' ' A' ' 88' ' ' ASN . 68.6 mttm . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.429 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 tttt . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.666 ' OE2' HG11 ' A' ' 47' ' ' VAL . 91.0 mt-10 -80.79 151.02 28.98 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 83.59 15.25 71.42 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -118.07 132.1 56.39 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.044 0.45 . . . . 0.0 110.456 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 61.9 tttm -58.24 106.09 0.34 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.601 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.435 HG11 ' HB2' ' A' ' 32' ' ' TRP . 14.5 m -110.55 -38.81 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.38 155.64 46.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.607 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.7 ttp -121.29 131.54 54.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.84 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.8 tp -93.95 123.67 37.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.425 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -119.5 124.3 46.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.0 mt -106.64 111.61 63.89 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.242 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.618 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.9 Cg_endo -78.9 -42.78 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 123.057 2.505 . . . . 0.0 112.615 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.578 ' C ' HD22 ' A' ' 24' ' ' LEU . 6.0 tptm -63.01 -39.05 93.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.777 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.0 mm? -99.54 5.81 45.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.907 0.384 . . . . 0.0 110.522 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 44.71 56.91 4.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.42 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -141.37 158.71 43.51 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.667 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -141.26 140.46 33.9 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.612 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -133.81 155.41 49.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.5 m -95.92 118.37 32.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.442 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -95.31 123.84 47.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.243 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 52.4 m-85 -103.76 142.92 33.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.551 ' HZ2' HG23 ' A' ' 47' ' ' VAL . 40.9 t-105 -61.54 130.92 48.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.952 0.406 . . . . 0.0 110.659 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 84.51 171.39 48.01 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.521 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.906 179.697 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.416 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.477 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 2.8 tpp -103.14 142.88 33.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -75.97 140.27 41.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.402 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.666 HG11 ' OE2' ' A' ' 12' ' ' GLU . 2.1 p -123.37 124.3 69.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.465 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 51' ' ' THR . 21.1 t -168.76 169.67 9.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.531 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -62.99 -37.39 86.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.29 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.649 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.0 m -83.98 -26.6 7.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.843 0.354 . . . . 0.0 110.552 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 48' ' ' SER . 64.8 p -99.05 142.58 30.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.823 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -143.83 175.45 9.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.654 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.497 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -91.36 155.07 44.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.731 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.59 84.29 2.0 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.746 2.298 . . . . 0.0 112.431 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.3 p -115.22 -7.64 12.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.727 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.08 89.29 0.07 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.68 84.65 0.07 OUTLIER Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.474 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -166.4 158.87 32.0 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.651 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 19.1 t-160 -78.71 121.9 25.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 88.9 m -119.2 128.39 54.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.564 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.584 ' C ' HD22 ' A' ' 62' ' ' LEU . 55.0 t -119.5 132.84 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.099 0.476 . . . . 0.0 110.238 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.584 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.8 mm? -113.18 140.56 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.625 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.9 t -118.84 136.69 53.88 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.427 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.163 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.929 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.575 ' HA3' HD11 ' A' ' 24' ' ' LEU . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.63 -39.9 84.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 110.391 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.565 HD23 ' N ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -95.54 101.72 13.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.98 -179.734 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.477 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 11.2 ptpt 175.84 145.95 0.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.567 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.68 -14.61 60.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.128 0.489 . . . . 0.0 110.698 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -79.67 -15.25 57.93 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.725 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.12 154.3 29.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.762 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.618 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -141.37 115.26 9.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.418 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.2 mt -89.19 131.43 35.32 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.236 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.588 ' C ' HD22 ' A' ' 84' ' ' LEU . 48.8 t -111.53 122.42 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.054 0.454 . . . . 0.0 109.852 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.588 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.4 mm? -112.67 132.47 55.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.696 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.456 ' HG2' HG23 ' A' ' 90' ' ' THR . 90.2 mt-10 -104.7 119.54 39.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.42 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.497 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 9.1 t80 -140.49 137.3 33.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.022 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 87' ' ' ASP . 50.1 t0 50.98 41.12 26.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.158 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 65.86 16.77 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.264 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -117.82 149.77 40.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.4 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -110.96 125.85 54.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.532 -179.136 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -110.15 125.76 53.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.455 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 143' ' ' GLY . 0.3 OUTLIER -97.81 108.18 20.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.697 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 62.9 m-85 -98.98 151.91 20.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.704 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -124.41 132.69 53.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.759 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.641 HD12 HD11 ' A' ' 98' ' ' ILE . 1.2 mm -65.86 119.62 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.059 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -89.84 -57.79 2.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.951 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -153.35 151.48 30.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.295 0.569 . . . . 0.0 109.934 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.641 HD11 HD12 ' A' ' 95' ' ' ILE . 16.0 mm -122.41 132.15 71.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.25 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.499 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 11.2 p90 -150.21 178.87 8.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.192 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.508 HG22 ' HB3' ' A' ' 133' ' ' ASP . 7.9 mt -125.87 138.65 53.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.664 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 102' ' ' HIS . 3.4 t -138.68 169.14 18.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.268 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.478 ' ND1' ' OD1' ' A' ' 133' ' ' ASP . 68.5 m-70 -68.86 168.23 13.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.672 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HA ' ' HE ' ' A' ' 134' ' ' ARG . . . -76.08 -9.51 58.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -105.35 20.06 19.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.062 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.606 ' O ' HG22 ' A' ' 108' ' ' VAL . 24.4 t70 -87.28 95.01 9.83 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.705 0.288 . . . . 0.0 110.761 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.958 ' O ' HG23 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -73.33 -20.21 60.84 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.122 0.487 . . . . 0.0 110.615 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.561 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 20.9 p -44.87 -14.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.445 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.666 ' HB ' HG21 ' A' ' 118' ' ' THR . 11.0 m -112.37 -12.16 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.406 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -109.48 13.49 8.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.958 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -92.61 -170.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.83 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -95.12 155.22 16.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.699 ' HZ3' HG21 ' A' ' 116' ' ' ILE . 97.0 mttt -131.73 -174.47 3.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.871 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -125.48 10.14 7.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.132 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.75 168.13 11.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.971 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.474 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 38.1 Cg_endo -75.76 97.55 1.11 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.084 2.522 . . . . 0.0 111.929 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.699 HG21 ' HZ3' ' A' ' 112' ' ' LYS . 51.2 mm -127.6 132.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.709 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 tt -106.14 123.85 48.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.245 0.545 . . . . 0.0 109.827 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.666 HG21 ' HB ' ' A' ' 108' ' ' VAL . 96.7 m -115.69 126.67 54.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.458 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.806 HD22 HG23 ' A' ' 121' ' ' THR . 0.6 OUTLIER -112.35 126.35 55.18 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.198 -179.398 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.765 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -122.89 117.45 25.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.078 179.239 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.806 HG23 HD22 ' A' ' 119' ' ' LEU . 42.9 p . . . . . 0 CA--C 1.51 -0.573 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.528 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.508 ' HB3' HG22 ' A' ' 100' ' ' ILE . 95.1 m-20 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.758 0.313 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.519 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 85.7 mtm180 -98.27 142.24 30.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.29 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.55 ' CD2' HD11 ' A' ' 137' ' ' ILE . 3.9 t80 -72.92 132.49 43.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.34 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.499 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 3.7 mm -118.05 120.12 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.55 HD11 ' CD2' ' A' ' 135' ' ' TYR . 16.5 mm -105.68 111.53 35.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.747 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 39.4 tt0 -99.03 129.18 45.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.083 0.468 . . . . 0.0 110.946 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -135.46 150.63 49.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.412 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.447 ' NZ ' ' HD2' ' A' ' 115' ' ' PRO . 53.4 tptt -115.75 140.99 48.68 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.682 HD13 ' C ' ' A' ' 141' ' ' LEU . 2.6 tm? -80.22 117.2 20.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.494 ' N ' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -108.34 -61.23 1.62 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.68 -179.155 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -104.72 151.99 17.38 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.7 m -150.43 148.94 29.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.952 0.406 . . . . 0.0 110.222 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' THR . 81.8 m-85 -132.2 156.92 45.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.404 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.9 p -137.09 125.13 22.86 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.315 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.449 ' CD ' ' O ' ' A' ' 147' ' ' LYS . 5.9 tmtt? . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.576 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.5 tptt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.917 0.389 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.446 ' HG3' ' CD1' ' A' ' 32' ' ' TRP . 56.4 mp0 -65.5 145.76 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.941 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.17 10.76 68.23 Favored Glycine 0 CA--C 1.517 0.214 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -119.47 136.15 54.44 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.079 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.91 117.9 5.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.829 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 32' ' ' TRP . 16.0 m -117.35 -43.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -129.19 161.48 30.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.951 0.405 . . . . 0.0 110.723 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.4 ttt -125.89 131.09 52.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.431 HD13 HD21 ' A' ' 84' ' ' LEU . 51.0 tp -95.76 123.55 39.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.51 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -120.24 128.17 53.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.146 0.498 . . . . 0.0 110.687 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mt -106.77 115.65 60.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.294 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 81' ' ' THR . 57.6 Cg_endo -77.88 -49.97 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.077 2.518 . . . . 0.0 112.526 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.477 ' HG2' ' HZ1' ' A' ' 77' ' ' LYS . 1.9 tptt -63.16 -37.06 85.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.074 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.67 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.7 mm? -96.77 5.81 49.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.977 0.418 . . . . 0.0 110.377 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 24' ' ' LEU . 12.9 mttt 40.21 53.96 2.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.463 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -136.73 159.47 41.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.068 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 2.2 mtmt -137.78 154.49 49.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.944 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.423 ' CG ' ' O ' ' A' ' 27' ' ' LYS . 76.8 m-85 -154.23 150.61 28.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.949 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.0 m -99.87 119.33 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.541 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 30' ' ' ILE . 1.7 mp -93.07 122.16 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.611 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -97.89 141.14 31.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.748 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.537 ' CZ3' HG22 ' A' ' 53' ' ' THR . 48.2 t-105 -60.51 130.3 45.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.778 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.408 ' HA2' HG12 ' A' ' 47' ' ' VAL . . . 93.85 156.54 32.53 Favored Glycine 0 C--N 1.33 0.22 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.609 179.392 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.551 ' SD ' HD21 ' A' ' 62' ' ' LEU . 2.6 tpp -96.38 127.88 42.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -64.27 142.34 58.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.606 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.462 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.0 p -124.26 125.87 71.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.743 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.642 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.2 OUTLIER -161.8 169.86 20.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.238 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -61.35 -38.97 88.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.183 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.767 HG21 ' O ' ' A' ' 109' ' ' ILE . 11.9 m -85.17 -31.79 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 48' ' ' SER . 67.3 p -82.61 155.35 24.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.633 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.19 170.85 21.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.375 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.537 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -87.77 152.93 52.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.641 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.17 83.03 1.91 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.712 2.275 . . . . 0.0 112.463 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 p -117.88 -1.45 11.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.35 89.49 0.08 OUTLIER Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.02 90.2 0.02 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.501 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -165.84 163.33 36.65 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.61 ' CE1' HD12 ' A' ' 110' ' ' ILE . 17.2 t-160 -87.33 106.27 17.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.9 m -101.01 124.15 46.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.354 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.57 ' O ' HD22 ' A' ' 62' ' ' LEU . 54.3 t -117.87 129.98 73.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.5 . . . . 0.0 110.081 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.57 HD22 ' O ' ' A' ' 61' ' ' VAL . 2.2 mm? -115.18 146.46 41.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.877 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 p -138.25 150.76 47.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.81 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.879 179.632 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.651 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -67.05 -40.33 87.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.204 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 76' ' ' LEU . 5.9 mt -90.4 86.33 6.43 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.906 0.384 . . . . 0.0 111.186 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.477 ' HZ1' ' HG2' ' A' ' 23' ' ' LYS . 56.7 pttt -178.84 155.58 0.79 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.932 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.13 -11.75 59.72 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.206 0.527 . . . . 0.0 110.731 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -79.86 -15.48 57.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.821 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.19 157.57 29.31 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.821 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.531 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -144.22 118.3 9.46 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.128 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 93' ' ' TYR . 35.4 mt -96.03 134.96 38.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.697 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.678 ' C ' HD22 ' A' ' 84' ' ' LEU . 2.1 t -118.31 126.22 74.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.437 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.678 HD22 ' C ' ' A' ' 83' ' ' VAL . 4.0 mm? -112.75 134.6 54.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.537 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.834 ' HG3' HG23 ' A' ' 90' ' ' THR . 0.1 OUTLIER -106.94 125.1 50.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.013 179.047 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.514 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -148.27 133.18 18.08 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.312 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 51.94 51.96 15.42 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.965 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 55.69 27.08 10.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.105 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.455 ' HG2' ' CB ' ' A' ' 146' ' ' SER . 39.0 mtpt -129.92 140.83 50.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.042 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.834 HG23 ' HG3' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -110.06 125.46 52.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.9 0.381 . . . . 0.0 110.379 -179.748 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.402 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 17.0 m-85 -104.32 135.26 46.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.164 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.593 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -102.88 113.81 27.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.087 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 82' ' ' LEU . 82.8 m-85 -111.81 147.16 36.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.681 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.589 ' HB3' HG21 ' A' ' 142' ' ' THR . 15.0 pt-20 -127.92 145.06 51.08 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.389 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.928 HG23 HD11 ' A' ' 98' ' ' ILE . 10.0 mm -67.04 120.39 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.318 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -94.49 -61.15 1.56 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.614 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.546 ' C ' HD13 ' A' ' 98' ' ' ILE . 61.6 tttp -148.74 140.99 24.06 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.32 0.581 . . . . 0.0 110.595 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.928 HD11 HG23 ' A' ' 95' ' ' ILE . 6.6 mm -117.33 136.75 53.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.026 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.459 ' C ' ' CD1' ' A' ' 99' ' ' TRP . 12.4 p90 -154.59 178.98 9.48 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.379 -0.529 . . . . 0.0 111.395 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.759 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.2 mp -128.46 133.52 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.674 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.3 t -145.11 160.33 41.58 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.633 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -61.62 150.85 35.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.366 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.54 ' HB2' HH11 ' A' ' 134' ' ' ARG . . . -62.79 -4.97 2.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.669 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.548 ' OD1' ' C ' ' A' ' 104' ' ' ASP . 2.1 p30 -99.56 13.52 33.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.849 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.593 ' OD2' ' OG1' ' A' ' 107' ' ' THR . 17.7 t0 -82.71 96.72 8.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.393 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 110' ' ' ILE . 8.7 ptm180 -66.49 -18.4 65.34 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.589 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.593 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 15.5 p -58.56 -16.56 16.19 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.719 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.896 HG13 HG21 ' A' ' 118' ' ' THR . 18.6 t -100.46 -14.44 7.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.399 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.767 ' O ' HG21 ' A' ' 50' ' ' VAL . 48.4 mm -117.02 23.51 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.956 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.61 HD12 ' CE1' ' A' ' 59' ' ' HIS . 0.7 OUTLIER -83.61 -162.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.877 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -106.28 134.51 49.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.358 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.561 ' H ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -115.5 126.61 54.5 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.754 -0.378 . . . . 0.0 109.982 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 113' ' ' GLU . 56.2 mp0 -77.72 15.17 0.88 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.105 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.408 ' H ' ' C ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -147.36 171.1 6.73 Favored Pre-proline 0 C--N 1.332 -0.163 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.954 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.501 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 56.7 Cg_endo -80.24 90.37 1.25 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.326 2.684 . . . . 0.0 111.949 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.22 133.54 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.725 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.845 ' C ' HD23 ' A' ' 117' ' ' LEU . 5.4 tt -106.88 124.02 49.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.492 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.896 HG21 HG13 ' A' ' 108' ' ' VAL . 31.8 m -119.32 126.99 52.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.362 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.806 HD23 ' N ' ' A' ' 120' ' ' THR . 5.5 tt -120.11 125.42 48.21 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.315 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.806 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -109.66 126.6 53.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 0.0 110.319 179.065 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 135' ' ' TYR . 1.2 p . . . . . 0 C--O 1.237 0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.519 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 133' ' ' ASP . 10.1 p-10 . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.54 HH11 ' HB2' ' A' ' 103' ' ' ALA . 42.3 mtt85 -103.44 140.59 37.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.069 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.529 ' CD1' HG13 ' A' ' 100' ' ' ILE . 8.1 t80 -84.71 128.87 34.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.556 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.42 HD13 HG21 ' A' ' 108' ' ' VAL . 1.3 mt -123.05 128.07 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.658 HG23 ' CD1' ' A' ' 95' ' ' ILE . 1.5 mp -106.39 114.85 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.578 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 6.0 tt0 -94.43 138.0 32.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.761 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -148.57 148.03 29.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -116.1 160.43 20.35 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.866 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -77.31 123.12 26.05 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.824 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.589 HG21 ' HB3' ' A' ' 94' ' ' GLU . 3.0 p -98.78 -40.15 8.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.355 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.593 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -145.36 162.99 28.21 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.5 p -139.39 142.87 37.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.874 0.369 . . . . 0.0 110.433 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -129.73 141.22 50.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.37 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.455 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 23.2 t -137.23 141.97 42.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.184 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.0 tptp . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.465 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.822 0.344 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.678 ' OE2' HG11 ' A' ' 47' ' ' VAL . 89.9 mt-10 -68.99 151.4 46.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.179 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.35 11.25 80.84 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.402 ' O ' HG13 ' A' ' 16' ' ' VAL . 75.2 mm-40 -118.16 135.01 54.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.4 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -59.01 118.2 5.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.217 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.494 HG11 ' HB2' ' A' ' 32' ' ' TRP . 17.1 m -117.48 -34.99 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.118 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.2 163.25 32.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.763 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.617 ' SD ' ' O ' ' A' ' 28' ' ' PHE . 7.6 tpp -121.94 142.56 50.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.527 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.419 HD13 HD21 ' A' ' 84' ' ' LEU . 27.6 tp -106.14 123.29 47.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.242 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -120.36 128.24 53.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.162 0.506 . . . . 0.0 111.003 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.48 HG22 ' H ' ' A' ' 24' ' ' LEU . 3.3 mt -105.88 116.76 59.21 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.213 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.615 ' CD ' ' O ' ' A' ' 81' ' ' THR . 59.3 Cg_endo -76.92 -50.09 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.79 2.327 . . . . 0.0 112.903 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.604 ' C ' HD22 ' A' ' 24' ' ' LEU . 10.1 tptp -60.43 -38.85 85.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.772 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.0 mm? -100.44 3.99 43.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.875 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.7 mptt 43.22 39.31 1.94 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.622 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.43 ' CB ' HD12 ' A' ' 21' ' ' ILE . 6.8 mmmt -115.53 150.62 36.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.434 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -131.93 147.88 52.49 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.849 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.617 ' O ' ' SD ' ' A' ' 18' ' ' MET . 85.3 m-85 -141.83 162.47 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.691 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.468 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 8.7 p -103.54 122.27 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.929 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mm -95.37 124.51 47.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.286 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -108.11 142.51 38.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.505 ' CZ2' ' HB ' ' A' ' 47' ' ' VAL . 51.3 t-105 -65.29 132.82 50.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.849 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.549 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 76.35 159.01 8.67 Favored Glycine 0 N--CA 1.46 0.293 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.408 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.414 179.614 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.571 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.549 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 1.2 ttp -91.4 138.04 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.504 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.681 ' CD1' HG21 ' A' ' 51' ' ' THR . 3.0 t80 -76.26 143.12 41.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.954 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.678 HG11 ' OE2' ' A' ' 12' ' ' GLU . 2.0 p -130.83 120.33 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.483 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.7 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.6 OUTLIER -170.9 174.98 4.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.577 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -62.92 -38.88 92.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.513 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.703 HG21 ' O ' ' A' ' 109' ' ' ILE . 2.0 m -85.12 -23.45 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.78 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.7 ' OG1' ' N ' ' A' ' 48' ' ' SER . 71.1 p -93.67 144.35 25.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.471 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 1.7 p -138.38 172.41 12.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.929 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.45 149.16 36.43 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.491 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.18 83.02 1.5 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.757 2.305 . . . . 0.0 112.647 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -127.46 -1.76 6.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.585 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.74 63.3 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.76 104.32 0.47 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.547 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -178.89 155.12 15.41 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.572 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 22.2 t-160 -78.65 103.24 8.46 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.5 m -99.11 114.97 27.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.434 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.464 ' O ' HD23 ' A' ' 62' ' ' LEU . 48.1 t -111.26 128.36 67.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.84 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 61' ' ' VAL . 25.7 mt -118.1 154.51 31.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.997 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 120' ' ' THR . 13.7 t -137.52 148.81 46.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.365 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.589 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.529 0.918 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.442 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.565 ' HA3' HD11 ' A' ' 24' ' ' LEU . . . . . . . . 0 CA--C 1.527 0.788 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -71.93 -40.74 68.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.791 0.329 . . . . 0.0 110.797 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.588 HD22 ' OH ' ' A' ' 135' ' ' TYR . 16.5 mt -89.83 91.49 8.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.455 ' HG3' ' H ' ' A' ' 80' ' ' ASP . 11.1 ptmt -179.21 135.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.386 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -71.68 -12.18 61.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.618 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -81.28 -15.9 54.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.104 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.55 ' OD1' ' C ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -67.55 153.36 43.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.487 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.615 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -141.36 116.5 9.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.062 0.458 . . . . 0.0 110.279 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.7 mt -93.28 129.47 39.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.777 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.633 ' C ' HD22 ' A' ' 84' ' ' LEU . 2.5 t -111.22 122.71 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.011 0.434 . . . . 0.0 110.361 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.633 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.3 mm? -109.69 136.67 48.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.43 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -102.29 123.91 46.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.179 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 89' ' ' LYS . 7.0 t80 -145.03 143.15 30.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.618 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 87' ' ' ASP . 65.3 t0 36.85 53.05 1.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.871 0.367 . . . . 0.0 111.406 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 56.4 25.77 9.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.335 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 86' ' ' TYR . 30.8 mtpt -125.11 145.42 49.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.491 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -108.21 124.17 49.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.48 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 12.4 m-85 -105.04 131.83 52.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.097 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.591 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -101.68 113.79 27.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.463 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 83.2 m-85 -110.03 152.29 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.624 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -126.32 137.77 53.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.489 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mm -67.38 119.01 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.582 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -88.27 -64.87 1.08 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.826 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -147.26 143.24 27.97 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.055 0.455 . . . . 0.0 110.349 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.784 HG23 HD13 ' A' ' 137' ' ' ILE . 1.7 mp -118.46 131.52 70.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.403 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 29.1 p90 -154.17 -174.55 5.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.5 mt -132.05 132.24 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.193 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.0 t -131.92 174.49 10.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -75.74 153.06 37.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.84 -25.54 68.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.608 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -85.87 10.2 14.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.556 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -82.09 90.6 6.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.396 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.847 ' O ' HG23 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -68.8 -21.62 64.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.29 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.543 ' C ' HD12 ' A' ' 110' ' ' ILE . 21.5 p -48.51 -11.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.384 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.912 HG13 HG21 ' A' ' 118' ' ' THR . 45.7 t -111.54 -11.03 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.035 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.703 ' O ' HG21 ' A' ' 50' ' ' VAL . 50.1 mm -111.9 10.14 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.015 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.847 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -80.78 -165.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.722 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -97.13 158.94 15.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.052 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HG3' ' CD2' ' A' ' 59' ' ' HIS . 66.9 mmtt -126.37 -168.02 1.8 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.263 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.442 ' C ' ' CG ' ' A' ' 114' ' ' GLU . 4.9 mm-40 -138.34 16.5 2.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.425 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.459 ' CB ' ' HD2' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -162.23 169.62 9.05 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.523 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.547 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 32.7 Cg_endo -70.06 90.21 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.174 2.583 . . . . 0.0 111.829 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.2 mm -122.27 133.09 69.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.029 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.467 ' C ' HD23 ' A' ' 117' ' ' LEU . 8.1 tt -108.38 123.69 49.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.734 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.912 HG21 HG13 ' A' ' 108' ' ' VAL . 94.5 m -122.68 128.4 50.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.38 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.881 HD23 ' N ' ' A' ' 120' ' ' THR . 5.1 tt -111.61 127.18 55.66 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.953 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.881 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -121.52 108.83 14.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.262 0.553 . . . . 0.0 110.524 179.323 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.589 ' OG1' ' O ' ' A' ' 64' ' ' GLY . 1.2 t . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.101 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.626 0.25 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -114.1 140.75 48.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.672 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.645 ' CD2' HD11 ' A' ' 137' ' ' ILE . 3.8 t80 -74.73 128.29 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.403 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 18.4 mm -112.81 117.62 55.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.761 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.784 HD13 HG23 ' A' ' 98' ' ' ILE . 15.9 mm -107.45 107.09 21.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -92.79 133.22 36.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.135 0.493 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.1 145.42 30.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 50.7 tttm -117.31 152.53 34.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.463 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 11.0 tp -78.68 122.26 25.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.075 0.464 . . . . 0.0 110.35 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.27 -41.75 5.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.841 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.591 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -136.23 156.88 23.22 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 82.2 p -138.51 151.02 46.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.805 0.336 . . . . 0.0 110.597 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' THR . 94.4 m-85 -134.54 151.16 50.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.607 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.402 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 60.3 p -140.96 134.13 29.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.555 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.4 mttt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.51 -179.92 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.898 0.38 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.48 124.93 24.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.936 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 113.15 -8.44 25.01 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -94.52 133.46 38.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.888 0.375 . . . . 0.0 110.26 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 89.0 tttt -57.93 122.04 12.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.323 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.29 -34.69 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.976 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.18 156.68 45.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.514 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.2 ttp -120.97 140.42 51.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.311 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.4 tp -105.84 129.45 54.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.62 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 1.073 HD21 ' N ' ' A' ' 21' ' ' ILE . 0.2 OUTLIER -121.52 133.62 55.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.993 0.425 . . . . 0.0 110.815 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.073 ' N ' HD21 ' A' ' 20' ' ' ASN . 3.5 mt -114.69 112.62 45.32 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.527 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.418 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 56.8 Cg_endo -77.16 -42.91 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.579 2.186 . . . . 0.0 112.412 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.77 ' NZ ' ' NZ ' ' A' ' 77' ' ' LYS . 19.9 tptm -62.26 -38.44 89.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.803 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.792 HD22 ' N ' ' A' ' 24' ' ' LEU . 2.9 mm? -101.74 4.04 40.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.945 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 22' ' ' PRO . 7.0 mptt 43.85 48.75 7.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.562 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -134.25 152.16 51.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.931 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.532 ' NZ ' ' OD1' ' A' ' 20' ' ' ASN . 8.6 mttp -130.43 143.04 50.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.675 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -130.88 145.66 52.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.743 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.3 p -95.06 113.83 25.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.644 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.594 HG12 HD11 ' A' ' 62' ' ' LEU . 1.2 mp -89.26 124.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.386 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 86.1 m-85 -106.06 149.66 26.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' A' ' 13' ' ' GLY . 24.0 t-105 -59.18 132.7 54.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.967 0.413 . . . . 0.0 110.824 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.523 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 75.04 162.41 9.83 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.592 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.277 179.237 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.614 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.541 ' CE ' ' H ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -94.99 140.04 30.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.684 0.278 . . . . 0.0 110.321 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -66.95 136.09 54.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.523 HG23 ' HA2' ' A' ' 33' ' ' GLY . 77.8 t -115.63 116.17 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.467 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.534 ' OG ' HG23 ' A' ' 51' ' ' THR . 50.1 p -161.88 166.74 25.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.549 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 42.0 t0 -66.75 -2.68 5.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.52 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.0 m -118.96 -30.06 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.81 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.534 HG23 ' OG ' ' A' ' 48' ' ' SER . 27.8 p -80.47 142.72 33.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.736 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 59' ' ' HIS . 1.1 t -146.82 167.8 23.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.293 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.665 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -89.87 158.99 44.0 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.979 0.418 . . . . 0.0 110.601 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.84 83.16 1.83 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.755 2.303 . . . . 0.0 112.367 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.6 p -112.38 -3.78 14.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.679 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.83 91.9 0.24 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.18 77.44 0.28 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.16 162.94 32.6 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.656 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 18.6 t-160 -82.91 116.96 22.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.9 m -111.31 124.39 52.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.299 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.541 ' H ' ' CE ' ' A' ' 45' ' ' MET . 97.6 t -118.01 129.08 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.006 0.431 . . . . 0.0 110.354 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.594 HD11 HG12 ' A' ' 30' ' ' ILE . 2.3 mm? -110.48 139.27 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.3 t -121.93 134.16 54.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.05 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.832 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.63 -42.11 95.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.754 0.311 . . . . 0.0 110.957 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.87 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.7 pp -92.18 101.73 14.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.988 0.423 . . . . 0.0 111.017 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.77 ' NZ ' ' NZ ' ' A' ' 23' ' ' LYS . 8.6 ptpt 170.96 135.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.472 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -67.57 -15.39 63.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.269 0.557 . . . . 0.0 110.536 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -80.62 -14.94 57.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.871 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -79.96 157.24 26.9 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.461 ' O ' HD23 ' A' ' 82' ' ' LEU . 1.9 p -137.57 147.17 44.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 81' ' ' THR . 63.1 mt -122.76 126.6 47.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.917 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.658 ' C ' HD22 ' A' ' 84' ' ' LEU . 2.7 t -112.55 124.76 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.997 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.658 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.7 mm? -110.73 137.78 47.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.44 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.615 ' HG2' HG23 ' A' ' 90' ' ' THR . 5.8 mm-40 -106.72 115.72 30.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.332 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.665 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 16.4 t80 -142.16 124.92 15.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.863 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.9 t70 61.19 44.24 10.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.733 0.302 . . . . 0.0 111.256 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 64.19 7.87 3.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.51 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -108.69 145.87 34.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.37 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.615 HG23 ' HG2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -111.48 120.71 43.06 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.481 -179.504 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 7.4 m-85 -98.98 143.3 29.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.372 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.87 110.61 21.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.843 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 82.9 m-85 -108.49 155.77 20.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.641 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -132.35 140.67 48.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.68 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mm -67.81 120.26 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.341 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.26 -65.03 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -144.53 137.88 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.309 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.89 130.93 65.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.015 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 19.2 p90 -152.83 -177.29 6.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.524 HG12 ' CD1' ' A' ' 135' ' ' TYR . 54.8 mt -125.72 132.74 70.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.253 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.539 HG22 ' CG1' ' A' ' 136' ' ' ILE . 1.5 t -133.7 166.62 22.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.928 0.395 . . . . 0.0 110.874 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.462 ' O ' HG23 ' A' ' 101' ' ' THR . 57.7 m80 -68.62 158.42 34.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.588 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.21 -15.59 62.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.697 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -97.47 8.49 44.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.697 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.4 87.7 4.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.986 0.422 . . . . 0.0 110.322 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.858 ' O ' HG23 ' A' ' 110' ' ' ILE . 10.9 ptp85 -65.63 -32.28 73.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.368 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.534 ' O ' HD12 ' A' ' 110' ' ' ILE . 6.9 p -42.94 -17.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.375 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.767 ' CG1' HG21 ' A' ' 118' ' ' THR . 48.4 t -106.42 -16.78 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.002 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.821 HG22 ' O ' ' A' ' 109' ' ' ILE . 45.4 mm -110.08 20.19 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.163 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.858 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -86.92 -165.36 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.941 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -97.02 151.37 19.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.44 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 98.4 mttt -135.99 134.99 39.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.571 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -83.7 14.21 4.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.084 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.15 159.61 70.25 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.992 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.93 92.9 1.09 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 123.126 2.551 . . . . 0.0 112.031 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.4 mm -124.73 137.34 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.189 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.735 ' C ' HD23 ' A' ' 117' ' ' LEU . 6.8 tt -109.78 118.0 35.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.203 0.525 . . . . 0.0 110.436 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.767 HG21 ' CG1' ' A' ' 108' ' ' VAL . 68.3 m -114.16 123.0 48.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.825 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.816 HD23 ' N ' ' A' ' 120' ' ' THR . 4.0 tt -107.79 120.77 43.18 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.558 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.816 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -115.87 114.68 25.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.154 0.502 . . . . 0.0 110.523 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.631 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.172 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.562 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 27.3 p30 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.657 0.265 . . . . 0.0 110.486 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -100.89 139.43 36.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.951 0.405 . . . . 0.0 110.341 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.524 ' CD1' HG12 ' A' ' 100' ' ' ILE . 1.9 t80 -76.42 136.22 39.44 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.172 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.539 ' CG1' HG22 ' A' ' 101' ' ' THR . 5.9 mm -122.55 113.54 38.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.696 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 137' ' ' ILE . 0.6 OUTLIER -107.18 112.88 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.271 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.439 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 44.7 tt0 -93.63 139.81 30.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.508 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.58 148.77 31.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.974 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.1 tttm -119.12 152.22 36.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.384 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 18.0 tp -77.45 119.21 20.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.25 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.2 p -95.43 -41.55 8.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.673 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.466 ' O ' HD11 ' A' ' 141' ' ' LEU . . . -144.78 179.93 21.6 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.1 p -154.03 161.42 41.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.731 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 90' ' ' THR . 94.5 m-85 -144.03 159.37 42.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.773 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.8 p -144.57 128.17 17.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.654 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.3 tttp . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.967 -1.015 . . . . 0.0 110.579 179.92 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.133 0.492 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -69.24 142.18 54.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.341 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.57 15.8 63.13 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -119.61 137.01 54.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.014 0.435 . . . . 0.0 110.375 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 106.81 0.77 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.46 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.409 HG23 ' N ' ' A' ' 17' ' ' ALA . 15.9 m -109.81 -40.53 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.971 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' N ' HG23 ' A' ' 16' ' ' VAL . . . -135.09 164.56 27.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.695 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.0 ttt -131.75 128.21 38.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.635 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 tt -98.11 116.79 31.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.069 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.497 ' ND2' ' HE3' ' A' ' 27' ' ' LYS . 48.5 t-20 -110.76 137.33 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.022 0.439 . . . . 0.0 111.235 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.57 HD12 ' HG3' ' A' ' 26' ' ' LYS . 9.3 mt -116.67 115.87 39.03 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.286 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.94 -39.0 0.69 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.677 2.251 . . . . 0.0 112.847 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.581 ' C ' HD22 ' A' ' 24' ' ' LEU . 47.5 tptt -64.1 -35.62 81.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.007 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.723 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.4 mm? -101.9 7.14 41.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 40.78 59.35 2.21 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.131 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.57 ' HG3' HD12 ' A' ' 21' ' ' ILE . 15.3 ptpt -150.33 166.52 29.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.668 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HE3' ' ND2' ' A' ' 20' ' ' ASN . 27.6 mtpt -139.82 146.49 39.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.144 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.454 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 49.4 m-85 -132.13 138.68 48.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.717 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 p -89.57 112.24 23.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.544 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.9 mm -84.09 120.72 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.395 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -100.69 140.37 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.024 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.5 ' CE2' HG22 ' A' ' 47' ' ' VAL . 58.6 t-105 -59.46 132.1 52.96 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.276 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.658 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 76.55 140.2 1.03 Allowed Glycine 0 N--CA 1.463 0.445 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.538 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.857 179.98 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.588 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.615 ' SD ' HD21 ' A' ' 62' ' ' LEU . 2.4 tpp -87.93 145.65 25.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.705 0.288 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.449 ' CD1' HG21 ' A' ' 51' ' ' THR . 2.4 t80 -77.13 139.13 39.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.658 HG23 ' HA2' ' A' ' 33' ' ' GLY . 94.2 t -117.24 120.76 65.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.401 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.659 ' CB ' ' HG1' ' A' ' 51' ' ' THR . 4.9 p -170.64 176.3 4.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.54 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.98 -18.76 61.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.734 HG21 ' O ' ' A' ' 109' ' ' ILE . 2.3 m -107.9 -21.28 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.9 0.381 . . . . 0.0 110.843 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.659 ' HG1' ' CB ' ' A' ' 48' ' ' SER . 17.3 p -89.49 127.95 35.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.288 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 59' ' ' HIS . 1.3 t -136.02 166.83 22.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.56 157.75 55.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.684 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.87 80.68 2.89 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.589 2.193 . . . . 0.0 112.528 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.4 p -113.02 -5.33 13.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.946 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.46 91.48 0.1 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.69 91.36 0.01 OUTLIER Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -170.25 162.43 35.65 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.66 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 17.0 t-160 -83.35 117.19 22.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.6 m -112.77 108.02 16.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.533 HG11 HD12 ' A' ' 109' ' ' ILE . 78.4 t -106.24 129.03 60.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 110.011 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.615 HD21 ' SD ' ' A' ' 45' ' ' MET . 27.1 mt -120.53 158.63 26.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.939 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 120' ' ' THR . 7.8 p -139.0 150.58 46.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.261 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -78.72 -41.91 29.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.832 0.348 . . . . 0.0 111.035 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.678 HD22 ' OH ' ' A' ' 135' ' ' TYR . 20.8 mt -89.83 80.92 6.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.085 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.69 142.38 1.18 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.462 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -77.83 -16.5 58.27 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.596 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -79.2 -15.19 58.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.143 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.423 ' OD1' ' C ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -70.57 153.67 42.65 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 p -136.08 142.42 44.33 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.044 0.45 . . . . 0.0 110.002 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.1 mt -119.12 123.54 44.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.878 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.664 HG12 HG22 ' A' ' 90' ' ' THR . 2.2 t -107.12 124.73 63.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.35 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.638 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.4 mm? -110.39 129.61 55.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.377 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.419 ' HG2' HG23 ' A' ' 90' ' ' THR . 80.6 mt-10 -101.0 124.25 46.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.216 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 1.8 t80 -149.8 130.37 13.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.992 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 55.46 43.29 28.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.136 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 65.27 8.17 4.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.458 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 52.1 mtmt -107.02 150.98 25.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.383 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.664 HG22 HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -117.29 121.97 42.64 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.798 -179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -104.12 130.53 51.84 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.457 ' OG1' ' C ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -99.75 114.98 28.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.13 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 81.7 m-85 -110.69 155.49 22.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.725 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -130.73 140.13 50.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.156 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.456 HD13 HG23 ' A' ' 137' ' ' ILE . 1.1 mm -62.38 119.69 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.203 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.68 -64.1 1.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.885 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -146.98 133.01 19.21 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.172 0.51 . . . . 0.0 110.452 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.498 HG23 HG13 ' A' ' 137' ' ' ILE . 1.6 mp -111.04 131.13 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.608 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.402 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 18.9 p90 -153.72 -178.16 6.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.092 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.427 HG12 ' CD1' ' A' ' 135' ' ' TYR . 2.7 mt -127.13 134.08 66.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.258 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.542 HG22 ' CD1' ' A' ' 136' ' ' ILE . 2.9 t -146.06 172.49 13.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.91 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.429 ' O ' HG23 ' A' ' 101' ' ' THR . 4.9 m-70 -61.77 156.48 20.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.48 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.528 ' HB2' ' HG3' ' A' ' 134' ' ' ARG . . . -74.5 -25.97 59.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.831 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -89.46 2.17 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.565 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -65.36 90.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.526 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.983 ' O ' HG23 ' A' ' 110' ' ' ILE . 22.9 ptt85 -56.11 -35.91 67.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.51 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.536 ' C ' HD12 ' A' ' 110' ' ' ILE . 2.5 p -40.64 -17.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.536 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.787 ' CG1' HG21 ' A' ' 118' ' ' THR . 6.5 t -110.61 -15.58 9.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.005 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.734 ' O ' HG21 ' A' ' 50' ' ' VAL . 48.2 mm -113.74 21.91 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.036 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.983 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -88.19 -169.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.858 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -94.03 147.44 23.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.4 mttt -133.22 147.95 52.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.449 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -97.58 11.66 36.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.847 0.356 . . . . 0.0 110.067 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -133.66 159.48 72.34 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.73 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.49 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 46.7 Cg_endo -76.02 89.79 1.21 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.043 2.495 . . . . 0.0 111.959 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.46 134.99 63.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.437 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.517 ' C ' HD23 ' A' ' 117' ' ' LEU . 9.2 tt -109.34 120.85 43.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.653 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.787 HG21 ' CG1' ' A' ' 108' ' ' VAL . 71.7 m -116.36 119.78 36.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.109 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 120' ' ' THR . 0.7 OUTLIER -110.67 114.65 28.2 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.462 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.716 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -106.63 127.86 53.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.462 . . . . 0.0 110.762 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.631 HG23 ' CD2' ' A' ' 119' ' ' LEU . 27.4 p . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 121.129 0.49 . . . . 0.0 111.56 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.164 0 CA-C-O 120.699 0.285 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.528 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -126.4 137.96 53.49 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 110.95 -179.62 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.678 ' OH ' HD22 ' A' ' 76' ' ' LEU . 5.2 t80 -79.57 126.39 30.82 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.542 ' CD1' HG22 ' A' ' 101' ' ' THR . 1.1 mt -122.02 126.51 74.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-O 121.218 0.532 . . . . 0.0 111.943 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.594 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp -108.17 112.76 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.287 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -95.4 136.65 35.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.548 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.87 153.53 47.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.549 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 8.4 tptt -116.55 146.72 42.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.948 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.549 ' H ' ' HD2' ' A' ' 140' ' ' LYS . 16.4 tp -69.69 124.09 23.08 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.107 0.479 . . . . 0.0 110.109 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.9 p -99.04 -47.94 5.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.629 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.457 ' C ' ' OG1' ' A' ' 92' ' ' THR . . . -141.97 172.05 24.26 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.2 p -144.9 134.76 23.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.614 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -122.93 146.29 47.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.196 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 97.9 p -134.14 123.99 25.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.485 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.419 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.0 tptt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.732 0.301 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 12' ' ' GLU . 2.1 pt-20 -58.22 135.87 57.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.073 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.39 2.68 61.77 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -115.32 140.45 49.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.793 0.33 . . . . 0.0 110.512 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -63.1 121.52 13.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.216 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.55 -39.47 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.96 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.3 156.95 43.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.628 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ttm -119.68 141.77 49.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.161 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 82' ' ' LEU . 29.0 tp -108.4 121.81 45.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.644 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -118.38 127.8 54.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.902 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 24' ' ' LEU . 6.0 mt -104.56 115.53 62.62 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.389 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.62 ' CD ' ' O ' ' A' ' 81' ' ' THR . 56.9 Cg_endo -77.11 -45.78 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.846 2.364 . . . . 0.0 112.52 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.632 ' C ' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -60.3 -40.25 89.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.489 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.771 HD22 ' N ' ' A' ' 24' ' ' LEU . 2.9 mm? -102.56 8.97 39.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.562 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 40.42 40.21 0.83 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.519 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.42 ' CB ' HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -112.07 157.91 20.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.519 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -138.71 139.89 38.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.584 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -137.06 159.09 42.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.855 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 m -101.99 122.38 43.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.001 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.4 mm -94.08 118.71 40.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.319 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -101.16 136.76 40.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.323 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.574 ' CZ3' ' SD ' ' A' ' 45' ' ' MET . 55.8 t-105 -60.41 133.05 55.72 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.616 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.568 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 77.62 163.98 21.63 Favored Glycine 0 C--N 1.331 0.258 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.868 179.26 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.582 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.703 ' CE ' ' H ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -95.46 134.45 38.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.627 0.251 . . . . 0.0 110.325 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.673 ' O ' ' SD ' ' A' ' 45' ' ' MET . 18.6 t80 -75.43 139.45 42.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.535 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.568 HG23 ' HA2' ' A' ' 33' ' ' GLY . 40.2 t -111.02 124.58 67.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.962 0.41 . . . . 0.0 110.433 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.538 ' OG ' ' CE2' ' A' ' 46' ' ' PHE . 18.8 m -160.92 165.38 30.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.604 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -69.0 -24.22 64.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.704 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.583 HG21 ' HA ' ' A' ' 110' ' ' ILE . 4.6 m -94.18 -40.52 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.161 0.505 . . . . 0.0 110.742 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.51 ' N ' HG23 ' A' ' 50' ' ' VAL . 81.7 p -76.18 155.56 34.44 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.716 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -148.97 171.6 16.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.606 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.466 HG22 ' CH2' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -87.41 156.75 53.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.754 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.452 ' HG3' HD23 ' A' ' 84' ' ' LEU . 68.0 Cg_endo -80.03 83.46 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.581 2.188 . . . . 0.0 112.445 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.0 p -113.85 -9.47 13.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.569 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.73 90.41 0.08 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.85 85.75 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.503 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.22 160.64 34.37 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.702 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 13.6 t-160 -83.65 116.66 22.74 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.7 m -111.81 127.19 55.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.234 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.703 ' H ' ' CE ' ' A' ' 45' ' ' MET . 54.6 t -117.29 129.75 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.354 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.538 HD22 ' O ' ' A' ' 61' ' ' VAL . 1.9 mm? -112.7 145.49 40.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.632 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 120' ' ' THR . 47.2 t -126.73 144.12 51.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.086 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.47 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.527 0.834 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.531 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -40.35 94.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.918 0.39 . . . . 0.0 110.165 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.33 111.4 17.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -174.23 141.12 0.71 Allowed 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -77.84 -12.36 59.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.052 0.454 . . . . 0.0 110.507 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -84.95 -15.51 44.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.137 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.401 ' HB2' ' CD ' ' A' ' 77' ' ' LYS . 1.2 t70 -69.5 152.76 44.45 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.62 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -142.04 115.01 8.7 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.304 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.465 ' HB3' HD11 ' A' ' 19' ' ' LEU . 67.2 mt -90.47 132.21 35.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.629 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.548 HG12 HG22 ' A' ' 90' ' ' THR . 2.1 t -109.85 115.54 49.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.994 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 117' ' ' LEU . 6.0 mp -94.98 123.47 38.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.196 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.457 ' HG2' HG23 ' A' ' 90' ' ' THR . 96.7 mt-10 -99.73 117.61 34.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.374 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -149.6 133.26 16.8 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.936 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 56.23 43.67 26.21 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.321 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.5 9.31 2.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.337 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -107.44 150.21 27.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.518 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -118.03 123.85 46.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.709 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 15.4 m-85 -107.31 132.63 52.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.271 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.18 112.37 24.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 111.634 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.703 ' CE2' HD22 ' A' ' 84' ' ' LEU . 75.6 m-85 -109.85 147.58 33.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.775 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.583 ' OE1' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -124.71 139.83 53.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 179.682 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.583 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 1.3 mm -63.5 117.13 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.286 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.495 ' OE1' ' OE2' ' A' ' 94' ' ' GLU . 7.8 mm100 -84.27 -67.97 0.75 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.844 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -145.83 139.66 26.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.109 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 137' ' ' ILE . 4.4 mt -112.81 127.78 69.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.61 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 25.8 p90 -150.89 -177.98 6.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.777 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.461 HD12 ' N ' ' A' ' 100' ' ' ILE . 3.6 mp -127.25 131.52 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.641 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.449 HG22 HD11 ' A' ' 136' ' ' ILE . 1.6 t -132.31 165.95 23.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.673 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -70.6 153.8 42.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.408 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.56 -13.32 61.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.697 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -92.67 8.02 40.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.76 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.599 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 68.1 t0 -85.98 89.91 7.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.581 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.849 ' O ' HG23 ' A' ' 110' ' ' ILE . 11.5 ptm180 -70.15 -24.19 63.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.429 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.599 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 12.9 p -49.56 -12.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.357 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.851 ' CG1' HG21 ' A' ' 118' ' ' THR . 43.9 t -111.02 -8.77 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.992 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 109' ' ' ILE . 29.9 mm -111.91 7.03 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 0.0 111.022 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.849 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -79.03 -161.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.629 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 14.1 ptpt -109.89 155.25 21.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.784 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.491 ' H ' ' HB2' ' A' ' 59' ' ' HIS . 99.3 mttt -138.54 144.06 39.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.451 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -85.74 10.88 12.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.999 0.428 . . . . 0.0 110.051 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.04 156.72 73.89 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.135 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.503 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 51.4 Cg_endo -76.89 88.48 1.39 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.975 2.45 . . . . 0.0 111.609 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.4 mm -124.07 131.43 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.916 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.851 HD12 HD21 ' A' ' 84' ' ' LEU . 5.3 tt -105.28 122.41 45.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.201 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.851 HG21 ' CG1' ' A' ' 108' ' ' VAL . 89.8 m -118.99 126.08 50.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.134 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.885 HD23 ' N ' ' A' ' 120' ' ' THR . 3.2 tt -107.7 124.55 50.17 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.599 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.885 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -120.99 113.97 20.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.448 0.642 . . . . 0.0 110.719 179.04 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.484 HG22 HD22 ' A' ' 119' ' ' LEU . 1.7 t . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.229 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.861 0.362 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -105.26 136.23 45.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.556 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.719 ' CD2' HD11 ' A' ' 137' ' ' ILE . 3.6 t80 -74.58 130.68 40.01 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.78 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.453 HD12 HG11 ' A' ' 108' ' ' VAL . 5.3 mm -115.21 117.22 54.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.936 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.719 HD11 ' CD2' ' A' ' 135' ' ' TYR . 12.8 mm -107.04 109.97 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.469 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 41.8 tt0 -92.06 137.0 32.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.054 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 117' ' ' LEU . . . -138.65 149.03 44.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.199 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 26.6 tptt -123.44 142.1 51.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.47 ' H ' ' HD2' ' A' ' 140' ' ' LYS . 21.3 tp -69.5 122.88 19.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.382 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.577 HG21 ' HB3' ' A' ' 94' ' ' GLU . 7.4 p -99.06 -46.82 5.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.734 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -142.04 -177.67 17.37 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.9 p -151.05 152.4 33.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.945 0.403 . . . . 0.0 110.713 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 90' ' ' THR . 90.5 m-85 -140.02 149.56 43.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.427 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.1 p -139.18 119.39 13.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.334 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.8 tttm . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.484 -179.835 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.985 0.421 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -78.6 154.35 30.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.88 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 76.7 18.79 78.62 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -125.75 147.6 49.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 120.835 0.35 . . . . 0.0 110.548 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -63.21 119.52 9.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.236 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.571 HG11 ' HB2' ' A' ' 32' ' ' TRP . 4.6 m -119.64 -20.94 4.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.226 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.516 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -149.19 161.38 42.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.709 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.5 ttt -116.51 141.23 48.45 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.627 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.608 ' HB2' HD11 ' A' ' 30' ' ' ILE . 4.0 tp -109.81 121.86 46.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.567 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -117.76 129.67 55.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.706 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.579 HG21 HD23 ' A' ' 24' ' ' LEU . 13.3 mt -113.84 109.17 50.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.2 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -77.92 -41.72 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.679 2.253 . . . . 0.0 113.208 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.575 ' HB3' HD22 ' A' ' 24' ' ' LEU . 6.6 tptp -58.78 -43.98 90.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.175 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.579 HD23 HG21 ' A' ' 21' ' ' ILE . 1.4 mm? -101.24 2.93 40.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.022 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 mttt 50.4 56.75 7.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.953 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -134.44 155.23 50.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.788 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.04 138.86 42.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.772 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -137.92 157.8 45.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.762 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 t -99.86 134.03 43.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.831 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 19' ' ' LEU . 36.4 mm -99.24 127.28 52.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.331 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -106.37 139.51 40.74 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.222 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.603 ' O ' ' N ' ' A' ' 13' ' ' GLY . 41.6 t-105 -70.29 131.78 44.69 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 71.57 173.24 17.1 Favored Glycine 0 C--O 1.23 -0.122 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.836 179.408 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.55 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.449 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 30.6 ttm -90.92 128.64 36.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -70.97 132.48 45.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.494 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 47' ' ' VAL . 2.3 p -115.46 109.88 29.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.171 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 t -150.5 172.06 16.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.471 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -63.49 -37.62 88.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.537 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.834 HG21 ' O ' ' A' ' 109' ' ' ILE . 13.0 m -83.92 -38.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.898 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.613 HG23 HG23 ' A' ' 50' ' ' VAL . 30.6 p -85.89 158.08 20.02 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.459 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 t -160.08 173.56 15.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.6 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.547 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -84.52 158.46 60.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.736 -179.745 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.552 ' HG3' HD23 ' A' ' 84' ' ' LEU . 74.4 Cg_endo -82.65 83.62 1.95 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.501 2.134 . . . . 0.0 112.654 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 p -119.7 -5.65 10.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.735 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.24 87.4 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.6 96.49 0.02 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.54 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -172.65 150.74 12.96 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.657 ' CE1' HD12 ' A' ' 110' ' ' ILE . 22.3 t-160 -76.4 102.47 5.97 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -96.36 125.1 40.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.013 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.561 HG11 ' CD1' ' A' ' 109' ' ' ILE . 55.2 t -117.75 130.54 72.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.042 0.449 . . . . 0.0 109.975 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 61' ' ' VAL . 2.1 mm? -114.18 139.65 49.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.16 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.8 t -112.89 134.11 54.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.846 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 120' ' ' THR . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.662 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.624 ' OE1' ' N ' ' A' ' 75' ' ' GLN . 0.1 OUTLIER -69.99 -42.52 72.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.462 -179.264 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.857 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.9 pp -92.56 108.64 20.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.21 0.529 . . . . 0.0 110.88 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.596 ' O ' HG21 ' A' ' 95' ' ' ILE . 16.6 ptpt 177.15 150.38 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.284 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -80.02 -12.4 59.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.497 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -87.98 -14.84 38.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.572 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.573 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 3.5 t70 -66.96 153.3 43.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.862 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.486 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.3 p -141.49 135.7 30.48 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.147 0.499 . . . . 0.0 109.69 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.47 HD21 ' OD2' ' A' ' 80' ' ' ASP . 7.2 mt -114.42 128.1 56.17 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.714 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.541 ' C ' HD12 ' A' ' 84' ' ' LEU . 2.4 t -106.77 121.47 59.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.954 0.407 . . . . 0.0 110.249 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.897 HD21 HD12 ' A' ' 117' ' ' LEU . 6.1 mp -105.1 121.59 44.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.208 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HG2' HG23 ' A' ' 90' ' ' THR . 92.8 mt-10 -101.71 113.7 27.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.108 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.516 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -147.86 132.76 18.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.843 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 t0 60.35 40.39 17.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.833 0.349 . . . . 0.0 111.404 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 63.71 11.13 5.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.178 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.673 ' NZ ' ' OH ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -110.61 149.66 30.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.566 179.798 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -115.18 113.31 23.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.747 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.673 ' OH ' ' NZ ' ' A' ' 89' ' ' LYS . 9.4 m-85 -100.77 129.01 46.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.477 ' N ' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -100.86 119.95 39.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.045 0.45 . . . . 0.0 111.637 -178.154 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.756 ' CE1' HD22 ' A' ' 84' ' ' LEU . 72.6 m-85 -111.55 158.16 19.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.248 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -133.79 139.69 46.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.262 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.775 HD12 HD11 ' A' ' 98' ' ' ILE . 7.0 mm -67.64 120.72 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.13 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -90.89 -62.68 1.4 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.613 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.541 ' O ' HD13 ' A' ' 98' ' ' ILE . 58.6 tttp -148.98 143.35 26.07 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.143 0.497 . . . . 0.0 110.247 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.775 HD11 HD12 ' A' ' 95' ' ' ILE . 14.8 mm -117.67 129.72 73.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.792 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.425 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 19.7 p90 -150.35 -176.71 5.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.031 0.443 . . . . 0.0 111.352 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.547 HG22 ' HB3' ' A' ' 133' ' ' ASP . 4.9 mt -126.04 132.63 70.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.4 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.584 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 3.1 t -131.84 171.32 13.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.839 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.42 ' O ' HG23 ' A' ' 101' ' ' THR . 0.7 OUTLIER -72.97 162.1 29.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.728 -179.754 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.13 -11.37 60.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.62 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -104.14 16.6 25.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.686 ' OD1' HG23 ' A' ' 107' ' ' THR . 31.6 t0 -86.31 101.42 13.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 110.377 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 109' ' ' ILE . 33.7 ptt180 -72.62 -21.32 61.13 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.799 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.686 HG23 ' OD1' ' A' ' 105' ' ' ASP . 21.3 p -45.73 -20.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.884 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 105' ' ' ASP . 10.6 m -101.42 -17.2 6.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.047 0.451 . . . . 0.0 110.291 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.834 ' O ' HG21 ' A' ' 50' ' ' VAL . 47.8 mm -109.89 23.36 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.657 HD12 ' CE1' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -89.01 -162.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -111.46 143.15 42.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.724 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -131.07 145.39 52.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.575 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -87.48 12.62 11.83 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.109 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.75 165.72 26.33 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.966 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.54 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 52.6 Cg_endo -78.87 98.52 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.854 2.369 . . . . 0.0 111.605 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.3 mm -126.02 131.66 71.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.331 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.897 HD12 HD21 ' A' ' 84' ' ' LEU . 9.6 tt -102.4 121.3 42.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.368 0.604 . . . . 0.0 110.203 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.8 m -117.52 106.18 12.88 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.491 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.995 HD12 ' N ' ' A' ' 120' ' ' THR . 0.1 OUTLIER -100.85 127.41 47.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.046 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.995 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -119.69 137.35 53.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.451 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.721 ' CG2' HD11 ' A' ' 119' ' ' LEU . 5.8 p . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.046 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.547 ' HB3' HG22 ' A' ' 100' ' ' ILE . 78.0 m-20 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.757 0.313 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -117.36 133.11 56.35 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.52 ' CE2' HD11 ' A' ' 137' ' ' ILE . 2.8 t80 -70.12 135.41 49.15 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.2 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.528 ' CG1' HG22 ' A' ' 101' ' ' THR . 43.5 mm -121.84 116.03 48.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.455 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.721 HD13 HG23 ' A' ' 98' ' ' ILE . 40.4 mm -101.76 108.42 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -97.65 138.36 35.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.107 0.479 . . . . 0.0 111.1 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.45 28.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.862 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.536 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 28.2 ttpt -121.97 157.59 30.95 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.024 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.804 HD23 ' N ' ' A' ' 142' ' ' THR . 3.9 tt -81.67 122.09 27.19 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.64 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.804 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -98.47 -40.37 8.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.709 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -150.76 155.13 26.01 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.14 158.19 45.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 111.277 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' THR . 95.2 m-85 -135.07 146.47 48.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.688 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.577 ' O ' ' O ' ' A' ' 147' ' ' LYS . 96.2 p -129.57 114.37 15.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.19 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.577 ' O ' ' O ' ' A' ' 146' ' ' SER . 55.0 tttt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.592 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.694 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER . . . . . 0 CA--C 1.526 0.053 0 CA-C-O 120.83 0.348 . . . . 0.0 110.565 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.559 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 54.1 mp0 -86.61 147.01 26.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.83 18.69 55.86 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.694 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 1.0 OUTLIER -123.65 131.13 53.54 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.842 0.354 . . . . 0.0 110.449 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.585 ' N ' ' CD2' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.4 100.97 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.023 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.446 HG11 ' HB2' ' A' ' 32' ' ' TRP . 13.0 m -100.34 -30.49 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.092 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.4 158.34 43.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.723 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.9 ttm -119.47 139.61 51.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.448 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 tp -105.53 113.84 27.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.475 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -107.13 126.04 51.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.245 0.545 . . . . 0.0 110.726 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 24' ' ' LEU . 10.3 mt -103.95 114.08 64.82 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.138 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.511 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.4 Cg_endo -77.33 -47.51 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.984 2.456 . . . . 0.0 112.871 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.573 ' C ' HD22 ' A' ' 24' ' ' LEU . 50.5 tptt -59.47 -40.51 87.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.574 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.798 HD22 ' N ' ' A' ' 24' ' ' LEU . 2.8 mm? -98.43 -3.57 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.582 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 52.87 39.77 29.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.972 0.415 . . . . 0.0 110.642 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.83 152.44 37.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.832 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -128.96 142.31 50.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.853 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -135.67 150.41 49.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.801 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.1 m -98.96 115.78 29.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.583 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.48 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.3 mp -93.14 127.03 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.63 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 15' ' ' LYS . 33.6 m-85 -107.55 143.1 36.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.869 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.598 ' HZ2' HG23 ' A' ' 47' ' ' VAL . 47.3 t-105 -61.84 127.29 30.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.736 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 89.1 168.21 43.59 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.915 179.499 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.766 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -104.27 139.25 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.72 0.295 . . . . 0.0 110.587 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.766 ' N ' ' SD ' ' A' ' 45' ' ' MET . 40.5 t80 -76.7 120.59 22.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.127 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.598 HG23 ' HZ2' ' A' ' 32' ' ' TRP . 2.2 p -97.53 120.37 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.661 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.21 166.53 32.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.414 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.51 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 41.0 t0 -64.07 -33.98 77.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.548 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.595 HG21 ' HA ' ' A' ' 110' ' ' ILE . 4.1 m -84.82 -41.62 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 110.863 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.52 ' N ' HG23 ' A' ' 50' ' ' VAL . 44.2 p -77.5 161.47 27.9 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.724 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.508 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -156.22 169.75 23.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.905 0.383 . . . . 0.0 110.587 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.402 ' H ' HG23 ' A' ' 53' ' ' THR . 0.1 OUTLIER -88.89 153.86 49.73 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.587 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.689 ' HG3' HD23 ' A' ' 84' ' ' LEU . 56.6 Cg_endo -73.23 85.56 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.874 2.383 . . . . 0.0 112.314 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -118.95 4.41 11.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.62 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.94 89.95 0.26 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.5 85.58 0.05 OUTLIER Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.44 161.91 35.31 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.714 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 12.3 t-160 -81.36 121.03 25.7 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.2 m -114.9 122.9 47.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.188 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.552 ' O ' HD22 ' A' ' 62' ' ' LEU . 39.9 t -115.98 128.61 73.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.338 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.552 HD22 ' O ' ' A' ' 61' ' ' VAL . 1.9 mm? -113.82 145.64 41.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.232 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.7 t -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.647 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.651 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' A' ' 24' ' ' LEU . . . . . . . . 0 CA--C 1.528 0.868 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -70.06 -39.44 75.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.935 0.398 . . . . 0.0 110.792 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.442 HD23 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -101.44 98.02 8.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.772 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.523 ' O ' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER 178.01 148.71 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.116 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -78.13 -13.83 59.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.54 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -83.17 -15.69 49.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.414 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.55 153.16 41.44 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.652 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.511 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -141.95 121.53 13.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.088 0.471 . . . . 0.0 109.8 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.2 mt -98.39 133.34 42.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.545 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.463 ' C ' HD12 ' A' ' 84' ' ' LEU . 3.1 t -111.92 122.62 66.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.927 0.394 . . . . 0.0 110.25 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.689 HD23 ' HG3' ' A' ' 54' ' ' PRO . 8.5 mp -102.33 124.45 47.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.105 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -101.22 115.22 29.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.093 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.632 ' O ' ' N ' ' A' ' 89' ' ' LYS . 5.6 t80 -144.55 143.07 30.64 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.812 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 86' ' ' TYR . 38.9 t70 38.05 52.64 1.57 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.738 0.304 . . . . 0.0 111.407 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 58.1 9.87 1.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.395 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.632 ' N ' ' O ' ' A' ' 86' ' ' TYR . 53.4 mtmt -104.57 143.72 32.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.55 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.438 HG22 HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -116.85 122.56 44.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.844 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -109.88 127.95 55.04 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.533 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -96.47 109.25 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.393 -179.65 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.606 ' CE1' HD22 ' A' ' 84' ' ' LEU . 52.9 m-85 -99.06 155.15 17.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.991 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -131.38 130.02 42.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.194 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.526 ' CD1' ' CG2' ' A' ' 137' ' ' ILE . 4.9 mm -61.11 119.32 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.648 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -89.79 -65.8 0.98 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.757 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -147.16 138.15 23.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.454 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.459 HG23 HG13 ' A' ' 137' ' ' ILE . 1.3 mp -113.62 133.27 60.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.404 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 18.6 p90 -153.48 -178.68 7.16 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.929 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.8 mp -125.27 129.67 73.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.491 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.539 HG22 ' CG1' ' A' ' 136' ' ' ILE . 4.8 t -128.85 172.94 10.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.673 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -73.9 153.41 39.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.69 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.95 -34.51 76.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.524 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -78.98 18.75 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.677 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -89.22 99.09 12.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.326 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.945 ' O ' HG23 ' A' ' 110' ' ' ILE . 23.1 ptt85 -80.15 -19.42 47.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.779 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.445 ' O ' HD12 ' A' ' 110' ' ' ILE . 6.8 p -48.1 -18.25 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.957 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.554 ' HB ' HG21 ' A' ' 118' ' ' THR . 4.1 m -110.52 -9.35 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.287 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.689 HG22 ' O ' ' A' ' 109' ' ' ILE . 39.2 mm -104.95 1.33 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.033 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.945 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -77.72 -167.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 12.6 ptmt -99.88 151.66 21.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.774 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.605 ' H ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -125.45 134.94 51.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.303 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -78.31 6.96 7.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.221 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.09 164.16 33.4 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.429 ' O ' HD13 ' A' ' 116' ' ' ILE . 36.4 Cg_endo -71.41 96.17 0.72 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.192 2.595 . . . . 0.0 112.155 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 115' ' ' PRO . 50.9 mm -128.98 133.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.46 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.834 ' C ' HD23 ' A' ' 117' ' ' LEU . 5.7 tt -106.69 120.36 41.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.161 0.505 . . . . 0.0 110.316 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.554 HG21 ' HB ' ' A' ' 108' ' ' VAL . 91.1 m -118.34 119.09 33.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.158 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.868 HD23 ' N ' ' A' ' 120' ' ' THR . 5.6 tt -105.73 127.81 53.31 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.609 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.868 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -120.83 117.76 28.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.817 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.651 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.7 t . . . . . 0 CA--C 1.514 -0.423 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.729 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.737 0.303 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -117.22 132.87 56.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.922 0.391 . . . . 0.0 110.411 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.621 ' HD2' HD11 ' A' ' 137' ' ' ILE . 5.3 t80 -75.79 125.96 30.08 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.915 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.675 ' C ' HD12 ' A' ' 137' ' ' ILE . 4.2 mm -112.91 118.59 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.91 0.386 . . . . 0.0 111.94 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.943 HD12 ' N ' ' A' ' 137' ' ' ILE . 1.3 mp -110.42 107.04 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -90.98 136.58 32.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.382 0.611 . . . . 0.0 111.344 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.2 36.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.911 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.522 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 50.9 tptt -111.69 139.85 46.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.352 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.711 HD13 ' C ' ' A' ' 141' ' ' LEU . 2.2 tm? -75.5 114.87 14.55 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.707 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.605 ' OG1' ' N ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -97.74 -65.39 0.97 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.273 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.605 ' N ' ' OG1' ' A' ' 142' ' ' THR . . . -101.41 151.19 18.66 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.257 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 89.9 p -137.35 126.91 25.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.93 0.395 . . . . 0.0 110.428 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -118.74 146.48 44.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.677 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.2 p -133.94 130.1 37.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.574 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.609 -179.962 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.607 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 12.5 tmtt? . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.839 0.352 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.467 ' OE2' ' NE1' ' A' ' 32' ' ' TRP . 9.0 mp0 -81.38 109.28 15.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.141 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 129.05 24.69 1.04 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.607 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -127.29 131.8 50.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.801 0.334 . . . . 0.0 110.458 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 96.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.986 0.422 . . . . 0.0 110.285 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 14' ' ' GLU . 5.6 m -100.71 -38.31 6.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.921 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.95 157.85 45.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 32.0 ttm -125.35 136.16 53.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.441 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.409 HD12 HD21 ' A' ' 84' ' ' LEU . 1.9 tt -101.72 119.05 38.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.19 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -111.89 137.73 49.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.367 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -119.26 112.96 35.59 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.892 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 81' ' ' THR . 56.3 Cg_endo -75.16 -40.26 0.91 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.882 2.388 . . . . 0.0 112.929 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.507 ' HB3' HD22 ' A' ' 24' ' ' LEU . 4.5 tmtt? -65.06 -37.57 88.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.716 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.62 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.7 mm? -96.24 3.02 53.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.738 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER 45.69 57.12 5.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HD3' ' CE2' ' A' ' 28' ' ' PHE . 18.1 ptpt -157.26 173.91 16.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.969 0.414 . . . . 0.0 110.629 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.01 158.09 43.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.619 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.455 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 87.7 m-85 -133.37 154.22 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.738 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.1 m -95.21 112.48 24.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.835 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.546 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.2 mp -93.79 122.04 44.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.425 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -102.71 146.1 28.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TRP . . . . . 0.469 ' O ' ' N ' ' A' ' 13' ' ' GLY . 51.6 t-105 -62.56 125.08 22.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.557 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.67 142.98 4.58 Favored Glycine 0 N--CA 1.46 0.291 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.376 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.623 179.791 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.574 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.504 ' HE2' ' O ' ' A' ' 46' ' ' PHE . 2.1 ttp -98.74 129.09 45.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.504 ' O ' ' HE2' ' A' ' 45' ' ' MET . 19.3 t80 -65.12 131.12 45.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.393 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.469 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.0 p -113.7 124.18 70.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.667 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.65 ' N ' ' OG1' ' A' ' 51' ' ' THR . 36.3 t -158.02 174.31 15.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.563 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -67.65 -13.75 62.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.602 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.71 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.5 m -111.17 -14.1 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.892 0.377 . . . . 0.0 110.556 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.65 ' OG1' ' N ' ' A' ' 48' ' ' SER . 29.3 p -104.32 141.22 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -142.18 167.48 22.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.473 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.406 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -83.11 162.65 53.81 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.917 -179.515 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -82.58 83.08 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.681 2.254 . . . . 0.0 112.437 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 55' ' ' SER . 0.9 OUTLIER -117.77 7.71 12.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.654 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.16 87.28 0.36 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.76 92.64 0.04 OUTLIER Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.526 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -170.25 160.09 32.78 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.689 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 19.2 t-160 -82.61 114.2 20.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.458 HG22 ' CD2' ' A' ' 62' ' ' LEU . 21.6 m -111.47 120.87 43.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.253 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.893 HG11 ' CD1' ' A' ' 109' ' ' ILE . 65.2 t -114.6 125.66 71.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 109.806 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.621 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.7 mm? -108.55 143.26 37.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.567 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.3 t -126.87 138.28 53.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.712 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.53 1.014 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 24' ' ' LEU . . . . . . . . 0 CA--C 1.524 0.626 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -87.17 -43.42 12.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 110.68 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.823 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.6 pp -108.47 103.99 13.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 111.218 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . 0.546 ' HG3' ' H ' ' A' ' 80' ' ' ASP . 2.3 ptmt 177.91 137.02 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.246 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.31 -17.62 62.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.058 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -79.49 -13.94 59.23 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.367 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.657 ' OD1' ' N ' ' A' ' 81' ' ' THR . 1.0 OUTLIER -70.65 155.35 40.85 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.935 -179.609 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.657 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -142.64 119.16 10.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.025 0.441 . . . . 0.0 109.981 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.9 mt -95.66 129.05 42.98 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.837 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.516 ' C ' HD22 ' A' ' 84' ' ' LEU . 21.3 t -113.43 118.1 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.033 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.516 HD22 ' C ' ' A' ' 83' ' ' VAL . 4.1 mm? -105.45 135.36 46.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.458 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.481 ' HG2' HG23 ' A' ' 90' ' ' THR . 95.9 mt-10 -106.48 123.73 48.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.946 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 87' ' ' ASP . 21.9 t80 -143.4 131.03 21.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.261 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 86' ' ' TYR . 8.6 t0 49.45 49.02 20.54 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.315 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 63.43 11.27 5.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.471 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 44.3 mtmt -109.94 145.24 37.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.987 0.423 . . . . 0.0 110.288 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.507 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -112.33 123.64 50.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.909 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -104.48 132.87 50.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.295 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.97 111.1 23.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.164 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 80.4 m-85 -109.6 150.36 28.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.48 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -131.18 140.38 49.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.827 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 95' ' ' ILE . 14.4 mm -60.76 122.23 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.557 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -104.02 -50.48 3.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.859 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 15.3 tptm -154.27 132.51 11.86 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.192 0.52 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 76' ' ' LEU . 71.9 mt -122.04 132.84 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.475 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 30.2 p90 -153.73 -176.06 5.66 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.797 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.729 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.8 mp -127.75 129.61 70.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.4 t -134.39 -171.12 2.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.694 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' HIS . . . . . 0.404 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 93.2 m-70 -78.31 153.89 31.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.14 -30.8 71.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.609 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -88.63 14.22 10.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.731 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.896 ' O ' HG22 ' A' ' 108' ' ' VAL . 3.8 t70 -75.58 94.34 3.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.039 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.728 ' O ' ' N ' ' A' ' 109' ' ' ILE . 30.6 ptt-85 -64.78 -34.28 77.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.664 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.652 ' O ' HD11 ' A' ' 110' ' ' ILE . 3.1 p -35.63 -25.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.93 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 105' ' ' ASP . 28.6 m -98.15 -24.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 110.801 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.893 ' CD1' HG11 ' A' ' 61' ' ' VAL . 8.1 mm -104.89 27.34 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.637 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.689 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.8 OUTLIER -90.85 -162.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.408 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -107.39 137.9 44.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.769 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.2 mttt -126.36 143.4 51.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.18 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.6 ' N ' ' OE2' ' A' ' 114' ' ' GLU . 15.0 mt-10 -90.97 11.4 22.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.569 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.6 ' OE2' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -136.7 168.68 15.91 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 110.589 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PRO . . . . . 0.526 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 51.7 Cg_endo -78.44 90.46 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.164 2.576 . . . . 0.0 112.251 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.484 HG21 ' HZ3' ' A' ' 112' ' ' LYS . 50.8 mm -122.57 129.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.757 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.806 ' C ' HD23 ' A' ' 117' ' ' LEU . 6.5 tt -104.08 122.26 44.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.71 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.639 HG21 ' HB ' ' A' ' 108' ' ' VAL . 19.6 m -114.27 113.61 24.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.13 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 120' ' ' THR . 1.8 tt -104.27 116.23 31.8 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.699 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.734 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -112.52 129.29 56.4 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.42 0.45 . . . . 0.0 110.196 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.616 HG23 ' CD2' ' A' ' 119' ' ' LEU . 71.4 p . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.397 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.82 0.343 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -123.53 134.61 53.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.209 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.578 ' CD2' HD11 ' A' ' 137' ' ' ILE . 4.2 t80 -87.43 125.14 34.1 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -122.16 128.52 75.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.016 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.578 HD11 ' CD2' ' A' ' 135' ' ' TYR . 7.2 mm -106.87 111.76 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.036 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 97' ' ' LYS . 67.5 tt0 -94.27 138.48 32.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.507 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -148.75 149.02 30.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.655 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -114.43 152.66 31.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.188 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' LEU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 11.2 tp -77.07 115.61 17.01 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.702 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.63 -42.18 12.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.123 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.404 ' O ' HD11 ' A' ' 141' ' ' LEU . . . -142.73 171.6 24.74 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 56.4 p -147.08 151.39 36.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 110.41 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -136.58 160.75 37.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.688 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.588 ' O ' ' C ' ' A' ' 147' ' ' LYS . 7.9 p -150.74 125.56 9.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.45 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.588 ' C ' ' O ' ' A' ' 146' ' ' SER . 17.4 tttm . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.471 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.9 p -108.94 9.48 26.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.684 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -54.73 -39.22 68.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.698 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.3 mtp -79.01 141.12 37.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.567 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.3 m -130.15 155.02 46.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.446 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.1 t -125.48 139.75 53.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.636 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.53 ' C ' ' OG1' ' A' ' 8' ' ' THR . 65.2 tt0 -151.73 93.6 1.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.594 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.53 ' OG1' ' C ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER 172.93 -37.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.56 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.679 ' OE1' ' CE1' ' A' ' 10' ' ' HIS . 9.2 mm-40 -97.84 153.41 18.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.486 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.679 ' CE1' ' OE1' ' A' ' 9' ' ' GLU . 1.2 p-80 -48.39 109.97 0.29 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.616 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -134.37 143.24 47.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.446 ' HG3' ' CD1' ' A' ' 32' ' ' TRP . 2.3 mp0 -59.85 137.87 57.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.356 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.29 9.17 70.34 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -115.49 141.25 48.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.839 0.352 . . . . 0.0 110.429 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 84.3 tttt -67.82 113.6 5.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.228 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.3 m -111.8 -37.22 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.028 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.494 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -141.36 158.33 44.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.665 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 44.9 ttp -118.05 138.42 52.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.415 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.487 HD12 HD11 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -102.42 121.9 43.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.077 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -122.46 135.29 54.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.119 0.485 . . . . 0.0 111.07 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.523 HG22 ' H ' ' A' ' 24' ' ' LEU . 3.8 mt -110.82 118.01 49.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.291 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD3' HG23 ' A' ' 83' ' ' VAL . 57.5 Cg_endo -75.58 -48.5 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.832 2.355 . . . . 0.0 112.728 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.54 ' C ' HD22 ' A' ' 24' ' ' LEU . 11.7 tptt -60.21 -44.93 94.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.815 HD22 ' N ' ' A' ' 24' ' ' LEU . 2.8 mm? -96.53 3.03 52.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.618 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.41 38.96 1.95 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.719 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HZ2' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -112.22 145.06 40.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.356 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.37 144.06 50.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -140.23 141.88 35.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.661 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.546 ' C ' HD12 ' A' ' 30' ' ' ILE . 5.0 p -86.68 121.21 28.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.712 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.559 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.1 mp -103.63 120.66 54.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.549 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 32.2 m-85 -106.2 150.31 25.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.727 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CD1' ' HG3' ' A' ' 12' ' ' GLU . 33.2 t-105 -60.12 128.63 37.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.696 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.29 160.51 12.3 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.28 86.12 2.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.586 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -78.37 113.44 16.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.894 0.378 . . . . 0.0 110.592 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.574 ' OD1' ' O ' ' A' ' 36' ' ' ASP . 67.2 t0 -84.46 -16.56 42.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.528 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.82 92.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.469 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.518 ' C ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -109.68 140.31 43.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.605 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.68 HD22 ' N ' ' A' ' 39' ' ' LEU . 2.8 mm? -93.58 13.04 23.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.542 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -55.4 -58.4 7.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.044 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -79.86 169.21 18.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.691 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.47 -53.07 0.57 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.49 131.21 73.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.166 0.507 . . . . 0.0 110.724 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.78 155.65 21.71 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.766 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -96.57 134.82 39.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.728 0.299 . . . . 0.0 110.576 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.766 ' N ' ' SD ' ' A' ' 45' ' ' MET . 1.9 t80 -64.02 132.55 50.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.712 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.56 120.24 61.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.558 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.525 ' N ' ' OG1' ' A' ' 51' ' ' THR . 43.2 p -160.69 169.66 22.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.498 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.554 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 47.8 t0 -62.45 -10.67 12.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.625 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.5 m -112.11 -34.25 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.71 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' A' ' 48' ' ' SER . 65.7 p -85.14 138.27 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.582 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.3 t -139.83 174.23 10.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.565 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.416 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -89.38 158.28 46.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.38 83.69 1.98 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.664 2.243 . . . . 0.0 112.694 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.9 p -118.83 -2.1 10.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.79 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.21 86.2 0.06 OUTLIER Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.59 101.55 0.01 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.513 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -178.42 165.32 34.52 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.696 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 16.2 t-160 -83.7 110.21 18.11 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.4 m -105.82 120.9 42.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.844 0.354 . . . . 0.0 110.426 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.615 ' C ' HD22 ' A' ' 62' ' ' LEU . 61.9 t -117.7 131.56 70.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.195 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.615 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.8 mm? -111.25 139.44 46.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.596 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 t -122.59 129.4 51.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.733 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.639 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -154.59 176.49 32.35 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -126.29 159.89 31.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.783 0.325 . . . . 0.0 110.717 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.795 HH12 HG22 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -105.42 127.99 53.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.423 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -108.95 -66.27 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.714 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 69' ' ' VAL . 0.4 OUTLIER -129.83 177.15 7.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.597 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.795 HG22 HH12 ' A' ' 66' ' ' ARG . 53.0 t -110.25 127.79 66.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.281 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -143.07 -67.94 0.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.529 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.606 ' HB ' HD12 ' A' ' 24' ' ' LEU . 19.5 p -113.38 20.49 16.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.438 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.645 ' OD1' ' N ' ' A' ' 73' ' ' LEU . 41.8 p-10 -58.21 -28.4 64.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.397 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.645 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 10.3 tt -62.9 -39.64 95.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.865 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.24 -20.08 55.74 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -68.83 -44.09 74.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.697 0.284 . . . . 0.0 110.656 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.555 HD22 ' HE2' ' A' ' 135' ' ' TYR . 5.3 mt -90.82 92.95 9.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.952 0.406 . . . . 0.0 110.352 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.534 ' HG3' ' H ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -174.73 147.67 1.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.06 -11.72 60.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.755 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.534 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 3.8 mtpt -84.13 -15.61 46.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.382 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.66 157.28 28.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.475 ' O ' HD23 ' A' ' 82' ' ' LEU . 1.8 p -137.02 149.87 47.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.969 0.414 . . . . 0.0 109.992 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 81' ' ' THR . 35.9 mt -118.8 120.07 36.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.224 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.65 ' C ' HD22 ' A' ' 84' ' ' LEU . 14.9 t -102.76 124.57 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.949 0.404 . . . . 0.0 110.642 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.65 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.2 mm? -113.0 133.16 55.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.127 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.531 ' HG2' HG23 ' A' ' 90' ' ' THR . 97.6 mt-10 -106.09 119.33 38.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.494 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.1 t80 -143.2 127.05 17.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.266 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 57.08 44.32 22.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.854 0.359 . . . . 0.0 111.194 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 64.32 15.62 9.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.486 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 6.4 mtmp? -116.4 140.85 48.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.185 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.65 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -108.65 124.46 50.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 15.8 m-85 -104.06 129.68 51.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 117.75 35.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 111.127 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.454 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 89.7 m-85 -112.34 163.83 13.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.593 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -139.04 133.86 32.21 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.824 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 77' ' ' LYS . 0.9 OUTLIER -65.52 123.78 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.201 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -99.89 -47.93 4.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.996 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -153.32 139.28 18.16 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.099 0.476 . . . . 0.0 110.532 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mt -116.51 130.58 71.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.539 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.499 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 20.0 p90 -151.62 -175.88 5.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.473 HG12 ' CD1' ' A' ' 135' ' ' TYR . 6.9 mt -129.31 135.21 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.498 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.539 HG22 HG13 ' A' ' 136' ' ' ILE . 6.5 t -134.86 171.23 14.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.665 ' ND1' ' O ' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -73.77 158.11 35.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.459 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.465 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . . . -69.53 -11.44 60.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.701 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.554 ' OD1' ' C ' ' A' ' 104' ' ' ASP . 12.4 p30 -100.82 15.51 28.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.694 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.405 ' OD2' ' OG1' ' A' ' 101' ' ' THR . 39.8 t0 -79.15 94.28 5.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.973 0.416 . . . . 0.0 110.594 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.48 ' O ' HG13 ' A' ' 110' ' ' ILE . 52.3 ptt85 -74.82 -20.51 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.524 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.787 ' O ' HD11 ' A' ' 110' ' ' ILE . 5.9 p -60.08 -26.28 66.06 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.313 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.831 ' CG1' HG21 ' A' ' 118' ' ' THR . 21.5 t -95.82 -4.83 10.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.809 HG22 ' O ' ' A' ' 109' ' ' ILE . 42.5 mm -118.78 14.05 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.03 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.787 HD11 ' O ' ' A' ' 107' ' ' THR . 0.7 OUTLIER -79.61 -160.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.71 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.401 ' H ' ' HB ' ' A' ' 110' ' ' ILE . 24.1 ttmt -99.24 149.64 22.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.378 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.489 ' N ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -129.73 126.24 37.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 113' ' ' GLU . 68.8 tt0 -76.6 7.65 4.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.028 0.442 . . . . 0.0 110.117 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.14 164.08 43.14 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.542 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.513 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 44.6 Cg_endo -76.33 87.81 1.4 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.961 2.44 . . . . 0.0 111.888 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.5 mm -119.1 130.47 73.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.968 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.83 ' C ' HD23 ' A' ' 117' ' ' LEU . 6.0 tt -103.56 118.57 37.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.149 0.5 . . . . 0.0 110.884 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.831 HG21 ' CG1' ' A' ' 108' ' ' VAL . 96.9 m -117.78 124.31 48.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.228 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 1.009 HD12 ' N ' ' A' ' 120' ' ' THR . 0.5 OUTLIER -106.44 122.7 46.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.493 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . 1.009 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -121.08 120.48 35.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.236 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.639 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.4 t -150.75 -179.11 6.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.158 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.617 ' SG ' ' C ' ' A' ' 121' ' ' THR . 1.2 p 157.25 -77.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.926 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.575 ' C ' ' O ' ' A' ' 122' ' ' CYS . 10.2 m-85 20.68 70.01 0.26 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.815 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.653 ' HD2' ' HB2' ' A' ' 131' ' ' ALA . 57.7 Cg_endo -76.67 153.6 34.17 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.913 2.408 . . . . 0.0 112.172 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.558 ' CE2' ' OD1' ' A' ' 126' ' ' ASP . 24.2 p90 -59.32 -32.67 70.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.445 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.558 ' OD1' ' CE2' ' A' ' 125' ' ' PHE . 38.6 m-20 -59.78 -44.13 94.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.472 ' CE1' ' O ' ' A' ' 128' ' ' ILE . 40.7 t80 -102.88 138.6 39.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.592 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.472 ' O ' ' CE1' ' A' ' 127' ' ' TYR . 96.6 mt -100.25 128.36 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.311 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.6 -141.95 15.88 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -89.36 101.77 14.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.509 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.653 ' HB2' ' HD2' ' A' ' 124' ' ' PRO . . . -48.0 150.92 1.84 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.56 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.665 ' O ' ' ND1' ' A' ' 102' ' ' HIS . 25.9 Cg_endo -61.51 -49.98 6.42 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.922 2.415 . . . . 0.0 111.996 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -109.56 116.03 31.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.434 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 103' ' ' ALA . 10.6 ptp180 -101.31 144.42 30.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.785 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.555 ' HE2' HD22 ' A' ' 76' ' ' LEU . 4.5 t80 -76.42 135.04 39.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.872 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.539 HG13 HG22 ' A' ' 101' ' ' THR . 5.1 mm -120.14 124.15 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 137' ' ' ILE . 1.2 mp -112.91 109.5 28.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.499 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 22.7 tp10 -94.19 136.78 34.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.143 0.497 . . . . 0.0 110.89 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.59 148.98 31.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.973 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 79.2 tttt -116.2 155.23 28.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.06 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.454 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 11.8 tp -78.86 122.53 26.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.009 0.433 . . . . 0.0 110.478 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.66 -38.13 6.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.782 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -143.29 159.67 27.51 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.9 p -144.61 149.51 35.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.764 0.316 . . . . 0.0 110.457 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 90' ' ' THR . 93.0 m-85 -128.97 153.8 47.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.598 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 77.4 p -146.86 126.99 13.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.729 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.591 179.995 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.478 ' C ' ' ND1' ' A' ' 3' ' ' HIS . 38.5 m -154.03 168.01 27.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 0.0 110.54 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.478 ' ND1' ' C ' ' A' ' 2' ' ' SER . 12.6 m80 72.68 85.34 0.12 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.458 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 30.6 ttm -80.33 147.96 30.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.488 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.638 ' H ' ' NZ ' ' A' ' 11' ' ' LYS . 10.7 t 63.95 -82.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.533 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.518 ' O ' ' C ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER 63.2 -1.32 0.54 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.516 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.618 ' CG ' ' H ' ' A' ' 8' ' ' THR . 2.5 tp60 29.31 -144.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.574 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.618 ' H ' ' CG ' ' A' ' 7' ' ' GLN . 75.3 p 51.8 -163.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.468 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.547 ' C ' ' O ' ' A' ' 8' ' ' THR . 44.9 mm-40 27.38 -98.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.005 0.431 . . . . 0.0 110.685 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.575 ' O ' ' OE1' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -154.45 -116.88 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.389 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.638 ' NZ ' ' H ' ' A' ' 5' ' ' SER . 64.1 tttt 87.55 159.06 0.07 Allowed 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -91.61 149.39 21.68 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 89.71 10.23 65.37 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.611 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -113.64 133.95 55.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.843 0.354 . . . . 0.0 110.412 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.48 106.24 0.52 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.289 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.4 HG23 ' N ' ' A' ' 17' ' ' ALA . 17.5 m -109.28 -40.53 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.971 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.426 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -128.17 160.32 32.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.7 ttp -123.7 147.1 47.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.189 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.8 tp -112.56 123.39 50.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.68 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -118.02 128.38 54.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.963 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.1 mt -106.42 106.34 57.15 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 81' ' ' THR . 55.6 Cg_endo -76.33 -40.39 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.82 2.347 . . . . 0.0 112.851 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.564 ' C ' HD22 ' A' ' 24' ' ' LEU . 48.4 tptt -58.48 -43.55 89.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.614 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.799 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.0 mm? -99.58 -0.03 41.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.569 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.25 49.49 17.07 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.593 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -127.66 165.42 20.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.402 . . . . 0.0 110.839 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -140.59 145.82 37.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.103 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -142.6 145.47 33.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.861 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -90.01 129.18 36.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.188 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.421 HD12 ' CD1' ' A' ' 62' ' ' LEU . 37.0 mm -103.23 119.58 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.004 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -102.36 142.71 33.13 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.967 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.51 ' CZ2' ' HB ' ' A' ' 47' ' ' VAL . 46.0 t-105 -60.63 119.36 7.96 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.855 0.36 . . . . 0.0 110.611 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 83.08 159.53 27.54 Favored Glycine 0 C--N 1.332 0.307 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.14 97.92 7.45 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.729 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -94.42 110.29 22.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.895 0.379 . . . . 0.0 111.02 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -78.67 -20.06 51.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.589 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.51 -29.97 68.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.525 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -104.36 128.29 52.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.395 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.538 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 3.1 mm? -83.9 -3.1 57.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.371 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 41' ' ' LYS . 27.1 tttt -71.64 133.44 45.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.134 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.589 ' C ' ' H ' ' A' ' 43' ' ' VAL . 68.7 mttm 24.78 85.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.599 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.27 13.57 0.16 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.589 ' H ' ' C ' ' A' ' 41' ' ' LYS . 2.5 t -90.92 99.52 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.385 0.612 . . . . 0.0 110.294 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.68 168.77 21.03 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.401 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 35.0 ttm -108.19 128.19 54.49 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.59 128.67 36.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.884 0.373 . . . . 0.0 110.565 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.51 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 1.1 m -109.35 133.67 53.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.71 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.696 ' N ' ' OG1' ' A' ' 51' ' ' THR . 12.9 m -161.5 177.17 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.576 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.559 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 46.5 t0 -67.7 -10.2 50.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.43 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 109' ' ' ILE . 4.6 m -118.1 -28.52 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.816 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.696 ' OG1' ' N ' ' A' ' 48' ' ' SER . 39.1 p -83.07 141.11 32.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.584 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 t -142.71 177.2 8.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.723 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.8 160.43 29.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.649 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.717 ' HG3' HD13 ' A' ' 84' ' ' LEU . 64.9 Cg_endo -77.53 83.1 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.863 2.375 . . . . 0.0 112.39 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.7 p -120.95 -1.51 9.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.25 90.96 0.15 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.72 86.85 0.04 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 115' ' ' PRO . . . -163.04 155.62 27.04 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.686 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 17.5 t-160 -79.43 112.17 16.41 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 m -104.28 127.0 51.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.526 ' C ' HD22 ' A' ' 62' ' ' LEU . 71.1 t -119.19 128.97 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 0.0 110.249 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.526 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.6 mm? -111.19 142.84 42.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.608 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.5 t -127.29 136.24 51.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.615 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -150.13 95.87 0.16 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.686 ' CG ' ' OD2' ' A' ' 126' ' ' ASP . 0.3 OUTLIER -70.66 139.13 51.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.625 ' CB ' ' O ' ' A' ' 65' ' ' HIS . 47.2 ttt-85 94.12 151.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.565 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 68' ' ' THR . 50.2 t0 -64.66 155.08 34.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.568 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.554 ' CB ' HE22 ' A' ' 75' ' ' GLN . 39.8 p -74.11 168.97 18.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.34 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 69' ' ' VAL . 8.3 p -99.49 114.38 37.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.502 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.528 ' O ' ' O ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER 33.19 -156.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.658 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 p 42.27 34.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.507 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.63 -42.38 99.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.602 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.534 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -62.63 -39.71 94.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.409 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.73 -40.64 97.57 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.554 HE22 ' CB ' ' A' ' 68' ' ' THR . 52.7 mt-30 -66.24 -40.36 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.694 0.283 . . . . 0.0 110.963 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.86 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.9 pp -100.52 108.71 20.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.186 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 14.7 ptmt 173.77 145.04 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.374 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -72.78 -14.06 61.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -83.0 -15.72 50.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.891 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.17 160.99 20.07 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.922 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.472 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -150.01 119.99 7.17 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.026 0.441 . . . . 0.0 109.973 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.5 131.77 43.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.074 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 43.8 t -112.94 130.32 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.015 0.436 . . . . 0.0 110.458 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.87 HD11 HD12 ' A' ' 117' ' ' LEU . 39.0 mt -113.01 126.47 55.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.53 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -104.45 116.49 32.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.442 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.426 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.3 t80 -149.09 131.4 15.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.852 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.4 t70 60.78 42.44 13.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.352 . . . . 0.0 111.241 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 61.34 15.69 6.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.021 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -115.2 146.97 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.496 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -115.74 123.35 48.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.936 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.433 ' HB3' ' CD1' ' A' ' 141' ' ' LEU . 20.2 m-85 -106.28 137.09 44.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.682 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.99 120.22 41.68 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.035 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.533 ' CE1' HD12 ' A' ' 84' ' ' LEU . 71.4 m-85 -112.91 155.65 24.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.729 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -130.3 138.73 50.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.59 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.2 mm -63.63 121.41 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.23 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -98.55 -52.8 3.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.933 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -150.46 141.49 23.0 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.465 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.511 HG23 HD12 ' A' ' 137' ' ' ILE . 76.3 mt -121.7 130.82 74.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.835 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -153.08 -176.15 5.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 110.854 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.46 HG22 ' CB ' ' A' ' 133' ' ' ASP . 4.5 mt -128.25 131.71 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.5 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.71 169.46 17.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 110.895 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.41 148.39 45.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.985 0.421 . . . . 0.0 110.452 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 134' ' ' ARG . . . -63.13 -19.48 64.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.629 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -88.96 11.8 17.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -84.9 88.4 7.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.375 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.838 ' O ' HG23 ' A' ' 110' ' ' ILE . 6.9 ptp85 -60.42 -31.82 70.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.485 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.496 ' O ' HD12 ' A' ' 110' ' ' ILE . 5.7 p -44.52 -14.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.25 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.886 HG12 HG21 ' A' ' 118' ' ' THR . 4.8 t -108.12 -16.43 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.044 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.763 HG22 ' O ' ' A' ' 109' ' ' ILE . 47.3 mm -107.51 12.16 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.048 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.838 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -79.42 -175.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.93 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -81.57 142.45 32.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.145 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.493 ' HB2' ' CG ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -116.09 130.59 56.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.949 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 4.6 mt-10 -78.15 16.77 0.7 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.056 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -160.23 167.14 14.42 Favored Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.771 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.446 ' O ' HD13 ' A' ' 116' ' ' ILE . 37.3 Cg_endo -73.21 101.9 1.4 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.678 2.252 . . . . 0.0 111.414 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 115' ' ' PRO . 50.6 mm -131.13 136.42 57.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.357 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.87 HD12 HD11 ' A' ' 84' ' ' LEU . 6.3 tt -108.65 119.65 40.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.358 0.599 . . . . 0.0 110.681 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.886 HG21 HG12 ' A' ' 108' ' ' VAL . 61.7 m -118.2 125.11 49.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.202 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.83 HD23 ' C ' ' A' ' 119' ' ' LEU . 6.2 tt -112.97 124.9 53.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.388 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.757 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -120.54 116.47 25.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.503 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.646 ' OG1' ' N ' ' A' ' 122' ' ' CYS . 0.1 OUTLIER -136.29 -168.57 2.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.356 -179.183 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.646 ' N ' ' OG1' ' A' ' 121' ' ' THR . 3.6 t 94.62 -77.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.53 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.582 ' H ' ' HG3' ' A' ' 134' ' ' ARG . 51.4 m-85 58.97 134.87 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.278 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.75 -48.92 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.8 2.333 . . . . 0.0 112.833 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.414 ' CG ' ' N ' ' A' ' 126' ' ' ASP . 4.1 p90 -63.43 -33.47 75.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.618 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.686 ' OD2' ' CG ' ' A' ' 65' ' ' HIS . 40.0 t0 -80.27 -55.39 4.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.826 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.509 ' CZ ' ' O ' ' A' ' 128' ' ' ILE . 40.3 t80 -68.02 142.13 56.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.509 ' O ' ' CZ ' ' A' ' 127' ' ' TYR . 50.8 mm -90.38 121.08 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.012 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.437 ' O ' ' OD1' ' A' ' 130' ' ' ASP . . . 128.82 -121.26 3.54 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 129' ' ' GLY . 99.2 m-20 -139.6 101.46 4.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 110.548 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.19 67.51 80.65 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.171 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.08 -37.83 69.32 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.764 2.309 . . . . 0.0 112.411 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.46 ' CB ' HG22 ' A' ' 100' ' ' ILE . 97.9 m-20 -106.68 161.77 14.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.748 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.582 ' HG3' ' H ' ' A' ' 123' ' ' TYR . 7.3 mpt_? -104.16 143.98 32.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.055 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 120' ' ' THR . 2.8 t80 -69.13 124.97 25.22 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.881 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 2.6 mm -111.01 112.16 39.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 137' ' ' ILE . 0.9 OUTLIER -100.37 112.22 32.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.233 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -95.51 140.29 30.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.389 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.85 138.76 21.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.966 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -110.47 150.86 28.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.242 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 91' ' ' TYR . 5.4 tp -72.46 122.59 21.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.355 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.94 -41.06 5.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.738 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.23 175.39 20.16 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 94.3 p -155.85 160.85 40.54 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.65 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' THR . 92.9 m-85 -147.87 152.47 37.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.582 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.1 p -147.57 132.66 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.759 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.4 p -64.62 154.97 34.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.808 0.337 . . . . 0.0 110.44 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.5 m170 -116.05 142.4 46.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.559 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.8 mtt -88.8 137.84 31.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.635 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.1 t -87.31 -64.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.679 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.8 m -144.61 -126.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.558 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -59.89 142.99 52.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.473 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 73.4 p -112.85 164.45 13.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.82 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.611 ' C ' ' H ' ' A' ' 11' ' ' LYS . 95.7 mt-10 -151.87 134.19 15.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.016 0.436 . . . . 0.0 110.296 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.2 m80 57.81 -3.35 0.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.776 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.611 ' H ' ' C ' ' A' ' 9' ' ' GLU . 54.6 mmtt -61.14 162.5 7.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.31 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.558 ' OE2' HG11 ' A' ' 47' ' ' VAL . 97.6 mt-10 -107.31 123.86 48.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.377 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.577 ' N ' ' OE2' ' A' ' 14' ' ' GLU . . . 114.42 1.78 23.18 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.654 ' CD ' ' H ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -115.34 139.79 49.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.859 0.362 . . . . 0.0 110.278 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 89.0 tttt -58.67 120.74 9.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.642 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.408 HG11 ' HB2' ' A' ' 32' ' ' TRP . 24.1 m -116.23 -18.05 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.84 158.63 39.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.539 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.2 ttp -120.76 133.14 55.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.392 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.502 HD13 ' H ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -99.19 129.74 45.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.352 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.502 ' H ' HD13 ' A' ' 19' ' ' LEU . 27.4 t-20 -125.69 124.01 40.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.988 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.433 HG22 ' H ' ' A' ' 24' ' ' LEU . 6.9 mt -105.9 109.74 63.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.855 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 81' ' ' THR . 57.2 Cg_endo -75.89 -42.92 0.36 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.577 2.185 . . . . 0.0 112.6 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HB3' HD22 ' A' ' 24' ' ' LEU . 8.1 tmtm? -60.57 -40.12 90.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.253 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.793 HD12 HG21 ' A' ' 71' ' ' THR . 3.7 mm? -98.53 -2.35 38.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 0.0 110.489 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 54.46 42.66 31.23 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.689 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.489 ' HE3' ' CZ ' ' A' ' 28' ' ' PHE . 4.2 mtpp -124.03 163.01 22.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.093 0.473 . . . . 0.0 110.636 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG2' ' CG ' ' A' ' 20' ' ' ASN . 34.9 mtmt -141.89 143.37 33.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.007 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.489 ' CZ ' ' HE3' ' A' ' 26' ' ' LYS . 89.4 m-85 -137.71 152.23 49.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.805 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 43' ' ' VAL . 4.9 t -97.15 124.82 41.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.772 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.531 HD12 HD11 ' A' ' 62' ' ' LEU . 40.4 mm -92.56 126.2 45.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.556 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.561 ' CE1' ' OG ' ' A' ' 29' ' ' SER . 89.1 m-85 -114.16 138.47 50.4 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.957 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.646 ' CZ3' HG22 ' A' ' 53' ' ' THR . 41.5 t-105 -60.74 126.85 28.92 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.604 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.634 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 84.28 169.79 45.96 Favored Glycine 0 C--N 1.331 0.289 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.77 99.3 3.51 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.783 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -101.11 114.72 28.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.837 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -73.54 -23.69 60.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.759 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.47 90.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.709 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 40' ' ' LYS . 1.3 m -69.76 131.35 44.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.435 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.6 mt -92.82 -1.63 56.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.472 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.414 ' H ' HG22 ' A' ' 38' ' ' THR . 50.0 mtmt -106.19 33.28 3.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.941 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -126.12 141.46 51.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.58 -31.5 0.46 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 29' ' ' SER . 0.0 OUTLIER -136.38 105.18 4.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.064 0.459 . . . . 0.0 110.827 179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.54 154.32 16.93 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.513 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 40.1 ttm -103.8 144.48 31.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.54 143.95 46.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.516 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' HA2' ' A' ' 33' ' ' GLY . 78.8 t -115.87 129.81 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.367 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.4 p -166.83 -173.92 2.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.65 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -89.28 -23.75 22.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 5.8 m -92.13 -38.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.687 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.459 ' N ' HG23 ' A' ' 50' ' ' VAL . 63.6 p -78.53 153.23 31.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.556 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 t -150.24 172.09 15.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.459 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.646 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -84.91 153.92 60.68 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.701 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.44 80.65 2.69 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.546 2.164 . . . . 0.0 112.34 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.5 p -107.48 -13.39 15.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.755 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.62 88.99 0.08 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.42 80.23 0.51 Allowed Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.455 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -165.97 158.42 31.32 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.695 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 15.3 t-160 -81.75 121.73 26.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.8 m -116.17 129.48 56.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.274 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.588 HG11 ' CD1' ' A' ' 109' ' ' ILE . 58.3 t -116.35 126.1 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.221 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.531 HD11 HD12 ' A' ' 30' ' ' ILE . 2.4 mm? -108.47 138.89 44.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.125 0.488 . . . . 0.0 110.529 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.3 t -121.63 138.67 54.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.876 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -152.5 155.27 26.03 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.516 ' O ' ' O ' ' A' ' 66' ' ' ARG . 3.1 m80 -98.7 132.18 44.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.864 0.364 . . . . 0.0 110.677 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.516 ' O ' ' O ' ' A' ' 65' ' ' HIS . 27.9 ttm180 56.7 127.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.393 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 69' ' ' VAL . 26.0 p-10 -66.83 -26.16 66.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.687 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.5 m -42.47 97.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.474 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 67' ' ' ASP . 11.6 m -122.75 31.72 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.62 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 1.9 m-85 67.78 -55.32 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.691 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.793 HG21 HD12 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -108.78 74.19 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.759 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.414 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 4.8 t70 -65.86 -38.48 88.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.538 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.417 ' O ' ' HE3' ' A' ' 77' ' ' LYS . 96.6 mt -73.6 -15.65 61.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.905 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' A' ' 77' ' ' LYS . . . -91.91 -44.99 4.02 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.3 mm100 -68.41 -41.22 80.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.78 0.324 . . . . 0.0 110.696 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.574 HD22 ' HE2' ' A' ' 135' ' ' TYR . 8.2 mt -93.85 89.42 6.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.491 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 74' ' ' GLY . 6.3 ptpt -176.25 145.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.427 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -69.8 -21.99 63.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.739 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -76.39 -14.63 60.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.152 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.68 154.93 39.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.789 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.427 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -137.92 133.17 33.45 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.4 mt -109.23 124.68 51.27 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.785 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.625 ' CG1' HG22 ' A' ' 90' ' ' THR . 40.0 t -106.37 116.65 50.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.981 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.868 HD21 HD12 ' A' ' 117' ' ' LEU . 8.1 mp -98.54 127.04 44.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.031 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.695 ' HG2' HG23 ' A' ' 90' ' ' THR . 95.4 mt-10 -106.54 117.3 33.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.244 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -148.23 131.95 16.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.846 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 59.32 49.33 9.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.514 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 56.91 13.28 1.43 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.049 0.452 . . . . 0.0 110.259 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -114.9 144.81 42.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.61 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.695 HG23 ' HG2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -114.08 123.31 49.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.673 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.412 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 14.6 m-85 -104.38 145.14 30.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.453 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.585 ' HG1' ' HE2' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -109.56 114.66 28.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.315 -179.173 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.522 ' CE1' HD22 ' A' ' 84' ' ' LEU . 78.3 m-85 -113.03 151.46 30.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.609 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -128.83 141.65 51.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.786 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.571 ' CD1' HD12 ' A' ' 137' ' ' ILE . 1.5 mm -64.38 119.2 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.362 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.17 -62.92 1.41 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.024 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -145.87 150.92 37.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.307 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.415 HG12 HD13 ' A' ' 137' ' ' ILE . 12.0 mt -122.62 134.35 66.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.059 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.705 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 15.8 p90 -161.87 -179.74 7.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.034 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.645 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.3 mp -128.69 129.25 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.257 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.46 HG22 ' CG1' ' A' ' 136' ' ' ILE . 7.6 t -127.16 173.5 9.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.006 0.432 . . . . 0.0 110.68 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.79 161.55 30.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.526 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.08 -11.74 60.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.761 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -101.71 22.69 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.628 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.596 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 50.1 t0 -92.04 100.83 13.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.594 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.852 ' O ' HG23 ' A' ' 110' ' ' ILE . 2.7 ptt180 -79.71 -20.06 47.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.372 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.596 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 20.0 p -48.39 -16.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.615 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.555 ' HB ' HG21 ' A' ' 118' ' ' THR . 8.8 m -109.4 -6.56 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.233 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 109' ' ' ILE . 47.8 mm -113.44 7.76 7.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.937 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.852 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -79.52 -171.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.467 ' CB ' ' HB ' ' A' ' 50' ' ' VAL . 19.5 ttpt -102.5 141.59 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.938 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 87.0 mttt -124.89 151.91 44.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.574 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -92.41 7.26 43.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.204 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -130.94 159.59 70.68 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.762 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.455 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 43.6 Cg_endo -74.58 94.88 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.978 2.452 . . . . 0.0 111.894 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 115' ' ' PRO . 48.2 mm -126.41 134.77 65.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.137 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.868 HD12 HD21 ' A' ' 84' ' ' LEU . 6.1 tt -108.92 118.48 36.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.251 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.555 HG21 ' HB ' ' A' ' 108' ' ' VAL . 92.1 m -115.14 119.69 37.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.369 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.994 HD12 ' N ' ' A' ' 120' ' ' THR . 0.7 OUTLIER -105.86 124.97 50.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.361 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.994 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -121.57 124.37 44.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.932 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.537 ' O ' ' CB ' ' A' ' 122' ' ' CYS . 1.3 t -152.17 170.45 19.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.305 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 121' ' ' THR . 1.7 p 158.19 -66.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.871 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.537 ' N ' ' HD3' ' A' ' 124' ' ' PRO . 17.1 m-85 38.54 60.76 5.03 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.646 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 123' ' ' TYR . 11.3 Cg_exo -70.81 160.81 48.2 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 123.291 2.661 . . . . 0.0 112.125 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -51.75 -25.34 7.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.362 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.603 ' O ' ' N ' ' A' ' 128' ' ' ILE . 38.2 t70 -94.63 5.55 51.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.549 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.581 ' O ' ' C ' ' A' ' 128' ' ' ILE . 2.2 t80 -43.11 -14.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.578 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.603 ' N ' ' O ' ' A' ' 126' ' ' ASP . 38.8 mm -19.99 92.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.589 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 127' ' ' TYR . . . 80.56 -102.2 2.08 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -104.04 118.93 37.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.688 0.28 . . . . 0.0 110.868 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -53.7 141.91 44.54 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.578 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.12 -27.93 56.89 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.623 2.215 . . . . 0.0 111.819 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.605 ' OD1' HG22 ' A' ' 100' ' ' ILE . 6.8 t0 -163.2 115.67 1.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.396 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.632 ' NE ' ' OG1' ' A' ' 120' ' ' THR . 5.6 ptm180 -98.42 138.55 35.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.094 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.574 ' HE2' HD22 ' A' ' 76' ' ' LEU . 4.5 t80 -69.92 136.53 50.69 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.827 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.705 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 9.3 mm -120.84 115.68 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.421 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.571 HD12 ' CD1' ' A' ' 95' ' ' ILE . 1.6 mm -106.99 107.32 22.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -94.24 140.32 29.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.197 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.75 142.92 27.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.132 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 67.2 tttt -117.44 152.78 34.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.996 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.479 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 7.2 tp -73.23 124.19 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.455 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.19 -43.65 5.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.343 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.27 -178.97 16.34 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 34.9 p -153.78 160.29 42.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.708 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.585 ' HE2' ' HG1' ' A' ' 92' ' ' THR . 59.7 m-85 -149.06 156.03 41.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.535 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 64.6 p -147.26 130.94 16.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.594 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.9 pttt . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.526 179.906 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.459 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 2.2 t 77.68 -127.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.352 . . . . 0.0 110.727 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 66.7 m80 -66.73 -40.0 88.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.428 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.423 ' O ' ' O ' ' A' ' 1' ' ' GLY . 3.0 tpt -151.46 -161.08 1.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.572 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.5 m -70.42 153.21 43.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.562 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 t -65.62 -83.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.775 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' O ' HG23 ' A' ' 8' ' ' THR . 87.3 mt-30 -106.14 134.87 48.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.543 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 7' ' ' GLN . 3.1 p -153.06 -114.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.715 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -97.79 -115.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.535 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -107.51 39.3 1.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.68 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.613 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 70.6 mmtt -65.52 151.23 46.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.799 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.64 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 52.9 mp0 -90.72 151.89 21.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.387 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 83.79 18.11 64.27 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.613 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -121.97 133.73 54.83 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.537 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 64.4 tttp -60.08 112.03 1.74 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.344 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 14' ' ' GLU . 24.5 m -114.07 -26.38 3.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.965 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -144.08 158.02 43.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.598 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.1 ttp -120.6 140.59 51.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.343 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.486 ' HB2' HD11 ' A' ' 30' ' ' ILE . 55.4 tp -108.96 125.66 52.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.577 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -121.25 133.88 55.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.432 HG22 ' H ' ' A' ' 24' ' ' LEU . 6.0 mt -119.59 111.24 36.39 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 81' ' ' THR . 56.8 Cg_endo -76.02 -36.94 1.74 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.735 2.29 . . . . 0.0 112.843 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.578 ' C ' HD22 ' A' ' 24' ' ' LEU . 39.8 tptt -61.1 -36.83 80.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.582 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.5 mm? -103.61 -0.51 29.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.642 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.59 50.72 16.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.247 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.22 175.7 9.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.036 0.446 . . . . 0.0 110.287 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.76 157.47 31.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.707 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -144.05 159.73 42.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.826 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.457 ' O ' HG23 ' A' ' 43' ' ' VAL . 4.3 m -99.83 116.14 31.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.012 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 62' ' ' LEU . 35.3 mm -80.39 126.67 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.247 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 70.8 m-85 -111.03 137.79 48.23 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.988 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 13' ' ' GLY . 41.5 t-105 -60.14 117.31 4.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.695 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.614 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 94.24 166.3 36.76 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.31 101.28 2.2 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.703 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -84.5 113.86 21.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.882 0.372 . . . . 0.0 110.808 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -62.13 -45.31 94.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.574 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.75 -48.88 75.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.553 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.484 ' O ' ' OG1' ' A' ' 38' ' ' THR . 2.9 p -110.52 92.96 4.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.194 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.97 108.38 16.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.809 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.77 -53.59 6.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.497 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.11 148.47 52.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.736 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.34 -16.63 21.58 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 29' ' ' SER . 5.1 m -116.6 94.92 3.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.379 0.609 . . . . 0.0 111.155 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.17 142.65 15.99 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.575 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 13.4 tpt -95.3 138.1 33.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.714 0.292 . . . . 0.0 110.713 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -77.69 137.56 38.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.982 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.614 HG23 ' HA2' ' A' ' 33' ' ' GLY . 86.9 t -119.34 114.81 45.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.242 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.54 ' N ' ' OG1' ' A' ' 51' ' ' THR . 6.1 m -163.28 169.35 19.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.686 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.575 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 65.1 t0 -70.85 -8.84 55.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.432 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.715 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.2 m -110.42 -22.95 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.645 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.54 ' OG1' ' N ' ' A' ' 48' ' ' SER . 37.0 p -85.58 138.21 32.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.398 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -131.0 168.17 17.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.22 161.0 28.57 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.594 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.522 ' HG3' HD23 ' A' ' 84' ' ' LEU . 66.7 Cg_endo -81.29 73.65 5.83 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.635 2.224 . . . . 0.0 112.365 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.6 p -115.76 -6.33 12.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.754 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.01 91.98 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.47 79.22 0.16 Allowed Glycine 0 CA--C 1.53 1.028 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.456 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -155.29 150.83 22.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.645 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 16.7 t-160 -77.58 104.99 8.44 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.46 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 38.3 m -100.19 122.43 43.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.433 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.599 ' C ' HD22 ' A' ' 62' ' ' LEU . 54.1 t -114.77 127.44 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 0.0 110.276 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.599 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.7 mm? -112.36 147.13 37.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.684 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 120' ' ' THR . 32.6 t -128.99 142.29 50.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.619 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -165.82 169.87 40.34 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 65' ' ' HIS . 0.1 OUTLIER -123.5 146.33 48.16 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.497 -0.414 . . . . 0.0 110.716 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 66' ' ' ARG . 51.5 mtt-85 -63.44 109.91 1.77 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.732 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -77.3 -72.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.708 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 88.7 m -136.24 139.57 42.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.683 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.1 m -82.34 96.6 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.335 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -134.02 -73.29 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.632 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.595 ' O ' ' NE2' ' A' ' 75' ' ' GLN . 0.8 OUTLIER -93.48 72.1 4.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.064 0.459 . . . . 0.0 110.652 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -64.61 -33.93 77.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.241 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.405 ' O ' ' HE3' ' A' ' 77' ' ' LYS . 17.0 mt -61.23 -45.55 94.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.809 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.42 -37.38 93.74 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.595 ' NE2' ' O ' ' A' ' 71' ' ' THR . 0.7 OUTLIER -64.37 -36.18 83.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 110.405 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.849 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.2 pp -136.13 112.56 9.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.324 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.489 ' O ' HG21 ' A' ' 95' ' ' ILE . 7.8 ptpt -179.99 144.68 0.19 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.348 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -79.52 -11.51 59.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.947 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -83.59 -13.95 53.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.898 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.683 ' OD1' ' N ' ' A' ' 81' ' ' THR . 23.4 t0 -81.06 158.04 25.21 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.215 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.683 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.6 p -138.48 135.44 35.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.7 mt -109.79 122.09 46.71 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.355 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.486 ' C ' HD12 ' A' ' 84' ' ' LEU . 5.7 t -104.33 121.93 56.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.995 0.426 . . . . 0.0 110.263 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.811 HD21 HD12 ' A' ' 117' ' ' LEU . 8.0 mp -103.59 129.54 50.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.367 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -105.44 120.86 42.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.941 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 2.1 t80 -149.38 127.67 12.14 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.933 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.517 ' OD1' ' O ' ' A' ' 87' ' ' ASP . 64.4 t0 54.02 52.68 12.38 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.827 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.2 m120 57.18 12.23 1.27 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.448 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 49.9 mtmt -112.72 141.63 46.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.956 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.454 ' HG1' ' HB2' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -113.65 126.08 54.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.339 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.454 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 10.5 m-85 -109.3 134.83 51.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.102 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.44 ' HG1' ' HE2' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -101.96 115.28 30.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.047 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.497 ' CE1' HD22 ' A' ' 84' ' ' LEU . 75.7 m-85 -110.95 144.27 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.582 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -119.74 138.27 53.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.672 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.493 ' CD1' HG23 ' A' ' 137' ' ' ILE . 2.3 mm -66.2 115.95 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.411 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -86.63 -60.62 1.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.593 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -152.72 145.1 24.03 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.197 0.522 . . . . 0.0 110.26 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.56 131.45 72.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.541 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.496 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 26.5 p90 -149.61 -177.51 5.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.01 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.734 HD12 ' N ' ' A' ' 100' ' ' ILE . 0.9 OUTLIER -130.33 132.42 64.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.356 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.2 t -138.98 178.9 6.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.712 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -68.5 148.71 50.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.564 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.9 -34.31 75.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.363 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -82.8 16.69 2.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.724 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.644 ' OD2' HG23 ' A' ' 108' ' ' VAL . 28.5 t70 -79.63 90.52 5.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.571 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.98 ' O ' HG23 ' A' ' 110' ' ' ILE . 17.0 ptp180 -63.57 -37.92 89.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.515 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.507 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 1.6 p -38.71 -18.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.522 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.851 HG12 HG21 ' A' ' 118' ' ' THR . 11.1 t -111.18 -16.53 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.107 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 109' ' ' ILE . 49.3 mm -112.32 22.34 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.98 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -89.94 -163.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.837 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -102.69 148.31 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.686 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.421 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 98.1 mttt -132.9 150.46 52.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.635 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -94.94 8.98 41.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.401 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.27 163.9 46.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.767 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.456 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 50.2 Cg_endo -79.04 98.5 1.19 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.071 2.514 . . . . 0.0 111.624 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 115' ' ' PRO . 50.2 mm -128.84 138.29 54.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.439 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.824 ' C ' HD23 ' A' ' 117' ' ' LEU . 6.5 tt -110.13 116.48 31.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.666 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.851 HG21 HG12 ' A' ' 108' ' ' VAL . 72.3 m -116.03 114.76 25.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.324 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.843 HD12 ' N ' ' A' ' 120' ' ' THR . 0.9 OUTLIER -103.71 116.32 32.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.026 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.843 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -107.22 122.87 47.39 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.431 0.457 . . . . 0.0 110.403 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.632 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.4 t -156.08 178.9 9.76 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.06 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 121' ' ' THR . 1.6 p 158.54 -75.14 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.791 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 47.88 67.01 4.9 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.027 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.4 160.82 32.06 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 123.08 2.52 . . . . 0.0 112.237 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.562 ' CE1' ' OD2' ' A' ' 126' ' ' ASP . 8.9 p90 -51.99 -17.19 0.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.978 0.418 . . . . 0.0 110.314 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.562 ' OD2' ' CE1' ' A' ' 125' ' ' PHE . 1.3 p30 -108.44 26.63 10.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.637 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.677 ' O ' ' O ' ' A' ' 129' ' ' GLY . 14.7 t80 -56.6 -49.36 75.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.632 ' C ' ' O ' ' A' ' 127' ' ' TYR . 21.6 mt 9.52 78.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 O-C-N 123.732 0.645 . . . . 0.0 110.739 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.677 ' O ' ' O ' ' A' ' 127' ' ' TYR . . . 87.98 157.2 31.54 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.558 ' C ' ' O ' ' A' ' 129' ' ' GLY . 10.0 p30 -27.39 99.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.896 0.379 . . . . 0.0 110.681 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 129' ' ' GLY . . . -47.69 130.41 11.08 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.623 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.64 -41.4 37.63 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.484 2.122 . . . . 0.0 111.876 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -124.5 125.94 45.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.418 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 134' ' ' ARG . 7.7 ttp180 -113.07 142.46 45.7 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.809 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.685 ' CE2' HD11 ' A' ' 137' ' ' ILE . 7.9 t80 -81.9 123.28 28.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 1.6 mt -119.55 124.17 72.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 120.978 0.418 . . . . 0.0 111.959 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.685 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.4 mp -103.04 112.62 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.816 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.496 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 10.4 tt0 -90.11 142.72 27.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.868 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -152.86 149.72 28.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.822 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.451 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 66.7 tttt -123.45 153.4 40.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.451 ' N ' ' CG ' ' A' ' 140' ' ' LYS . 13.8 tp -71.7 126.6 30.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.435 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.68 -36.83 5.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.628 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.425 ' C ' ' OG1' ' A' ' 92' ' ' THR . . . -141.32 162.33 26.87 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.0 p -142.72 133.17 24.94 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.294 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.454 ' HB2' ' HG1' ' A' ' 90' ' ' THR . 62.8 m-85 -123.01 101.6 7.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.684 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.526 ' O ' ' O ' ' A' ' 147' ' ' LYS . 8.6 p -89.38 136.93 32.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.703 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.526 ' O ' ' O ' ' A' ' 146' ' ' SER . 22.0 mtpt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.554 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.684 ' O ' ' ND1' ' A' ' 3' ' ' HIS . 16.1 p -77.37 170.09 17.17 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.684 ' ND1' ' O ' ' A' ' 2' ' ' SER . 6.8 m80 83.91 129.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 42.8 mtm -96.02 140.15 31.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.621 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.5 t -93.83 35.45 1.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.656 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.0 t -74.39 153.74 39.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.82 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -103.49 44.06 1.04 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.495 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.08 -48.73 13.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.034 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.631 ' O ' ' N ' ' A' ' 11' ' ' LYS . 2.7 tm-20 -128.94 165.05 21.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.654 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.422 ' ND1' ' N ' ' A' ' 10' ' ' HIS . 0.5 OUTLIER -51.38 79.26 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.573 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.631 ' N ' ' O ' ' A' ' 9' ' ' GLU . 27.4 ttmt -105.12 157.57 17.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.645 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -92.12 147.58 22.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.292 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.41 3.74 68.96 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.556 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.8 OUTLIER -109.7 137.5 47.41 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.878 0.371 . . . . 0.0 110.483 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -62.77 117.17 5.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.195 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.31 -39.93 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.746 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.92 162.18 33.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.7 ttm -127.2 135.66 50.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.527 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tt -101.53 121.53 42.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.195 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 21' ' ' ILE . 3.8 t30 -116.79 136.07 53.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.419 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.596 HD13 HE22 ' A' ' 75' ' ' GLN . 3.4 mt -113.57 118.3 43.53 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.175 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.664 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.7 Cg_endo -76.55 -48.36 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.857 2.371 . . . . 0.0 112.674 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.566 ' C ' HD22 ' A' ' 24' ' ' LEU . 27.1 tptp -61.57 -39.4 91.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.764 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.1 mm? -99.49 0.68 42.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.768 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt 45.61 38.74 4.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.909 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -117.18 157.59 25.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.841 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -137.57 136.35 37.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.725 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -126.27 120.96 31.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.414 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.8 m -67.32 119.42 12.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.916 0.389 . . . . 0.0 110.646 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.543 HD12 ' CD1' ' A' ' 62' ' ' LEU . 40.0 mm -95.73 120.68 45.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.542 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -106.71 147.97 28.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.641 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.768 ' CZ3' ' SD ' ' A' ' 45' ' ' MET . 46.4 t-105 -60.8 117.73 5.77 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.861 0.362 . . . . 0.0 110.454 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.666 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 85.94 153.67 22.37 Favored Glycine 0 C--N 1.332 0.311 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' CB ' ' OG ' ' A' ' 63' ' ' SER . . . -124.25 78.99 1.7 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.662 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -101.85 133.41 46.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.648 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -88.2 -3.89 58.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.554 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.38 -25.96 67.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.546 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.507 ' OG1' ' N ' ' A' ' 39' ' ' LEU . 6.9 t -64.9 -153.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.517 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 39' ' ' LEU . 7.6 mp -72.62 -124.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.684 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -92.67 -48.03 6.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.697 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -61.92 131.6 50.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.473 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.5 39.65 1.51 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.93 126.32 49.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.467 0.651 . . . . 0.0 110.781 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.22 -172.8 42.16 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.768 ' SD ' ' CZ3' ' A' ' 32' ' ' TRP . 1.5 tmt? -93.68 146.97 23.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.94 0.4 . . . . 0.0 110.965 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.562 ' O ' ' SD ' ' A' ' 45' ' ' MET . 57.8 t80 -76.72 130.29 37.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.371 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.666 HG23 ' HA2' ' A' ' 33' ' ' GLY . 63.5 t -96.62 125.96 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.429 . . . . 0.0 110.669 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.588 ' HG ' ' CB ' ' A' ' 51' ' ' THR . 38.5 p -160.45 176.25 11.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.575 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.586 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 65.9 t0 -82.7 -7.14 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.542 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.703 HG21 ' O ' ' A' ' 109' ' ' ILE . 9.0 m -115.45 -32.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.599 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.588 ' CB ' ' HG ' ' A' ' 48' ' ' SER . 72.8 p -78.9 145.35 34.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.78 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -145.24 171.18 14.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.535 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.467 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -90.04 154.39 47.31 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.848 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.78 84.25 1.8 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.689 2.259 . . . . 0.0 112.415 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -117.02 -4.49 11.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.828 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.15 88.98 0.07 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.13 91.23 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.471 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.96 165.34 38.67 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.502 ' CD2' ' HD2' ' A' ' 112' ' ' LYS . 13.2 t-160 -84.24 111.87 19.77 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.413 HG22 HD23 ' A' ' 62' ' ' LEU . 61.2 m -105.61 123.22 47.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.352 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.587 ' O ' HD22 ' A' ' 62' ' ' LEU . 44.9 t -116.57 126.87 74.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.549 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.587 HD22 ' O ' ' A' ' 61' ' ' VAL . 2.5 mm? -114.16 143.97 43.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.819 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 34' ' ' ALA . 4.9 p -132.86 147.5 52.3 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.56 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.469 ' O ' HG22 ' A' ' 121' ' ' THR . . . -169.43 161.94 35.47 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.713 ' ND1' ' CG ' ' A' ' 123' ' ' TYR . 90.6 m-70 -110.62 145.41 37.93 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.639 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 47.07 -79.62 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.718 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 65' ' ' HIS . 20.2 t0 59.92 148.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.6 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.578 HG23 ' OG1' ' A' ' 71' ' ' THR . 8.1 m 61.43 148.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.624 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.4 t -113.78 -49.4 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.719 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -138.19 -12.68 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.606 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.578 ' OG1' HG23 ' A' ' 68' ' ' THR . 57.1 p -87.7 25.46 1.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.33 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' N ' HG21 ' A' ' 68' ' ' THR . 2.6 m-20 -62.75 -36.02 81.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.657 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.715 HD13 ' O ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -61.8 -42.4 98.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.417 -179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.415 ' HA3' HD11 ' A' ' 24' ' ' LEU . . . -68.51 -34.59 79.49 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.596 HE22 HD13 ' A' ' 21' ' ' ILE . 52.7 mm-40 -61.49 -41.15 96.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.716 0.293 . . . . 0.0 110.792 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.84 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.0 pp -97.11 109.3 22.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.44 . . . . 0.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.42 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 2.3 ptpt 172.2 143.32 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.445 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.63 -14.83 63.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.721 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -82.07 -14.32 56.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.239 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.23 158.91 34.98 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.06 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.664 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -147.67 111.05 4.91 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.235 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.0 mt -87.77 131.24 34.58 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.224 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.679 HG12 HG22 ' A' ' 90' ' ' THR . 2.8 t -112.61 122.39 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.204 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.588 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.2 mm? -107.98 133.24 52.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.343 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.635 ' HG2' HG23 ' A' ' 90' ' ' THR . 96.5 mt-10 -104.25 118.04 35.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.373 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.467 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 1.0 OUTLIER -146.87 125.81 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.764 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 60.14 51.65 5.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.156 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 56.53 11.39 0.85 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.445 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.454 ' HG2' ' CB ' ' A' ' 146' ' ' SER . 45.0 mtpt -112.01 145.05 40.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.612 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.679 HG22 HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -113.71 117.2 30.86 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.344 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.424 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 8.6 m-85 -95.17 136.23 35.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.412 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.481 ' O ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -105.91 113.79 27.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.659 -179.447 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -110.9 147.23 35.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.525 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -123.67 138.9 54.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.651 ' CD1' HG23 ' A' ' 137' ' ' ILE . 8.0 mm -65.89 118.98 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.038 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -95.94 -62.01 1.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.485 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -139.77 135.27 32.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.407 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.9 mt -114.18 127.86 71.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.205 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 21.4 p90 -151.14 -176.35 5.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.73 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.435 HG12 ' CD1' ' A' ' 135' ' ' TYR . 8.0 mt -129.34 138.85 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.46 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.42 HG23 ' HE ' ' A' ' 134' ' ' ARG . 2.2 t -137.55 170.43 16.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.093 0.473 . . . . 0.0 110.776 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.56 ' C ' ' H ' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -73.57 154.72 39.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.555 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.55 8.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.67 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' A' ' 102' ' ' HIS . 57.8 t0 -131.53 36.53 3.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.556 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.541 ' H ' HH21 ' A' ' 134' ' ' ARG . 21.7 t0 -96.44 94.78 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.69 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.985 ' O ' HG23 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -62.45 -35.52 79.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.463 179.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.529 ' C ' HD12 ' A' ' 110' ' ' ILE . 1.2 p -44.91 -13.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.354 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.891 ' CG1' HG21 ' A' ' 118' ' ' THR . 15.7 t -113.46 -12.67 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.116 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.734 HG22 ' O ' ' A' ' 109' ' ' ILE . 50.9 mm -117.68 22.2 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.164 0.507 . . . . 0.0 111.064 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 1.016 HD13 ' H ' ' A' ' 110' ' ' ILE . 0.2 OUTLIER -87.28 -161.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.706 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -104.45 147.07 27.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 98.6 mttt -142.82 136.27 28.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.305 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.15 16.23 8.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.465 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -125.93 151.47 71.4 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.784 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.471 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 37.0 Cg_endo -72.33 80.84 1.57 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.995 2.464 . . . . 0.0 111.275 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.4 mm -115.5 132.85 63.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.287 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.812 ' C ' HD23 ' A' ' 117' ' ' LEU . 5.7 tt -106.13 118.79 37.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.178 0.513 . . . . 0.0 110.739 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.891 HG21 ' CG1' ' A' ' 108' ' ' VAL . 90.8 m -112.78 120.88 43.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.162 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.702 HD23 ' N ' ' A' ' 120' ' ' THR . 0.4 OUTLIER -108.26 119.68 40.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.414 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.702 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -111.17 115.63 29.71 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.81 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.509 HG23 ' CD2' ' A' ' 119' ' ' LEU . 3.6 p -141.27 158.6 43.68 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.652 ' O ' ' C ' ' A' ' 123' ' ' TYR . 13.9 t 171.76 -80.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.78 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.733 ' CD1' ' N ' ' A' ' 123' ' ' TYR . 0.0 OUTLIER 0.24 72.81 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.388 0 O-C-N 123.954 0.784 . . . . 0.0 110.546 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.561 ' HD3' ' SG ' ' A' ' 122' ' ' CYS . 60.1 Cg_endo -81.08 169.02 16.59 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 123.175 2.583 . . . . 0.0 112.277 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -63.28 -29.02 70.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.389 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -61.35 -45.88 92.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.583 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -107.29 126.25 52.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.603 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.8 mm -98.46 129.19 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.231 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.72 -118.95 5.93 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 130' ' ' ASP . 0.6 OUTLIER -116.63 105.03 11.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.337 . . . . 0.0 110.57 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.85 152.05 21.43 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.509 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.21 -28.8 85.59 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.958 2.439 . . . . 0.0 111.975 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 40.1 p-10 -138.53 126.64 22.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.613 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.541 HH21 ' H ' ' A' ' 105' ' ' ASP . 29.6 ptt180 -98.76 141.83 31.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.733 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.62 ' H ' ' HB2' ' A' ' 122' ' ' CYS . 3.1 t80 -75.57 130.85 39.48 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 101' ' ' THR . 3.3 mm -118.96 116.98 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.195 0.521 . . . . 0.0 112.076 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.651 HG23 ' CD1' ' A' ' 95' ' ' ILE . 1.2 mp -106.77 110.32 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.543 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.49 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 48.4 tt0 -90.18 134.91 33.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.034 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -144.35 142.81 30.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.006 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 59.5 tttt -114.65 153.32 30.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.181 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 92' ' ' THR . 27.8 tp -74.62 116.94 15.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.12 -33.87 10.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -154.74 158.66 28.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 38.3 p -138.42 151.62 47.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 0.0 110.384 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.494 ' N ' ' O ' ' A' ' 90' ' ' THR . 90.2 m-85 -130.04 145.08 51.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.458 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.454 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 5.2 p -136.68 129.07 30.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.553 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 146' ' ' SER . 13.8 mttm . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.339 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.571 ' O ' ' CB ' ' A' ' 3' ' ' HIS . 86.6 p -61.47 -35.02 76.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.399 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.633 ' C ' ' H ' ' A' ' 5' ' ' SER . 4.3 t60 86.65 71.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.181 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.585 ' O ' ' O ' ' A' ' 5' ' ' SER . 78.4 mtm 47.98 4.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.691 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.633 ' H ' ' C ' ' A' ' 3' ' ' HIS . 3.5 m 40.42 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.771 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.2 t -73.36 146.07 45.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.477 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -122.38 168.12 12.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.433 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.581 ' O ' HG22 ' A' ' 8' ' ' THR . 29.9 m 65.69 5.08 3.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.686 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.624 ' C ' ' H ' ' A' ' 11' ' ' LYS . 83.3 tt0 -93.72 162.2 14.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.578 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.493 ' N ' ' HG2' ' A' ' 9' ' ' GLU . 97.7 m-70 -64.85 33.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.632 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 9' ' ' GLU . 22.3 tptp -72.81 144.92 47.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.481 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.02 141.01 55.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.94 0.4 . . . . 0.0 110.335 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.5 14.06 66.57 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -119.38 141.54 48.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.328 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.403 ' NZ ' ' HB2' ' A' ' 18' ' ' MET . 12.4 tmtt? -62.31 112.25 2.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.257 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 32' ' ' TRP . 16.5 m -112.94 -43.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.721 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.472 ' N ' HG23 ' A' ' 16' ' ' VAL . . . -129.53 162.27 28.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.76 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.434 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 50.8 ttm -125.84 143.0 51.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.51 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.429 HD13 HD21 ' A' ' 84' ' ' LEU . 21.1 tp -107.01 127.75 53.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.409 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -124.88 125.88 44.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.04 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 24' ' ' LEU . 4.8 mt -105.01 119.68 52.43 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.934 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 81' ' ' THR . 59.5 Cg_endo -76.66 -48.18 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.637 2.225 . . . . 0.0 112.918 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' C ' HD22 ' A' ' 24' ' ' LEU . 16.7 tptp -59.34 -43.87 92.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.985 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.81 HD22 ' N ' ' A' ' 24' ' ' LEU . 2.7 mm? -96.93 -0.57 47.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.362 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.15 37.69 8.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.622 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -107.65 157.21 18.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.533 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -140.06 145.6 37.9 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.683 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -143.73 150.75 39.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.876 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.2 m -99.06 116.26 30.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.76 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.627 HG12 HD11 ' A' ' 62' ' ' LEU . 1.7 mp -86.13 122.54 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.42 139.02 34.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.714 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.484 ' HB2' HG11 ' A' ' 16' ' ' VAL . 42.6 t-105 -60.43 127.73 33.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 110.654 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.488 ' HA2' HG12 ' A' ' 47' ' ' VAL . . . 77.64 175.28 43.32 Favored Glycine 0 C--N 1.329 0.188 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.62 108.92 3.58 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.889 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -93.72 114.74 27.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.767 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -77.22 -8.6 57.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.543 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.56 -36.18 82.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.507 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.1 t -109.07 127.27 53.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.456 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.9 mp -84.23 -8.99 58.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.464 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.587 ' HD3' ' H ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -63.59 -41.41 98.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.441 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.67 132.29 38.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.51 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 63' ' ' SER . . . -123.65 -41.59 0.41 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 30' ' ' ILE . 21.2 t -82.19 93.49 2.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.101 0.476 . . . . 0.0 111.069 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.18 155.46 22.45 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.758 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -100.91 131.35 46.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.758 ' N ' ' SD ' ' A' ' 45' ' ' MET . 1.5 t80 -65.59 132.97 50.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.682 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.488 HG12 ' HA2' ' A' ' 33' ' ' GLY . 1.8 p -122.47 114.97 44.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.351 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.665 ' N ' ' OG1' ' A' ' 51' ' ' THR . 16.0 p -157.96 173.13 17.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.6 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.21 -14.8 11.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.6 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.787 HG21 ' O ' ' A' ' 109' ' ' ILE . 5.3 m -110.57 -38.61 3.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.784 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.665 ' OG1' ' N ' ' A' ' 48' ' ' SER . 62.5 p -77.45 140.39 39.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.606 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.481 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -144.9 167.05 23.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.245 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.478 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -85.5 157.02 58.97 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.73 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.52 83.98 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.529 2.153 . . . . 0.0 112.343 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 p -115.16 -2.92 12.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.688 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.19 91.12 0.18 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.34 81.68 0.14 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.456 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -163.38 162.19 34.67 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.607 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 20.0 t-160 -83.22 118.59 23.73 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.4 m -117.21 126.5 52.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.051 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.667 ' O ' ' SD ' ' A' ' 45' ' ' MET . 70.4 t -116.58 132.34 66.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 110.038 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.627 HD11 HG12 ' A' ' 30' ' ' ILE . 2.7 mm? -112.63 135.39 53.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.724 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.605 ' O ' ' O ' ' A' ' 42' ' ' GLY . 26.8 t -117.7 132.81 56.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.603 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.94 131.47 5.74 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.491 ' HA ' ' CD1' ' A' ' 123' ' ' TYR . 23.6 t60 -73.81 128.45 35.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.728 0.299 . . . . 0.0 110.403 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.469 ' H ' ' HB2' ' A' ' 123' ' ' TYR . 4.2 ptt180 79.09 138.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.424 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.576 ' O ' ' C ' ' A' ' 68' ' ' THR . 14.5 p-10 -112.15 -59.65 1.97 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.266 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.576 ' C ' ' O ' ' A' ' 67' ' ' ASP . 9.9 p 20.26 52.06 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.726 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 67' ' ' ASP . 12.2 m -67.9 94.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.58 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -99.45 -11.78 20.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.455 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.475 HG22 ' N ' ' A' ' 74' ' ' GLY . 2.6 m -97.38 91.34 5.44 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.315 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.599 ' OD1' HD12 ' A' ' 76' ' ' LEU . 56.5 m-20 -57.73 -47.84 81.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.213 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.768 HD12 ' N ' ' A' ' 73' ' ' LEU . 6.2 mp -78.02 -13.37 59.9 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.547 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.475 ' N ' HG22 ' A' ' 71' ' ' THR . . . -64.18 -50.53 59.64 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -139.74 -15.86 1.03 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.221 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.599 HD12 ' OD1' ' A' ' 72' ' ' ASP . 2.3 mt -90.8 60.72 4.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.91 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.622 ' HZ3' ' HB2' ' A' ' 80' ' ' ASP . 23.3 pttm -164.29 143.66 7.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.211 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.67 -19.3 59.24 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.228 0.537 . . . . 0.0 110.164 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -71.14 -15.51 62.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.817 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.686 ' OD1' ' N ' ' A' ' 81' ' ' THR . 6.0 t0 -68.86 152.34 45.43 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.175 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.686 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -141.22 121.95 14.34 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.128 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.0 mt -99.65 117.49 34.13 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.606 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.651 ' C ' HD22 ' A' ' 84' ' ' LEU . 45.2 t -100.47 121.89 51.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.969 0.414 . . . . 0.0 110.097 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 83' ' ' VAL . 4.0 mm? -109.36 131.62 54.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.296 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.581 ' HG3' HG23 ' A' ' 90' ' ' THR . 54.9 mp0 -102.5 123.47 46.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.83 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 5.3 t80 -143.62 119.19 10.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.87 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 57.35 51.1 10.41 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.745 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 62.34 7.7 2.42 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.675 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 56.9 mtmt -107.57 142.85 36.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.808 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.623 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -113.29 123.95 51.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.688 -179.372 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.402 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 22.1 m-85 -106.69 128.66 54.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.144 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.04 115.46 29.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.219 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 86.5 m-85 -109.97 153.47 24.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.639 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -126.88 139.29 53.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.64 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.489 HD13 ' HA ' ' A' ' 95' ' ' ILE . 9.1 mm -61.86 119.89 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.181 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -88.53 -67.15 0.85 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.553 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -148.97 136.37 20.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.295 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.2 mp -108.04 135.12 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.149 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.607 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 15.0 p90 -160.71 -178.86 7.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.268 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.846 HD12 ' N ' ' A' ' 100' ' ' ILE . 0.5 OUTLIER -126.2 132.82 70.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.316 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 102' ' ' HIS . 1.3 t -136.11 175.66 9.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 110.894 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.407 ' O ' HG23 ' A' ' 101' ' ' THR . 67.2 m80 -76.31 151.21 36.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.9 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.85 -18.47 65.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.788 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -94.28 17.31 13.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.048 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.628 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 21.4 t0 -91.89 100.42 13.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.837 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.911 ' O ' HG23 ' A' ' 110' ' ' ILE . 3.0 ptp85 -69.17 -32.57 71.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.268 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.628 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 6.3 p -37.85 -20.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.356 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.716 ' CG1' HG21 ' A' ' 118' ' ' THR . 18.5 t -105.26 -19.4 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.013 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.787 ' O ' HG21 ' A' ' 50' ' ' VAL . 45.4 mm -113.19 27.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.801 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.911 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -91.18 -168.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.433 ' N ' ' HB ' ' A' ' 50' ' ' VAL . 33.9 ttmt -97.1 147.87 23.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.538 ' HZ3' HG21 ' A' ' 116' ' ' ILE . 99.3 mttt -130.82 155.55 46.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 110.588 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -102.26 13.39 34.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.329 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.98 169.2 10.75 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.971 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.456 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 47.6 Cg_endo -79.66 95.4 1.04 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 123.284 2.656 . . . . 0.0 112.438 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.538 HG21 ' HZ3' ' A' ' 112' ' ' LYS . 49.7 mm -126.16 128.54 71.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.568 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.758 ' C ' HD23 ' A' ' 117' ' ' LEU . 4.7 tt -104.52 121.01 42.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.903 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.716 HG21 ' CG1' ' A' ' 108' ' ' VAL . 89.2 m -115.65 126.64 54.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.343 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.84 HD12 ' N ' ' A' ' 120' ' ' THR . 2.5 tp -111.98 127.85 55.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.056 0.455 . . . . 0.0 111.671 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.84 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -122.05 129.19 52.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.039 178.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.722 ' CG2' HD11 ' A' ' 119' ' ' LEU . 65.7 p -134.9 164.54 27.35 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.244 0.545 . . . . 0.0 111.768 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.631 ' CB ' ' O ' ' A' ' 121' ' ' THR . 0.5 OUTLIER 150.38 -76.16 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.935 179.202 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.62 ' O ' ' N ' ' A' ' 125' ' ' PHE . 26.1 m-85 48.5 159.81 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.011 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.94 62.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.268 1.979 . . . . 0.0 112.641 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.661 ' CD1' ' N ' ' A' ' 126' ' ' ASP . 1.7 p90 -79.9 -42.61 23.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.945 0.402 . . . . 0.0 110.715 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.661 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 25.4 t70 -126.82 -24.5 3.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.385 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.691 ' CE2' ' O ' ' A' ' 128' ' ' ILE . 60.4 t80 -105.73 132.49 51.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.553 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.691 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 88.7 mt -72.22 125.57 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.02 -154.24 25.34 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -73.25 108.23 6.01 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.293 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.588 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . . . -45.41 148.58 1.15 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.895 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.542 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 52.1 Cg_exo -49.16 -37.04 38.09 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.28 1.987 . . . . 0.0 111.937 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.542 ' OD1' ' O ' ' A' ' 132' ' ' PRO . 97.0 m-20 -145.06 157.47 44.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.55 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -119.16 134.33 55.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.29 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 120' ' ' THR . 6.6 t80 -68.53 133.01 47.93 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.969 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.607 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 37.8 mm -118.76 115.15 47.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.086 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.424 HG23 ' CD1' ' A' ' 95' ' ' ILE . 2.1 mm -107.96 108.53 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -91.4 146.65 23.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.02 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -153.05 142.96 22.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.428 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -115.64 150.46 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.146 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 6.5 tp -77.48 123.24 26.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.353 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.03 -40.36 5.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.826 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -136.99 164.23 25.26 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.0 p -151.1 152.44 33.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.826 0.346 . . . . 0.0 110.386 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 90' ' ' THR . 87.1 m-85 -136.44 155.04 50.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.487 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.1 p -143.27 125.62 15.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.583 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.1 tttt . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.562 -179.85 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.0 t -118.46 131.83 56.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 110.697 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -82.42 -162.15 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.56 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.9 ttm -69.3 137.45 53.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.638 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.1 -10.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.621 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 m -74.23 148.29 41.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 51.9 18.2 0.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.66 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.569 ' O ' ' O ' ' A' ' 9' ' ' GLU . 95.5 m -134.85 138.53 44.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.002 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.569 ' O ' ' O ' ' A' ' 8' ' ' THR . 50.1 tp10 52.6 155.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.46 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.474 ' N ' ' HG3' ' A' ' 9' ' ' GLU . 53.3 m80 -68.4 113.21 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.928 0.394 . . . . 0.0 110.554 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -135.4 140.67 45.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.401 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.444 ' CD ' ' H ' ' A' ' 12' ' ' GLU . 35.1 mp0 -70.18 123.89 22.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.025 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 109.43 11.74 20.97 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -118.48 134.43 55.08 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.333 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.537 ' N ' ' CD2' ' A' ' 31' ' ' TYR . 40.3 tttm -57.97 112.69 1.58 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.352 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 m -114.2 -38.22 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.877 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.79 154.97 49.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.541 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.413 ' CE ' ' OE1' ' A' ' 85' ' ' GLU . 16.2 ttp -118.74 137.94 53.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.436 ' CD1' HD21 ' A' ' 84' ' ' LEU . 46.2 tp -106.1 119.26 38.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.145 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -118.87 127.14 53.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 111.328 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.843 HD13 ' OE1' ' A' ' 75' ' ' GLN . 4.5 mt -109.82 116.95 53.25 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.516 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.03 -45.74 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.529 2.153 . . . . 0.0 113.036 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.511 ' C ' HD22 ' A' ' 24' ' ' LEU . 19.1 tptm -62.52 -38.6 90.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.773 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.2 mm? -96.4 4.62 52.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.999 0.428 . . . . 0.0 110.442 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 41.9 49.09 4.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.127 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -135.33 157.7 46.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.963 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -138.92 140.18 38.26 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.47 142.38 47.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.457 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 m -90.73 123.76 34.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.687 HG12 HD11 ' A' ' 62' ' ' LEU . 1.7 mp -96.28 123.19 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.453 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.537 ' CD2' ' N ' ' A' ' 15' ' ' LYS . 42.1 m-85 -103.11 145.06 30.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.787 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.599 ' O ' ' N ' ' A' ' 13' ' ' GLY . 41.1 t-105 -59.1 130.05 45.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.974 0.416 . . . . 0.0 110.521 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.573 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 82.59 141.07 3.82 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HB1' ' OG ' ' A' ' 63' ' ' SER . . . -118.96 81.33 1.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.925 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -101.66 108.94 20.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.496 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -85.58 -7.98 58.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.624 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.64 -13.63 48.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.633 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.45 -147.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.693 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.9 mt -38.37 -63.05 0.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.783 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.401 ' HE3' ' OH ' ' A' ' 123' ' ' TYR . 87.6 tttt 62.14 111.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.053 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -112.84 -4.84 13.92 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.802 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.53 -31.99 7.9 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.46 92.39 2.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.96 0.409 . . . . 0.0 110.527 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.34 141.79 14.42 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.692 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -93.41 125.58 38.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.692 ' N ' ' SD ' ' A' ' 45' ' ' MET . 16.7 t80 -66.84 140.87 57.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.26 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.573 HG23 ' HA2' ' A' ' 33' ' ' GLY . 54.4 t -114.58 129.46 70.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.633 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.628 ' N ' ' OG1' ' A' ' 51' ' ' THR . 11.6 t -163.21 166.42 23.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.59 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 36.8 t0 -68.94 -11.48 60.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.433 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.662 HG21 ' O ' ' A' ' 109' ' ' ILE . 6.1 m -109.01 -14.55 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.528 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 48' ' ' SER . 25.5 p -85.73 149.1 25.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.554 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.521 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.8 OUTLIER -140.74 164.85 29.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.951 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.44 HG22 ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -95.38 151.93 38.98 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.216 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.89 54.23 3.99 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.757 2.305 . . . . 0.0 112.634 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.2 p -102.4 -7.69 21.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.264 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.07 81.17 0.04 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.78 103.15 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.584 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.7 160.41 34.0 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.738 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 22.1 t-160 -81.42 99.37 8.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.8 m -94.02 126.54 39.29 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.677 ' O ' ' SD ' ' A' ' 45' ' ' MET . 71.8 t -116.52 128.93 73.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.077 0.465 . . . . 0.0 110.232 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.687 HD11 HG12 ' A' ' 30' ' ' ILE . 2.7 mm? -114.58 141.55 47.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.73 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.465 ' OG ' ' HB1' ' A' ' 34' ' ' ALA . 4.8 p -128.4 146.61 50.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.707 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.66 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -176.91 -179.44 47.31 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -115.92 160.01 20.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.901 0.382 . . . . 0.0 110.534 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -54.08 137.43 40.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.6 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -84.57 -108.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.576 ' OG1' ' OG1' ' A' ' 71' ' ' THR . 4.5 p -128.36 -178.44 4.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.465 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 72.8 t -60.34 -46.09 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.79 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.99 70.63 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.683 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.576 ' OG1' ' OG1' ' A' ' 68' ' ' THR . 0.0 OUTLIER -164.62 -67.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 0.0 110.541 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.515 ' OD1' ' O ' ' A' ' 72' ' ' ASP . 26.8 t0 -63.36 -27.82 69.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.498 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.0 tp -60.91 -42.88 98.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.199 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.7 -28.09 48.31 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.843 ' OE1' HD13 ' A' ' 21' ' ' ILE . 20.4 mm100 -63.82 -39.42 94.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.688 0.28 . . . . 0.0 110.669 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.859 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.6 pp -91.25 102.45 15.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.39 0.614 . . . . 0.0 111.333 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.529 ' HG3' ' H ' ' A' ' 80' ' ' ASP . 20.6 pttm 176.83 152.56 0.19 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.221 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.32 -31.73 70.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.359 0.599 . . . . 0.0 110.727 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 mmtt -69.78 -14.15 62.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.501 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.67 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 1.2 t70 -82.67 152.95 25.62 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.566 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.493 ' O ' HD23 ' A' ' 82' ' ' LEU . 2.6 p -138.85 149.55 45.02 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 81' ' ' THR . 41.1 mt -121.58 123.66 42.5 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.8 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.55 ' C ' HD22 ' A' ' 84' ' ' LEU . 10.7 t -103.74 116.96 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.55 HD22 ' C ' ' A' ' 83' ' ' VAL . 2.7 mm? -105.69 132.35 51.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.53 -178.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.499 ' HG2' HG23 ' A' ' 90' ' ' THR . 28.6 mt-10 -108.75 123.53 49.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.55 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.587 ' O ' ' N ' ' A' ' 89' ' ' LYS . 12.2 t80 -144.48 145.22 31.75 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.034 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.417 ' N ' ' CD1' ' A' ' 86' ' ' TYR . 34.8 t70 36.95 51.29 0.96 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.759 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.0 m120 59.32 25.12 13.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.961 0.41 . . . . 0.0 110.598 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 86' ' ' TYR . 54.5 mtmt -124.07 144.34 49.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.107 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.499 HG23 ' HG2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -111.69 126.92 55.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.565 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -112.47 131.86 55.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.278 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.431 ' O ' HD22 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -102.59 106.24 16.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.343 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 53.1 m-85 -97.08 161.49 13.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.354 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.67 ' OE1' ' O ' ' A' ' 80' ' ' ASP . 2.8 tp10 -136.85 137.23 39.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.514 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.599 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 1.9 mm -65.54 124.2 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.554 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -98.72 -62.89 1.18 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.544 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -141.14 138.9 33.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.319 0.58 . . . . 0.0 109.786 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.727 HG23 HD13 ' A' ' 137' ' ' ILE . 46.6 mt -120.36 127.62 75.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.833 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.599 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 22.4 p90 -152.72 -177.59 6.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.816 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.707 HG22 ' OD2' ' A' ' 133' ' ' ASP . 2.4 mp -125.68 132.82 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.757 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.623 HG21 HG21 ' A' ' 108' ' ' VAL . 2.0 t -143.32 166.45 24.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -65.9 147.83 52.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.236 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.44 80.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.64 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' ARG . 46.7 t0 -63.91 -33.34 75.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.611 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.447 ' OD2' ' OG1' ' A' ' 107' ' ' THR . 14.6 t70 -40.13 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.447 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 109' ' ' ILE . 11.1 ptp85 -68.96 -26.09 64.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.806 ' O ' HD11 ' A' ' 110' ' ' ILE . 10.9 p -49.1 -21.93 0.83 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.587 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.625 HG11 HD12 ' A' ' 136' ' ' ILE . 6.8 t -97.77 -13.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.166 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.791 HG22 ' O ' ' A' ' 109' ' ' ILE . 48.1 mm -114.83 18.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.273 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.806 HD11 ' O ' ' A' ' 107' ' ' THR . 0.4 OUTLIER -79.1 -156.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.889 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.421 ' H ' ' HB ' ' A' ' 110' ' ' ILE . 22.3 ttmt -107.76 148.18 29.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.524 ' HG2' ' CG ' ' A' ' 59' ' ' HIS . 71.9 mmtt -125.15 141.66 51.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.906 0.384 . . . . 0.0 110.257 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.578 ' O ' ' OE2' ' A' ' 114' ' ' GLU . 51.4 mm-40 -89.62 10.78 21.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.722 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.578 ' OE2' ' O ' ' A' ' 113' ' ' GLU . 44.0 mm-40 -143.11 152.65 58.67 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.584 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 12.0 Cg_endo -62.15 84.49 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.642 2.228 . . . . 0.0 110.771 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.65 132.11 66.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.787 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.785 ' C ' HD23 ' A' ' 117' ' ' LEU . 5.5 tt -107.54 119.77 40.33 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.277 0.56 . . . . 0.0 109.923 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.562 HG21 ' CG1' ' A' ' 108' ' ' VAL . 73.1 m -116.15 117.44 30.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.742 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.946 HD12 ' N ' ' A' ' 120' ' ' THR . 1.0 OUTLIER -107.54 124.69 50.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.85 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.946 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -119.03 122.74 42.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.578 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.66 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.3 t -161.02 176.15 11.69 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.224 0.535 . . . . 0.0 111.989 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.636 ' CB ' ' O ' ' A' ' 121' ' ' THR . 0.1 OUTLIER 152.07 -66.09 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.192 179.595 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.722 ' CG ' ' O ' ' A' ' 123' ' ' TYR . 5.8 p90 -31.01 95.53 0.08 OUTLIER Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.711 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.476 ' N ' ' O ' ' A' ' 122' ' ' CYS . 60.9 Cg_endo -81.64 -168.24 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.518 2.146 . . . . 0.0 111.863 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -65.15 -20.08 66.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.397 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.465 ' C ' ' OD1' ' A' ' 126' ' ' ASP . 43.8 t0 -63.11 -65.44 0.69 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.159 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.593 ' CE2' ' O ' ' A' ' 130' ' ' ASP . 43.5 t80 -71.38 128.74 36.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.199 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.6 mt -91.71 90.55 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 125.87 -128.15 6.38 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.616 ' CB ' HH21 ' A' ' 134' ' ' ARG . 52.9 p-10 -105.15 114.91 29.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.747 0.308 . . . . 0.0 110.621 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.74 157.19 15.3 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.69 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -49.8 -37.92 46.13 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.338 2.025 . . . . 0.0 112.356 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.707 ' OD2' HG22 ' A' ' 100' ' ' ILE . 4.8 t0 -140.08 133.11 29.45 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.616 HH21 ' CB ' ' A' ' 130' ' ' ASP . 92.6 mtt180 -99.02 144.11 28.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.235 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.484 ' CE2' HD11 ' A' ' 137' ' ' ILE . 4.6 t80 -75.57 132.57 40.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.625 HD12 HG11 ' A' ' 108' ' ' VAL . 15.8 mm -110.88 110.94 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.727 HD13 HG23 ' A' ' 98' ' ' ILE . 51.2 mm -101.28 108.89 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -96.76 142.2 29.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.31 0.576 . . . . 0.0 111.407 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -153.54 146.98 24.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.04 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -116.57 157.47 25.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.901 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.691 HD13 ' C ' ' A' ' 141' ' ' LEU . 2.6 tm? -87.77 118.41 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.119 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -108.44 -65.03 1.16 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.441 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.548 ' N ' ' OG1' ' A' ' 142' ' ' THR . . . -93.16 156.9 23.04 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.0 p -152.6 152.1 31.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.518 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -142.87 132.82 24.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.411 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.3 t -121.63 131.94 54.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.998 0.428 . . . . 0.0 110.434 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.622 -179.27 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -75.38 13.32 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 110.562 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -89.67 127.64 35.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.611 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 73.0 mtp -121.61 -174.93 2.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.412 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.38 35.24 4.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.562 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.5 p -136.29 -175.23 3.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.597 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.42 ' H ' ' HG2' ' A' ' 7' ' ' GLN . 13.6 pt20 -88.33 124.8 34.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.015 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.548 HG22 ' N ' ' A' ' 9' ' ' GLU . 20.8 m -119.0 -118.63 0.31 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.388 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.548 ' N ' HG22 ' A' ' 8' ' ' THR . 21.7 tt0 -166.17 121.75 1.24 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.018 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.497 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 0.2 OUTLIER 79.64 11.52 1.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.533 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -68.07 131.69 45.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.846 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.462 ' HG2' HG21 ' A' ' 47' ' ' VAL . 50.5 mt-10 -64.99 130.4 43.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.914 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 95.54 21.38 24.41 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -128.45 146.35 50.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.994 0.426 . . . . 0.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -64.26 119.8 10.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.065 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 17' ' ' ALA . 5.0 m -119.59 -46.12 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.626 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -128.22 169.54 14.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.457 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.7 tpp -127.75 139.72 52.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.399 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.719 ' HB2' HD11 ' A' ' 30' ' ' ILE . 5.6 tp -108.18 124.49 50.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.338 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 26' ' ' LYS . 21.5 t-20 -118.33 129.3 55.36 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.0 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.408 HG22 ' H ' ' A' ' 24' ' ' LEU . 24.5 mt -114.73 111.87 45.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.202 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.8 -37.65 1.13 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.647 2.231 . . . . 0.0 112.993 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.813 ' NZ ' ' HZ1' ' A' ' 77' ' ' LYS . 2.1 tptm -62.33 -37.24 84.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.701 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.715 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.3 mm? -98.95 -3.34 35.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.402 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 54.62 65.8 1.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.339 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.431 ' C ' ' CG ' ' A' ' 27' ' ' LYS . 16.0 ptmt -165.72 -175.19 3.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.077 0.465 . . . . 0.0 111.26 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' CG ' ' C ' ' A' ' 26' ' ' LYS . 4.1 mtpt -155.32 155.75 34.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.292 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.426 ' CZ ' ' HE2' ' A' ' 26' ' ' LYS . 78.9 m-85 -135.82 146.48 47.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.449 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.7 m -87.18 118.45 26.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.956 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.873 HD12 HD11 ' A' ' 62' ' ' LEU . 41.1 mm -85.1 113.92 24.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -99.22 135.53 40.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.848 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.535 ' O ' ' N ' ' A' ' 13' ' ' GLY . 28.3 t-105 -60.62 122.18 14.06 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.015 0.436 . . . . 0.0 110.829 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 86.97 156.77 29.84 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.01 84.96 2.26 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.449 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -96.85 98.63 10.28 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.507 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' C ' ' OD1' ' A' ' 36' ' ' ASP . 47.5 p30 -82.84 -6.24 59.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.221 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.42 ' N ' ' OD1' ' A' ' 36' ' ' ASP . . . -68.42 -43.29 77.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.5 p -84.79 165.8 17.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.547 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.39 69.41 9.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.336 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -104.52 -176.18 3.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.432 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -76.31 150.19 36.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.663 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.431 ' H ' ' CG ' ' A' ' 67' ' ' ASP . . . -75.83 55.52 3.03 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.623 ' CG2' HD13 ' A' ' 30' ' ' ILE . 2.5 p -159.63 92.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.372 0.606 . . . . 0.0 110.529 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.48 160.83 24.12 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.674 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -104.27 129.97 52.08 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.674 ' N ' ' SD ' ' A' ' 45' ' ' MET . 5.5 t80 -63.06 145.95 54.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.983 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.479 HG22 ' CE2' ' A' ' 32' ' ' TRP . 46.1 t -118.55 128.01 75.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.483 ' HG ' ' CB ' ' A' ' 51' ' ' THR . 59.8 p -167.1 173.85 8.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.435 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.91 -6.73 53.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.768 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.704 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.5 m -114.1 -23.04 4.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.664 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.483 ' CB ' ' HG ' ' A' ' 48' ' ' SER . 23.7 p -87.21 159.05 18.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.531 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.49 171.61 19.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.187 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.505 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -91.16 156.49 43.85 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.413 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.772 ' HG3' HD23 ' A' ' 84' ' ' LEU . 70.8 Cg_endo -75.81 83.13 2.0 Allowed 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.687 2.258 . . . . 0.0 112.444 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.8 p -115.3 -4.72 12.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.719 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.82 89.66 0.08 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.78 87.12 0.04 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.442 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -162.32 168.47 37.31 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.517 ' CD2' ' HE2' ' A' ' 112' ' ' LYS . 16.8 t-160 -89.16 116.93 27.77 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.9 m -111.97 127.22 55.8 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.073 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.674 ' O ' ' SD ' ' A' ' 45' ' ' MET . 58.6 t -119.35 126.14 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.994 0.426 . . . . 0.0 110.787 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.873 HD11 HD12 ' A' ' 30' ' ' ILE . 2.3 mm? -116.23 145.78 42.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.629 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 93.7 p -137.93 154.33 49.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.825 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.39 156.74 27.12 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.755 ' O ' ' N ' ' A' ' 67' ' ' ASP . 65.1 t-80 -140.91 142.71 34.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.412 0.149 . . . . 0.0 110.609 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.477 ' C ' ' O ' ' A' ' 65' ' ' HIS . 8.6 ttt180 26.18 -76.5 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.573 0.546 . . . . 0.0 111.434 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.755 ' N ' ' O ' ' A' ' 65' ' ' HIS . 0.2 OUTLIER 40.48 -165.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.772 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.2 m -124.7 89.52 3.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.131 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 69' ' ' VAL . 32.1 m -131.17 129.58 62.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.713 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -117.52 12.61 14.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.958 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.481 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -107.46 46.59 0.93 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.177 0.513 . . . . 0.0 110.335 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.605 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 55.1 m-20 -63.3 -39.27 94.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.778 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -59.36 -37.13 77.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.883 -179.318 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.33 -16.11 67.48 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -28.1 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.586 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.605 ' CD2' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -120.85 91.57 3.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.018 0.437 . . . . 0.0 110.88 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.813 ' HZ1' ' NZ ' ' A' ' 23' ' ' LYS . 60.0 pttt -177.95 147.4 0.46 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.977 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.6 -18.12 61.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.921 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -77.35 -15.54 59.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.595 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.535 ' OD2' HD21 ' A' ' 82' ' ' LEU . 3.7 t70 -76.76 154.57 33.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.927 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.483 ' O ' HD23 ' A' ' 82' ' ' LEU . 1.9 p -139.45 139.89 37.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.535 HD21 ' OD2' ' A' ' 80' ' ' ASP . 13.0 mt -118.67 129.75 55.46 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.755 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.461 ' C ' HD12 ' A' ' 84' ' ' LEU . 2.3 t -111.62 118.29 57.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.772 HD23 ' HG3' ' A' ' 54' ' ' PRO . 7.6 mp -99.3 130.87 45.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.57 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -114.9 115.11 26.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.55 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.626 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.2 t80 -147.61 130.25 15.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.4 ' OD1' ' O ' ' A' ' 87' ' ' ASP . 61.9 t0 64.01 40.37 7.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.668 0.27 . . . . 0.0 111.325 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 63.17 11.0 4.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.449 ' HB3' ' CE1' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -107.64 143.18 36.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.962 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.575 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -111.66 124.8 53.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.32 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 5.6 m-85 -113.6 137.49 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.907 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.585 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -105.86 118.76 37.42 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.619 ' CE1' HD22 ' A' ' 84' ' ' LEU . 64.7 m-85 -113.27 161.46 17.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.983 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -141.12 140.2 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.246 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.533 HD12 ' H ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -66.92 124.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.57 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -96.11 -60.24 1.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.184 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -144.4 143.81 31.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.25 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.8 mt -117.38 133.43 64.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.483 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 18.4 p90 -153.0 -175.63 5.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.004 0.43 . . . . 0.0 111.433 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 mt -125.52 133.06 70.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.536 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.555 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 1.7 t -133.71 168.32 18.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.132 0.491 . . . . 0.0 110.906 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -76.65 157.05 32.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.48 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.53 -9.23 40.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.661 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.559 ' OD1' ' O ' ' A' ' 104' ' ' ASP . 57.7 t0 -109.26 23.75 14.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.881 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.621 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 67.2 t0 -88.95 92.67 9.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.645 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.736 ' O ' HG23 ' A' ' 110' ' ' ILE . 12.2 ptp85 -65.27 -34.76 79.1 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.161 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.621 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 10.2 p -42.29 -17.02 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.472 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.865 ' CG1' HG21 ' A' ' 118' ' ' THR . 58.9 t -102.79 -20.89 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.046 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.704 ' O ' HG21 ' A' ' 50' ' ' VAL . 48.4 mm -110.31 21.99 5.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.992 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.736 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -82.73 -172.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.146 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -87.27 142.52 27.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.888 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.517 ' HE2' ' CD2' ' A' ' 59' ' ' HIS . 2.5 tppt? -121.42 147.26 45.97 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.934 0.397 . . . . 0.0 110.57 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 113' ' ' GLU . 1.6 mp0 -101.47 15.72 27.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.031 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.11 171.81 6.21 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.29 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.442 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 54.7 Cg_endo -80.06 95.43 1.01 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 123.014 2.476 . . . . 0.0 111.668 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 116' ' ' ILE . 49.2 mm -127.66 139.05 52.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.625 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.771 ' C ' HD23 ' A' ' 117' ' ' LEU . 5.5 tt -112.44 120.11 40.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.35 0.595 . . . . 0.0 110.195 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.865 HG21 ' CG1' ' A' ' 108' ' ' VAL . 85.7 m -111.95 116.61 30.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.099 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.826 HD23 ' N ' ' A' ' 120' ' ' THR . 3.7 tt -108.97 122.4 47.15 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.412 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.826 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -106.29 124.33 49.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.055 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.505 HG22 HD22 ' A' ' 119' ' ' LEU . 0.8 OUTLIER -105.11 127.42 52.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.755 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.5 ' C ' ' CD1' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -118.21 80.34 1.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.856 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 123' ' ' TYR . 2.4 m-85 -131.03 120.82 18.48 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.317 -178.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.627 ' CB ' ' H ' ' A' ' 129' ' ' GLY . 69.1 Cg_endo -77.81 76.18 4.44 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.327 2.018 . . . . 0.0 112.081 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -72.09 -28.28 63.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.481 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -131.92 -36.13 1.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.706 ' CE2' ' O ' ' A' ' 130' ' ' ASP . 72.3 t80 -61.29 -36.64 80.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.425 ' HB ' ' O ' ' A' ' 127' ' ' TYR . 69.6 mt 68.1 85.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.427 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.627 ' H ' ' CB ' ' A' ' 124' ' ' PRO . . . 120.21 -116.47 3.26 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.706 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 21.5 t70 -101.87 101.07 11.46 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.714 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HA ' ' CG ' ' A' ' 127' ' ' TYR . . . -63.7 148.9 93.69 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.593 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.507 ' HD3' ' CD1' ' A' ' 127' ' ' TYR . 29.8 Cg_endo -64.85 -60.11 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.673 2.249 . . . . 0.0 112.178 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -98.15 158.14 15.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.156 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -110.45 131.56 54.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.099 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.438 ' HB3' ' OG1' ' A' ' 121' ' ' THR . 2.0 t80 -64.42 141.86 58.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.538 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.462 ' CG1' HG22 ' A' ' 101' ' ' THR . 5.9 mm -128.4 116.71 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 137' ' ' ILE . 1.3 mp -105.32 112.11 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.469 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 45.4 tt0 -93.96 139.34 31.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.9 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.52 148.77 33.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.205 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.9 tttm -122.03 148.41 44.88 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.992 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.788 HD23 ' C ' ' A' ' 141' ' ' LEU . 8.2 tt -73.14 115.33 12.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.162 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.445 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.7 OUTLIER -88.8 -43.38 11.29 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.912 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.585 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -134.9 160.51 24.31 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 62.5 p -136.23 142.74 44.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.588 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.575 ' N ' ' O ' ' A' ' 90' ' ' THR . 92.6 m-85 -130.53 154.96 47.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.464 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.55 ' O ' ' OXT' ' A' ' 147' ' ' LYS . 20.2 p -141.77 121.19 13.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.299 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.55 ' OXT' ' O ' ' A' ' 146' ' ' SER . 18.5 ttmt . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.621 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.4 p -75.16 159.92 31.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.524 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.49 122.71 12.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.395 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.632 ' SD ' ' O ' ' A' ' 4' ' ' MET . 0.3 OUTLIER -136.2 157.24 47.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.744 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 6' ' ' SER . 9.4 m -153.42 74.14 1.0 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.347 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 5' ' ' SER . 0.6 OUTLIER 44.39 104.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.621 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 6' ' ' SER . 97.9 mm-40 42.45 96.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.75 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.506 HG21 ' H ' ' A' ' 5' ' ' SER . 2.7 t -156.85 166.91 32.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.817 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 60.53 165.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.651 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -91.06 104.55 17.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.556 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -129.8 127.16 39.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.24 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.693 ' CD ' ' H ' ' A' ' 12' ' ' GLU . 1.0 OUTLIER -68.14 148.6 50.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.374 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.24 0.76 76.5 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -115.33 131.97 56.76 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.333 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . 60.7 tttm -57.38 125.35 22.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.064 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 m -117.06 -37.98 2.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.135 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -140.92 167.37 22.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.865 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.453 ' SD ' ' HA ' ' A' ' 29' ' ' SER . 4.5 tpp -121.0 147.64 45.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.452 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 83' ' ' VAL . 51.1 tp -114.76 115.47 27.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.003 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.471 HD22 ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -105.24 135.94 45.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.302 179.201 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 25' ' ' LYS . 8.3 mt -113.34 90.67 17.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.125 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 20' ' ' ASN . 31.6 Cg_exo -55.5 -42.68 65.5 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 123.178 2.585 . . . . 0.0 112.746 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.608 ' C ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -60.31 -42.75 96.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.715 -178.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.81 HD22 ' N ' ' A' ' 24' ' ' LEU . 2.8 mm? -100.41 2.65 42.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.147 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 21' ' ' ILE . 75.3 mmtt 50.34 36.02 12.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.432 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -113.6 173.09 6.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.377 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.408 ' CD ' ' OD1' ' A' ' 20' ' ' ASN . 30.9 mtmm -148.57 142.18 25.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.98 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -134.07 152.55 51.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.851 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.453 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -95.11 120.52 35.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.578 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.414 HD11 ' HB2' ' A' ' 19' ' ' LEU . 48.9 mm -88.76 117.29 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.236 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 87.3 m-85 -102.37 135.81 43.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.113 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -59.66 125.55 24.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.586 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 74.35 173.65 30.14 Favored Glycine 0 C--N 1.331 0.266 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.96 135.42 46.57 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.642 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -93.01 95.51 9.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.698 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 37' ' ' ALA . 50.2 p-10 -67.92 -31.36 71.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.359 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.555 ' N ' ' OD1' ' A' ' 36' ' ' ASP . . . -74.8 -63.69 1.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.078 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.2 p -83.28 165.38 19.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.461 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.2 mp -76.54 142.25 40.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.41 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.636 ' NZ ' ' OG1' ' A' ' 68' ' ' THR . 22.2 pttp -83.75 149.95 26.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.923 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -63.77 -44.86 92.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.968 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.425 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . . . -162.94 -55.45 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.09 135.44 37.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -118.42 139.09 14.29 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.432 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 2.3 ttp -97.9 129.38 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.12 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -63.73 143.28 57.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.586 HG23 ' HA2' ' A' ' 33' ' ' GLY . 55.4 t -122.85 128.55 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.77 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.787 ' HG ' ' H ' ' A' ' 51' ' ' THR . 7.3 p -164.18 168.96 18.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.507 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -64.03 -35.29 80.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.698 HG21 ' O ' ' A' ' 109' ' ' ILE . 4.4 m -87.62 -25.34 6.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.802 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.787 ' H ' ' HG ' ' A' ' 48' ' ' SER . 43.5 p -77.23 140.38 40.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.737 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.616 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 1.3 p -131.75 171.31 13.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.847 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.12 155.87 36.08 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.948 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.685 ' HG3' HD13 ' A' ' 84' ' ' LEU . 65.4 Cg_endo -77.77 62.89 7.97 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.723 2.282 . . . . 0.0 112.325 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.415 ' O ' ' OH ' ' A' ' 91' ' ' TYR . 86.7 p -112.63 -3.8 14.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.77 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.52 91.24 0.08 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.09 88.35 0.01 OUTLIER Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.485 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -161.04 152.32 22.91 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.616 ' N ' ' OG1' ' A' ' 52' ' ' THR . 19.8 t-160 -78.69 106.18 10.5 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.3 m -101.8 124.44 47.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.231 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.639 HG11 ' CD1' ' A' ' 109' ' ' ILE . 74.3 t -117.62 129.46 74.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.521 HD22 ' C ' ' A' ' 61' ' ' VAL . 3.0 mm? -108.04 144.36 35.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.167 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.2 t -128.1 136.54 51.33 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.755 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.402 ' N ' HG22 ' A' ' 121' ' ' THR . . . -153.21 139.49 6.95 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.57 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.757 ' NE2' ' CZ ' ' A' ' 123' ' ' TYR . 16.2 m170 -81.97 144.9 30.58 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.492 -0.417 . . . . 0.0 110.482 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 122' ' ' CYS . 0.0 OUTLIER -46.86 -15.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.47 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 69' ' ' VAL . 25.0 t70 -63.23 -39.96 96.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.636 ' OG1' ' NZ ' ' A' ' 40' ' ' LYS . 13.9 m -72.8 101.63 3.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.703 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -132.81 126.39 54.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.344 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.575 ' CE2' HG22 ' A' ' 68' ' ' THR . 0.1 OUTLIER -135.26 -96.73 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.79 0.328 . . . . 0.0 110.548 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.516 HG21 HD12 ' A' ' 24' ' ' LEU . 17.0 p -94.98 76.14 3.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.366 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.422 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 46.3 m-20 -62.86 -40.19 96.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.489 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -63.55 -35.9 82.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.59 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' HD2' ' A' ' 77' ' ' LYS . . . -78.96 -33.54 36.53 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -66.07 -35.81 81.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.631 0.253 . . . . 0.0 111.246 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.605 HD22 ' OH ' ' A' ' 135' ' ' TYR . 11.3 mt -88.37 83.29 6.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.845 0.355 . . . . 0.0 111.005 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.437 ' NZ ' ' HD3' ' A' ' 23' ' ' LYS . 14.2 ptmt -177.8 134.6 0.17 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.837 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.65 -10.63 59.89 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.394 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -82.92 -14.9 53.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.064 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.43 ' OD2' HD21 ' A' ' 82' ' ' LEU . 3.7 t70 -64.21 155.16 32.7 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.637 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.439 ' O ' HD23 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -133.25 140.29 47.41 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.033 0.445 . . . . 0.0 110.067 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 81' ' ' THR . 21.2 mt -119.8 120.58 36.92 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.485 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.508 ' O ' HD12 ' A' ' 19' ' ' LEU . 2.9 t -107.13 130.32 59.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.045 0.45 . . . . 0.0 110.492 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.752 HD11 HD12 ' A' ' 117' ' ' LEU . 27.1 mt -113.79 128.83 56.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.474 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HG2' HG23 ' A' ' 90' ' ' THR . 83.9 mt-10 -104.46 118.27 36.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.564 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.535 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -153.19 129.38 10.45 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.869 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.435 ' C ' ' N ' ' A' ' 89' ' ' LYS . 58.2 m-20 61.24 54.29 3.28 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.844 0.354 . . . . 0.0 111.338 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 51.59 15.31 0.34 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.699 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.435 ' N ' ' C ' ' A' ' 87' ' ' ASP . 20.6 mtpt -119.33 143.23 47.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.37 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.479 HG22 ' CG1' ' A' ' 83' ' ' VAL . 4.6 m -115.14 120.55 40.14 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.346 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.415 ' OH ' ' O ' ' A' ' 55' ' ' SER . 13.6 m-85 -99.62 136.06 40.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.177 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.561 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -108.27 119.01 38.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.218 -178.496 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.627 ' CE1' HD12 ' A' ' 84' ' ' LEU . 91.4 m-85 -113.1 165.13 12.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.62 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -143.44 139.89 30.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.942 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mt -69.01 121.63 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.804 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -97.04 -42.19 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.587 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -158.25 140.08 13.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.692 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.5 mt -118.25 126.59 75.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.256 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.8 p90 -149.37 -179.23 6.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.598 HG22 ' HB3' ' A' ' 133' ' ' ASP . 1.3 mp -125.21 126.89 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.047 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 102' ' ' HIS . 1.7 t -129.11 173.38 10.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.711 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.487 ' ND1' ' N ' ' A' ' 102' ' ' HIS . 1.0 OUTLIER -73.16 152.73 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.649 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.82 -18.51 65.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.743 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -92.58 4.53 53.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.696 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.852 ' O ' HG22 ' A' ' 108' ' ' VAL . 41.9 t0 -75.3 60.55 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.373 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 109' ' ' ILE . 28.1 ptt85 -38.53 -23.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.747 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 105' ' ' ASP . 65.5 p -46.5 -16.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.599 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.852 HG22 ' O ' ' A' ' 105' ' ' ASP . 3.9 m -106.25 -13.03 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 120.952 0.406 . . . . 0.0 110.339 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.755 HG22 ' O ' ' A' ' 109' ' ' ILE . 41.6 mm -112.89 21.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.549 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.573 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -88.95 -163.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.862 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -104.07 140.56 37.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.632 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -131.4 140.41 49.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.566 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -87.74 11.44 15.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.058 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.93 160.33 69.05 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.845 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.485 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 39.6 Cg_endo -77.32 99.37 1.29 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.895 2.397 . . . . 0.0 111.563 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.421 HD13 ' O ' ' A' ' 115' ' ' PRO . 49.8 mm -130.36 133.27 64.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.179 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.752 HD12 HD11 ' A' ' 84' ' ' LEU . 6.5 tt -107.94 117.85 35.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.249 0.547 . . . . 0.0 110.249 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 61.2 m -118.27 123.02 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.971 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.872 HD23 ' C ' ' A' ' 119' ' ' LEU . 1.0 OUTLIER -109.23 131.53 54.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.93 0.395 . . . . 0.0 111.043 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 135' ' ' TYR . 0.2 OUTLIER -126.32 121.65 33.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.895 179.469 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.68 ' O ' ' SG ' ' A' ' 122' ' ' CYS . 69.5 p -136.57 159.33 42.12 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.586 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.68 ' SG ' ' O ' ' A' ' 121' ' ' THR . 1.3 m 152.58 -66.79 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.794 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.757 ' CZ ' ' NE2' ' A' ' 65' ' ' HIS . 19.7 m-85 55.36 109.42 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.338 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -46.37 -72.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.821 2.348 . . . . 0.0 113.496 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 0.5 OUTLIER -53.39 -49.51 67.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.005 -178.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -56.53 -41.11 76.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.987 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.462 ' O ' ' N ' ' A' ' 129' ' ' GLY . 14.1 t80 -71.66 139.54 49.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.733 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.9 mm -53.08 90.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.158 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 127' ' ' TYR . . . 104.3 -114.33 4.69 Favored Glycine 0 CA--C 1.517 0.216 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.435 ' O ' ' HD3' ' A' ' 132' ' ' PRO . 25.2 t70 -137.79 136.52 37.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.911 0.386 . . . . 0.0 110.372 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.733 ' O ' ' NH1' ' A' ' 134' ' ' ARG . . . -112.24 83.97 5.58 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.271 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 130' ' ' ASP . 50.2 Cg_exo -50.55 -37.68 52.94 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.781 2.321 . . . . 0.0 112.282 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.598 ' HB3' HG22 ' A' ' 100' ' ' ILE . 65.6 m-20 -115.8 149.17 38.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.429 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.733 ' NH1' ' O ' ' A' ' 131' ' ' ALA . 62.5 mmt-85 -103.59 136.6 43.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.732 ' CE2' HD11 ' A' ' 137' ' ' ILE . 5.0 t80 -68.13 130.6 43.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.674 -0.411 . . . . 0.0 109.903 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.6 mm -120.58 118.91 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.732 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp -108.1 109.02 26.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -91.13 140.05 30.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.906 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.13 137.3 18.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.955 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 69.2 tttt -112.54 158.53 19.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.022 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.537 ' N ' ' CG ' ' A' ' 140' ' ' LYS . 10.6 tp -77.06 122.68 25.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.449 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.25 -38.19 6.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.515 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.561 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -148.7 149.68 21.73 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.5 p -135.6 152.96 51.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.379 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -128.54 147.66 50.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.779 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.8 t -133.37 136.93 45.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 110.526 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.8 tptp . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.563 -179.665 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.2 p -120.27 136.17 54.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.825 0.345 . . . . 0.0 110.576 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -156.08 155.95 33.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.673 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 98.5 mmm -41.43 146.25 0.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.416 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 t -151.73 168.55 24.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.431 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.2 p -76.68 166.38 23.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.697 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.428 ' O ' ' CB ' ' A' ' 11' ' ' LYS . 12.7 mm-40 -83.49 127.9 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.706 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.49 ' O ' HG22 ' A' ' 8' ' ' THR . 26.4 m -113.47 -1.37 14.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.425 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.5 -96.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.358 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.515 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 1.5 m80 -97.6 14.09 27.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.339 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 7' ' ' GLN . 9.9 tmtt? -70.39 125.94 28.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.113 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.751 ' CD ' ' H ' ' A' ' 12' ' ' GLU . 1.8 mp0 -67.58 151.09 47.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.358 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.39 9.8 81.1 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -121.47 135.68 55.02 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.343 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -61.86 122.83 16.39 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.948 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 17' ' ' ALA . 14.3 m -117.29 -40.72 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.137 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.556 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -140.44 165.6 27.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.648 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.1 ttp -130.45 137.25 49.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.633 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.5 tp -99.11 127.69 45.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.486 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.488 ' ND2' ' HG2' ' A' ' 27' ' ' LYS . 0.3 OUTLIER -117.4 125.91 51.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.205 179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.431 HG22 ' H ' ' A' ' 24' ' ' LEU . 2.9 mt -103.24 108.37 58.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.445 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -75.41 -40.1 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.435 2.09 . . . . 0.0 112.392 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.612 ' C ' HD22 ' A' ' 24' ' ' LEU . 6.0 tptp -60.64 -42.99 98.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.803 HD22 ' N ' ' A' ' 24' ' ' LEU . 2.7 mm? -99.13 3.4 46.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.562 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.86 51.3 16.19 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.474 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -132.1 173.13 11.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.989 0.424 . . . . 0.0 110.974 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.488 ' HG2' ' ND2' ' A' ' 20' ' ' ASN . 2.7 mtpp -143.67 152.3 41.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.203 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -146.63 130.49 17.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.939 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.446 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 13.3 m -83.01 112.77 20.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 30' ' ' ILE . 1.5 mp -83.14 124.75 39.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.446 ' CE1' ' O ' ' A' ' 29' ' ' SER . 83.9 m-85 -110.1 140.6 44.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.858 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.515 ' CD1' ' O ' ' A' ' 10' ' ' HIS . 37.3 t-105 -60.69 118.35 6.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.963 0.411 . . . . 0.0 110.693 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.644 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 92.85 158.56 34.41 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.72 103.4 6.09 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.887 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -101.55 139.55 37.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.845 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.405 ' OD1' ' CE1' ' A' ' 65' ' ' HIS . 38.6 m-20 -83.37 -23.27 32.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.494 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.76 -40.1 84.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.821 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.3 p -72.76 134.8 45.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.625 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -98.39 -0.78 42.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.615 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.619 ' O ' ' C ' ' A' ' 41' ' ' LYS . 61.4 pttt -37.73 166.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.191 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.619 ' C ' ' O ' ' A' ' 40' ' ' LYS . 95.3 mttt -12.35 -77.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.432 0.458 . . . . 0.0 111.277 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.45 ' O ' ' OD2' ' A' ' 67' ' ' ASP . . . 137.78 59.74 0.05 OUTLIER Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 43' ' ' VAL . 3.2 p -166.49 101.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 121.056 0.455 . . . . 0.0 110.773 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.65 154.49 19.2 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.579 ' SD ' HG23 ' A' ' 60' ' ' THR . 3.3 tpp -90.52 132.89 35.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.53 121.58 18.09 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.383 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.644 HG23 ' HA2' ' A' ' 33' ' ' GLY . 17.2 t -91.95 127.69 44.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.665 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.698 ' N ' ' OG1' ' A' ' 51' ' ' THR . 7.2 t -164.13 165.18 22.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.495 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -64.07 -34.26 77.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.675 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.718 HG21 ' O ' ' A' ' 109' ' ' ILE . 2.8 m -89.58 -12.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.957 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.698 ' OG1' ' N ' ' A' ' 48' ' ' SER . 24.9 p -84.95 144.2 28.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.019 0.438 . . . . 0.0 110.866 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.489 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.7 OUTLIER -134.92 174.55 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.934 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.94 159.87 27.97 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.801 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.647 ' HG3' HD23 ' A' ' 84' ' ' LEU . 72.4 Cg_endo -81.5 66.2 8.62 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.606 2.204 . . . . 0.0 112.522 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.1 p -112.89 -6.32 13.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.541 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.0 92.68 0.09 OUTLIER Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.545 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.5 85.01 0.04 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.499 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -156.87 155.06 26.05 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.489 ' N ' ' OG1' ' A' ' 52' ' ' THR . 19.9 t-160 -80.08 104.65 10.79 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.579 HG23 ' SD ' ' A' ' 45' ' ' MET . 26.0 m -101.08 122.45 43.6 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.888 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.572 ' C ' HD22 ' A' ' 62' ' ' LEU . 54.9 t -111.91 124.81 68.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.157 0.503 . . . . 0.0 110.423 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.599 ' O ' HG23 ' A' ' 120' ' ' THR . 2.6 mm? -113.01 139.5 48.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.382 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.0 m -140.87 153.61 45.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.072 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.75 143.52 11.81 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.405 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 79.0 m80 -115.73 129.24 56.39 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.306 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.564 ' O ' ' O ' ' A' ' 67' ' ' ASP . 43.9 mtp180 59.73 -95.88 0.06 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.631 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 66' ' ' ARG . 59.8 m-20 51.92 119.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.752 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.415 ' O ' ' OG1' ' A' ' 68' ' ' THR . 4.3 p -97.46 79.93 2.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.395 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.7 t -123.11 130.45 74.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.677 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.681 ' O ' ' N ' ' A' ' 72' ' ' ASP . 41.2 t80 -81.72 -114.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.384 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.531 ' C ' ' O ' ' A' ' 70' ' ' PHE . 41.1 p 28.11 33.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.673 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.681 ' N ' ' O ' ' A' ' 70' ' ' PHE . 55.1 m-20 -62.16 -36.89 83.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.168 0.509 . . . . 0.0 110.924 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 73' ' ' LEU . 3.6 mm? -62.72 -32.17 73.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.44 -18.21 59.16 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.429 ' OE1' ' OD1' ' A' ' 72' ' ' ASP . 85.4 mt-30 -72.93 -39.52 66.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.999 0.428 . . . . 0.0 110.446 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.55 ' CD1' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -109.12 103.65 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.137 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.492 ' O ' HG21 ' A' ' 95' ' ' ILE . 4.6 ptpt -179.07 150.44 0.46 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -78.93 -13.37 59.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.523 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -86.87 -13.7 44.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.117 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 81' ' ' THR . 2.5 t0 -75.25 153.61 37.92 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.704 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.638 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -137.98 143.3 40.6 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.5 mt -118.3 129.89 55.71 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.927 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 2.8 t -115.46 121.6 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.547 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.647 HD23 ' HG3' ' A' ' 54' ' ' PRO . 10.2 mp -101.06 133.2 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.224 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HG2' HG23 ' A' ' 90' ' ' THR . 85.1 mt-10 -107.98 120.7 43.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.209 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.556 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.5 t80 -147.23 137.3 23.19 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.083 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 50.59 42.03 26.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 0.0 111.043 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 19.3 m-20 63.41 26.78 15.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.295 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 40.4 mttm -116.26 170.84 8.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.973 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.427 HG23 ' HG2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -139.25 111.84 7.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.684 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.9 m-85 -96.27 136.92 36.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.203 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -104.86 113.12 26.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.802 0.334 . . . . 0.0 111.452 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 85.1 m-85 -110.2 151.68 27.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.554 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -128.04 140.2 52.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.408 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.492 HG21 ' O ' ' A' ' 77' ' ' LYS . 2.4 mm -68.99 118.49 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.033 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -94.44 -59.23 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -144.84 140.05 28.13 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.27 0.557 . . . . 0.0 110.59 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 mp -119.67 127.93 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.78 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.487 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 23.1 p90 -144.06 -175.78 4.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.569 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.514 HG13 ' CD1' ' A' ' 135' ' ' TYR . 4.2 mp -126.32 132.45 70.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.471 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.502 HG22 HD11 ' A' ' 136' ' ' ILE . 2.3 t -134.51 165.3 25.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 110.73 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -73.95 149.42 41.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.331 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.1 -10.91 3.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.648 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -108.28 24.6 12.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.131 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.512 ' OD2' HG23 ' A' ' 108' ' ' VAL . 20.4 t0 -90.18 102.01 14.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.944 0.402 . . . . 0.0 110.585 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.811 ' O ' HG23 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -70.91 -35.91 72.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.606 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.539 ' O ' HD12 ' A' ' 110' ' ' ILE . 2.2 p -42.06 -18.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.586 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.783 ' CG1' HG21 ' A' ' 118' ' ' THR . 4.0 t -104.68 -15.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.012 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 109' ' ' ILE . 52.1 mm -114.44 20.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.187 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.811 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -82.68 -173.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -92.53 146.1 23.94 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.846 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.469 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.6 mttt -133.46 177.21 7.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.294 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -129.86 17.05 5.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.913 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -135.43 158.76 73.78 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.499 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 37.2 Cg_endo -74.59 86.65 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 123.186 2.59 . . . . 0.0 110.693 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.8 mm -121.78 133.4 68.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.1 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.794 ' C ' HD23 ' A' ' 117' ' ' LEU . 6.2 tt -108.1 119.78 40.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.216 0.531 . . . . 0.0 110.335 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.783 HG21 ' CG1' ' A' ' 108' ' ' VAL . 88.2 m -114.89 117.88 31.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.394 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 120' ' ' THR . 5.6 tp -105.98 128.38 53.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.28 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.64 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -113.89 114.16 25.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.284 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.521 ' HB ' ' CZ ' ' A' ' 123' ' ' TYR . 1.2 p -94.47 136.65 34.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.985 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 17.6 t -134.36 61.64 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.145 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 123' ' ' TYR . 0.5 OUTLIER -102.95 137.29 19.23 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.092 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.86 51.43 2.34 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.53 2.153 . . . . 0.0 112.126 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.65 ' CG ' ' N ' ' A' ' 126' ' ' ASP . 3.1 p90 -59.38 -48.5 81.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.446 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.65 ' N ' ' CG ' ' A' ' 125' ' ' PHE . 25.4 t70 -113.37 -31.32 6.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.515 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 128' ' ' ILE . 87.1 t80 -89.59 161.11 16.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.499 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.711 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 88.0 mt -104.69 115.17 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.769 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.97 -118.35 5.13 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.473 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 43.1 t0 -86.12 100.71 12.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.341 . . . . 0.0 110.567 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . . . -60.01 113.05 6.35 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.122 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -48.57 -43.3 33.86 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.224 1.95 . . . . 0.0 112.149 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -85.91 148.15 25.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.237 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.41 ' NE ' ' HB ' ' A' ' 120' ' ' THR . 35.5 ttp180 -123.52 119.42 29.9 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.135 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.514 ' CD1' HG13 ' A' ' 100' ' ' ILE . 4.6 t80 -69.18 137.94 53.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.961 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 101' ' ' THR . 6.8 mm -122.63 122.13 65.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 137' ' ' ILE . 1.2 mp -107.17 112.03 38.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.487 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 38.4 tt0 -95.59 134.06 38.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.942 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.74 145.23 34.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.18 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -117.37 145.83 43.8 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.215 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 16.9 tp -69.8 123.26 20.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.491 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.2 p -99.33 -43.66 6.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.224 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.582 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -145.89 165.9 28.0 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 35.4 p -139.55 142.28 37.19 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.708 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -124.53 143.57 50.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.3 p -133.51 127.31 32.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.442 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.4 tttp . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.724 179.779 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.553 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.578 ' O ' ' O ' ' A' ' 3' ' ' HIS . 14.8 m 26.08 76.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.777 0.322 . . . . 0.0 110.505 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.578 ' O ' ' O ' ' A' ' 2' ' ' SER . 84.7 t60 54.72 140.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.476 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.2 mtt -101.01 115.88 31.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.346 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.539 ' O ' ' OG ' ' A' ' 6' ' ' SER . 10.2 p -140.23 143.05 35.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.544 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.539 ' OG ' ' O ' ' A' ' 5' ' ' SER . 16.0 m -171.9 83.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.63 151.25 38.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.533 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m -65.24 118.82 9.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.51 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.634 ' C ' ' CG ' ' A' ' 10' ' ' HIS . 96.8 mt-10 -149.63 6.08 0.62 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.559 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.634 ' CG ' ' C ' ' A' ' 9' ' ' GLU . 1.7 m-70 86.65 9.79 0.21 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.498 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -75.5 137.46 40.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.606 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.9 mp0 -68.96 137.45 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.279 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 94.84 12.98 54.85 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -120.35 134.92 55.18 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.801 0.334 . . . . 0.0 110.498 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' NZ ' ' SD ' ' A' ' 18' ' ' MET . 88.3 tttt -57.99 120.06 7.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.349 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.14 -31.95 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.78 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.45 161.94 36.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.673 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.502 ' SD ' ' OG ' ' A' ' 29' ' ' SER . 1.0 OUTLIER -123.45 133.88 54.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.432 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.852 ' HB2' HD11 ' A' ' 30' ' ' ILE . 2.0 tt -104.1 122.56 45.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.622 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.427 HD22 ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -115.29 126.12 54.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.85 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.427 ' N ' HD22 ' A' ' 20' ' ' ASN . 7.9 mt -102.86 114.82 65.02 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.322 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 81' ' ' THR . 60.8 Cg_endo -77.68 -43.9 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.812 2.341 . . . . 0.0 112.527 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.6 ' C ' HD22 ' A' ' 24' ' ' LEU . 24.2 tptp -60.37 -41.72 94.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.569 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.822 HD22 ' N ' ' A' ' 24' ' ' LEU . 2.8 mm? -98.31 0.24 45.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.812 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 49.79 42.07 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.68 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -119.96 162.65 18.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.9 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -135.38 145.06 46.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.765 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 19' ' ' LEU . 61.8 m-85 -141.0 150.45 43.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.584 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.502 ' OG ' ' SD ' ' A' ' 18' ' ' MET . 9.9 m -103.27 119.65 39.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.801 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.852 HD11 ' HB2' ' A' ' 19' ' ' LEU . 4.6 mp -83.8 124.18 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.259 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 42.1 m-85 -107.17 135.04 49.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.989 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.518 ' O ' ' N ' ' A' ' 13' ' ' GLY . 26.2 t-105 -60.42 127.75 33.27 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.6 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.468 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 75.05 144.67 1.09 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -110.5 81.44 1.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.758 0.313 . . . . 0.0 110.685 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -77.16 131.38 38.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.482 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -89.49 -1.81 58.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.543 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.31 85.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.743 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 m -83.15 154.28 24.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.65 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.795 HD22 ' N ' ' A' ' 39' ' ' LEU . 2.9 mm? -76.89 144.11 39.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.506 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.561 ' C ' ' O ' ' A' ' 39' ' ' LEU . 7.3 mtmm -25.87 104.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.484 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.25 -52.81 4.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.06 -56.25 0.08 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 43' ' ' VAL . 2.3 p -173.31 122.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.095 0.474 . . . . 0.0 110.566 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.44 150.5 16.84 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -96.21 127.92 42.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.747 0.308 . . . . 0.0 110.655 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.507 ' O ' ' SD ' ' A' ' 45' ' ' MET . 9.5 t80 -69.1 131.8 45.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.527 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.6 t -111.26 128.87 67.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.567 ' N ' ' OG1' ' A' ' 51' ' ' THR . 33.0 p -161.99 171.8 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.584 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 39.4 t0 -74.98 10.1 1.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.464 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.782 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.7 m -132.27 -15.58 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.665 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 48' ' ' SER . 2.6 p -87.8 139.7 30.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.611 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.65 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -131.04 169.52 15.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.633 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.64 154.71 38.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.466 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.725 ' HG3' HD13 ' A' ' 84' ' ' LEU . 59.3 Cg_endo -78.97 61.08 8.03 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.835 2.357 . . . . 0.0 112.214 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.33 -5.36 17.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.64 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.99 91.94 0.09 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.92 92.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.428 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.27 155.18 26.02 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.65 ' N ' ' OG1' ' A' ' 52' ' ' THR . 21.7 t-160 -79.59 112.59 17.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.932 0.396 . . . . 0.0 110.1 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.3 m -105.48 123.39 47.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.348 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.585 ' C ' HD22 ' A' ' 62' ' ' LEU . 63.5 t -116.7 127.42 74.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.476 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.585 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.2 mm? -109.76 145.51 36.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.616 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 120' ' ' THR . 44.1 t -130.3 144.13 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.591 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.592 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -171.84 178.72 43.94 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.565 ' ND1' ' CD1' ' A' ' 123' ' ' TYR . 28.3 m-70 -119.85 150.72 39.99 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 122.636 -0.332 . . . . 0.0 110.625 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -55.36 117.14 3.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.473 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.599 ' O ' ' C ' ' A' ' 68' ' ' THR . 96.8 m-20 -103.67 115.69 30.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.817 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.774 HG22 HG22 ' A' ' 69' ' ' VAL . 7.5 m 18.77 -125.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.455 0.472 . . . . 0.0 110.694 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.774 HG22 HG22 ' A' ' 68' ' ' THR . 6.9 m -120.39 -148.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.54 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.687 ' C ' ' H ' ' A' ' 72' ' ' ASP . 89.4 t80 57.67 158.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.438 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.414 ' N ' ' CG ' ' A' ' 70' ' ' PHE . 25.2 m 62.26 -28.05 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.521 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.687 ' H ' ' C ' ' A' ' 70' ' ' PHE . 50.4 m-20 -59.66 -46.03 90.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.874 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -42.86 93.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.756 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.586 ' O ' ' CG ' ' A' ' 77' ' ' LYS . . . -67.83 -23.88 74.19 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -71.24 -36.36 71.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.757 0.313 . . . . 0.0 110.817 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -88.85 73.69 8.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.642 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.586 ' CG ' ' O ' ' A' ' 74' ' ' GLY . 10.5 ptpt -169.38 129.86 1.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.436 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -74.75 -10.46 59.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.582 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -79.95 -16.36 55.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.361 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.686 ' OD1' ' N ' ' A' ' 81' ' ' THR . 34.5 t0 -71.38 154.38 41.61 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.586 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.686 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.6 OUTLIER -141.3 117.7 10.81 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.916 0.389 . . . . 0.0 110.803 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 51.8 mt -90.7 128.96 36.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.642 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.634 HG12 HG22 ' A' ' 90' ' ' THR . 2.3 t -105.23 127.08 60.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.383 . . . . 0.0 110.239 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.829 HD11 HD12 ' A' ' 117' ' ' LEU . 33.4 mt -111.07 122.89 49.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.96 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.41 ' HG2' HG23 ' A' ' 90' ' ' THR . 84.2 mt-10 -99.59 119.35 37.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.69 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -150.06 129.39 12.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.995 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 56.46 43.98 25.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.996 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASN . . . . . 0.509 ' OD1' ' C ' ' A' ' 147' ' ' LYS . 6.3 t-20 61.82 15.4 7.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.645 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -114.99 137.13 52.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.202 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.634 HG22 HG12 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -107.67 124.04 49.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.755 -178.909 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -108.89 125.56 52.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.096 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.428 ' OG1' ' C ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -94.95 107.09 19.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.143 -179.383 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.576 ' CE1' HD12 ' A' ' 84' ' ' LEU . 40.2 m-85 -95.09 156.92 16.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.577 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.5 134.1 45.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.55 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.695 HG23 HD11 ' A' ' 98' ' ' ILE . 1.1 mm -65.7 114.59 3.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.246 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -83.57 -66.18 0.92 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.842 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.552 ' C ' HD13 ' A' ' 98' ' ' ILE . 29.1 tptp -150.36 146.91 27.01 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.506 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.695 HD11 HG23 ' A' ' 95' ' ' ILE . 5.2 mm -114.16 135.36 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.51 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 14.3 p90 -155.43 178.68 9.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.683 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.427 HG22 ' HB3' ' A' ' 133' ' ' ASP . 2.3 mt -127.47 128.83 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.151 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 102' ' ' HIS . 3.0 t -131.05 172.87 11.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.497 ' O ' HG23 ' A' ' 101' ' ' THR . 25.1 t60 -62.92 171.95 1.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.551 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.36 -20.47 28.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.555 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.55 19.32 17.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.449 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.524 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 28.9 t0 -83.17 92.4 7.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.71 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.966 ' O ' HG23 ' A' ' 110' ' ' ILE . 36.6 ptt180 -63.52 -37.84 88.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.234 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.524 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 9.4 p -37.0 -18.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.258 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.858 ' CG1' HG21 ' A' ' 118' ' ' THR . 10.9 t -108.86 -21.3 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.711 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.782 ' O ' HG21 ' A' ' 50' ' ' VAL . 33.5 mm -109.71 28.13 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.966 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -93.07 -165.71 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.329 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -99.57 141.5 32.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.647 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.474 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.1 mttt -128.21 135.46 49.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.206 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -81.63 7.98 10.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.499 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.52 160.18 69.34 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.431 ' O ' HD13 ' A' ' 116' ' ' ILE . 41.1 Cg_endo -74.69 101.23 1.42 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.936 2.424 . . . . 0.0 111.972 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 115' ' ' PRO . 49.2 mm -131.33 135.11 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.788 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.829 HD12 HD11 ' A' ' 84' ' ' LEU . 9.4 tt -106.32 118.58 37.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.794 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.858 HG21 ' CG1' ' A' ' 108' ' ' VAL . 53.6 m -122.75 121.35 36.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.364 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.861 HD23 ' C ' ' A' ' 119' ' ' LEU . 5.8 tt -109.26 124.71 51.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.015 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.743 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -116.51 124.54 50.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.376 178.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.673 ' O ' ' SG ' ' A' ' 122' ' ' CYS . 1.7 t -151.07 177.93 9.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.848 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.673 ' SG ' ' O ' ' A' ' 121' ' ' THR . 1.3 m 155.1 -75.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.507 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.565 ' CD1' ' ND1' ' A' ' 65' ' ' HIS . 21.1 m-85 25.84 67.68 0.46 Allowed Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.75 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.623 ' CD ' ' HB2' ' A' ' 131' ' ' ALA . 59.9 Cg_endo -77.41 149.25 27.36 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.812 2.342 . . . . 0.0 111.953 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -66.65 -31.28 71.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.388 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -60.39 -48.68 80.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.518 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.444 ' CD1' ' HD3' ' A' ' 132' ' ' PRO . 35.4 t80 -85.79 135.43 33.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.402 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.607 ' H ' HD12 ' A' ' 128' ' ' ILE . 2.8 mp -101.98 118.17 48.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.425 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.72 -104.37 1.86 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.515 ' HB3' HH12 ' A' ' 134' ' ' ARG . 0.2 OUTLIER -128.72 105.43 8.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 0.0 110.624 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.623 ' HB2' ' CD ' ' A' ' 124' ' ' PRO . . . -41.11 144.99 0.61 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.547 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.444 ' HD3' ' CD1' ' A' ' 127' ' ' TYR . 26.0 Cg_endo -62.12 -29.62 81.24 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.882 2.388 . . . . 0.0 112.212 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.427 ' HB3' HG22 ' A' ' 100' ' ' ILE . 96.0 m-20 -128.89 140.28 51.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.394 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.515 HH12 ' HB3' ' A' ' 130' ' ' ASP . 1.3 mpt_? -115.72 138.25 51.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.659 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.751 ' CE2' HD11 ' A' ' 137' ' ' ILE . 4.5 t80 -73.23 123.94 24.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.024 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 2.4 mm -115.8 118.67 59.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.883 -178.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.751 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp -105.24 107.22 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 46.3 tt0 -88.3 134.95 33.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.308 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.84 138.96 21.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.482 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.534 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 31.6 ttpt -109.27 161.28 15.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.807 HD13 ' C ' ' A' ' 141' ' ' LEU . 2.6 tm? -91.77 115.89 28.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.241 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.564 ' N ' HD22 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -110.94 -66.01 1.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.898 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.553 ' O ' HD21 ' A' ' 141' ' ' LEU . . . -83.32 165.53 43.04 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.415 ' O ' ' CG ' ' A' ' 145' ' ' TYR . 12.4 p -158.15 158.08 33.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.799 0.333 . . . . 0.0 110.582 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 90' ' ' THR . 79.4 m-85 -153.99 104.8 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.523 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.5 p -98.99 122.28 42.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.637 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.509 ' C ' ' OD1' ' A' ' 88' ' ' ASN . 68.6 mttm . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.429 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.582 ' O ' ' O ' ' A' ' 1' ' ' GLY . 2.1 m 53.59 134.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 110.799 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -88.49 -18.41 28.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.604 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.445 ' HG2' ' H ' ' A' ' 5' ' ' SER . 4.5 ttt 67.55 -132.71 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.532 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.445 ' H ' ' HG2' ' A' ' 4' ' ' MET . 74.5 m -68.68 -68.5 0.39 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.775 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 7' ' ' GLN . 67.7 p -153.02 -163.41 1.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.517 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 6' ' ' SER . 18.3 mp0 56.61 115.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.513 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.487 ' OG1' ' N ' ' A' ' 9' ' ' GLU . 54.5 p -101.46 -77.78 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.569 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 10' ' ' HIS . 0.1 OUTLIER 165.88 -30.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.672 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.488 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 57.1 t-80 -98.37 -2.05 40.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.671 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -65.47 138.92 58.41 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.621 -0.432 . . . . 0.0 109.944 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.666 ' OE2' HG11 ' A' ' 47' ' ' VAL . 91.0 mt-10 -80.79 151.02 28.98 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 83.59 15.25 71.42 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -118.07 132.1 56.39 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.044 0.45 . . . . 0.0 110.456 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 61.9 tttm -58.24 106.09 0.34 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.601 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.435 HG11 ' HB2' ' A' ' 32' ' ' TRP . 14.5 m -110.55 -38.81 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.38 155.64 46.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.607 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.7 ttp -121.29 131.54 54.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.84 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.8 tp -93.95 123.67 37.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.425 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -119.5 124.3 46.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.0 mt -106.64 111.61 63.89 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.242 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.618 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.9 Cg_endo -78.9 -42.78 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 123.057 2.505 . . . . 0.0 112.615 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.578 ' C ' HD22 ' A' ' 24' ' ' LEU . 6.0 tptm -63.01 -39.05 93.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.777 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.0 mm? -99.54 5.81 45.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.907 0.384 . . . . 0.0 110.522 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 44.71 56.91 4.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.42 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 1.027 ' HZ3' HG21 ' A' ' 71' ' ' THR . 19.2 mtmt -141.37 158.71 43.51 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.667 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -141.26 140.46 33.9 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.612 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -133.81 155.41 49.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.5 m -95.92 118.37 32.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.442 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -95.31 123.84 47.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.243 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 52.4 m-85 -103.76 142.92 33.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.551 ' HZ2' HG23 ' A' ' 47' ' ' VAL . 40.9 t-105 -61.54 130.92 48.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.952 0.406 . . . . 0.0 110.659 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 84.51 171.39 48.01 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.1 91.8 1.89 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.906 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -98.85 101.69 13.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.657 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 37' ' ' ALA . 42.1 p30 -70.97 -23.03 62.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.696 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.511 ' N ' ' OD1' ' A' ' 36' ' ' ASP . . . -56.48 -49.22 75.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.705 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.672 ' C ' HD22 ' A' ' 39' ' ' LEU . 58.2 p -87.64 163.85 16.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.551 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.672 HD22 ' C ' ' A' ' 38' ' ' THR . 4.1 mm? -112.5 126.49 55.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.635 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -153.24 -80.44 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.358 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -138.57 154.61 48.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.921 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.04 39.16 3.14 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.12 92.21 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 120.943 0.401 . . . . 0.0 110.701 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.74 153.14 19.56 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.477 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 2.8 tpp -103.14 142.88 33.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -75.97 140.27 41.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.402 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.666 HG11 ' OE2' ' A' ' 12' ' ' GLU . 2.1 p -123.37 124.3 69.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.465 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 51' ' ' THR . 21.1 t -168.76 169.67 9.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.531 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -62.99 -37.39 86.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.29 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.649 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.0 m -83.98 -26.6 7.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.843 0.354 . . . . 0.0 110.552 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 48' ' ' SER . 64.8 p -99.05 142.58 30.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.823 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -143.83 175.45 9.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.654 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.497 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -91.36 155.07 44.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.731 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.59 84.29 2.0 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.746 2.298 . . . . 0.0 112.431 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.3 p -115.22 -7.64 12.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.727 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.08 89.29 0.07 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.68 84.65 0.07 OUTLIER Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.474 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -166.4 158.87 32.0 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.651 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 19.1 t-160 -78.71 121.9 25.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 88.9 m -119.2 128.39 54.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.564 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.584 ' C ' HD22 ' A' ' 62' ' ' LEU . 55.0 t -119.5 132.84 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.099 0.476 . . . . 0.0 110.238 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.584 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.8 mm? -113.18 140.56 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.625 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.554 ' OG ' ' OH ' ' A' ' 123' ' ' TYR . 37.9 t -118.84 136.69 53.88 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.427 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.57 87.59 0.14 Allowed Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.562 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -66.31 135.02 53.8 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.583 -0.363 . . . . 0.0 110.026 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.562 ' O ' ' O ' ' A' ' 65' ' ' HIS . 77.7 ttt-85 54.88 133.38 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.559 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -119.6 -172.86 2.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.294 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.6 p -97.42 -110.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.748 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.432 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 1.2 p -179.25 -14.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.513 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.544 ' CE2' ' NZ ' ' A' ' 26' ' ' LYS . 1.6 p90 -96.01 154.39 17.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.481 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 1.027 HG21 ' HZ3' ' A' ' 26' ' ' LYS . 22.6 p 52.4 8.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.66 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 70' ' ' PHE . 51.9 t0 -61.14 -43.24 99.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.129 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -60.94 -41.3 95.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.039 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.575 ' HA3' HD11 ' A' ' 24' ' ' LEU . . . -64.79 -28.95 74.04 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.63 -39.9 84.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 110.391 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.565 HD23 ' N ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -95.54 101.72 13.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.98 -179.734 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.477 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 11.2 ptpt 175.84 145.95 0.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.567 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.68 -14.61 60.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.128 0.489 . . . . 0.0 110.698 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -79.67 -15.25 57.93 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.725 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.12 154.3 29.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.762 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.618 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -141.37 115.26 9.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.418 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.2 mt -89.19 131.43 35.32 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.236 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.588 ' C ' HD22 ' A' ' 84' ' ' LEU . 48.8 t -111.53 122.42 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.054 0.454 . . . . 0.0 109.852 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.588 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.4 mm? -112.67 132.47 55.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.696 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.456 ' HG2' HG23 ' A' ' 90' ' ' THR . 90.2 mt-10 -104.7 119.54 39.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.42 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.497 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 9.1 t80 -140.49 137.3 33.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.022 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.433 ' CG ' ' O ' ' A' ' 87' ' ' ASP . 50.1 t0 50.98 41.12 26.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.158 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 65.86 16.77 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.264 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -117.82 149.77 40.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.4 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -110.96 125.85 54.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.532 -179.136 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -110.15 125.76 53.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.455 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 143' ' ' GLY . 0.3 OUTLIER -97.81 108.18 20.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.697 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 62.9 m-85 -98.98 151.91 20.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.704 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -124.41 132.69 53.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.759 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.641 HD12 HD11 ' A' ' 98' ' ' ILE . 1.2 mm -65.86 119.62 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.059 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -89.84 -57.79 2.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.951 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -153.35 151.48 30.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.295 0.569 . . . . 0.0 109.934 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.641 HD11 HD12 ' A' ' 95' ' ' ILE . 16.0 mm -122.41 132.15 71.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.25 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.499 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 11.2 p90 -150.21 178.87 8.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.192 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.508 HG22 ' HB3' ' A' ' 133' ' ' ASP . 7.9 mt -125.87 138.65 53.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.664 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 102' ' ' HIS . 3.4 t -138.68 169.14 18.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.268 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.478 ' ND1' ' OD1' ' A' ' 133' ' ' ASP . 68.5 m-70 -68.86 168.23 13.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.672 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HA ' ' HE ' ' A' ' 134' ' ' ARG . . . -76.08 -9.51 58.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -105.35 20.06 19.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.062 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.606 ' O ' HG22 ' A' ' 108' ' ' VAL . 24.4 t70 -87.28 95.01 9.83 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.705 0.288 . . . . 0.0 110.761 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.958 ' O ' HG23 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -73.33 -20.21 60.84 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.122 0.487 . . . . 0.0 110.615 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.561 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 20.9 p -44.87 -14.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.445 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.666 ' HB ' HG21 ' A' ' 118' ' ' THR . 11.0 m -112.37 -12.16 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.406 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.759 HG22 ' O ' ' A' ' 109' ' ' ILE . 49.0 mm -109.48 13.49 8.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.958 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -92.61 -170.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.83 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -95.12 155.22 16.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.699 ' HZ3' HG21 ' A' ' 116' ' ' ILE . 97.0 mttt -131.73 -174.47 3.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.871 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -125.48 10.14 7.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.132 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.75 168.13 11.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.971 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.474 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 38.1 Cg_endo -75.76 97.55 1.11 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.084 2.522 . . . . 0.0 111.929 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.699 HG21 ' HZ3' ' A' ' 112' ' ' LYS . 51.2 mm -127.6 132.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.709 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 tt -106.14 123.85 48.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.245 0.545 . . . . 0.0 109.827 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.666 HG21 ' HB ' ' A' ' 108' ' ' VAL . 96.7 m -115.69 126.67 54.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.458 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.806 HD22 HG23 ' A' ' 121' ' ' THR . 0.6 OUTLIER -112.35 126.35 55.18 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.198 -179.398 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.765 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -122.89 117.45 25.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.078 179.239 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.806 HG23 HD22 ' A' ' 119' ' ' LEU . 42.9 p -131.27 176.29 8.4 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.528 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.649 ' CB ' ' O ' ' A' ' 121' ' ' THR . 5.1 t 97.77 -68.13 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.056 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.631 ' O ' ' O ' ' A' ' 124' ' ' PRO . 18.3 m-85 62.27 155.67 0.11 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.27 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.631 ' O ' ' O ' ' A' ' 123' ' ' TYR . 71.1 Cg_exo -41.85 -125.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.163 2.576 . . . . 0.0 113.157 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.585 ' O ' ' N ' ' A' ' 127' ' ' TYR . 47.5 p90 -58.35 -34.9 71.16 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.565 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 125' ' ' PHE . 81.3 m-20 -37.67 -24.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.411 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.665 ' CD1' ' N ' ' A' ' 128' ' ' ILE . 3.5 t80 -90.98 163.14 14.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.327 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.665 ' N ' ' CD1' ' A' ' 127' ' ' TYR . 2.0 mt -67.72 95.36 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.94 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.61 -128.18 8.66 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -133.88 114.94 13.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.762 0.315 . . . . 0.0 110.685 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.585 ' CB ' ' SG ' ' A' ' 122' ' ' CYS . . . -118.51 81.23 17.56 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.502 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -53.12 -38.25 80.58 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.699 2.266 . . . . 0.0 111.881 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.508 ' HB3' HG22 ' A' ' 100' ' ' ILE . 95.1 m-20 -107.86 144.27 35.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.607 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.519 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 85.7 mtm180 -98.27 142.24 30.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.29 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.55 ' CD2' HD11 ' A' ' 137' ' ' ILE . 3.9 t80 -72.92 132.49 43.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.34 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.499 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 3.7 mm -118.05 120.12 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.55 HD11 ' CD2' ' A' ' 135' ' ' TYR . 16.5 mm -105.68 111.53 35.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.747 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 39.4 tt0 -99.03 129.18 45.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.083 0.468 . . . . 0.0 110.946 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -135.46 150.63 49.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.412 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.447 ' NZ ' ' HD2' ' A' ' 115' ' ' PRO . 53.4 tptt -115.75 140.99 48.68 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.682 HD13 ' C ' ' A' ' 141' ' ' LEU . 2.6 tm? -80.22 117.2 20.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.494 ' N ' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -108.34 -61.23 1.62 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.68 -179.155 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -104.72 151.99 17.38 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.7 m -150.43 148.94 29.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.952 0.406 . . . . 0.0 110.222 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' THR . 81.8 m-85 -132.2 156.92 45.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.404 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.9 p -137.09 125.13 22.86 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.315 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.449 ' CD ' ' O ' ' A' ' 147' ' ' LYS . 5.9 tmtt? . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.576 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 t -60.17 -48.46 81.65 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.818 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -152.37 108.27 3.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.131 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 69.1 mmm -126.48 99.64 5.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.649 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.3 p -144.35 2.88 1.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.6 p -64.42 153.96 37.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.647 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.531 ' OE1' ' OE1' ' A' ' 14' ' ' GLU . 0.1 OUTLIER -97.97 -166.74 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.455 -179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.453 ' H ' ' HG3' ' A' ' 7' ' ' GLN . 0.2 OUTLIER 77.03 -17.61 0.55 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.44 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 7' ' ' GLN . 98.7 mt-10 -67.98 -172.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.493 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -112.65 91.83 3.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.468 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -131.79 129.32 40.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.183 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.446 ' HG3' ' CD1' ' A' ' 32' ' ' TRP . 56.4 mp0 -65.5 145.76 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.941 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.17 10.76 68.23 Favored Glycine 0 CA--C 1.517 0.214 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.531 ' OE1' ' OE1' ' A' ' 7' ' ' GLN . 6.3 mt-10 -119.47 136.15 54.44 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.079 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.91 117.9 5.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.829 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 32' ' ' TRP . 16.0 m -117.35 -43.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -129.19 161.48 30.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.951 0.405 . . . . 0.0 110.723 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.4 ttt -125.89 131.09 52.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.431 HD13 HD21 ' A' ' 84' ' ' LEU . 51.0 tp -95.76 123.55 39.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.51 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -120.24 128.17 53.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.146 0.498 . . . . 0.0 110.687 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mt -106.77 115.65 60.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.294 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 81' ' ' THR . 57.6 Cg_endo -77.88 -49.97 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.077 2.518 . . . . 0.0 112.526 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.477 ' HG2' ' HZ1' ' A' ' 77' ' ' LYS . 1.9 tptt -63.16 -37.06 85.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.074 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.67 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.7 mm? -96.77 5.81 49.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.977 0.418 . . . . 0.0 110.377 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 24' ' ' LEU . 12.9 mttt 40.21 53.96 2.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.463 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.412 ' NZ ' ' OG1' ' A' ' 71' ' ' THR . 19.6 mtmt -136.73 159.47 41.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.068 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 2.2 mtmt -137.78 154.49 49.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.944 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.423 ' CG ' ' O ' ' A' ' 27' ' ' LYS . 76.8 m-85 -154.23 150.61 28.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.949 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.436 ' O ' HG23 ' A' ' 43' ' ' VAL . 45.0 m -99.87 119.33 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.541 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.478 HD12 ' N ' ' A' ' 30' ' ' ILE . 1.7 mp -93.07 122.16 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.611 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -97.89 141.14 31.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.748 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.537 ' CZ3' HG22 ' A' ' 53' ' ' THR . 48.2 t-105 -60.51 130.3 45.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.778 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.408 ' HA2' HG12 ' A' ' 47' ' ' VAL . . . 93.85 156.54 32.53 Favored Glycine 0 C--N 1.33 0.22 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.0 78.4 1.58 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.609 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -99.36 108.23 20.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.711 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -76.54 -21.46 55.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.511 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.53 -37.43 86.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.48 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.811 ' C ' HD23 ' A' ' 39' ' ' LEU . 92.6 m -83.28 16.38 2.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.601 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.811 HD23 ' C ' ' A' ' 38' ' ' THR . 1.2 pt? 30.79 -152.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.744 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' CB ' ' A' ' 41' ' ' LYS . 18.8 ttmt 54.38 172.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.617 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 76.08 158.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.363 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.3 -55.1 0.47 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 29' ' ' SER . 3.4 m -128.07 129.24 69.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.107 0.48 . . . . 0.0 111.049 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.93 155.17 21.68 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.551 ' SD ' HD21 ' A' ' 62' ' ' LEU . 2.6 tpp -96.38 127.88 42.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -64.27 142.34 58.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.606 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.462 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.0 p -124.26 125.87 71.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.743 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.642 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.2 OUTLIER -161.8 169.86 20.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.238 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -61.35 -38.97 88.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.183 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.767 HG21 ' O ' ' A' ' 109' ' ' ILE . 11.9 m -85.17 -31.79 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 48' ' ' SER . 67.3 p -82.61 155.35 24.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.633 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.19 170.85 21.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.375 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.537 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -87.77 152.93 52.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.641 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.17 83.03 1.91 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.712 2.275 . . . . 0.0 112.463 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 p -117.88 -1.45 11.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.35 89.49 0.08 OUTLIER Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.02 90.2 0.02 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.501 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -165.84 163.33 36.65 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.61 ' CE1' HD12 ' A' ' 110' ' ' ILE . 17.2 t-160 -87.33 106.27 17.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.9 m -101.01 124.15 46.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.354 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.57 ' O ' HD22 ' A' ' 62' ' ' LEU . 54.3 t -117.87 129.98 73.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.5 . . . . 0.0 110.081 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.57 HD22 ' O ' ' A' ' 61' ' ' VAL . 2.2 mm? -115.18 146.46 41.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.877 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 p -138.25 150.76 47.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.4 130.87 6.33 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.879 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.518 ' O ' ' O ' ' A' ' 66' ' ' ARG . 11.8 t-160 -107.49 114.3 28.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.717 0.294 . . . . 0.0 110.575 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.518 ' O ' ' O ' ' A' ' 65' ' ' HIS . 50.5 ttp85 35.9 99.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.174 0.512 . . . . 0.0 111.29 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 66' ' ' ARG . 91.8 m-20 -140.75 153.97 46.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.771 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.0 p -92.67 112.44 24.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.562 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.512 ' O ' HG23 ' A' ' 69' ' ' VAL . 9.9 m -131.57 128.28 60.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.761 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -127.15 2.7 6.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.741 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.412 ' OG1' ' NZ ' ' A' ' 26' ' ' LYS . 70.7 p -110.51 20.8 17.33 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.244 0.545 . . . . 0.0 110.402 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.458 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 1.6 p30 -55.58 -24.82 34.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.374 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 tp -56.34 -36.21 68.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.385 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.38 -29.81 21.01 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -67.05 -40.33 87.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.204 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 76' ' ' LEU . 5.9 mt -90.4 86.33 6.43 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.906 0.384 . . . . 0.0 111.186 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.477 ' HZ1' ' HG2' ' A' ' 23' ' ' LYS . 56.7 pttt -178.84 155.58 0.79 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.932 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.13 -11.75 59.72 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.206 0.527 . . . . 0.0 110.731 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -79.86 -15.48 57.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.821 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.19 157.57 29.31 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.821 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.531 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -144.22 118.3 9.46 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.128 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 93' ' ' TYR . 35.4 mt -96.03 134.96 38.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.697 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.678 ' C ' HD22 ' A' ' 84' ' ' LEU . 2.1 t -118.31 126.22 74.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.437 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.678 HD22 ' C ' ' A' ' 83' ' ' VAL . 4.0 mm? -112.75 134.6 54.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.537 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.834 ' HG3' HG23 ' A' ' 90' ' ' THR . 0.1 OUTLIER -106.94 125.1 50.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.013 179.047 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.514 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -148.27 133.18 18.08 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.312 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 51.94 51.96 15.42 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.965 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 55.69 27.08 10.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.105 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.455 ' HG2' ' CB ' ' A' ' 146' ' ' SER . 39.0 mtpt -129.92 140.83 50.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.042 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.834 HG23 ' HG3' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -110.06 125.46 52.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.9 0.381 . . . . 0.0 110.379 -179.748 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.402 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 17.0 m-85 -104.32 135.26 46.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.164 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.593 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -102.88 113.81 27.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.087 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 82' ' ' LEU . 82.8 m-85 -111.81 147.16 36.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.681 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.589 ' HB3' HG21 ' A' ' 142' ' ' THR . 15.0 pt-20 -127.92 145.06 51.08 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.389 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.928 HG23 HD11 ' A' ' 98' ' ' ILE . 10.0 mm -67.04 120.39 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.318 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 24.1 mm100 -94.49 -61.15 1.56 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.614 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.546 ' C ' HD13 ' A' ' 98' ' ' ILE . 61.6 tttp -148.74 140.99 24.06 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.32 0.581 . . . . 0.0 110.595 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.928 HD11 HG23 ' A' ' 95' ' ' ILE . 6.6 mm -117.33 136.75 53.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.026 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.459 ' C ' ' CD1' ' A' ' 99' ' ' TRP . 12.4 p90 -154.59 178.98 9.48 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.379 -0.529 . . . . 0.0 111.395 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.759 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.2 mp -128.46 133.52 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.674 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.3 t -145.11 160.33 41.58 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.633 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -61.62 150.85 35.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.366 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.54 ' HB2' HH11 ' A' ' 134' ' ' ARG . . . -62.79 -4.97 2.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.669 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.548 ' OD1' ' C ' ' A' ' 104' ' ' ASP . 2.1 p30 -99.56 13.52 33.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.849 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.593 ' OD2' ' OG1' ' A' ' 107' ' ' THR . 17.7 t0 -82.71 96.72 8.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.393 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 110' ' ' ILE . 8.7 ptm180 -66.49 -18.4 65.34 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.589 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.593 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 15.5 p -58.56 -16.56 16.19 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.719 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.896 HG13 HG21 ' A' ' 118' ' ' THR . 18.6 t -100.46 -14.44 7.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.399 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.767 ' O ' HG21 ' A' ' 50' ' ' VAL . 48.4 mm -117.02 23.51 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.956 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.61 HD12 ' CE1' ' A' ' 59' ' ' HIS . 0.7 OUTLIER -83.61 -162.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.877 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -106.28 134.51 49.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.358 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.561 ' H ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -115.5 126.61 54.5 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.754 -0.378 . . . . 0.0 109.982 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 113' ' ' GLU . 56.2 mp0 -77.72 15.17 0.88 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.105 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.408 ' H ' ' C ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -147.36 171.1 6.73 Favored Pre-proline 0 C--N 1.332 -0.163 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.954 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.501 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 56.7 Cg_endo -80.24 90.37 1.25 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.326 2.684 . . . . 0.0 111.949 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.22 133.54 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.725 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.845 ' C ' HD23 ' A' ' 117' ' ' LEU . 5.4 tt -106.88 124.02 49.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.492 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.896 HG21 HG13 ' A' ' 108' ' ' VAL . 31.8 m -119.32 126.99 52.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.362 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.806 HD23 ' N ' ' A' ' 120' ' ' THR . 5.5 tt -120.11 125.42 48.21 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.315 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.806 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -109.66 126.6 53.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 0.0 110.319 179.065 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.518 ' HB ' ' CE2' ' A' ' 123' ' ' TYR . 1.2 p -102.12 130.15 48.65 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.519 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.469 ' C ' ' CD1' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -137.63 72.85 1.42 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.345 0.593 . . . . 0.0 110.621 179.374 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.828 ' H ' ' CD ' ' A' ' 124' ' ' PRO . 0.1 OUTLIER -118.96 -25.84 0.08 OUTLIER Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.395 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.828 ' CD ' ' H ' ' A' ' 123' ' ' TYR . 73.3 Cg_exo -46.45 93.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.068 1.845 . . . . 0.0 112.614 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 127' ' ' TYR . 48.2 p90 -77.18 -26.67 53.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.382 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -40.26 -26.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.259 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.663 ' CE2' ' O ' ' A' ' 128' ' ' ILE . 41.7 t80 -81.7 161.43 23.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.652 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.663 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 48.1 mm -86.17 91.97 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.327 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.76 -126.55 8.95 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -89.54 114.27 25.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.831 0.348 . . . . 0.0 110.872 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -43.87 110.77 1.02 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.332 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.496 ' HD3' ' CE2' ' A' ' 127' ' ' TYR . 51.2 Cg_exo -49.75 -46.25 28.23 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.415 2.077 . . . . 0.0 112.253 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -97.66 124.43 41.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.099 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.54 HH11 ' HB2' ' A' ' 103' ' ' ALA . 42.3 mtt85 -103.44 140.59 37.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.069 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.529 ' CD1' HG13 ' A' ' 100' ' ' ILE . 8.1 t80 -84.71 128.87 34.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.556 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.42 HD13 HG21 ' A' ' 108' ' ' VAL . 1.3 mt -123.05 128.07 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.658 HG23 ' CD1' ' A' ' 95' ' ' ILE . 1.5 mp -106.39 114.85 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.578 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 6.0 tt0 -94.43 138.0 32.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.761 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -148.57 148.03 29.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -116.1 160.43 20.35 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.866 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -77.31 123.12 26.05 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.824 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.589 HG21 ' HB3' ' A' ' 94' ' ' GLU . 3.0 p -98.78 -40.15 8.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.355 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.593 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -145.36 162.99 28.21 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.5 p -139.39 142.87 37.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.874 0.369 . . . . 0.0 110.433 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -129.73 141.22 50.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.37 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.455 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 23.2 t -137.23 141.97 42.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.184 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.0 tptp . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.465 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 55.78 -169.09 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.331 . . . . 0.0 110.502 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -114.23 148.66 37.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.635 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.431 ' C ' ' H ' ' A' ' 6' ' ' SER . 3.6 ptm -85.65 -177.34 6.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.525 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.1 t -77.45 28.08 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.776 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 4' ' ' MET . 80.7 p -62.57 -22.0 66.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.542 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -108.63 124.28 50.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.61 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.593 ' O ' ' O ' ' A' ' 9' ' ' GLU . 1.1 t -116.51 -6.13 11.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.574 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.593 ' O ' ' O ' ' A' ' 8' ' ' THR . 11.0 pt-20 -48.28 -116.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.702 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.531 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 8.2 m-70 -112.05 18.67 18.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.594 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.83 131.4 46.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.596 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.678 ' OE2' HG11 ' A' ' 47' ' ' VAL . 89.9 mt-10 -68.99 151.4 46.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.179 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.35 11.25 80.84 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.402 ' O ' HG13 ' A' ' 16' ' ' VAL . 75.2 mm-40 -118.16 135.01 54.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.4 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -59.01 118.2 5.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.217 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.494 HG11 ' HB2' ' A' ' 32' ' ' TRP . 17.1 m -117.48 -34.99 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.118 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.2 163.25 32.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.763 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.617 ' SD ' ' O ' ' A' ' 28' ' ' PHE . 7.6 tpp -121.94 142.56 50.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.527 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.419 HD13 HD21 ' A' ' 84' ' ' LEU . 27.6 tp -106.14 123.29 47.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.242 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -120.36 128.24 53.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.162 0.506 . . . . 0.0 111.003 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.48 HG22 ' H ' ' A' ' 24' ' ' LEU . 3.3 mt -105.88 116.76 59.21 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.213 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.615 ' CD ' ' O ' ' A' ' 81' ' ' THR . 59.3 Cg_endo -76.92 -50.09 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.79 2.327 . . . . 0.0 112.903 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.604 ' C ' HD22 ' A' ' 24' ' ' LEU . 10.1 tptp -60.43 -38.85 85.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.772 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.0 mm? -100.44 3.99 43.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.875 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.7 mptt 43.22 39.31 1.94 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.622 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.43 ' CB ' HD12 ' A' ' 21' ' ' ILE . 6.8 mmmt -115.53 150.62 36.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.434 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -131.93 147.88 52.49 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.849 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.617 ' O ' ' SD ' ' A' ' 18' ' ' MET . 85.3 m-85 -141.83 162.47 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.691 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 43' ' ' VAL . 8.7 p -103.54 122.27 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.929 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mm -95.37 124.51 47.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.286 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -108.11 142.51 38.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.531 ' CD1' ' O ' ' A' ' 10' ' ' HIS . 51.3 t-105 -65.29 132.82 50.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.849 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.549 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 76.35 159.01 8.67 Favored Glycine 0 N--CA 1.46 0.293 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.23 77.86 1.44 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.414 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -103.82 142.17 34.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.902 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.74 -9.13 53.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.508 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.61 81.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.578 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.1 p -67.2 104.02 1.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.458 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.81 -41.73 99.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.616 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -61.63 -41.14 97.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.547 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt 40.88 -143.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.553 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.54 -50.51 0.98 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 29' ' ' SER . 0.0 OUTLIER -154.36 107.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.549 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.23 140.9 16.45 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.549 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 1.2 ttp -91.4 138.04 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.504 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.681 ' CD1' HG21 ' A' ' 51' ' ' THR . 3.0 t80 -76.26 143.12 41.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.954 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.678 HG11 ' OE2' ' A' ' 12' ' ' GLU . 2.0 p -130.83 120.33 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.483 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.7 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.6 OUTLIER -170.9 174.98 4.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.577 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -62.92 -38.88 92.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.513 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.703 HG21 ' O ' ' A' ' 109' ' ' ILE . 2.0 m -85.12 -23.45 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.78 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.7 ' OG1' ' N ' ' A' ' 48' ' ' SER . 71.1 p -93.67 144.35 25.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.471 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 1.7 p -138.38 172.41 12.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.929 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.45 149.16 36.43 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.491 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.18 83.02 1.5 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.757 2.305 . . . . 0.0 112.647 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -127.46 -1.76 6.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.585 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.74 63.3 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.76 104.32 0.47 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.547 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -178.89 155.12 15.41 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.572 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 22.2 t-160 -78.65 103.24 8.46 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.5 m -99.11 114.97 27.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.434 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.464 ' O ' HD23 ' A' ' 62' ' ' LEU . 48.1 t -111.26 128.36 67.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.84 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 61' ' ' VAL . 25.7 mt -118.1 154.51 31.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.997 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 120' ' ' THR . 13.7 t -137.52 148.81 46.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.365 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.589 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -163.92 168.52 38.47 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.442 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.669 ' CE1' ' O ' ' A' ' 66' ' ' ARG . 0.7 OUTLIER -100.61 138.74 37.26 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.528 -0.395 . . . . 0.0 110.671 179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.669 ' O ' ' CE1' ' A' ' 65' ' ' HIS . 54.4 ttt85 -58.13 130.44 46.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.389 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.13 -163.35 1.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.612 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 68' ' ' THR . 8.9 t -129.33 52.25 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.576 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.601 ' O ' ' CB ' ' A' ' 70' ' ' PHE . 9.7 t -63.93 -39.54 85.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.283 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.601 ' CB ' ' O ' ' A' ' 69' ' ' VAL . 5.3 t80 90.31 11.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.267 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.0 p -108.43 23.13 14.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.665 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -62.01 -33.29 74.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.457 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.4 mt -61.41 -33.83 74.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.714 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.565 ' HA3' HD11 ' A' ' 24' ' ' LEU . . . -86.7 -24.81 37.37 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -71.93 -40.74 68.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.791 0.329 . . . . 0.0 110.797 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.588 HD22 ' OH ' ' A' ' 135' ' ' TYR . 16.5 mt -89.83 91.49 8.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.455 ' HG3' ' H ' ' A' ' 80' ' ' ASP . 11.1 ptmt -179.21 135.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.386 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -71.68 -12.18 61.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.618 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -81.28 -15.9 54.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.104 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.55 ' OD1' ' C ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -67.55 153.36 43.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.487 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.615 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -141.36 116.5 9.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.062 0.458 . . . . 0.0 110.279 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.7 mt -93.28 129.47 39.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.777 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.633 ' C ' HD22 ' A' ' 84' ' ' LEU . 2.5 t -111.22 122.71 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.011 0.434 . . . . 0.0 110.361 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.633 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.3 mm? -109.69 136.67 48.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.43 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -102.29 123.91 46.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.179 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 89' ' ' LYS . 7.0 t80 -145.03 143.15 30.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.618 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.49 ' OD1' ' O ' ' A' ' 87' ' ' ASP . 65.3 t0 36.85 53.05 1.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.871 0.367 . . . . 0.0 111.406 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 56.4 25.77 9.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.335 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 86' ' ' TYR . 30.8 mtpt -125.11 145.42 49.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.491 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -108.21 124.17 49.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.48 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 12.4 m-85 -105.04 131.83 52.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.097 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.591 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -101.68 113.79 27.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.463 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 83.2 m-85 -110.03 152.29 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.624 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -126.32 137.77 53.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.489 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mm -67.38 119.01 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.582 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -88.27 -64.87 1.08 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.826 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -147.26 143.24 27.97 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.055 0.455 . . . . 0.0 110.349 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.784 HG23 HD13 ' A' ' 137' ' ' ILE . 1.7 mp -118.46 131.52 70.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.403 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 29.1 p90 -154.17 -174.55 5.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.5 mt -132.05 132.24 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.193 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.0 t -131.92 174.49 10.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -75.74 153.06 37.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 131' ' ' ALA . . . -62.84 -25.54 68.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.608 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -85.87 10.2 14.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.556 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -82.09 90.6 6.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.396 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.847 ' O ' HG23 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -68.8 -21.62 64.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.29 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.543 ' C ' HD12 ' A' ' 110' ' ' ILE . 21.5 p -48.51 -11.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.384 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.912 HG13 HG21 ' A' ' 118' ' ' THR . 45.7 t -111.54 -11.03 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.035 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.703 ' O ' HG21 ' A' ' 50' ' ' VAL . 50.1 mm -111.9 10.14 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.015 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.847 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -80.78 -165.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.722 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -97.13 158.94 15.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.052 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HG3' ' CD2' ' A' ' 59' ' ' HIS . 66.9 mmtt -126.37 -168.02 1.8 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.263 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.442 ' C ' ' CG ' ' A' ' 114' ' ' GLU . 4.9 mm-40 -138.34 16.5 2.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.425 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.459 ' CB ' ' HD2' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -162.23 169.62 9.05 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.523 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.547 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 32.7 Cg_endo -70.06 90.21 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.174 2.583 . . . . 0.0 111.829 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.2 mm -122.27 133.09 69.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.029 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.467 ' C ' HD23 ' A' ' 117' ' ' LEU . 8.1 tt -108.38 123.69 49.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.734 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.912 HG21 HG13 ' A' ' 108' ' ' VAL . 94.5 m -122.68 128.4 50.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.38 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.881 HD23 ' N ' ' A' ' 120' ' ' THR . 5.1 tt -111.61 127.18 55.66 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.953 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.881 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -121.52 108.83 14.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.262 0.553 . . . . 0.0 110.524 179.323 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.625 ' C ' ' SG ' ' A' ' 122' ' ' CYS . 1.2 t -135.95 175.25 9.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.101 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.625 ' SG ' ' C ' ' A' ' 121' ' ' THR . 1.6 p 154.45 -71.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.702 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.545 ' C ' ' O ' ' A' ' 122' ' ' CYS . 74.7 m-85 26.34 66.85 0.49 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.809 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -84.73 -163.68 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 123.013 2.476 . . . . 0.0 112.186 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -64.22 -32.64 74.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.58 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -89.76 19.93 4.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.614 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.649 ' O ' ' C ' ' A' ' 128' ' ' ILE . 6.9 t80 -57.97 -47.29 83.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.649 ' C ' ' O ' ' A' ' 127' ' ' TYR . 2.6 mp 1.76 87.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 O-C-N 123.828 0.705 . . . . 0.0 110.676 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.584 ' O ' ' CE1' ' A' ' 127' ' ' TYR . . . 101.14 -90.67 0.88 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 131' ' ' ALA . 14.7 p-10 -140.51 110.33 6.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.744 0.306 . . . . 0.0 110.63 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 130' ' ' ASP . . . -38.13 119.13 0.99 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.615 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -48.25 -41.16 35.23 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.522 2.148 . . . . 0.0 111.996 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -127.08 126.05 42.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.331 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.466 ' HG2' ' SG ' ' A' ' 122' ' ' CYS . 29.4 mtm180 -114.1 140.75 48.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.672 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.645 ' CD2' HD11 ' A' ' 137' ' ' ILE . 3.8 t80 -74.73 128.29 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.403 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 18.4 mm -112.81 117.62 55.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.761 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.784 HD13 HG23 ' A' ' 98' ' ' ILE . 15.9 mm -107.45 107.09 21.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -92.79 133.22 36.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.135 0.493 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.1 145.42 30.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 50.7 tttm -117.31 152.53 34.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.463 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 11.0 tp -78.68 122.26 25.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.075 0.464 . . . . 0.0 110.35 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.27 -41.75 5.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.841 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.591 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -136.23 156.88 23.22 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 82.2 p -138.51 151.02 46.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.805 0.336 . . . . 0.0 110.597 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' THR . 94.4 m-85 -134.54 151.16 50.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.607 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.402 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 60.3 p -140.96 134.13 29.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.555 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.4 mttt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.51 -179.92 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.564 ' O ' ' OG ' ' A' ' 5' ' ' SER . 1.3 t 84.26 133.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 110.525 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -70.0 -26.6 64.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.609 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.9 ttt -60.76 -38.47 85.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.379 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.564 ' OG ' ' O ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -60.36 159.5 10.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.745 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t -65.02 156.65 30.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.695 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -76.55 -77.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.655 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.409 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 70.6 p -139.41 152.02 46.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.528 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 11' ' ' LYS . 83.2 mt-10 -156.84 152.91 27.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.941 0.401 . . . . 0.0 110.169 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 67.57 -9.59 0.42 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.702 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' H ' ' C ' ' A' ' 9' ' ' GLU . 23.6 mmtt -74.47 127.34 32.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.207 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.48 124.93 24.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.936 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 113.15 -8.44 25.01 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -94.52 133.46 38.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.888 0.375 . . . . 0.0 110.26 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 89.0 tttt -57.93 122.04 12.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.323 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.29 -34.69 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.976 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.18 156.68 45.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.514 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.2 ttp -120.97 140.42 51.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.311 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.4 tp -105.84 129.45 54.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.62 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 1.073 HD21 ' N ' ' A' ' 21' ' ' ILE . 0.2 OUTLIER -121.52 133.62 55.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.993 0.425 . . . . 0.0 110.815 179.624 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.073 ' N ' HD21 ' A' ' 20' ' ' ASN . 3.5 mt -114.69 112.62 45.32 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.527 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.418 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 56.8 Cg_endo -77.16 -42.91 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.579 2.186 . . . . 0.0 112.412 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.77 ' NZ ' ' NZ ' ' A' ' 77' ' ' LYS . 19.9 tptm -62.26 -38.44 89.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.803 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.792 HD22 ' N ' ' A' ' 24' ' ' LEU . 2.9 mm? -101.74 4.04 40.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.945 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 22' ' ' PRO . 7.0 mptt 43.85 48.75 7.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.562 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.645 ' NZ ' ' OG1' ' A' ' 71' ' ' THR . 26.6 mtmt -134.25 152.16 51.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.931 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.532 ' NZ ' ' OD1' ' A' ' 20' ' ' ASN . 8.6 mttp -130.43 143.04 50.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.675 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -130.88 145.66 52.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.743 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.3 p -95.06 113.83 25.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.644 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.594 HG12 HD11 ' A' ' 62' ' ' LEU . 1.2 mp -89.26 124.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.386 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 86.1 m-85 -106.06 149.66 26.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' A' ' 13' ' ' GLY . 24.0 t-105 -59.18 132.7 54.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.967 0.413 . . . . 0.0 110.824 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.523 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 75.04 162.41 9.83 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.4 117.48 22.26 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.277 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -93.07 117.5 30.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.733 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -88.55 -2.97 58.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.619 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.46 -57.78 2.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.802 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.405 ' H ' HG22 ' A' ' 38' ' ' THR . 2.6 t -87.73 133.68 33.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.772 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 5.2 mt -98.15 0.84 46.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.551 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -62.13 -42.9 99.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.652 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -90.78 -72.45 0.58 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.543 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.64 -51.04 3.66 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -77.1 96.98 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.023 0.44 . . . . 0.0 110.53 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.16 158.16 24.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.541 ' CE ' ' H ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -94.99 140.04 30.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.684 0.278 . . . . 0.0 110.321 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -66.95 136.09 54.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.523 HG23 ' HA2' ' A' ' 33' ' ' GLY . 77.8 t -115.63 116.17 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.467 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.534 ' OG ' HG23 ' A' ' 51' ' ' THR . 50.1 p -161.88 166.74 25.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 42.0 t0 -66.75 -2.68 5.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.52 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.0 m -118.96 -30.06 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.81 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.534 HG23 ' OG ' ' A' ' 48' ' ' SER . 27.8 p -80.47 142.72 33.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.736 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 59' ' ' HIS . 1.1 t -146.82 167.8 23.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.293 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.665 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -89.87 158.99 44.0 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.979 0.418 . . . . 0.0 110.601 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.84 83.16 1.83 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.755 2.303 . . . . 0.0 112.367 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.6 p -112.38 -3.78 14.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.679 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.83 91.9 0.24 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.18 77.44 0.28 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.16 162.94 32.6 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.656 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 18.6 t-160 -82.91 116.96 22.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.9 m -111.31 124.39 52.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.299 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.541 ' H ' ' CE ' ' A' ' 45' ' ' MET . 97.6 t -118.01 129.08 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.006 0.431 . . . . 0.0 110.354 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.594 HD11 HG12 ' A' ' 30' ' ' ILE . 2.3 mm? -110.48 139.27 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.3 t -121.93 134.16 54.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.05 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -153.98 111.18 0.48 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.562 ' O ' ' C ' ' A' ' 66' ' ' ARG . 1.5 p80 -61.85 151.53 34.22 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.259 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.562 ' C ' ' O ' ' A' ' 65' ' ' HIS . 19.2 tpt180 -25.59 101.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.72 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -108.42 110.25 21.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.605 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 46.2 p -99.36 109.6 22.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.38 . . . . 0.0 110.427 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.59 9.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.79 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 64.87 52.93 1.52 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.094 0.473 . . . . 0.0 110.644 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.645 ' OG1' ' NZ ' ' A' ' 26' ' ' LYS . 18.4 m -137.92 -0.79 2.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.671 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.525 ' O ' HD23 ' A' ' 76' ' ' LEU . 90.3 m-20 -62.49 -34.67 77.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.706 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.7 mt -61.23 -44.31 97.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.936 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.62 -31.01 57.26 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.63 -42.11 95.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.754 0.311 . . . . 0.0 110.957 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.87 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.7 pp -92.18 101.73 14.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.988 0.423 . . . . 0.0 111.017 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.77 ' NZ ' ' NZ ' ' A' ' 23' ' ' LYS . 8.6 ptpt 170.96 135.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.472 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -67.57 -15.39 63.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.269 0.557 . . . . 0.0 110.536 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -80.62 -14.94 57.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.871 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -79.96 157.24 26.9 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.461 ' O ' HD23 ' A' ' 82' ' ' LEU . 1.9 p -137.57 147.17 44.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 81' ' ' THR . 63.1 mt -122.76 126.6 47.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.917 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.658 ' C ' HD22 ' A' ' 84' ' ' LEU . 2.7 t -112.55 124.76 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.997 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.658 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.7 mm? -110.73 137.78 47.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.44 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.615 ' HG2' HG23 ' A' ' 90' ' ' THR . 5.8 mm-40 -106.72 115.72 30.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.332 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.665 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 16.4 t80 -142.16 124.92 15.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.863 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.9 t70 61.19 44.24 10.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.733 0.302 . . . . 0.0 111.256 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 64.19 7.87 3.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.51 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -108.69 145.87 34.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.37 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.615 HG23 ' HG2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -111.48 120.71 43.06 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.481 -179.504 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.419 ' CD1' ' N ' ' A' ' 91' ' ' TYR . 7.4 m-85 -98.98 143.3 29.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.372 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.87 110.61 21.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.843 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 82.9 m-85 -108.49 155.77 20.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.641 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -132.35 140.67 48.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.68 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mm -67.81 120.26 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.341 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.26 -65.03 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -144.53 137.88 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.309 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.89 130.93 65.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.015 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 19.2 p90 -152.83 -177.29 6.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.524 HG12 ' CD1' ' A' ' 135' ' ' TYR . 54.8 mt -125.72 132.74 70.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.253 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.539 HG22 ' CG1' ' A' ' 136' ' ' ILE . 1.5 t -133.7 166.62 22.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.928 0.395 . . . . 0.0 110.874 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.462 ' O ' HG23 ' A' ' 101' ' ' THR . 57.7 m80 -68.62 158.42 34.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.588 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.442 ' CB ' ' H ' ' A' ' 131' ' ' ALA . . . -71.21 -15.59 62.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.697 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.543 ' OD1' ' CG ' ' A' ' 130' ' ' ASP . 75.2 m-20 -97.47 8.49 44.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.697 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.4 87.7 4.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.986 0.422 . . . . 0.0 110.322 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.858 ' O ' HG23 ' A' ' 110' ' ' ILE . 10.9 ptp85 -65.63 -32.28 73.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.368 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.534 ' O ' HD12 ' A' ' 110' ' ' ILE . 6.9 p -42.94 -17.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.375 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.767 ' CG1' HG21 ' A' ' 118' ' ' THR . 48.4 t -106.42 -16.78 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.002 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.821 HG22 ' O ' ' A' ' 109' ' ' ILE . 45.4 mm -110.08 20.19 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.163 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.858 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -86.92 -165.36 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.941 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -97.02 151.37 19.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.44 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 98.4 mttt -135.99 134.99 39.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.571 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -83.7 14.21 4.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.084 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.15 159.61 70.25 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.992 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.93 92.9 1.09 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 123.126 2.551 . . . . 0.0 112.031 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.4 mm -124.73 137.34 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.189 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.735 ' C ' HD23 ' A' ' 117' ' ' LEU . 6.8 tt -109.78 118.0 35.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.203 0.525 . . . . 0.0 110.436 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.767 HG21 ' CG1' ' A' ' 108' ' ' VAL . 68.3 m -114.16 123.0 48.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.825 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.816 HD23 ' N ' ' A' ' 120' ' ' THR . 4.0 tt -107.79 120.77 43.18 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.558 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.816 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -115.87 114.68 25.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.154 0.502 . . . . 0.0 110.523 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.68 ' OG1' ' N ' ' A' ' 122' ' ' CYS . 0.0 OUTLIER -133.43 -166.07 1.72 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.172 -178.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.68 ' N ' ' OG1' ' A' ' 121' ' ' THR . 3.5 t 94.42 -63.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.342 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.701 ' CG ' ' O ' ' A' ' 123' ' ' TYR . 9.1 p90 -32.58 96.27 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.43 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.479 ' N ' ' O ' ' A' ' 122' ' ' CYS . 58.5 Cg_endo -82.22 -100.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.618 2.212 . . . . 0.0 112.191 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -118.06 -8.9 10.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.566 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.536 ' C ' ' OD1' ' A' ' 126' ' ' ASP . 40.1 p30 -89.84 11.12 21.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.514 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.68 ' CZ ' ' O ' ' A' ' 129' ' ' GLY . 35.2 t80 -51.41 -39.87 58.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.694 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.589 ' C ' ' O ' ' A' ' 127' ' ' TYR . 84.4 mt 21.43 78.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.381 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.68 ' O ' ' CZ ' ' A' ' 127' ' ' TYR . . . 67.95 -46.97 0.34 Allowed Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.545 ' OD1' ' O ' ' A' ' 129' ' ' GLY . 85.8 m-20 -141.45 126.02 17.84 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.791 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.52 ' HB3' ' CG ' ' A' ' 134' ' ' ARG . . . -77.42 135.19 65.56 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.45 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -44.66 -37.09 11.03 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.446 2.097 . . . . 0.0 111.784 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.562 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 27.3 p30 -167.29 114.69 0.78 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.486 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.52 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 77.5 mtp180 -100.89 139.43 36.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.951 0.405 . . . . 0.0 110.341 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.524 ' CD1' HG12 ' A' ' 100' ' ' ILE . 1.9 t80 -76.42 136.22 39.44 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.172 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.539 ' CG1' HG22 ' A' ' 101' ' ' THR . 5.9 mm -122.55 113.54 38.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.696 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 137' ' ' ILE . 0.6 OUTLIER -107.18 112.88 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.271 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.439 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 44.7 tt0 -93.63 139.81 30.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.508 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.58 148.77 31.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.974 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.1 tttm -119.12 152.22 36.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.384 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 18.0 tp -77.45 119.21 20.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.25 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.2 p -95.43 -41.55 8.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.673 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.466 ' O ' HD11 ' A' ' 141' ' ' LEU . . . -144.78 179.93 21.6 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.1 p -154.03 161.42 41.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.731 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 90' ' ' THR . 94.5 m-85 -144.03 159.37 42.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.773 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.8 p -144.57 128.17 17.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.654 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.3 tttp . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.967 -1.015 . . . . 0.0 110.579 179.92 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.8 p -61.15 -36.34 79.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.748 0.309 . . . . 0.0 110.642 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' A' ' 4' ' ' MET . 96.9 m-70 -82.88 -149.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.327 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.444 ' O ' ' O ' ' A' ' 3' ' ' HIS . 92.0 mtp 59.13 123.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.463 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.434 ' O ' ' OG ' ' A' ' 5' ' ' SER . 10.8 t 60.23 44.12 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.36 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.4 t -133.88 151.32 51.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.607 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -109.79 178.63 4.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.041 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.493 ' O ' ' C ' ' A' ' 9' ' ' GLU . 74.3 m -62.3 -48.55 79.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.991 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 8' ' ' THR . 36.7 tt0 31.8 -116.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.483 ' N ' ' HG2' ' A' ' 9' ' ' GLU . 50.1 m-70 -136.23 26.53 3.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.53 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -79.55 142.6 35.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.133 0.492 . . . . 0.0 110.613 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -69.24 142.18 54.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.341 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.57 15.8 63.13 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -119.61 137.01 54.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.014 0.435 . . . . 0.0 110.375 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 106.81 0.77 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.46 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.409 HG23 ' N ' ' A' ' 17' ' ' ALA . 15.9 m -109.81 -40.53 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.971 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' N ' HG23 ' A' ' 16' ' ' VAL . . . -135.09 164.56 27.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.695 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.0 ttt -131.75 128.21 38.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.635 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 tt -98.11 116.79 31.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.069 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.497 ' ND2' ' HE3' ' A' ' 27' ' ' LYS . 48.5 t-20 -110.76 137.33 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.022 0.439 . . . . 0.0 111.235 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.57 HD12 ' HG3' ' A' ' 26' ' ' LYS . 9.3 mt -116.67 115.87 39.03 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.286 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.94 -39.0 0.69 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.677 2.251 . . . . 0.0 112.847 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.581 ' C ' HD22 ' A' ' 24' ' ' LEU . 47.5 tptt -64.1 -35.62 81.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.007 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.723 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.4 mm? -101.9 7.14 41.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 40.78 59.35 2.21 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.131 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.57 ' HG3' HD12 ' A' ' 21' ' ' ILE . 15.3 ptpt -150.33 166.52 29.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.668 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HE3' ' ND2' ' A' ' 20' ' ' ASN . 27.6 mtpt -139.82 146.49 39.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.144 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.454 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 49.4 m-85 -132.13 138.68 48.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.717 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 p -89.57 112.24 23.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.544 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.9 mm -84.09 120.72 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.395 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -100.69 140.37 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.024 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.5 ' CE2' HG22 ' A' ' 47' ' ' VAL . 58.6 t-105 -59.46 132.1 52.96 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.276 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.658 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 76.55 140.2 1.03 Allowed Glycine 0 N--CA 1.463 0.445 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.33 78.64 1.13 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.857 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -90.19 134.26 34.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.78 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.517 ' OD1' ' O ' ' A' ' 36' ' ' ASP . 56.7 t0 -85.0 -8.09 58.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.494 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.63 -38.61 84.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.778 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.29 133.47 37.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.765 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.3 mt -101.76 6.19 41.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.318 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -62.34 -51.53 67.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.034 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -154.68 166.79 32.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.517 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 63' ' ' SER . . . -104.18 -12.22 29.89 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.38 98.31 5.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.314 0.578 . . . . 0.0 110.982 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.85 152.98 20.48 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.615 ' SD ' HD21 ' A' ' 62' ' ' LEU . 2.4 tpp -87.93 145.65 25.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.705 0.288 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.449 ' CD1' HG21 ' A' ' 51' ' ' THR . 2.4 t80 -77.13 139.13 39.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.658 HG23 ' HA2' ' A' ' 33' ' ' GLY . 94.2 t -117.24 120.76 65.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.401 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.659 ' CB ' ' HG1' ' A' ' 51' ' ' THR . 4.9 p -170.64 176.3 4.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.54 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.98 -18.76 61.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.734 HG21 ' O ' ' A' ' 109' ' ' ILE . 2.3 m -107.9 -21.28 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.9 0.381 . . . . 0.0 110.843 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.659 ' HG1' ' CB ' ' A' ' 48' ' ' SER . 17.3 p -89.49 127.95 35.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.288 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 59' ' ' HIS . 1.3 t -136.02 166.83 22.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.56 157.75 55.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.684 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.87 80.68 2.89 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.589 2.193 . . . . 0.0 112.528 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.4 p -113.02 -5.33 13.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.946 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.46 91.48 0.1 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.69 91.36 0.01 OUTLIER Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -170.25 162.43 35.65 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.66 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 17.0 t-160 -83.35 117.19 22.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.6 m -112.77 108.02 16.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.533 HG11 HD12 ' A' ' 109' ' ' ILE . 78.4 t -106.24 129.03 60.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 110.011 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.615 HD21 ' SD ' ' A' ' 45' ' ' MET . 27.1 mt -120.53 158.63 26.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.939 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 120' ' ' THR . 7.8 p -139.0 150.58 46.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.261 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.17 177.94 41.55 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.484 ' HA ' ' CD1' ' A' ' 123' ' ' TYR . 3.2 p-80 -97.43 132.99 42.61 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.523 -0.398 . . . . 0.0 110.789 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.721 ' O ' ' CG ' ' A' ' 125' ' ' PHE . 60.6 ttt85 -84.83 77.25 10.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.159 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 68' ' ' THR . 1.0 OUTLIER -107.9 157.43 18.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.718 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.51 ' O ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER 57.15 128.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.642 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 69' ' ' VAL . 34.8 t -77.78 -10.53 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.627 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.482 ' O ' ' CB ' ' A' ' 71' ' ' THR . 44.5 t80 -72.17 159.83 33.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.441 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' A' ' 70' ' ' PHE . 2.1 m 80.74 -11.98 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.546 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -62.54 -38.48 90.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.076 0.465 . . . . 0.0 110.429 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.634 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . 29.6 mt -62.07 -38.7 89.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.362 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.19 -29.26 37.92 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.432 ' HG3' HG22 ' A' ' 71' ' ' THR . 84.1 mt-30 -78.72 -41.91 29.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.832 0.348 . . . . 0.0 111.035 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.678 HD22 ' OH ' ' A' ' 135' ' ' TYR . 20.8 mt -89.83 80.92 6.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.085 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.634 ' NZ ' ' O ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -172.69 142.38 1.18 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.462 179.587 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -77.83 -16.5 58.27 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.596 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -79.2 -15.19 58.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.143 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' OD1' ' C ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -70.57 153.67 42.65 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 p -136.08 142.42 44.33 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.044 0.45 . . . . 0.0 110.002 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.1 mt -119.12 123.54 44.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.878 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.664 HG12 HG22 ' A' ' 90' ' ' THR . 2.2 t -107.12 124.73 63.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.35 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.638 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.4 mm? -110.39 129.61 55.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.377 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.419 ' HG2' HG23 ' A' ' 90' ' ' THR . 80.6 mt-10 -101.0 124.25 46.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.216 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 1.8 t80 -149.8 130.37 13.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.992 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 55.46 43.29 28.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.136 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 65.27 8.17 4.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.458 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 52.1 mtmt -107.02 150.98 25.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.383 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.664 HG22 HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -117.29 121.97 42.64 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.798 -179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -104.12 130.53 51.84 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.457 ' OG1' ' C ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -99.75 114.98 28.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.13 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 81.7 m-85 -110.69 155.49 22.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.725 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -130.73 140.13 50.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.156 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.456 HD13 HG23 ' A' ' 137' ' ' ILE . 1.1 mm -62.38 119.69 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.203 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.68 -64.1 1.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.885 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -146.98 133.01 19.21 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.172 0.51 . . . . 0.0 110.452 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.498 HG23 HG13 ' A' ' 137' ' ' ILE . 1.6 mp -111.04 131.13 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.608 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.402 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 18.9 p90 -153.72 -178.16 6.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.092 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.427 HG12 ' CD1' ' A' ' 135' ' ' TYR . 2.7 mt -127.13 134.08 66.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.258 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.542 HG22 ' CD1' ' A' ' 136' ' ' ILE . 2.9 t -146.06 172.49 13.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.91 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.429 ' O ' HG23 ' A' ' 101' ' ' THR . 4.9 m-70 -61.77 156.48 20.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.48 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.528 ' HB2' ' HG3' ' A' ' 134' ' ' ARG . . . -74.5 -25.97 59.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.831 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -89.46 2.17 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.565 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -65.36 90.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.526 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.983 ' O ' HG23 ' A' ' 110' ' ' ILE . 22.9 ptt85 -56.11 -35.91 67.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.51 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.536 ' C ' HD12 ' A' ' 110' ' ' ILE . 2.5 p -40.64 -17.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.536 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.787 ' CG1' HG21 ' A' ' 118' ' ' THR . 6.5 t -110.61 -15.58 9.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.005 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.734 ' O ' HG21 ' A' ' 50' ' ' VAL . 48.2 mm -113.74 21.91 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.036 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.983 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -88.19 -169.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.858 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -94.03 147.44 23.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.4 mttt -133.22 147.95 52.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.449 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -97.58 11.66 36.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.847 0.356 . . . . 0.0 110.067 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -133.66 159.48 72.34 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.73 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.49 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 46.7 Cg_endo -76.02 89.79 1.21 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.043 2.495 . . . . 0.0 111.959 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.46 134.99 63.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.437 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.517 ' C ' HD23 ' A' ' 117' ' ' LEU . 9.2 tt -109.34 120.85 43.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.653 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.787 HG21 ' CG1' ' A' ' 108' ' ' VAL . 71.7 m -116.36 119.78 36.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.109 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 120' ' ' THR . 0.7 OUTLIER -110.67 114.65 28.2 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.462 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.716 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -106.63 127.86 53.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.462 . . . . 0.0 110.762 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.631 HG23 ' CD2' ' A' ' 119' ' ' LEU . 27.4 p -135.76 162.39 32.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.129 0.49 . . . . 0.0 111.56 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.612 ' O ' ' O ' ' A' ' 123' ' ' TYR . 0.5 OUTLIER 179.61 -79.76 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.937 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.612 ' O ' ' O ' ' A' ' 122' ' ' CYS . 5.8 m-85 50.64 151.9 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.732 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.22 56.77 0.43 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.717 2.278 . . . . 0.0 112.244 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.721 ' CG ' ' O ' ' A' ' 66' ' ' ARG . 3.2 p90 -87.01 -31.49 20.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.575 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.703 ' OD2' ' CE2' ' A' ' 125' ' ' PHE . 62.1 m-20 -128.96 -17.56 3.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.757 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.687 ' CE2' ' O ' ' A' ' 128' ' ' ILE . 71.6 t80 -109.71 155.33 21.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.607 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.687 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 87.2 mt -93.44 119.71 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.237 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.89 -115.37 5.25 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -121.2 108.0 13.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.734 0.302 . . . . 0.0 110.682 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.577 ' O ' ' NH1' ' A' ' 134' ' ' ARG . . . -45.79 111.45 1.4 Allowed Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.695 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.85 -42.06 52.91 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.552 2.168 . . . . 0.0 112.022 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.82 150.42 24.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.25 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.577 ' NH1' ' O ' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -126.4 137.96 53.49 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 110.95 -179.62 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.678 ' OH ' HD22 ' A' ' 76' ' ' LEU . 5.2 t80 -79.57 126.39 30.82 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.542 ' CD1' HG22 ' A' ' 101' ' ' THR . 1.1 mt -122.02 126.51 74.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-O 121.218 0.532 . . . . 0.0 111.943 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.594 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp -108.17 112.76 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.287 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -95.4 136.65 35.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.548 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.87 153.53 47.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.549 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 8.4 tptt -116.55 146.72 42.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.948 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.549 ' H ' ' HD2' ' A' ' 140' ' ' LYS . 16.4 tp -69.69 124.09 23.08 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.107 0.479 . . . . 0.0 110.109 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.9 p -99.04 -47.94 5.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.629 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.457 ' C ' ' OG1' ' A' ' 92' ' ' THR . . . -141.97 172.05 24.26 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.2 p -144.9 134.76 23.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.614 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -122.93 146.29 47.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.196 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 97.9 p -134.14 123.99 25.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.485 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.419 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 55.87 -165.17 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.79 0.329 . . . . 0.0 110.488 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.589 ' O ' ' OG ' ' A' ' 5' ' ' SER . 78.0 t60 -102.95 106.54 17.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.365 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.419 ' CG ' ' H ' ' A' ' 5' ' ' SER . 0.4 OUTLIER 42.81 -123.66 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.576 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.589 ' OG ' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER 52.86 77.53 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.615 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.586 ' O ' ' OE1' ' A' ' 14' ' ' GLU . 67.7 m -72.05 145.54 48.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.471 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -126.46 41.5 3.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.656 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.54 -41.77 2.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.572 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.63 158.12 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.612 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.625 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -82.54 18.28 1.54 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.568 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -55.28 145.58 21.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.208 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 12' ' ' GLU . 2.1 pt-20 -58.22 135.87 57.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.073 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.39 2.68 61.77 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.586 ' OE1' ' O ' ' A' ' 6' ' ' SER . 76.2 mm-40 -115.32 140.45 49.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.793 0.33 . . . . 0.0 110.512 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -63.1 121.52 13.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.216 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.55 -39.47 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.96 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.3 156.95 43.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.628 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ttm -119.68 141.77 49.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.161 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 82' ' ' LEU . 29.0 tp -108.4 121.81 45.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.644 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -118.38 127.8 54.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.902 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 24' ' ' LEU . 6.0 mt -104.56 115.53 62.62 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.389 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.62 ' CD ' ' O ' ' A' ' 81' ' ' THR . 56.9 Cg_endo -77.11 -45.78 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.846 2.364 . . . . 0.0 112.52 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.632 ' C ' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -60.3 -40.25 89.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.489 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.771 HD22 ' N ' ' A' ' 24' ' ' LEU . 2.9 mm? -102.56 8.97 39.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.562 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 40.42 40.21 0.83 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.519 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.42 ' CB ' HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -112.07 157.91 20.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.519 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -138.71 139.89 38.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.584 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -137.06 159.09 42.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.855 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 m -101.99 122.38 43.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.001 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.4 mm -94.08 118.71 40.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.319 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -101.16 136.76 40.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.323 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 10' ' ' HIS . 55.8 t-105 -60.41 133.05 55.72 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.616 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.568 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 77.62 163.98 21.63 Favored Glycine 0 C--N 1.331 0.258 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -163.52 93.21 0.74 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.868 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -78.46 134.07 37.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.763 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -70.84 -40.39 72.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.642 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.77 64.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.557 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 48.5 p -101.86 144.16 30.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.542 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.0 mt -110.83 131.31 55.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.527 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -130.75 -160.55 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.624 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -61.65 -42.08 98.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.489 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.91 -4.59 4.65 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.77 92.45 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.398 . . . . 0.0 110.49 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.35 148.68 19.44 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.703 ' CE ' ' H ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -95.46 134.45 38.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.627 0.251 . . . . 0.0 110.325 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.673 ' O ' ' SD ' ' A' ' 45' ' ' MET . 18.6 t80 -75.43 139.45 42.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.535 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.568 HG23 ' HA2' ' A' ' 33' ' ' GLY . 40.2 t -111.02 124.58 67.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.962 0.41 . . . . 0.0 110.433 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.538 ' OG ' ' CE2' ' A' ' 46' ' ' PHE . 18.8 m -160.92 165.38 30.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.604 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -69.0 -24.22 64.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.704 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.583 HG21 ' HA ' ' A' ' 110' ' ' ILE . 4.6 m -94.18 -40.52 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.161 0.505 . . . . 0.0 110.742 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.51 ' N ' HG23 ' A' ' 50' ' ' VAL . 81.7 p -76.18 155.56 34.44 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.716 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -148.97 171.6 16.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.606 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.466 HG22 ' CH2' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -87.41 156.75 53.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.754 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.452 ' HG3' HD23 ' A' ' 84' ' ' LEU . 68.0 Cg_endo -80.03 83.46 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.581 2.188 . . . . 0.0 112.445 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.0 p -113.85 -9.47 13.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.569 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.73 90.41 0.08 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.85 85.75 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.503 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.22 160.64 34.37 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.702 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 13.6 t-160 -83.65 116.66 22.74 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.7 m -111.81 127.19 55.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.234 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.703 ' H ' ' CE ' ' A' ' 45' ' ' MET . 54.6 t -117.29 129.75 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.354 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.538 HD22 ' O ' ' A' ' 61' ' ' VAL . 1.9 mm? -112.7 145.49 40.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.632 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 120' ' ' THR . 47.2 t -126.73 144.12 51.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.086 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.47 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -164.16 166.58 37.73 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.531 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.57 ' N ' ' ND1' ' A' ' 65' ' ' HIS . 0.5 OUTLIER -116.87 145.18 43.74 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.554 -0.38 . . . . 0.0 110.536 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.0 ttp180 -96.18 135.09 38.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.5 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -156.7 -50.74 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.621 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 68' ' ' THR . 5.7 t -127.47 129.32 47.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.495 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.92 135.69 52.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.647 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -122.35 -17.41 7.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.64 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -134.65 75.84 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.595 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -64.12 -40.67 96.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.58 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.668 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -62.48 -44.34 96.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.921 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.64 -32.46 83.21 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -40.35 94.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.918 0.39 . . . . 0.0 110.165 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.33 111.4 17.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.668 ' NZ ' ' O ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -174.23 141.12 0.71 Allowed 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -77.84 -12.36 59.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.052 0.454 . . . . 0.0 110.507 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -84.95 -15.51 44.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.137 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.401 ' HB2' ' CD ' ' A' ' 77' ' ' LYS . 1.2 t70 -69.5 152.76 44.45 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.62 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -142.04 115.01 8.7 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.304 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.465 ' HB3' HD11 ' A' ' 19' ' ' LEU . 67.2 mt -90.47 132.21 35.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.629 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.548 HG12 HG22 ' A' ' 90' ' ' THR . 2.1 t -109.85 115.54 49.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.994 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 117' ' ' LEU . 6.0 mp -94.98 123.47 38.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.196 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.457 ' HG2' HG23 ' A' ' 90' ' ' THR . 96.7 mt-10 -99.73 117.61 34.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.374 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -149.6 133.26 16.8 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.936 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 56.23 43.67 26.21 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.321 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.5 9.31 2.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.337 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -107.44 150.21 27.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.518 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -118.03 123.85 46.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.709 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 15.4 m-85 -107.31 132.63 52.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.271 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.18 112.37 24.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 111.634 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.703 ' CE2' HD22 ' A' ' 84' ' ' LEU . 75.6 m-85 -109.85 147.58 33.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.775 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.583 ' OE1' ' O ' ' A' ' 95' ' ' ILE . 0.5 OUTLIER -124.71 139.83 53.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 179.682 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.583 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 1.3 mm -63.5 117.13 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.286 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.495 ' OE1' ' OE2' ' A' ' 94' ' ' GLU . 7.8 mm100 -84.27 -67.97 0.75 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.844 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -145.83 139.66 26.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.109 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 137' ' ' ILE . 4.4 mt -112.81 127.78 69.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.61 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 25.8 p90 -150.89 -177.98 6.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.777 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.461 HD12 ' N ' ' A' ' 100' ' ' ILE . 3.6 mp -127.25 131.52 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.641 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.449 HG22 HD11 ' A' ' 136' ' ' ILE . 1.6 t -132.31 165.95 23.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.673 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -70.6 153.8 42.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.408 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.56 -13.32 61.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.697 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -92.67 8.02 40.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.76 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.599 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 68.1 t0 -85.98 89.91 7.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.581 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.849 ' O ' HG23 ' A' ' 110' ' ' ILE . 11.5 ptm180 -70.15 -24.19 63.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.429 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.599 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 12.9 p -49.56 -12.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.357 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.851 ' CG1' HG21 ' A' ' 118' ' ' THR . 43.9 t -111.02 -8.77 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.992 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.718 HG22 ' O ' ' A' ' 109' ' ' ILE . 29.9 mm -111.91 7.03 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 0.0 111.022 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.849 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -79.03 -161.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.629 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 14.1 ptpt -109.89 155.25 21.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.784 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.491 ' H ' ' HB2' ' A' ' 59' ' ' HIS . 99.3 mttt -138.54 144.06 39.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.451 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -85.74 10.88 12.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.999 0.428 . . . . 0.0 110.051 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.04 156.72 73.89 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.135 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.503 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 51.4 Cg_endo -76.89 88.48 1.39 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.975 2.45 . . . . 0.0 111.609 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.4 mm -124.07 131.43 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.916 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.851 HD12 HD21 ' A' ' 84' ' ' LEU . 5.3 tt -105.28 122.41 45.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.201 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.851 HG21 ' CG1' ' A' ' 108' ' ' VAL . 89.8 m -118.99 126.08 50.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.134 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.885 HD23 ' N ' ' A' ' 120' ' ' THR . 3.2 tt -107.7 124.55 50.17 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.599 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.885 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -120.99 113.97 20.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.448 0.642 . . . . 0.0 110.719 179.04 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.682 ' O ' ' SG ' ' A' ' 122' ' ' CYS . 1.7 t -144.81 169.79 17.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.229 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.682 ' SG ' ' O ' ' A' ' 121' ' ' THR . 1.3 m 153.99 -71.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.503 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.503 ' C ' ' O ' ' A' ' 122' ' ' CYS . 51.5 m-85 28.6 70.77 0.5 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.896 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 127' ' ' TYR . 62.3 Cg_endo -77.79 160.36 31.01 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.889 2.392 . . . . 0.0 112.115 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.635 ' CE2' ' OD1' ' A' ' 126' ' ' ASP . 50.6 p90 -48.54 -13.71 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.872 0.368 . . . . 0.0 110.393 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.635 ' OD1' ' CE2' ' A' ' 125' ' ' PHE . 78.2 m-20 -102.7 12.11 36.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.861 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.659 ' CZ ' ' O ' ' A' ' 129' ' ' GLY . 39.3 t80 -51.3 -51.78 51.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.252 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.646 ' C ' ' O ' ' A' ' 127' ' ' TYR . 30.0 mm 9.92 94.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 O-C-N 123.508 0.505 . . . . 0.0 110.723 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.659 ' O ' ' CZ ' ' A' ' 127' ' ' TYR . . . 96.6 -95.52 1.77 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 131' ' ' ALA . 3.5 m-20 -132.82 113.17 12.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.634 0.254 . . . . 0.0 110.703 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' ASP . . . -37.26 140.49 0.47 Allowed Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.683 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.15 -20.12 56.57 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.693 2.262 . . . . 0.0 111.724 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -167.07 124.91 1.28 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.766 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -105.26 136.23 45.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.556 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.719 ' CD2' HD11 ' A' ' 137' ' ' ILE . 3.6 t80 -74.58 130.68 40.01 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.78 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.453 HD12 HG11 ' A' ' 108' ' ' VAL . 5.3 mm -115.21 117.22 54.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.936 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.719 HD11 ' CD2' ' A' ' 135' ' ' TYR . 12.8 mm -107.04 109.97 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.469 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 41.8 tt0 -92.06 137.0 32.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.054 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 117' ' ' LEU . . . -138.65 149.03 44.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.199 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 26.6 tptt -123.44 142.1 51.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.47 ' H ' ' HD2' ' A' ' 140' ' ' LYS . 21.3 tp -69.5 122.88 19.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.382 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.577 HG21 ' HB3' ' A' ' 94' ' ' GLU . 7.4 p -99.06 -46.82 5.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.734 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -142.04 -177.67 17.37 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.9 p -151.05 152.4 33.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.945 0.403 . . . . 0.0 110.713 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 90' ' ' THR . 90.5 m-85 -140.02 149.56 43.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.427 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.1 p -139.18 119.39 13.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.334 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.8 tttm . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.484 -179.835 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 1' ' ' GLY . 4.4 p 36.25 -158.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 0.0 110.567 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -111.33 167.01 10.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.675 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 34.4 tpp -61.03 -85.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.641 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.665 ' O ' ' N ' ' A' ' 7' ' ' GLN . 77.3 p -165.98 128.41 1.98 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.528 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 47.26 -79.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.843 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.665 ' N ' ' O ' ' A' ' 5' ' ' SER . 93.2 mm-40 60.31 50.8 5.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.627 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.8 p -118.54 139.15 51.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.286 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 10' ' ' HIS . 36.5 tp10 -162.57 -118.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.446 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.429 ' N ' ' HG3' ' A' ' 9' ' ' GLU . 3.4 m-70 -72.92 -12.39 60.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.414 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -62.29 127.4 31.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.26 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -78.6 154.35 30.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.88 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 76.7 18.79 78.62 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -125.75 147.6 49.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 120.835 0.35 . . . . 0.0 110.548 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -63.21 119.52 9.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.236 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.571 HG11 ' HB2' ' A' ' 32' ' ' TRP . 4.6 m -119.64 -20.94 4.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.226 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.516 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -149.19 161.38 42.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.709 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.5 ttt -116.51 141.23 48.45 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.627 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.608 ' HB2' HD11 ' A' ' 30' ' ' ILE . 4.0 tp -109.81 121.86 46.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.567 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -117.76 129.67 55.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.706 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.579 HG21 HD23 ' A' ' 24' ' ' LEU . 13.3 mt -113.84 109.17 50.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.2 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -77.92 -41.72 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.679 2.253 . . . . 0.0 113.208 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.575 ' HB3' HD22 ' A' ' 24' ' ' LEU . 6.6 tptp -58.78 -43.98 90.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.175 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.579 HD23 HG21 ' A' ' 21' ' ' ILE . 1.4 mm? -101.24 2.93 40.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.022 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 mttt 50.4 56.75 7.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.953 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -134.44 155.23 50.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.788 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.04 138.86 42.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.772 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -137.92 157.8 45.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.762 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 t -99.86 134.03 43.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.831 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 19' ' ' LEU . 36.4 mm -99.24 127.28 52.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.331 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -106.37 139.51 40.74 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.222 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.603 ' O ' ' N ' ' A' ' 13' ' ' GLY . 41.6 t-105 -70.29 131.78 44.69 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 71.57 173.24 17.1 Favored Glycine 0 C--O 1.23 -0.122 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.65 78.89 1.37 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.836 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -94.74 149.19 21.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.757 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -72.26 -17.21 61.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.604 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.561 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.95 -38.0 89.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.685 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.474 ' C ' HD22 ' A' ' 39' ' ' LEU . 31.9 m -62.53 133.77 55.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.607 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.561 ' CD2' ' O ' ' A' ' 37' ' ' ALA . 4.4 mm? -100.13 134.01 43.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.654 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.5 tttp 69.57 63.05 0.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.52 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.457 ' HG3' ' N ' ' A' ' 42' ' ' GLY . 4.3 tptm -89.82 -120.82 0.06 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.41 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.457 ' N ' ' HG3' ' A' ' 41' ' ' LYS . . . 122.79 -54.79 0.7 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.5 t -125.06 92.32 2.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 120.944 0.402 . . . . 0.0 110.661 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.96 143.07 17.83 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.449 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 30.6 ttm -90.92 128.64 36.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -70.97 132.48 45.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.494 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 47' ' ' VAL . 2.3 p -115.46 109.88 29.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.171 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 t -150.5 172.06 16.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.471 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -63.49 -37.62 88.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.537 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.834 HG21 ' O ' ' A' ' 109' ' ' ILE . 13.0 m -83.92 -38.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.898 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.613 HG23 HG23 ' A' ' 50' ' ' VAL . 30.6 p -85.89 158.08 20.02 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.459 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 t -160.08 173.56 15.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.6 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.547 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -84.52 158.46 60.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.736 -179.745 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.552 ' HG3' HD23 ' A' ' 84' ' ' LEU . 74.4 Cg_endo -82.65 83.62 1.95 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.501 2.134 . . . . 0.0 112.654 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 p -119.7 -5.65 10.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.735 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.24 87.4 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.6 96.49 0.02 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.54 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -172.65 150.74 12.96 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.657 ' CE1' HD12 ' A' ' 110' ' ' ILE . 22.3 t-160 -76.4 102.47 5.97 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -96.36 125.1 40.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.013 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.561 HG11 ' CD1' ' A' ' 109' ' ' ILE . 55.2 t -117.75 130.54 72.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.042 0.449 . . . . 0.0 109.975 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 61' ' ' VAL . 2.1 mm? -114.18 139.65 49.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.16 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.8 t -112.89 134.11 54.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.846 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 120' ' ' THR . . . -131.35 71.77 0.49 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.595 ' H ' ' CD2' ' A' ' 65' ' ' HIS . 0.0 OUTLIER -54.12 137.24 40.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.602 0.239 . . . . 0.0 110.528 -179.668 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 mtm-85 71.97 174.49 0.29 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.941 0.401 . . . . 0.0 110.621 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -94.45 122.76 37.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.78 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.8 t -146.86 46.88 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.557 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.92 118.58 53.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.444 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -75.25 -61.91 1.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.73 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.42 ' O ' ' OE1' ' A' ' 75' ' ' GLN . 0.3 OUTLIER -113.72 98.62 7.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.937 179.729 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.499 ' O ' HD23 ' A' ' 76' ' ' LEU . 26.2 m-20 -60.1 -42.3 94.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.569 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.41 ' O ' ' HE3' ' A' ' 77' ' ' LYS . 46.0 mt -62.92 -41.55 99.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.587 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.33 -42.51 93.97 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.624 ' OE1' ' N ' ' A' ' 75' ' ' GLN . 0.1 OUTLIER -69.99 -42.52 72.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.462 -179.264 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.857 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.9 pp -92.56 108.64 20.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.21 0.529 . . . . 0.0 110.88 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.596 ' O ' HG21 ' A' ' 95' ' ' ILE . 16.6 ptpt 177.15 150.38 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.284 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -80.02 -12.4 59.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.497 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -87.98 -14.84 38.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.572 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.573 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 3.5 t70 -66.96 153.3 43.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.862 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.486 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.3 p -141.49 135.7 30.48 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.147 0.499 . . . . 0.0 109.69 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.47 HD21 ' OD2' ' A' ' 80' ' ' ASP . 7.2 mt -114.42 128.1 56.17 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.714 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.541 ' C ' HD12 ' A' ' 84' ' ' LEU . 2.4 t -106.77 121.47 59.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.954 0.407 . . . . 0.0 110.249 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.897 HD21 HD12 ' A' ' 117' ' ' LEU . 6.1 mp -105.1 121.59 44.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.208 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HG2' HG23 ' A' ' 90' ' ' THR . 92.8 mt-10 -101.71 113.7 27.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.108 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.516 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -147.86 132.76 18.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.843 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 t0 60.35 40.39 17.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.833 0.349 . . . . 0.0 111.404 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 63.71 11.13 5.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.178 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.673 ' NZ ' ' OH ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -110.61 149.66 30.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.566 179.798 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -115.18 113.31 23.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.747 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.673 ' OH ' ' NZ ' ' A' ' 89' ' ' LYS . 9.4 m-85 -100.77 129.01 46.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.477 ' N ' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -100.86 119.95 39.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.045 0.45 . . . . 0.0 111.637 -178.154 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.756 ' CE1' HD22 ' A' ' 84' ' ' LEU . 72.6 m-85 -111.55 158.16 19.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.248 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -133.79 139.69 46.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.262 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.775 HD12 HD11 ' A' ' 98' ' ' ILE . 7.0 mm -67.64 120.72 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.13 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -90.89 -62.68 1.4 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.613 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.541 ' O ' HD13 ' A' ' 98' ' ' ILE . 58.6 tttp -148.98 143.35 26.07 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.143 0.497 . . . . 0.0 110.247 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.775 HD11 HD12 ' A' ' 95' ' ' ILE . 14.8 mm -117.67 129.72 73.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.792 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.425 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 19.7 p90 -150.35 -176.71 5.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.031 0.443 . . . . 0.0 111.352 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.547 HG22 ' HB3' ' A' ' 133' ' ' ASP . 4.9 mt -126.04 132.63 70.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.4 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.584 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 3.1 t -131.84 171.32 13.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.839 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.42 ' O ' HG23 ' A' ' 101' ' ' THR . 0.7 OUTLIER -72.97 162.1 29.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.728 -179.754 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.13 -11.37 60.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.62 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -104.14 16.6 25.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.686 ' OD1' HG23 ' A' ' 107' ' ' THR . 31.6 t0 -86.31 101.42 13.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 110.377 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 109' ' ' ILE . 33.7 ptt180 -72.62 -21.32 61.13 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.799 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.686 HG23 ' OD1' ' A' ' 105' ' ' ASP . 21.3 p -45.73 -20.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.884 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 105' ' ' ASP . 10.6 m -101.42 -17.2 6.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.047 0.451 . . . . 0.0 110.291 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.834 ' O ' HG21 ' A' ' 50' ' ' VAL . 47.8 mm -109.89 23.36 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.657 HD12 ' CE1' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -89.01 -162.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -111.46 143.15 42.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.724 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -131.07 145.39 52.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.575 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -87.48 12.62 11.83 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.109 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.75 165.72 26.33 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.966 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.54 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 52.6 Cg_endo -78.87 98.52 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.854 2.369 . . . . 0.0 111.605 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.3 mm -126.02 131.66 71.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.331 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.897 HD12 HD21 ' A' ' 84' ' ' LEU . 9.6 tt -102.4 121.3 42.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.368 0.604 . . . . 0.0 110.203 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.8 m -117.52 106.18 12.88 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.491 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.995 HD12 ' N ' ' A' ' 120' ' ' THR . 0.1 OUTLIER -100.85 127.41 47.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.046 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.995 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -119.69 137.35 53.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.451 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.721 ' CG2' HD11 ' A' ' 119' ' ' LEU . 5.8 p -134.01 169.96 16.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.046 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.687 ' SG ' ' O ' ' A' ' 121' ' ' THR . 5.4 m 95.01 -73.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.337 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.631 ' CE2' ' CZ ' ' A' ' 134' ' ' ARG . 53.0 m-85 56.3 111.9 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.013 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.549 ' HA ' ' H ' ' A' ' 131' ' ' ALA . 50.2 Cg_exo -49.58 -43.11 40.62 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.368 2.046 . . . . 0.0 112.776 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.7 ' CG ' ' N ' ' A' ' 126' ' ' ASP . 0.8 OUTLIER -65.77 -50.77 63.53 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.993 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.7 ' N ' ' CG ' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -70.62 -43.76 68.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.208 -179.308 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.701 ' CE2' ' O ' ' A' ' 128' ' ' ILE . 17.7 t80 -55.15 141.63 34.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.555 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.701 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 8.8 mm -54.87 108.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.412 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.93 -113.76 4.25 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -141.54 106.38 4.92 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.615 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.549 ' H ' ' HA ' ' A' ' 124' ' ' PRO . . . -72.14 119.24 73.51 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.188 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.576 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 59.3 Cg_exo -47.49 -31.55 13.82 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.278 1.985 . . . . 0.0 111.909 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.576 ' OD1' ' O ' ' A' ' 132' ' ' PRO . 78.0 m-20 -155.84 178.53 10.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.502 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.631 ' CZ ' ' CE2' ' A' ' 123' ' ' TYR . 41.4 ttm180 -117.36 133.11 56.35 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.52 ' CE2' HD11 ' A' ' 137' ' ' ILE . 2.8 t80 -70.12 135.41 49.15 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.2 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.528 ' CG1' HG22 ' A' ' 101' ' ' THR . 43.5 mm -121.84 116.03 48.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.455 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.721 HD13 HG23 ' A' ' 98' ' ' ILE . 40.4 mm -101.76 108.42 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -97.65 138.36 35.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.107 0.479 . . . . 0.0 111.1 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.45 28.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.862 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.536 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 28.2 ttpt -121.97 157.59 30.95 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.024 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.804 HD23 ' N ' ' A' ' 142' ' ' THR . 3.9 tt -81.67 122.09 27.19 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.64 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.804 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -98.47 -40.37 8.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.709 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -150.76 155.13 26.01 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.14 158.19 45.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 111.277 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' THR . 95.2 m-85 -135.07 146.47 48.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.688 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.577 ' O ' ' O ' ' A' ' 147' ' ' LYS . 96.2 p -129.57 114.37 15.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.19 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.577 ' O ' ' O ' ' A' ' 146' ' ' SER . 55.0 tttt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.592 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.563 ' O ' ' O ' ' A' ' 1' ' ' GLY . 1.4 p 29.96 99.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 0.0 110.558 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.557 ' O ' ' O ' ' A' ' 4' ' ' MET . 86.4 t60 32.97 90.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.496 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.557 ' O ' ' O ' ' A' ' 3' ' ' HIS . 77.2 mtm -30.2 151.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.3 p -72.02 158.99 34.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.505 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.6 p -132.43 147.77 52.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.512 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 52.1 mm-40 -58.37 -113.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.535 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.46 116.06 29.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.346 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.452 ' O ' ' OE2' ' A' ' 14' ' ' GLU . 95.8 mt-10 -148.6 -160.75 1.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.523 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -91.15 1.24 57.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.512 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.694 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -70.18 150.88 46.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.565 -179.538 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.559 ' OE1' ' N ' ' A' ' 12' ' ' GLU . 54.1 mp0 -86.61 147.01 26.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.83 18.69 55.86 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.694 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 1.0 OUTLIER -123.65 131.13 53.54 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.842 0.354 . . . . 0.0 110.449 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.585 ' N ' ' CD2' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.4 100.97 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.023 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.446 HG11 ' HB2' ' A' ' 32' ' ' TRP . 13.0 m -100.34 -30.49 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.092 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.4 158.34 43.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.723 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.9 ttm -119.47 139.61 51.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.448 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 tp -105.53 113.84 27.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.475 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -107.13 126.04 51.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.245 0.545 . . . . 0.0 110.726 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 24' ' ' LEU . 10.3 mt -103.95 114.08 64.82 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.138 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.511 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.4 Cg_endo -77.33 -47.51 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.984 2.456 . . . . 0.0 112.871 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.573 ' C ' HD22 ' A' ' 24' ' ' LEU . 50.5 tptt -59.47 -40.51 87.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.574 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.798 HD22 ' N ' ' A' ' 24' ' ' LEU . 2.8 mm? -98.43 -3.57 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.582 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 52.87 39.77 29.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.972 0.415 . . . . 0.0 110.642 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.83 152.44 37.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.832 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -128.96 142.31 50.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.853 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -135.67 150.41 49.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.801 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.1 m -98.96 115.78 29.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.583 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.48 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.3 mp -93.14 127.03 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.63 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 15' ' ' LYS . 33.6 m-85 -107.55 143.1 36.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.869 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.598 ' HZ2' HG23 ' A' ' 47' ' ' VAL . 47.3 t-105 -61.84 127.29 30.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.736 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 89.1 168.21 43.59 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.17 110.85 0.93 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.915 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -101.8 125.77 48.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 0.0 110.716 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.472 ' C ' ' OD1' ' A' ' 36' ' ' ASP . 51.5 p30 -81.12 -3.83 53.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.511 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.94 -64.58 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.614 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.3 p -86.32 168.02 14.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.517 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.8 tp -98.36 86.53 3.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.413 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -80.96 -171.97 3.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.458 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -51.78 -28.63 16.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.371 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 63' ' ' SER . . . 108.52 -36.3 4.45 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.5 96.87 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.152 0.501 . . . . 0.0 110.355 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.04 161.02 23.79 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.766 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -104.27 139.25 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.72 0.295 . . . . 0.0 110.587 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.766 ' N ' ' SD ' ' A' ' 45' ' ' MET . 40.5 t80 -76.7 120.59 22.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.127 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.598 HG23 ' HZ2' ' A' ' 32' ' ' TRP . 2.2 p -97.53 120.37 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.661 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.21 166.53 32.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.414 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.51 ' OD1' ' O ' ' A' ' 49' ' ' ASP . 41.0 t0 -64.07 -33.98 77.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.548 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.595 HG21 ' HA ' ' A' ' 110' ' ' ILE . 4.1 m -84.82 -41.62 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 110.863 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.52 ' N ' HG23 ' A' ' 50' ' ' VAL . 44.2 p -77.5 161.47 27.9 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.724 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.508 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -156.22 169.75 23.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.905 0.383 . . . . 0.0 110.587 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.402 ' H ' HG23 ' A' ' 53' ' ' THR . 0.1 OUTLIER -88.89 153.86 49.73 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.587 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.689 ' HG3' HD23 ' A' ' 84' ' ' LEU . 56.6 Cg_endo -73.23 85.56 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.874 2.383 . . . . 0.0 112.314 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -118.95 4.41 11.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.62 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.94 89.95 0.26 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.5 85.58 0.05 OUTLIER Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.44 161.91 35.31 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.714 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 12.3 t-160 -81.36 121.03 25.7 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.2 m -114.9 122.9 47.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.188 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.552 ' O ' HD22 ' A' ' 62' ' ' LEU . 39.9 t -115.98 128.61 73.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.338 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.552 HD22 ' O ' ' A' ' 61' ' ' VAL . 1.9 mm? -113.82 145.64 41.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.232 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 42' ' ' GLY . 35.7 t -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.647 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.651 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -157.27 164.54 32.96 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.466 ' ND1' ' N ' ' A' ' 65' ' ' HIS . 0.0 OUTLIER -123.05 153.53 39.74 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.864 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 61.8 101.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.471 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -65.15 -31.68 72.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.214 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 70.63 107.03 0.06 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.592 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 69' ' ' VAL . 2.5 m -45.15 -26.7 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.49 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.553 ' C ' ' H ' ' A' ' 72' ' ' ASP . 3.1 m-85 -73.93 143.57 45.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.669 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 53.8 p 50.33 6.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.479 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 70' ' ' PHE . 25.5 t0 -59.36 -47.04 86.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.538 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 73' ' ' LEU . 15.3 tp -60.64 -42.49 97.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.902 0.382 . . . . 0.0 110.814 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' A' ' 24' ' ' LEU . . . -63.26 -30.12 76.55 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -70.06 -39.44 75.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.935 0.398 . . . . 0.0 110.792 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.452 ' CD2' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -101.44 98.02 8.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.772 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.523 ' O ' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER 178.01 148.71 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.116 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -78.13 -13.83 59.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.54 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -83.17 -15.69 49.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.414 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.55 153.16 41.44 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.652 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.511 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -141.95 121.53 13.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.088 0.471 . . . . 0.0 109.8 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.2 mt -98.39 133.34 42.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.545 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.463 ' C ' HD12 ' A' ' 84' ' ' LEU . 3.1 t -111.92 122.62 66.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.927 0.394 . . . . 0.0 110.25 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.689 HD23 ' HG3' ' A' ' 54' ' ' PRO . 8.5 mp -102.33 124.45 47.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.105 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -101.22 115.22 29.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.093 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.632 ' O ' ' N ' ' A' ' 89' ' ' LYS . 5.6 t80 -144.55 143.07 30.64 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.812 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 86' ' ' TYR . 38.9 t70 38.05 52.64 1.57 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.738 0.304 . . . . 0.0 111.407 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 58.1 9.87 1.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.395 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.632 ' N ' ' O ' ' A' ' 86' ' ' TYR . 53.4 mtmt -104.57 143.72 32.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.55 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.438 HG22 HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -116.85 122.56 44.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.844 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -109.88 127.95 55.04 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.533 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -96.47 109.25 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.393 -179.65 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.606 ' CE1' HD22 ' A' ' 84' ' ' LEU . 52.9 m-85 -99.06 155.15 17.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.991 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -131.38 130.02 42.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.194 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.526 ' CD1' ' CG2' ' A' ' 137' ' ' ILE . 4.9 mm -61.11 119.32 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.648 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -89.79 -65.8 0.98 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.757 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -147.16 138.15 23.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.454 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.459 HG23 HG13 ' A' ' 137' ' ' ILE . 1.3 mp -113.62 133.27 60.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.404 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 18.6 p90 -153.48 -178.68 7.16 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.929 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.8 mp -125.27 129.67 73.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.491 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.539 HG22 ' CG1' ' A' ' 136' ' ' ILE . 4.8 t -128.85 172.94 10.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.673 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -73.9 153.41 39.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.69 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.95 -34.51 76.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.524 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -78.98 18.75 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.677 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -89.22 99.09 12.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.326 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.945 ' O ' HG23 ' A' ' 110' ' ' ILE . 23.1 ptt85 -80.15 -19.42 47.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.779 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.445 ' O ' HD12 ' A' ' 110' ' ' ILE . 6.8 p -48.1 -18.25 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.957 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.554 ' HB ' HG21 ' A' ' 118' ' ' THR . 4.1 m -110.52 -9.35 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.287 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.689 HG22 ' O ' ' A' ' 109' ' ' ILE . 39.2 mm -104.95 1.33 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.033 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.945 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -77.72 -167.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 12.6 ptmt -99.88 151.66 21.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.774 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.605 ' H ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -125.45 134.94 51.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.303 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -78.31 6.96 7.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.221 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.09 164.16 33.4 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.429 ' O ' HD13 ' A' ' 116' ' ' ILE . 36.4 Cg_endo -71.41 96.17 0.72 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.192 2.595 . . . . 0.0 112.155 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 115' ' ' PRO . 50.9 mm -128.98 133.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.46 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.834 ' C ' HD23 ' A' ' 117' ' ' LEU . 5.7 tt -106.69 120.36 41.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.161 0.505 . . . . 0.0 110.316 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.554 HG21 ' HB ' ' A' ' 108' ' ' VAL . 91.1 m -118.34 119.09 33.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.158 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.868 HD23 ' N ' ' A' ' 120' ' ' THR . 5.6 tt -105.73 127.81 53.31 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.609 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.868 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -120.83 117.76 28.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.817 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.651 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.7 t -151.5 -170.04 3.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.729 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.632 ' SG ' ' O ' ' A' ' 121' ' ' THR . 1.6 p 152.46 -85.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.593 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.487 ' CD1' ' N ' ' A' ' 123' ' ' TYR . 11.4 m-85 44.2 66.95 4.35 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.05 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -82.75 178.4 6.09 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 123.151 2.567 . . . . 0.0 112.304 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -54.09 -24.77 18.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.315 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.51 ' C ' ' OD1' ' A' ' 126' ' ' ASP . 2.0 p30 -93.64 13.11 23.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.556 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.681 ' CZ ' ' O ' ' A' ' 129' ' ' GLY . 53.0 t80 -58.47 -48.44 80.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.29 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.644 ' C ' ' O ' ' A' ' 127' ' ' TYR . 96.2 mt 4.03 78.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 O-C-N 123.918 0.761 . . . . 0.0 110.516 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.681 ' O ' ' CZ ' ' A' ' 127' ' ' TYR . . . 112.0 -100.69 1.19 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 131' ' ' ALA . 20.1 t70 -133.35 104.89 6.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.741 0.305 . . . . 0.0 110.574 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 130' ' ' ASP . . . -38.21 139.39 0.65 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.757 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.93 -21.34 37.61 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.797 2.332 . . . . 0.0 112.0 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -138.95 143.54 38.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.554 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.474 ' HG3' ' SG ' ' A' ' 122' ' ' CYS . 4.9 ttt180 -117.22 132.87 56.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.922 0.391 . . . . 0.0 110.411 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.621 ' HD2' HD11 ' A' ' 137' ' ' ILE . 5.3 t80 -75.79 125.96 30.08 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.915 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.675 ' C ' HD12 ' A' ' 137' ' ' ILE . 4.2 mm -112.91 118.59 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.91 0.386 . . . . 0.0 111.94 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.943 HD12 ' N ' ' A' ' 137' ' ' ILE . 1.3 mp -110.42 107.04 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -90.98 136.58 32.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.382 0.611 . . . . 0.0 111.344 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.2 36.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.911 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.522 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 50.9 tptt -111.69 139.85 46.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.352 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.711 HD13 ' C ' ' A' ' 141' ' ' LEU . 2.2 tm? -75.5 114.87 14.55 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.707 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.605 ' OG1' ' N ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -97.74 -65.39 0.97 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.273 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.605 ' N ' ' OG1' ' A' ' 142' ' ' THR . . . -101.41 151.19 18.66 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.257 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 89.9 p -137.35 126.91 25.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.93 0.395 . . . . 0.0 110.428 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -118.74 146.48 44.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.677 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.2 p -133.94 130.1 37.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.574 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.609 -179.962 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.587 ' O ' ' O ' ' A' ' 1' ' ' GLY . 8.7 m 26.35 100.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.818 0.342 . . . . 0.0 110.592 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -98.26 -101.31 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.798 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.489 ' CG ' ' O ' ' A' ' 4' ' ' MET . 7.9 ptp -129.83 128.57 42.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.842 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 4' ' ' MET . 1.3 m -169.33 -152.12 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.469 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 71.43 84.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.598 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -128.38 8.08 5.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.492 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m 64.34 -129.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.531 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 52.6 -106.07 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.571 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.553 ' O ' ' OE2' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -127.55 43.93 3.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.694 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.607 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 12.5 tmtt? -68.43 127.28 32.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.531 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.553 ' OE2' ' O ' ' A' ' 10' ' ' HIS . 9.0 mp0 -81.38 109.28 15.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.141 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 129.05 24.69 1.04 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.607 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -127.29 131.8 50.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.801 0.334 . . . . 0.0 110.458 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 96.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.986 0.422 . . . . 0.0 110.285 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 14' ' ' GLU . 5.6 m -100.71 -38.31 6.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.921 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.95 157.85 45.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 32.0 ttm -125.35 136.16 53.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.441 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.409 HD12 HD21 ' A' ' 84' ' ' LEU . 1.9 tt -101.72 119.05 38.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.19 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -111.89 137.73 49.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.367 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -119.26 112.96 35.59 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.892 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 81' ' ' THR . 56.3 Cg_endo -75.16 -40.26 0.91 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.882 2.388 . . . . 0.0 112.929 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.507 ' HB3' HD22 ' A' ' 24' ' ' LEU . 4.5 tmtt? -65.06 -37.57 88.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.716 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.62 HD22 ' N ' ' A' ' 24' ' ' LEU . 3.7 mm? -96.24 3.02 53.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.738 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER 45.69 57.12 5.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HD3' ' CE2' ' A' ' 28' ' ' PHE . 18.1 ptpt -157.26 173.91 16.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.969 0.414 . . . . 0.0 110.629 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.01 158.09 43.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.619 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.455 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 87.7 m-85 -133.37 154.22 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.738 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.1 m -95.21 112.48 24.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.835 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.546 ' CD1' ' N ' ' A' ' 30' ' ' ILE . 1.2 mp -93.79 122.04 44.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.425 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.481 ' CD1' ' HE2' ' A' ' 41' ' ' LYS . 86.3 m-85 -102.71 146.1 28.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TRP . . . . . 0.469 ' O ' ' N ' ' A' ' 13' ' ' GLY . 51.6 t-105 -62.56 125.08 22.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.557 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.67 142.98 4.58 Favored Glycine 0 N--CA 1.46 0.291 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.74 94.36 3.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.623 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -99.38 108.09 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.861 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.22 -32.97 74.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.509 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.39 90.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.646 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.0 m -66.81 127.64 33.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.345 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.401 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 5.1 mp -96.61 85.96 3.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.586 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 12.5 mmtt 175.63 -5.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.604 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.481 ' HE2' ' CD1' ' A' ' 31' ' ' TYR . 3.4 tptt -125.41 166.87 15.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.46 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.33 -51.72 0.03 OUTLIER Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.7 m -110.69 117.76 55.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.418 0.627 . . . . 0.0 110.546 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.99 167.28 31.68 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.114 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.504 ' HE2' ' O ' ' A' ' 46' ' ' PHE . 2.1 ttp -98.74 129.09 45.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.504 ' O ' ' HE2' ' A' ' 45' ' ' MET . 19.3 t80 -65.12 131.12 45.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.393 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.469 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.0 p -113.7 124.18 70.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.667 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.65 ' N ' ' OG1' ' A' ' 51' ' ' THR . 36.3 t -158.02 174.31 15.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.563 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -67.65 -13.75 62.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.602 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.71 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.5 m -111.17 -14.1 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.892 0.377 . . . . 0.0 110.556 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.65 ' OG1' ' N ' ' A' ' 48' ' ' SER . 29.3 p -104.32 141.22 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -142.18 167.48 22.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.473 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.406 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -83.11 162.65 53.81 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.917 -179.515 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -82.58 83.08 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.681 2.254 . . . . 0.0 112.437 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 55' ' ' SER . 0.9 OUTLIER -117.77 7.71 12.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.654 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.16 87.28 0.36 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.76 92.64 0.04 OUTLIER Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.526 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -170.25 160.09 32.78 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.689 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 19.2 t-160 -82.61 114.2 20.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.458 HG22 ' CD2' ' A' ' 62' ' ' LEU . 21.6 m -111.47 120.87 43.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.253 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.893 HG11 ' CD1' ' A' ' 109' ' ' ILE . 65.2 t -114.6 125.66 71.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 109.806 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.621 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.7 mm? -108.55 143.26 37.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.567 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.3 t -126.87 138.28 53.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.712 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 123' ' ' TYR . . . -160.26 -179.0 34.75 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.68 ' O ' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -84.68 154.22 22.62 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.402 -0.469 . . . . 0.0 110.86 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.639 ' NH1' ' O ' ' A' ' 126' ' ' ASP . 29.0 ptt180 -36.41 -21.11 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.586 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 65' ' ' HIS . 23.1 t70 -25.84 97.95 0.01 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.539 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' ARG . 54.7 m -156.34 -23.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.528 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.44 -30.95 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.623 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -60.02 -44.06 94.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.626 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.5 p -135.33 51.47 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.532 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 73' ' ' LEU . 30.3 p-10 -55.56 -44.41 76.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.452 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.458 HD13 ' HA ' ' A' ' 73' ' ' LEU . 3.9 mm? -62.01 -41.95 98.63 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.079 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 24' ' ' LEU . . . -79.55 -15.55 79.49 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -87.17 -43.42 12.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 110.68 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.823 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.6 pp -108.47 103.99 13.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 111.218 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.546 ' HG3' ' H ' ' A' ' 80' ' ' ASP . 2.3 ptmt 177.91 137.02 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.246 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.31 -17.62 62.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.058 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -79.49 -13.94 59.23 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.367 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.657 ' OD1' ' N ' ' A' ' 81' ' ' THR . 1.0 OUTLIER -70.65 155.35 40.85 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.935 -179.609 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.657 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -142.64 119.16 10.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.025 0.441 . . . . 0.0 109.981 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.9 mt -95.66 129.05 42.98 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.837 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.516 ' C ' HD22 ' A' ' 84' ' ' LEU . 21.3 t -113.43 118.1 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.033 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.516 HD22 ' C ' ' A' ' 83' ' ' VAL . 4.1 mm? -105.45 135.36 46.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.458 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.481 ' HG2' HG23 ' A' ' 90' ' ' THR . 95.9 mt-10 -106.48 123.73 48.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.946 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 87' ' ' ASP . 21.9 t80 -143.4 131.03 21.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.261 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 86' ' ' TYR . 8.6 t0 49.45 49.02 20.54 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.315 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 63.43 11.27 5.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.471 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 44.3 mtmt -109.94 145.24 37.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.987 0.423 . . . . 0.0 110.288 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.507 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -112.33 123.64 50.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.909 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -104.48 132.87 50.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.295 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.97 111.1 23.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.164 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 80.4 m-85 -109.6 150.36 28.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.48 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -131.18 140.38 49.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.827 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 95' ' ' ILE . 14.4 mm -60.76 122.23 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.557 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -104.02 -50.48 3.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.859 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 15.3 tptm -154.27 132.51 11.86 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.192 0.52 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 76' ' ' LEU . 71.9 mt -122.04 132.84 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.475 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 30.2 p90 -153.73 -176.06 5.66 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.797 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.729 HD12 ' N ' ' A' ' 100' ' ' ILE . 1.8 mp -127.75 129.61 70.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.4 t -134.39 -171.12 2.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.694 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' HIS . . . . . 0.404 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 93.2 m-70 -78.31 153.89 31.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.14 -30.8 71.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.609 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -88.63 14.22 10.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.731 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.896 ' O ' HG22 ' A' ' 108' ' ' VAL . 3.8 t70 -75.58 94.34 3.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.039 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.728 ' O ' ' N ' ' A' ' 109' ' ' ILE . 30.6 ptt-85 -64.78 -34.28 77.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.664 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.652 ' O ' HD11 ' A' ' 110' ' ' ILE . 3.1 p -35.63 -25.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.93 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 105' ' ' ASP . 28.6 m -98.15 -24.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 110.801 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.893 ' CD1' HG11 ' A' ' 61' ' ' VAL . 8.1 mm -104.89 27.34 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.637 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.689 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.8 OUTLIER -90.85 -162.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.408 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -107.39 137.9 44.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.769 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.2 mttt -126.36 143.4 51.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.18 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.6 ' N ' ' OE2' ' A' ' 114' ' ' GLU . 15.0 mt-10 -90.97 11.4 22.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.569 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.6 ' OE2' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -136.7 168.68 15.91 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 110.589 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.526 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 51.7 Cg_endo -78.44 90.46 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.164 2.576 . . . . 0.0 112.251 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.484 HG21 ' HZ3' ' A' ' 112' ' ' LYS . 50.8 mm -122.57 129.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.757 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.806 ' C ' HD23 ' A' ' 117' ' ' LEU . 6.5 tt -104.08 122.26 44.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.71 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.639 HG21 ' HB ' ' A' ' 108' ' ' VAL . 19.6 m -114.27 113.61 24.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.13 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 120' ' ' THR . 1.8 tt -104.27 116.23 31.8 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.699 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.734 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -112.52 129.29 56.4 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.42 0.45 . . . . 0.0 110.196 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.616 HG23 ' CD2' ' A' ' 119' ' ' LEU . 71.4 p -134.43 156.38 48.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.397 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' CYS . . . . . 0.548 ' O ' ' O ' ' A' ' 123' ' ' TYR . 1.0 OUTLIER 158.01 -62.15 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.676 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.548 ' O ' ' O ' ' A' ' 122' ' ' CYS . 8.2 m-85 54.46 144.59 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.757 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 127' ' ' TYR . 45.8 Cg_endo -71.54 -57.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.759 2.306 . . . . 0.0 112.475 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.639 ' CE2' ' OD2' ' A' ' 126' ' ' ASP . 1.6 p90 -56.99 -33.71 67.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.277 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.639 ' O ' ' NH1' ' A' ' 66' ' ' ARG . 4.0 m-20 -63.09 -37.73 88.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.444 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.609 ' O ' ' N ' ' A' ' 129' ' ' GLY . 4.0 t80 -110.7 118.55 36.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.445 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.505 ' C ' ' O ' ' A' ' 127' ' ' TYR . 88.1 mt -32.13 89.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.298 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 127' ' ' TYR . . . 104.2 -159.58 16.29 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -91.77 106.07 18.19 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.476 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -45.02 103.67 0.35 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.626 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.62 -40.92 63.46 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.695 2.264 . . . . 0.0 112.018 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -118.11 158.81 24.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.543 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.524 ' HA ' ' SG ' ' A' ' 122' ' ' CYS . 0.8 OUTLIER -123.53 134.61 53.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.209 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.578 ' CD2' HD11 ' A' ' 137' ' ' ILE . 4.2 t80 -87.43 125.14 34.1 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -122.16 128.52 75.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.016 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.578 HD11 ' CD2' ' A' ' 135' ' ' TYR . 7.2 mm -106.87 111.76 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.036 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 97' ' ' LYS . 67.5 tt0 -94.27 138.48 32.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.507 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -148.75 149.02 30.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.655 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -114.43 152.66 31.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.188 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 11.2 tp -77.07 115.61 17.01 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.702 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.63 -42.18 12.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.123 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.404 ' O ' HD11 ' A' ' 141' ' ' LEU . . . -142.73 171.6 24.74 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 56.4 p -147.08 151.39 36.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 110.41 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -136.58 160.75 37.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.688 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.588 ' O ' ' C ' ' A' ' 147' ' ' LYS . 7.9 p -150.74 125.56 9.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.45 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.588 ' C ' ' O ' ' A' ' 146' ' ' SER . 17.4 tttm . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.471 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 tttp . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.844 0.354 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.446 ' HG3' ' CD1' ' A' ' 32' ' ' TRP . 2.3 mp0 -59.85 137.87 57.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.356 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.29 9.17 70.34 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -115.49 141.25 48.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.839 0.352 . . . . 0.0 110.429 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 84.3 tttt -67.82 113.6 5.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.228 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.3 m -111.8 -37.22 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.028 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.494 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -141.36 158.33 44.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.665 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 44.9 ttp -118.05 138.42 52.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.415 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.487 HD12 HD11 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -102.42 121.9 43.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.077 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -122.46 135.29 54.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.119 0.485 . . . . 0.0 111.07 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.523 HG22 ' H ' ' A' ' 24' ' ' LEU . 3.8 mt -110.82 118.01 49.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.291 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD3' HG23 ' A' ' 83' ' ' VAL . 57.5 Cg_endo -75.58 -48.5 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.832 2.355 . . . . 0.0 112.728 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.54 ' C ' HD22 ' A' ' 24' ' ' LEU . 11.7 tptt -60.21 -44.93 94.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.815 ' N ' HD22 ' A' ' 24' ' ' LEU . 2.8 mm? -96.53 3.03 52.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.618 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.41 38.96 1.95 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.719 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HZ2' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -112.22 145.06 40.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.356 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.37 144.06 50.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -140.23 141.88 35.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.661 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.546 ' C ' HD12 ' A' ' 30' ' ' ILE . 5.0 p -86.68 121.21 28.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.712 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.559 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.1 mp -103.63 120.66 54.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.549 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 32.2 m-85 -106.2 150.31 25.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.727 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CD1' ' HG3' ' A' ' 12' ' ' GLU . 33.2 t-105 -60.12 128.63 37.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.696 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.29 160.51 12.3 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.405 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.586 179.597 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.591 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.766 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -96.57 134.82 39.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.728 0.299 . . . . 0.0 110.576 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.766 ' N ' ' SD ' ' A' ' 45' ' ' MET . 1.9 t80 -64.02 132.55 50.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.712 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.56 120.24 61.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.558 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.525 ' N ' ' OG1' ' A' ' 51' ' ' THR . 43.2 p -160.69 169.66 22.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.498 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.554 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 47.8 t0 -62.45 -10.67 12.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.625 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.5 m -112.11 -34.25 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.71 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' A' ' 48' ' ' SER . 65.7 p -85.14 138.27 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.582 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.3 t -139.83 174.23 10.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.565 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.416 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -89.38 158.28 46.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.38 83.69 1.98 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.664 2.243 . . . . 0.0 112.694 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.9 p -118.83 -2.1 10.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.79 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.21 86.2 0.06 OUTLIER Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.59 101.55 0.01 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.513 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -178.42 165.32 34.52 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.696 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 16.2 t-160 -83.7 110.21 18.11 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.4 m -105.82 120.9 42.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.844 0.354 . . . . 0.0 110.426 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.615 ' C ' HD22 ' A' ' 62' ' ' LEU . 61.9 t -117.7 131.56 70.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.195 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.615 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.8 mm? -111.25 139.44 46.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.596 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 t -122.59 129.4 51.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.733 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.639 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.531 1.041 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.548 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -68.83 -44.09 74.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.697 0.284 . . . . 0.0 110.656 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.555 HD22 ' HE2' ' A' ' 135' ' ' TYR . 5.3 mt -90.82 92.95 9.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.952 0.406 . . . . 0.0 110.352 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.534 ' HG3' ' H ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -174.73 147.67 1.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.06 -11.72 60.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.755 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.534 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 3.8 mtpt -84.13 -15.61 46.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.382 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.66 157.28 28.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.475 ' O ' HD23 ' A' ' 82' ' ' LEU . 1.8 p -137.02 149.87 47.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.969 0.414 . . . . 0.0 109.992 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.475 HD12 HD22 ' A' ' 117' ' ' LEU . 35.9 mt -118.8 120.07 36.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.224 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.65 ' C ' HD22 ' A' ' 84' ' ' LEU . 14.9 t -102.76 124.57 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.949 0.404 . . . . 0.0 110.642 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.65 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.2 mm? -113.0 133.16 55.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.127 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.531 ' HG2' HG23 ' A' ' 90' ' ' THR . 97.6 mt-10 -106.09 119.33 38.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.494 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.1 t80 -143.2 127.05 17.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.266 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 57.08 44.32 22.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.854 0.359 . . . . 0.0 111.194 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 64.32 15.62 9.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.486 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 6.4 mtmp? -116.4 140.85 48.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.185 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.65 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -108.65 124.46 50.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 15.8 m-85 -104.06 129.68 51.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 117.75 35.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 111.127 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.454 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 89.7 m-85 -112.34 163.83 13.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.593 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -139.04 133.86 32.21 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.824 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 77' ' ' LYS . 0.9 OUTLIER -65.52 123.78 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.201 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -99.89 -47.93 4.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.996 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -153.32 139.28 18.16 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.099 0.476 . . . . 0.0 110.532 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mt -116.51 130.58 71.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.539 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.499 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 20.0 p90 -151.62 -175.88 5.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.473 HG12 ' CD1' ' A' ' 135' ' ' TYR . 6.9 mt -129.31 135.21 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.498 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.539 HG22 HG13 ' A' ' 136' ' ' ILE . 6.5 t -134.86 171.23 14.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -73.77 158.11 35.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.459 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.465 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . . . -69.53 -11.44 60.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.701 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.554 ' C ' ' OD1' ' A' ' 104' ' ' ASP . 12.4 p30 -100.82 15.51 28.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.694 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.405 ' OD2' ' OG1' ' A' ' 101' ' ' THR . 39.8 t0 -79.15 94.28 5.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.973 0.416 . . . . 0.0 110.594 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.48 ' O ' HG13 ' A' ' 110' ' ' ILE . 52.3 ptt85 -74.82 -20.51 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.524 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.787 ' O ' HD11 ' A' ' 110' ' ' ILE . 5.9 p -60.08 -26.28 66.06 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.313 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.831 ' CG1' HG21 ' A' ' 118' ' ' THR . 21.5 t -95.82 -4.83 10.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.809 ' O ' HG22 ' A' ' 109' ' ' ILE . 42.5 mm -118.78 14.05 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.03 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.787 HD11 ' O ' ' A' ' 107' ' ' THR . 0.7 OUTLIER -79.61 -160.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.71 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.401 ' H ' ' HB ' ' A' ' 110' ' ' ILE . 24.1 ttmt -99.24 149.64 22.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.378 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.489 ' N ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -129.73 126.24 37.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 113' ' ' GLU . 68.8 tt0 -76.6 7.65 4.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.028 0.442 . . . . 0.0 110.117 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.14 164.08 43.14 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.542 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.513 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 44.6 Cg_endo -76.33 87.81 1.4 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.961 2.44 . . . . 0.0 111.888 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.5 mm -119.1 130.47 73.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.968 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.83 HD23 ' C ' ' A' ' 117' ' ' LEU . 6.0 tt -103.56 118.57 37.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.149 0.5 . . . . 0.0 110.884 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.831 HG21 ' CG1' ' A' ' 108' ' ' VAL . 96.9 m -117.78 124.31 48.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.228 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 1.009 HD12 ' N ' ' A' ' 120' ' ' THR . 0.5 OUTLIER -106.44 122.7 46.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.493 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 1.009 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -121.08 120.48 35.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.236 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.639 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.4 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.158 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.779 0.323 . . . . 0.0 110.434 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 103' ' ' ALA . 10.6 ptp180 -101.31 144.42 30.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.785 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.555 ' HE2' HD22 ' A' ' 76' ' ' LEU . 4.5 t80 -76.42 135.04 39.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.872 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.539 HG13 HG22 ' A' ' 101' ' ' THR . 5.1 mm -120.14 124.15 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 137' ' ' ILE . 1.2 mp -112.91 109.5 28.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.499 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 22.7 tp10 -94.19 136.78 34.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.143 0.497 . . . . 0.0 110.89 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.59 148.98 31.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.973 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 79.2 tttt -116.2 155.23 28.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.06 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.454 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 11.8 tp -78.86 122.53 26.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.009 0.433 . . . . 0.0 110.478 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.66 -38.13 6.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.782 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -143.29 159.67 27.51 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.9 p -144.61 149.51 35.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.764 0.316 . . . . 0.0 110.457 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 90' ' ' THR . 93.0 m-85 -128.97 153.8 47.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.598 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 77.4 p -146.86 126.99 13.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.729 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.591 179.995 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.611 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 64.1 tttt . . . . . 0 N--CA 1.461 0.114 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -91.61 149.39 21.68 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 89.71 10.23 65.37 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.611 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -113.64 133.95 55.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.843 0.354 . . . . 0.0 110.412 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.48 106.24 0.52 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.289 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.4 HG23 ' N ' ' A' ' 17' ' ' ALA . 17.5 m -109.28 -40.53 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.971 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.426 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -128.17 160.32 32.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.7 ttp -123.7 147.1 47.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.189 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.8 tp -112.56 123.39 50.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.68 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.526 HD21 ' CD ' ' A' ' 27' ' ' LYS . 3.3 t-20 -118.02 128.38 54.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.963 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.1 mt -106.42 106.34 57.15 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 81' ' ' THR . 55.6 Cg_endo -76.33 -40.39 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.82 2.347 . . . . 0.0 112.851 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.564 ' C ' HD22 ' A' ' 24' ' ' LEU . 48.4 tptt -58.48 -43.55 89.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.614 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.799 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.0 mm? -99.58 -0.03 41.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.569 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.25 49.49 17.07 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.593 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -127.66 165.42 20.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.402 . . . . 0.0 110.839 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.526 ' CD ' HD21 ' A' ' 20' ' ' ASN . 15.4 mtmt -140.59 145.82 37.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.103 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -142.6 145.47 33.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.861 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -90.01 129.18 36.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.188 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.421 HD12 ' CD1' ' A' ' 62' ' ' LEU . 37.0 mm -103.23 119.58 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.004 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -102.36 142.71 33.13 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.967 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.51 ' CZ2' ' HB ' ' A' ' 47' ' ' VAL . 46.0 t-105 -60.63 119.36 7.96 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.855 0.36 . . . . 0.0 110.611 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 83.08 159.53 27.54 Favored Glycine 0 C--N 1.332 0.307 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.579 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.729 -179.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.555 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.401 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 35.0 ttm -108.19 128.19 54.49 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.59 128.67 36.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.884 0.373 . . . . 0.0 110.565 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.51 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 1.1 m -109.35 133.67 53.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.71 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.696 ' N ' ' OG1' ' A' ' 51' ' ' THR . 12.9 m -161.5 177.17 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.576 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.559 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 46.5 t0 -67.7 -10.2 50.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.43 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 109' ' ' ILE . 4.6 m -118.1 -28.52 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.816 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.696 ' OG1' ' N ' ' A' ' 48' ' ' SER . 39.1 p -83.07 141.11 32.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.584 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 t -142.71 177.2 8.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.723 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.8 160.43 29.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.649 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.717 ' HG3' HD13 ' A' ' 84' ' ' LEU . 64.9 Cg_endo -77.53 83.1 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.863 2.375 . . . . 0.0 112.39 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.7 p -120.95 -1.51 9.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.25 90.96 0.15 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.72 86.85 0.04 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 115' ' ' PRO . . . -163.04 155.62 27.04 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.686 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 17.5 t-160 -79.43 112.17 16.41 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 m -104.28 127.0 51.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.526 ' C ' HD22 ' A' ' 62' ' ' LEU . 71.1 t -119.19 128.97 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 0.0 110.249 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.526 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.6 mm? -111.19 142.84 42.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.608 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.5 t -127.29 136.24 51.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.615 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.526 0.764 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.594 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -66.24 -40.36 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.694 0.283 . . . . 0.0 110.963 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.86 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.9 pp -100.52 108.71 20.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.186 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 14.7 ptmt 173.77 145.04 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.374 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -72.78 -14.06 61.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -83.0 -15.72 50.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.891 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.17 160.99 20.07 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.922 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.472 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -150.01 119.99 7.17 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.026 0.441 . . . . 0.0 109.973 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.5 131.77 43.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.074 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 43.8 t -112.94 130.32 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.015 0.436 . . . . 0.0 110.458 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.87 HD11 HD12 ' A' ' 117' ' ' LEU . 39.0 mt -113.01 126.47 55.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.53 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -104.45 116.49 32.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.442 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.426 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.3 t80 -149.09 131.4 15.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.852 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.4 t70 60.78 42.44 13.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.352 . . . . 0.0 111.241 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.2 m120 61.34 15.69 6.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.021 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -115.2 146.97 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.496 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -115.74 123.35 48.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.936 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.433 ' HB3' ' CD1' ' A' ' 141' ' ' LEU . 20.2 m-85 -106.28 137.09 44.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.682 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.99 120.22 41.68 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.035 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.533 ' CE1' HD12 ' A' ' 84' ' ' LEU . 71.4 m-85 -112.91 155.65 24.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.729 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -130.3 138.73 50.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.59 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.2 mm -63.63 121.41 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.23 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -98.55 -52.8 3.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.933 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -150.46 141.49 23.0 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.465 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.511 HG23 HD12 ' A' ' 137' ' ' ILE . 76.3 mt -121.7 130.82 74.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.835 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -153.08 -176.15 5.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 110.854 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.46 HG22 ' CB ' ' A' ' 133' ' ' ASP . 4.5 mt -128.25 131.71 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.5 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.71 169.46 17.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 110.895 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.41 148.39 45.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.985 0.421 . . . . 0.0 110.452 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 134' ' ' ARG . . . -63.13 -19.48 64.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.629 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -88.96 11.8 17.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -84.9 88.4 7.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.375 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.838 ' O ' HG23 ' A' ' 110' ' ' ILE . 6.9 ptp85 -60.42 -31.82 70.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.485 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.496 ' O ' HD12 ' A' ' 110' ' ' ILE . 5.7 p -44.52 -14.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.25 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.886 HG12 HG21 ' A' ' 118' ' ' THR . 4.8 t -108.12 -16.43 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.044 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.763 ' O ' HG22 ' A' ' 109' ' ' ILE . 47.3 mm -107.51 12.16 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.048 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.838 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -79.42 -175.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.93 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -81.57 142.45 32.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.145 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.493 ' HB2' ' CG ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -116.09 130.59 56.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.949 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 4.6 mt-10 -78.15 16.77 0.7 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.056 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -160.23 167.14 14.42 Favored Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.771 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.446 ' O ' HD13 ' A' ' 116' ' ' ILE . 37.3 Cg_endo -73.21 101.9 1.4 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.678 2.252 . . . . 0.0 111.414 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 115' ' ' PRO . 50.6 mm -131.13 136.42 57.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.357 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.87 HD12 HD11 ' A' ' 84' ' ' LEU . 6.3 tt -108.65 119.65 40.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.358 0.599 . . . . 0.0 110.681 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.886 HG21 HG12 ' A' ' 108' ' ' VAL . 61.7 m -118.2 125.11 49.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.202 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.83 ' C ' HD23 ' A' ' 119' ' ' LEU . 6.2 tt -112.97 124.9 53.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.388 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.757 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -120.54 116.47 25.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.503 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.634 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 0.1 OUTLIER . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.356 -179.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.46 ' CB ' HG22 ' A' ' 100' ' ' ILE . 97.9 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.829 0.347 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 103' ' ' ALA . 7.3 mpt_? -104.16 143.98 32.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.055 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 120' ' ' THR . 2.8 t80 -69.13 124.97 25.22 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.881 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 2.6 mm -111.01 112.16 39.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 137' ' ' ILE . 0.9 OUTLIER -100.37 112.22 32.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.233 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -95.51 140.29 30.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.389 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.85 138.76 21.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.966 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -110.47 150.86 28.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.242 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 91' ' ' TYR . 5.4 tp -72.46 122.59 21.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.355 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.94 -41.06 5.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.738 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.23 175.39 20.16 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 94.3 p -155.85 160.85 40.54 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.65 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' THR . 92.9 m-85 -147.87 152.47 37.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.582 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.1 p -147.57 132.66 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.759 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.604 ' O ' ' OE1' ' A' ' 14' ' ' GLU . 54.6 mmtt . . . . . 0 C--O 1.225 -0.205 0 N-CA-C 110.31 -0.256 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.558 ' OE2' HG11 ' A' ' 47' ' ' VAL . 97.6 mt-10 -107.31 123.86 48.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.377 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.577 ' N ' ' OE2' ' A' ' 14' ' ' GLU . . . 114.42 1.78 23.18 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.654 ' CD ' ' H ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -115.34 139.79 49.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.859 0.362 . . . . 0.0 110.278 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 89.0 tttt -58.67 120.74 9.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.642 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.408 HG11 ' HB2' ' A' ' 32' ' ' TRP . 24.1 m -116.23 -18.05 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.84 158.63 39.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.539 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.2 ttp -120.76 133.14 55.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.392 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.502 HD13 ' H ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -99.19 129.74 45.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.352 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.502 ' H ' HD13 ' A' ' 19' ' ' LEU . 27.4 t-20 -125.69 124.01 40.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.988 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.496 HD13 ' NE2' ' A' ' 75' ' ' GLN . 6.9 mt -105.9 109.74 63.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.855 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 81' ' ' THR . 57.2 Cg_endo -75.89 -42.92 0.36 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.577 2.185 . . . . 0.0 112.6 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HB3' HD22 ' A' ' 24' ' ' LEU . 8.1 tmtm? -60.57 -40.12 90.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.253 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.668 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.7 mm? -98.53 -2.35 38.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 0.0 110.489 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 54.46 42.66 31.23 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.689 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.489 ' HE3' ' CZ ' ' A' ' 28' ' ' PHE . 4.2 mtpp -124.03 163.01 22.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.093 0.473 . . . . 0.0 110.636 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG2' ' CG ' ' A' ' 20' ' ' ASN . 34.9 mtmt -141.89 143.37 33.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.007 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.489 ' CZ ' ' HE3' ' A' ' 26' ' ' LYS . 89.4 m-85 -137.71 152.23 49.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.805 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.561 ' OG ' ' CE1' ' A' ' 31' ' ' TYR . 4.9 t -97.15 124.82 41.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.772 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.531 HD12 HD11 ' A' ' 62' ' ' LEU . 40.4 mm -92.56 126.2 45.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.556 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.561 ' CE1' ' OG ' ' A' ' 29' ' ' SER . 89.1 m-85 -114.16 138.47 50.4 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.957 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.646 ' CZ3' HG22 ' A' ' 53' ' ' THR . 41.5 t-105 -60.74 126.85 28.92 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.604 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.634 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 84.28 169.79 45.96 Favored Glycine 0 C--N 1.331 0.289 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.51 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.783 179.607 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.599 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.513 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 40.1 ttm -103.8 144.48 31.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.54 143.95 46.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.516 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' HA2' ' A' ' 33' ' ' GLY . 78.8 t -115.87 129.81 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.367 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.4 p -166.83 -173.92 2.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.65 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -89.28 -23.75 22.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 5.8 m -92.13 -38.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.687 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.459 ' N ' HG23 ' A' ' 50' ' ' VAL . 63.6 p -78.53 153.23 31.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.556 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 t -150.24 172.09 15.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.459 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.646 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -84.91 153.92 60.68 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.701 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.44 80.65 2.69 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.546 2.164 . . . . 0.0 112.34 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.5 p -107.48 -13.39 15.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.755 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.62 88.99 0.08 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.42 80.23 0.51 Allowed Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.455 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -165.97 158.42 31.32 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.695 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 15.3 t-160 -81.75 121.73 26.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.8 m -116.17 129.48 56.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.274 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.588 HG11 ' CD1' ' A' ' 109' ' ' ILE . 58.3 t -116.35 126.1 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.221 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.531 HD11 HD12 ' A' ' 30' ' ' ILE . 2.4 mm? -108.47 138.89 44.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.125 0.488 . . . . 0.0 110.529 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.3 t -121.63 138.67 54.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.876 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.531 1.037 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' A' ' 77' ' ' LYS . . . . . . . . 0 CA--C 1.523 0.557 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.496 ' NE2' HD13 ' A' ' 21' ' ' ILE . 92.5 mm-40 -68.41 -41.22 80.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.78 0.324 . . . . 0.0 110.696 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.574 HD22 ' HE2' ' A' ' 135' ' ' TYR . 8.2 mt -93.85 89.42 6.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.491 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 74' ' ' GLY . 6.3 ptpt -176.25 145.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.427 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -69.8 -21.99 63.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.739 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -76.39 -14.63 60.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.152 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.68 154.93 39.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.789 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.427 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -137.92 133.17 33.45 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.4 mt -109.23 124.68 51.27 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.785 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.625 ' CG1' HG22 ' A' ' 90' ' ' THR . 40.0 t -106.37 116.65 50.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.981 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.868 HD21 HD12 ' A' ' 117' ' ' LEU . 8.1 mp -98.54 127.04 44.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.031 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.695 ' HG2' HG23 ' A' ' 90' ' ' THR . 95.4 mt-10 -106.54 117.3 33.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.244 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -148.23 131.95 16.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.846 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 59.32 49.33 9.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.514 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 56.91 13.28 1.43 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.049 0.452 . . . . 0.0 110.259 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -114.9 144.81 42.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.61 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.695 HG23 ' HG2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -114.08 123.31 49.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.673 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 14.6 m-85 -104.38 145.14 30.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.453 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.585 ' HG1' ' HE2' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -109.56 114.66 28.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.315 -179.173 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.522 ' CE1' HD22 ' A' ' 84' ' ' LEU . 78.3 m-85 -113.03 151.46 30.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.609 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -128.83 141.65 51.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.786 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.571 ' CD1' HD12 ' A' ' 137' ' ' ILE . 1.5 mm -64.38 119.2 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.362 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.17 -62.92 1.41 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.024 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -145.87 150.92 37.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.307 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.415 HG12 HD13 ' A' ' 137' ' ' ILE . 12.0 mt -122.62 134.35 66.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.059 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.705 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 15.8 p90 -161.87 -179.74 7.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.034 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.645 ' N ' HD12 ' A' ' 100' ' ' ILE . 1.3 mp -128.69 129.25 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.257 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.46 HG22 ' CG1' ' A' ' 136' ' ' ILE . 7.6 t -127.16 173.5 9.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.006 0.432 . . . . 0.0 110.68 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.79 161.55 30.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.526 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.08 -11.74 60.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.761 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -101.71 22.69 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.628 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.596 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 50.1 t0 -92.04 100.83 13.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.594 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.852 ' O ' HG23 ' A' ' 110' ' ' ILE . 2.7 ptt180 -79.71 -20.06 47.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.372 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.596 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 20.0 p -48.39 -16.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.615 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.555 ' HB ' HG21 ' A' ' 118' ' ' THR . 8.8 m -109.4 -6.56 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.233 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.718 ' O ' HG22 ' A' ' 109' ' ' ILE . 47.8 mm -113.44 7.76 7.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.937 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.852 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -79.52 -171.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.467 ' CB ' ' HB ' ' A' ' 50' ' ' VAL . 19.5 ttpt -102.5 141.59 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.938 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 87.0 mttt -124.89 151.91 44.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.574 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -92.41 7.26 43.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.204 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -130.94 159.59 70.68 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.762 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.455 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 43.6 Cg_endo -74.58 94.88 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.978 2.452 . . . . 0.0 111.894 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 115' ' ' PRO . 48.2 mm -126.41 134.77 65.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.137 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.868 HD12 HD21 ' A' ' 84' ' ' LEU . 6.1 tt -108.92 118.48 36.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.251 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.555 HG21 ' HB ' ' A' ' 108' ' ' VAL . 92.1 m -115.14 119.69 37.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.369 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.994 HD12 ' N ' ' A' ' 120' ' ' THR . 0.7 OUTLIER -105.86 124.97 50.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.361 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.994 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -121.57 124.37 44.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.932 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.513 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.3 t . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.305 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.605 ' OD1' HG22 ' A' ' 100' ' ' ILE . 6.8 t0 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.706 0.289 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.632 ' NE ' ' OG1' ' A' ' 120' ' ' THR . 5.6 ptm180 -98.42 138.55 35.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.094 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.574 ' HE2' HD22 ' A' ' 76' ' ' LEU . 4.5 t80 -69.92 136.53 50.69 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.827 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.705 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 9.3 mm -120.84 115.68 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.421 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.571 HD12 ' CD1' ' A' ' 95' ' ' ILE . 1.6 mm -106.99 107.32 22.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -94.24 140.32 29.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.197 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.75 142.92 27.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.132 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 67.2 tttt -117.44 152.78 34.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.996 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.479 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 7.2 tp -73.23 124.19 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.455 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.19 -43.65 5.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.343 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.27 -178.97 16.34 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 34.9 p -153.78 160.29 42.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.708 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.585 ' HE2' ' HG1' ' A' ' 92' ' ' THR . 59.7 m-85 -149.06 156.03 41.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.535 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 64.6 p -147.26 130.94 16.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.594 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.9 pttt . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.526 179.906 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.613 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 70.6 mmtt . . . . . 0 C--O 1.231 0.105 0 CA-C-O 121.115 0.484 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.64 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 52.9 mp0 -90.72 151.89 21.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.387 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 83.79 18.11 64.27 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.613 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -121.97 133.73 54.83 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.537 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 64.4 tttp -60.08 112.03 1.74 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.344 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 14' ' ' GLU . 24.5 m -114.07 -26.38 3.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.965 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -144.08 158.02 43.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.598 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.1 ttp -120.6 140.59 51.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.343 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.486 ' HB2' HD11 ' A' ' 30' ' ' ILE . 55.4 tp -108.96 125.66 52.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.577 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -121.25 133.88 55.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.432 HG22 ' H ' ' A' ' 24' ' ' LEU . 6.0 mt -119.59 111.24 36.39 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 81' ' ' THR . 56.8 Cg_endo -76.02 -36.94 1.74 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.735 2.29 . . . . 0.0 112.843 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.578 ' C ' HD22 ' A' ' 24' ' ' LEU . 39.8 tptt -61.1 -36.83 80.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.582 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.726 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.5 mm? -103.61 -0.51 29.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.642 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.59 50.72 16.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.247 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.22 175.7 9.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.036 0.446 . . . . 0.0 110.287 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.76 157.47 31.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.707 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -144.05 159.73 42.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.826 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.409 ' OG ' ' NZ ' ' A' ' 15' ' ' LYS . 4.3 m -99.83 116.14 31.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.012 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 62' ' ' LEU . 35.3 mm -80.39 126.67 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.247 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 70.8 m-85 -111.03 137.79 48.23 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.988 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 13' ' ' GLY . 41.5 t-105 -60.14 117.31 4.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.695 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.614 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 94.24 166.3 36.76 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.703 179.585 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.615 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.575 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 13.4 tpt -95.3 138.1 33.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.714 0.292 . . . . 0.0 110.713 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -77.69 137.56 38.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.982 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.614 HG23 ' HA2' ' A' ' 33' ' ' GLY . 86.9 t -119.34 114.81 45.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.242 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.54 ' N ' ' OG1' ' A' ' 51' ' ' THR . 6.1 m -163.28 169.35 19.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.686 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.575 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 65.1 t0 -70.85 -8.84 55.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.432 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.715 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.2 m -110.42 -22.95 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.645 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.54 ' OG1' ' N ' ' A' ' 48' ' ' SER . 37.0 p -85.58 138.21 32.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.398 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -131.0 168.17 17.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.22 161.0 28.57 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.594 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.522 ' HG3' HD23 ' A' ' 84' ' ' LEU . 66.7 Cg_endo -81.29 73.65 5.83 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.635 2.224 . . . . 0.0 112.365 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.6 p -115.76 -6.33 12.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.754 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.01 91.98 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.47 79.22 0.16 Allowed Glycine 0 CA--C 1.53 1.028 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.456 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -155.29 150.83 22.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.645 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 16.7 t-160 -77.58 104.99 8.44 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.46 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 38.3 m -100.19 122.43 43.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.433 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.599 ' C ' HD22 ' A' ' 62' ' ' LEU . 54.1 t -114.77 127.44 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 0.0 110.276 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.599 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.7 mm? -112.36 147.13 37.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.684 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 120' ' ' THR . 32.6 t -128.99 142.29 50.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.619 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.531 1.076 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.542 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.464 ' OE1' ' N ' ' A' ' 75' ' ' GLN . 0.7 OUTLIER -64.37 -36.18 83.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 110.405 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.849 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.2 pp -136.13 112.56 9.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.324 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.489 ' O ' HG21 ' A' ' 95' ' ' ILE . 7.8 ptpt -179.99 144.68 0.19 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.348 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -79.52 -11.51 59.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.947 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -83.59 -13.95 53.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.898 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.683 ' OD1' ' N ' ' A' ' 81' ' ' THR . 23.4 t0 -81.06 158.04 25.21 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.215 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.683 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.6 p -138.48 135.44 35.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.7 mt -109.79 122.09 46.71 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.355 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.486 ' C ' HD12 ' A' ' 84' ' ' LEU . 5.7 t -104.33 121.93 56.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.995 0.426 . . . . 0.0 110.263 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.811 HD21 HD12 ' A' ' 117' ' ' LEU . 8.0 mp -103.59 129.54 50.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.367 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -105.44 120.86 42.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.941 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 2.1 t80 -149.38 127.67 12.14 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.933 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 64.4 t0 54.02 52.68 12.38 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.827 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.487 HD22 ' N ' ' A' ' 88' ' ' ASN . 1.3 m-80 57.18 12.23 1.27 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.448 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 49.9 mtmt -112.72 141.63 46.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.956 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.454 ' HG1' ' HB2' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -113.65 126.08 54.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.339 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 10.5 m-85 -109.3 134.83 51.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.102 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.44 ' HG1' ' HE2' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -101.96 115.28 30.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.047 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.497 ' CE1' HD22 ' A' ' 84' ' ' LEU . 75.7 m-85 -110.95 144.27 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.582 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -119.74 138.27 53.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.672 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.493 ' CD1' HG23 ' A' ' 137' ' ' ILE . 2.3 mm -66.2 115.95 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.411 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -86.63 -60.62 1.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.593 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -152.72 145.1 24.03 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.197 0.522 . . . . 0.0 110.26 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.56 131.45 72.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.541 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.496 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 26.5 p90 -149.61 -177.51 5.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.01 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.734 ' N ' HD12 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -130.33 132.42 64.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.356 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.2 t -138.98 178.9 6.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.712 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -68.5 148.71 50.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.564 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.9 -34.31 75.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.363 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -82.8 16.69 2.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.724 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.644 ' OD2' HG23 ' A' ' 108' ' ' VAL . 28.5 t70 -79.63 90.52 5.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.571 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.98 ' O ' HG23 ' A' ' 110' ' ' ILE . 17.0 ptp180 -63.57 -37.92 89.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.515 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.507 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 1.6 p -38.71 -18.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.522 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.851 HG12 HG21 ' A' ' 118' ' ' THR . 11.1 t -111.18 -16.53 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.107 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.785 ' O ' HG22 ' A' ' 109' ' ' ILE . 49.3 mm -112.32 22.34 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.98 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -89.94 -163.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.837 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -102.69 148.31 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.686 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.421 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 98.1 mttt -132.9 150.46 52.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.635 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -94.94 8.98 41.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.401 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.27 163.9 46.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.767 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.456 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 50.2 Cg_endo -79.04 98.5 1.19 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.071 2.514 . . . . 0.0 111.624 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 115' ' ' PRO . 50.2 mm -128.84 138.29 54.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.439 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.824 HD23 ' C ' ' A' ' 117' ' ' LEU . 6.5 tt -110.13 116.48 31.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.666 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.851 HG21 HG12 ' A' ' 108' ' ' VAL . 72.3 m -116.03 114.76 25.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.324 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.843 HD12 ' N ' ' A' ' 120' ' ' THR . 0.9 OUTLIER -103.71 116.32 32.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.026 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.843 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -107.22 122.87 47.39 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.431 0.457 . . . . 0.0 110.403 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.632 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.4 t . . . . . 0 CA--C 1.513 -0.464 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.06 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.698 0.285 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 134' ' ' ARG . 7.7 ttp180 -113.07 142.46 45.7 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.809 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.685 ' CE2' HD11 ' A' ' 137' ' ' ILE . 7.9 t80 -81.9 123.28 28.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 1.6 mt -119.55 124.17 72.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 120.978 0.418 . . . . 0.0 111.959 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.685 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.4 mp -103.04 112.62 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.816 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.496 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 10.4 tt0 -90.11 142.72 27.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.868 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -152.86 149.72 28.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.822 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.451 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 66.7 tttt -123.45 153.4 40.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.451 ' N ' ' CG ' ' A' ' 140' ' ' LYS . 13.8 tp -71.7 126.6 30.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.435 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.68 -36.83 5.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.628 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.425 ' C ' ' OG1' ' A' ' 92' ' ' THR . . . -141.32 162.33 26.87 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.0 p -142.72 133.17 24.94 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.294 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.454 ' HB2' ' HG1' ' A' ' 90' ' ' THR . 62.8 m-85 -123.01 101.6 7.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.684 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.526 ' O ' ' O ' ' A' ' 147' ' ' LYS . 8.6 p -89.38 136.93 32.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.703 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.526 ' O ' ' O ' ' A' ' 146' ' ' SER . 22.0 mtpt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.554 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.556 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 27.4 ttmt . . . . . 0 N--CA 1.458 -0.038 0 CA-C-O 120.842 0.353 . . . . 0.0 110.645 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -92.12 147.58 22.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.292 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.41 3.74 68.96 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.556 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.8 OUTLIER -109.7 137.5 47.41 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.878 0.371 . . . . 0.0 110.483 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -62.77 117.17 5.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.195 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.31 -39.93 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.746 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.92 162.18 33.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.7 ttm -127.2 135.66 50.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.527 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tt -101.53 121.53 42.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.195 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 21' ' ' ILE . 3.8 t30 -116.79 136.07 53.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.419 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.596 HD13 HE22 ' A' ' 75' ' ' GLN . 3.4 mt -113.57 118.3 43.53 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.175 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.664 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.7 Cg_endo -76.55 -48.36 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.857 2.371 . . . . 0.0 112.674 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.566 ' C ' HD22 ' A' ' 24' ' ' LEU . 27.1 tptp -61.57 -39.4 91.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.764 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.1 mm? -99.49 0.68 42.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.768 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt 45.61 38.74 4.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.909 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -117.18 157.59 25.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.841 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -137.57 136.35 37.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.725 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -126.27 120.96 31.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.414 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.8 m -67.32 119.42 12.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.916 0.389 . . . . 0.0 110.646 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.543 HD12 ' CD1' ' A' ' 62' ' ' LEU . 40.0 mm -95.73 120.68 45.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.542 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -106.71 147.97 28.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.641 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.768 ' CZ3' ' SD ' ' A' ' 45' ' ' MET . 46.4 t-105 -60.8 117.73 5.77 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.861 0.362 . . . . 0.0 110.454 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.666 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 85.94 153.67 22.37 Favored Glycine 0 C--N 1.332 0.311 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' CB ' ' OG ' ' A' ' 63' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.411 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.662 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.554 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.768 ' SD ' ' CZ3' ' A' ' 32' ' ' TRP . 1.5 tmt? -93.68 146.97 23.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.94 0.4 . . . . 0.0 110.965 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.562 ' O ' ' SD ' ' A' ' 45' ' ' MET . 57.8 t80 -76.72 130.29 37.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.371 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.666 HG23 ' HA2' ' A' ' 33' ' ' GLY . 63.5 t -96.62 125.96 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.429 . . . . 0.0 110.669 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.588 ' HG ' ' CB ' ' A' ' 51' ' ' THR . 38.5 p -160.45 176.25 11.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.575 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.586 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 65.9 t0 -82.7 -7.14 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.542 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.703 HG21 ' O ' ' A' ' 109' ' ' ILE . 9.0 m -115.45 -32.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.599 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.588 ' CB ' ' HG ' ' A' ' 48' ' ' SER . 72.8 p -78.9 145.35 34.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.78 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -145.24 171.18 14.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.535 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.467 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -90.04 154.39 47.31 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.848 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.78 84.25 1.8 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.689 2.259 . . . . 0.0 112.415 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -117.02 -4.49 11.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.828 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.15 88.98 0.07 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.13 91.23 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.471 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.96 165.34 38.67 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.502 ' CD2' ' HD2' ' A' ' 112' ' ' LYS . 13.2 t-160 -84.24 111.87 19.77 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.413 HG22 HD23 ' A' ' 62' ' ' LEU . 61.2 m -105.61 123.22 47.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.352 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.587 ' O ' HD22 ' A' ' 62' ' ' LEU . 44.9 t -116.57 126.87 74.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.549 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.587 HD22 ' O ' ' A' ' 61' ' ' VAL . 2.5 mm? -114.16 143.97 43.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.819 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 34' ' ' ALA . 4.9 p -132.86 147.5 52.3 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.56 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.469 ' O ' HG22 ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.534 1.225 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.415 ' HA3' HD11 ' A' ' 24' ' ' LEU . . . . . . . . 0 CA--C 1.525 0.668 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.596 HE22 HD13 ' A' ' 21' ' ' ILE . 52.7 mm-40 -61.49 -41.15 96.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.716 0.293 . . . . 0.0 110.792 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.84 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.0 pp -97.11 109.3 22.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.44 . . . . 0.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.42 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 2.3 ptpt 172.2 143.32 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.445 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.63 -14.83 63.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.721 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -82.07 -14.32 56.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.239 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.23 158.91 34.98 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.06 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.664 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -147.67 111.05 4.91 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.235 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.0 mt -87.77 131.24 34.58 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.224 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.679 HG12 HG22 ' A' ' 90' ' ' THR . 2.8 t -112.61 122.39 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.204 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.588 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.2 mm? -107.98 133.24 52.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.343 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.635 ' HG2' HG23 ' A' ' 90' ' ' THR . 96.5 mt-10 -104.25 118.04 35.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.373 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.467 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 1.0 OUTLIER -146.87 125.81 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.764 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 60.14 51.65 5.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.156 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 56.53 11.39 0.85 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.445 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.454 ' HG2' ' CB ' ' A' ' 146' ' ' SER . 45.0 mtpt -112.01 145.05 40.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.612 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.679 HG22 HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -113.71 117.2 30.86 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.344 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 8.6 m-85 -95.17 136.23 35.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.412 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.481 ' O ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -105.91 113.79 27.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.659 -179.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -110.9 147.23 35.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.525 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -123.67 138.9 54.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.651 ' CD1' HG23 ' A' ' 137' ' ' ILE . 8.0 mm -65.89 118.98 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.038 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -95.94 -62.01 1.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.485 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -139.77 135.27 32.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.407 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.9 mt -114.18 127.86 71.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.205 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 21.4 p90 -151.14 -176.35 5.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.73 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.435 HG12 ' CD1' ' A' ' 135' ' ' TYR . 8.0 mt -129.34 138.85 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.46 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.42 HG23 ' HE ' ' A' ' 134' ' ' ARG . 2.2 t -137.55 170.43 16.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.093 0.473 . . . . 0.0 110.776 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.56 ' C ' ' H ' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -73.57 154.72 39.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.555 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.55 8.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.67 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' A' ' 102' ' ' HIS . 57.8 t0 -131.53 36.53 3.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.556 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.541 ' H ' HH21 ' A' ' 134' ' ' ARG . 21.7 t0 -96.44 94.78 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.69 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.985 ' O ' HG23 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -62.45 -35.52 79.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.463 179.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.529 ' C ' HD12 ' A' ' 110' ' ' ILE . 1.2 p -44.91 -13.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.354 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.891 ' CG1' HG21 ' A' ' 118' ' ' THR . 15.7 t -113.46 -12.67 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.116 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.734 ' O ' HG22 ' A' ' 109' ' ' ILE . 50.9 mm -117.68 22.2 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.164 0.507 . . . . 0.0 111.064 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 1.016 ' H ' HD13 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -87.28 -161.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.706 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -104.45 147.07 27.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 98.6 mttt -142.82 136.27 28.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.305 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.15 16.23 8.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.465 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -125.93 151.47 71.4 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.784 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.471 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 37.0 Cg_endo -72.33 80.84 1.57 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.995 2.464 . . . . 0.0 111.275 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.4 mm -115.5 132.85 63.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.287 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.812 HD23 ' C ' ' A' ' 117' ' ' LEU . 5.7 tt -106.13 118.79 37.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.178 0.513 . . . . 0.0 110.739 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.891 HG21 ' CG1' ' A' ' 108' ' ' VAL . 90.8 m -112.78 120.88 43.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.162 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.702 HD23 ' N ' ' A' ' 120' ' ' THR . 0.4 OUTLIER -108.26 119.68 40.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.414 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.702 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -111.17 115.63 29.71 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.81 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.509 HG23 ' CD2' ' A' ' 119' ' ' LEU . 3.6 p . . . . . 0 CA--C 1.513 -0.455 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 40.1 p-10 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.717 0.294 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.541 HH21 ' H ' ' A' ' 105' ' ' ASP . 29.6 ptt180 -98.76 141.83 31.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.733 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.578 ' CE2' HD11 ' A' ' 137' ' ' ILE . 3.1 t80 -75.57 130.85 39.48 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 101' ' ' THR . 3.3 mm -118.96 116.98 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.195 0.521 . . . . 0.0 112.076 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.651 HG23 ' CD1' ' A' ' 95' ' ' ILE . 1.2 mp -106.77 110.32 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.543 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.49 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 48.4 tt0 -90.18 134.91 33.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.034 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -144.35 142.81 30.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.006 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 59.5 tttt -114.65 153.32 30.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.181 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 92' ' ' THR . 27.8 tp -74.62 116.94 15.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.12 -33.87 10.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -154.74 158.66 28.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 38.3 p -138.42 151.62 47.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 0.0 110.384 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.494 ' N ' ' O ' ' A' ' 90' ' ' THR . 90.2 m-85 -130.04 145.08 51.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.458 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.454 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 5.2 p -136.68 129.07 30.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.553 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 146' ' ' SER . 13.8 mttm . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.339 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.3 tptp . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.646 0.26 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.02 141.01 55.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.94 0.4 . . . . 0.0 110.335 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.5 14.06 66.57 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -119.38 141.54 48.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.328 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.403 ' NZ ' ' HB2' ' A' ' 18' ' ' MET . 12.4 tmtt? -62.31 112.25 2.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.257 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 32' ' ' TRP . 16.5 m -112.94 -43.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.721 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.472 ' N ' HG23 ' A' ' 16' ' ' VAL . . . -129.53 162.27 28.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.76 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.434 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 50.8 ttm -125.84 143.0 51.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.51 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.429 HD13 HD21 ' A' ' 84' ' ' LEU . 21.1 tp -107.01 127.75 53.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.409 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.467 HD22 ' N ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -124.88 125.88 44.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.04 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 24' ' ' LEU . 4.8 mt -105.01 119.68 52.43 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.934 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 81' ' ' THR . 59.5 Cg_endo -76.66 -48.18 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.637 2.225 . . . . 0.0 112.918 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.518 ' C ' HD22 ' A' ' 24' ' ' LEU . 16.7 tptp -59.34 -43.87 92.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.985 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.81 ' N ' HD22 ' A' ' 24' ' ' LEU . 2.7 mm? -96.93 -0.57 47.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.362 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.15 37.69 8.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.622 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -107.65 157.21 18.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.533 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -140.06 145.6 37.9 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.683 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -143.73 150.75 39.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.876 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.2 m -99.06 116.26 30.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.76 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.627 HG12 HD11 ' A' ' 62' ' ' LEU . 1.7 mp -86.13 122.54 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.42 139.02 34.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.714 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.484 ' HB2' HG11 ' A' ' 16' ' ' VAL . 42.6 t-105 -60.43 127.73 33.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 110.654 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.488 ' HA2' HG12 ' A' ' 47' ' ' VAL . . . 77.64 175.28 43.32 Favored Glycine 0 C--N 1.329 0.188 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.639 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.889 179.306 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.638 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.758 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -100.91 131.35 46.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.758 ' N ' ' SD ' ' A' ' 45' ' ' MET . 1.5 t80 -65.59 132.97 50.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.682 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.488 HG12 ' HA2' ' A' ' 33' ' ' GLY . 1.8 p -122.47 114.97 44.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.351 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.665 ' N ' ' OG1' ' A' ' 51' ' ' THR . 16.0 p -157.96 173.13 17.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.6 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.21 -14.8 11.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.6 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.787 HG21 ' O ' ' A' ' 109' ' ' ILE . 5.3 m -110.57 -38.61 3.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.784 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.665 ' OG1' ' N ' ' A' ' 48' ' ' SER . 62.5 p -77.45 140.39 39.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.606 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.481 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -144.9 167.05 23.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.245 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.478 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -85.5 157.02 58.97 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.73 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.52 83.98 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.529 2.153 . . . . 0.0 112.343 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 p -115.16 -2.92 12.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.688 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.19 91.12 0.18 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.34 81.68 0.14 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.456 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -163.38 162.19 34.67 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.607 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 20.0 t-160 -83.22 118.59 23.73 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.4 m -117.21 126.5 52.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.051 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.667 ' O ' ' SD ' ' A' ' 45' ' ' MET . 70.4 t -116.58 132.34 66.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 110.038 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.627 HD11 HG12 ' A' ' 30' ' ' ILE . 2.7 mm? -112.63 135.39 53.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.724 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 26.8 t -117.7 132.81 56.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.603 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.955 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.962 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.311 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -139.74 -15.86 1.03 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.221 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.463 HD23 ' N ' ' A' ' 76' ' ' LEU . 2.3 mt -90.8 60.72 4.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.91 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.516 ' HE2' ' N ' ' A' ' 80' ' ' ASP . 23.3 pttm -164.29 143.66 7.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.211 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.67 -19.3 59.24 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.228 0.537 . . . . 0.0 110.164 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -71.14 -15.51 62.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.817 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.686 ' OD1' ' N ' ' A' ' 81' ' ' THR . 6.0 t0 -68.86 152.34 45.43 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.175 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.686 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -141.22 121.95 14.34 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.128 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.0 mt -99.65 117.49 34.13 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.606 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.651 ' C ' HD22 ' A' ' 84' ' ' LEU . 45.2 t -100.47 121.89 51.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.969 0.414 . . . . 0.0 110.097 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 83' ' ' VAL . 4.0 mm? -109.36 131.62 54.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.296 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.581 ' HG3' HG23 ' A' ' 90' ' ' THR . 54.9 mp0 -102.5 123.47 46.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.83 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 5.3 t80 -143.62 119.19 10.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.87 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 57.35 51.1 10.41 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.745 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 62.34 7.7 2.42 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.675 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 56.9 mtmt -107.57 142.85 36.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.808 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.623 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -113.29 123.95 51.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.688 -179.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.402 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 22.1 m-85 -106.69 128.66 54.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.144 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.04 115.46 29.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.219 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 86.5 m-85 -109.97 153.47 24.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.639 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -126.88 139.29 53.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.64 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.489 ' HA ' HD13 ' A' ' 95' ' ' ILE . 9.1 mm -61.86 119.89 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.181 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -88.53 -67.15 0.85 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.553 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -148.97 136.37 20.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.295 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.2 mp -108.04 135.12 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.149 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.607 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 15.0 p90 -160.71 -178.86 7.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.268 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.846 ' N ' HD12 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -126.2 132.82 70.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.316 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 102' ' ' HIS . 1.3 t -136.11 175.66 9.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 110.894 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.407 ' O ' HG23 ' A' ' 101' ' ' THR . 67.2 m80 -76.31 151.21 36.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.9 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.85 -18.47 65.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.788 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -94.28 17.31 13.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.048 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.628 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 21.4 t0 -91.89 100.42 13.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.837 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.911 ' O ' HG23 ' A' ' 110' ' ' ILE . 3.0 ptp85 -69.17 -32.57 71.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.268 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.628 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 6.3 p -37.85 -20.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.356 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.716 ' CG1' HG21 ' A' ' 118' ' ' THR . 18.5 t -105.26 -19.4 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.013 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.787 ' O ' HG21 ' A' ' 50' ' ' VAL . 45.4 mm -113.19 27.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.801 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.911 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -91.18 -168.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.433 ' N ' ' HB ' ' A' ' 50' ' ' VAL . 33.9 ttmt -97.1 147.87 23.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.538 ' HZ3' HG21 ' A' ' 116' ' ' ILE . 99.3 mttt -130.82 155.55 46.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 110.588 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -102.26 13.39 34.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.329 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.98 169.2 10.75 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.971 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.456 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 47.6 Cg_endo -79.66 95.4 1.04 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 123.284 2.656 . . . . 0.0 112.438 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.538 HG21 ' HZ3' ' A' ' 112' ' ' LYS . 49.7 mm -126.16 128.54 71.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.568 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.758 HD23 ' C ' ' A' ' 117' ' ' LEU . 4.7 tt -104.52 121.01 42.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.903 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.716 HG21 ' CG1' ' A' ' 108' ' ' VAL . 89.2 m -115.65 126.64 54.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.343 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.84 HD12 ' N ' ' A' ' 120' ' ' THR . 2.5 tp -111.98 127.85 55.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.056 0.455 . . . . 0.0 111.671 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.84 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -122.05 129.19 52.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.039 178.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.722 ' CG2' HD11 ' A' ' 119' ' ' LEU . 65.7 p . . . . . 0 CA--C 1.506 -0.744 0 CA-C-O 121.244 0.545 . . . . 0.0 111.768 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.494 ' HB3' HG22 ' A' ' 100' ' ' ILE . 97.0 m-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.877 0.37 . . . . 0.0 110.55 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -119.16 134.33 55.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.29 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 120' ' ' THR . 6.6 t80 -68.53 133.01 47.93 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.969 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.607 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 37.8 mm -118.76 115.15 47.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.086 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.424 HG23 ' CD1' ' A' ' 95' ' ' ILE . 2.1 mm -107.96 108.53 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -91.4 146.65 23.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.02 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -153.05 142.96 22.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.428 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -115.64 150.46 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.146 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 6.5 tp -77.48 123.24 26.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.353 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.03 -40.36 5.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.826 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -136.99 164.23 25.26 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.0 p -151.1 152.44 33.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.826 0.346 . . . . 0.0 110.386 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 90' ' ' THR . 87.1 m-85 -136.44 155.04 50.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.487 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.1 p -143.27 125.62 15.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.583 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.1 tttt . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.562 -179.85 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt . . . . . 0 CA--C 1.521 -0.152 0 CA-C-O 120.882 0.373 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 35.1 mp0 -70.18 123.89 22.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.025 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 109.43 11.74 20.97 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -118.48 134.43 55.08 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.333 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.537 ' N ' ' CD2' ' A' ' 31' ' ' TYR . 40.3 tttm -57.97 112.69 1.58 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.352 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 m -114.2 -38.22 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.877 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.79 154.97 49.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.541 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.413 ' CE ' ' OE1' ' A' ' 85' ' ' GLU . 16.2 ttp -118.74 137.94 53.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.436 ' CD1' HD21 ' A' ' 84' ' ' LEU . 46.2 tp -106.1 119.26 38.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.145 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.594 HD22 ' N ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -118.87 127.14 53.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 111.328 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.066 HD13 HE22 ' A' ' 75' ' ' GLN . 4.5 mt -109.82 116.95 53.25 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.516 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.03 -45.74 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.529 2.153 . . . . 0.0 113.036 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.511 ' C ' HD22 ' A' ' 24' ' ' LEU . 19.1 tptm -62.52 -38.6 90.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.773 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.2 mm? -96.4 4.62 52.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.999 0.428 . . . . 0.0 110.442 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 41.9 49.09 4.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.127 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -135.33 157.7 46.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.963 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -138.92 140.18 38.26 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.47 142.38 47.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.457 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 m -90.73 123.76 34.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.687 HG12 HD11 ' A' ' 62' ' ' LEU . 1.7 mp -96.28 123.19 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.453 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.537 ' CD2' ' N ' ' A' ' 15' ' ' LYS . 42.1 m-85 -103.11 145.06 30.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.787 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.599 ' O ' ' N ' ' A' ' 13' ' ' GLY . 41.1 t-105 -59.1 130.05 45.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.974 0.416 . . . . 0.0 110.521 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.573 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 82.59 141.07 3.82 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HB1' ' OG ' ' A' ' 63' ' ' SER . . . . . . . . 0 C--N 1.325 -0.476 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.925 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.495 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.692 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -93.41 125.58 38.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.692 ' N ' ' SD ' ' A' ' 45' ' ' MET . 16.7 t80 -66.84 140.87 57.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.26 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.573 HG23 ' HA2' ' A' ' 33' ' ' GLY . 54.4 t -114.58 129.46 70.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.633 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.628 ' N ' ' OG1' ' A' ' 51' ' ' THR . 11.6 t -163.21 166.42 23.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.59 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 36.8 t0 -68.94 -11.48 60.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.433 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.662 HG21 ' O ' ' A' ' 109' ' ' ILE . 6.1 m -109.01 -14.55 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.528 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 48' ' ' SER . 25.5 p -85.73 149.1 25.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.554 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.521 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.8 OUTLIER -140.74 164.85 29.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.951 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.44 HG22 ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -95.38 151.93 38.98 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.216 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.89 54.23 3.99 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.757 2.305 . . . . 0.0 112.634 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.2 p -102.4 -7.69 21.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.264 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.07 81.17 0.04 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.78 103.15 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.584 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.7 160.41 34.0 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.738 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 22.1 t-160 -81.42 99.37 8.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.8 m -94.02 126.54 39.29 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.677 ' O ' ' SD ' ' A' ' 45' ' ' MET . 71.8 t -116.52 128.93 73.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.077 0.465 . . . . 0.0 110.232 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.687 HD11 HG12 ' A' ' 30' ' ' ILE . 2.7 mm? -114.58 141.55 47.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.73 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.465 ' OG ' ' HB1' ' A' ' 34' ' ' ALA . 4.8 p -128.4 146.61 50.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.707 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.66 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.531 1.05 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.644 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 1.066 HE22 HD13 ' A' ' 21' ' ' ILE . 91.8 mm-40 -63.82 -39.42 94.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.688 0.28 . . . . 0.0 110.669 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.859 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.6 pp -91.25 102.45 15.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.39 0.614 . . . . 0.0 111.333 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.529 ' HG3' ' H ' ' A' ' 80' ' ' ASP . 20.6 pttm 176.83 152.56 0.19 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.221 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.32 -31.73 70.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.359 0.599 . . . . 0.0 110.727 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 mmtt -69.78 -14.15 62.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.501 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.67 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 1.2 t70 -82.67 152.95 25.62 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.566 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.493 ' O ' HD23 ' A' ' 82' ' ' LEU . 2.6 p -138.85 149.55 45.02 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 81' ' ' THR . 41.1 mt -121.58 123.66 42.5 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.8 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.55 ' C ' HD22 ' A' ' 84' ' ' LEU . 10.7 t -103.74 116.96 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.55 HD22 ' C ' ' A' ' 83' ' ' VAL . 2.7 mm? -105.69 132.35 51.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.53 -178.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.499 ' HG2' HG23 ' A' ' 90' ' ' THR . 28.6 mt-10 -108.75 123.53 49.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.55 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.587 ' O ' ' N ' ' A' ' 89' ' ' LYS . 12.2 t80 -144.48 145.22 31.75 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.034 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.417 ' N ' ' CD1' ' A' ' 86' ' ' TYR . 34.8 t70 36.95 51.29 0.96 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.759 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.0 m120 59.32 25.12 13.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.961 0.41 . . . . 0.0 110.598 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 86' ' ' TYR . 54.5 mtmt -124.07 144.34 49.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.107 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.499 HG23 ' HG2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -111.69 126.92 55.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.565 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -112.47 131.86 55.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.278 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.431 ' O ' HD22 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -102.59 106.24 16.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.343 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 53.1 m-85 -97.08 161.49 13.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.354 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.67 ' OE1' ' O ' ' A' ' 80' ' ' ASP . 2.8 tp10 -136.85 137.23 39.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.514 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.599 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 1.9 mm -65.54 124.2 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.554 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -98.72 -62.89 1.18 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.544 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -141.14 138.9 33.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.319 0.58 . . . . 0.0 109.786 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.727 HG23 HD13 ' A' ' 137' ' ' ILE . 46.6 mt -120.36 127.62 75.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.833 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.599 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 22.4 p90 -152.72 -177.59 6.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.816 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.707 HG22 ' OD2' ' A' ' 133' ' ' ASP . 2.4 mp -125.68 132.82 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.757 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.623 HG21 HG21 ' A' ' 108' ' ' VAL . 2.0 t -143.32 166.45 24.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -65.9 147.83 52.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.236 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.44 80.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.64 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' ARG . 46.7 t0 -63.91 -33.34 75.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.611 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.447 ' OD2' ' OG1' ' A' ' 107' ' ' THR . 14.6 t70 -40.13 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.447 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 109' ' ' ILE . 11.1 ptp85 -68.96 -26.09 64.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.806 ' O ' HD11 ' A' ' 110' ' ' ILE . 10.9 p -49.1 -21.93 0.83 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.587 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.625 HG11 HD12 ' A' ' 136' ' ' ILE . 6.8 t -97.77 -13.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.166 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.791 ' O ' HG22 ' A' ' 109' ' ' ILE . 48.1 mm -114.83 18.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.273 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.806 HD11 ' O ' ' A' ' 107' ' ' THR . 0.4 OUTLIER -79.1 -156.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.889 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.421 ' H ' ' HB ' ' A' ' 110' ' ' ILE . 22.3 ttmt -107.76 148.18 29.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.524 ' HG2' ' CG ' ' A' ' 59' ' ' HIS . 71.9 mmtt -125.15 141.66 51.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.906 0.384 . . . . 0.0 110.257 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.578 ' O ' ' OE2' ' A' ' 114' ' ' GLU . 51.4 mm-40 -89.62 10.78 21.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.722 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.578 ' OE2' ' O ' ' A' ' 113' ' ' GLU . 44.0 mm-40 -143.11 152.65 58.67 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.584 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 12.0 Cg_endo -62.15 84.49 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.642 2.228 . . . . 0.0 110.771 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.65 132.11 66.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.787 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.785 HD23 ' C ' ' A' ' 117' ' ' LEU . 5.5 tt -107.54 119.77 40.33 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.277 0.56 . . . . 0.0 109.923 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.562 HG21 ' CG1' ' A' ' 108' ' ' VAL . 73.1 m -116.15 117.44 30.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.742 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.946 HD12 ' N ' ' A' ' 120' ' ' THR . 1.0 OUTLIER -107.54 124.69 50.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.85 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.946 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -119.03 122.74 42.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.578 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.66 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.3 t . . . . . 0 CA--C 1.513 -0.48 0 CA-C-O 121.224 0.535 . . . . 0.0 111.989 -179.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.707 ' OD2' HG22 ' A' ' 100' ' ' ILE . 4.8 t0 . . . . . 0 CA--C 1.522 -0.096 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -99.02 144.11 28.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.235 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.484 ' CE2' HD11 ' A' ' 137' ' ' ILE . 4.6 t80 -75.57 132.57 40.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.625 HD12 HG11 ' A' ' 108' ' ' VAL . 15.8 mm -110.88 110.94 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.727 HD13 HG23 ' A' ' 98' ' ' ILE . 51.2 mm -101.28 108.89 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -96.76 142.2 29.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.31 0.576 . . . . 0.0 111.407 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -153.54 146.98 24.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.04 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -116.57 157.47 25.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.901 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.691 ' C ' HD13 ' A' ' 141' ' ' LEU . 2.6 tm? -87.77 118.41 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.119 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -108.44 -65.03 1.16 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.441 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.548 ' N ' ' OG1' ' A' ' 142' ' ' THR . . . -93.16 156.9 23.04 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.0 p -152.6 152.1 31.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.518 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -142.87 132.82 24.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.411 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.3 t -121.63 131.94 54.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.998 0.428 . . . . 0.0 110.434 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.622 -179.27 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 tptm . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.462 ' HG2' HG21 ' A' ' 47' ' ' VAL . 50.5 mt-10 -64.99 130.4 43.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.914 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 95.54 21.38 24.41 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -128.45 146.35 50.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.994 0.426 . . . . 0.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -64.26 119.8 10.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.065 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 17' ' ' ALA . 5.0 m -119.59 -46.12 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.626 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -128.22 169.54 14.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.457 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.7 tpp -127.75 139.72 52.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.399 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.719 ' HB2' HD11 ' A' ' 30' ' ' ILE . 5.6 tp -108.18 124.49 50.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.338 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 26' ' ' LYS . 21.5 t-20 -118.33 129.3 55.36 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.0 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.408 HG22 ' H ' ' A' ' 24' ' ' LEU . 24.5 mt -114.73 111.87 45.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.202 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.8 -37.65 1.13 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.647 2.231 . . . . 0.0 112.993 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.813 ' NZ ' ' HZ1' ' A' ' 77' ' ' LYS . 2.1 tptm -62.33 -37.24 84.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.701 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.715 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.3 mm? -98.95 -3.34 35.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.402 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 54.62 65.8 1.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.339 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.431 ' C ' ' CG ' ' A' ' 27' ' ' LYS . 16.0 ptmt -165.72 -175.19 3.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.077 0.465 . . . . 0.0 111.26 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' CG ' ' C ' ' A' ' 26' ' ' LYS . 4.1 mtpt -155.32 155.75 34.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.292 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.426 ' CZ ' ' HE2' ' A' ' 26' ' ' LYS . 78.9 m-85 -135.82 146.48 47.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.449 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.7 m -87.18 118.45 26.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.956 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.873 HD12 HD11 ' A' ' 62' ' ' LEU . 41.1 mm -85.1 113.92 24.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -99.22 135.53 40.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.848 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.535 ' O ' ' N ' ' A' ' 13' ' ' GLY . 28.3 t-105 -60.62 122.18 14.06 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.015 0.436 . . . . 0.0 110.829 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 86.97 156.77 29.84 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.449 179.806 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.555 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.674 ' SD ' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -104.27 129.97 52.08 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.674 ' N ' ' SD ' ' A' ' 45' ' ' MET . 5.5 t80 -63.06 145.95 54.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.983 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.479 HG22 ' CE2' ' A' ' 32' ' ' TRP . 46.1 t -118.55 128.01 75.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.483 ' HG ' ' CB ' ' A' ' 51' ' ' THR . 59.8 p -167.1 173.85 8.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.435 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.91 -6.73 53.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.768 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.704 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.5 m -114.1 -23.04 4.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.664 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.483 ' CB ' ' HG ' ' A' ' 48' ' ' SER . 23.7 p -87.21 159.05 18.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.531 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.49 171.61 19.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.187 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.505 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -91.16 156.49 43.85 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.413 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.772 ' HG3' HD23 ' A' ' 84' ' ' LEU . 70.8 Cg_endo -75.81 83.13 2.0 Allowed 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.687 2.258 . . . . 0.0 112.444 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.8 p -115.3 -4.72 12.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.719 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.82 89.66 0.08 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.78 87.12 0.04 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.442 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -162.32 168.47 37.31 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.517 ' CD2' ' HE2' ' A' ' 112' ' ' LYS . 16.8 t-160 -89.16 116.93 27.77 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.9 m -111.97 127.22 55.8 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.073 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.674 ' O ' ' SD ' ' A' ' 45' ' ' MET . 58.6 t -119.35 126.14 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.994 0.426 . . . . 0.0 110.787 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.873 HD11 HD12 ' A' ' 30' ' ' ILE . 2.3 mm? -116.23 145.78 42.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.629 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 93.7 p -137.93 154.33 49.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.825 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.751 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.616 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.658 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -28.1 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.586 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -120.85 91.57 3.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.018 0.437 . . . . 0.0 110.88 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.813 ' HZ1' ' NZ ' ' A' ' 23' ' ' LYS . 60.0 pttt -177.95 147.4 0.46 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.977 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.6 -18.12 61.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.921 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -77.35 -15.54 59.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.595 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.535 ' OD2' HD21 ' A' ' 82' ' ' LEU . 3.7 t70 -76.76 154.57 33.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.927 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.483 ' O ' HD23 ' A' ' 82' ' ' LEU . 1.9 p -139.45 139.89 37.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.535 HD21 ' OD2' ' A' ' 80' ' ' ASP . 13.0 mt -118.67 129.75 55.46 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.755 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.461 ' C ' HD12 ' A' ' 84' ' ' LEU . 2.3 t -111.62 118.29 57.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.772 HD23 ' HG3' ' A' ' 54' ' ' PRO . 7.6 mp -99.3 130.87 45.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.57 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -114.9 115.11 26.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.55 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.626 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.2 t80 -147.61 130.25 15.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 61.9 t0 64.01 40.37 7.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.668 0.27 . . . . 0.0 111.325 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 63.17 11.0 4.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.449 ' HB3' ' CE1' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -107.64 143.18 36.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.962 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.575 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -111.66 124.8 53.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.32 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.538 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 5.6 m-85 -113.6 137.49 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.907 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.585 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -105.86 118.76 37.42 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.619 ' CE1' HD22 ' A' ' 84' ' ' LEU . 64.7 m-85 -113.27 161.46 17.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.983 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -141.12 140.2 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.246 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.533 HD12 ' H ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -66.92 124.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.57 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -96.11 -60.24 1.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.184 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -144.4 143.81 31.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.25 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.8 mt -117.38 133.43 64.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.483 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 18.4 p90 -153.0 -175.63 5.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.004 0.43 . . . . 0.0 111.433 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 mt -125.52 133.06 70.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.536 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.555 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 1.7 t -133.71 168.32 18.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.132 0.491 . . . . 0.0 110.906 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.524 ' CD2' ' N ' ' A' ' 102' ' ' HIS . 1.5 m170 -76.65 157.05 32.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.48 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.53 -9.23 40.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.661 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.559 ' O ' ' OD1' ' A' ' 104' ' ' ASP . 57.7 t0 -109.26 23.75 14.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.881 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.621 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 67.2 t0 -88.95 92.67 9.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.645 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.736 ' O ' HG23 ' A' ' 110' ' ' ILE . 12.2 ptp85 -65.27 -34.76 79.1 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.161 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.621 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 10.2 p -42.29 -17.02 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.472 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.865 ' CG1' HG21 ' A' ' 118' ' ' THR . 58.9 t -102.79 -20.89 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.046 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.704 ' O ' HG21 ' A' ' 50' ' ' VAL . 48.4 mm -110.31 21.99 5.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.992 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.736 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -82.73 -172.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.146 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -87.27 142.52 27.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.888 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.517 ' HE2' ' CD2' ' A' ' 59' ' ' HIS . 2.5 tppt? -121.42 147.26 45.97 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.934 0.397 . . . . 0.0 110.57 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 113' ' ' GLU . 1.6 mp0 -101.47 15.72 27.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.031 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.11 171.81 6.21 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.29 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.442 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 54.7 Cg_endo -80.06 95.43 1.01 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 123.014 2.476 . . . . 0.0 111.668 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 116' ' ' ILE . 49.2 mm -127.66 139.05 52.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.625 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.771 HD23 ' C ' ' A' ' 117' ' ' LEU . 5.5 tt -112.44 120.11 40.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.35 0.595 . . . . 0.0 110.195 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.865 HG21 ' CG1' ' A' ' 108' ' ' VAL . 85.7 m -111.95 116.61 30.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.099 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.826 HD23 ' N ' ' A' ' 120' ' ' THR . 3.7 tt -108.97 122.4 47.15 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.412 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.826 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -106.29 124.33 49.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.505 HG22 HD22 ' A' ' 119' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.755 -179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 . . . . . 0 N--CA 1.456 -0.141 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -110.45 131.56 54.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.099 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.438 ' HB3' ' OG1' ' A' ' 121' ' ' THR . 2.0 t80 -64.42 141.86 58.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.538 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.462 ' CG1' HG22 ' A' ' 101' ' ' THR . 5.9 mm -128.4 116.71 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 137' ' ' ILE . 1.3 mp -105.32 112.11 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.469 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 45.4 tt0 -93.96 139.34 31.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.9 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.52 148.77 33.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.205 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.9 tttm -122.03 148.41 44.88 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.992 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.788 HD23 ' C ' ' A' ' 141' ' ' LEU . 8.2 tt -73.14 115.33 12.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.162 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.445 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.7 OUTLIER -88.8 -43.38 11.29 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.912 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.585 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -134.9 160.51 24.31 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 62.5 p -136.23 142.74 44.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.588 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.575 ' N ' ' O ' ' A' ' 90' ' ' THR . 92.6 m-85 -130.53 154.96 47.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.464 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.55 ' O ' ' OXT' ' A' ' 147' ' ' LYS . 20.2 p -141.77 121.19 13.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.299 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.55 ' OXT' ' O ' ' A' ' 146' ' ' SER . 18.5 ttmt . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.621 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.5 tptt . . . . . 0 N--CA 1.455 -0.204 0 CA-C-O 120.751 0.31 . . . . 0.0 110.24 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.693 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 1.0 OUTLIER -68.14 148.6 50.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.374 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.24 0.76 76.5 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -115.33 131.97 56.76 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.333 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . 60.7 tttm -57.38 125.35 22.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.064 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 m -117.06 -37.98 2.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.135 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -140.92 167.37 22.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.865 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.453 ' SD ' ' HA ' ' A' ' 29' ' ' SER . 4.5 tpp -121.0 147.64 45.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.452 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 83' ' ' VAL . 51.1 tp -114.76 115.47 27.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.003 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.471 HD22 ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -105.24 135.94 45.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.302 179.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 25' ' ' LYS . 8.3 mt -113.34 90.67 17.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.125 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 20' ' ' ASN . 31.6 Cg_exo -55.5 -42.68 65.5 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 123.178 2.585 . . . . 0.0 112.746 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.608 ' C ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -60.31 -42.75 96.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.715 -178.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.81 ' N ' HD22 ' A' ' 24' ' ' LEU . 2.8 mm? -100.41 2.65 42.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.147 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 21' ' ' ILE . 75.3 mmtt 50.34 36.02 12.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.432 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -113.6 173.09 6.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.377 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.408 ' CD ' ' OD1' ' A' ' 20' ' ' ASN . 30.9 mtmm -148.57 142.18 25.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.98 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -134.07 152.55 51.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.851 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.453 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -95.11 120.52 35.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.578 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.414 HD11 ' HB2' ' A' ' 19' ' ' LEU . 48.9 mm -88.76 117.29 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.236 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 87.3 m-85 -102.37 135.81 43.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.113 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -59.66 125.55 24.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.586 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 74.35 173.65 30.14 Favored Glycine 0 C--N 1.331 0.266 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.57 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.642 179.617 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.628 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.432 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 2.3 ttp -97.9 129.38 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.12 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -63.73 143.28 57.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.586 HG23 ' HA2' ' A' ' 33' ' ' GLY . 55.4 t -122.85 128.55 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.77 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.787 ' HG ' ' H ' ' A' ' 51' ' ' THR . 7.3 p -164.18 168.96 18.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.507 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -64.03 -35.29 80.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.698 HG21 ' O ' ' A' ' 109' ' ' ILE . 4.4 m -87.62 -25.34 6.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.802 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.787 ' H ' ' HG ' ' A' ' 48' ' ' SER . 43.5 p -77.23 140.38 40.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.737 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.616 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 1.3 p -131.75 171.31 13.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.847 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.12 155.87 36.08 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.948 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.685 ' HG3' HD13 ' A' ' 84' ' ' LEU . 65.4 Cg_endo -77.77 62.89 7.97 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.723 2.282 . . . . 0.0 112.325 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.415 ' O ' ' OH ' ' A' ' 91' ' ' TYR . 86.7 p -112.63 -3.8 14.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.77 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.52 91.24 0.08 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.09 88.35 0.01 OUTLIER Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.485 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -161.04 152.32 22.91 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.616 ' N ' ' OG1' ' A' ' 52' ' ' THR . 19.8 t-160 -78.69 106.18 10.5 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.3 m -101.8 124.44 47.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.231 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.639 HG11 ' CD1' ' A' ' 109' ' ' ILE . 74.3 t -117.62 129.46 74.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.521 HD22 ' C ' ' A' ' 61' ' ' VAL . 3.0 mm? -108.04 144.36 35.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.167 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.2 t -128.1 136.54 51.33 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.755 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.402 ' N ' HG22 ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.531 1.088 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.57 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' HD2' ' A' ' 77' ' ' LYS . . . . . . . . 0 CA--C 1.528 0.885 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -66.07 -35.81 81.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.631 0.253 . . . . 0.0 111.246 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.605 HD22 ' OH ' ' A' ' 135' ' ' TYR . 11.3 mt -88.37 83.29 6.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.845 0.355 . . . . 0.0 111.005 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.437 ' NZ ' ' HD3' ' A' ' 23' ' ' LYS . 14.2 ptmt -177.8 134.6 0.17 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.837 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.65 -10.63 59.89 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.394 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -82.92 -14.9 53.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.064 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.43 ' OD2' HD21 ' A' ' 82' ' ' LEU . 3.7 t70 -64.21 155.16 32.7 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.637 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.439 ' O ' HD23 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -133.25 140.29 47.41 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.033 0.445 . . . . 0.0 110.067 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 81' ' ' THR . 21.2 mt -119.8 120.58 36.92 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.485 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.508 ' O ' HD12 ' A' ' 19' ' ' LEU . 2.9 t -107.13 130.32 59.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.045 0.45 . . . . 0.0 110.492 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.752 HD11 HD12 ' A' ' 117' ' ' LEU . 27.1 mt -113.79 128.83 56.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.474 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HG2' HG23 ' A' ' 90' ' ' THR . 83.9 mt-10 -104.46 118.27 36.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.564 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.535 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -153.19 129.38 10.45 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.869 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.435 ' C ' ' N ' ' A' ' 89' ' ' LYS . 58.2 m-20 61.24 54.29 3.28 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.844 0.354 . . . . 0.0 111.338 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 51.59 15.31 0.34 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.699 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.435 ' N ' ' C ' ' A' ' 87' ' ' ASP . 20.6 mtpt -119.33 143.23 47.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.37 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.479 HG22 ' CG1' ' A' ' 83' ' ' VAL . 4.6 m -115.14 120.55 40.14 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.346 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.415 ' OH ' ' O ' ' A' ' 55' ' ' SER . 13.6 m-85 -99.62 136.06 40.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.177 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.561 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -108.27 119.01 38.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.218 -178.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.627 ' CE1' HD12 ' A' ' 84' ' ' LEU . 91.4 m-85 -113.1 165.13 12.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.62 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -143.44 139.89 30.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.942 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mt -69.01 121.63 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.804 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -97.04 -42.19 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.587 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -158.25 140.08 13.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.692 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.5 mt -118.25 126.59 75.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.256 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.8 p90 -149.37 -179.23 6.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.598 HG22 ' HB3' ' A' ' 133' ' ' ASP . 1.3 mp -125.21 126.89 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.047 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 102' ' ' HIS . 1.7 t -129.11 173.38 10.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.711 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.487 ' ND1' ' N ' ' A' ' 102' ' ' HIS . 1.0 OUTLIER -73.16 152.73 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.649 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.82 -18.51 65.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.743 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -92.58 4.53 53.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.696 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.852 ' O ' HG22 ' A' ' 108' ' ' VAL . 41.9 t0 -75.3 60.55 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.373 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 109' ' ' ILE . 28.1 ptt85 -38.53 -23.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.747 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 105' ' ' ASP . 65.5 p -46.5 -16.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.599 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.852 HG22 ' O ' ' A' ' 105' ' ' ASP . 3.9 m -106.25 -13.03 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 120.952 0.406 . . . . 0.0 110.339 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.755 ' O ' HG22 ' A' ' 109' ' ' ILE . 41.6 mm -112.89 21.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.549 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.573 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -88.95 -163.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.862 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -104.07 140.56 37.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.632 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -131.4 140.41 49.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.566 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -87.74 11.44 15.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.058 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.93 160.33 69.05 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.845 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.485 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 39.6 Cg_endo -77.32 99.37 1.29 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.895 2.397 . . . . 0.0 111.563 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.421 HD13 ' O ' ' A' ' 115' ' ' PRO . 49.8 mm -130.36 133.27 64.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.179 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.752 HD12 HD11 ' A' ' 84' ' ' LEU . 6.5 tt -107.94 117.85 35.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.249 0.547 . . . . 0.0 110.249 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 61.2 m -118.27 123.02 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.971 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.872 ' C ' HD23 ' A' ' 119' ' ' LEU . 1.0 OUTLIER -109.23 131.53 54.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.93 0.395 . . . . 0.0 111.043 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 135' ' ' TYR . 0.2 OUTLIER -126.32 121.65 33.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.895 179.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.604 HG23 HD21 ' A' ' 119' ' ' LEU . 69.5 p . . . . . 0 CA--C 1.511 -0.531 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.586 -179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.598 ' HB3' HG22 ' A' ' 100' ' ' ILE . 65.6 m-20 . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.766 0.317 . . . . 0.0 110.429 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 62.5 mmt-85 -103.59 136.6 43.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.732 ' CE2' HD11 ' A' ' 137' ' ' ILE . 5.0 t80 -68.13 130.6 43.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.674 -0.411 . . . . 0.0 109.903 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.6 mm -120.58 118.91 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.732 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp -108.1 109.02 26.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -91.13 140.05 30.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.906 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.13 137.3 18.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.955 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 69.2 tttt -112.54 158.53 19.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.022 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.537 ' N ' ' CG ' ' A' ' 140' ' ' LYS . 10.6 tp -77.06 122.68 25.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.449 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.25 -38.19 6.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.515 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.561 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -148.7 149.68 21.73 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.5 p -135.6 152.96 51.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.379 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -128.54 147.66 50.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.779 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.8 t -133.37 136.93 45.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 110.526 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.8 tptp . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.563 -179.665 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.414 ' HD3' ' N ' ' A' ' 12' ' ' GLU . 9.9 tmtt? . . . . . 0 CA--C 1.527 0.068 0 CA-C-O 120.806 0.336 . . . . 0.0 110.113 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.751 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 1.8 mp0 -67.58 151.09 47.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.358 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.39 9.8 81.1 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -121.47 135.68 55.02 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.343 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -61.86 122.83 16.39 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.948 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 17' ' ' ALA . 14.3 m -117.29 -40.72 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.137 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.556 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -140.44 165.6 27.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.648 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.1 ttp -130.45 137.25 49.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.633 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.5 tp -99.11 127.69 45.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.486 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.598 HD21 ' NZ ' ' A' ' 27' ' ' LYS . 16.7 t-20 -117.4 125.91 51.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.205 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.431 HG22 ' H ' ' A' ' 24' ' ' LEU . 2.9 mt -103.24 108.37 58.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.445 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -75.41 -40.1 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.435 2.09 . . . . 0.0 112.392 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.612 ' C ' HD22 ' A' ' 24' ' ' LEU . 6.0 tptp -60.64 -42.99 98.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.803 ' N ' HD22 ' A' ' 24' ' ' LEU . 2.7 mm? -99.13 3.4 46.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.562 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.86 51.3 16.19 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.474 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -132.1 173.13 11.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.989 0.424 . . . . 0.0 110.974 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.598 ' NZ ' HD21 ' A' ' 20' ' ' ASN . 2.7 mtpp -143.67 152.3 41.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.203 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -146.63 130.49 17.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.939 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.446 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 13.3 m -83.01 112.77 20.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 30' ' ' ILE . 1.5 mp -83.14 124.75 39.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.446 ' CE1' ' O ' ' A' ' 29' ' ' SER . 83.9 m-85 -110.1 140.6 44.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.858 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 37.3 t-105 -60.69 118.35 6.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.963 0.411 . . . . 0.0 110.693 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.644 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 92.85 158.56 34.41 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.51 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.887 179.713 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.62 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.579 ' SD ' HG23 ' A' ' 60' ' ' THR . 3.3 tpp -90.52 132.89 35.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.53 121.58 18.09 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.383 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.644 HG23 ' HA2' ' A' ' 33' ' ' GLY . 17.2 t -91.95 127.69 44.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.665 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.698 ' N ' ' OG1' ' A' ' 51' ' ' THR . 7.2 t -164.13 165.18 22.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.495 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -64.07 -34.26 77.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.675 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.718 HG21 ' O ' ' A' ' 109' ' ' ILE . 2.8 m -89.58 -12.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.957 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.698 ' OG1' ' N ' ' A' ' 48' ' ' SER . 24.9 p -84.95 144.2 28.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.019 0.438 . . . . 0.0 110.866 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.489 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.7 OUTLIER -134.92 174.55 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.934 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.94 159.87 27.97 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.801 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.647 ' HG3' HD23 ' A' ' 84' ' ' LEU . 72.4 Cg_endo -81.5 66.2 8.62 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.606 2.204 . . . . 0.0 112.522 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.1 p -112.89 -6.32 13.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.541 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.0 92.68 0.09 OUTLIER Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.545 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.5 85.01 0.04 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.499 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -156.87 155.06 26.05 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.489 ' N ' ' OG1' ' A' ' 52' ' ' THR . 19.9 t-160 -80.08 104.65 10.79 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.579 HG23 ' SD ' ' A' ' 45' ' ' MET . 26.0 m -101.08 122.45 43.6 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.888 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.572 ' C ' HD22 ' A' ' 62' ' ' LEU . 54.9 t -111.91 124.81 68.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.157 0.503 . . . . 0.0 110.423 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.599 ' O ' HG23 ' A' ' 120' ' ' THR . 2.6 mm? -113.01 139.5 48.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.382 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.0 m -140.87 153.61 45.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.072 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.802 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.725 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.758 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -72.93 -39.52 66.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.999 0.428 . . . . 0.0 110.446 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.454 ' H ' HD12 ' A' ' 76' ' ' LEU . 0.2 OUTLIER -109.12 103.65 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.137 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.492 ' O ' HG21 ' A' ' 95' ' ' ILE . 4.6 ptpt -179.07 150.44 0.46 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -78.93 -13.37 59.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.523 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -86.87 -13.7 44.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.117 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 81' ' ' THR . 2.5 t0 -75.25 153.61 37.92 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.704 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.638 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -137.98 143.3 40.6 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.5 mt -118.3 129.89 55.71 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.927 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 2.8 t -115.46 121.6 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.547 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.647 HD23 ' HG3' ' A' ' 54' ' ' PRO . 10.2 mp -101.06 133.2 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.224 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HG2' HG23 ' A' ' 90' ' ' THR . 85.1 mt-10 -107.98 120.7 43.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.209 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.556 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.5 t80 -147.23 137.3 23.19 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.083 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 50.59 42.03 26.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 0.0 111.043 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.6 m120 63.41 26.78 15.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.295 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 40.4 mttm -116.26 170.84 8.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.973 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.427 HG23 ' HG2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -139.25 111.84 7.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.684 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.9 m-85 -96.27 136.92 36.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.203 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -104.86 113.12 26.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.802 0.334 . . . . 0.0 111.452 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 85.1 m-85 -110.2 151.68 27.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.554 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -128.04 140.2 52.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.408 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.492 HG21 ' O ' ' A' ' 77' ' ' LYS . 2.4 mm -68.99 118.49 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.033 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -94.44 -59.23 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -144.84 140.05 28.13 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.27 0.557 . . . . 0.0 110.59 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 mp -119.67 127.93 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.78 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.487 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 23.1 p90 -144.06 -175.78 4.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.569 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.514 HG13 ' CD1' ' A' ' 135' ' ' TYR . 4.2 mp -126.32 132.45 70.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.471 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.502 HG22 HD11 ' A' ' 136' ' ' ILE . 2.3 t -134.51 165.3 25.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 110.73 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -73.95 149.42 41.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.331 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.1 -10.91 3.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.648 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -108.28 24.6 12.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.131 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.512 ' OD2' HG23 ' A' ' 108' ' ' VAL . 20.4 t0 -90.18 102.01 14.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.944 0.402 . . . . 0.0 110.585 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.811 ' O ' HG23 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -70.91 -35.91 72.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.606 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.539 ' O ' HD12 ' A' ' 110' ' ' ILE . 2.2 p -42.06 -18.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.586 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.783 ' CG1' HG21 ' A' ' 118' ' ' THR . 4.0 t -104.68 -15.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.012 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.759 ' O ' HG22 ' A' ' 109' ' ' ILE . 52.1 mm -114.44 20.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.187 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.811 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -82.68 -173.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -92.53 146.1 23.94 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.846 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.469 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.6 mttt -133.46 177.21 7.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.294 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -129.86 17.05 5.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.913 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -135.43 158.76 73.78 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.499 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 37.2 Cg_endo -74.59 86.65 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 123.186 2.59 . . . . 0.0 110.693 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.8 mm -121.78 133.4 68.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.1 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.794 HD23 ' C ' ' A' ' 117' ' ' LEU . 6.2 tt -108.1 119.78 40.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.216 0.531 . . . . 0.0 110.335 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.783 HG21 ' CG1' ' A' ' 108' ' ' VAL . 88.2 m -114.89 117.88 31.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.394 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 120' ' ' THR . 5.6 tp -105.98 128.38 53.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.28 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.64 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -113.89 114.16 25.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.284 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.462 ' OG1' ' HB3' ' A' ' 135' ' ' TYR . 1.2 p . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.985 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 . . . . . 0 C--O 1.232 0.148 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.41 ' NE ' ' HB ' ' A' ' 120' ' ' THR . 35.5 ttp180 -123.52 119.42 29.9 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.135 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.514 ' CD1' HG13 ' A' ' 100' ' ' ILE . 4.6 t80 -69.18 137.94 53.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.961 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 101' ' ' THR . 6.8 mm -122.63 122.13 65.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 137' ' ' ILE . 1.2 mp -107.17 112.03 38.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.487 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 38.4 tt0 -95.59 134.06 38.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.942 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.74 145.23 34.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.18 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -117.37 145.83 43.8 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.215 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 16.9 tp -69.8 123.26 20.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.491 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.2 p -99.33 -43.66 6.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.224 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.582 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -145.89 165.9 28.0 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 35.4 p -139.55 142.28 37.19 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.708 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -124.53 143.57 50.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.3 p -133.51 127.31 32.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.442 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.4 tttp . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.724 179.779 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.79 0.328 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.9 mp0 -68.96 137.45 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.279 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 94.84 12.98 54.85 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -120.35 134.92 55.18 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.801 0.334 . . . . 0.0 110.498 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' NZ ' ' SD ' ' A' ' 18' ' ' MET . 88.3 tttt -57.99 120.06 7.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.349 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.14 -31.95 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.78 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.45 161.94 36.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.673 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.502 ' SD ' ' OG ' ' A' ' 29' ' ' SER . 1.0 OUTLIER -123.45 133.88 54.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.432 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.852 ' HB2' HD11 ' A' ' 30' ' ' ILE . 2.0 tt -104.1 122.56 45.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.622 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.427 HD22 ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -115.29 126.12 54.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.85 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.427 ' N ' HD22 ' A' ' 20' ' ' ASN . 7.9 mt -102.86 114.82 65.02 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.322 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 81' ' ' THR . 60.8 Cg_endo -77.68 -43.9 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.812 2.341 . . . . 0.0 112.527 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.6 ' C ' HD22 ' A' ' 24' ' ' LEU . 24.2 tptp -60.37 -41.72 94.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.569 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.822 ' N ' HD22 ' A' ' 24' ' ' LEU . 2.8 mm? -98.31 0.24 45.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.812 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 49.79 42.07 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.68 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -119.96 162.65 18.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.9 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -135.38 145.06 46.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.765 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 19' ' ' LEU . 61.8 m-85 -141.0 150.45 43.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.584 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.502 ' OG ' ' SD ' ' A' ' 18' ' ' MET . 9.9 m -103.27 119.65 39.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.801 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.852 HD11 ' HB2' ' A' ' 19' ' ' LEU . 4.6 mp -83.8 124.18 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.259 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 42.1 m-85 -107.17 135.04 49.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.989 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.518 ' O ' ' N ' ' A' ' 13' ' ' GLY . 26.2 t-105 -60.42 127.75 33.27 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.6 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.468 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 75.05 144.67 1.09 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.243 0 CA-C-O 120.758 0.313 . . . . 0.0 110.685 179.881 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.637 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -96.21 127.92 42.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.747 0.308 . . . . 0.0 110.655 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.507 ' O ' ' SD ' ' A' ' 45' ' ' MET . 9.5 t80 -69.1 131.8 45.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.527 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.6 t -111.26 128.87 67.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.567 ' N ' ' OG1' ' A' ' 51' ' ' THR . 33.0 p -161.99 171.8 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.584 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 39.4 t0 -74.98 10.1 1.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.464 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.782 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.7 m -132.27 -15.58 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.665 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 48' ' ' SER . 2.6 p -87.8 139.7 30.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.611 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.65 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -131.04 169.52 15.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.633 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.64 154.71 38.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.466 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.725 ' HG3' HD13 ' A' ' 84' ' ' LEU . 59.3 Cg_endo -78.97 61.08 8.03 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.835 2.357 . . . . 0.0 112.214 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.33 -5.36 17.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.64 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.99 91.94 0.09 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.92 92.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.428 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.27 155.18 26.02 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.65 ' N ' ' OG1' ' A' ' 52' ' ' THR . 21.7 t-160 -79.59 112.59 17.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.932 0.396 . . . . 0.0 110.1 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.3 m -105.48 123.39 47.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.348 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.585 ' C ' HD22 ' A' ' 62' ' ' LEU . 63.5 t -116.7 127.42 74.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.476 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.585 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.2 mm? -109.76 145.51 36.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.616 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 120' ' ' THR . 44.1 t -130.3 144.13 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.591 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.592 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.528 0.883 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.586 ' O ' ' CG ' ' A' ' 77' ' ' LYS . . . . . . . . 0 CA--C 1.526 0.722 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -71.24 -36.36 71.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.757 0.313 . . . . 0.0 110.817 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -88.85 73.69 8.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.642 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.586 ' CG ' ' O ' ' A' ' 74' ' ' GLY . 10.5 ptpt -169.38 129.86 1.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.436 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -74.75 -10.46 59.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.582 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -79.95 -16.36 55.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.361 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.686 ' OD1' ' N ' ' A' ' 81' ' ' THR . 34.5 t0 -71.38 154.38 41.61 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.586 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.686 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.6 OUTLIER -141.3 117.7 10.81 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.916 0.389 . . . . 0.0 110.803 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 51.8 mt -90.7 128.96 36.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.642 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.634 HG12 HG22 ' A' ' 90' ' ' THR . 2.3 t -105.23 127.08 60.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.383 . . . . 0.0 110.239 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.829 HD11 HD12 ' A' ' 117' ' ' LEU . 33.4 mt -111.07 122.89 49.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.96 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.41 ' HG2' HG23 ' A' ' 90' ' ' THR . 84.2 mt-10 -99.59 119.35 37.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.69 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -150.06 129.39 12.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.995 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 56.46 43.98 25.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.996 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . 0.509 ' OD1' ' C ' ' A' ' 147' ' ' LYS . 6.3 t-20 61.82 15.4 7.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.645 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -114.99 137.13 52.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.202 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.634 HG22 HG12 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -107.67 124.04 49.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.755 -178.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -108.89 125.56 52.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.096 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.428 ' OG1' ' C ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -94.95 107.09 19.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.143 -179.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.576 ' CE1' HD12 ' A' ' 84' ' ' LEU . 40.2 m-85 -95.09 156.92 16.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.577 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.5 134.1 45.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.55 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.695 HG23 HD11 ' A' ' 98' ' ' ILE . 1.1 mm -65.7 114.59 3.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.246 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -83.57 -66.18 0.92 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.842 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.552 ' C ' HD13 ' A' ' 98' ' ' ILE . 29.1 tptp -150.36 146.91 27.01 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.506 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.695 HD11 HG23 ' A' ' 95' ' ' ILE . 5.2 mm -114.16 135.36 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.51 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 14.3 p90 -155.43 178.68 9.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.683 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.427 HG22 ' HB3' ' A' ' 133' ' ' ASP . 2.3 mt -127.47 128.83 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.151 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 102' ' ' HIS . 3.0 t -131.05 172.87 11.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.497 ' O ' HG23 ' A' ' 101' ' ' THR . 25.1 t60 -62.92 171.95 1.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.551 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.36 -20.47 28.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.555 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.55 19.32 17.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.449 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.524 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 28.9 t0 -83.17 92.4 7.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.71 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.966 ' O ' HG23 ' A' ' 110' ' ' ILE . 36.6 ptt180 -63.52 -37.84 88.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.234 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.524 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 9.4 p -37.0 -18.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.258 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.858 ' CG1' HG21 ' A' ' 118' ' ' THR . 10.9 t -108.86 -21.3 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.711 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.782 ' O ' HG21 ' A' ' 50' ' ' VAL . 33.5 mm -109.71 28.13 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.966 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -93.07 -165.71 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.329 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -99.57 141.5 32.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.647 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.474 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.1 mttt -128.21 135.46 49.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.206 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -81.63 7.98 10.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.499 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.52 160.18 69.34 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.431 ' O ' HD13 ' A' ' 116' ' ' ILE . 41.1 Cg_endo -74.69 101.23 1.42 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.936 2.424 . . . . 0.0 111.972 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 115' ' ' PRO . 49.2 mm -131.33 135.11 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.788 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.829 HD12 HD11 ' A' ' 84' ' ' LEU . 9.4 tt -106.32 118.58 37.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.794 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.858 HG21 ' CG1' ' A' ' 108' ' ' VAL . 53.6 m -122.75 121.35 36.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.364 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.861 ' C ' HD23 ' A' ' 119' ' ' LEU . 5.8 tt -109.26 124.71 51.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.015 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.743 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -116.51 124.54 50.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.376 178.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.592 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.7 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.848 -179.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.427 ' HB3' HG22 ' A' ' 100' ' ' ILE . 96.0 m-20 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.798 0.332 . . . . 0.0 110.394 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -115.72 138.25 51.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.659 -179.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.751 ' CE2' HD11 ' A' ' 137' ' ' ILE . 4.5 t80 -73.23 123.94 24.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.024 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 2.4 mm -115.8 118.67 59.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.883 -178.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.751 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp -105.24 107.22 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 46.3 tt0 -88.3 134.95 33.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.308 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.84 138.96 21.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.482 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.534 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 31.6 ttpt -109.27 161.28 15.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.807 ' C ' HD13 ' A' ' 141' ' ' LEU . 2.6 tm? -91.77 115.89 28.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.241 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.564 ' N ' HD22 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -110.94 -66.01 1.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.898 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.553 ' O ' HD21 ' A' ' 141' ' ' LEU . . . -83.32 165.53 43.04 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . 0.415 ' O ' ' CG ' ' A' ' 145' ' ' TYR . 12.4 p -158.15 158.08 33.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.799 0.333 . . . . 0.0 110.582 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 90' ' ' THR . 79.4 m-85 -153.99 104.8 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.523 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.5 p -98.99 122.28 42.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.637 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.509 ' C ' ' OD1' ' A' ' 88' ' ' ASN . 68.6 mttm . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.429 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 tttt . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.666 ' OE2' HG11 ' A' ' 47' ' ' VAL . 91.0 mt-10 -80.79 151.02 28.98 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 83.59 15.25 71.42 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -118.07 132.1 56.39 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.044 0.45 . . . . 0.0 110.456 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 61.9 tttm -58.24 106.09 0.34 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.601 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.435 HG11 ' HB2' ' A' ' 32' ' ' TRP . 14.5 m -110.55 -38.81 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.38 155.64 46.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.607 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.7 ttp -121.29 131.54 54.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.84 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.8 tp -93.95 123.67 37.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.425 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -119.5 124.3 46.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.0 mt -106.64 111.61 63.89 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.242 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.618 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.9 Cg_endo -78.9 -42.78 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 123.057 2.505 . . . . 0.0 112.615 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.578 ' C ' HD22 ' A' ' 24' ' ' LEU . 6.0 tptm -63.01 -39.05 93.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.777 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.0 mm? -99.54 5.81 45.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.907 0.384 . . . . 0.0 110.522 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 44.71 56.91 4.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.42 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -141.37 158.71 43.51 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.667 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -141.26 140.46 33.9 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.612 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -133.81 155.41 49.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.5 m -95.92 118.37 32.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.442 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -95.31 123.84 47.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.243 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 52.4 m-85 -103.76 142.92 33.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.551 ' HZ2' HG23 ' A' ' 47' ' ' VAL . 40.9 t-105 -61.54 130.92 48.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.952 0.406 . . . . 0.0 110.659 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 84.51 171.39 48.01 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.521 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.906 179.697 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.416 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.477 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 2.8 tpp -103.14 142.88 33.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -75.97 140.27 41.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.402 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.666 HG11 ' OE2' ' A' ' 12' ' ' GLU . 2.1 p -123.37 124.3 69.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.465 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 51' ' ' THR . 21.1 t -168.76 169.67 9.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.531 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -62.99 -37.39 86.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.29 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.649 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.0 m -83.98 -26.6 7.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.843 0.354 . . . . 0.0 110.552 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 48' ' ' SER . 64.8 p -99.05 142.58 30.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.823 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -143.83 175.45 9.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.654 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.497 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -91.36 155.07 44.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.731 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.59 84.29 2.0 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.746 2.298 . . . . 0.0 112.431 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.3 p -115.22 -7.64 12.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.727 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.08 89.29 0.07 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.68 84.65 0.07 OUTLIER Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.474 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -166.4 158.87 32.0 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.651 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 19.1 t-160 -78.71 121.9 25.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 88.9 m -119.2 128.39 54.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.564 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.584 ' C ' HD22 ' A' ' 62' ' ' LEU . 55.0 t -119.5 132.84 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.099 0.476 . . . . 0.0 110.238 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.584 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.8 mm? -113.18 140.56 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.625 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 37.9 t -118.84 136.69 53.88 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.427 -179.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.163 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.929 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.575 ' HA3' HD11 ' A' ' 24' ' ' LEU . . . . . . . . 0 CA--C 1.523 0.573 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.63 -39.9 84.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 110.391 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.565 HD23 ' N ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -95.54 101.72 13.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.98 -179.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.477 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 11.2 ptpt 175.84 145.95 0.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.567 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.68 -14.61 60.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.128 0.489 . . . . 0.0 110.698 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -79.67 -15.25 57.93 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.725 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.12 154.3 29.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.762 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.618 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -141.37 115.26 9.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.418 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.2 mt -89.19 131.43 35.32 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.236 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.588 ' C ' HD22 ' A' ' 84' ' ' LEU . 48.8 t -111.53 122.42 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.054 0.454 . . . . 0.0 109.852 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.588 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.4 mm? -112.67 132.47 55.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.696 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.456 ' HG2' HG23 ' A' ' 90' ' ' THR . 90.2 mt-10 -104.7 119.54 39.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.42 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.497 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 9.1 t80 -140.49 137.3 33.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.022 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.433 ' O ' ' CG ' ' A' ' 87' ' ' ASP . 50.1 t0 50.98 41.12 26.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.158 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 65.86 16.77 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.264 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -117.82 149.77 40.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.4 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -110.96 125.85 54.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.532 -179.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -110.15 125.76 53.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.455 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 143' ' ' GLY . 0.3 OUTLIER -97.81 108.18 20.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.697 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 62.9 m-85 -98.98 151.91 20.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.704 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -124.41 132.69 53.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.759 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.641 HD12 HD11 ' A' ' 98' ' ' ILE . 1.2 mm -65.86 119.62 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.059 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -89.84 -57.79 2.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.951 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -153.35 151.48 30.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.295 0.569 . . . . 0.0 109.934 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.641 HD11 HD12 ' A' ' 95' ' ' ILE . 16.0 mm -122.41 132.15 71.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.25 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.499 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 11.2 p90 -150.21 178.87 8.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.192 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.508 HG22 ' HB3' ' A' ' 133' ' ' ASP . 7.9 mt -125.87 138.65 53.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.664 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 102' ' ' HIS . 3.4 t -138.68 169.14 18.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.268 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.478 ' ND1' ' OD1' ' A' ' 133' ' ' ASP . 68.5 m-70 -68.86 168.23 13.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.672 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HA ' ' HE ' ' A' ' 134' ' ' ARG . . . -76.08 -9.51 58.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -105.35 20.06 19.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.062 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.606 ' O ' HG22 ' A' ' 108' ' ' VAL . 24.4 t70 -87.28 95.01 9.83 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.705 0.288 . . . . 0.0 110.761 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.958 ' O ' HG23 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -73.33 -20.21 60.84 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.122 0.487 . . . . 0.0 110.615 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.561 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 20.9 p -44.87 -14.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.445 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.666 ' HB ' HG21 ' A' ' 118' ' ' THR . 11.0 m -112.37 -12.16 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.406 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.759 ' O ' HG22 ' A' ' 109' ' ' ILE . 49.0 mm -109.48 13.49 8.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.958 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -92.61 -170.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.83 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -95.12 155.22 16.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.699 ' HZ3' HG21 ' A' ' 116' ' ' ILE . 97.0 mttt -131.73 -174.47 3.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.871 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -125.48 10.14 7.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.132 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.75 168.13 11.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.971 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.474 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 38.1 Cg_endo -75.76 97.55 1.11 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.084 2.522 . . . . 0.0 111.929 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.699 HG21 ' HZ3' ' A' ' 112' ' ' LYS . 51.2 mm -127.6 132.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.709 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 tt -106.14 123.85 48.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.245 0.545 . . . . 0.0 109.827 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.666 HG21 ' HB ' ' A' ' 108' ' ' VAL . 96.7 m -115.69 126.67 54.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.458 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.806 HD22 HG23 ' A' ' 121' ' ' THR . 0.6 OUTLIER -112.35 126.35 55.18 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.198 -179.398 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.765 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -122.89 117.45 25.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.078 179.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.806 HG23 HD22 ' A' ' 119' ' ' LEU . 42.9 p . . . . . 0 CA--C 1.51 -0.573 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.528 -179.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.508 ' HB3' HG22 ' A' ' 100' ' ' ILE . 95.1 m-20 . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 120.758 0.313 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.519 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 85.7 mtm180 -98.27 142.24 30.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.29 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.55 ' CD2' HD11 ' A' ' 137' ' ' ILE . 3.9 t80 -72.92 132.49 43.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.34 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.499 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 3.7 mm -118.05 120.12 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.55 HD11 ' CD2' ' A' ' 135' ' ' TYR . 16.5 mm -105.68 111.53 35.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.747 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 39.4 tt0 -99.03 129.18 45.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.083 0.468 . . . . 0.0 110.946 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -135.46 150.63 49.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.412 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.447 ' NZ ' ' HD2' ' A' ' 115' ' ' PRO . 53.4 tptt -115.75 140.99 48.68 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.682 ' C ' HD13 ' A' ' 141' ' ' LEU . 2.6 tm? -80.22 117.2 20.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.494 ' N ' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -108.34 -61.23 1.62 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.68 -179.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -104.72 151.99 17.38 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.7 m -150.43 148.94 29.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.952 0.406 . . . . 0.0 110.222 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' THR . 81.8 m-85 -132.2 156.92 45.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.404 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.9 p -137.09 125.13 22.86 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.315 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.449 ' O ' ' CD ' ' A' ' 147' ' ' LYS . 5.9 tmtt? . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.576 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.5 tptt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.917 0.389 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.446 ' HG3' ' CD1' ' A' ' 32' ' ' TRP . 56.4 mp0 -65.5 145.76 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.941 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.17 10.76 68.23 Favored Glycine 0 CA--C 1.517 0.214 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -119.47 136.15 54.44 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.079 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.91 117.9 5.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.829 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 32' ' ' TRP . 16.0 m -117.35 -43.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -129.19 161.48 30.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.951 0.405 . . . . 0.0 110.723 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.4 ttt -125.89 131.09 52.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.431 HD13 HD21 ' A' ' 84' ' ' LEU . 51.0 tp -95.76 123.55 39.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.51 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -120.24 128.17 53.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.146 0.498 . . . . 0.0 110.687 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mt -106.77 115.65 60.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.294 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 81' ' ' THR . 57.6 Cg_endo -77.88 -49.97 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.077 2.518 . . . . 0.0 112.526 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.477 ' HG2' ' HZ1' ' A' ' 77' ' ' LYS . 1.9 tptt -63.16 -37.06 85.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.074 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.67 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.7 mm? -96.77 5.81 49.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.977 0.418 . . . . 0.0 110.377 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 24' ' ' LEU . 12.9 mttt 40.21 53.96 2.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.463 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -136.73 159.47 41.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.068 179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.423 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 2.2 mtmt -137.78 154.49 49.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.944 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.423 ' CG ' ' O ' ' A' ' 27' ' ' LYS . 76.8 m-85 -154.23 150.61 28.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.949 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 45.0 m -99.87 119.33 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.541 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 30' ' ' ILE . 1.7 mp -93.07 122.16 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.611 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -97.89 141.14 31.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.748 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.537 ' CZ3' HG22 ' A' ' 53' ' ' THR . 48.2 t-105 -60.51 130.3 45.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.778 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.408 ' HA2' HG12 ' A' ' 47' ' ' VAL . . . 93.85 156.54 32.53 Favored Glycine 0 C--N 1.33 0.22 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.598 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.609 179.392 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.562 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.551 ' SD ' HD21 ' A' ' 62' ' ' LEU . 2.6 tpp -96.38 127.88 42.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -64.27 142.34 58.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.606 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.462 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.0 p -124.26 125.87 71.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.743 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.642 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.2 OUTLIER -161.8 169.86 20.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.238 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -61.35 -38.97 88.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.183 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.767 HG21 ' O ' ' A' ' 109' ' ' ILE . 11.9 m -85.17 -31.79 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 48' ' ' SER . 67.3 p -82.61 155.35 24.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.633 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.19 170.85 21.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.375 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.537 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -87.77 152.93 52.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.641 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.17 83.03 1.91 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.712 2.275 . . . . 0.0 112.463 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 p -117.88 -1.45 11.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.35 89.49 0.08 OUTLIER Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.02 90.2 0.02 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.501 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -165.84 163.33 36.65 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.61 ' CE1' HD12 ' A' ' 110' ' ' ILE . 17.2 t-160 -87.33 106.27 17.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.9 m -101.01 124.15 46.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.354 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.57 ' O ' HD22 ' A' ' 62' ' ' LEU . 54.3 t -117.87 129.98 73.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.5 . . . . 0.0 110.081 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.57 HD22 ' O ' ' A' ' 61' ' ' VAL . 2.2 mm? -115.18 146.46 41.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.877 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 p -138.25 150.76 47.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.81 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.879 179.632 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.651 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -67.05 -40.33 87.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.204 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 76' ' ' LEU . 5.9 mt -90.4 86.33 6.43 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.906 0.384 . . . . 0.0 111.186 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.477 ' HZ1' ' HG2' ' A' ' 23' ' ' LYS . 56.7 pttt -178.84 155.58 0.79 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.932 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.13 -11.75 59.72 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.206 0.527 . . . . 0.0 110.731 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -79.86 -15.48 57.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.821 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.19 157.57 29.31 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.821 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.531 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -144.22 118.3 9.46 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.128 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 93' ' ' TYR . 35.4 mt -96.03 134.96 38.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.697 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.678 ' C ' HD22 ' A' ' 84' ' ' LEU . 2.1 t -118.31 126.22 74.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.437 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.678 HD22 ' C ' ' A' ' 83' ' ' VAL . 4.0 mm? -112.75 134.6 54.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.537 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.834 ' HG3' HG23 ' A' ' 90' ' ' THR . 0.1 OUTLIER -106.94 125.1 50.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.013 179.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.514 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -148.27 133.18 18.08 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.312 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 51.94 51.96 15.42 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.965 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 55.69 27.08 10.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.105 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.455 ' HG2' ' CB ' ' A' ' 146' ' ' SER . 39.0 mtpt -129.92 140.83 50.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.042 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.834 HG23 ' HG3' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -110.06 125.46 52.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.9 0.381 . . . . 0.0 110.379 -179.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.402 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 17.0 m-85 -104.32 135.26 46.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.164 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.593 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -102.88 113.81 27.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.087 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 82' ' ' LEU . 82.8 m-85 -111.81 147.16 36.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.681 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.589 ' HB3' HG21 ' A' ' 142' ' ' THR . 15.0 pt-20 -127.92 145.06 51.08 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.389 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.928 HG23 HD11 ' A' ' 98' ' ' ILE . 10.0 mm -67.04 120.39 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.318 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.547 HE21 ' HG3' ' A' ' 94' ' ' GLU . 96.3 mm-40 -94.49 -61.15 1.56 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.614 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.546 ' C ' HD13 ' A' ' 98' ' ' ILE . 61.6 tttp -148.74 140.99 24.06 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.32 0.581 . . . . 0.0 110.595 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.928 HD11 HG23 ' A' ' 95' ' ' ILE . 6.6 mm -117.33 136.75 53.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.026 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.459 ' C ' ' CD1' ' A' ' 99' ' ' TRP . 12.4 p90 -154.59 178.98 9.48 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.379 -0.529 . . . . 0.0 111.395 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.759 ' N ' HD12 ' A' ' 100' ' ' ILE . 1.2 mp -128.46 133.52 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.674 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.3 t -145.11 160.33 41.58 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.633 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -61.62 150.85 35.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.366 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.54 ' HB2' HH11 ' A' ' 134' ' ' ARG . . . -62.79 -4.97 2.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.669 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.548 ' C ' ' OD1' ' A' ' 104' ' ' ASP . 2.1 p30 -99.56 13.52 33.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.849 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.593 ' OD2' ' OG1' ' A' ' 107' ' ' THR . 17.7 t0 -82.71 96.72 8.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.393 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 110' ' ' ILE . 8.7 ptm180 -66.49 -18.4 65.34 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.589 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.593 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 15.5 p -58.56 -16.56 16.19 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.719 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.896 HG13 HG21 ' A' ' 118' ' ' THR . 18.6 t -100.46 -14.44 7.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.399 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.767 ' O ' HG21 ' A' ' 50' ' ' VAL . 48.4 mm -117.02 23.51 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.956 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.61 HD12 ' CE1' ' A' ' 59' ' ' HIS . 0.7 OUTLIER -83.61 -162.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.877 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -106.28 134.51 49.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.358 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.561 ' H ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -115.5 126.61 54.5 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.754 -0.378 . . . . 0.0 109.982 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 113' ' ' GLU . 56.2 mp0 -77.72 15.17 0.88 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.105 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.408 ' H ' ' C ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -147.36 171.1 6.73 Favored Pre-proline 0 C--N 1.332 -0.163 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.954 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.501 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 56.7 Cg_endo -80.24 90.37 1.25 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.326 2.684 . . . . 0.0 111.949 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.22 133.54 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.725 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.845 HD23 ' C ' ' A' ' 117' ' ' LEU . 5.4 tt -106.88 124.02 49.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.492 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.896 HG21 HG13 ' A' ' 108' ' ' VAL . 31.8 m -119.32 126.99 52.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.362 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.806 HD23 ' N ' ' A' ' 120' ' ' THR . 5.5 tt -120.11 125.42 48.21 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.315 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.806 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -109.66 126.6 53.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 0.0 110.319 179.065 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.402 ' OG1' ' HB3' ' A' ' 135' ' ' TYR . 1.2 p . . . . . 0 C--O 1.237 0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.519 -178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.524 ' N ' ' OD1' ' A' ' 133' ' ' ASP . 10.1 p-10 . . . . . 0 N--CA 1.455 -0.207 0 CA-C-O 120.824 0.345 . . . . 0.0 110.099 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.54 HH11 ' HB2' ' A' ' 103' ' ' ALA . 42.3 mtt85 -103.44 140.59 37.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.069 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.529 ' CD1' HG13 ' A' ' 100' ' ' ILE . 8.1 t80 -84.71 128.87 34.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.556 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.42 HD13 HG21 ' A' ' 108' ' ' VAL . 1.3 mt -123.05 128.07 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.658 HG23 ' CD1' ' A' ' 95' ' ' ILE . 1.5 mp -106.39 114.85 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.578 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 6.0 tt0 -94.43 138.0 32.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.761 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -148.57 148.03 29.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -116.1 160.43 20.35 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.866 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -77.31 123.12 26.05 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.824 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.589 HG21 ' HB3' ' A' ' 94' ' ' GLU . 3.0 p -98.78 -40.15 8.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.355 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.593 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -145.36 162.99 28.21 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.5 p -139.39 142.87 37.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.874 0.369 . . . . 0.0 110.433 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -129.73 141.22 50.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.37 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.455 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 23.2 t -137.23 141.97 42.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.184 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.0 tptp . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.465 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.822 0.344 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.678 ' OE2' HG11 ' A' ' 47' ' ' VAL . 89.9 mt-10 -68.99 151.4 46.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.179 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.35 11.25 80.84 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.402 ' O ' HG13 ' A' ' 16' ' ' VAL . 75.2 mm-40 -118.16 135.01 54.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.4 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -59.01 118.2 5.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.217 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.494 HG11 ' HB2' ' A' ' 32' ' ' TRP . 17.1 m -117.48 -34.99 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.118 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.2 163.25 32.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.763 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.617 ' SD ' ' O ' ' A' ' 28' ' ' PHE . 7.6 tpp -121.94 142.56 50.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.527 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.419 HD13 HD21 ' A' ' 84' ' ' LEU . 27.6 tp -106.14 123.29 47.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.242 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -120.36 128.24 53.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.162 0.506 . . . . 0.0 111.003 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.48 HG22 ' H ' ' A' ' 24' ' ' LEU . 3.3 mt -105.88 116.76 59.21 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.213 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.615 ' CD ' ' O ' ' A' ' 81' ' ' THR . 59.3 Cg_endo -76.92 -50.09 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.79 2.327 . . . . 0.0 112.903 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.604 ' C ' HD22 ' A' ' 24' ' ' LEU . 10.1 tptp -60.43 -38.85 85.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.772 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.0 mm? -100.44 3.99 43.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.875 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.7 mptt 43.22 39.31 1.94 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.622 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.43 ' CB ' HD12 ' A' ' 21' ' ' ILE . 6.8 mmmt -115.53 150.62 36.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.434 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -131.93 147.88 52.49 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.849 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.617 ' O ' ' SD ' ' A' ' 18' ' ' MET . 85.3 m-85 -141.83 162.47 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.691 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.468 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 8.7 p -103.54 122.27 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.929 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mm -95.37 124.51 47.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.286 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -108.11 142.51 38.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.505 ' CZ2' ' HB ' ' A' ' 47' ' ' VAL . 51.3 t-105 -65.29 132.82 50.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.849 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.549 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 76.35 159.01 8.67 Favored Glycine 0 N--CA 1.46 0.293 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.408 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.414 179.614 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.571 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.549 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 1.2 ttp -91.4 138.04 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.504 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.681 ' CD1' HG21 ' A' ' 51' ' ' THR . 3.0 t80 -76.26 143.12 41.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.954 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.678 HG11 ' OE2' ' A' ' 12' ' ' GLU . 2.0 p -130.83 120.33 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.483 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.7 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.6 OUTLIER -170.9 174.98 4.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.577 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -62.92 -38.88 92.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.513 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.703 HG21 ' O ' ' A' ' 109' ' ' ILE . 2.0 m -85.12 -23.45 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.78 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.7 ' OG1' ' N ' ' A' ' 48' ' ' SER . 71.1 p -93.67 144.35 25.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.471 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 1.7 p -138.38 172.41 12.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.929 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.45 149.16 36.43 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.491 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.18 83.02 1.5 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.757 2.305 . . . . 0.0 112.647 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -127.46 -1.76 6.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.585 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.74 63.3 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.76 104.32 0.47 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.547 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -178.89 155.12 15.41 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.572 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 22.2 t-160 -78.65 103.24 8.46 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.5 m -99.11 114.97 27.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.434 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.464 ' O ' HD23 ' A' ' 62' ' ' LEU . 48.1 t -111.26 128.36 67.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.84 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 61' ' ' VAL . 25.7 mt -118.1 154.51 31.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.997 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 120' ' ' THR . 13.7 t -137.52 148.81 46.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.365 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.589 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.529 0.918 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.442 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.565 ' HA3' HD11 ' A' ' 24' ' ' LEU . . . . . . . . 0 CA--C 1.527 0.788 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -71.93 -40.74 68.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.791 0.329 . . . . 0.0 110.797 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.588 HD22 ' OH ' ' A' ' 135' ' ' TYR . 16.5 mt -89.83 91.49 8.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.455 ' HG3' ' H ' ' A' ' 80' ' ' ASP . 11.1 ptmt -179.21 135.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.386 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -71.68 -12.18 61.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.618 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -81.28 -15.9 54.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.104 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.55 ' C ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -67.55 153.36 43.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.487 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.615 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -141.36 116.5 9.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.062 0.458 . . . . 0.0 110.279 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.7 mt -93.28 129.47 39.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.777 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.633 ' C ' HD22 ' A' ' 84' ' ' LEU . 2.5 t -111.22 122.71 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.011 0.434 . . . . 0.0 110.361 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.633 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.3 mm? -109.69 136.67 48.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.43 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -102.29 123.91 46.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.179 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 89' ' ' LYS . 7.0 t80 -145.03 143.15 30.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.618 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.49 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 65.3 t0 36.85 53.05 1.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.871 0.367 . . . . 0.0 111.406 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 56.4 25.77 9.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.335 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 86' ' ' TYR . 30.8 mtpt -125.11 145.42 49.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.491 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -108.21 124.17 49.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.48 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 12.4 m-85 -105.04 131.83 52.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.097 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.591 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -101.68 113.79 27.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.463 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 83.2 m-85 -110.03 152.29 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.624 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -126.32 137.77 53.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.489 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mm -67.38 119.01 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.582 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -88.27 -64.87 1.08 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.826 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -147.26 143.24 27.97 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.055 0.455 . . . . 0.0 110.349 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.784 HG23 HD13 ' A' ' 137' ' ' ILE . 1.7 mp -118.46 131.52 70.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.403 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 29.1 p90 -154.17 -174.55 5.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.5 mt -132.05 132.24 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.193 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.0 t -131.92 174.49 10.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -75.74 153.06 37.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -62.84 -25.54 68.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.608 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -85.87 10.2 14.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.556 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -82.09 90.6 6.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.396 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.847 ' O ' HG23 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -68.8 -21.62 64.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.29 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.543 ' C ' HD12 ' A' ' 110' ' ' ILE . 21.5 p -48.51 -11.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.384 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.912 HG13 HG21 ' A' ' 118' ' ' THR . 45.7 t -111.54 -11.03 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.035 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.703 ' O ' HG21 ' A' ' 50' ' ' VAL . 50.1 mm -111.9 10.14 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.015 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.847 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -80.78 -165.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.722 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -97.13 158.94 15.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.052 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HG3' ' CD2' ' A' ' 59' ' ' HIS . 66.9 mmtt -126.37 -168.02 1.8 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.263 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.442 ' C ' ' CG ' ' A' ' 114' ' ' GLU . 4.9 mm-40 -138.34 16.5 2.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.425 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.459 ' CB ' ' HD2' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -162.23 169.62 9.05 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.523 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.547 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 32.7 Cg_endo -70.06 90.21 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.174 2.583 . . . . 0.0 111.829 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.2 mm -122.27 133.09 69.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.029 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 117' ' ' LEU . 8.1 tt -108.38 123.69 49.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.734 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.912 HG21 HG13 ' A' ' 108' ' ' VAL . 94.5 m -122.68 128.4 50.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.38 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.881 HD23 ' N ' ' A' ' 120' ' ' THR . 5.1 tt -111.61 127.18 55.66 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.953 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.881 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -121.52 108.83 14.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.262 0.553 . . . . 0.0 110.524 179.323 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.589 ' OG1' ' O ' ' A' ' 64' ' ' GLY . 1.2 t . . . . . 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.101 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.626 0.25 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 29.4 mtm180 -114.1 140.75 48.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.672 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.645 ' CD2' HD11 ' A' ' 137' ' ' ILE . 3.8 t80 -74.73 128.29 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.403 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 18.4 mm -112.81 117.62 55.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.761 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.784 HD13 HG23 ' A' ' 98' ' ' ILE . 15.9 mm -107.45 107.09 21.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -92.79 133.22 36.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.135 0.493 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.1 145.42 30.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 50.7 tttm -117.31 152.53 34.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.463 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 11.0 tp -78.68 122.26 25.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.075 0.464 . . . . 0.0 110.35 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.27 -41.75 5.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.841 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.591 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -136.23 156.88 23.22 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 82.2 p -138.51 151.02 46.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.805 0.336 . . . . 0.0 110.597 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' THR . 94.4 m-85 -134.54 151.16 50.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.607 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.402 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 60.3 p -140.96 134.13 29.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.555 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.4 mttt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.51 -179.92 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.898 0.38 . . . . 0.0 110.207 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.48 124.93 24.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.936 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 113.15 -8.44 25.01 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -94.52 133.46 38.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.888 0.375 . . . . 0.0 110.26 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 89.0 tttt -57.93 122.04 12.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.323 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.29 -34.69 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.976 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.18 156.68 45.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.514 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.2 ttp -120.97 140.42 51.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.311 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.4 tp -105.84 129.45 54.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.62 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.691 ' ND2' ' NZ ' ' A' ' 27' ' ' LYS . 57.1 t-20 -121.52 133.62 55.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.993 0.425 . . . . 0.0 110.815 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.501 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 3.5 mt -114.69 112.62 45.32 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.527 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.418 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 56.8 Cg_endo -77.16 -42.91 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.579 2.186 . . . . 0.0 112.412 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.77 ' NZ ' ' NZ ' ' A' ' 77' ' ' LYS . 19.9 tptm -62.26 -38.44 89.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.803 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.792 ' N ' HD22 ' A' ' 24' ' ' LEU . 2.9 mm? -101.74 4.04 40.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.945 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 22' ' ' PRO . 7.0 mptt 43.85 48.75 7.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.562 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 26.6 mtmt -134.25 152.16 51.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.931 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.691 ' NZ ' ' ND2' ' A' ' 20' ' ' ASN . 8.6 mttp -130.43 143.04 50.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.675 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -130.88 145.66 52.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.743 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.3 p -95.06 113.83 25.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.644 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.594 HG12 HD11 ' A' ' 62' ' ' LEU . 1.2 mp -89.26 124.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.386 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 86.1 m-85 -106.06 149.66 26.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' A' ' 13' ' ' GLY . 24.0 t-105 -59.18 132.7 54.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.967 0.413 . . . . 0.0 110.824 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.523 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 75.04 162.41 9.83 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.592 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.277 179.237 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.614 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.541 ' CE ' ' H ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -94.99 140.04 30.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.684 0.278 . . . . 0.0 110.321 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -66.95 136.09 54.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.523 HG23 ' HA2' ' A' ' 33' ' ' GLY . 77.8 t -115.63 116.17 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.467 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.534 ' OG ' HG23 ' A' ' 51' ' ' THR . 50.1 p -161.88 166.74 25.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.549 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 42.0 t0 -66.75 -2.68 5.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.52 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.0 m -118.96 -30.06 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.81 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.534 HG23 ' OG ' ' A' ' 48' ' ' SER . 27.8 p -80.47 142.72 33.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.736 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 59' ' ' HIS . 1.1 t -146.82 167.8 23.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.293 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.665 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -89.87 158.99 44.0 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.979 0.418 . . . . 0.0 110.601 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.84 83.16 1.83 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.755 2.303 . . . . 0.0 112.367 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.6 p -112.38 -3.78 14.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.679 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.83 91.9 0.24 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.18 77.44 0.28 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.16 162.94 32.6 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.656 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 18.6 t-160 -82.91 116.96 22.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.9 m -111.31 124.39 52.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.299 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.541 ' H ' ' CE ' ' A' ' 45' ' ' MET . 97.6 t -118.01 129.08 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.006 0.431 . . . . 0.0 110.354 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.594 HD11 HG12 ' A' ' 30' ' ' ILE . 2.3 mm? -110.48 139.27 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.3 t -121.93 134.16 54.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.05 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.526 0.754 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.527 0.832 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.63 -42.11 95.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.754 0.311 . . . . 0.0 110.957 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.87 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.7 pp -92.18 101.73 14.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.988 0.423 . . . . 0.0 111.017 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.77 ' NZ ' ' NZ ' ' A' ' 23' ' ' LYS . 8.6 ptpt 170.96 135.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.472 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -67.57 -15.39 63.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.269 0.557 . . . . 0.0 110.536 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -80.62 -14.94 57.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.871 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -79.96 157.24 26.9 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.461 ' O ' HD23 ' A' ' 82' ' ' LEU . 1.9 p -137.57 147.17 44.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 81' ' ' THR . 63.1 mt -122.76 126.6 47.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.917 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.658 ' C ' HD22 ' A' ' 84' ' ' LEU . 2.7 t -112.55 124.76 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.997 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.658 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.7 mm? -110.73 137.78 47.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.44 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.615 ' HG2' HG23 ' A' ' 90' ' ' THR . 5.8 mm-40 -106.72 115.72 30.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.332 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.665 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 16.4 t80 -142.16 124.92 15.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.863 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.9 t70 61.19 44.24 10.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.733 0.302 . . . . 0.0 111.256 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 64.19 7.87 3.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.51 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -108.69 145.87 34.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.37 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.615 HG23 ' HG2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -111.48 120.71 43.06 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.481 -179.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.419 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 7.4 m-85 -98.98 143.3 29.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.372 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.87 110.61 21.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.843 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 82.9 m-85 -108.49 155.77 20.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.641 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -132.35 140.67 48.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.68 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mm -67.81 120.26 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.341 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.26 -65.03 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -144.53 137.88 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.309 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.89 130.93 65.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.015 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 19.2 p90 -152.83 -177.29 6.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.524 HG12 ' CD1' ' A' ' 135' ' ' TYR . 54.8 mt -125.72 132.74 70.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.253 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.539 HG22 ' CG1' ' A' ' 136' ' ' ILE . 1.5 t -133.7 166.62 22.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.928 0.395 . . . . 0.0 110.874 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.462 ' O ' HG23 ' A' ' 101' ' ' THR . 57.7 m80 -68.62 158.42 34.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.588 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -71.21 -15.59 62.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.697 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -97.47 8.49 44.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.697 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.4 87.7 4.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.986 0.422 . . . . 0.0 110.322 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.858 ' O ' HG23 ' A' ' 110' ' ' ILE . 10.9 ptp85 -65.63 -32.28 73.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.368 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.534 ' O ' HD12 ' A' ' 110' ' ' ILE . 6.9 p -42.94 -17.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.375 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.767 ' CG1' HG21 ' A' ' 118' ' ' THR . 48.4 t -106.42 -16.78 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.002 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.821 ' O ' HG22 ' A' ' 109' ' ' ILE . 45.4 mm -110.08 20.19 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.163 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.858 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -86.92 -165.36 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.941 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -97.02 151.37 19.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.44 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 98.4 mttt -135.99 134.99 39.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.571 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -83.7 14.21 4.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.084 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.15 159.61 70.25 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.992 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.93 92.9 1.09 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 123.126 2.551 . . . . 0.0 112.031 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.4 mm -124.73 137.34 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.189 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.735 HD23 ' C ' ' A' ' 117' ' ' LEU . 6.8 tt -109.78 118.0 35.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.203 0.525 . . . . 0.0 110.436 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.767 HG21 ' CG1' ' A' ' 108' ' ' VAL . 68.3 m -114.16 123.0 48.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.825 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.816 HD23 ' N ' ' A' ' 120' ' ' THR . 4.0 tt -107.79 120.77 43.18 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.558 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.816 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -115.87 114.68 25.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.154 0.502 . . . . 0.0 110.523 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.631 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.172 -178.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.562 ' OD1' ' O ' ' A' ' 133' ' ' ASP . 27.3 p30 . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.657 0.265 . . . . 0.0 110.486 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -100.89 139.43 36.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.951 0.405 . . . . 0.0 110.341 -179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.524 ' CD1' HG12 ' A' ' 100' ' ' ILE . 1.9 t80 -76.42 136.22 39.44 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.172 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.539 ' CG1' HG22 ' A' ' 101' ' ' THR . 5.9 mm -122.55 113.54 38.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.696 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 137' ' ' ILE . 0.6 OUTLIER -107.18 112.88 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.439 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 44.7 tt0 -93.63 139.81 30.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.508 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.58 148.77 31.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.974 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.1 tttm -119.12 152.22 36.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.384 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 18.0 tp -77.45 119.21 20.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.25 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.2 p -95.43 -41.55 8.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.673 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.466 ' O ' HD11 ' A' ' 141' ' ' LEU . . . -144.78 179.93 21.6 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.1 p -154.03 161.42 41.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.731 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 90' ' ' THR . 94.5 m-85 -144.03 159.37 42.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.773 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.8 p -144.57 128.17 17.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.654 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.3 tttp . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.967 -1.015 . . . . 0.0 110.579 179.92 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 121.133 0.492 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -69.24 142.18 54.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.341 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.57 15.8 63.13 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -119.61 137.01 54.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.014 0.435 . . . . 0.0 110.375 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 106.81 0.77 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.46 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.409 HG23 ' N ' ' A' ' 17' ' ' ALA . 15.9 m -109.81 -40.53 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.971 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' N ' HG23 ' A' ' 16' ' ' VAL . . . -135.09 164.56 27.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.695 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.0 ttt -131.75 128.21 38.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.635 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 tt -98.11 116.79 31.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.069 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.497 ' ND2' ' HE3' ' A' ' 27' ' ' LYS . 48.5 t-20 -110.76 137.33 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.022 0.439 . . . . 0.0 111.235 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.57 HD12 ' HG3' ' A' ' 26' ' ' LYS . 9.3 mt -116.67 115.87 39.03 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.286 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.94 -39.0 0.69 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.677 2.251 . . . . 0.0 112.847 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.581 ' C ' HD22 ' A' ' 24' ' ' LEU . 47.5 tptt -64.1 -35.62 81.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.007 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.723 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.4 mm? -101.9 7.14 41.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 40.78 59.35 2.21 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.131 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.57 ' HG3' HD12 ' A' ' 21' ' ' ILE . 15.3 ptpt -150.33 166.52 29.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.668 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HE3' ' ND2' ' A' ' 20' ' ' ASN . 27.6 mtpt -139.82 146.49 39.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.144 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.454 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 49.4 m-85 -132.13 138.68 48.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.717 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 p -89.57 112.24 23.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.544 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.9 mm -84.09 120.72 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.395 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -100.69 140.37 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.024 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.5 ' CE2' HG22 ' A' ' 47' ' ' VAL . 58.6 t-105 -59.46 132.1 52.96 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.276 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.658 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 76.55 140.2 1.03 Allowed Glycine 0 N--CA 1.463 0.445 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.538 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.857 179.98 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.588 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.615 ' SD ' HD21 ' A' ' 62' ' ' LEU . 2.4 tpp -87.93 145.65 25.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.705 0.288 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.449 ' CD1' HG21 ' A' ' 51' ' ' THR . 2.4 t80 -77.13 139.13 39.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.658 HG23 ' HA2' ' A' ' 33' ' ' GLY . 94.2 t -117.24 120.76 65.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.401 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.659 ' CB ' ' HG1' ' A' ' 51' ' ' THR . 4.9 p -170.64 176.3 4.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.54 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.98 -18.76 61.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.734 HG21 ' O ' ' A' ' 109' ' ' ILE . 2.3 m -107.9 -21.28 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.9 0.381 . . . . 0.0 110.843 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.659 ' HG1' ' CB ' ' A' ' 48' ' ' SER . 17.3 p -89.49 127.95 35.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.288 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 59' ' ' HIS . 1.3 t -136.02 166.83 22.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.56 157.75 55.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.684 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.87 80.68 2.89 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.589 2.193 . . . . 0.0 112.528 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.4 p -113.02 -5.33 13.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.946 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.46 91.48 0.1 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.69 91.36 0.01 OUTLIER Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -170.25 162.43 35.65 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.66 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 17.0 t-160 -83.35 117.19 22.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.6 m -112.77 108.02 16.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.533 HG11 HD12 ' A' ' 109' ' ' ILE . 78.4 t -106.24 129.03 60.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 110.011 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.615 HD21 ' SD ' ' A' ' 45' ' ' MET . 27.1 mt -120.53 158.63 26.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.939 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 120' ' ' THR . 7.8 p -139.0 150.58 46.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.261 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -179.866 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.689 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 84.1 mt-30 -78.72 -41.91 29.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.832 0.348 . . . . 0.0 111.035 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.678 HD22 ' OH ' ' A' ' 135' ' ' TYR . 20.8 mt -89.83 80.92 6.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.085 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.69 142.38 1.18 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.462 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -77.83 -16.5 58.27 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.596 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -79.2 -15.19 58.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.143 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.423 ' OD1' ' C ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -70.57 153.67 42.65 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 p -136.08 142.42 44.33 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.044 0.45 . . . . 0.0 110.002 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.1 mt -119.12 123.54 44.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.878 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.664 HG12 HG22 ' A' ' 90' ' ' THR . 2.2 t -107.12 124.73 63.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.35 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.638 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.4 mm? -110.39 129.61 55.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.377 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.419 ' HG2' HG23 ' A' ' 90' ' ' THR . 80.6 mt-10 -101.0 124.25 46.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.216 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 1.8 t80 -149.8 130.37 13.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.992 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 55.46 43.29 28.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.136 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 65.27 8.17 4.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.458 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 52.1 mtmt -107.02 150.98 25.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.383 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.664 HG22 HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -117.29 121.97 42.64 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.798 -179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -104.12 130.53 51.84 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.457 ' OG1' ' C ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -99.75 114.98 28.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.13 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 81.7 m-85 -110.69 155.49 22.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.725 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -130.73 140.13 50.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.156 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.456 HD13 HG23 ' A' ' 137' ' ' ILE . 1.1 mm -62.38 119.69 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.203 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.68 -64.1 1.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.885 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -146.98 133.01 19.21 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.172 0.51 . . . . 0.0 110.452 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.498 HG23 HG13 ' A' ' 137' ' ' ILE . 1.6 mp -111.04 131.13 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.608 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.402 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 18.9 p90 -153.72 -178.16 6.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.092 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.427 HG12 ' CD1' ' A' ' 135' ' ' TYR . 2.7 mt -127.13 134.08 66.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.258 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.542 HG22 ' CD1' ' A' ' 136' ' ' ILE . 2.9 t -146.06 172.49 13.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.91 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.429 ' O ' HG23 ' A' ' 101' ' ' THR . 4.9 m-70 -61.77 156.48 20.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.48 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.528 ' HB2' ' HG3' ' A' ' 134' ' ' ARG . . . -74.5 -25.97 59.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.831 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -89.46 2.17 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.565 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -65.36 90.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.526 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.983 ' O ' HG23 ' A' ' 110' ' ' ILE . 22.9 ptt85 -56.11 -35.91 67.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.51 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.536 ' C ' HD12 ' A' ' 110' ' ' ILE . 2.5 p -40.64 -17.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.536 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.787 ' CG1' HG21 ' A' ' 118' ' ' THR . 6.5 t -110.61 -15.58 9.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.005 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.734 ' O ' HG21 ' A' ' 50' ' ' VAL . 48.2 mm -113.74 21.91 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.036 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.983 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -88.19 -169.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.858 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -94.03 147.44 23.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.4 mttt -133.22 147.95 52.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.449 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -97.58 11.66 36.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.847 0.356 . . . . 0.0 110.067 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -133.66 159.48 72.34 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.73 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.49 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 46.7 Cg_endo -76.02 89.79 1.21 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.043 2.495 . . . . 0.0 111.959 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.46 134.99 63.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.437 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.517 HD23 ' C ' ' A' ' 117' ' ' LEU . 9.2 tt -109.34 120.85 43.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.653 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.787 HG21 ' CG1' ' A' ' 108' ' ' VAL . 71.7 m -116.36 119.78 36.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.109 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 120' ' ' THR . 0.7 OUTLIER -110.67 114.65 28.2 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.462 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.716 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -106.63 127.86 53.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.462 . . . . 0.0 110.762 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.631 HG23 ' CD2' ' A' ' 119' ' ' LEU . 27.4 p . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 121.129 0.49 . . . . 0.0 111.56 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.521 -0.164 0 CA-C-O 120.699 0.285 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.528 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.0 OUTLIER -126.4 137.96 53.49 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 110.95 -179.62 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.678 ' OH ' HD22 ' A' ' 76' ' ' LEU . 5.2 t80 -79.57 126.39 30.82 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.542 ' CD1' HG22 ' A' ' 101' ' ' THR . 1.1 mt -122.02 126.51 74.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-O 121.218 0.532 . . . . 0.0 111.943 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.594 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp -108.17 112.76 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.287 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -95.4 136.65 35.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.548 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.87 153.53 47.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.549 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 8.4 tptt -116.55 146.72 42.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.948 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.549 ' H ' ' HD2' ' A' ' 140' ' ' LYS . 16.4 tp -69.69 124.09 23.08 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.107 0.479 . . . . 0.0 110.109 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.9 p -99.04 -47.94 5.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.629 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.457 ' C ' ' OG1' ' A' ' 92' ' ' THR . . . -141.97 172.05 24.26 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.2 p -144.9 134.76 23.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.614 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -122.93 146.29 47.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.196 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 97.9 p -134.14 123.99 25.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.485 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.419 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.0 tptt . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.732 0.301 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 12' ' ' GLU . 2.1 pt-20 -58.22 135.87 57.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.073 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.39 2.68 61.77 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -115.32 140.45 49.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.793 0.33 . . . . 0.0 110.512 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -63.1 121.52 13.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.216 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.55 -39.47 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.96 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.3 156.95 43.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.628 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ttm -119.68 141.77 49.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.161 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 82' ' ' LEU . 29.0 tp -108.4 121.81 45.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.644 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -118.38 127.8 54.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.902 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 24' ' ' LEU . 6.0 mt -104.56 115.53 62.62 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.389 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.62 ' CD ' ' O ' ' A' ' 81' ' ' THR . 56.9 Cg_endo -77.11 -45.78 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.846 2.364 . . . . 0.0 112.52 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.632 ' C ' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -60.3 -40.25 89.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.489 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.771 ' N ' HD22 ' A' ' 24' ' ' LEU . 2.9 mm? -102.56 8.97 39.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.562 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 40.42 40.21 0.83 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.519 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.42 ' CB ' HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -112.07 157.91 20.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.519 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -138.71 139.89 38.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.584 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -137.06 159.09 42.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.855 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 m -101.99 122.38 43.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.001 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.4 mm -94.08 118.71 40.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.319 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -101.16 136.76 40.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.323 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.574 ' CZ3' ' SD ' ' A' ' 45' ' ' MET . 55.8 t-105 -60.41 133.05 55.72 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.616 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.568 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 77.62 163.98 21.63 Favored Glycine 0 C--N 1.331 0.258 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.868 179.26 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.582 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.703 ' CE ' ' H ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -95.46 134.45 38.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.627 0.251 . . . . 0.0 110.325 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.673 ' O ' ' SD ' ' A' ' 45' ' ' MET . 18.6 t80 -75.43 139.45 42.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.535 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.568 HG23 ' HA2' ' A' ' 33' ' ' GLY . 40.2 t -111.02 124.58 67.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.962 0.41 . . . . 0.0 110.433 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.538 ' OG ' ' CE2' ' A' ' 46' ' ' PHE . 18.8 m -160.92 165.38 30.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.604 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -69.0 -24.22 64.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.704 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.583 HG21 ' HA ' ' A' ' 110' ' ' ILE . 4.6 m -94.18 -40.52 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.161 0.505 . . . . 0.0 110.742 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.51 ' N ' HG23 ' A' ' 50' ' ' VAL . 81.7 p -76.18 155.56 34.44 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.716 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -148.97 171.6 16.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.606 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.466 HG22 ' CH2' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -87.41 156.75 53.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.754 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.452 ' HG3' HD23 ' A' ' 84' ' ' LEU . 68.0 Cg_endo -80.03 83.46 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.581 2.188 . . . . 0.0 112.445 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.0 p -113.85 -9.47 13.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.569 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.73 90.41 0.08 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.85 85.75 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.503 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.22 160.64 34.37 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.702 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 13.6 t-160 -83.65 116.66 22.74 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.7 m -111.81 127.19 55.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.234 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.703 ' H ' ' CE ' ' A' ' 45' ' ' MET . 54.6 t -117.29 129.75 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.354 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.538 HD22 ' O ' ' A' ' 61' ' ' VAL . 1.9 mm? -112.7 145.49 40.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.632 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 120' ' ' THR . 47.2 t -126.73 144.12 51.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.086 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.47 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.527 0.834 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.531 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.621 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -40.35 94.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.918 0.39 . . . . 0.0 110.165 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.33 111.4 17.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.42 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 0.0 OUTLIER -174.23 141.12 0.71 Allowed 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -77.84 -12.36 59.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.052 0.454 . . . . 0.0 110.507 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -84.95 -15.51 44.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.137 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.401 ' HB2' ' CD ' ' A' ' 77' ' ' LYS . 1.2 t70 -69.5 152.76 44.45 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.62 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -142.04 115.01 8.7 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.304 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.465 ' HB3' HD11 ' A' ' 19' ' ' LEU . 67.2 mt -90.47 132.21 35.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.629 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.548 HG12 HG22 ' A' ' 90' ' ' THR . 2.1 t -109.85 115.54 49.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.994 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 117' ' ' LEU . 6.0 mp -94.98 123.47 38.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.196 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.457 ' HG2' HG23 ' A' ' 90' ' ' THR . 96.7 mt-10 -99.73 117.61 34.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.374 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -149.6 133.26 16.8 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.936 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 56.23 43.67 26.21 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.321 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.5 9.31 2.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.337 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -107.44 150.21 27.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.518 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -118.03 123.85 46.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.709 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 15.4 m-85 -107.31 132.63 52.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.271 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.18 112.37 24.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 111.634 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.703 ' CE2' HD22 ' A' ' 84' ' ' LEU . 75.6 m-85 -109.85 147.58 33.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.775 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.645 ' OE2' ' NE2' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -124.71 139.83 53.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 179.682 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.583 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 1.3 mm -63.5 117.13 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.286 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.645 ' NE2' ' OE2' ' A' ' 94' ' ' GLU . 55.9 mm-40 -84.27 -67.97 0.75 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.844 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -145.83 139.66 26.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.109 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 137' ' ' ILE . 4.4 mt -112.81 127.78 69.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.61 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 25.8 p90 -150.89 -177.98 6.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.777 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 100' ' ' ILE . 3.6 mp -127.25 131.52 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.641 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.449 HG22 HD11 ' A' ' 136' ' ' ILE . 1.6 t -132.31 165.95 23.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.673 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -70.6 153.8 42.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.408 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.56 -13.32 61.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.697 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -92.67 8.02 40.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.76 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.599 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 68.1 t0 -85.98 89.91 7.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.581 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.849 ' O ' HG23 ' A' ' 110' ' ' ILE . 11.5 ptm180 -70.15 -24.19 63.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.429 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.599 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 12.9 p -49.56 -12.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.357 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.851 ' CG1' HG21 ' A' ' 118' ' ' THR . 43.9 t -111.02 -8.77 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.992 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.718 ' O ' HG22 ' A' ' 109' ' ' ILE . 29.9 mm -111.91 7.03 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 0.0 111.022 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.849 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -79.03 -161.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.629 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 14.1 ptpt -109.89 155.25 21.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.784 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.491 ' H ' ' HB2' ' A' ' 59' ' ' HIS . 99.3 mttt -138.54 144.06 39.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.451 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -85.74 10.88 12.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.999 0.428 . . . . 0.0 110.051 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.04 156.72 73.89 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.135 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.503 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 51.4 Cg_endo -76.89 88.48 1.39 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.975 2.45 . . . . 0.0 111.609 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.4 mm -124.07 131.43 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.916 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.851 HD12 HD21 ' A' ' 84' ' ' LEU . 5.3 tt -105.28 122.41 45.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.201 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.851 HG21 ' CG1' ' A' ' 108' ' ' VAL . 89.8 m -118.99 126.08 50.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.134 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.885 HD23 ' N ' ' A' ' 120' ' ' THR . 3.2 tt -107.7 124.55 50.17 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.599 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.885 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -120.99 113.97 20.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.448 0.642 . . . . 0.0 110.719 179.04 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.484 HG22 HD22 ' A' ' 119' ' ' LEU . 1.7 t . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.229 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.861 0.362 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -105.26 136.23 45.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.556 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.719 ' CD2' HD11 ' A' ' 137' ' ' ILE . 3.6 t80 -74.58 130.68 40.01 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.78 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.453 HD12 HG11 ' A' ' 108' ' ' VAL . 5.3 mm -115.21 117.22 54.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.936 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.719 HD11 ' CD2' ' A' ' 135' ' ' TYR . 12.8 mm -107.04 109.97 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.469 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 41.8 tt0 -92.06 137.0 32.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.054 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 117' ' ' LEU . . . -138.65 149.03 44.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.199 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 26.6 tptt -123.44 142.1 51.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.47 ' H ' ' HD2' ' A' ' 140' ' ' LYS . 21.3 tp -69.5 122.88 19.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.382 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.577 HG21 ' HB3' ' A' ' 94' ' ' GLU . 7.4 p -99.06 -46.82 5.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.734 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -142.04 -177.67 17.37 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.9 p -151.05 152.4 33.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.945 0.403 . . . . 0.0 110.713 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 90' ' ' THR . 90.5 m-85 -140.02 149.56 43.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.427 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.1 p -139.18 119.39 13.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.334 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.8 tttm . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.484 -179.835 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.985 0.421 . . . . 0.0 110.26 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -78.6 154.35 30.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.88 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 76.7 18.79 78.62 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -125.75 147.6 49.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 120.835 0.35 . . . . 0.0 110.548 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -63.21 119.52 9.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.236 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.571 HG11 ' HB2' ' A' ' 32' ' ' TRP . 4.6 m -119.64 -20.94 4.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.226 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.516 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -149.19 161.38 42.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.709 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.5 ttt -116.51 141.23 48.45 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.627 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.608 ' HB2' HD11 ' A' ' 30' ' ' ILE . 4.0 tp -109.81 121.86 46.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.567 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -117.76 129.67 55.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.706 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.579 HG21 HD23 ' A' ' 24' ' ' LEU . 13.3 mt -113.84 109.17 50.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.2 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -77.92 -41.72 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.679 2.253 . . . . 0.0 113.208 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.575 ' HB3' HD22 ' A' ' 24' ' ' LEU . 6.6 tptp -58.78 -43.98 90.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.175 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.579 HD23 HG21 ' A' ' 21' ' ' ILE . 1.4 mm? -101.24 2.93 40.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.022 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 mttt 50.4 56.75 7.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.953 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -134.44 155.23 50.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.788 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.04 138.86 42.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.772 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -137.92 157.8 45.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.762 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 t -99.86 134.03 43.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.831 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 19' ' ' LEU . 36.4 mm -99.24 127.28 52.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.331 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -106.37 139.51 40.74 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.222 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.603 ' O ' ' N ' ' A' ' 13' ' ' GLY . 41.6 t-105 -70.29 131.78 44.69 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 71.57 173.24 17.1 Favored Glycine 0 C--O 1.23 -0.122 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.556 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.836 179.408 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.55 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.449 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 30.6 ttm -90.92 128.64 36.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -70.97 132.48 45.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.494 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 47' ' ' VAL . 2.3 p -115.46 109.88 29.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.171 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 t -150.5 172.06 16.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.471 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -63.49 -37.62 88.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.537 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.834 HG21 ' O ' ' A' ' 109' ' ' ILE . 13.0 m -83.92 -38.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.898 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.613 HG23 HG23 ' A' ' 50' ' ' VAL . 30.6 p -85.89 158.08 20.02 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.459 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 t -160.08 173.56 15.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.6 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.547 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -84.52 158.46 60.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.736 -179.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.552 ' HG3' HD23 ' A' ' 84' ' ' LEU . 74.4 Cg_endo -82.65 83.62 1.95 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.501 2.134 . . . . 0.0 112.654 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 p -119.7 -5.65 10.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.735 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.24 87.4 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.6 96.49 0.02 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.54 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -172.65 150.74 12.96 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.657 ' CE1' HD12 ' A' ' 110' ' ' ILE . 22.3 t-160 -76.4 102.47 5.97 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -96.36 125.1 40.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.013 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.561 HG11 ' CD1' ' A' ' 109' ' ' ILE . 55.2 t -117.75 130.54 72.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.042 0.449 . . . . 0.0 109.975 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 61' ' ' VAL . 2.1 mm? -114.18 139.65 49.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.16 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.8 t -112.89 134.11 54.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.846 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 120' ' ' THR . . . . . . . . 0 CA--C 1.525 0.716 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.662 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.624 ' OE1' ' N ' ' A' ' 75' ' ' GLN . 0.1 OUTLIER -69.99 -42.52 72.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.462 -179.264 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.857 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.9 pp -92.56 108.64 20.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.21 0.529 . . . . 0.0 110.88 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.596 ' O ' HG21 ' A' ' 95' ' ' ILE . 16.6 ptpt 177.15 150.38 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.284 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -80.02 -12.4 59.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.497 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -87.98 -14.84 38.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.572 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.573 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 3.5 t70 -66.96 153.3 43.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.862 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.486 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.3 p -141.49 135.7 30.48 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.147 0.499 . . . . 0.0 109.69 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.47 HD21 ' OD2' ' A' ' 80' ' ' ASP . 7.2 mt -114.42 128.1 56.17 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.714 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.541 ' C ' HD12 ' A' ' 84' ' ' LEU . 2.4 t -106.77 121.47 59.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.954 0.407 . . . . 0.0 110.249 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.897 HD21 HD12 ' A' ' 117' ' ' LEU . 6.1 mp -105.1 121.59 44.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.208 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HG2' HG23 ' A' ' 90' ' ' THR . 92.8 mt-10 -101.71 113.7 27.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.108 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.516 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -147.86 132.76 18.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.843 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 t0 60.35 40.39 17.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.833 0.349 . . . . 0.0 111.404 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 63.71 11.13 5.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.178 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.673 ' NZ ' ' OH ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -110.61 149.66 30.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.566 179.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -115.18 113.31 23.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.747 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.673 ' OH ' ' NZ ' ' A' ' 89' ' ' LYS . 9.4 m-85 -100.77 129.01 46.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.477 ' N ' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -100.86 119.95 39.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.045 0.45 . . . . 0.0 111.637 -178.154 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.756 ' CE1' HD22 ' A' ' 84' ' ' LEU . 72.6 m-85 -111.55 158.16 19.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.248 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -133.79 139.69 46.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.262 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.775 HD12 HD11 ' A' ' 98' ' ' ILE . 7.0 mm -67.64 120.72 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.13 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.477 ' NE2' ' HB2' ' A' ' 140' ' ' LYS . 44.5 mt-30 -90.89 -62.68 1.4 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.613 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.541 ' O ' HD13 ' A' ' 98' ' ' ILE . 58.6 tttp -148.98 143.35 26.07 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.143 0.497 . . . . 0.0 110.247 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.775 HD11 HD12 ' A' ' 95' ' ' ILE . 14.8 mm -117.67 129.72 73.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.792 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.425 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 19.7 p90 -150.35 -176.71 5.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.031 0.443 . . . . 0.0 111.352 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.547 HG22 ' HB3' ' A' ' 133' ' ' ASP . 4.9 mt -126.04 132.63 70.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.4 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.584 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 3.1 t -131.84 171.32 13.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.839 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.502 ' CD2' ' OD1' ' A' ' 133' ' ' ASP . 26.7 m170 -72.97 162.1 29.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.728 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.13 -11.37 60.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.62 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -104.14 16.6 25.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.686 ' OD1' HG23 ' A' ' 107' ' ' THR . 31.6 t0 -86.31 101.42 13.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 110.377 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 109' ' ' ILE . 33.7 ptt180 -72.62 -21.32 61.13 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.799 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.686 HG23 ' OD1' ' A' ' 105' ' ' ASP . 21.3 p -45.73 -20.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.884 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 105' ' ' ASP . 10.6 m -101.42 -17.2 6.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.047 0.451 . . . . 0.0 110.291 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.834 ' O ' HG21 ' A' ' 50' ' ' VAL . 47.8 mm -109.89 23.36 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.657 HD12 ' CE1' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -89.01 -162.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -111.46 143.15 42.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.724 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -131.07 145.39 52.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.575 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -87.48 12.62 11.83 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.109 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.75 165.72 26.33 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.966 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.54 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 52.6 Cg_endo -78.87 98.52 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.854 2.369 . . . . 0.0 111.605 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.3 mm -126.02 131.66 71.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.331 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.897 HD12 HD21 ' A' ' 84' ' ' LEU . 9.6 tt -102.4 121.3 42.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.368 0.604 . . . . 0.0 110.203 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.8 m -117.52 106.18 12.88 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.491 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.995 HD12 ' N ' ' A' ' 120' ' ' THR . 0.1 OUTLIER -100.85 127.41 47.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.046 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.995 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -119.69 137.35 53.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.451 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.721 ' CG2' HD11 ' A' ' 119' ' ' LEU . 5.8 p . . . . . 0 C--N 1.326 -0.452 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.046 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.547 ' HB3' HG22 ' A' ' 100' ' ' ILE . 78.0 m-20 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.757 0.313 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -117.36 133.11 56.35 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.52 ' CE2' HD11 ' A' ' 137' ' ' ILE . 2.8 t80 -70.12 135.41 49.15 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.2 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.528 ' CG1' HG22 ' A' ' 101' ' ' THR . 43.5 mm -121.84 116.03 48.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.455 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.721 HD13 HG23 ' A' ' 98' ' ' ILE . 40.4 mm -101.76 108.42 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -97.65 138.36 35.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.107 0.479 . . . . 0.0 111.1 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.45 28.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.862 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.536 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 28.2 ttpt -121.97 157.59 30.95 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.024 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.804 HD23 ' N ' ' A' ' 142' ' ' THR . 3.9 tt -81.67 122.09 27.19 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.64 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.804 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -98.47 -40.37 8.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.709 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -150.76 155.13 26.01 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.14 158.19 45.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 111.277 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' THR . 95.2 m-85 -135.07 146.47 48.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.688 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.577 ' O ' ' O ' ' A' ' 147' ' ' LYS . 96.2 p -129.57 114.37 15.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.19 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.577 ' O ' ' O ' ' A' ' 146' ' ' SER . 55.0 tttt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.592 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.694 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER . . . . . 0 CA--C 1.526 0.053 0 CA-C-O 120.83 0.348 . . . . 0.0 110.565 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 54.1 mp0 -86.61 147.01 26.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.83 18.69 55.86 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.694 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 1.0 OUTLIER -123.65 131.13 53.54 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.842 0.354 . . . . 0.0 110.449 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.585 ' N ' ' CD2' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.4 100.97 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.023 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.446 HG11 ' HB2' ' A' ' 32' ' ' TRP . 13.0 m -100.34 -30.49 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.092 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.4 158.34 43.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.723 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.9 ttm -119.47 139.61 51.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.448 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 tp -105.53 113.84 27.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.475 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -107.13 126.04 51.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.245 0.545 . . . . 0.0 110.726 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 24' ' ' LEU . 10.3 mt -103.95 114.08 64.82 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.138 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.511 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.4 Cg_endo -77.33 -47.51 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.984 2.456 . . . . 0.0 112.871 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.573 ' C ' HD22 ' A' ' 24' ' ' LEU . 50.5 tptt -59.47 -40.51 87.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.574 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.798 ' N ' HD22 ' A' ' 24' ' ' LEU . 2.8 mm? -98.43 -3.57 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.582 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 52.87 39.77 29.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.972 0.415 . . . . 0.0 110.642 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.83 152.44 37.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.832 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -128.96 142.31 50.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.853 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -135.67 150.41 49.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.801 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.1 m -98.96 115.78 29.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.583 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.48 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.3 mp -93.14 127.03 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.63 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 15' ' ' LYS . 33.6 m-85 -107.55 143.1 36.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.869 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.598 ' HZ2' HG23 ' A' ' 47' ' ' VAL . 47.3 t-105 -61.84 127.29 30.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.736 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 89.1 168.21 43.59 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.503 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.915 179.499 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.622 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.766 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -104.27 139.25 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.72 0.295 . . . . 0.0 110.587 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.766 ' N ' ' SD ' ' A' ' 45' ' ' MET . 40.5 t80 -76.7 120.59 22.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.127 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.598 HG23 ' HZ2' ' A' ' 32' ' ' TRP . 2.2 p -97.53 120.37 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.661 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.21 166.53 32.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.414 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.51 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 41.0 t0 -64.07 -33.98 77.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.548 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.595 HG21 ' HA ' ' A' ' 110' ' ' ILE . 4.1 m -84.82 -41.62 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 110.863 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.52 ' N ' HG23 ' A' ' 50' ' ' VAL . 44.2 p -77.5 161.47 27.9 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.724 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.508 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -156.22 169.75 23.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.905 0.383 . . . . 0.0 110.587 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.402 ' H ' HG23 ' A' ' 53' ' ' THR . 0.1 OUTLIER -88.89 153.86 49.73 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.587 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.689 ' HG3' HD23 ' A' ' 84' ' ' LEU . 56.6 Cg_endo -73.23 85.56 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.874 2.383 . . . . 0.0 112.314 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -118.95 4.41 11.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.62 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.94 89.95 0.26 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.5 85.58 0.05 OUTLIER Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.44 161.91 35.31 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.714 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 12.3 t-160 -81.36 121.03 25.7 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.2 m -114.9 122.9 47.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.188 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.552 ' O ' HD22 ' A' ' 62' ' ' LEU . 39.9 t -115.98 128.61 73.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.338 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.552 HD22 ' O ' ' A' ' 61' ' ' VAL . 1.9 mm? -113.82 145.64 41.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.232 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.7 t -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.647 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.651 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.53 0.989 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' A' ' 24' ' ' LEU . . . . . . . . 0 CA--C 1.528 0.868 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -70.06 -39.44 75.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.935 0.398 . . . . 0.0 110.792 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.442 HD23 ' N ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -101.44 98.02 8.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.772 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.523 ' O ' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER 178.01 148.71 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.116 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -78.13 -13.83 59.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.54 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -83.17 -15.69 49.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.414 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.55 153.16 41.44 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.652 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.511 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -141.95 121.53 13.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.088 0.471 . . . . 0.0 109.8 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.2 mt -98.39 133.34 42.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.545 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.463 ' C ' HD12 ' A' ' 84' ' ' LEU . 3.1 t -111.92 122.62 66.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.927 0.394 . . . . 0.0 110.25 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.689 HD23 ' HG3' ' A' ' 54' ' ' PRO . 8.5 mp -102.33 124.45 47.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.105 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -101.22 115.22 29.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.093 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.632 ' O ' ' N ' ' A' ' 89' ' ' LYS . 5.6 t80 -144.55 143.07 30.64 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.812 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 86' ' ' TYR . 38.9 t70 38.05 52.64 1.57 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.738 0.304 . . . . 0.0 111.407 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 58.1 9.87 1.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.395 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.632 ' N ' ' O ' ' A' ' 86' ' ' TYR . 53.4 mtmt -104.57 143.72 32.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.55 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.438 HG22 HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -116.85 122.56 44.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.844 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -109.88 127.95 55.04 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.533 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -96.47 109.25 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.393 -179.65 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.606 ' CE1' HD22 ' A' ' 84' ' ' LEU . 52.9 m-85 -99.06 155.15 17.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.991 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -131.38 130.02 42.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.194 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.526 ' CD1' ' CG2' ' A' ' 137' ' ' ILE . 4.9 mm -61.11 119.32 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.648 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -89.79 -65.8 0.98 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.757 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -147.16 138.15 23.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.454 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.459 HG23 HG13 ' A' ' 137' ' ' ILE . 1.3 mp -113.62 133.27 60.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.404 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 18.6 p90 -153.48 -178.68 7.16 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.929 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.475 ' N ' HD12 ' A' ' 100' ' ' ILE . 1.8 mp -125.27 129.67 73.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.491 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.539 HG22 ' CG1' ' A' ' 136' ' ' ILE . 4.8 t -128.85 172.94 10.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.673 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -73.9 153.41 39.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.69 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.95 -34.51 76.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.524 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -78.98 18.75 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.677 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -89.22 99.09 12.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.326 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.945 ' O ' HG23 ' A' ' 110' ' ' ILE . 23.1 ptt85 -80.15 -19.42 47.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.779 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.445 ' O ' HD12 ' A' ' 110' ' ' ILE . 6.8 p -48.1 -18.25 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.957 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.554 ' HB ' HG21 ' A' ' 118' ' ' THR . 4.1 m -110.52 -9.35 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.287 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.689 ' O ' HG22 ' A' ' 109' ' ' ILE . 39.2 mm -104.95 1.33 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.033 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.945 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -77.72 -167.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 12.6 ptmt -99.88 151.66 21.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.774 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.605 ' H ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -125.45 134.94 51.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.303 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -78.31 6.96 7.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.221 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.09 164.16 33.4 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.429 ' O ' HD13 ' A' ' 116' ' ' ILE . 36.4 Cg_endo -71.41 96.17 0.72 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.192 2.595 . . . . 0.0 112.155 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 115' ' ' PRO . 50.9 mm -128.98 133.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.46 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.834 HD23 ' C ' ' A' ' 117' ' ' LEU . 5.7 tt -106.69 120.36 41.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.161 0.505 . . . . 0.0 110.316 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.554 HG21 ' HB ' ' A' ' 108' ' ' VAL . 91.1 m -118.34 119.09 33.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.158 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.868 HD23 ' N ' ' A' ' 120' ' ' THR . 5.6 tt -105.73 127.81 53.31 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.609 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.868 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -120.83 117.76 28.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.817 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.651 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.7 t . . . . . 0 CA--C 1.514 -0.423 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.729 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.737 0.303 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -117.22 132.87 56.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.922 0.391 . . . . 0.0 110.411 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.621 ' HD2' HD11 ' A' ' 137' ' ' ILE . 5.3 t80 -75.79 125.96 30.08 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.915 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.675 ' C ' HD12 ' A' ' 137' ' ' ILE . 4.2 mm -112.91 118.59 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.91 0.386 . . . . 0.0 111.94 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.943 ' N ' HD12 ' A' ' 137' ' ' ILE . 1.3 mp -110.42 107.04 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -90.98 136.58 32.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.382 0.611 . . . . 0.0 111.344 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.2 36.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.911 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.522 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 50.9 tptt -111.69 139.85 46.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.352 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.711 ' C ' HD13 ' A' ' 141' ' ' LEU . 2.2 tm? -75.5 114.87 14.55 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.707 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.605 ' OG1' ' N ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -97.74 -65.39 0.97 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.273 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.605 ' N ' ' OG1' ' A' ' 142' ' ' THR . . . -101.41 151.19 18.66 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.257 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 89.9 p -137.35 126.91 25.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.93 0.395 . . . . 0.0 110.428 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -118.74 146.48 44.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.677 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.2 p -133.94 130.1 37.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.574 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.609 -179.962 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.607 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 12.5 tmtt? . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 120.839 0.352 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.467 ' OE2' ' NE1' ' A' ' 32' ' ' TRP . 9.0 mp0 -81.38 109.28 15.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.141 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 129.05 24.69 1.04 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.607 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -127.29 131.8 50.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.801 0.334 . . . . 0.0 110.458 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 96.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.986 0.422 . . . . 0.0 110.285 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 14' ' ' GLU . 5.6 m -100.71 -38.31 6.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.921 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.95 157.85 45.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 32.0 ttm -125.35 136.16 53.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.441 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.409 HD12 HD21 ' A' ' 84' ' ' LEU . 1.9 tt -101.72 119.05 38.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.19 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -111.89 137.73 49.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.367 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -119.26 112.96 35.59 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.892 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 81' ' ' THR . 56.3 Cg_endo -75.16 -40.26 0.91 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.882 2.388 . . . . 0.0 112.929 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.507 ' HB3' HD22 ' A' ' 24' ' ' LEU . 4.5 tmtt? -65.06 -37.57 88.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.716 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.62 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.7 mm? -96.24 3.02 53.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.738 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER 45.69 57.12 5.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HD3' ' CE2' ' A' ' 28' ' ' PHE . 18.1 ptpt -157.26 173.91 16.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.969 0.414 . . . . 0.0 110.629 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.01 158.09 43.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.619 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.455 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 87.7 m-85 -133.37 154.22 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.738 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.1 m -95.21 112.48 24.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.835 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.546 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.2 mp -93.79 122.04 44.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.425 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -102.71 146.1 28.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TRP . . . . . 0.469 ' O ' ' N ' ' A' ' 13' ' ' GLY . 51.6 t-105 -62.56 125.08 22.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.557 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.67 142.98 4.58 Favored Glycine 0 N--CA 1.46 0.291 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.376 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.623 179.791 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.574 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.504 ' HE2' ' O ' ' A' ' 46' ' ' PHE . 2.1 ttp -98.74 129.09 45.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.504 ' O ' ' HE2' ' A' ' 45' ' ' MET . 19.3 t80 -65.12 131.12 45.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.393 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.469 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.0 p -113.7 124.18 70.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.667 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.65 ' N ' ' OG1' ' A' ' 51' ' ' THR . 36.3 t -158.02 174.31 15.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.563 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -67.65 -13.75 62.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.602 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.71 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.5 m -111.17 -14.1 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.892 0.377 . . . . 0.0 110.556 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.65 ' OG1' ' N ' ' A' ' 48' ' ' SER . 29.3 p -104.32 141.22 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -142.18 167.48 22.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.473 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.406 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -83.11 162.65 53.81 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.917 -179.515 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -82.58 83.08 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.681 2.254 . . . . 0.0 112.437 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 55' ' ' SER . 0.9 OUTLIER -117.77 7.71 12.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.654 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.16 87.28 0.36 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.76 92.64 0.04 OUTLIER Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.526 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -170.25 160.09 32.78 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.689 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 19.2 t-160 -82.61 114.2 20.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.458 HG22 ' CD2' ' A' ' 62' ' ' LEU . 21.6 m -111.47 120.87 43.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.253 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.893 HG11 ' CD1' ' A' ' 109' ' ' ILE . 65.2 t -114.6 125.66 71.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 109.806 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.621 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.7 mm? -108.55 143.26 37.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.567 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.3 t -126.87 138.28 53.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.712 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 121' ' ' THR . . . . . . . . 0 CA--C 1.53 1.014 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 24' ' ' LEU . . . . . . . . 0 CA--C 1.524 0.626 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -87.17 -43.42 12.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 110.68 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.823 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.6 pp -108.47 103.99 13.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 111.218 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . 0.546 ' HG3' ' H ' ' A' ' 80' ' ' ASP . 2.3 ptmt 177.91 137.02 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.246 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.31 -17.62 62.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.058 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -79.49 -13.94 59.23 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.367 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.657 ' OD1' ' N ' ' A' ' 81' ' ' THR . 1.0 OUTLIER -70.65 155.35 40.85 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.935 -179.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.657 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -142.64 119.16 10.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.025 0.441 . . . . 0.0 109.981 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.9 mt -95.66 129.05 42.98 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.837 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.516 ' C ' HD22 ' A' ' 84' ' ' LEU . 21.3 t -113.43 118.1 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.033 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.516 HD22 ' C ' ' A' ' 83' ' ' VAL . 4.1 mm? -105.45 135.36 46.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.458 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.481 ' HG2' HG23 ' A' ' 90' ' ' THR . 95.9 mt-10 -106.48 123.73 48.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.946 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 87' ' ' ASP . 21.9 t80 -143.4 131.03 21.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.261 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 86' ' ' TYR . 8.6 t0 49.45 49.02 20.54 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.315 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 63.43 11.27 5.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.471 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 44.3 mtmt -109.94 145.24 37.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.987 0.423 . . . . 0.0 110.288 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.507 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -112.33 123.64 50.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.909 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -104.48 132.87 50.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.295 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.97 111.1 23.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.164 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 80.4 m-85 -109.6 150.36 28.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.48 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -131.18 140.38 49.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.827 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 95' ' ' ILE . 14.4 mm -60.76 122.23 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.557 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -104.02 -50.48 3.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.859 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 15.3 tptm -154.27 132.51 11.86 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.192 0.52 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 76' ' ' LEU . 71.9 mt -122.04 132.84 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.475 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 30.2 p90 -153.73 -176.06 5.66 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.797 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.729 ' N ' HD12 ' A' ' 100' ' ' ILE . 1.8 mp -127.75 129.61 70.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.4 t -134.39 -171.12 2.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.694 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' HIS . . . . . 0.404 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 93.2 m-70 -78.31 153.89 31.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.14 -30.8 71.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.609 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -88.63 14.22 10.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.731 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.896 ' O ' HG22 ' A' ' 108' ' ' VAL . 3.8 t70 -75.58 94.34 3.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.039 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.728 ' O ' ' N ' ' A' ' 109' ' ' ILE . 30.6 ptt-85 -64.78 -34.28 77.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.664 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.652 ' O ' HD11 ' A' ' 110' ' ' ILE . 3.1 p -35.63 -25.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.93 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 105' ' ' ASP . 28.6 m -98.15 -24.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 110.801 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.893 ' CD1' HG11 ' A' ' 61' ' ' VAL . 8.1 mm -104.89 27.34 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.637 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.689 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.8 OUTLIER -90.85 -162.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.408 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -107.39 137.9 44.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.769 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.2 mttt -126.36 143.4 51.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.18 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.6 ' N ' ' OE2' ' A' ' 114' ' ' GLU . 15.0 mt-10 -90.97 11.4 22.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.569 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.6 ' OE2' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -136.7 168.68 15.91 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 110.589 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PRO . . . . . 0.526 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 51.7 Cg_endo -78.44 90.46 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.164 2.576 . . . . 0.0 112.251 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.484 HG21 ' HZ3' ' A' ' 112' ' ' LYS . 50.8 mm -122.57 129.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.757 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.806 HD23 ' C ' ' A' ' 117' ' ' LEU . 6.5 tt -104.08 122.26 44.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.71 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.639 HG21 ' HB ' ' A' ' 108' ' ' VAL . 19.6 m -114.27 113.61 24.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.13 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 120' ' ' THR . 1.8 tt -104.27 116.23 31.8 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.699 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.734 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -112.52 129.29 56.4 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.42 0.45 . . . . 0.0 110.196 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.616 HG23 ' CD2' ' A' ' 119' ' ' LEU . 71.4 p . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.397 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.82 0.343 . . . . 0.0 110.543 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -123.53 134.61 53.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.209 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.578 ' CD2' HD11 ' A' ' 137' ' ' ILE . 4.2 t80 -87.43 125.14 34.1 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -122.16 128.52 75.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.016 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.578 HD11 ' CD2' ' A' ' 135' ' ' TYR . 7.2 mm -106.87 111.76 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.036 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 97' ' ' LYS . 67.5 tt0 -94.27 138.48 32.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.507 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -148.75 149.02 30.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.655 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -114.43 152.66 31.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.188 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' LEU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 11.2 tp -77.07 115.61 17.01 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.702 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.63 -42.18 12.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.123 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.404 ' O ' HD11 ' A' ' 141' ' ' LEU . . . -142.73 171.6 24.74 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 56.4 p -147.08 151.39 36.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 110.41 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -136.58 160.75 37.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.688 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.588 ' O ' ' C ' ' A' ' 147' ' ' LYS . 7.9 p -150.74 125.56 9.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.45 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.588 ' C ' ' O ' ' A' ' 146' ' ' SER . 17.4 tttm . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.471 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.9 p -108.94 9.48 26.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.861 0.362 . . . . 0.0 110.684 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -54.73 -39.22 68.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.698 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 95.3 mtp -79.01 141.12 37.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.567 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.3 m -130.15 155.02 46.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.446 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 43.1 t -125.48 139.75 53.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.636 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.53 ' C ' ' OG1' ' A' ' 8' ' ' THR . 65.2 tt0 -151.73 93.6 1.88 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.594 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.53 ' OG1' ' C ' ' A' ' 7' ' ' GLN . 0.0 OUTLIER 172.93 -37.92 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.56 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.679 ' OE1' ' CE1' ' A' ' 10' ' ' HIS . 9.2 mm-40 -97.84 153.41 18.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.486 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.679 ' CE1' ' OE1' ' A' ' 9' ' ' GLU . 1.2 p-80 -48.39 109.97 0.29 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.616 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 tttp -134.37 143.24 47.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.427 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.446 ' HG3' ' CD1' ' A' ' 32' ' ' TRP . 2.3 mp0 -59.85 137.87 57.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.356 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.29 9.17 70.34 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 70.9 mm-40 -115.49 141.25 48.3 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.839 0.352 . . . . 0.0 110.429 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 84.3 tttt -67.82 113.6 5.7 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.228 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.3 m -111.8 -37.22 2.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.028 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.494 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -141.36 158.33 44.02 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.665 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 44.9 ttp -118.05 138.42 52.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.415 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.487 HD12 HD11 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -102.42 121.9 43.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.077 179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -122.46 135.29 54.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.119 0.485 . . . . 0.0 111.07 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.523 HG22 ' H ' ' A' ' 24' ' ' LEU . 3.8 mt -110.82 118.01 49.27 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.291 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.417 ' HD3' HG23 ' A' ' 83' ' ' VAL . 57.5 Cg_endo -75.58 -48.5 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.832 2.355 . . . . 0.0 112.728 -179.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.54 ' C ' HD22 ' A' ' 24' ' ' LEU . 11.7 tptt -60.21 -44.93 94.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.904 -179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.815 ' N ' HD22 ' A' ' 24' ' ' LEU . 2.8 mm? -96.53 3.03 52.93 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.618 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 43.41 38.96 1.95 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.719 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.431 ' HZ2' ' HA ' ' A' ' 26' ' ' LYS . 0.0 OUTLIER -112.22 145.06 40.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.356 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.37 144.06 50.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.111 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -140.23 141.88 35.85 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.661 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.546 ' C ' HD12 ' A' ' 30' ' ' ILE . 5.0 p -86.68 121.21 28.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.712 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.559 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.1 mp -103.63 120.66 54.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.549 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.466 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 32.2 m-85 -106.2 150.31 25.99 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.727 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.446 ' CD1' ' HG3' ' A' ' 12' ' ' GLU . 33.2 t-105 -60.12 128.63 37.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.696 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.29 160.51 12.3 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -137.28 86.12 2.17 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.586 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -78.37 113.44 16.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.894 0.378 . . . . 0.0 110.592 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.574 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 67.2 t0 -84.46 -16.56 42.1 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.528 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.82 92.3 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.469 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.518 ' C ' HD22 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -109.68 140.31 43.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.605 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.68 ' N ' HD22 ' A' ' 39' ' ' LEU . 2.8 mm? -93.58 13.04 23.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.542 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -55.4 -58.4 7.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.044 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -79.86 169.21 18.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.691 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -110.47 -53.07 0.57 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.864 -0.895 . . . . 0.0 110.864 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 89.3 t -124.49 131.21 73.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 CA-C-O 121.166 0.507 . . . . 0.0 110.724 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.78 155.65 21.71 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.766 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -96.57 134.82 39.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.728 0.299 . . . . 0.0 110.576 -179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.766 ' N ' ' SD ' ' A' ' 45' ' ' MET . 1.9 t80 -64.02 132.55 50.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.712 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -121.56 120.24 61.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.558 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.525 ' N ' ' OG1' ' A' ' 51' ' ' THR . 43.2 p -160.69 169.66 22.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.498 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.554 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 47.8 t0 -62.45 -10.67 12.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.625 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.5 m -112.11 -34.25 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.71 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.525 ' OG1' ' N ' ' A' ' 48' ' ' SER . 65.7 p -85.14 138.27 32.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.914 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.582 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.3 t -139.83 174.23 10.72 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.565 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.416 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -89.38 158.28 46.29 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 -179.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.38 83.69 1.98 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.664 2.243 . . . . 0.0 112.694 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.9 p -118.83 -2.1 10.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.79 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.21 86.2 0.06 OUTLIER Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.59 101.55 0.01 OUTLIER Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.513 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -178.42 165.32 34.52 Favored Glycine 0 CA--C 1.523 0.578 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.696 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 16.2 t-160 -83.7 110.21 18.11 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.986 -0.375 . . . . 0.0 109.986 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 60.4 m -105.82 120.9 42.9 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.844 0.354 . . . . 0.0 110.426 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.615 ' C ' HD22 ' A' ' 62' ' ' LEU . 61.9 t -117.7 131.56 70.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.195 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.615 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.8 mm? -111.25 139.44 46.63 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.596 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 23.2 t -122.59 129.4 51.86 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.733 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.639 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -154.59 176.49 32.35 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -126.29 159.89 31.87 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.783 0.325 . . . . 0.0 110.717 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.795 HH12 HG22 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -105.42 127.99 53.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.423 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -108.95 -66.27 1.07 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.714 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.581 HG22 ' H ' ' A' ' 69' ' ' VAL . 0.4 OUTLIER -129.83 177.15 7.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.597 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.795 HG22 HH12 ' A' ' 66' ' ' ARG . 53.0 t -110.25 127.79 66.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.281 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -143.07 -67.94 0.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.529 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.606 ' HB ' HD12 ' A' ' 24' ' ' LEU . 19.5 p -113.38 20.49 16.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.438 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.645 ' OD1' ' N ' ' A' ' 73' ' ' LEU . 41.8 p-10 -58.21 -28.4 64.8 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.397 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.645 ' N ' ' OD1' ' A' ' 72' ' ' ASP . 10.3 tt -62.9 -39.64 95.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.865 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.24 -20.08 55.74 Favored Glycine 0 CA--C 1.523 0.548 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.7 mm100 -68.83 -44.09 74.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.697 0.284 . . . . 0.0 110.656 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.555 HD22 ' HE2' ' A' ' 135' ' ' TYR . 5.3 mt -90.82 92.95 9.02 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.952 0.406 . . . . 0.0 110.352 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.534 ' HG3' ' H ' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -174.73 147.67 1.05 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.285 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.06 -11.72 60.16 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.755 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.534 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 3.8 mtpt -84.13 -15.61 46.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.382 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -78.66 157.28 28.67 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.856 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.475 ' O ' HD23 ' A' ' 82' ' ' LEU . 1.8 p -137.02 149.87 47.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.969 0.414 . . . . 0.0 109.992 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.475 HD12 HD22 ' A' ' 117' ' ' LEU . 35.9 mt -118.8 120.07 36.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.224 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.65 ' C ' HD22 ' A' ' 84' ' ' LEU . 14.9 t -102.76 124.57 56.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 120.949 0.404 . . . . 0.0 110.642 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.65 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.2 mm? -113.0 133.16 55.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.127 -179.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.531 ' HG2' HG23 ' A' ' 90' ' ' THR . 97.6 mt-10 -106.09 119.33 38.92 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.494 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.1 t80 -143.2 127.05 17.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.266 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 57.08 44.32 22.78 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.854 0.359 . . . . 0.0 111.194 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 64.32 15.62 9.58 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.486 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 6.4 mtmp? -116.4 140.85 48.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.185 179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.65 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -108.65 124.46 50.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.822 -179.4 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.421 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 15.8 m-85 -104.06 129.68 51.72 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.21 117.75 35.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.896 0.379 . . . . 0.0 111.127 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.454 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 89.7 m-85 -112.34 163.83 13.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.593 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -139.04 133.86 32.21 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.824 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.43 ' HB ' ' O ' ' A' ' 77' ' ' LYS . 0.9 OUTLIER -65.52 123.78 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.201 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -99.89 -47.93 4.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.996 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -153.32 139.28 18.16 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.099 0.476 . . . . 0.0 110.532 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mt -116.51 130.58 71.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.539 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.499 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 20.0 p90 -151.62 -175.88 5.38 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.905 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.473 HG12 ' CD1' ' A' ' 135' ' ' TYR . 6.9 mt -129.31 135.21 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.498 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.539 HG22 HG13 ' A' ' 136' ' ' ILE . 6.5 t -134.86 171.23 14.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.754 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.665 ' ND1' ' O ' ' A' ' 132' ' ' PRO . 0.1 OUTLIER -73.77 158.11 35.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.459 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.465 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . . . -69.53 -11.44 60.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.701 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.554 ' C ' ' OD1' ' A' ' 104' ' ' ASP . 12.4 p30 -100.82 15.51 28.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.694 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.405 ' OD2' ' OG1' ' A' ' 101' ' ' THR . 39.8 t0 -79.15 94.28 5.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.973 0.416 . . . . 0.0 110.594 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.48 ' O ' HG13 ' A' ' 110' ' ' ILE . 52.3 ptt85 -74.82 -20.51 59.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.524 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.787 ' O ' HD11 ' A' ' 110' ' ' ILE . 5.9 p -60.08 -26.28 66.06 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.313 -179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.831 ' CG1' HG21 ' A' ' 118' ' ' THR . 21.5 t -95.82 -4.83 10.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.433 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.809 ' O ' HG22 ' A' ' 109' ' ' ILE . 42.5 mm -118.78 14.05 7.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.03 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.787 HD11 ' O ' ' A' ' 107' ' ' THR . 0.7 OUTLIER -79.61 -160.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.71 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.401 ' H ' ' HB ' ' A' ' 110' ' ' ILE . 24.1 ttmt -99.24 149.64 22.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.378 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.489 ' N ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -129.73 126.24 37.77 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 113' ' ' GLU . 68.8 tt0 -76.6 7.65 4.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.028 0.442 . . . . 0.0 110.117 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -138.14 164.08 43.14 Favored Pre-proline 0 C--N 1.33 -0.251 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.542 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.513 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 44.6 Cg_endo -76.33 87.81 1.4 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.961 2.44 . . . . 0.0 111.888 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.5 mm -119.1 130.47 73.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.968 -179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.83 HD23 ' C ' ' A' ' 117' ' ' LEU . 6.0 tt -103.56 118.57 37.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.149 0.5 . . . . 0.0 110.884 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.831 HG21 ' CG1' ' A' ' 108' ' ' VAL . 96.9 m -117.78 124.31 48.11 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.228 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 1.009 HD12 ' N ' ' A' ' 120' ' ' THR . 0.5 OUTLIER -106.44 122.7 46.81 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.493 -179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 1.009 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -121.08 120.48 35.46 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.236 179.02 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.639 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.4 t -150.75 -179.11 6.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.158 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.617 ' SG ' ' C ' ' A' ' 121' ' ' THR . 1.2 p 157.25 -77.66 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.926 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.575 ' C ' ' O ' ' A' ' 122' ' ' CYS . 10.2 m-85 20.68 70.01 0.26 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.815 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.653 ' HD2' ' HB2' ' A' ' 131' ' ' ALA . 57.7 Cg_endo -76.67 153.6 34.17 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.913 2.408 . . . . 0.0 112.172 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.558 ' CE2' ' OD1' ' A' ' 126' ' ' ASP . 24.2 p90 -59.32 -32.67 70.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.445 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.558 ' OD1' ' CE2' ' A' ' 125' ' ' PHE . 38.6 m-20 -59.78 -44.13 94.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.788 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.472 ' CE1' ' O ' ' A' ' 128' ' ' ILE . 40.7 t80 -102.88 138.6 39.55 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.592 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.472 ' O ' ' CE1' ' A' ' 127' ' ' TYR . 96.6 mt -100.25 128.36 52.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.311 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.6 -141.95 15.88 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -89.36 101.77 14.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.339 . . . . 0.0 110.509 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.653 ' HB2' ' HD2' ' A' ' 124' ' ' PRO . . . -48.0 150.92 1.84 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.56 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.665 ' O ' ' ND1' ' A' ' 102' ' ' HIS . 25.9 Cg_endo -61.51 -49.98 6.42 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.922 2.415 . . . . 0.0 111.996 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -109.56 116.03 31.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.434 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.465 ' NE ' ' HA ' ' A' ' 103' ' ' ALA . 10.6 ptp180 -101.31 144.42 30.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.785 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.555 ' HE2' HD22 ' A' ' 76' ' ' LEU . 4.5 t80 -76.42 135.04 39.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.872 -179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.539 HG13 HG22 ' A' ' 101' ' ' THR . 5.1 mm -120.14 124.15 72.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 137' ' ' ILE . 1.2 mp -112.91 109.5 28.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.499 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 22.7 tp10 -94.19 136.78 34.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.143 0.497 . . . . 0.0 110.89 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.59 148.98 31.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.973 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.434 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 79.2 tttt -116.2 155.23 28.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.06 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.454 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 11.8 tp -78.86 122.53 26.21 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-O 121.009 0.433 . . . . 0.0 110.478 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.66 -38.13 6.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.782 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -143.29 159.67 27.51 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.9 p -144.61 149.51 35.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.764 0.316 . . . . 0.0 110.457 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.415 ' N ' ' O ' ' A' ' 90' ' ' THR . 93.0 m-85 -128.97 153.8 47.2 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.598 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 77.4 p -146.86 126.99 13.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.729 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 8.3 ttpt . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.591 179.995 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.478 ' C ' ' ND1' ' A' ' 3' ' ' HIS . 38.5 m -154.03 168.01 27.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.81 0.338 . . . . 0.0 110.54 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.478 ' ND1' ' C ' ' A' ' 2' ' ' SER . 12.6 m80 72.68 85.34 0.12 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.458 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 30.6 ttm -80.33 147.96 30.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.488 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.638 ' H ' ' NZ ' ' A' ' 11' ' ' LYS . 10.7 t 63.95 -82.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.533 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.518 ' O ' ' C ' ' A' ' 7' ' ' GLN . 0.1 OUTLIER 63.2 -1.32 0.54 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.516 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.618 ' CG ' ' H ' ' A' ' 8' ' ' THR . 2.5 tp60 29.31 -144.88 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.574 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.618 ' H ' ' CG ' ' A' ' 7' ' ' GLN . 75.3 p 51.8 -163.53 0.07 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.468 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.547 ' C ' ' O ' ' A' ' 8' ' ' THR . 44.9 mm-40 27.38 -98.55 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.005 0.431 . . . . 0.0 110.685 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.575 ' O ' ' OE1' ' A' ' 14' ' ' GLU . 0.4 OUTLIER -154.45 -116.88 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.389 179.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.638 ' NZ ' ' H ' ' A' ' 5' ' ' SER . 64.1 tttt 87.55 159.06 0.07 Allowed 'General case' 0 N--CA 1.461 0.114 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -91.61 149.39 21.68 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 89.71 10.23 65.37 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.611 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -113.64 133.95 55.01 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 120.843 0.354 . . . . 0.0 110.412 179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.48 106.24 0.52 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.289 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.4 HG23 ' N ' ' A' ' 17' ' ' ALA . 17.5 m -109.28 -40.53 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.971 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.426 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -128.17 160.32 32.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.485 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 20.7 ttp -123.7 147.1 47.76 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.189 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.8 tp -112.56 123.39 50.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.68 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.526 HD21 ' CD ' ' A' ' 27' ' ' LYS . 3.3 t-20 -118.02 128.38 54.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.963 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.1 mt -106.42 106.34 57.15 Favored Pre-proline 0 C--N 1.33 -0.278 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 81' ' ' THR . 55.6 Cg_endo -76.33 -40.39 0.63 Allowed 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.82 2.347 . . . . 0.0 112.851 -178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.564 ' C ' HD22 ' A' ' 24' ' ' LEU . 48.4 tptt -58.48 -43.55 89.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.614 -179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.799 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.0 mm? -99.58 -0.03 41.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.569 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.25 49.49 17.07 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.648 -0.421 . . . . 0.0 110.593 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.2 mtpp -127.66 165.42 20.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.945 0.402 . . . . 0.0 110.839 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.526 ' CD ' HD21 ' A' ' 20' ' ' ASN . 15.4 mtmt -140.59 145.82 37.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.103 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -142.6 145.47 33.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.861 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.0 m -90.01 129.18 36.36 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.188 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.421 HD12 ' CD1' ' A' ' 62' ' ' LEU . 37.0 mm -103.23 119.58 51.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.004 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -102.36 142.71 33.13 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.967 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.51 ' CZ2' ' HB ' ' A' ' 47' ' ' VAL . 46.0 t-105 -60.63 119.36 7.96 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 120.855 0.36 . . . . 0.0 110.611 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 83.08 159.53 27.54 Favored Glycine 0 C--N 1.332 0.307 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.14 97.92 7.45 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.566 -0.453 . . . . 0.0 110.729 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -94.42 110.29 22.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.895 0.379 . . . . 0.0 111.02 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -78.67 -20.06 51.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.589 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.51 -29.97 68.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.525 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 p -104.36 128.29 52.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.395 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.538 ' N ' ' CD2' ' A' ' 39' ' ' LEU . 3.1 mm? -83.9 -3.1 57.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.371 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 41' ' ' LYS . 27.1 tttt -71.64 133.44 45.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.134 -179.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.589 ' C ' ' H ' ' A' ' 43' ' ' VAL . 68.7 mttm 24.78 85.41 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.599 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.27 13.57 0.16 Allowed Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.589 ' H ' ' C ' ' A' ' 41' ' ' LYS . 2.5 t -90.92 99.52 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.385 0.612 . . . . 0.0 110.294 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -129.68 168.77 21.03 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.401 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 35.0 ttm -108.19 128.19 54.49 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -70.59 128.67 36.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.884 0.373 . . . . 0.0 110.565 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.51 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 1.1 m -109.35 133.67 53.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.71 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.696 ' N ' ' OG1' ' A' ' 51' ' ' THR . 12.9 m -161.5 177.17 10.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.576 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.559 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 46.5 t0 -67.7 -10.2 50.35 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.43 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 109' ' ' ILE . 4.6 m -118.1 -28.52 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.816 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.696 ' OG1' ' N ' ' A' ' 48' ' ' SER . 39.1 p -83.07 141.11 32.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.584 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.8 t -142.71 177.2 8.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.723 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.8 160.43 29.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.649 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.717 ' HG3' HD13 ' A' ' 84' ' ' LEU . 64.9 Cg_endo -77.53 83.1 2.23 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.863 2.375 . . . . 0.0 112.39 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 83.7 p -120.95 -1.51 9.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.619 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 142.25 90.96 0.15 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.72 86.85 0.04 OUTLIER Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 115' ' ' PRO . . . -163.04 155.62 27.04 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.686 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 17.5 t-160 -79.43 112.17 16.41 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.4 m -104.28 127.0 51.86 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.526 ' C ' HD22 ' A' ' 62' ' ' LEU . 71.1 t -119.19 128.97 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.917 0.389 . . . . 0.0 110.249 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.526 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.6 mm? -111.19 142.84 42.86 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.608 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 38.5 t -127.29 136.24 51.68 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.615 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.634 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -150.13 95.87 0.16 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.686 ' CG ' ' OD2' ' A' ' 126' ' ' ASP . 0.3 OUTLIER -70.66 139.13 51.2 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.625 ' CB ' ' O ' ' A' ' 65' ' ' HIS . 47.2 ttt-85 94.12 151.66 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.565 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 68' ' ' THR . 50.2 t0 -64.66 155.08 34.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.568 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.554 ' CB ' HE22 ' A' ' 75' ' ' GLN . 39.8 p -74.11 168.97 18.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.34 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.666 ' O ' HG13 ' A' ' 69' ' ' VAL . 8.3 p -99.49 114.38 37.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.502 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.528 ' O ' ' O ' ' A' ' 69' ' ' VAL . 0.2 OUTLIER 33.19 -156.66 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.658 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.2 p 42.27 34.44 0.5 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.507 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -62.63 -42.38 99.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.602 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.534 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -62.63 -39.71 94.68 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.409 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -64.73 -40.64 97.57 Favored Glycine 0 C--N 1.337 0.595 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.554 HE22 ' CB ' ' A' ' 68' ' ' THR . 52.7 mt-30 -66.24 -40.36 90.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.694 0.283 . . . . 0.0 110.963 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.86 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.9 pp -100.52 108.71 20.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.186 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.451 ' HB3' ' O ' ' A' ' 76' ' ' LEU . 14.7 ptmt 173.77 145.04 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.374 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -72.78 -14.06 61.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.674 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.0 mttm -83.0 -15.72 50.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.891 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.17 160.99 20.07 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.922 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.472 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -150.01 119.99 7.17 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.026 0.441 . . . . 0.0 109.973 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 14.3 mt -97.5 131.77 43.81 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.074 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 43.8 t -112.94 130.32 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.015 0.436 . . . . 0.0 110.458 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.87 HD11 HD12 ' A' ' 117' ' ' LEU . 39.0 mt -113.01 126.47 55.53 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.53 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -104.45 116.49 32.2 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.442 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.426 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.3 t80 -149.09 131.4 15.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.852 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.4 t70 60.78 42.44 13.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.352 . . . . 0.0 111.241 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 10.2 m120 61.34 15.69 6.75 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.021 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -115.2 146.97 40.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.496 179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -115.74 123.35 48.05 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.936 -179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.433 ' HB3' ' CD1' ' A' ' 141' ' ' LEU . 20.2 m-85 -106.28 137.09 44.84 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.682 179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.99 120.22 41.68 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.639 -0.424 . . . . 0.0 111.035 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.533 ' CE1' HD12 ' A' ' 84' ' ' LEU . 71.4 m-85 -112.91 155.65 24.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.729 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -130.3 138.73 50.62 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.59 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 9.2 mm -63.63 121.41 12.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 120.315 -0.554 . . . . 0.0 110.23 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 71.3 mm-40 -98.55 -52.8 3.51 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.933 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -150.46 141.49 23.0 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.465 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.511 HG23 HD12 ' A' ' 137' ' ' ILE . 76.3 mt -121.7 130.82 74.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.835 -179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 27.2 p90 -153.08 -176.15 5.65 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.868 0.366 . . . . 0.0 110.854 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.46 HG22 ' CB ' ' A' ' 133' ' ' ASP . 4.5 mt -128.25 131.71 68.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.5 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.3 t -142.71 169.46 17.54 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.045 0.45 . . . . 0.0 110.895 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -72.41 148.39 45.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.985 0.421 . . . . 0.0 110.452 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 134' ' ' ARG . . . -63.13 -19.48 64.5 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.629 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -88.96 11.8 17.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.082 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -84.9 88.4 7.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.375 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.838 ' O ' HG23 ' A' ' 110' ' ' ILE . 6.9 ptp85 -60.42 -31.82 70.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.485 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.496 ' O ' HD12 ' A' ' 110' ' ' ILE . 5.7 p -44.52 -14.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.25 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.886 HG12 HG21 ' A' ' 118' ' ' THR . 4.8 t -108.12 -16.43 8.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.044 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.763 ' O ' HG22 ' A' ' 109' ' ' ILE . 47.3 mm -107.51 12.16 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.048 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.838 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -79.42 -175.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.93 179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 18.4 ttmt -81.57 142.45 32.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.145 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.493 ' HB2' ' CG ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -116.09 130.59 56.88 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.317 -0.401 . . . . 0.0 109.949 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 113' ' ' GLU . 4.6 mt-10 -78.15 16.77 0.7 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.056 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 112' ' ' LYS . 0.0 OUTLIER -160.23 167.14 14.42 Favored Pre-proline 0 C--N 1.332 -0.19 0 C-N-CA 120.654 -0.419 . . . . 0.0 110.771 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.446 ' O ' HD13 ' A' ' 116' ' ' ILE . 37.3 Cg_endo -73.21 101.9 1.4 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.678 2.252 . . . . 0.0 111.414 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.446 HD13 ' O ' ' A' ' 115' ' ' PRO . 50.6 mm -131.13 136.42 57.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.357 -179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.87 HD12 HD11 ' A' ' 84' ' ' LEU . 6.3 tt -108.65 119.65 40.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.358 0.599 . . . . 0.0 110.681 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.886 HG21 HG12 ' A' ' 108' ' ' VAL . 61.7 m -118.2 125.11 49.52 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.202 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.83 ' C ' HD23 ' A' ' 119' ' ' LEU . 6.2 tt -112.97 124.9 53.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.388 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.757 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -120.54 116.47 25.46 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.503 179.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.646 ' OG1' ' N ' ' A' ' 122' ' ' CYS . 0.1 OUTLIER -136.29 -168.57 2.26 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.356 -179.183 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.646 ' N ' ' OG1' ' A' ' 121' ' ' THR . 3.6 t 94.62 -77.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.53 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.582 ' H ' ' HG3' ' A' ' 134' ' ' ARG . 51.4 m-85 58.97 134.87 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.278 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.75 -48.92 0.62 Allowed 'Trans proline' 0 N--CA 1.495 1.608 0 C-N-CA 122.8 2.333 . . . . 0.0 112.833 -179.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.414 ' CG ' ' N ' ' A' ' 126' ' ' ASP . 4.1 p90 -63.43 -33.47 75.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.618 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.686 ' OD2' ' CG ' ' A' ' 65' ' ' HIS . 40.0 t0 -80.27 -55.39 4.94 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.826 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.509 ' CZ ' ' O ' ' A' ' 128' ' ' ILE . 40.3 t80 -68.02 142.13 56.0 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.509 ' O ' ' CZ ' ' A' ' 127' ' ' TYR . 50.8 mm -90.38 121.08 40.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.012 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.437 ' O ' ' OD1' ' A' ' 130' ' ' ASP . . . 128.82 -121.26 3.54 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.437 ' OD1' ' O ' ' A' ' 129' ' ' GLY . 99.2 m-20 -139.6 101.46 4.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.798 0.332 . . . . 0.0 110.548 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.19 67.51 80.65 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.171 179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -52.08 -37.83 69.32 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.764 2.309 . . . . 0.0 112.411 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.46 ' CB ' HG22 ' A' ' 100' ' ' ILE . 97.9 m-20 -106.68 161.77 14.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.748 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.582 ' HG3' ' H ' ' A' ' 123' ' ' TYR . 7.3 mpt_? -104.16 143.98 32.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.055 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 120' ' ' THR . 2.8 t80 -69.13 124.97 25.22 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.413 -0.515 . . . . 0.0 109.881 -178.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.431 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 2.6 mm -111.01 112.16 39.33 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.561 HG22 ' O ' ' A' ' 137' ' ' ILE . 0.9 OUTLIER -100.37 112.22 32.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.233 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -95.51 140.29 30.56 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.389 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.85 138.76 21.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.966 179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -110.47 150.86 28.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.242 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.433 ' CD1' ' HB3' ' A' ' 91' ' ' TYR . 5.4 tp -72.46 122.59 21.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.355 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.94 -41.06 5.06 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.738 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.23 175.39 20.16 Favored Glycine 0 CA--C 1.522 0.52 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 94.3 p -155.85 160.85 40.54 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.65 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' THR . 92.9 m-85 -147.87 152.47 37.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.582 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.1 p -147.57 132.66 18.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.759 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.22 -0.465 0 CA-C-O 117.989 -1.005 . . . . 0.0 110.549 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 84.4 p -64.62 154.97 34.77 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.808 0.337 . . . . 0.0 110.44 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 65.5 m170 -116.05 142.4 46.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.559 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.8 mtt -88.8 137.84 31.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.635 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.1 t -87.31 -64.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.679 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 58.8 m -144.61 -126.8 0.08 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.558 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -59.89 142.99 52.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.473 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 73.4 p -112.85 164.45 13.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.82 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.611 ' C ' ' H ' ' A' ' 11' ' ' LYS . 95.7 mt-10 -151.87 134.19 15.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.016 0.436 . . . . 0.0 110.296 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 36.2 m80 57.81 -3.35 0.06 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.776 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.611 ' H ' ' C ' ' A' ' 9' ' ' GLU . 54.6 mmtt -61.14 162.5 7.27 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.31 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.558 ' OE2' HG11 ' A' ' 47' ' ' VAL . 97.6 mt-10 -107.31 123.86 48.95 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.377 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.577 ' N ' ' OE2' ' A' ' 14' ' ' GLU . . . 114.42 1.78 23.18 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.654 ' CD ' ' H ' ' A' ' 14' ' ' GLU . 0.0 OUTLIER -115.34 139.79 49.68 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.859 0.362 . . . . 0.0 110.278 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 89.0 tttt -58.67 120.74 9.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.642 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.408 HG11 ' HB2' ' A' ' 32' ' ' TRP . 24.1 m -116.23 -18.05 7.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.682 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -154.84 158.63 39.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.539 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.2 ttp -120.76 133.14 55.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.392 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.502 HD13 ' H ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -99.19 129.74 45.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.352 -179.875 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.502 ' H ' HD13 ' A' ' 19' ' ' LEU . 27.4 t-20 -125.69 124.01 40.16 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.988 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.496 HD13 ' NE2' ' A' ' 75' ' ' GLN . 6.9 mt -105.9 109.74 63.45 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.855 179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HD2' ' O ' ' A' ' 81' ' ' THR . 57.2 Cg_endo -75.89 -42.92 0.36 Allowed 'Trans proline' 0 C--N 1.312 -1.378 0 C-N-CA 122.577 2.185 . . . . 0.0 112.6 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HB3' HD22 ' A' ' 24' ' ' LEU . 8.1 tmtm? -60.57 -40.12 90.48 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.253 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.793 HD12 HG21 ' A' ' 71' ' ' THR . 3.7 mm? -98.53 -2.35 38.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 0.0 110.489 179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 54.46 42.66 31.23 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.689 179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.489 ' HE3' ' CZ ' ' A' ' 28' ' ' PHE . 4.2 mtpp -124.03 163.01 22.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.093 0.473 . . . . 0.0 110.636 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG2' ' CG ' ' A' ' 20' ' ' ASN . 34.9 mtmt -141.89 143.37 33.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.007 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.489 ' CZ ' ' HE3' ' A' ' 26' ' ' LYS . 89.4 m-85 -137.71 152.23 49.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.805 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 43' ' ' VAL . 4.9 t -97.15 124.82 41.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.772 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.531 HD12 HD11 ' A' ' 62' ' ' LEU . 40.4 mm -92.56 126.2 45.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.556 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.561 ' CE1' ' OG ' ' A' ' 29' ' ' SER . 89.1 m-85 -114.16 138.47 50.4 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.957 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.646 ' CZ3' HG22 ' A' ' 53' ' ' THR . 41.5 t-105 -60.74 126.85 28.92 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.604 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.634 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 84.28 169.79 45.96 Favored Glycine 0 C--N 1.331 0.289 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -141.77 99.3 3.51 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.783 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -101.11 114.72 28.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.837 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -73.54 -23.69 60.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.759 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.47 90.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.709 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 40' ' ' LYS . 1.3 m -69.76 131.35 44.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.435 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 14.6 mt -92.82 -1.63 56.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.472 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.414 ' H ' HG22 ' A' ' 38' ' ' THR . 50.0 mtmt -106.19 33.28 3.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.941 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -126.12 141.46 51.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -132.58 -31.5 0.46 Allowed Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 29' ' ' SER . 0.0 OUTLIER -136.38 105.18 4.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-O 121.064 0.459 . . . . 0.0 110.827 179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.54 154.32 16.93 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.513 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 40.1 ttm -103.8 144.48 31.43 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -73.54 143.95 46.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.516 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG23 ' HA2' ' A' ' 33' ' ' GLY . 78.8 t -115.87 129.81 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.367 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 27.4 p -166.83 -173.92 2.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.65 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -89.28 -23.75 22.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.489 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.542 ' CG2' ' O ' ' A' ' 109' ' ' ILE . 5.8 m -92.13 -38.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.687 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.459 ' N ' HG23 ' A' ' 50' ' ' VAL . 63.6 p -78.53 153.23 31.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.556 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 t -150.24 172.09 15.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.459 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.646 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -84.91 153.92 60.68 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.701 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.44 80.65 2.69 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.546 2.164 . . . . 0.0 112.34 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 72.5 p -107.48 -13.39 15.09 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.755 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.62 88.99 0.08 OUTLIER Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 74.42 80.23 0.51 Allowed Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.455 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -165.97 158.42 31.32 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.695 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 15.3 t-160 -81.75 121.73 26.77 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 32.8 m -116.17 129.48 56.34 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.274 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.588 HG11 ' CD1' ' A' ' 109' ' ' ILE . 58.3 t -116.35 126.1 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.221 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.531 HD11 HD12 ' A' ' 30' ' ' ILE . 2.4 mm? -108.47 138.89 44.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.125 0.488 . . . . 0.0 110.529 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.3 t -121.63 138.67 54.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.876 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -152.5 155.27 26.03 Favored Glycine 0 CA--C 1.531 1.037 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.516 ' O ' ' O ' ' A' ' 66' ' ' ARG . 3.1 m80 -98.7 132.18 44.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.864 0.364 . . . . 0.0 110.677 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.516 ' O ' ' O ' ' A' ' 65' ' ' HIS . 27.9 ttm180 56.7 127.91 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.393 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.65 ' O ' HG13 ' A' ' 69' ' ' VAL . 26.0 p-10 -66.83 -26.16 66.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.687 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.5 m -42.47 97.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.474 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 67' ' ' ASP . 11.6 m -122.75 31.72 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.62 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 70' ' ' PHE . 1.9 m-85 67.78 -55.32 0.49 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.691 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.793 HG21 HD12 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -108.78 74.19 0.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.759 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.414 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 4.8 t70 -65.86 -38.48 88.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.538 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.417 ' O ' ' HE3' ' A' ' 77' ' ' LYS . 96.6 mt -73.6 -15.65 61.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.905 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' A' ' 77' ' ' LYS . . . -91.91 -44.99 4.02 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.496 ' NE2' HD13 ' A' ' 21' ' ' ILE . 92.5 mm-40 -68.41 -41.22 80.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.78 0.324 . . . . 0.0 110.696 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.574 HD22 ' HE2' ' A' ' 135' ' ' TYR . 8.2 mt -93.85 89.42 6.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.491 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 74' ' ' GLY . 6.3 ptpt -176.25 145.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.427 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -69.8 -21.99 63.35 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.739 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -76.39 -14.63 60.06 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.152 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.68 154.93 39.47 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.789 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.427 ' O ' ' HD2' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -137.92 133.17 33.45 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.838 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 50.4 mt -109.23 124.68 51.27 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.785 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.625 ' CG1' HG22 ' A' ' 90' ' ' THR . 40.0 t -106.37 116.65 50.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 C-N-CA 120.405 -0.518 . . . . 0.0 109.981 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.868 HD21 HD12 ' A' ' 117' ' ' LEU . 8.1 mp -98.54 127.04 44.32 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.031 -179.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.695 ' HG2' HG23 ' A' ' 90' ' ' THR . 95.4 mt-10 -106.54 117.3 33.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.244 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -148.23 131.95 16.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.846 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 59.32 49.33 9.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.514 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 56.91 13.28 1.43 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.049 0.452 . . . . 0.0 110.259 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -114.9 144.81 42.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.61 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.695 HG23 ' HG2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -114.08 123.31 49.34 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.673 -179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.412 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 14.6 m-85 -104.38 145.14 30.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.453 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.585 ' HG1' ' HE2' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -109.56 114.66 28.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.315 -179.173 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.522 ' CE1' HD22 ' A' ' 84' ' ' LEU . 78.3 m-85 -113.03 151.46 30.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.609 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -128.83 141.65 51.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.786 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.571 ' CD1' HD12 ' A' ' 137' ' ' ILE . 1.5 mm -64.38 119.2 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 C-N-CA 119.98 -0.688 . . . . 0.0 110.362 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -86.17 -62.92 1.41 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.024 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -145.87 150.92 37.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.307 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.415 HG12 HD13 ' A' ' 137' ' ' ILE . 12.0 mt -122.62 134.35 66.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.059 -179.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.705 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 15.8 p90 -161.87 -179.74 7.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.034 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.645 ' N ' HD12 ' A' ' 100' ' ' ILE . 1.3 mp -128.69 129.25 68.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.257 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.46 HG22 ' CG1' ' A' ' 136' ' ' ILE . 7.6 t -127.16 173.5 9.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.006 0.432 . . . . 0.0 110.68 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.79 161.55 30.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.526 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -73.08 -11.74 60.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.761 -179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -101.71 22.69 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.628 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.596 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 50.1 t0 -92.04 100.83 13.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.594 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.852 ' O ' HG23 ' A' ' 110' ' ' ILE . 2.7 ptt180 -79.71 -20.06 47.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.372 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.596 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 20.0 p -48.39 -16.9 0.12 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.615 -179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.555 ' HB ' HG21 ' A' ' 118' ' ' THR . 8.8 m -109.4 -6.56 11.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.233 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.718 ' O ' HG22 ' A' ' 109' ' ' ILE . 47.8 mm -113.44 7.76 7.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.937 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.852 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -79.52 -171.7 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.819 -179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.467 ' CB ' ' HB ' ' A' ' 50' ' ' VAL . 19.5 ttpt -102.5 141.59 35.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.938 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.402 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 87.0 mttt -124.89 151.91 44.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.574 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -92.41 7.26 43.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.204 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -130.94 159.59 70.68 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.762 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.455 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 43.6 Cg_endo -74.58 94.88 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.978 2.452 . . . . 0.0 111.894 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 115' ' ' PRO . 48.2 mm -126.41 134.77 65.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.137 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.868 HD12 HD21 ' A' ' 84' ' ' LEU . 6.1 tt -108.92 118.48 36.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.251 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.555 HG21 ' HB ' ' A' ' 108' ' ' VAL . 92.1 m -115.14 119.69 37.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.369 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.994 HD12 ' N ' ' A' ' 120' ' ' THR . 0.7 OUTLIER -105.86 124.97 50.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.361 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.994 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -121.57 124.37 44.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.932 179.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.537 ' O ' ' CB ' ' A' ' 122' ' ' CYS . 1.3 t -152.17 170.45 19.94 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.305 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 121' ' ' THR . 1.7 p 158.19 -66.04 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.871 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.537 ' N ' ' HD3' ' A' ' 124' ' ' PRO . 17.1 m-85 38.54 60.76 5.03 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.646 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 123' ' ' TYR . 11.3 Cg_exo -70.81 160.81 48.2 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 123.291 2.661 . . . . 0.0 112.125 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -51.75 -25.34 7.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.362 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.603 ' O ' ' N ' ' A' ' 128' ' ' ILE . 38.2 t70 -94.63 5.55 51.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.549 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.581 ' O ' ' C ' ' A' ' 128' ' ' ILE . 2.2 t80 -43.11 -14.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.578 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.603 ' N ' ' O ' ' A' ' 126' ' ' ASP . 38.8 mm -19.99 92.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.589 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 127' ' ' TYR . . . 80.56 -102.2 2.08 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 110.759 -0.936 . . . . 0.0 110.759 -179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -104.04 118.93 37.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.688 0.28 . . . . 0.0 110.868 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -53.7 141.91 44.54 Favored Pre-proline 0 C--O 1.232 0.177 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.578 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.12 -27.93 56.89 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.623 2.215 . . . . 0.0 111.819 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.605 ' OD1' HG22 ' A' ' 100' ' ' ILE . 6.8 t0 -163.2 115.67 1.53 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.396 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.632 ' NE ' ' OG1' ' A' ' 120' ' ' THR . 5.6 ptm180 -98.42 138.55 35.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.094 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.574 ' HE2' HD22 ' A' ' 76' ' ' LEU . 4.5 t80 -69.92 136.53 50.69 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 120.455 -0.498 . . . . 0.0 109.827 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.705 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 9.3 mm -120.84 115.68 47.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 C-N-CA 120.375 -0.53 . . . . 0.0 111.421 -179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.571 HD12 ' CD1' ' A' ' 95' ' ' ILE . 1.6 mm -106.99 107.32 22.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -94.24 140.32 29.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.197 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.75 142.92 27.16 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.132 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.436 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 67.2 tttt -117.44 152.78 34.3 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.996 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.479 ' HB2' ' CE2' ' A' ' 93' ' ' TYR . 7.2 tp -73.23 124.19 25.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.455 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.19 -43.65 5.41 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.343 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -137.27 -178.97 16.34 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 34.9 p -153.78 160.29 42.21 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.708 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.585 ' HE2' ' HG1' ' A' ' 92' ' ' THR . 59.7 m-85 -149.06 156.03 41.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.535 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 64.6 p -147.26 130.94 16.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.594 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 62.9 pttt . . . . . 0 C--O 1.221 -0.422 0 CA-C-O 118.003 -0.999 . . . . 0.0 110.526 179.906 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.459 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.459 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 2.2 t 77.68 -127.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.838 0.352 . . . . 0.0 110.727 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -66.73 -40.0 88.19 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.428 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.423 ' O ' ' O ' ' A' ' 1' ' ' GLY . 3.0 tpt -151.46 -161.08 1.25 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.572 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 60.5 m -70.42 153.21 43.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.562 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.3 t -65.62 -83.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.775 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' O ' HG23 ' A' ' 8' ' ' THR . 87.3 mt-30 -106.14 134.87 48.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.543 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 7' ' ' GLN . 3.1 p -153.06 -114.57 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.715 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -97.79 -115.63 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.535 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -107.51 39.3 1.94 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.68 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.613 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 70.6 mmtt -65.52 151.23 46.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.799 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.64 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 52.9 mp0 -90.72 151.89 21.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.387 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 83.79 18.11 64.27 Favored Glycine 0 CA--C 1.519 0.336 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.613 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.2 OUTLIER -121.97 133.73 54.83 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.537 179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 64.4 tttp -60.08 112.03 1.74 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.344 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.44 HG13 ' O ' ' A' ' 14' ' ' GLU . 24.5 m -114.07 -26.38 3.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.965 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 30' ' ' ILE . . . -144.08 158.02 43.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.598 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.1 ttp -120.6 140.59 51.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.343 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.486 ' HB2' HD11 ' A' ' 30' ' ' ILE . 55.4 tp -108.96 125.66 52.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.577 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -121.25 133.88 55.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.432 HG22 ' H ' ' A' ' 24' ' ' LEU . 6.0 mt -119.59 111.24 36.39 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 81' ' ' THR . 56.8 Cg_endo -76.02 -36.94 1.74 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.735 2.29 . . . . 0.0 112.843 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.578 ' C ' HD22 ' A' ' 24' ' ' LEU . 39.8 tptt -61.1 -36.83 80.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.582 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.726 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.5 mm? -103.61 -0.51 29.54 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.642 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 53.59 50.72 16.6 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.247 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -141.22 175.7 9.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.036 0.446 . . . . 0.0 110.287 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -158.76 157.47 31.73 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.707 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -144.05 159.73 42.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.826 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.457 ' O ' HG23 ' A' ' 43' ' ' VAL . 4.3 m -99.83 116.14 31.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.012 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 62' ' ' LEU . 35.3 mm -80.39 126.67 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.247 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 70.8 m-85 -111.03 137.79 48.23 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.988 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.435 ' O ' ' N ' ' A' ' 13' ' ' GLY . 41.5 t-105 -60.14 117.31 4.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.695 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.614 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 94.24 166.3 36.76 Favored Glycine 0 C--N 1.335 0.475 0 N-CA-C 111.094 -0.802 . . . . 0.0 111.094 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -155.31 101.28 2.2 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.703 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -84.5 113.86 21.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.882 0.372 . . . . 0.0 110.808 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -62.13 -45.31 94.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.574 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.75 -48.88 75.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.553 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.484 ' O ' ' OG1' ' A' ' 38' ' ' THR . 2.9 p -110.52 92.96 4.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.194 179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 86.5 mt -83.97 108.38 16.91 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.809 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -79.77 -53.59 6.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.497 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -131.11 148.47 52.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.736 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -57.34 -16.63 21.58 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 29' ' ' SER . 5.1 m -116.6 94.92 3.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 CA-C-O 121.379 0.609 . . . . 0.0 111.155 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -108.17 142.65 15.99 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.575 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 13.4 tpt -95.3 138.1 33.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.714 0.292 . . . . 0.0 110.713 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -77.69 137.56 38.57 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.982 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.614 HG23 ' HA2' ' A' ' 33' ' ' GLY . 86.9 t -119.34 114.81 45.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.242 179.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.54 ' N ' ' OG1' ' A' ' 51' ' ' THR . 6.1 m -163.28 169.35 19.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.686 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.575 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 65.1 t0 -70.85 -8.84 55.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.432 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.715 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.2 m -110.42 -22.95 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.645 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.54 ' OG1' ' N ' ' A' ' 48' ' ' SER . 37.0 p -85.58 138.21 32.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.398 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.572 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -131.0 168.17 17.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.891 -179.71 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.22 161.0 28.57 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.594 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.522 ' HG3' HD23 ' A' ' 84' ' ' LEU . 66.7 Cg_endo -81.29 73.65 5.83 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.635 2.224 . . . . 0.0 112.365 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 33.6 p -115.76 -6.33 12.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.754 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 146.01 91.98 0.12 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.47 79.22 0.16 Allowed Glycine 0 CA--C 1.53 1.028 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.456 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -155.29 150.83 22.41 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.483 -1.047 . . . . 0.0 110.483 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.645 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 16.7 t-160 -77.58 104.99 8.44 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.46 ' HA ' ' HE1' ' A' ' 45' ' ' MET . 38.3 m -100.19 122.43 43.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.433 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.599 ' C ' HD22 ' A' ' 62' ' ' LEU . 54.1 t -114.77 127.44 72.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.966 0.412 . . . . 0.0 110.276 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.599 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.7 mm? -112.36 147.13 37.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.684 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 120' ' ' THR . 32.6 t -128.99 142.29 50.97 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.619 -179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.632 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -165.82 169.87 40.34 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 111.394 -0.682 . . . . 0.0 111.394 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.584 ' ND1' ' N ' ' A' ' 65' ' ' HIS . 0.1 OUTLIER -123.5 146.33 48.16 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 122.497 -0.414 . . . . 0.0 110.716 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.453 HH11 ' HD3' ' A' ' 66' ' ' ARG . 51.5 mtt-85 -63.44 109.91 1.77 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.732 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -77.3 -72.26 0.36 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.708 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 88.7 m -136.24 139.57 42.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.683 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 1.1 m -82.34 96.6 3.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.335 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -134.02 -73.29 0.48 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.632 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.595 ' O ' ' NE2' ' A' ' 75' ' ' GLN . 0.8 OUTLIER -93.48 72.1 4.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.064 0.459 . . . . 0.0 110.652 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -64.61 -33.93 77.09 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.241 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.405 ' O ' ' HE3' ' A' ' 77' ' ' LYS . 17.0 mt -61.23 -45.55 94.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.809 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.42 -37.38 93.74 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.595 ' NE2' ' O ' ' A' ' 71' ' ' THR . 0.7 OUTLIER -64.37 -36.18 83.3 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.785 0.326 . . . . 0.0 110.405 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.849 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.2 pp -136.13 112.56 9.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.324 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.489 ' O ' HG21 ' A' ' 95' ' ' ILE . 7.8 ptpt -179.99 144.68 0.19 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 120.858 0.361 . . . . 0.0 110.348 179.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -79.52 -11.51 59.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.947 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -83.59 -13.95 53.19 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.898 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.683 ' OD1' ' N ' ' A' ' 81' ' ' THR . 23.4 t0 -81.06 158.04 25.21 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.215 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.683 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.6 p -138.48 135.44 35.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.7 mt -109.79 122.09 46.71 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.355 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.486 ' C ' HD12 ' A' ' 84' ' ' LEU . 5.7 t -104.33 121.93 56.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.995 0.426 . . . . 0.0 110.263 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.811 HD21 HD12 ' A' ' 117' ' ' LEU . 8.0 mp -103.59 129.54 50.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.367 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.9 mt-10 -105.44 120.86 42.66 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.941 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.444 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 2.1 t80 -149.38 127.67 12.14 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.933 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 64.4 t0 54.02 52.68 12.38 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.827 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.487 HD22 ' N ' ' A' ' 88' ' ' ASN . 1.3 m-80 57.18 12.23 1.27 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.448 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 49.9 mtmt -112.72 141.63 46.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.956 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.454 ' HG1' ' HB2' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -113.65 126.08 54.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.339 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 10.5 m-85 -109.3 134.83 51.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.102 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.44 ' HG1' ' HE2' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -101.96 115.28 30.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.047 -179.349 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.497 ' CE1' HD22 ' A' ' 84' ' ' LEU . 75.7 m-85 -110.95 144.27 40.3 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.582 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -119.74 138.27 53.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.672 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.493 ' CD1' HG23 ' A' ' 137' ' ' ILE . 2.3 mm -66.2 115.95 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.411 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 81.9 mm-40 -86.63 -60.62 1.94 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.593 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 54.3 tttt -152.72 145.1 24.03 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 121.197 0.522 . . . . 0.0 110.26 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.7 mp -119.56 131.45 72.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.541 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.496 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 26.5 p90 -149.61 -177.51 5.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.01 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.734 ' N ' HD12 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -130.33 132.42 64.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.356 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.2 t -138.98 178.9 6.82 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.712 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -68.5 148.71 50.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.564 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.9 -34.31 75.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.363 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -82.8 16.69 2.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.724 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.644 ' OD2' HG23 ' A' ' 108' ' ' VAL . 28.5 t70 -79.63 90.52 5.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.571 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.98 ' O ' HG23 ' A' ' 110' ' ' ILE . 17.0 ptp180 -63.57 -37.92 89.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.515 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.507 ' N ' ' HG3' ' A' ' 106' ' ' ARG . 1.6 p -38.71 -18.33 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.522 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.851 HG12 HG21 ' A' ' 118' ' ' THR . 11.1 t -111.18 -16.53 9.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.107 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.785 ' O ' HG22 ' A' ' 109' ' ' ILE . 49.3 mm -112.32 22.34 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.904 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.98 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -89.94 -163.28 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.837 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.9 ttmt -102.69 148.31 25.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.686 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.421 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 98.1 mttt -132.9 150.46 52.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.635 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -94.94 8.98 41.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.401 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.27 163.9 46.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.767 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.456 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 50.2 Cg_endo -79.04 98.5 1.19 Allowed 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 123.071 2.514 . . . . 0.0 111.624 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 115' ' ' PRO . 50.2 mm -128.84 138.29 54.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.179 -0.919 . . . . 0.0 111.439 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.824 HD23 ' C ' ' A' ' 117' ' ' LEU . 6.5 tt -110.13 116.48 31.61 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.666 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.851 HG21 HG12 ' A' ' 108' ' ' VAL . 72.3 m -116.03 114.76 25.01 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.324 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.843 HD12 ' N ' ' A' ' 120' ' ' THR . 0.9 OUTLIER -103.71 116.32 32.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.026 179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.843 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -107.22 122.87 47.39 Favored 'General case' 0 C--N 1.333 -0.145 0 O-C-N 123.431 0.457 . . . . 0.0 110.403 179.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.632 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.4 t -156.08 178.9 9.76 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.06 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 121' ' ' THR . 1.6 p 158.54 -75.14 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.791 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 47.88 67.01 4.9 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.027 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.4 160.82 32.06 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 123.08 2.52 . . . . 0.0 112.237 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.562 ' CE1' ' OD2' ' A' ' 126' ' ' ASP . 8.9 p90 -51.99 -17.19 0.93 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.978 0.418 . . . . 0.0 110.314 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.562 ' OD2' ' CE1' ' A' ' 125' ' ' PHE . 1.3 p30 -108.44 26.63 10.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.637 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.677 ' O ' ' O ' ' A' ' 129' ' ' GLY . 14.7 t80 -56.6 -49.36 75.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.632 ' C ' ' O ' ' A' ' 127' ' ' TYR . 21.6 mt 9.52 78.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 O-C-N 123.732 0.645 . . . . 0.0 110.739 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.677 ' O ' ' O ' ' A' ' 127' ' ' TYR . . . 87.98 157.2 31.54 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.558 ' C ' ' O ' ' A' ' 129' ' ' GLY . 10.0 p30 -27.39 99.16 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.896 0.379 . . . . 0.0 110.681 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' A' ' 129' ' ' GLY . . . -47.69 130.41 11.08 Favored Pre-proline 0 CA--C 1.534 0.344 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.623 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -48.64 -41.4 37.63 Favored 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.484 2.122 . . . . 0.0 111.876 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -124.5 125.94 45.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.418 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.447 HH11 ' HD3' ' A' ' 134' ' ' ARG . 7.7 ttp180 -113.07 142.46 45.7 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.809 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.685 ' CE2' HD11 ' A' ' 137' ' ' ILE . 7.9 t80 -81.9 123.28 28.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 1.6 mt -119.55 124.17 72.43 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 CA-C-O 120.978 0.418 . . . . 0.0 111.959 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.685 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.4 mp -103.04 112.62 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.816 178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.496 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 10.4 tt0 -90.11 142.72 27.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.868 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -152.86 149.72 28.58 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.822 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.451 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 66.7 tttt -123.45 153.4 40.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.108 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.451 ' N ' ' CG ' ' A' ' 140' ' ' LYS . 13.8 tp -71.7 126.6 30.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.435 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.68 -36.83 5.36 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.628 179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.425 ' C ' ' OG1' ' A' ' 92' ' ' THR . . . -141.32 162.33 26.87 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 83.0 p -142.72 133.17 24.94 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.294 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.454 ' HB2' ' HG1' ' A' ' 90' ' ' THR . 62.8 m-85 -123.01 101.6 7.52 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.684 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.526 ' O ' ' O ' ' A' ' 147' ' ' LYS . 8.6 p -89.38 136.93 32.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.703 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.526 ' O ' ' O ' ' A' ' 146' ' ' SER . 22.0 mtpt . . . . . 0 C--O 1.22 -0.462 0 CA-C-O 117.976 -1.011 . . . . 0.0 110.554 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.684 ' O ' ' ND1' ' A' ' 3' ' ' HIS . 16.1 p -77.37 170.09 17.17 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.684 ' ND1' ' O ' ' A' ' 2' ' ' SER . 6.8 m80 83.91 129.72 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.632 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 42.8 mtm -96.02 140.15 31.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.621 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.5 t -93.83 35.45 1.14 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.656 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.0 t -74.39 153.74 39.11 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.82 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -103.49 44.06 1.04 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.495 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.08 -48.73 13.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.034 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.631 ' O ' ' N ' ' A' ' 11' ' ' LYS . 2.7 tm-20 -128.94 165.05 21.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.654 -179.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.729 ' CD2' ' H ' ' A' ' 10' ' ' HIS . 0.5 OUTLIER -51.38 79.26 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.573 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.631 ' N ' ' O ' ' A' ' 9' ' ' GLU . 27.4 ttmt -105.12 157.57 17.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.645 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -92.12 147.58 22.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.292 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.41 3.74 68.96 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.556 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.8 OUTLIER -109.7 137.5 47.41 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.878 0.371 . . . . 0.0 110.483 -179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -62.77 117.17 5.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.195 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.1 m -116.31 -39.93 2.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.746 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.92 162.18 33.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.592 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 37.7 ttm -127.2 135.66 50.96 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.527 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.3 tt -101.53 121.53 42.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.195 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 21' ' ' ILE . 3.8 t30 -116.79 136.07 53.25 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.419 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.596 HD13 HE22 ' A' ' 75' ' ' GLN . 3.4 mt -113.57 118.3 43.53 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.175 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.664 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.7 Cg_endo -76.55 -48.36 0.13 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.857 2.371 . . . . 0.0 112.674 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.566 ' C ' HD22 ' A' ' 24' ' ' LEU . 27.1 tptp -61.57 -39.4 91.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.764 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.1 mm? -99.49 0.68 42.94 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.768 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt 45.61 38.74 4.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.909 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.9 mtpt -117.18 157.59 25.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.841 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.6 mtmt -137.57 136.35 37.5 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.725 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -126.27 120.96 31.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.414 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.8 m -67.32 119.42 12.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.916 0.389 . . . . 0.0 110.646 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.543 HD12 ' CD1' ' A' ' 62' ' ' LEU . 40.0 mm -95.73 120.68 45.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.542 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -106.71 147.97 28.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.641 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.768 ' CZ3' ' SD ' ' A' ' 45' ' ' MET . 46.4 t-105 -60.8 117.73 5.77 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.861 0.362 . . . . 0.0 110.454 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.666 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 85.94 153.67 22.37 Favored Glycine 0 C--N 1.332 0.311 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' CB ' ' OG ' ' A' ' 63' ' ' SER . . . -124.25 78.99 1.7 Allowed 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 120.796 -0.362 . . . . 0.0 110.662 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -101.85 133.41 46.65 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.648 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 43.6 p-10 -88.2 -3.89 58.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.554 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.38 -25.96 67.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.546 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.507 ' OG1' ' N ' ' A' ' 39' ' ' LEU . 6.9 t -64.9 -153.8 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.517 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.7 HD12 ' N ' ' A' ' 39' ' ' LEU . 7.6 mp -72.62 -124.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.684 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -92.67 -48.03 6.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.697 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.0 tptt -61.92 131.6 50.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.473 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -139.5 39.65 1.51 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.4 t -96.93 126.32 49.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.467 0.651 . . . . 0.0 110.781 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.22 -172.8 42.16 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.768 ' SD ' ' CZ3' ' A' ' 32' ' ' TRP . 1.5 tmt? -93.68 146.97 23.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.94 0.4 . . . . 0.0 110.965 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.562 ' O ' ' SD ' ' A' ' 45' ' ' MET . 57.8 t80 -76.72 130.29 37.54 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.371 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.666 HG23 ' HA2' ' A' ' 33' ' ' GLY . 63.5 t -96.62 125.96 49.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.002 0.429 . . . . 0.0 110.669 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.588 ' HG ' ' CB ' ' A' ' 51' ' ' THR . 38.5 p -160.45 176.25 11.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.575 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.586 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 65.9 t0 -82.7 -7.14 59.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.542 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.703 HG21 ' O ' ' A' ' 109' ' ' ILE . 9.0 m -115.45 -32.18 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.599 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.588 ' CB ' ' HG ' ' A' ' 48' ' ' SER . 72.8 p -78.9 145.35 34.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.78 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -145.24 171.18 14.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.535 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.467 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.3 OUTLIER -90.04 154.39 47.31 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.848 -179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.78 84.25 1.8 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.689 2.259 . . . . 0.0 112.415 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.6 p -117.02 -4.49 11.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.828 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.15 88.98 0.07 OUTLIER Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.059 -0.816 . . . . 0.0 111.059 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.13 91.23 0.01 OUTLIER Glycine 0 CA--C 1.528 0.901 0 N-CA-C 110.846 -0.901 . . . . 0.0 110.846 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.471 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.96 165.34 38.67 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.679 -0.969 . . . . 0.0 110.679 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.502 ' CD2' ' HD2' ' A' ' 112' ' ' LYS . 13.2 t-160 -84.24 111.87 19.77 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.413 HG22 HD23 ' A' ' 62' ' ' LEU . 61.2 m -105.61 123.22 47.56 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.352 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.587 ' O ' HD22 ' A' ' 62' ' ' LEU . 44.9 t -116.57 126.87 74.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.549 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.587 HD22 ' O ' ' A' ' 61' ' ' VAL . 2.5 mm? -114.16 143.97 43.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.819 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.423 ' OG ' ' CB ' ' A' ' 34' ' ' ALA . 4.9 p -132.86 147.5 52.3 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.56 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.469 ' O ' HG22 ' A' ' 121' ' ' THR . . . -169.43 161.94 35.47 Favored Glycine 0 CA--C 1.534 1.225 0 N-CA-C 111.429 -0.668 . . . . 0.0 111.429 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.713 ' ND1' ' CG ' ' A' ' 123' ' ' TYR . 90.6 m-70 -110.62 145.41 37.93 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.664 -0.415 . . . . 0.0 110.639 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 47.07 -79.62 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.718 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.687 ' N ' ' O ' ' A' ' 65' ' ' HIS . 20.2 t0 59.92 148.46 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.6 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.578 HG23 ' OG1' ' A' ' 71' ' ' THR . 8.1 m 61.43 148.99 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.624 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 96.4 t -113.78 -49.4 5.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.719 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -138.19 -12.68 1.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.606 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.578 ' OG1' HG23 ' A' ' 68' ' ' THR . 57.1 p -87.7 25.46 1.49 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.33 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.473 ' N ' HG21 ' A' ' 68' ' ' THR . 2.6 m-20 -62.75 -36.02 81.7 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.657 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.715 ' O ' HD13 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -61.8 -42.4 98.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.417 -179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.415 ' HA3' HD11 ' A' ' 24' ' ' LEU . . . -68.51 -34.59 79.49 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.596 HE22 HD13 ' A' ' 21' ' ' ILE . 52.7 mm-40 -61.49 -41.15 96.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.716 0.293 . . . . 0.0 110.792 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.84 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.0 pp -97.11 109.3 22.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.025 0.44 . . . . 0.0 110.789 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.42 ' CG ' ' C ' ' A' ' 76' ' ' LEU . 2.3 ptpt 172.2 143.32 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.445 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -69.63 -14.83 63.02 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.721 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -82.07 -14.32 56.01 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.239 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.23 158.91 34.98 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.06 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.664 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -147.67 111.05 4.91 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.235 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 19.0 mt -87.77 131.24 34.58 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.224 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.679 HG12 HG22 ' A' ' 90' ' ' THR . 2.8 t -112.61 122.39 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.204 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.588 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.2 mm? -107.98 133.24 52.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.343 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.635 ' HG2' HG23 ' A' ' 90' ' ' THR . 96.5 mt-10 -104.25 118.04 35.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.373 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.467 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 1.0 OUTLIER -146.87 125.81 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.764 -179.83 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 60.14 51.65 5.55 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.156 179.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 56.53 11.39 0.85 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.445 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.454 ' HG2' ' CB ' ' A' ' 146' ' ' SER . 45.0 mtpt -112.01 145.05 40.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.612 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.679 HG22 HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -113.71 117.2 30.86 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.344 -179.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 8.6 m-85 -95.17 136.23 35.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.412 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.481 ' O ' HD12 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -105.91 113.79 27.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.659 -179.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -110.9 147.23 35.04 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.525 179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -123.67 138.9 54.45 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.882 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.651 ' CD1' HG23 ' A' ' 137' ' ' ILE . 8.0 mm -65.89 118.98 9.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 C-N-CA 120.279 -0.569 . . . . 0.0 110.038 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -95.94 -62.01 1.35 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.485 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.0 tptm -139.77 135.27 32.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.407 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.9 mt -114.18 127.86 71.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.205 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.49 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 21.4 p90 -151.14 -176.35 5.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.73 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.435 HG12 ' CD1' ' A' ' 135' ' ' TYR . 8.0 mt -129.34 138.85 53.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.46 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.42 HG23 ' HE ' ' A' ' 134' ' ' ARG . 2.2 t -137.55 170.43 16.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.093 0.473 . . . . 0.0 110.776 -179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.56 ' C ' ' H ' ' A' ' 104' ' ' ASP . 0.4 OUTLIER -73.57 154.72 39.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.555 -179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.55 8.58 0.11 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.67 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.56 ' H ' ' C ' ' A' ' 102' ' ' HIS . 57.8 t0 -131.53 36.53 3.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.556 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.541 ' H ' HH21 ' A' ' 134' ' ' ARG . 21.7 t0 -96.44 94.78 7.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.69 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.985 ' O ' HG23 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -62.45 -35.52 79.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.463 179.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.529 ' C ' HD12 ' A' ' 110' ' ' ILE . 1.2 p -44.91 -13.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.354 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.891 ' CG1' HG21 ' A' ' 118' ' ' THR . 15.7 t -113.46 -12.67 11.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.116 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.734 ' O ' HG22 ' A' ' 109' ' ' ILE . 50.9 mm -117.68 22.2 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.164 0.507 . . . . 0.0 111.064 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 1.016 ' H ' HD13 ' A' ' 110' ' ' ILE . 0.2 OUTLIER -87.28 -161.93 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.706 179.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 30.1 ttmt -104.45 147.07 27.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.04 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 98.6 mttt -142.82 136.27 28.61 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.305 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.15 16.23 8.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.465 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -125.93 151.47 71.4 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.784 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.471 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 37.0 Cg_endo -72.33 80.84 1.57 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.995 2.464 . . . . 0.0 111.275 179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.4 mm -115.5 132.85 63.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.287 -179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.812 HD23 ' C ' ' A' ' 117' ' ' LEU . 5.7 tt -106.13 118.79 37.53 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.178 0.513 . . . . 0.0 110.739 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.891 HG21 ' CG1' ' A' ' 108' ' ' VAL . 90.8 m -112.78 120.88 43.0 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.784 -0.643 . . . . 0.0 110.162 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.702 HD23 ' N ' ' A' ' 120' ' ' THR . 0.4 OUTLIER -108.26 119.68 40.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.414 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.702 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -111.17 115.63 29.71 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.81 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.509 HG23 ' CD2' ' A' ' 119' ' ' LEU . 3.6 p -141.27 158.6 43.68 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.652 ' O ' ' C ' ' A' ' 123' ' ' TYR . 13.9 t 171.76 -80.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.78 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.733 ' N ' ' CD1' ' A' ' 123' ' ' TYR . 0.0 OUTLIER 0.24 72.81 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.388 0 O-C-N 123.954 0.784 . . . . 0.0 110.546 -179.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.561 ' HD3' ' SG ' ' A' ' 122' ' ' CYS . 60.1 Cg_endo -81.08 169.02 16.59 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 123.175 2.583 . . . . 0.0 112.277 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 47.5 p90 -63.28 -29.02 70.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.389 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -61.35 -45.88 92.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.583 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -107.29 126.25 52.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.603 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 42.8 mm -98.46 129.19 49.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.231 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 105.72 -118.95 5.93 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.415 ' OD1' ' N ' ' A' ' 130' ' ' ASP . 0.6 OUTLIER -116.63 105.03 11.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.807 0.337 . . . . 0.0 110.57 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -55.85 152.05 21.43 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.509 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -61.21 -28.8 85.59 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 C-N-CA 122.958 2.439 . . . . 0.0 111.975 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 40.1 p-10 -138.53 126.64 22.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.613 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.541 HH21 ' H ' ' A' ' 105' ' ' ASP . 29.6 ptt180 -98.76 141.83 31.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.733 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.62 ' H ' ' HB2' ' A' ' 122' ' ' CYS . 3.1 t80 -75.57 130.85 39.48 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.403 HD11 HG22 ' A' ' 101' ' ' THR . 3.3 mm -118.96 116.98 52.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.195 0.521 . . . . 0.0 112.076 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.651 HG23 ' CD1' ' A' ' 95' ' ' ILE . 1.2 mp -106.77 110.32 31.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.543 177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.49 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 48.4 tt0 -90.18 134.91 33.99 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.034 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -144.35 142.81 30.63 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.619 -0.718 . . . . 0.0 111.006 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.442 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 59.5 tttt -114.65 153.32 30.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.181 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 92' ' ' THR . 27.8 tp -74.62 116.94 15.88 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.248 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -100.12 -33.87 10.28 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.325 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.469 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -154.74 158.66 28.45 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 38.3 p -138.42 151.62 47.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 0.0 110.384 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.494 ' N ' ' O ' ' A' ' 90' ' ' THR . 90.2 m-85 -130.04 145.08 51.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.458 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.454 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 5.2 p -136.68 129.07 30.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.553 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 146' ' ' SER . 13.8 mttm . . . . . 0 C--O 1.22 -0.461 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.339 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.571 ' O ' ' CB ' ' A' ' 3' ' ' HIS . 86.6 p -61.47 -35.02 76.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.816 0.341 . . . . 0.0 110.399 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.633 ' C ' ' H ' ' A' ' 5' ' ' SER . 4.3 t60 86.65 71.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.181 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.585 ' O ' ' O ' ' A' ' 5' ' ' SER . 78.4 mtm 47.98 4.31 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.691 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.633 ' H ' ' C ' ' A' ' 3' ' ' HIS . 3.5 m 40.42 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.771 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 44.2 t -73.36 146.07 45.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.477 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -122.38 168.12 12.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.433 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.581 ' O ' HG22 ' A' ' 8' ' ' THR . 29.9 m 65.69 5.08 3.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.686 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.624 ' C ' ' H ' ' A' ' 11' ' ' LYS . 83.3 tt0 -93.72 162.2 14.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.578 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.493 ' N ' ' HG2' ' A' ' 9' ' ' GLU . 97.7 m-70 -64.85 33.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.632 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.624 ' H ' ' C ' ' A' ' 9' ' ' GLU . 22.3 tptp -72.81 144.92 47.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.481 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -59.02 141.01 55.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.94 0.4 . . . . 0.0 110.335 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.5 14.06 66.57 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -119.38 141.54 48.98 Favored 'General case' 0 N--CA 1.444 -0.743 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.328 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.403 ' NZ ' ' HB2' ' A' ' 18' ' ' MET . 12.4 tmtt? -62.31 112.25 2.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.257 179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 32' ' ' TRP . 16.5 m -112.94 -43.8 4.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.721 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.472 ' N ' HG23 ' A' ' 16' ' ' VAL . . . -129.53 162.27 28.58 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.76 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.434 ' O ' ' OE1' ' A' ' 85' ' ' GLU . 50.8 ttm -125.84 143.0 51.25 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.51 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.429 HD13 HD21 ' A' ' 84' ' ' LEU . 21.1 tp -107.01 127.75 53.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.409 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.467 HD22 ' N ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -124.88 125.88 44.66 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.04 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.536 HG22 ' H ' ' A' ' 24' ' ' LEU . 4.8 mt -105.01 119.68 52.43 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.934 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.469 ' HD2' ' O ' ' A' ' 81' ' ' THR . 59.5 Cg_endo -76.66 -48.18 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.502 0 C-N-CA 122.637 2.225 . . . . 0.0 112.918 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.518 ' C ' HD22 ' A' ' 24' ' ' LEU . 16.7 tptp -59.34 -43.87 92.7 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.985 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.81 ' N ' HD22 ' A' ' 24' ' ' LEU . 2.7 mm? -96.93 -0.57 47.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.362 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.15 37.69 8.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.622 179.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.7 mtmt -107.65 157.21 18.27 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.533 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -140.06 145.6 37.9 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.683 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -143.73 150.75 39.11 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.876 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.2 m -99.06 116.26 30.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.76 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.627 HG12 HD11 ' A' ' 62' ' ' LEU . 1.7 mp -86.13 122.54 38.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.812 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -98.42 139.02 34.8 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.714 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.484 ' HB2' HG11 ' A' ' 16' ' ' VAL . 42.6 t-105 -60.43 127.73 33.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.053 0.454 . . . . 0.0 110.654 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.488 ' HA2' HG12 ' A' ' 47' ' ' VAL . . . 77.64 175.28 43.32 Favored Glycine 0 C--N 1.329 0.188 0 N-CA-C 111.081 -0.808 . . . . 0.0 111.081 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -151.62 108.92 3.58 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 120.363 -0.535 . . . . 0.0 110.889 179.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -93.72 114.74 27.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.767 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -77.22 -8.6 57.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.543 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.56 -36.18 82.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.507 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.1 t -109.07 127.27 53.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.456 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.508 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.9 mp -84.23 -8.99 58.88 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.464 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.587 ' HD3' ' H ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -63.59 -41.41 98.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.441 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.67 132.29 38.17 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.51 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 63' ' ' SER . . . -123.65 -41.59 0.41 Allowed Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 30' ' ' ILE . 21.2 t -82.19 93.49 2.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 CA-C-O 121.101 0.476 . . . . 0.0 111.069 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.18 155.46 22.45 Favored Glycine 0 CA--C 1.524 0.638 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.758 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -100.91 131.35 46.84 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.758 ' N ' ' SD ' ' A' ' 45' ' ' MET . 1.5 t80 -65.59 132.97 50.17 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.682 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.488 HG12 ' HA2' ' A' ' 33' ' ' GLY . 1.8 p -122.47 114.97 44.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.351 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.665 ' N ' ' OG1' ' A' ' 51' ' ' THR . 16.0 p -157.96 173.13 17.24 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.6 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -59.21 -14.8 11.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.6 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.787 HG21 ' O ' ' A' ' 109' ' ' ILE . 5.3 m -110.57 -38.61 3.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.784 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.665 ' OG1' ' N ' ' A' ' 48' ' ' SER . 62.5 p -77.45 140.39 39.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.606 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.481 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -144.9 167.05 23.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.245 -179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.478 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -85.5 157.02 58.97 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.73 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -78.52 83.98 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.529 2.153 . . . . 0.0 112.343 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 8.0 p -115.16 -2.92 12.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.688 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 141.19 91.12 0.18 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.434 -0.666 . . . . 0.0 111.434 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.34 81.68 0.14 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.456 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -163.38 162.19 34.67 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 110.763 -0.935 . . . . 0.0 110.763 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.607 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 20.0 t-160 -83.22 118.59 23.73 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.4 m -117.21 126.5 52.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.051 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.667 ' O ' ' SD ' ' A' ' 45' ' ' MET . 70.4 t -116.58 132.34 66.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.097 0.475 . . . . 0.0 110.038 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.627 HD11 HG12 ' A' ' 30' ' ' ILE . 2.7 mm? -112.63 135.39 53.41 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.724 -179.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.605 ' O ' ' O ' ' A' ' 42' ' ' GLY . 26.8 t -117.7 132.81 56.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.603 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -135.94 131.47 5.74 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.491 ' HA ' ' CD1' ' A' ' 123' ' ' TYR . 23.6 t60 -73.81 128.45 35.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.728 0.299 . . . . 0.0 110.403 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.469 ' H ' ' HB2' ' A' ' 123' ' ' TYR . 4.2 ptt180 79.09 138.82 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.424 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.576 ' O ' ' C ' ' A' ' 68' ' ' THR . 14.5 p-10 -112.15 -59.65 1.97 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.266 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.576 ' C ' ' O ' ' A' ' 67' ' ' ASP . 9.9 p 20.26 52.06 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.726 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.529 ' N ' ' O ' ' A' ' 67' ' ' ASP . 12.2 m -67.9 94.99 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.58 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -99.45 -11.78 20.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.455 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.475 HG22 ' N ' ' A' ' 74' ' ' GLY . 2.6 m -97.38 91.34 5.44 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.315 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.599 ' OD1' HD12 ' A' ' 76' ' ' LEU . 56.5 m-20 -57.73 -47.84 81.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.213 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.768 ' N ' HD12 ' A' ' 73' ' ' LEU . 6.2 mp -78.02 -13.37 59.9 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.547 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.475 ' N ' HG22 ' A' ' 71' ' ' THR . . . -64.18 -50.53 59.64 Favored Glycine 0 CA--C 1.519 0.311 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -139.74 -15.86 1.03 Allowed 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.221 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.599 HD12 ' OD1' ' A' ' 72' ' ' ASP . 2.3 mt -90.8 60.72 4.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.924 0.392 . . . . 0.0 110.91 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.622 ' HZ3' ' HB2' ' A' ' 80' ' ' ASP . 23.3 pttm -164.29 143.66 7.57 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.211 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -75.67 -19.3 59.24 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.228 0.537 . . . . 0.0 110.164 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 44.4 mttp -71.14 -15.51 62.5 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.817 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.686 ' OD1' ' N ' ' A' ' 81' ' ' THR . 6.0 t0 -68.86 152.34 45.43 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.175 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.686 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.7 OUTLIER -141.22 121.95 14.34 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.128 179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 55.0 mt -99.65 117.49 34.13 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.606 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.651 ' C ' HD22 ' A' ' 84' ' ' LEU . 45.2 t -100.47 121.89 51.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.969 0.414 . . . . 0.0 110.097 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 83' ' ' VAL . 4.0 mm? -109.36 131.62 54.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.296 -178.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.581 ' HG3' HG23 ' A' ' 90' ' ' THR . 54.9 mp0 -102.5 123.47 46.31 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.83 179.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 5.3 t80 -143.62 119.19 10.38 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.87 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 33.7 t70 57.35 51.1 10.41 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 120.943 -0.303 . . . . 0.0 111.745 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 62.34 7.7 2.42 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.675 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 56.9 mtmt -107.57 142.85 36.86 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.808 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.623 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -113.29 123.95 51.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.688 -179.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.402 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 22.1 m-85 -106.69 128.66 54.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.144 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.04 115.46 29.79 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.219 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 86.5 m-85 -109.97 153.47 24.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.639 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -126.88 139.29 53.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.64 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.489 ' HA ' HD13 ' A' ' 95' ' ' ILE . 9.1 mm -61.86 119.89 6.81 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.181 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -88.53 -67.15 0.85 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.553 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.3 tptt -148.97 136.37 20.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.295 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 2.2 mp -108.04 135.12 47.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.149 -179.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.607 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 15.0 p90 -160.71 -178.86 7.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.268 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.846 ' N ' HD12 ' A' ' 100' ' ' ILE . 0.5 OUTLIER -126.2 132.82 70.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.316 -179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 102' ' ' HIS . 1.3 t -136.11 175.66 9.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.881 0.372 . . . . 0.0 110.894 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.407 ' O ' HG23 ' A' ' 101' ' ' THR . 67.2 m80 -76.31 151.21 36.78 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.9 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -65.85 -18.47 65.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.788 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -94.28 17.31 13.02 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.048 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.628 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 21.4 t0 -91.89 100.42 13.1 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.837 -179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.911 ' O ' HG23 ' A' ' 110' ' ' ILE . 3.0 ptp85 -69.17 -32.57 71.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.268 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.628 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 6.3 p -37.85 -20.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.356 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.716 ' CG1' HG21 ' A' ' 118' ' ' THR . 18.5 t -105.26 -19.4 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.013 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.787 ' O ' HG21 ' A' ' 50' ' ' VAL . 45.4 mm -113.19 27.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.801 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.911 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -91.18 -168.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.901 179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.433 ' N ' ' HB ' ' A' ' 50' ' ' VAL . 33.9 ttmt -97.1 147.87 23.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.712 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.538 ' HZ3' HG21 ' A' ' 116' ' ' ILE . 99.3 mttt -130.82 155.55 46.51 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.854 0.359 . . . . 0.0 110.588 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -102.26 13.39 34.78 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.329 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.98 169.2 10.75 Favored Pre-proline 0 C--N 1.331 -0.196 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.971 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.456 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 47.6 Cg_endo -79.66 95.4 1.04 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 123.284 2.656 . . . . 0.0 112.438 179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.538 HG21 ' HZ3' ' A' ' 112' ' ' LYS . 49.7 mm -126.16 128.54 71.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 114.775 -1.102 . . . . 0.0 110.568 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.758 HD23 ' C ' ' A' ' 117' ' ' LEU . 4.7 tt -104.52 121.01 42.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.903 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.716 HG21 ' CG1' ' A' ' 108' ' ' VAL . 89.2 m -115.65 126.64 54.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.343 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.84 HD12 ' N ' ' A' ' 120' ' ' THR . 2.5 tp -111.98 127.85 55.99 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.056 0.455 . . . . 0.0 111.671 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.84 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -122.05 129.19 52.2 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.039 178.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.722 ' CG2' HD11 ' A' ' 119' ' ' LEU . 65.7 p -134.9 164.54 27.35 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-O 121.244 0.545 . . . . 0.0 111.768 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.631 ' CB ' ' O ' ' A' ' 121' ' ' THR . 0.5 OUTLIER 150.38 -76.16 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.005 -0.998 . . . . 0.0 110.935 179.202 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.62 ' O ' ' N ' ' A' ' 125' ' ' PHE . 26.1 m-85 48.5 159.81 0.03 OUTLIER Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.065 -0.97 . . . . 0.0 111.011 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -55.94 62.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.5 1.903 0 C-N-CA 122.268 1.979 . . . . 0.0 112.641 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.661 ' CD1' ' N ' ' A' ' 126' ' ' ASP . 1.7 p90 -79.9 -42.61 23.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.945 0.402 . . . . 0.0 110.715 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.661 ' N ' ' CD1' ' A' ' 125' ' ' PHE . 25.4 t70 -126.82 -24.5 3.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.385 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.691 ' CE2' ' O ' ' A' ' 128' ' ' ILE . 60.4 t80 -105.73 132.49 51.8 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.553 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.691 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 88.7 mt -72.22 125.57 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.02 -154.24 25.34 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -73.25 108.23 6.01 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.293 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.588 ' HB3' ' SG ' ' A' ' 122' ' ' CYS . . . -45.41 148.58 1.15 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.895 -179.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.542 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 52.1 Cg_exo -49.16 -37.04 38.09 Favored 'Trans proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.28 1.987 . . . . 0.0 111.937 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.542 ' OD1' ' O ' ' A' ' 132' ' ' PRO . 97.0 m-20 -145.06 157.47 44.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.55 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -119.16 134.33 55.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.29 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.438 ' O ' ' HA ' ' A' ' 120' ' ' THR . 6.6 t80 -68.53 133.01 47.93 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.649 -0.42 . . . . 0.0 109.969 -179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.607 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 37.8 mm -118.76 115.15 47.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.086 -179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.424 HG23 ' CD1' ' A' ' 95' ' ' ILE . 2.1 mm -107.96 108.53 25.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -91.4 146.65 23.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.02 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -153.05 142.96 22.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.428 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -115.64 150.46 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.146 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 6.5 tp -77.48 123.24 26.31 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.353 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -108.03 -40.36 5.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.826 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -136.99 164.23 25.26 Favored Glycine 0 CA--C 1.523 0.583 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.0 p -151.1 152.44 33.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.826 0.346 . . . . 0.0 110.386 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 90' ' ' THR . 87.1 m-85 -136.44 155.04 50.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.487 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.1 p -143.27 125.62 15.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.583 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 64.1 tttt . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.562 -179.85 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.0 t -118.46 131.83 56.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 110.697 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.3 m80 -82.42 -162.15 0.54 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.56 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.9 ttm -69.3 137.45 53.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.638 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.1 -10.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.621 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 m -74.23 148.29 41.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 51.9 18.2 0.76 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.66 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.569 ' O ' ' O ' ' A' ' 9' ' ' GLU . 95.5 m -134.85 138.53 44.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.002 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.569 ' O ' ' O ' ' A' ' 8' ' ' THR . 50.1 tp10 52.6 155.77 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.46 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.474 ' N ' ' HG3' ' A' ' 9' ' ' GLU . 53.3 m80 -68.4 113.21 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.928 0.394 . . . . 0.0 110.554 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 mmtt -135.4 140.67 45.15 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.401 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.444 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 35.1 mp0 -70.18 123.89 22.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.025 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 109.43 11.74 20.97 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -118.48 134.43 55.08 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.333 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.537 ' N ' ' CD2' ' A' ' 31' ' ' TYR . 40.3 tttm -57.97 112.69 1.58 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.352 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.0 m -114.2 -38.22 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.877 -179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.79 154.97 49.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.541 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.413 ' CE ' ' OE1' ' A' ' 85' ' ' GLU . 16.2 ttp -118.74 137.94 53.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.238 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.436 ' CD1' HD21 ' A' ' 84' ' ' LEU . 46.2 tp -106.1 119.26 38.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.145 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.594 HD22 ' N ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -118.87 127.14 53.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.179 0.514 . . . . 0.0 111.328 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.066 HD13 HE22 ' A' ' 75' ' ' GLN . 4.5 mt -109.82 116.95 53.25 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.516 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.03 -45.74 0.16 Allowed 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.529 2.153 . . . . 0.0 113.036 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.511 ' C ' HD22 ' A' ' 24' ' ' LEU . 19.1 tptm -62.52 -38.6 90.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.773 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.2 mm? -96.4 4.62 52.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.999 0.428 . . . . 0.0 110.442 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 41.9 49.09 4.0 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.127 179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -135.33 157.7 46.23 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.963 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -138.92 140.18 38.26 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.837 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.47 142.38 47.06 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.457 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.8 m -90.73 123.76 34.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.903 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.687 HG12 HD11 ' A' ' 62' ' ' LEU . 1.7 mp -96.28 123.19 48.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.453 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.537 ' CD2' ' N ' ' A' ' 15' ' ' LYS . 42.1 m-85 -103.11 145.06 30.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.787 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.599 ' O ' ' N ' ' A' ' 13' ' ' GLY . 41.1 t-105 -59.1 130.05 45.13 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.974 0.416 . . . . 0.0 110.521 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.573 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 82.59 141.07 3.82 Favored Glycine 0 C--N 1.329 0.192 0 N-CA-C 110.844 -0.902 . . . . 0.0 110.844 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HB1' ' OG ' ' A' ' 63' ' ' SER . . . -118.96 81.33 1.68 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.925 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -101.66 108.94 20.62 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.496 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 22.7 p30 -85.58 -7.98 58.54 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.624 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.64 -13.63 48.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.633 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.45 -147.68 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.693 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 43.9 mt -38.37 -63.05 0.53 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.783 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.401 ' HE3' ' OH ' ' A' ' 123' ' ' TYR . 87.6 tttt 62.14 111.86 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.053 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 47.4 mtpt -112.84 -4.84 13.92 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.802 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.53 -31.99 7.9 Favored Glycine 0 CA--C 1.527 0.837 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.46 92.39 2.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 CA-C-O 120.96 0.409 . . . . 0.0 110.527 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -122.34 141.79 14.42 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.692 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -93.41 125.58 38.09 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.692 ' N ' ' SD ' ' A' ' 45' ' ' MET . 16.7 t80 -66.84 140.87 57.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.26 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.573 HG23 ' HA2' ' A' ' 33' ' ' GLY . 54.4 t -114.58 129.46 70.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.633 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.628 ' N ' ' OG1' ' A' ' 51' ' ' THR . 11.6 t -163.21 166.42 23.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.59 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.438 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 36.8 t0 -68.94 -11.48 60.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.433 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.662 HG21 ' O ' ' A' ' 109' ' ' ILE . 6.1 m -109.01 -14.55 10.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.528 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.628 ' OG1' ' N ' ' A' ' 48' ' ' SER . 25.5 p -85.73 149.1 25.52 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.554 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.521 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.8 OUTLIER -140.74 164.85 29.1 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.951 179.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.44 HG22 ' CH2' ' A' ' 32' ' ' TRP . 0.0 OUTLIER -95.38 151.93 38.98 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.216 179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.89 54.23 3.99 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 C-N-CA 122.757 2.305 . . . . 0.0 112.634 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 81.2 p -102.4 -7.69 21.77 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.264 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 165.07 81.17 0.04 OUTLIER Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.78 103.15 0.01 OUTLIER Glycine 0 CA--C 1.529 0.965 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.584 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.7 160.41 34.0 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.738 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 22.1 t-160 -81.42 99.37 8.69 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 23.8 m -94.02 126.54 39.29 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.677 ' O ' ' SD ' ' A' ' 45' ' ' MET . 71.8 t -116.52 128.93 73.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.077 0.465 . . . . 0.0 110.232 -179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.687 HD11 HG12 ' A' ' 30' ' ' ILE . 2.7 mm? -114.58 141.55 47.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.73 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.465 ' OG ' ' HB1' ' A' ' 34' ' ' ALA . 4.8 p -128.4 146.61 50.74 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.707 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.66 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -176.91 -179.44 47.31 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 111.51 -0.636 . . . . 0.0 111.51 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -115.92 160.01 20.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.901 0.382 . . . . 0.0 110.534 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -54.08 137.43 40.12 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.6 -179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -84.57 -108.32 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.115 -179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.576 ' OG1' ' OG1' ' A' ' 71' ' ' THR . 4.5 p -128.36 -178.44 4.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.465 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 72.8 t -60.34 -46.09 95.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.79 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -100.99 70.63 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.683 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.576 ' OG1' ' OG1' ' A' ' 68' ' ' THR . 0.0 OUTLIER -164.62 -67.97 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.016 0.436 . . . . 0.0 110.541 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.515 ' O ' ' OD1' ' A' ' 72' ' ' ASP . 26.8 t0 -63.36 -27.82 69.58 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.498 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 56.0 tp -60.91 -42.88 98.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.199 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.7 -28.09 48.31 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.006 -0.838 . . . . 0.0 111.006 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 1.066 HE22 HD13 ' A' ' 21' ' ' ILE . 91.8 mm-40 -63.82 -39.42 94.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.688 0.28 . . . . 0.0 110.669 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.859 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.6 pp -91.25 102.45 15.17 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.39 0.614 . . . . 0.0 111.333 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.529 ' HG3' ' H ' ' A' ' 80' ' ' ASP . 20.6 pttm 176.83 152.56 0.19 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.221 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -69.32 -31.73 70.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.359 0.599 . . . . 0.0 110.727 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.8 mmtt -69.78 -14.15 62.63 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.501 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.67 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 1.2 t70 -82.67 152.95 25.62 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.566 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.493 ' O ' HD23 ' A' ' 82' ' ' LEU . 2.6 p -138.85 149.55 45.02 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 81' ' ' THR . 41.1 mt -121.58 123.66 42.5 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.8 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.55 ' C ' HD22 ' A' ' 84' ' ' LEU . 10.7 t -103.74 116.96 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 -179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.55 HD22 ' C ' ' A' ' 83' ' ' VAL . 2.7 mm? -105.69 132.35 51.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.53 -178.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.499 ' HG2' HG23 ' A' ' 90' ' ' THR . 28.6 mt-10 -108.75 123.53 49.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.55 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.587 ' O ' ' N ' ' A' ' 89' ' ' LYS . 12.2 t80 -144.48 145.22 31.75 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.034 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.417 ' N ' ' CD1' ' A' ' 86' ' ' TYR . 34.8 t70 36.95 51.29 0.96 Allowed 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.759 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 16.0 m120 59.32 25.12 13.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.961 0.41 . . . . 0.0 110.598 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.587 ' N ' ' O ' ' A' ' 86' ' ' TYR . 54.5 mtmt -124.07 144.34 49.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.107 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.499 HG23 ' HG2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -111.69 126.92 55.55 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.565 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -112.47 131.86 55.36 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.278 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.431 ' O ' HD22 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -102.59 106.24 16.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.343 -179.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 53.1 m-85 -97.08 161.49 13.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.354 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.67 ' OE1' ' O ' ' A' ' 80' ' ' ASP . 2.8 tp10 -136.85 137.23 39.48 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.514 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.599 ' N ' ' OE1' ' A' ' 94' ' ' GLU . 1.9 mm -65.54 124.2 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 119.412 -0.915 . . . . 0.0 109.554 -179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -98.72 -62.89 1.18 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.544 -178.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 71.0 tttt -141.14 138.9 33.79 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.319 0.58 . . . . 0.0 109.786 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.727 HG23 HD13 ' A' ' 137' ' ' ILE . 46.6 mt -120.36 127.62 75.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.833 -179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.599 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 22.4 p90 -152.72 -177.59 6.35 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.816 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.707 HG22 ' OD2' ' A' ' 133' ' ' ASP . 2.4 mp -125.68 132.82 70.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.757 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.623 HG21 HG21 ' A' ' 108' ' ' VAL . 2.0 t -143.32 166.45 24.71 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.924 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -65.9 147.83 52.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.236 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.33 -36.44 80.15 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.64 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 106' ' ' ARG . 46.7 t0 -63.91 -33.34 75.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.611 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.447 ' OD2' ' OG1' ' A' ' 107' ' ' THR . 14.6 t70 -40.13 95.84 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.447 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.543 ' O ' ' N ' ' A' ' 109' ' ' ILE . 11.1 ptp85 -68.96 -26.09 64.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.562 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.806 ' O ' HD11 ' A' ' 110' ' ' ILE . 10.9 p -49.1 -21.93 0.83 Allowed 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.587 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.625 HG11 HD12 ' A' ' 136' ' ' ILE . 6.8 t -97.77 -13.32 8.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.166 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.791 ' O ' HG22 ' A' ' 109' ' ' ILE . 48.1 mm -114.83 18.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.273 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.806 HD11 ' O ' ' A' ' 107' ' ' THR . 0.4 OUTLIER -79.1 -156.64 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.763 0.316 . . . . 0.0 110.889 179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.421 ' H ' ' HB ' ' A' ' 110' ' ' ILE . 22.3 ttmt -107.76 148.18 29.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.614 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.524 ' HG2' ' CG ' ' A' ' 59' ' ' HIS . 71.9 mmtt -125.15 141.66 51.97 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.906 0.384 . . . . 0.0 110.257 179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.578 ' O ' ' OE2' ' A' ' 114' ' ' GLU . 51.4 mm-40 -89.62 10.78 21.82 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.722 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.578 ' OE2' ' O ' ' A' ' 113' ' ' GLU . 44.0 mm-40 -143.11 152.65 58.67 Favored Pre-proline 0 C--O 1.233 0.204 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.032 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.584 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 12.0 Cg_endo -62.15 84.49 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.642 2.228 . . . . 0.0 110.771 179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.6 mm -115.65 132.11 66.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.787 -179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.785 HD23 ' C ' ' A' ' 117' ' ' LEU . 5.5 tt -107.54 119.77 40.33 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.277 0.56 . . . . 0.0 109.923 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.562 HG21 ' CG1' ' A' ' 108' ' ' VAL . 73.1 m -116.15 117.44 30.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.25 -0.887 . . . . 0.0 109.742 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.946 HD12 ' N ' ' A' ' 120' ' ' THR . 1.0 OUTLIER -107.54 124.69 50.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.85 179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.946 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -119.03 122.74 42.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.578 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.66 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.3 t -161.02 176.15 11.69 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-O 121.224 0.535 . . . . 0.0 111.989 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.636 ' CB ' ' O ' ' A' ' 121' ' ' THR . 0.1 OUTLIER 152.07 -66.09 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.192 179.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.722 ' O ' ' CG ' ' A' ' 123' ' ' TYR . 5.8 p90 -31.01 95.53 0.08 OUTLIER Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.711 -179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.476 ' N ' ' O ' ' A' ' 122' ' ' CYS . 60.9 Cg_endo -81.64 -168.24 0.59 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.518 2.146 . . . . 0.0 111.863 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -65.15 -20.08 66.29 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.397 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.465 ' C ' ' OD1' ' A' ' 126' ' ' ASP . 43.8 t0 -63.11 -65.44 0.69 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.159 -179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.593 ' CE2' ' O ' ' A' ' 130' ' ' ASP . 43.5 t80 -71.38 128.74 36.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.199 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 84.6 mt -91.71 90.55 3.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 125.87 -128.15 6.38 Favored Glycine 0 CA--C 1.527 0.804 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.616 ' CB ' HH21 ' A' ' 134' ' ' ARG . 52.9 p-10 -105.15 114.91 29.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.747 0.308 . . . . 0.0 110.621 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -57.74 157.19 15.3 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.69 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -49.8 -37.92 46.13 Favored 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.338 2.025 . . . . 0.0 112.356 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.707 ' OD2' HG22 ' A' ' 100' ' ' ILE . 4.8 t0 -140.08 133.11 29.45 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.616 HH21 ' CB ' ' A' ' 130' ' ' ASP . 92.6 mtt180 -99.02 144.11 28.53 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.235 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.484 ' CE2' HD11 ' A' ' 137' ' ' ILE . 4.6 t80 -75.57 132.57 40.77 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.625 HD12 HG11 ' A' ' 108' ' ' VAL . 15.8 mm -110.88 110.94 34.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.727 HD13 HG23 ' A' ' 98' ' ' ILE . 51.2 mm -101.28 108.89 24.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -96.76 142.2 29.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.31 0.576 . . . . 0.0 111.407 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -153.54 146.98 24.91 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.04 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.2 ptmm? -116.57 157.47 25.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.901 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.691 ' C ' HD13 ' A' ' 141' ' ' LEU . 2.6 tm? -87.77 118.41 27.27 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.119 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -108.44 -65.03 1.16 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.441 -179.528 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.548 ' N ' ' OG1' ' A' ' 142' ' ' THR . . . -93.16 156.9 23.04 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.0 p -152.6 152.1 31.42 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.518 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -142.87 132.82 24.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.411 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 1.3 t -121.63 131.94 54.39 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.998 0.428 . . . . 0.0 110.434 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 34.5 mtpt . . . . . 0 C--O 1.22 -0.46 0 CA-C-O 118.021 -0.99 . . . . 0.0 110.622 -179.27 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -75.38 13.32 0.77 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 110.562 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -89.67 127.64 35.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.611 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 73.0 mtp -121.61 -174.93 2.97 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.412 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.38 35.24 4.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.562 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 59.5 p -136.29 -175.23 3.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.597 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.42 ' H ' ' HG2' ' A' ' 7' ' ' GLN . 13.6 pt20 -88.33 124.8 34.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.015 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.548 HG22 ' N ' ' A' ' 9' ' ' GLU . 20.8 m -119.0 -118.63 0.31 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.388 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.548 ' N ' HG22 ' A' ' 8' ' ' THR . 21.7 tt0 -166.17 121.75 1.24 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.018 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.497 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 0.2 OUTLIER 79.64 11.52 1.27 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.533 -179.542 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -68.07 131.69 45.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.846 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.462 ' HG2' HG21 ' A' ' 47' ' ' VAL . 50.5 mt-10 -64.99 130.4 43.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.277 -0.42 . . . . 0.0 109.914 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.535 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 95.54 21.38 24.41 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -128.45 146.35 50.83 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 120.994 0.426 . . . . 0.0 110.652 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -64.26 119.8 10.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.065 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.419 HG23 ' N ' ' A' ' 17' ' ' ALA . 5.0 m -119.59 -46.12 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.626 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -128.22 169.54 14.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.457 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.7 tpp -127.75 139.72 52.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.399 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.719 ' HB2' HD11 ' A' ' 30' ' ' ILE . 5.6 tp -108.18 124.49 50.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.338 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.403 ' OD1' ' O ' ' A' ' 26' ' ' LYS . 21.5 t-20 -118.33 129.3 55.36 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.0 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.408 HG22 ' H ' ' A' ' 24' ' ' LEU . 24.5 mt -114.73 111.87 45.65 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.202 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.8 -37.65 1.13 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.647 2.231 . . . . 0.0 112.993 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.813 ' NZ ' ' HZ1' ' A' ' 77' ' ' LYS . 2.1 tptm -62.33 -37.24 84.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.701 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.715 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.3 mm? -98.95 -3.34 35.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.402 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt 54.62 65.8 1.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 120.488 -0.485 . . . . 0.0 111.339 178.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.431 ' C ' ' CG ' ' A' ' 27' ' ' LYS . 16.0 ptmt -165.72 -175.19 3.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.077 0.465 . . . . 0.0 111.26 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' CG ' ' C ' ' A' ' 26' ' ' LYS . 4.1 mtpt -155.32 155.75 34.27 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.292 -179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.426 ' CZ ' ' HE2' ' A' ' 26' ' ' LYS . 78.9 m-85 -135.82 146.48 47.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.449 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.7 m -87.18 118.45 26.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.266 -0.425 . . . . 0.0 109.956 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.873 HD12 HD11 ' A' ' 62' ' ' LEU . 41.1 mm -85.1 113.92 24.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -99.22 135.53 40.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.848 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.535 ' O ' ' N ' ' A' ' 13' ' ' GLY . 28.3 t-105 -60.62 122.18 14.06 Favored 'General case' 0 C--O 1.224 -0.259 0 CA-C-O 121.015 0.436 . . . . 0.0 110.829 -179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.475 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 86.97 156.77 29.84 Favored Glycine 0 N--CA 1.46 0.279 0 N-CA-C 111.096 -0.802 . . . . 0.0 111.096 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -118.01 84.96 2.26 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.449 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -96.85 98.63 10.28 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.721 -0.392 . . . . 0.0 110.507 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' C ' ' OD1' ' A' ' 36' ' ' ASP . 47.5 p30 -82.84 -6.24 59.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.221 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.42 ' N ' ' OD1' ' A' ' 36' ' ' ASP . . . -68.42 -43.29 77.52 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.893 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 82.5 p -84.79 165.8 17.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.547 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.4 mt -88.39 69.41 9.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.336 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -104.52 -176.18 3.01 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.432 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -76.31 150.19 36.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.663 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.431 ' H ' ' CG ' ' A' ' 67' ' ' ASP . . . -75.83 55.52 3.03 Favored Glycine 0 CA--C 1.525 0.671 0 N-CA-C 111.32 -0.712 . . . . 0.0 111.32 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.623 ' CG2' HD13 ' A' ' 30' ' ' ILE . 2.5 p -159.63 92.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.372 0.606 . . . . 0.0 110.529 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.48 160.83 24.12 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.674 ' SD ' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -104.27 129.97 52.08 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.674 ' N ' ' SD ' ' A' ' 45' ' ' MET . 5.5 t80 -63.06 145.95 54.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.983 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.479 HG22 ' CE2' ' A' ' 32' ' ' TRP . 46.1 t -118.55 128.01 75.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.599 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.483 ' HG ' ' CB ' ' A' ' 51' ' ' THR . 59.8 p -167.1 173.85 8.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.435 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -76.91 -6.73 53.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.768 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.704 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.5 m -114.1 -23.04 4.45 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.082 0 C-N-CA 120.711 -0.395 . . . . 0.0 110.664 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.483 ' CB ' ' HG ' ' A' ' 48' ' ' SER . 23.7 p -87.21 159.05 18.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.531 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.49 171.61 19.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.187 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.505 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -91.16 156.49 43.85 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.413 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.772 ' HG3' HD23 ' A' ' 84' ' ' LEU . 70.8 Cg_endo -75.81 83.13 2.0 Allowed 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.687 2.258 . . . . 0.0 112.444 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 79.8 p -115.3 -4.72 12.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.719 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.82 89.66 0.08 OUTLIER Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.78 87.12 0.04 OUTLIER Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.664 -0.975 . . . . 0.0 110.664 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.442 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -162.32 168.47 37.31 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.517 ' CD2' ' HE2' ' A' ' 112' ' ' LYS . 16.8 t-160 -89.16 116.93 27.77 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.9 m -111.97 127.22 55.8 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.073 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.674 ' O ' ' SD ' ' A' ' 45' ' ' MET . 58.6 t -119.35 126.14 75.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.994 0.426 . . . . 0.0 110.787 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.873 HD11 HD12 ' A' ' 30' ' ' ILE . 2.3 mm? -116.23 145.78 42.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.629 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 93.7 p -137.93 154.33 49.42 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.825 179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.39 156.74 27.12 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.755 ' O ' ' N ' ' A' ' 67' ' ' ASP . 65.1 t-80 -140.91 142.71 34.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.412 0.149 . . . . 0.0 110.609 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.477 ' C ' ' O ' ' A' ' 65' ' ' HIS . 8.6 ttt180 26.18 -76.5 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.446 0 O-C-N 123.573 0.546 . . . . 0.0 111.434 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.755 ' N ' ' O ' ' A' ' 65' ' ' HIS . 0.2 OUTLIER 40.48 -165.39 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.772 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 93.2 m -124.7 89.52 3.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.131 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 69' ' ' VAL . 32.1 m -131.17 129.58 62.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.713 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -117.52 12.61 14.18 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.958 179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.481 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.1 OUTLIER -107.46 46.59 0.93 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.177 0.513 . . . . 0.0 110.335 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.605 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 55.1 m-20 -63.3 -39.27 94.11 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.82 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.778 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.1 OUTLIER -59.36 -37.13 77.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.883 -179.318 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.33 -16.11 67.48 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -28.1 36.95 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.586 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.605 ' CD2' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -120.85 91.57 3.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.018 0.437 . . . . 0.0 110.88 179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.813 ' HZ1' ' NZ ' ' A' ' 23' ' ' LYS . 60.0 pttt -177.95 147.4 0.46 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.977 179.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.6 -18.12 61.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.921 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.6 mttm -77.35 -15.54 59.34 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.595 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.535 ' OD2' HD21 ' A' ' 82' ' ' LEU . 3.7 t70 -76.76 154.57 33.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.927 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.483 ' O ' HD23 ' A' ' 82' ' ' LEU . 1.9 p -139.45 139.89 37.17 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.535 HD21 ' OD2' ' A' ' 80' ' ' ASP . 13.0 mt -118.67 129.75 55.46 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.755 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.461 ' C ' HD12 ' A' ' 84' ' ' LEU . 2.3 t -111.62 118.29 57.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.772 HD23 ' HG3' ' A' ' 54' ' ' PRO . 7.6 mp -99.3 130.87 45.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.57 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -114.9 115.11 26.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.55 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.626 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.2 t80 -147.61 130.25 15.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.698 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.4 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 61.9 t0 64.01 40.37 7.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.668 0.27 . . . . 0.0 111.325 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 63.17 11.0 4.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.172 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.449 ' HB3' ' CE1' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -107.64 143.18 36.46 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.962 179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.575 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -111.66 124.8 53.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.32 -179.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.538 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 5.6 m-85 -113.6 137.49 51.51 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.907 -179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.585 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -105.86 118.76 37.42 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.619 ' CE1' HD22 ' A' ' 84' ' ' LEU . 64.7 m-85 -113.27 161.46 17.18 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.983 178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -141.12 140.2 34.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.246 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.533 HD12 ' H ' ' A' ' 77' ' ' LYS . 0.4 OUTLIER -66.92 124.97 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.57 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -96.11 -60.24 1.67 Allowed 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.184 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -144.4 143.81 31.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.25 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.8 mt -117.38 133.43 64.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.483 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 18.4 p90 -153.0 -175.63 5.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.004 0.43 . . . . 0.0 111.433 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 4.3 mt -125.52 133.06 70.14 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.536 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.555 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 1.7 t -133.71 168.32 18.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.132 0.491 . . . . 0.0 110.906 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.524 ' CD2' ' N ' ' A' ' 102' ' ' HIS . 1.5 m170 -76.65 157.05 32.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.48 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.53 -9.23 40.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.661 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.559 ' O ' ' OD1' ' A' ' 104' ' ' ASP . 57.7 t0 -109.26 23.75 14.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.881 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.621 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 67.2 t0 -88.95 92.67 9.32 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.645 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.736 ' O ' HG23 ' A' ' 110' ' ' ILE . 12.2 ptp85 -65.27 -34.76 79.1 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.161 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.621 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 10.2 p -42.29 -17.02 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.472 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.865 ' CG1' HG21 ' A' ' 118' ' ' THR . 58.9 t -102.79 -20.89 5.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.046 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.704 ' O ' HG21 ' A' ' 50' ' ' VAL . 48.4 mm -110.31 21.99 5.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.992 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.736 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -82.73 -172.25 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.146 179.51 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -87.27 142.52 27.83 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.888 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.517 ' HE2' ' CD2' ' A' ' 59' ' ' HIS . 2.5 tppt? -121.42 147.26 45.97 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.934 0.397 . . . . 0.0 110.57 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.458 ' OE1' ' N ' ' A' ' 113' ' ' GLU . 1.6 mp0 -101.47 15.72 27.94 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.031 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -152.11 171.81 6.21 Favored Pre-proline 0 N--CA 1.462 0.145 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.29 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.442 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 54.7 Cg_endo -80.06 95.43 1.01 Allowed 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 123.014 2.476 . . . . 0.0 111.668 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.4 HD13 ' HA ' ' A' ' 116' ' ' ILE . 49.2 mm -127.66 139.05 52.98 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.625 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.771 HD23 ' C ' ' A' ' 117' ' ' LEU . 5.5 tt -112.44 120.11 40.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.35 0.595 . . . . 0.0 110.195 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.865 HG21 ' CG1' ' A' ' 108' ' ' VAL . 85.7 m -111.95 116.61 30.88 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.099 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.826 HD23 ' N ' ' A' ' 120' ' ' THR . 3.7 tt -108.97 122.4 47.15 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.412 -179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.826 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -106.29 124.33 49.43 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.055 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.505 HG22 HD22 ' A' ' 119' ' ' LEU . 0.8 OUTLIER -105.11 127.42 52.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.227 0.537 . . . . 0.0 111.755 -179.069 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.5 ' C ' ' CD1' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -118.21 80.34 1.51 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.435 -0.802 . . . . 0.0 108.856 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 123' ' ' TYR . 2.4 m-85 -131.03 120.82 18.48 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.317 -178.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.627 ' CB ' ' H ' ' A' ' 129' ' ' GLY . 69.1 Cg_endo -77.81 76.18 4.44 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.327 2.018 . . . . 0.0 112.081 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -72.09 -28.28 63.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.481 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -131.92 -36.13 1.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.706 ' CE2' ' O ' ' A' ' 130' ' ' ASP . 72.3 t80 -61.29 -36.64 80.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.85 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.425 ' HB ' ' O ' ' A' ' 127' ' ' TYR . 69.6 mt 68.1 85.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.427 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.627 ' H ' ' CB ' ' A' ' 124' ' ' PRO . . . 120.21 -116.47 3.26 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.706 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 21.5 t70 -101.87 101.07 11.46 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.905 -0.318 . . . . 0.0 110.714 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.445 ' HA ' ' CG ' ' A' ' 127' ' ' TYR . . . -63.7 148.9 93.69 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.593 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.507 ' HD3' ' CD1' ' A' ' 127' ' ' TYR . 29.8 Cg_endo -64.85 -60.11 0.14 Allowed 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.673 2.249 . . . . 0.0 112.178 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -98.15 158.14 15.73 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.156 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -110.45 131.56 54.94 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.099 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.438 ' HB3' ' OG1' ' A' ' 121' ' ' THR . 2.0 t80 -64.42 141.86 58.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.538 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.462 ' CG1' HG22 ' A' ' 101' ' ' THR . 5.9 mm -128.4 116.71 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.505 HG22 ' O ' ' A' ' 137' ' ' ILE . 1.3 mp -105.32 112.11 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.469 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 45.4 tt0 -93.96 139.34 31.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.9 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -145.52 148.77 33.58 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.205 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.9 tttm -122.03 148.41 44.88 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.992 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.788 HD23 ' C ' ' A' ' 141' ' ' LEU . 8.2 tt -73.14 115.33 12.34 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.162 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.445 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.7 OUTLIER -88.8 -43.38 11.29 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.912 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.585 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -134.9 160.51 24.31 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 62.5 p -136.23 142.74 44.06 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.576 -0.45 . . . . 0.0 110.588 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.575 ' N ' ' O ' ' A' ' 90' ' ' THR . 92.6 m-85 -130.53 154.96 47.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.464 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.55 ' O ' ' OXT' ' A' ' 147' ' ' LYS . 20.2 p -141.77 121.19 13.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.299 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.55 ' OXT' ' O ' ' A' ' 146' ' ' SER . 18.5 ttmt . . . . . 0 C--O 1.221 -0.428 0 CA-C-O 117.887 -1.054 . . . . 0.0 110.621 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.4 p -75.16 159.92 31.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.524 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.49 122.71 12.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.395 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.632 ' O ' ' SD ' ' A' ' 4' ' ' MET . 0.3 OUTLIER -136.2 157.24 47.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.744 -179.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 6' ' ' SER . 9.4 m -153.42 74.14 1.0 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.347 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.541 ' O ' ' O ' ' A' ' 5' ' ' SER . 0.6 OUTLIER 44.39 104.05 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.621 -179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.455 ' O ' ' O ' ' A' ' 6' ' ' SER . 97.9 mm-40 42.45 96.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.75 -179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.506 HG21 ' H ' ' A' ' 5' ' ' SER . 2.7 t -156.85 166.91 32.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.817 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 60.53 165.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.651 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -91.06 104.55 17.12 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.556 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -129.8 127.16 39.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.24 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.693 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 1.0 OUTLIER -68.14 148.6 50.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.374 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 90.24 0.76 76.5 Favored Glycine 0 CA--C 1.519 0.333 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -115.33 131.97 56.76 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.333 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.441 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . 60.7 tttm -57.38 125.35 22.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.064 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 4.1 m -117.06 -37.98 2.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.135 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.535 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -140.92 167.37 22.34 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.865 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.453 ' SD ' ' HA ' ' A' ' 29' ' ' SER . 4.5 tpp -121.0 147.64 45.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.452 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.508 HD12 ' O ' ' A' ' 83' ' ' VAL . 51.1 tp -114.76 115.47 27.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.003 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.471 HD22 ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -105.24 135.94 45.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.302 179.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.533 ' O ' ' N ' ' A' ' 25' ' ' LYS . 8.3 mt -113.34 90.67 17.54 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.125 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 20' ' ' ASN . 31.6 Cg_exo -55.5 -42.68 65.5 Favored 'Trans proline' 0 N--CA 1.496 1.633 0 C-N-CA 123.178 2.585 . . . . 0.0 112.746 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.608 ' C ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -60.31 -42.75 96.2 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.715 -178.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.81 ' N ' HD22 ' A' ' 24' ' ' LEU . 2.8 mm? -100.41 2.65 42.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.147 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.533 ' N ' ' O ' ' A' ' 21' ' ' ILE . 75.3 mmtt 50.34 36.02 12.05 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 120.25 -0.58 . . . . 0.0 110.432 179.073 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 mtpt -113.6 173.09 6.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.377 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.408 ' CD ' ' OD1' ' A' ' 20' ' ' ASN . 30.9 mtmm -148.57 142.18 25.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.98 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 62.8 m-85 -134.07 152.55 51.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.851 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.453 ' HA ' ' SD ' ' A' ' 18' ' ' MET . 0.0 OUTLIER -95.11 120.52 35.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.578 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.414 HD11 ' HB2' ' A' ' 19' ' ' LEU . 48.9 mm -88.76 117.29 31.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.236 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.441 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 87.3 m-85 -102.37 135.81 43.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.113 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . . . . . . . . . 53.4 t-105 -59.66 125.55 24.07 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.889 0.376 . . . . 0.0 110.585 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.586 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 74.35 173.65 30.14 Favored Glycine 0 C--N 1.331 0.266 0 N-CA-C 111.214 -0.755 . . . . 0.0 111.214 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.96 135.42 46.57 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.642 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -93.01 95.51 9.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.698 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.555 ' OD1' ' N ' ' A' ' 37' ' ' ALA . 50.2 p-10 -67.92 -31.36 71.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.359 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.555 ' N ' ' OD1' ' A' ' 36' ' ' ASP . . . -74.8 -63.69 1.2 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.078 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.2 p -83.28 165.38 19.41 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.461 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.552 HD12 ' N ' ' A' ' 39' ' ' LEU . 10.2 mp -76.54 142.25 40.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.41 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.636 ' NZ ' ' OG1' ' A' ' 68' ' ' THR . 22.2 pttp -83.75 149.95 26.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.923 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -63.77 -44.86 92.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.968 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.425 ' O ' ' NZ ' ' A' ' 40' ' ' LYS . . . -162.94 -55.45 0.02 OUTLIER Glycine 0 CA--C 1.524 0.635 0 N-CA-C 110.917 -0.873 . . . . 0.0 110.917 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 57.3 t -140.09 135.44 37.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.899 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -118.42 139.09 14.29 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.432 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 2.3 ttp -97.9 129.38 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.12 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -63.73 143.28 57.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.932 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.586 HG23 ' HA2' ' A' ' 33' ' ' GLY . 55.4 t -122.85 128.55 75.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.77 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.787 ' HG ' ' H ' ' A' ' 51' ' ' THR . 7.3 p -164.18 168.96 18.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.507 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -64.03 -35.29 80.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.834 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.698 HG21 ' O ' ' A' ' 109' ' ' ILE . 4.4 m -87.62 -25.34 6.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.814 0.34 . . . . 0.0 110.802 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.787 ' H ' ' HG ' ' A' ' 48' ' ' SER . 43.5 p -77.23 140.38 40.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.737 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.616 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 1.3 p -131.75 171.31 13.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.847 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.12 155.87 36.08 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.948 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.685 ' HG3' HD13 ' A' ' 84' ' ' LEU . 65.4 Cg_endo -77.77 62.89 7.97 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.723 2.282 . . . . 0.0 112.325 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.415 ' O ' ' OH ' ' A' ' 91' ' ' TYR . 86.7 p -112.63 -3.8 14.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.77 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 153.52 91.24 0.08 OUTLIER Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.09 88.35 0.01 OUTLIER Glycine 0 CA--C 1.528 0.864 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.485 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -161.04 152.32 22.91 Favored Glycine 0 CA--C 1.521 0.441 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.616 ' N ' ' OG1' ' A' ' 52' ' ' THR . 19.8 t-160 -78.69 106.18 10.5 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 33.3 m -101.8 124.44 47.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.231 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.639 HG11 ' CD1' ' A' ' 109' ' ' ILE . 74.3 t -117.62 129.46 74.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.521 HD22 ' C ' ' A' ' 61' ' ' VAL . 3.0 mm? -108.04 144.36 35.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.167 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.2 t -128.1 136.54 51.33 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.755 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.402 ' N ' HG22 ' A' ' 121' ' ' THR . . . -153.21 139.49 6.95 Favored Glycine 0 CA--C 1.531 1.088 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.57 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.757 ' NE2' ' CZ ' ' A' ' 123' ' ' TYR . 16.2 m170 -81.97 144.9 30.58 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 122.492 -0.417 . . . . 0.0 110.482 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 122' ' ' CYS . 0.0 OUTLIER -46.86 -15.98 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.47 -179.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.48 ' O ' HG23 ' A' ' 69' ' ' VAL . 25.0 t70 -63.23 -39.96 96.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.918 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.636 ' OG1' ' NZ ' ' A' ' 40' ' ' LYS . 13.9 m -72.8 101.63 3.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.703 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -132.81 126.39 54.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.344 179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.575 ' CE2' HG22 ' A' ' 68' ' ' THR . 0.1 OUTLIER -135.26 -96.73 0.25 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.79 0.328 . . . . 0.0 110.548 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.516 HG21 HD12 ' A' ' 24' ' ' LEU . 17.0 p -94.98 76.14 3.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.366 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.422 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 46.3 m-20 -62.86 -40.19 96.71 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.489 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 1.2 pp -63.55 -35.9 82.0 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.59 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.407 ' O ' ' HD2' ' A' ' 77' ' ' LYS . . . -78.96 -33.54 36.53 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -66.07 -35.81 81.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.631 0.253 . . . . 0.0 111.246 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.605 HD22 ' OH ' ' A' ' 135' ' ' TYR . 11.3 mt -88.37 83.29 6.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.845 0.355 . . . . 0.0 111.005 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.437 ' NZ ' ' HD3' ' A' ' 23' ' ' LYS . 14.2 ptmt -177.8 134.6 0.17 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.837 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -73.65 -10.63 59.89 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.394 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -82.92 -14.9 53.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.064 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.43 ' OD2' HD21 ' A' ' 82' ' ' LEU . 3.7 t70 -64.21 155.16 32.7 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.637 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.439 ' O ' HD23 ' A' ' 82' ' ' LEU . 1.0 OUTLIER -133.25 140.29 47.41 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 121.033 0.445 . . . . 0.0 110.067 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 81' ' ' THR . 21.2 mt -119.8 120.58 36.92 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.485 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.508 ' O ' HD12 ' A' ' 19' ' ' LEU . 2.9 t -107.13 130.32 59.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.045 0.45 . . . . 0.0 110.492 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.752 HD11 HD12 ' A' ' 117' ' ' LEU . 27.1 mt -113.79 128.83 56.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.474 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HG2' HG23 ' A' ' 90' ' ' THR . 83.9 mt-10 -104.46 118.27 36.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.564 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.535 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -153.19 129.38 10.45 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.869 -179.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.435 ' C ' ' N ' ' A' ' 89' ' ' LYS . 58.2 m-20 61.24 54.29 3.28 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.844 0.354 . . . . 0.0 111.338 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 51.59 15.31 0.34 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.699 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.435 ' N ' ' C ' ' A' ' 87' ' ' ASP . 20.6 mtpt -119.33 143.23 47.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.37 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.479 HG22 ' CG1' ' A' ' 83' ' ' VAL . 4.6 m -115.14 120.55 40.14 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.614 -0.434 . . . . 0.0 110.346 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.415 ' OH ' ' O ' ' A' ' 55' ' ' SER . 13.6 m-85 -99.62 136.06 40.12 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.177 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.561 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -108.27 119.01 38.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.218 -178.496 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.627 ' CE1' HD12 ' A' ' 84' ' ' LEU . 91.4 m-85 -113.1 165.13 12.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.62 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -143.44 139.89 30.13 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.942 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.3 mt -69.01 121.63 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.804 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 3.0 mm100 -97.04 -42.19 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.587 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -158.25 140.08 13.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.692 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.5 mt -118.25 126.59 75.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 C-N-CA 120.47 -0.492 . . . . 0.0 110.256 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 19.8 p90 -149.37 -179.23 6.9 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.963 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.598 HG22 ' HB3' ' A' ' 133' ' ' ASP . 1.3 mp -125.21 126.89 71.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.047 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 102' ' ' HIS . 1.7 t -129.11 173.38 10.52 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.991 0.424 . . . . 0.0 110.711 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.487 ' ND1' ' N ' ' A' ' 102' ' ' HIS . 1.0 OUTLIER -73.16 152.73 41.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.649 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -66.82 -18.51 65.41 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.743 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -92.58 4.53 53.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.696 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.852 ' O ' HG22 ' A' ' 108' ' ' VAL . 41.9 t0 -75.3 60.55 1.12 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.373 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 109' ' ' ILE . 28.1 ptt85 -38.53 -23.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.747 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 105' ' ' ASP . 65.5 p -46.5 -16.1 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.599 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.852 HG22 ' O ' ' A' ' 105' ' ' ASP . 3.9 m -106.25 -13.03 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 CA-C-O 120.952 0.406 . . . . 0.0 110.339 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.755 ' O ' HG22 ' A' ' 109' ' ' ILE . 41.6 mm -112.89 21.61 6.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.549 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.573 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -88.95 -163.86 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.862 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -104.07 140.56 37.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.632 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -131.4 140.41 49.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.566 178.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -87.74 11.44 15.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.058 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.93 160.33 69.05 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.845 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.485 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 39.6 Cg_endo -77.32 99.37 1.29 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.895 2.397 . . . . 0.0 111.563 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.421 HD13 ' O ' ' A' ' 115' ' ' PRO . 49.8 mm -130.36 133.27 64.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.179 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.752 HD12 HD11 ' A' ' 84' ' ' LEU . 6.5 tt -107.94 117.85 35.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.249 0.547 . . . . 0.0 110.249 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 61' ' ' VAL . 61.2 m -118.27 123.02 44.39 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.971 179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.872 ' C ' HD23 ' A' ' 119' ' ' LEU . 1.0 OUTLIER -109.23 131.53 54.98 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.93 0.395 . . . . 0.0 111.043 -179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 135' ' ' TYR . 0.2 OUTLIER -126.32 121.65 33.19 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.895 179.469 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.68 ' O ' ' SG ' ' A' ' 122' ' ' CYS . 69.5 p -136.57 159.33 42.12 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.586 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.68 ' SG ' ' O ' ' A' ' 121' ' ' THR . 1.3 m 152.58 -66.79 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.794 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.757 ' CZ ' ' NE2' ' A' ' 65' ' ' HIS . 19.7 m-85 55.36 109.42 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.338 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -46.37 -72.17 0.05 OUTLIER 'Trans proline' 0 N--CA 1.499 1.832 0 C-N-CA 122.821 2.348 . . . . 0.0 113.496 -179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.511 ' CD1' ' N ' ' A' ' 125' ' ' PHE . 0.5 OUTLIER -53.39 -49.51 67.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.005 -178.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -56.53 -41.11 76.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.312 -0.404 . . . . 0.0 109.987 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.462 ' O ' ' N ' ' A' ' 129' ' ' GLY . 14.1 t80 -71.66 139.54 49.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.733 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 47.9 mm -53.08 90.09 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.158 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 127' ' ' TYR . . . 104.3 -114.33 4.69 Favored Glycine 0 CA--C 1.517 0.216 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.435 ' O ' ' HD3' ' A' ' 132' ' ' PRO . 25.2 t70 -137.79 136.52 37.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.911 0.386 . . . . 0.0 110.372 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.733 ' O ' ' NH1' ' A' ' 134' ' ' ARG . . . -112.24 83.97 5.58 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.271 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 130' ' ' ASP . 50.2 Cg_exo -50.55 -37.68 52.94 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.781 2.321 . . . . 0.0 112.282 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.598 ' HB3' HG22 ' A' ' 100' ' ' ILE . 65.6 m-20 -115.8 149.17 38.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.429 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.733 ' NH1' ' O ' ' A' ' 131' ' ' ALA . 62.5 mmt-85 -103.59 136.6 43.0 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.732 ' CE2' HD11 ' A' ' 137' ' ' ILE . 5.0 t80 -68.13 130.6 43.42 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.674 -0.411 . . . . 0.0 109.903 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.6 mm -120.58 118.91 58.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.732 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp -108.1 109.02 26.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -91.13 140.05 30.18 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.906 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.13 137.3 18.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.955 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.537 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 69.2 tttt -112.54 158.53 19.82 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.022 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.537 ' N ' ' CG ' ' A' ' 140' ' ' LYS . 10.6 tp -77.06 122.68 25.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.449 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.25 -38.19 6.61 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.515 179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.561 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -148.7 149.68 21.73 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.812 -0.915 . . . . 0.0 110.812 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 5.5 p -135.6 152.96 51.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.379 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -128.54 147.66 50.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.779 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.8 t -133.37 136.93 45.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.072 0.463 . . . . 0.0 110.526 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 2.8 tptp . . . . . 0 C--O 1.219 -0.502 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.563 -179.665 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 88.2 p -120.27 136.17 54.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.825 0.345 . . . . 0.0 110.576 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -156.08 155.95 33.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.673 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 98.5 mmm -41.43 146.25 0.22 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.416 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 t -151.73 168.55 24.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.431 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.2 p -76.68 166.38 23.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.697 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.428 ' O ' ' CB ' ' A' ' 11' ' ' LYS . 12.7 mm-40 -83.49 127.9 34.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.706 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.49 ' O ' HG22 ' A' ' 8' ' ' THR . 26.4 m -113.47 -1.37 14.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.425 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.5 -96.04 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.358 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.515 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 1.5 m80 -97.6 14.09 27.85 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.339 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' A' ' 7' ' ' GLN . 9.9 tmtt? -70.39 125.94 28.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.113 -179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.751 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 1.8 mp0 -67.58 151.09 47.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.358 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.39 9.8 81.1 Favored Glycine 0 CA--C 1.519 0.306 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -121.47 135.68 55.02 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 120.649 -0.421 . . . . 0.0 110.343 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -61.86 122.83 16.39 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.948 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 17' ' ' ALA . 14.3 m -117.29 -40.72 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.137 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.556 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -140.44 165.6 27.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.648 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.1 ttp -130.45 137.25 49.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.633 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 28.5 tp -99.11 127.69 45.11 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.486 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.598 HD21 ' NZ ' ' A' ' 27' ' ' LYS . 16.7 t-20 -117.4 125.91 51.77 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.205 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.431 HG22 ' H ' ' A' ' 24' ' ' LEU . 2.9 mt -103.24 108.37 58.7 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.445 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -75.41 -40.1 0.9 Allowed 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 122.435 2.09 . . . . 0.0 112.392 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.612 ' C ' HD22 ' A' ' 24' ' ' LEU . 6.0 tptp -60.64 -42.99 98.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.803 ' N ' HD22 ' A' ' 24' ' ' LEU . 2.7 mm? -99.13 3.4 46.57 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.562 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 48.86 51.3 16.19 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.474 179.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.5 mtpp -132.1 173.13 11.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.989 0.424 . . . . 0.0 110.974 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.598 ' NZ ' HD21 ' A' ' 20' ' ' ASN . 2.7 mtpp -143.67 152.3 41.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.203 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -146.63 130.49 17.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.939 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.446 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 13.3 m -83.01 112.77 20.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.967 0.413 . . . . 0.0 110.968 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 30' ' ' ILE . 1.5 mp -83.14 124.75 39.82 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.75 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.446 ' CE1' ' O ' ' A' ' 29' ' ' SER . 83.9 m-85 -110.1 140.6 44.0 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.858 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.515 ' CD1' ' O ' ' A' ' 10' ' ' HIS . 37.3 t-105 -60.69 118.35 6.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.963 0.411 . . . . 0.0 110.693 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.644 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 92.85 158.56 34.41 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.199 -0.761 . . . . 0.0 111.199 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -132.72 103.4 6.09 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.385 -0.526 . . . . 0.0 110.887 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -101.55 139.55 37.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.845 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.405 ' OD1' ' CE1' ' A' ' 65' ' ' HIS . 38.6 m-20 -83.37 -23.27 32.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.494 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.76 -40.1 84.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.821 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.3 p -72.76 134.8 45.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.625 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.57 ' O ' ' O ' ' A' ' 40' ' ' LYS . 0.7 OUTLIER -98.39 -0.78 42.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.615 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.619 ' O ' ' C ' ' A' ' 41' ' ' LYS . 61.4 pttt -37.73 166.1 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.191 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.619 ' C ' ' O ' ' A' ' 40' ' ' LYS . 95.3 mttt -12.35 -77.8 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 O-C-N 123.432 0.458 . . . . 0.0 111.277 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.45 ' O ' ' OD2' ' A' ' 67' ' ' ASP . . . 137.78 59.74 0.05 OUTLIER Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 43' ' ' VAL . 3.2 p -166.49 101.82 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 121.056 0.455 . . . . 0.0 110.773 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.65 154.49 19.2 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.579 ' SD ' HG23 ' A' ' 60' ' ' THR . 3.3 tpp -90.52 132.89 35.43 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -70.53 121.58 18.09 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.383 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.644 HG23 ' HA2' ' A' ' 33' ' ' GLY . 17.2 t -91.95 127.69 44.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.665 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.698 ' N ' ' OG1' ' A' ' 51' ' ' THR . 7.2 t -164.13 165.18 22.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.495 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -64.07 -34.26 77.63 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.675 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.718 HG21 ' O ' ' A' ' 109' ' ' ILE . 2.8 m -89.58 -12.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.957 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.698 ' OG1' ' N ' ' A' ' 48' ' ' SER . 24.9 p -84.95 144.2 28.48 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.019 0.438 . . . . 0.0 110.866 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.489 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.7 OUTLIER -134.92 174.55 10.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.934 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.94 159.87 27.97 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.801 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.647 ' HG3' HD23 ' A' ' 84' ' ' LEU . 72.4 Cg_endo -81.5 66.2 8.62 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.606 2.204 . . . . 0.0 112.522 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.1 p -112.89 -6.32 13.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.541 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.0 92.68 0.09 OUTLIER Glycine 0 CA--C 1.525 0.707 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.545 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 58.5 85.01 0.04 OUTLIER Glycine 0 CA--C 1.529 0.932 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.499 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -156.87 155.06 26.05 Favored Glycine 0 CA--C 1.522 0.512 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.489 ' N ' ' OG1' ' A' ' 52' ' ' THR . 19.9 t-160 -80.08 104.65 10.79 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.579 HG23 ' SD ' ' A' ' 45' ' ' MET . 26.0 m -101.08 122.45 43.6 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.888 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.572 ' C ' HD22 ' A' ' 62' ' ' LEU . 54.9 t -111.91 124.81 68.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.157 0.503 . . . . 0.0 110.423 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.599 ' O ' HG23 ' A' ' 120' ' ' THR . 2.6 mm? -113.01 139.5 48.61 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.382 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.0 m -140.87 153.61 45.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.072 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -145.75 143.52 11.81 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.109 -0.796 . . . . 0.0 111.109 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.405 ' CE1' ' OD1' ' A' ' 36' ' ' ASP . 79.0 m80 -115.73 129.24 56.39 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.306 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.564 ' O ' ' O ' ' A' ' 67' ' ' ASP . 43.9 mtp180 59.73 -95.88 0.06 Allowed 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.631 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.564 ' O ' ' O ' ' A' ' 66' ' ' ARG . 59.8 m-20 51.92 119.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.752 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.415 ' O ' ' OG1' ' A' ' 68' ' ' THR . 4.3 p -97.46 79.93 2.81 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.395 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 40.7 t -123.11 130.45 74.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.677 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.681 ' O ' ' N ' ' A' ' 72' ' ' ASP . 41.2 t80 -81.72 -114.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.384 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.531 ' C ' ' O ' ' A' ' 70' ' ' PHE . 41.1 p 28.11 33.62 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.673 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.681 ' N ' ' O ' ' A' ' 70' ' ' PHE . 55.1 m-20 -62.16 -36.89 83.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.168 0.509 . . . . 0.0 110.924 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.563 HD22 ' N ' ' A' ' 73' ' ' LEU . 3.6 mm? -62.72 -32.17 73.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.44 -18.21 59.16 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.409 -0.676 . . . . 0.0 111.409 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.429 ' OE1' ' OD1' ' A' ' 72' ' ' ASP . 85.4 mt-30 -72.93 -39.52 66.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.999 0.428 . . . . 0.0 110.446 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.55 ' CD1' ' O ' ' A' ' 72' ' ' ASP . 0.2 OUTLIER -109.12 103.65 12.69 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.137 -179.427 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.492 ' O ' HG21 ' A' ' 95' ' ' ILE . 4.6 ptpt -179.07 150.44 0.46 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.61 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -78.93 -13.37 59.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.523 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.6 mttm -86.87 -13.7 44.13 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.117 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.638 ' OD1' ' N ' ' A' ' 81' ' ' THR . 2.5 t0 -75.25 153.61 37.92 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.704 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.638 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.0 OUTLIER -137.98 143.3 40.6 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.5 mt -118.3 129.89 55.71 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.927 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 91' ' ' TYR . 2.8 t -115.46 121.6 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.547 -179.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.647 HD23 ' HG3' ' A' ' 54' ' ' PRO . 10.2 mp -101.06 133.2 45.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.224 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' HG2' HG23 ' A' ' 90' ' ' THR . 85.1 mt-10 -107.98 120.7 43.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.209 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.556 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.5 t80 -147.23 137.3 23.19 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.083 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 50.59 42.03 26.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.791 0.329 . . . . 0.0 111.043 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 4.6 m120 63.41 26.78 15.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.295 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 40.4 mttm -116.26 170.84 8.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.973 179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.427 HG23 ' HG2' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -139.25 111.84 7.72 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.684 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 7.9 m-85 -96.27 136.92 36.1 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.203 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -104.86 113.12 26.52 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.802 0.334 . . . . 0.0 111.452 -179.288 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.46 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 85.1 m-85 -110.2 151.68 27.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.554 178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -128.04 140.2 52.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.408 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.492 HG21 ' O ' ' A' ' 77' ' ' LYS . 2.4 mm -68.99 118.49 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.033 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 72.4 mm-40 -94.44 -59.23 1.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -144.84 140.05 28.13 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.27 0.557 . . . . 0.0 110.59 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.4 mp -119.67 127.93 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.78 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.487 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 23.1 p90 -144.06 -175.78 4.74 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.569 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.514 HG13 ' CD1' ' A' ' 135' ' ' TYR . 4.2 mp -126.32 132.45 70.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.471 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.502 HG22 HD11 ' A' ' 136' ' ' ILE . 2.3 t -134.51 165.3 25.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 110.73 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -73.95 149.42 41.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.331 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -59.1 -10.91 3.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.648 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -108.28 24.6 12.76 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.131 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.512 ' OD2' HG23 ' A' ' 108' ' ' VAL . 20.4 t0 -90.18 102.01 14.73 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.944 0.402 . . . . 0.0 110.585 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.811 ' O ' HG23 ' A' ' 110' ' ' ILE . 0.5 OUTLIER -70.91 -35.91 72.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.606 179.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.539 ' O ' HD12 ' A' ' 110' ' ' ILE . 2.2 p -42.06 -18.58 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.586 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.783 ' CG1' HG21 ' A' ' 118' ' ' THR . 4.0 t -104.68 -15.98 8.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.012 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.759 ' O ' HG22 ' A' ' 109' ' ' ILE . 52.1 mm -114.44 20.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.187 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.811 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -82.68 -173.65 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.114 179.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 16.2 ttpt -92.53 146.1 23.94 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.846 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.469 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.6 mttt -133.46 177.21 7.87 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.294 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -129.86 17.05 5.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.913 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -135.43 158.76 73.78 Favored Pre-proline 0 CA--C 1.531 0.216 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.541 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.499 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 37.2 Cg_endo -74.59 86.65 1.33 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 123.186 2.59 . . . . 0.0 110.693 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.8 mm -121.78 133.4 68.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.1 -178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.794 HD23 ' C ' ' A' ' 117' ' ' LEU . 6.2 tt -108.1 119.78 40.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.216 0.531 . . . . 0.0 110.335 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.783 HG21 ' CG1' ' A' ' 108' ' ' VAL . 88.2 m -114.89 117.88 31.92 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.394 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.64 HD12 ' N ' ' A' ' 120' ' ' THR . 5.6 tp -105.98 128.38 53.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.28 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.64 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -113.89 114.16 25.86 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.284 179.278 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.521 ' HB ' ' CZ ' ' A' ' 123' ' ' TYR . 1.2 p -94.47 136.65 34.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.985 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . . . . . . . . . 17.6 t -134.36 61.64 1.67 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.145 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.604 ' N ' ' CD1' ' A' ' 123' ' ' TYR . 0.5 OUTLIER -102.95 137.29 19.23 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.092 -179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.86 51.43 2.34 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.53 2.153 . . . . 0.0 112.126 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.65 ' CG ' ' N ' ' A' ' 126' ' ' ASP . 3.1 p90 -59.38 -48.5 81.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.446 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.65 ' N ' ' CG ' ' A' ' 125' ' ' PHE . 25.4 t70 -113.37 -31.32 6.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.515 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.711 ' CE2' ' O ' ' A' ' 128' ' ' ILE . 87.1 t80 -89.59 161.11 16.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.499 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.711 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 88.0 mt -104.69 115.17 46.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.769 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 88.97 -118.35 5.13 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.473 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 43.1 t0 -86.12 100.71 12.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.341 . . . . 0.0 110.567 -179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 127' ' ' TYR . . . -60.01 113.05 6.35 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.122 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -48.57 -43.3 33.86 Favored 'Trans proline' 0 N--CA 1.495 1.583 0 C-N-CA 122.224 1.95 . . . . 0.0 112.149 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -85.91 148.15 25.92 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.237 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.41 ' NE ' ' HB ' ' A' ' 120' ' ' THR . 35.5 ttp180 -123.52 119.42 29.9 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.135 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.514 ' CD1' HG13 ' A' ' 100' ' ' ILE . 4.6 t80 -69.18 137.94 53.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.961 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.502 HD11 HG22 ' A' ' 101' ' ' THR . 6.8 mm -122.63 122.13 65.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 112.348 0.499 . . . . 0.0 112.348 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.502 HG22 ' O ' ' A' ' 137' ' ' ILE . 1.2 mp -107.17 112.03 38.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.487 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 38.4 tt0 -95.59 134.06 38.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.942 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.74 145.23 34.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.18 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -117.37 145.83 43.8 Favored 'General case' 0 CA--C 1.521 -0.153 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.215 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.46 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 16.9 tp -69.8 123.26 20.98 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.491 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.2 p -99.33 -43.66 6.5 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.224 179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.582 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -145.89 165.9 28.0 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 35.4 p -139.55 142.28 37.19 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.701 -0.4 . . . . 0.0 110.708 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -124.53 143.57 50.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.429 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 27.3 p -133.51 127.31 32.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.442 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 40.4 tttp . . . . . 0 C--O 1.219 -0.501 0 CA-C-O 118.05 -0.976 . . . . 0.0 110.724 179.779 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.553 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.578 ' O ' ' O ' ' A' ' 3' ' ' HIS . 14.8 m 26.08 76.82 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.777 0.322 . . . . 0.0 110.505 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.578 ' O ' ' O ' ' A' ' 2' ' ' SER . 84.7 t60 54.72 140.68 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.476 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.2 mtt -101.01 115.88 31.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.346 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.539 ' O ' ' OG ' ' A' ' 6' ' ' SER . 10.2 p -140.23 143.05 35.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.544 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.539 ' OG ' ' O ' ' A' ' 5' ' ' SER . 16.0 m -171.9 83.03 0.07 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.516 179.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.63 151.25 38.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.533 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.9 m -65.24 118.82 9.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.51 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.634 ' C ' ' CG ' ' A' ' 10' ' ' HIS . 96.8 mt-10 -149.63 6.08 0.62 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.559 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.634 ' CG ' ' C ' ' A' ' 9' ' ' GLU . 1.7 m-70 86.65 9.79 0.21 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.498 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 40.7 mmtm -75.5 137.46 40.92 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.606 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 59.9 mp0 -68.96 137.45 53.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.279 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 94.84 12.98 54.85 Favored Glycine 0 CA--C 1.523 0.532 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -120.35 134.92 55.18 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 120.801 0.334 . . . . 0.0 110.498 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' NZ ' ' SD ' ' A' ' 18' ' ' MET . 88.3 tttt -57.99 120.06 7.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.349 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.14 -31.95 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.78 -179.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -140.45 161.94 36.52 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.673 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.502 ' SD ' ' OG ' ' A' ' 29' ' ' SER . 1.0 OUTLIER -123.45 133.88 54.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.432 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.852 ' HB2' HD11 ' A' ' 30' ' ' ILE . 2.0 tt -104.1 122.56 45.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.622 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.427 HD22 ' N ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -115.29 126.12 54.11 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.85 -179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.427 ' N ' HD22 ' A' ' 20' ' ' ASN . 7.9 mt -102.86 114.82 65.02 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.322 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.522 ' CD ' ' O ' ' A' ' 81' ' ' THR . 60.8 Cg_endo -77.68 -43.9 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.812 2.341 . . . . 0.0 112.527 -179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.6 ' C ' HD22 ' A' ' 24' ' ' LEU . 24.2 tptp -60.37 -41.72 94.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.569 -179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.822 ' N ' HD22 ' A' ' 24' ' ' LEU . 2.8 mm? -98.31 0.24 45.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.812 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 49.79 42.07 23.27 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.68 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -119.96 162.65 18.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.9 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.1 mtmt -135.38 145.06 46.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.765 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.434 ' O ' ' N ' ' A' ' 19' ' ' LEU . 61.8 m-85 -141.0 150.45 43.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.584 179.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.502 ' OG ' ' SD ' ' A' ' 18' ' ' MET . 9.9 m -103.27 119.65 39.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.801 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.852 HD11 ' HB2' ' A' ' 19' ' ' LEU . 4.6 mp -83.8 124.18 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.259 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 15' ' ' LYS . 42.1 m-85 -107.17 135.04 49.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.989 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.518 ' O ' ' N ' ' A' ' 13' ' ' GLY . 26.2 t-105 -60.42 127.75 33.27 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.6 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.468 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 75.05 144.67 1.09 Allowed Glycine 0 CA--C 1.521 0.436 0 N-CA-C 111.18 -0.768 . . . . 0.0 111.18 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -110.5 81.44 1.43 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.758 0.313 . . . . 0.0 110.685 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -77.16 131.38 38.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.482 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 40.5 p-10 -89.49 -1.81 58.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.543 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.35 -40.31 85.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.743 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 m -83.15 154.28 24.37 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.65 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.795 ' N ' HD22 ' A' ' 39' ' ' LEU . 2.9 mm? -76.89 144.11 39.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.506 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.561 ' C ' ' O ' ' A' ' 39' ' ' LEU . 7.3 mtmm -25.87 104.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.484 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -91.25 -52.81 4.63 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.69 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -179.06 -56.25 0.08 OUTLIER Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 43' ' ' VAL . 2.3 p -173.31 122.78 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.488 0 CA-C-O 121.095 0.474 . . . . 0.0 110.566 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -106.44 150.5 16.84 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -96.21 127.92 42.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.747 0.308 . . . . 0.0 110.655 179.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.507 ' O ' ' SD ' ' A' ' 45' ' ' MET . 9.5 t80 -69.1 131.8 45.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.527 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.6 t -111.26 128.87 67.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.683 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.567 ' N ' ' OG1' ' A' ' 51' ' ' THR . 33.0 p -161.99 171.8 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.584 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.465 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 39.4 t0 -74.98 10.1 1.62 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.464 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.782 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.7 m -132.27 -15.58 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.665 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 48' ' ' SER . 2.6 p -87.8 139.7 30.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.611 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.65 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -131.04 169.52 15.74 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.633 -179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.64 154.71 38.38 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.466 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.725 ' HG3' HD13 ' A' ' 84' ' ' LEU . 59.3 Cg_endo -78.97 61.08 8.03 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.835 2.357 . . . . 0.0 112.214 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -107.33 -5.36 17.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.64 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.99 91.94 0.09 OUTLIER Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 55.92 92.51 0.01 OUTLIER Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.943 -0.863 . . . . 0.0 110.943 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.428 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.27 155.18 26.02 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.65 ' N ' ' OG1' ' A' ' 52' ' ' THR . 21.7 t-160 -79.59 112.59 17.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.932 0.396 . . . . 0.0 110.1 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 16.3 m -105.48 123.39 47.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.348 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.585 ' C ' HD22 ' A' ' 62' ' ' LEU . 63.5 t -116.7 127.42 74.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.476 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.585 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.2 mm? -109.76 145.51 36.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.616 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 120' ' ' THR . 44.1 t -130.3 144.13 51.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.591 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.592 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -171.84 178.72 43.94 Favored Glycine 0 CA--C 1.528 0.883 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.565 ' ND1' ' CD1' ' A' ' 123' ' ' TYR . 28.3 m-70 -119.85 150.72 39.99 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 122.636 -0.332 . . . . 0.0 110.625 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -55.36 117.14 3.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.473 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.599 ' O ' ' C ' ' A' ' 68' ' ' THR . 96.8 m-20 -103.67 115.69 30.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.817 -179.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.774 HG22 HG22 ' A' ' 69' ' ' VAL . 7.5 m 18.77 -125.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.455 0.472 . . . . 0.0 110.694 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.774 HG22 HG22 ' A' ' 68' ' ' THR . 6.9 m -120.39 -148.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.54 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.687 ' C ' ' H ' ' A' ' 72' ' ' ASP . 89.4 t80 57.67 158.04 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.438 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.414 ' N ' ' CG ' ' A' ' 70' ' ' PHE . 25.2 m 62.26 -28.05 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.521 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.687 ' H ' ' C ' ' A' ' 70' ' ' PHE . 50.4 m-20 -59.66 -46.03 90.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.874 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -42.86 93.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.756 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.586 ' O ' ' CG ' ' A' ' 77' ' ' LYS . . . -67.83 -23.88 74.19 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.181 -0.768 . . . . 0.0 111.181 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -71.24 -36.36 71.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.757 0.313 . . . . 0.0 110.817 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 76' ' ' LEU . 0.2 OUTLIER -88.85 73.69 8.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.642 -179.044 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.586 ' CG ' ' O ' ' A' ' 74' ' ' GLY . 10.5 ptpt -169.38 129.86 1.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.436 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -74.75 -10.46 59.54 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.582 179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -79.95 -16.36 55.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.361 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.686 ' OD1' ' N ' ' A' ' 81' ' ' THR . 34.5 t0 -71.38 154.38 41.61 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.586 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.686 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.6 OUTLIER -141.3 117.7 10.81 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.916 0.389 . . . . 0.0 110.803 -179.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 93' ' ' TYR . 51.8 mt -90.7 128.96 36.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.642 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.634 HG12 HG22 ' A' ' 90' ' ' THR . 2.3 t -105.23 127.08 60.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.903 0.383 . . . . 0.0 110.239 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.829 HD11 HD12 ' A' ' 117' ' ' LEU . 33.4 mt -111.07 122.89 49.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.96 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.41 ' HG2' HG23 ' A' ' 90' ' ' THR . 84.2 mt-10 -99.59 119.35 37.93 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.69 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -150.06 129.39 12.89 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.995 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 56.46 43.98 25.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.996 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . 0.509 ' OD1' ' C ' ' A' ' 147' ' ' LYS . 6.3 t-20 61.82 15.4 7.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.645 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -114.99 137.13 52.36 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.202 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.634 HG22 HG12 ' A' ' 83' ' ' VAL . 0.3 OUTLIER -107.67 124.04 49.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.755 -178.909 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -108.89 125.56 52.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.096 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.428 ' OG1' ' C ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -94.95 107.09 19.12 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.143 -179.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.576 ' CE1' HD12 ' A' ' 84' ' ' LEU . 40.2 m-85 -95.09 156.92 16.12 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.577 179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -131.5 134.1 45.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.55 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.695 HG23 HD11 ' A' ' 98' ' ' ILE . 1.1 mm -65.7 114.59 3.07 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.246 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -83.57 -66.18 0.92 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.842 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.552 ' C ' HD13 ' A' ' 98' ' ' ILE . 29.1 tptp -150.36 146.91 27.01 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.506 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.695 HD11 HG23 ' A' ' 95' ' ' ILE . 5.2 mm -114.16 135.36 54.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.691 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.51 ' CZ3' ' HB2' ' A' ' 138' ' ' GLU . 14.3 p90 -155.43 178.68 9.95 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.683 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.427 HG22 ' HB3' ' A' ' 133' ' ' ASP . 2.3 mt -127.47 128.83 70.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.151 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 102' ' ' HIS . 3.0 t -131.05 172.87 11.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.899 -179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.497 ' O ' HG23 ' A' ' 101' ' ' THR . 25.1 t60 -62.92 171.95 1.94 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.551 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -86.36 -20.47 28.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.555 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -100.55 19.32 17.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.449 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.524 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 28.9 t0 -83.17 92.4 7.44 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.71 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.966 ' O ' HG23 ' A' ' 110' ' ' ILE . 36.6 ptt180 -63.52 -37.84 88.86 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.234 179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.524 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 9.4 p -37.0 -18.52 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.258 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.858 ' CG1' HG21 ' A' ' 118' ' ' THR . 10.9 t -108.86 -21.3 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.711 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.782 ' O ' HG21 ' A' ' 50' ' ' VAL . 33.5 mm -109.71 28.13 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.899 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.966 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -93.07 -165.71 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.329 179.746 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.7 ttmt -99.57 141.5 32.29 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.647 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.474 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.1 mttt -128.21 135.46 49.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.206 179.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -81.63 7.98 10.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.499 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.52 160.18 69.34 Favored Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.619 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.431 ' O ' HD13 ' A' ' 116' ' ' ILE . 41.1 Cg_endo -74.69 101.23 1.42 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.936 2.424 . . . . 0.0 111.972 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.431 HD13 ' O ' ' A' ' 115' ' ' PRO . 49.2 mm -131.33 135.11 60.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.788 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.829 HD12 HD11 ' A' ' 84' ' ' LEU . 9.4 tt -106.32 118.58 37.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.794 179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.858 HG21 ' CG1' ' A' ' 108' ' ' VAL . 53.6 m -122.75 121.35 36.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.364 179.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.861 ' C ' HD23 ' A' ' 119' ' ' LEU . 5.8 tt -109.26 124.71 51.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.015 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.743 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.2 OUTLIER -116.51 124.54 50.15 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.376 178.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.673 ' O ' ' SG ' ' A' ' 122' ' ' CYS . 1.7 t -151.07 177.93 9.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.848 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.673 ' SG ' ' O ' ' A' ' 121' ' ' THR . 1.3 m 155.1 -75.64 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.507 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.565 ' CD1' ' ND1' ' A' ' 65' ' ' HIS . 21.1 m-85 25.84 67.68 0.46 Allowed Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.75 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.623 ' CD ' ' HB2' ' A' ' 131' ' ' ALA . 59.9 Cg_endo -77.41 149.25 27.36 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.812 2.342 . . . . 0.0 111.953 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 35.3 p90 -66.65 -31.28 71.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.388 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -60.39 -48.68 80.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.518 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.444 ' CD1' ' HD3' ' A' ' 132' ' ' PRO . 35.4 t80 -85.79 135.43 33.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.402 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.607 ' H ' HD12 ' A' ' 128' ' ' ILE . 2.8 mp -101.98 118.17 48.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.425 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 109.72 -104.37 1.86 Allowed Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.902 -0.879 . . . . 0.0 110.902 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.515 ' HB3' HH12 ' A' ' 134' ' ' ARG . 0.2 OUTLIER -128.72 105.43 8.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.825 0.345 . . . . 0.0 110.624 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.623 ' HB2' ' CD ' ' A' ' 124' ' ' PRO . . . -41.11 144.99 0.61 Allowed Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.547 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.444 ' HD3' ' CD1' ' A' ' 127' ' ' TYR . 26.0 Cg_endo -62.12 -29.62 81.24 Favored 'Trans proline' 0 C--N 1.302 -1.882 0 C-N-CA 122.882 2.388 . . . . 0.0 112.212 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.427 ' HB3' HG22 ' A' ' 100' ' ' ILE . 96.0 m-20 -128.89 140.28 51.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.394 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.515 HH12 ' HB3' ' A' ' 130' ' ' ASP . 1.3 mpt_? -115.72 138.25 51.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.659 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.751 ' CE2' HD11 ' A' ' 137' ' ' ILE . 4.5 t80 -73.23 123.94 24.67 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.024 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.414 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 2.4 mm -115.8 118.67 59.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.883 -178.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.751 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp -105.24 107.22 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 177.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.51 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 46.3 tt0 -88.3 134.95 33.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.308 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -149.84 138.96 21.19 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.482 178.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.534 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 31.6 ttpt -109.27 161.28 15.4 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.882 -179.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.807 ' C ' HD13 ' A' ' 141' ' ' LEU . 2.6 tm? -91.77 115.89 28.44 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.241 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.564 ' N ' HD22 ' A' ' 141' ' ' LEU . 0.2 OUTLIER -110.94 -66.01 1.12 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.898 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.553 ' O ' HD21 ' A' ' 141' ' ' LEU . . . -83.32 165.53 43.04 Favored Glycine 0 CA--C 1.523 0.558 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.415 ' O ' ' CG ' ' A' ' 145' ' ' TYR . 12.4 p -158.15 158.08 33.94 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.799 0.333 . . . . 0.0 110.582 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 90' ' ' THR . 79.4 m-85 -153.99 104.8 2.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.523 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 5.5 p -98.99 122.28 42.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.637 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.509 ' C ' ' OD1' ' A' ' 88' ' ' ASN . 68.6 mttm . . . . . 0 C--O 1.22 -0.472 0 CA-C-O 118.022 -0.99 . . . . 0.0 110.429 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.582 ' O ' ' O ' ' A' ' 1' ' ' GLY . 2.1 m 53.59 134.63 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.848 0.356 . . . . 0.0 110.799 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -88.49 -18.41 28.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.604 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.445 ' HG2' ' H ' ' A' ' 5' ' ' SER . 4.5 ttt 67.55 -132.71 0.12 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.532 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.445 ' H ' ' HG2' ' A' ' 4' ' ' MET . 74.5 m -68.68 -68.5 0.39 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.775 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.451 ' O ' ' O ' ' A' ' 7' ' ' GLN . 67.7 p -153.02 -163.41 1.69 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.517 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.451 ' O ' ' O ' ' A' ' 6' ' ' SER . 18.3 mp0 56.61 115.58 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.513 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.487 ' OG1' ' N ' ' A' ' 9' ' ' GLU . 54.5 p -101.46 -77.78 0.54 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.569 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.488 ' OE1' ' N ' ' A' ' 10' ' ' HIS . 0.1 OUTLIER 165.88 -30.57 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.672 179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.488 ' N ' ' OE1' ' A' ' 9' ' ' GLU . 57.1 t-80 -98.37 -2.05 40.15 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.671 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -65.47 138.92 58.41 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.621 -0.432 . . . . 0.0 109.944 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.666 ' OE2' HG11 ' A' ' 47' ' ' VAL . 91.0 mt-10 -80.79 151.02 28.98 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 83.59 15.25 71.42 Favored Glycine 0 CA--C 1.52 0.382 0 N-CA-C 111.183 -0.767 . . . . 0.0 111.183 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -118.07 132.1 56.39 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.044 0.45 . . . . 0.0 110.456 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.49 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 61.9 tttm -58.24 106.09 0.34 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.601 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.435 HG11 ' HB2' ' A' ' 32' ' ' TRP . 14.5 m -110.55 -38.81 3.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.38 155.64 46.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.607 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 49.7 ttp -121.29 131.54 54.27 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.84 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 49.8 tp -93.95 123.67 37.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.425 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -119.5 124.3 46.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.871 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.0 mt -106.64 111.61 63.89 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.242 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.618 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.9 Cg_endo -78.9 -42.78 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.362 0 C-N-CA 123.057 2.505 . . . . 0.0 112.615 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.578 ' C ' HD22 ' A' ' 24' ' ' LEU . 6.0 tptm -63.01 -39.05 93.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.777 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.0 mm? -99.54 5.81 45.97 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.907 0.384 . . . . 0.0 110.522 179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 44.71 56.91 4.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.42 179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 1.027 ' HZ3' HG21 ' A' ' 71' ' ' THR . 19.2 mtmt -141.37 158.71 43.51 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.667 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -141.26 140.46 33.9 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.612 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -133.81 155.41 49.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.72 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.5 m -95.92 118.37 32.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.442 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 24.3 mm -95.31 123.84 47.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.243 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.49 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 52.4 m-85 -103.76 142.92 33.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.004 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.551 ' HZ2' HG23 ' A' ' 47' ' ' VAL . 40.9 t-105 -61.54 130.92 48.3 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.952 0.406 . . . . 0.0 110.659 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.477 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 84.51 171.39 48.01 Favored Glycine 0 N--CA 1.459 0.226 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.1 91.8 1.89 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 120.324 -0.551 . . . . 0.0 110.906 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 -98.85 101.69 13.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.657 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 37' ' ' ALA . 42.1 p30 -70.97 -23.03 62.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.696 179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.511 ' N ' ' OD1' ' A' ' 36' ' ' ASP . . . -56.48 -49.22 75.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.705 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.672 ' C ' HD22 ' A' ' 39' ' ' LEU . 58.2 p -87.64 163.85 16.36 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.551 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.672 HD22 ' C ' ' A' ' 38' ' ' THR . 4.1 mm? -112.5 126.49 55.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.635 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 mttm -153.24 -80.44 0.1 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.358 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -138.57 154.61 48.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.921 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.04 39.16 3.14 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.407 -0.677 . . . . 0.0 111.407 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.12 92.21 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 120.943 0.401 . . . . 0.0 110.701 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.74 153.14 19.56 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.477 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 2.8 tpp -103.14 142.88 33.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -75.97 140.27 41.97 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.402 -179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.666 HG11 ' OE2' ' A' ' 12' ' ' GLU . 2.1 p -123.37 124.3 69.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.465 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.532 ' O ' ' O ' ' A' ' 51' ' ' THR . 21.1 t -168.76 169.67 9.81 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.531 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -62.99 -37.39 86.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.29 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.649 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.0 m -83.98 -26.6 7.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.843 0.354 . . . . 0.0 110.552 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.532 ' O ' ' O ' ' A' ' 48' ' ' SER . 64.8 p -99.05 142.58 30.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.823 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -143.83 175.45 9.99 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.654 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.497 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -91.36 155.07 44.55 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.731 -179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.59 84.29 2.0 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.746 2.298 . . . . 0.0 112.431 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 77.3 p -115.22 -7.64 12.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.727 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.08 89.29 0.07 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 64.68 84.65 0.07 OUTLIER Glycine 0 CA--C 1.528 0.845 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.474 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -166.4 158.87 32.0 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.651 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 19.1 t-160 -78.71 121.9 25.32 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 88.9 m -119.2 128.39 54.18 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.564 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.584 ' C ' HD22 ' A' ' 62' ' ' LEU . 55.0 t -119.5 132.84 68.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.099 0.476 . . . . 0.0 110.238 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.584 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.8 mm? -113.18 140.56 47.83 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.625 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.554 ' OG ' ' OH ' ' A' ' 123' ' ' TYR . 37.9 t -118.84 136.69 53.88 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.427 -179.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -151.57 87.59 0.14 Allowed Glycine 0 CA--C 1.533 1.163 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.562 ' O ' ' O ' ' A' ' 66' ' ' ARG . 0.3 OUTLIER -66.31 135.02 53.8 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 122.583 -0.363 . . . . 0.0 110.026 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.562 ' O ' ' O ' ' A' ' 65' ' ' HIS . 77.7 ttt-85 54.88 133.38 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.559 -179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -119.6 -172.86 2.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.294 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 69.6 p -97.42 -110.66 0.16 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.748 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.432 ' O ' ' CG2' ' A' ' 69' ' ' VAL . 1.2 p -179.25 -14.17 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.513 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.544 ' CE2' ' NZ ' ' A' ' 26' ' ' LYS . 1.6 p90 -96.01 154.39 17.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.481 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 1.027 HG21 ' HZ3' ' A' ' 26' ' ' LYS . 22.6 p 52.4 8.78 0.09 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.66 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.49 ' H ' ' C ' ' A' ' 70' ' ' PHE . 51.9 t0 -61.14 -43.24 99.19 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.129 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.2 mt -60.94 -41.3 95.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.039 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.575 ' HA3' HD11 ' A' ' 24' ' ' LEU . . . -64.79 -28.95 74.04 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -67.63 -39.9 84.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.934 0.397 . . . . 0.0 110.391 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.565 HD23 ' N ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -95.54 101.72 13.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.98 -179.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.477 ' O ' ' HB ' ' A' ' 95' ' ' ILE . 11.2 ptpt 175.84 145.95 0.08 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.567 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -74.68 -14.61 60.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.128 0.489 . . . . 0.0 110.698 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt -79.67 -15.25 57.93 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.725 179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -79.12 154.3 29.46 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.762 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.618 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.3 OUTLIER -141.37 115.26 9.15 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.418 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 63.2 mt -89.19 131.43 35.32 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.236 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.588 ' C ' HD22 ' A' ' 84' ' ' LEU . 48.8 t -111.53 122.42 65.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.054 0.454 . . . . 0.0 109.852 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.588 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.4 mm? -112.67 132.47 55.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.696 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.456 ' HG2' HG23 ' A' ' 90' ' ' THR . 90.2 mt-10 -104.7 119.54 39.23 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.468 -0.493 . . . . 0.0 110.42 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.497 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 9.1 t80 -140.49 137.3 33.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.022 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.433 ' O ' ' CG ' ' A' ' 87' ' ' ASP . 50.1 t0 50.98 41.12 26.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.158 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 65.86 16.77 10.62 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.264 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.3 mttm -117.82 149.77 40.28 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.4 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.505 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.2 OUTLIER -110.96 125.85 54.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.532 -179.136 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -110.15 125.76 53.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.455 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 143' ' ' GLY . 0.3 OUTLIER -97.81 108.18 20.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.697 -179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.585 ' CE2' ' HB2' ' A' ' 141' ' ' LEU . 62.9 m-85 -98.98 151.91 20.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.704 179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -124.41 132.69 53.52 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.759 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.641 HD12 HD11 ' A' ' 98' ' ' ILE . 1.2 mm -65.86 119.62 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.059 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -89.84 -57.79 2.74 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.544 -0.463 . . . . 0.0 110.951 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 20.7 tttt -153.35 151.48 30.01 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.295 0.569 . . . . 0.0 109.934 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.641 HD11 HD12 ' A' ' 95' ' ' ILE . 16.0 mm -122.41 132.15 71.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.25 -179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.499 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 11.2 p90 -150.21 178.87 8.58 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 120.689 -0.404 . . . . 0.0 111.192 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.508 HG22 ' HB3' ' A' ' 133' ' ' ASP . 7.9 mt -125.87 138.65 53.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.664 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.443 HG23 ' O ' ' A' ' 102' ' ' HIS . 3.4 t -138.68 169.14 18.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.268 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.478 ' ND1' ' OD1' ' A' ' 133' ' ' ASP . 68.5 m-70 -68.86 168.23 13.96 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.672 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.519 ' HA ' ' HE ' ' A' ' 134' ' ' ARG . . . -76.08 -9.51 58.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.641 -179.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.6 p-10 -105.35 20.06 19.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.062 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.606 ' O ' HG22 ' A' ' 108' ' ' VAL . 24.4 t70 -87.28 95.01 9.83 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.705 0.288 . . . . 0.0 110.761 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.958 ' O ' HG23 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -73.33 -20.21 60.84 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.122 0.487 . . . . 0.0 110.615 179.638 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.561 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 20.9 p -44.87 -14.7 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.445 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.666 ' HB ' HG21 ' A' ' 118' ' ' THR . 11.0 m -112.37 -12.16 11.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.406 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.759 ' O ' HG22 ' A' ' 109' ' ' ILE . 49.0 mm -109.48 13.49 8.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.785 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.958 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -92.61 -170.49 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.83 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 23.7 ttmt -95.12 155.22 16.82 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.135 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.699 ' HZ3' HG21 ' A' ' 116' ' ' ILE . 97.0 mttt -131.73 -174.47 3.42 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.871 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -125.48 10.14 7.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.132 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.75 168.13 11.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.971 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.474 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 38.1 Cg_endo -75.76 97.55 1.11 Allowed 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 123.084 2.522 . . . . 0.0 111.929 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.699 HG21 ' HZ3' ' A' ' 112' ' ' LYS . 51.2 mm -127.6 132.19 69.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.318 -0.856 . . . . 0.0 110.709 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 tt -106.14 123.85 48.67 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.245 0.545 . . . . 0.0 109.827 179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.666 HG21 ' HB ' ' A' ' 108' ' ' VAL . 96.7 m -115.69 126.67 54.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.458 -179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.806 HD22 HG23 ' A' ' 121' ' ' THR . 0.6 OUTLIER -112.35 126.35 55.18 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.198 -179.398 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.765 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -122.89 117.45 25.6 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.256 -0.577 . . . . 0.0 111.078 179.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.806 HG23 HD22 ' A' ' 119' ' ' LEU . 42.9 p -131.27 176.29 8.4 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.528 -179.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.649 ' CB ' ' O ' ' A' ' 121' ' ' THR . 5.1 t 97.77 -68.13 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.77 -1.105 . . . . 0.0 110.056 -179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.631 ' O ' ' O ' ' A' ' 124' ' ' PRO . 18.3 m-85 62.27 155.67 0.11 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.27 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.631 ' O ' ' O ' ' A' ' 123' ' ' TYR . 71.1 Cg_exo -41.85 -125.67 0.0 OUTLIER 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.163 2.576 . . . . 0.0 113.157 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.585 ' O ' ' N ' ' A' ' 127' ' ' TYR . 47.5 p90 -58.35 -34.9 71.16 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.565 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 125' ' ' PHE . 81.3 m-20 -37.67 -24.04 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.411 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.665 ' CD1' ' N ' ' A' ' 128' ' ' ILE . 3.5 t80 -90.98 163.14 14.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.327 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.665 ' N ' ' CD1' ' A' ' 127' ' ' TYR . 2.0 mt -67.72 95.36 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.94 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 110.61 -128.18 8.66 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -179.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -133.88 114.94 13.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.762 0.315 . . . . 0.0 110.685 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.585 ' CB ' ' SG ' ' A' ' 122' ' ' CYS . . . -118.51 81.23 17.56 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.502 179.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -53.12 -38.25 80.58 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.699 2.266 . . . . 0.0 111.881 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.508 ' HB3' HG22 ' A' ' 100' ' ' ILE . 95.1 m-20 -107.86 144.27 35.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.607 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.519 ' HE ' ' HA ' ' A' ' 103' ' ' ALA . 85.7 mtm180 -98.27 142.24 30.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.29 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.55 ' CD2' HD11 ' A' ' 137' ' ' ILE . 3.9 t80 -72.92 132.49 43.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.34 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.499 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 3.7 mm -118.05 120.12 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.55 HD11 ' CD2' ' A' ' 135' ' ' TYR . 16.5 mm -105.68 111.53 35.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.747 177.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.488 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 39.4 tt0 -99.03 129.18 45.3 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.083 0.468 . . . . 0.0 110.946 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -135.46 150.63 49.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.412 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.447 ' NZ ' ' HD2' ' A' ' 115' ' ' PRO . 53.4 tptt -115.75 140.99 48.68 Favored 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.05 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.682 ' C ' HD13 ' A' ' 141' ' ' LEU . 2.6 tm? -80.22 117.2 20.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.494 ' N ' HD22 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -108.34 -61.23 1.62 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.68 -179.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.548 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -104.72 151.99 17.38 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 3.7 m -150.43 148.94 29.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.952 0.406 . . . . 0.0 110.222 179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' THR . 81.8 m-85 -132.2 156.92 45.59 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.404 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 84.9 p -137.09 125.13 22.86 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.315 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.449 ' O ' ' CD ' ' A' ' 147' ' ' LYS . 5.9 tmtt? . . . . . 0 C--O 1.22 -0.481 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.576 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 t -60.17 -48.46 81.65 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.912 -0.315 . . . . 0.0 110.818 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -152.37 108.27 3.36 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.131 179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 69.1 mmm -126.48 99.64 5.91 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.649 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.3 p -144.35 2.88 1.14 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.73 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 88.6 p -64.42 153.96 37.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.647 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.691 ' NE2' ' OE1' ' A' ' 14' ' ' GLU . 3.1 tp60 -97.97 -166.74 1.42 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.455 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.453 ' H ' ' HG3' ' A' ' 7' ' ' GLN . 0.2 OUTLIER 77.03 -17.61 0.55 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.44 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 7' ' ' GLN . 98.7 mt-10 -67.98 -172.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.493 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -112.65 91.83 3.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.468 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.5 tptt -131.79 129.32 40.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.183 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.446 ' HG3' ' CD1' ' A' ' 32' ' ' TRP . 56.4 mp0 -65.5 145.76 55.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.941 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.17 10.76 68.23 Favored Glycine 0 CA--C 1.517 0.214 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.691 ' OE1' ' NE2' ' A' ' 7' ' ' GLN . 6.3 mt-10 -119.47 136.15 54.44 Favored 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.079 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.91 117.9 5.59 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.829 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 32' ' ' TRP . 16.0 m -117.35 -43.98 3.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.223 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.514 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -129.19 161.48 30.03 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.951 0.405 . . . . 0.0 110.723 -179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 24.4 ttt -125.89 131.09 52.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.488 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.431 HD13 HD21 ' A' ' 84' ' ' LEU . 51.0 tp -95.76 123.55 39.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.51 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -120.24 128.17 53.1 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.146 0.498 . . . . 0.0 110.687 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.0 mt -106.77 115.65 60.09 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.294 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.531 ' CD ' ' O ' ' A' ' 81' ' ' THR . 57.6 Cg_endo -77.88 -49.97 0.09 OUTLIER 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 123.077 2.518 . . . . 0.0 112.526 -179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.477 ' HG2' ' HZ1' ' A' ' 77' ' ' LYS . 1.9 tptt -63.16 -37.06 85.73 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.074 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.67 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.7 mm? -96.77 5.81 49.9 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.977 0.418 . . . . 0.0 110.377 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 24' ' ' LEU . 12.9 mttt 40.21 53.96 2.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.463 179.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.412 ' NZ ' ' OG1' ' A' ' 71' ' ' THR . 19.6 mtmt -136.73 159.47 41.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.068 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 2.2 mtmt -137.78 154.49 49.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.944 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.423 ' CG ' ' O ' ' A' ' 27' ' ' LYS . 76.8 m-85 -154.23 150.61 28.24 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.949 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.436 ' O ' HG23 ' A' ' 43' ' ' VAL . 45.0 m -99.87 119.33 38.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.541 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 30' ' ' ILE . 1.7 mp -93.07 122.16 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.611 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -97.89 141.14 31.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.866 -0.607 . . . . 0.0 110.748 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.537 ' CZ3' HG22 ' A' ' 53' ' ' THR . 48.2 t-105 -60.51 130.3 45.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.778 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.408 ' HA2' HG12 ' A' ' 47' ' ' VAL . . . 93.85 156.54 32.53 Favored Glycine 0 C--N 1.33 0.22 0 N-CA-C 111.124 -0.791 . . . . 0.0 111.124 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -144.0 78.4 1.58 Allowed 'General case' 0 N--CA 1.447 -0.598 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.609 179.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -99.36 108.23 20.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.711 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -76.54 -21.46 55.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.511 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.53 -37.43 86.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.48 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.811 ' C ' HD23 ' A' ' 39' ' ' LEU . 92.6 m -83.28 16.38 2.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.601 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.811 HD23 ' C ' ' A' ' 38' ' ' THR . 1.2 pt? 30.79 -152.83 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.744 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.42 ' O ' ' CB ' ' A' ' 41' ' ' LYS . 18.8 ttmt 54.38 172.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.617 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' CB ' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER 76.08 158.05 0.2 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.363 179.931 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -112.3 -55.1 0.47 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 110.414 -1.074 . . . . 0.0 110.414 179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 29' ' ' SER . 3.4 m -128.07 129.24 69.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.107 0.48 . . . . 0.0 111.049 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.93 155.17 21.68 Favored Glycine 0 CA--C 1.523 0.562 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.145 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.551 ' SD ' HD21 ' A' ' 62' ' ' LEU . 2.6 tpp -96.38 127.88 42.79 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.929 -0.396 . . . . 0.0 109.929 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -64.27 142.34 58.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.606 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.462 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.0 p -124.26 125.87 71.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.743 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.642 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.2 OUTLIER -161.8 169.86 20.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.238 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -61.35 -38.97 88.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.183 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.767 HG21 ' O ' ' A' ' 109' ' ' ILE . 11.9 m -85.17 -31.79 7.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.642 ' OG1' ' N ' ' A' ' 48' ' ' SER . 67.3 p -82.61 155.35 24.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.633 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.19 170.85 21.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.375 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.537 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -87.77 152.93 52.13 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.641 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -75.17 83.03 1.91 Allowed 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.712 2.275 . . . . 0.0 112.463 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 5.0 p -117.88 -1.45 11.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.35 89.49 0.08 OUTLIER Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 60.02 90.2 0.02 OUTLIER Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.501 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -165.84 163.33 36.65 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.61 ' CE1' HD12 ' A' ' 110' ' ' ILE . 17.2 t-160 -87.33 106.27 17.82 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 96.9 m -101.01 124.15 46.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.354 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.57 ' O ' HD22 ' A' ' 62' ' ' LEU . 54.3 t -117.87 129.98 73.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.151 0.5 . . . . 0.0 110.081 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.57 HD22 ' O ' ' A' ' 61' ' ' VAL . 2.2 mm? -115.18 146.46 41.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.877 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.7 p -138.25 150.76 47.0 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.113 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.4 130.87 6.33 Favored Glycine 0 CA--C 1.527 0.81 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.879 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.518 ' O ' ' O ' ' A' ' 66' ' ' ARG . 11.8 t-160 -107.49 114.3 28.21 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.717 0.294 . . . . 0.0 110.575 179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.518 ' O ' ' O ' ' A' ' 65' ' ' HIS . 50.5 ttp85 35.9 99.27 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.174 0.512 . . . . 0.0 111.29 179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 66' ' ' ARG . 91.8 m-20 -140.75 153.97 46.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.771 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 62.0 p -92.67 112.44 24.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.562 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 69' ' ' VAL . 9.9 m -131.57 128.28 60.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.761 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -127.15 2.7 6.45 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.741 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.412 ' OG1' ' NZ ' ' A' ' 26' ' ' LYS . 70.7 p -110.51 20.8 17.33 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.244 0.545 . . . . 0.0 110.402 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.458 ' O ' ' HG ' ' A' ' 76' ' ' LEU . 1.6 p30 -55.58 -24.82 34.81 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.374 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.9 tp -56.34 -36.21 68.5 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.385 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.38 -29.81 21.01 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -67.05 -40.33 87.12 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.204 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 76' ' ' LEU . 5.9 mt -90.4 86.33 6.43 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.906 0.384 . . . . 0.0 111.186 -179.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.477 ' HZ1' ' HG2' ' A' ' 23' ' ' LYS . 56.7 pttt -178.84 155.58 0.79 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.932 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -80.13 -11.75 59.72 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.206 0.527 . . . . 0.0 110.731 -179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.6 mmtt -79.86 -15.48 57.28 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.821 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -78.19 157.57 29.31 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.696 -0.402 . . . . 0.0 110.821 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.531 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -144.22 118.3 9.46 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.128 179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 93' ' ' TYR . 35.4 mt -96.03 134.96 38.43 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.697 -179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.678 ' C ' HD22 ' A' ' 84' ' ' LEU . 2.1 t -118.31 126.22 74.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.449 -0.501 . . . . 0.0 110.437 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.678 HD22 ' C ' ' A' ' 83' ' ' VAL . 4.0 mm? -112.75 134.6 54.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.537 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.834 ' HG3' HG23 ' A' ' 90' ' ' THR . 0.1 OUTLIER -106.94 125.1 50.56 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.013 179.047 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.514 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 1.0 OUTLIER -148.27 133.18 18.08 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.312 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 51.94 51.96 15.42 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.854 0.359 . . . . 0.0 111.965 178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 55.69 27.08 10.1 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.105 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.455 ' HG2' ' CB ' ' A' ' 146' ' ' SER . 39.0 mtpt -129.92 140.83 50.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.042 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.834 HG23 ' HG3' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -110.06 125.46 52.97 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.9 0.381 . . . . 0.0 110.379 -179.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.402 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 17.0 m-85 -104.32 135.26 46.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.164 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.593 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -102.88 113.81 27.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.087 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.487 ' O ' ' N ' ' A' ' 82' ' ' LEU . 82.8 m-85 -111.81 147.16 36.31 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.681 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.589 ' HB3' HG21 ' A' ' 142' ' ' THR . 15.0 pt-20 -127.92 145.06 51.08 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.389 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.928 HG23 HD11 ' A' ' 98' ' ' ILE . 10.0 mm -67.04 120.39 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 C-N-CA 119.633 -0.827 . . . . 0.0 110.318 -179.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.547 HE21 ' HG3' ' A' ' 94' ' ' GLU . 96.3 mm-40 -94.49 -61.15 1.56 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.614 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.546 ' C ' HD13 ' A' ' 98' ' ' ILE . 61.6 tttp -148.74 140.99 24.06 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.32 0.581 . . . . 0.0 110.595 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.928 HD11 HG23 ' A' ' 95' ' ' ILE . 6.6 mm -117.33 136.75 53.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.026 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.459 ' C ' ' CD1' ' A' ' 99' ' ' TRP . 12.4 p90 -154.59 178.98 9.48 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.379 -0.529 . . . . 0.0 111.395 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.759 ' N ' HD12 ' A' ' 100' ' ' ILE . 1.2 mp -128.46 133.52 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.137 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.674 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.3 t -145.11 160.33 41.58 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.633 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 53.8 m170 -61.62 150.85 35.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.366 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.54 ' HB2' HH11 ' A' ' 134' ' ' ARG . . . -62.79 -4.97 2.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.669 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.548 ' C ' ' OD1' ' A' ' 104' ' ' ASP . 2.1 p30 -99.56 13.52 33.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.849 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.593 ' OD2' ' OG1' ' A' ' 107' ' ' THR . 17.7 t0 -82.71 96.72 8.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.393 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.452 ' O ' HG13 ' A' ' 110' ' ' ILE . 8.7 ptm180 -66.49 -18.4 65.34 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.589 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.593 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 15.5 p -58.56 -16.56 16.19 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.719 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.896 HG13 HG21 ' A' ' 118' ' ' THR . 18.6 t -100.46 -14.44 7.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.399 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.767 ' O ' HG21 ' A' ' 50' ' ' VAL . 48.4 mm -117.02 23.51 5.33 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.956 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.61 HD12 ' CE1' ' A' ' 59' ' ' HIS . 0.7 OUTLIER -83.61 -162.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.877 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -106.28 134.51 49.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.358 -179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.561 ' H ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -115.5 126.61 54.5 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.754 -0.378 . . . . 0.0 109.982 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.523 ' OE1' ' N ' ' A' ' 113' ' ' GLU . 56.2 mp0 -77.72 15.17 0.88 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.105 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.408 ' H ' ' C ' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -147.36 171.1 6.73 Favored Pre-proline 0 C--N 1.332 -0.163 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.954 -179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.501 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 56.7 Cg_endo -80.24 90.37 1.25 Allowed 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 123.326 2.684 . . . . 0.0 111.949 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 49.4 mm -121.22 133.54 67.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.725 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.845 HD23 ' C ' ' A' ' 117' ' ' LEU . 5.4 tt -106.88 124.02 49.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.492 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.896 HG21 HG13 ' A' ' 108' ' ' VAL . 31.8 m -119.32 126.99 52.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.362 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.806 HD23 ' N ' ' A' ' 120' ' ' THR . 5.5 tt -120.11 125.42 48.21 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.908 -0.317 . . . . 0.0 111.315 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.806 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -109.66 126.6 53.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.907 0.384 . . . . 0.0 110.319 179.065 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.518 ' HB ' ' CE2' ' A' ' 123' ' ' TYR . 1.2 p -102.12 130.15 48.65 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.519 -178.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.469 ' C ' ' CD1' ' A' ' 123' ' ' TYR . 0.0 OUTLIER -137.63 72.85 1.42 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 121.345 0.593 . . . . 0.0 110.621 179.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.828 ' H ' ' CD ' ' A' ' 124' ' ' PRO . 0.1 OUTLIER -118.96 -25.84 0.08 OUTLIER Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.395 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.828 ' CD ' ' H ' ' A' ' 123' ' ' TYR . 73.3 Cg_exo -46.45 93.31 0.02 OUTLIER 'Trans proline' 0 N--CA 1.496 1.64 0 C-N-CA 122.068 1.845 . . . . 0.0 112.614 -179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 127' ' ' TYR . 48.2 p90 -77.18 -26.67 53.17 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.382 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -40.26 -26.85 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.259 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.663 ' CE2' ' O ' ' A' ' 128' ' ' ILE . 41.7 t80 -81.7 161.43 23.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.652 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.663 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 48.1 mm -86.17 91.97 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.327 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 98.76 -126.55 8.95 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -89.54 114.27 25.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.831 0.348 . . . . 0.0 110.872 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -43.87 110.77 1.02 Allowed Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.332 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.496 ' HD3' ' CE2' ' A' ' 127' ' ' TYR . 51.2 Cg_exo -49.75 -46.25 28.23 Favored 'Trans proline' 0 N--CA 1.497 1.729 0 C-N-CA 122.415 2.077 . . . . 0.0 112.253 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -97.66 124.43 41.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.099 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.54 HH11 ' HB2' ' A' ' 103' ' ' ALA . 42.3 mtt85 -103.44 140.59 37.28 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.069 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.529 ' CD1' HG13 ' A' ' 100' ' ' ILE . 8.1 t80 -84.71 128.87 34.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.556 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.42 HD13 HG21 ' A' ' 108' ' ' VAL . 1.3 mt -123.05 128.07 74.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.658 HG23 ' CD1' ' A' ' 95' ' ' ILE . 1.5 mp -106.39 114.85 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.578 179.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.433 ' HB2' ' CZ3' ' A' ' 99' ' ' TRP . 6.0 tt0 -94.43 138.0 32.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.761 179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -148.57 148.03 29.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -116.1 160.43 20.35 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.866 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 15.9 tp -77.31 123.12 26.05 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.824 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.589 HG21 ' HB3' ' A' ' 94' ' ' GLU . 3.0 p -98.78 -40.15 8.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.355 179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.593 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -145.36 162.99 28.21 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.922 -0.871 . . . . 0.0 110.922 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.5 p -139.39 142.87 37.51 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.874 0.369 . . . . 0.0 110.433 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -129.73 141.22 50.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.37 -179.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.455 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 23.2 t -137.23 141.97 42.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.184 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 18.0 tptp . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 117.928 -1.034 . . . . 0.0 110.465 179.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 55.78 -169.09 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.794 0.331 . . . . 0.0 110.502 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -114.23 148.66 37.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.635 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.431 ' C ' ' H ' ' A' ' 6' ' ' SER . 3.6 ptm -85.65 -177.34 6.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.525 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.1 t -77.45 28.08 0.16 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.776 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.431 ' H ' ' C ' ' A' ' 4' ' ' MET . 80.7 p -62.57 -22.0 66.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.542 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.6 mt-30 -108.63 124.28 50.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.61 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.593 ' O ' ' O ' ' A' ' 9' ' ' GLU . 1.1 t -116.51 -6.13 11.69 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.574 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.593 ' O ' ' O ' ' A' ' 8' ' ' THR . 11.0 pt-20 -48.28 -116.13 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.702 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.531 ' O ' ' CD1' ' A' ' 32' ' ' TRP . 8.2 m-70 -112.05 18.67 18.53 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.594 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -64.83 131.4 46.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.596 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.678 ' OE2' HG11 ' A' ' 47' ' ' VAL . 89.9 mt-10 -68.99 151.4 46.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.179 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.35 11.25 80.84 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 -179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.402 ' O ' HG13 ' A' ' 16' ' ' VAL . 75.2 mm-40 -118.16 135.01 54.5 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.4 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -59.01 118.2 5.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.217 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.494 HG11 ' HB2' ' A' ' 32' ' ' TRP . 17.1 m -117.48 -34.99 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.118 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -139.2 163.25 32.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.763 -179.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.617 ' SD ' ' O ' ' A' ' 28' ' ' PHE . 7.6 tpp -121.94 142.56 50.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.527 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.419 HD13 HD21 ' A' ' 84' ' ' LEU . 27.6 tp -106.14 123.29 47.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.242 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -120.36 128.24 53.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.162 0.506 . . . . 0.0 111.003 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.48 HG22 ' H ' ' A' ' 24' ' ' LEU . 3.3 mt -105.88 116.76 59.21 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.213 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.615 ' CD ' ' O ' ' A' ' 81' ' ' THR . 59.3 Cg_endo -76.92 -50.09 0.1 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.79 2.327 . . . . 0.0 112.903 -179.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.604 ' C ' HD22 ' A' ' 24' ' ' LEU . 10.1 tptp -60.43 -38.85 85.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.772 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.0 mm? -100.44 3.99 43.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.875 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 9.7 mptt 43.22 39.31 1.94 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.622 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.43 ' CB ' HD12 ' A' ' 21' ' ' ILE . 6.8 mmmt -115.53 150.62 36.28 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.434 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -131.93 147.88 52.49 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.849 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.617 ' O ' ' SD ' ' A' ' 18' ' ' MET . 85.3 m-85 -141.83 162.47 35.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.691 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 43' ' ' VAL . 8.7 p -103.54 122.27 44.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.929 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mm -95.37 124.51 47.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.286 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -108.11 142.51 38.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.531 ' CD1' ' O ' ' A' ' 10' ' ' HIS . 51.3 t-105 -65.29 132.82 50.04 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.849 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.549 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 76.35 159.01 8.67 Favored Glycine 0 N--CA 1.46 0.293 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -122.23 77.86 1.44 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 120.651 -0.42 . . . . 0.0 110.414 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -103.82 142.17 34.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.902 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.74 -9.13 53.3 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.508 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.72 -36.61 81.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.578 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.1 p -67.2 104.02 1.36 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.458 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 8.2 tt -62.81 -41.73 99.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.616 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -61.63 -41.14 97.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.547 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.1 ttmt 40.88 -143.93 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.553 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.54 -50.51 0.98 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 29' ' ' SER . 0.0 OUTLIER -154.36 107.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.842 0.353 . . . . 0.0 110.549 179.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.23 140.9 16.45 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.876 -0.89 . . . . 0.0 110.876 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.549 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 1.2 ttp -91.4 138.04 31.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.504 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.681 ' CD1' HG21 ' A' ' 51' ' ' THR . 3.0 t80 -76.26 143.12 41.13 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.954 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.678 HG11 ' OE2' ' A' ' 12' ' ' GLU . 2.0 p -130.83 120.33 47.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.483 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.7 ' N ' ' OG1' ' A' ' 51' ' ' THR . 0.6 OUTLIER -170.9 174.98 4.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.577 -179.934 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.3 t0 -62.92 -38.88 92.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.513 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.703 HG21 ' O ' ' A' ' 109' ' ' ILE . 2.0 m -85.12 -23.45 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.78 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.7 ' OG1' ' N ' ' A' ' 48' ' ' SER . 71.1 p -93.67 144.35 25.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.471 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.527 ' OG1' ' N ' ' A' ' 59' ' ' HIS . 1.7 p -138.38 172.41 12.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.929 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.45 149.16 36.43 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.491 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.18 83.02 1.5 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.757 2.305 . . . . 0.0 112.647 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.3 t -127.46 -1.76 6.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.585 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.74 63.3 0.01 OUTLIER Glycine 0 CA--C 1.526 0.737 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 82.76 104.32 0.47 Allowed Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.547 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -178.89 155.12 15.41 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.572 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 22.2 t-160 -78.65 103.24 8.46 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.5 m -99.11 114.97 27.97 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.434 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.464 ' O ' HD23 ' A' ' 62' ' ' LEU . 48.1 t -111.26 128.36 67.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 109.84 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 61' ' ' VAL . 25.7 mt -118.1 154.51 31.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.997 -179.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 120' ' ' THR . 13.7 t -137.52 148.81 46.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.365 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.589 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -163.92 168.52 38.47 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.442 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.64 ' CD2' ' N ' ' A' ' 66' ' ' ARG . 2.4 t-160 -100.61 138.74 37.26 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.528 -0.395 . . . . 0.0 110.671 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.64 ' N ' ' CD2' ' A' ' 65' ' ' HIS . 54.4 ttt85 -58.13 130.44 46.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.389 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.13 -163.35 1.1 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.612 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.431 ' O ' HG23 ' A' ' 68' ' ' THR . 8.9 t -129.33 52.25 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.576 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.601 ' O ' ' CB ' ' A' ' 70' ' ' PHE . 9.7 t -63.93 -39.54 85.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.283 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.601 ' CB ' ' O ' ' A' ' 69' ' ' VAL . 5.3 t80 90.31 11.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.267 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 60.0 p -108.43 23.13 14.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.665 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -62.01 -33.29 74.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.457 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 62.4 mt -61.41 -33.83 74.36 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.714 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.565 ' HA3' HD11 ' A' ' 24' ' ' LEU . . . -86.7 -24.81 37.37 Favored Glycine 0 CA--C 1.527 0.788 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 96.0 mm-40 -71.93 -40.74 68.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.791 0.329 . . . . 0.0 110.797 179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.588 HD22 ' OH ' ' A' ' 135' ' ' TYR . 16.5 mt -89.83 91.49 8.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.859 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.455 ' HG3' ' H ' ' A' ' 80' ' ' ASP . 11.1 ptmt -179.21 135.09 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.386 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -71.68 -12.18 61.2 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.618 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -81.28 -15.9 54.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.104 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.55 ' C ' ' OD1' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -67.55 153.36 43.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.487 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.615 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -141.36 116.5 9.97 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.062 0.458 . . . . 0.0 110.279 -179.692 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 29.7 mt -93.28 129.47 39.35 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.777 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.633 ' C ' HD22 ' A' ' 84' ' ' LEU . 2.5 t -111.22 122.71 66.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.011 0.434 . . . . 0.0 110.361 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.633 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.3 mm? -109.69 136.67 48.67 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.43 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -102.29 123.91 46.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.179 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.591 ' O ' ' N ' ' A' ' 89' ' ' LYS . 7.0 t80 -145.03 143.15 30.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.618 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.49 ' O ' ' OD1' ' A' ' 87' ' ' ASP . 65.3 t0 36.85 53.05 1.09 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.871 0.367 . . . . 0.0 111.406 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 56.4 25.77 9.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.335 179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.591 ' N ' ' O ' ' A' ' 86' ' ' TYR . 30.8 mtpt -125.11 145.42 49.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.491 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.523 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.1 OUTLIER -108.21 124.17 49.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.48 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 12.4 m-85 -105.04 131.83 52.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.097 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.591 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.1 OUTLIER -101.68 113.79 27.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.889 0.376 . . . . 0.0 110.96 -179.668 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.463 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 83.2 m-85 -110.03 152.29 26.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.624 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -126.32 137.77 53.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.489 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.8 mm -67.38 119.01 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 C-N-CA 120.395 -0.522 . . . . 0.0 110.582 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 13.7 mt-30 -88.27 -64.87 1.08 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.826 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 27.0 ttpt -147.26 143.24 27.97 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.055 0.455 . . . . 0.0 110.349 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.784 HG23 HD13 ' A' ' 137' ' ' ILE . 1.7 mp -118.46 131.52 70.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.705 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.403 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 29.1 p90 -154.17 -174.55 5.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.863 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 3.5 mt -132.05 132.24 61.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.193 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.0 t -131.92 174.49 10.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.827 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 16.9 t-80 -75.74 153.06 37.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.495 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 131' ' ' ALA . . . -62.84 -25.54 68.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.608 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -85.87 10.2 14.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.556 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -82.09 90.6 6.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.396 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.847 ' O ' HG23 ' A' ' 110' ' ' ILE . 0.0 OUTLIER -68.8 -21.62 64.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.29 179.924 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.543 ' C ' HD12 ' A' ' 110' ' ' ILE . 21.5 p -48.51 -11.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.384 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.912 HG13 HG21 ' A' ' 118' ' ' THR . 45.7 t -111.54 -11.03 11.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.035 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.703 ' O ' HG21 ' A' ' 50' ' ' VAL . 50.1 mm -111.9 10.14 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.015 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.847 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -80.78 -165.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.722 179.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 11.5 ttpt -97.13 158.94 15.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.052 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.502 ' HG3' ' CD2' ' A' ' 59' ' ' HIS . 66.9 mmtt -126.37 -168.02 1.8 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.263 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.442 ' C ' ' CG ' ' A' ' 114' ' ' GLU . 4.9 mm-40 -138.34 16.5 2.77 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.425 179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.459 ' CB ' ' HD2' ' A' ' 115' ' ' PRO . 0.1 OUTLIER -162.23 169.62 9.05 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.523 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.547 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 32.7 Cg_endo -70.06 90.21 0.55 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.174 2.583 . . . . 0.0 111.829 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 51.2 mm -122.27 133.09 69.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.029 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 117' ' ' LEU . 8.1 tt -108.38 123.69 49.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.734 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.912 HG21 HG13 ' A' ' 108' ' ' VAL . 94.5 m -122.68 128.4 50.55 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.38 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.881 HD23 ' N ' ' A' ' 120' ' ' THR . 5.1 tt -111.61 127.18 55.66 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.953 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.881 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -121.52 108.83 14.08 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.262 0.553 . . . . 0.0 110.524 179.323 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.625 ' C ' ' SG ' ' A' ' 122' ' ' CYS . 1.2 t -135.95 175.25 9.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.101 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.625 ' SG ' ' C ' ' A' ' 121' ' ' THR . 1.6 p 154.45 -71.02 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.702 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.545 ' C ' ' O ' ' A' ' 122' ' ' CYS . 74.7 m-85 26.34 66.85 0.49 Allowed Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.809 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -84.73 -163.68 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 123.013 2.476 . . . . 0.0 112.186 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -64.22 -32.64 74.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.58 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -89.76 19.93 4.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.614 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.649 ' O ' ' C ' ' A' ' 128' ' ' ILE . 6.9 t80 -57.97 -47.29 83.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.649 ' C ' ' O ' ' A' ' 127' ' ' TYR . 2.6 mp 1.76 87.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 O-C-N 123.828 0.705 . . . . 0.0 110.676 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.584 ' O ' ' CE1' ' A' ' 127' ' ' TYR . . . 101.14 -90.67 0.88 Allowed Glycine 0 CA--C 1.526 0.756 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.422 ' O ' ' C ' ' A' ' 131' ' ' ALA . 14.7 p-10 -140.51 110.33 6.45 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.744 0.306 . . . . 0.0 110.63 -179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 103' ' ' ALA . . . -38.13 119.13 0.99 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.615 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -48.25 -41.16 35.23 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.522 2.148 . . . . 0.0 111.996 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -127.08 126.05 42.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.331 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.466 ' HG2' ' SG ' ' A' ' 122' ' ' CYS . 29.4 mtm180 -114.1 140.75 48.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.672 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.645 ' CD2' HD11 ' A' ' 137' ' ' ILE . 3.8 t80 -74.73 128.29 35.2 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 -179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.403 HG21 ' CZ2' ' A' ' 99' ' ' TRP . 18.4 mm -112.81 117.62 55.8 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.761 -178.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.784 HD13 HG23 ' A' ' 98' ' ' ILE . 15.9 mm -107.45 107.09 21.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -92.79 133.22 36.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.135 0.493 . . . . 0.0 110.912 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -146.1 145.42 30.52 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.918 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.4 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 50.7 tttm -117.31 152.53 34.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.022 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.463 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 11.0 tp -78.68 122.26 25.74 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.075 0.464 . . . . 0.0 110.35 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.27 -41.75 5.45 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.841 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.591 ' O ' ' OG1' ' A' ' 92' ' ' THR . . . -136.23 156.88 23.22 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 82.2 p -138.51 151.02 46.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.805 0.336 . . . . 0.0 110.597 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.523 ' N ' ' O ' ' A' ' 90' ' ' THR . 94.4 m-85 -134.54 151.16 50.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.607 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.402 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 60.3 p -140.96 134.13 29.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.555 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 30.4 mttt . . . . . 0 C--O 1.221 -0.433 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.51 -179.92 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.551 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.564 ' O ' ' OG ' ' A' ' 5' ' ' SER . 1.3 t 84.26 133.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.875 0.369 . . . . 0.0 110.525 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -70.0 -26.6 64.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.609 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.9 ttt -60.76 -38.47 85.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.379 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.564 ' OG ' ' O ' ' A' ' 2' ' ' SER . 0.1 OUTLIER -60.36 159.5 10.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.745 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.9 t -65.02 156.65 30.68 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.695 -179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -76.55 -77.98 0.13 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.655 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.409 ' O ' ' HG3' ' A' ' 9' ' ' GLU . 70.6 p -139.41 152.02 46.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.528 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.494 ' C ' ' H ' ' A' ' 11' ' ' LYS . 83.2 mt-10 -156.84 152.91 27.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.941 0.401 . . . . 0.0 110.169 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 67.57 -9.59 0.42 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.702 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' H ' ' C ' ' A' ' 9' ' ' GLU . 23.6 mmtt -74.47 127.34 32.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.207 179.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -66.48 124.93 24.14 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.936 -179.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.55 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 113.15 -8.44 25.01 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 111.134 -0.787 . . . . 0.0 111.134 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -94.52 133.46 38.12 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 120.888 0.375 . . . . 0.0 110.26 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.409 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . 89.0 tttt -57.93 122.04 12.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.323 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.29 -34.69 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.976 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -142.18 156.68 45.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.514 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 19.2 ttp -120.97 140.42 51.91 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.311 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 22.4 tp -105.84 129.45 54.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.62 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.691 ' ND2' ' NZ ' ' A' ' 27' ' ' LYS . 57.1 t-20 -121.52 133.62 55.03 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.993 0.425 . . . . 0.0 110.815 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.501 ' N ' ' OD1' ' A' ' 20' ' ' ASN . 3.5 mt -114.69 112.62 45.32 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.527 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.418 ' O ' ' CE ' ' A' ' 25' ' ' LYS . 56.8 Cg_endo -77.16 -42.91 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.579 2.186 . . . . 0.0 112.412 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.77 ' NZ ' ' NZ ' ' A' ' 77' ' ' LYS . 19.9 tptm -62.26 -38.44 89.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.803 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.792 ' N ' HD22 ' A' ' 24' ' ' LEU . 2.9 mm? -101.74 4.04 40.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.945 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.418 ' CE ' ' O ' ' A' ' 22' ' ' PRO . 7.0 mptt 43.85 48.75 7.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.562 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.645 ' NZ ' ' OG1' ' A' ' 71' ' ' THR . 26.6 mtmt -134.25 152.16 51.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.931 179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.691 ' NZ ' ' ND2' ' A' ' 20' ' ' ASN . 8.6 mttp -130.43 143.04 50.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.675 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -130.88 145.66 52.07 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.743 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 6.3 p -95.06 113.83 25.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.644 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.594 HG12 HD11 ' A' ' 62' ' ' LEU . 1.2 mp -89.26 124.3 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.386 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 86.1 m-85 -106.06 149.66 26.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.775 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.55 ' O ' ' N ' ' A' ' 13' ' ' GLY . 24.0 t-105 -59.18 132.7 54.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.967 0.413 . . . . 0.0 110.824 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.523 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 75.04 162.41 9.83 Favored Glycine 0 C--N 1.334 0.422 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -127.4 117.48 22.26 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.277 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -93.07 117.5 30.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.733 -179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 39.6 p-10 -88.55 -2.97 58.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.619 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.46 -57.78 2.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.802 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.405 ' H ' HG22 ' A' ' 38' ' ' THR . 2.6 t -87.73 133.68 33.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.772 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.53 HD22 ' CD2' ' A' ' 65' ' ' HIS . 5.2 mt -98.15 0.84 46.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.551 -179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -62.13 -42.9 99.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.652 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -90.78 -72.45 0.58 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.543 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.64 -51.04 3.66 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.999 -0.84 . . . . 0.0 110.999 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.1 m -77.1 96.98 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.023 0.44 . . . . 0.0 110.53 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -138.16 158.16 24.69 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.885 -0.886 . . . . 0.0 110.885 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.541 ' CE ' ' H ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -94.99 140.04 30.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.684 0.278 . . . . 0.0 110.321 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -66.95 136.09 54.8 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.899 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.523 HG23 ' HA2' ' A' ' 33' ' ' GLY . 77.8 t -115.63 116.17 51.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.467 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.534 ' OG ' HG23 ' A' ' 51' ' ' THR . 50.1 p -161.88 166.74 25.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.514 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.549 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 42.0 t0 -66.75 -2.68 5.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.52 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.673 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.0 m -118.96 -30.06 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.81 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.534 HG23 ' OG ' ' A' ' 48' ' ' SER . 27.8 p -80.47 142.72 33.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.736 -179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.45 ' O ' ' O ' ' A' ' 59' ' ' HIS . 1.1 t -146.82 167.8 23.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.293 179.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.665 ' OG1' ' CE2' ' A' ' 86' ' ' TYR . 0.2 OUTLIER -89.87 158.99 44.0 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-O 120.979 0.418 . . . . 0.0 110.601 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.84 83.16 1.83 Allowed 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.755 2.303 . . . . 0.0 112.367 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 87.6 p -112.38 -3.78 14.42 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.679 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 138.83 91.9 0.24 Allowed Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.18 77.44 0.28 Allowed Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.693 -0.963 . . . . 0.0 110.693 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -158.16 162.94 32.6 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.656 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 18.6 t-160 -82.91 116.96 22.43 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 89.9 m -111.31 124.39 52.13 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.299 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.541 ' H ' ' CE ' ' A' ' 45' ' ' MET . 97.6 t -118.01 129.08 74.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.006 0.431 . . . . 0.0 110.354 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.594 HD11 HG12 ' A' ' 30' ' ' ILE . 2.3 mm? -110.48 139.27 45.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.642 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 35.3 t -121.93 134.16 54.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.05 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.631 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -153.98 111.18 0.48 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.562 ' O ' ' C ' ' A' ' 66' ' ' ARG . 4.8 p-80 -61.85 151.53 34.22 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.259 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.562 ' C ' ' O ' ' A' ' 65' ' ' HIS . 19.2 tpt180 -25.59 101.05 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.72 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -108.42 110.25 21.74 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.605 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 46.2 p -99.36 109.6 22.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.38 . . . . 0.0 110.427 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -148.59 9.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.79 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER 64.87 52.93 1.52 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.094 0.473 . . . . 0.0 110.644 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.645 ' OG1' ' NZ ' ' A' ' 26' ' ' LYS . 18.4 m -137.92 -0.79 2.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.671 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.525 ' O ' HD23 ' A' ' 76' ' ' LEU . 90.3 m-20 -62.49 -34.67 77.33 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.706 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 15.7 mt -61.23 -44.31 97.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.936 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.62 -31.01 57.26 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -64.63 -42.11 95.71 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.754 0.311 . . . . 0.0 110.957 -179.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.87 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.7 pp -92.18 101.73 14.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.988 0.423 . . . . 0.0 111.017 -179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.77 ' NZ ' ' NZ ' ' A' ' 23' ' ' LYS . 8.6 ptpt 170.96 135.55 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.472 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.4 mp0 -67.57 -15.39 63.63 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.269 0.557 . . . . 0.0 110.536 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -80.62 -14.94 57.75 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.871 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -79.96 157.24 26.9 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.919 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.461 ' O ' HD23 ' A' ' 82' ' ' LEU . 1.9 p -137.57 147.17 44.86 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.461 HD23 ' O ' ' A' ' 81' ' ' THR . 63.1 mt -122.76 126.6 47.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.917 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.658 ' C ' HD22 ' A' ' 84' ' ' LEU . 2.7 t -112.55 124.76 69.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 120.538 -0.465 . . . . 0.0 109.997 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.658 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.7 mm? -110.73 137.78 47.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.44 -178.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.615 ' HG2' HG23 ' A' ' 90' ' ' THR . 5.8 mm-40 -106.72 115.72 30.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.332 178.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.665 ' CE2' ' OG1' ' A' ' 53' ' ' THR . 16.4 t80 -142.16 124.92 15.97 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.863 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.9 t70 61.19 44.24 10.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.733 0.302 . . . . 0.0 111.256 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 64.19 7.87 3.75 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.51 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -108.69 145.87 34.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.37 179.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.615 HG23 ' HG2' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -111.48 120.71 43.06 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.481 -179.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.419 ' N ' ' CD1' ' A' ' 91' ' ' TYR . 7.4 m-85 -98.98 143.3 29.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.372 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.87 110.61 21.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.843 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 82.9 m-85 -108.49 155.77 20.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.641 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -132.35 140.67 48.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.68 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 1.1 mm -67.81 120.26 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 119.844 -0.742 . . . . 0.0 110.341 -179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -92.26 -65.03 1.04 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.0 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -144.53 137.88 27.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.309 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 1.8 mp -112.89 130.93 65.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.015 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 19.2 p90 -152.83 -177.29 6.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.081 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.524 HG12 ' CD1' ' A' ' 135' ' ' TYR . 54.8 mt -125.72 132.74 70.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.253 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.539 HG22 ' CG1' ' A' ' 136' ' ' ILE . 1.5 t -133.7 166.62 22.19 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.928 0.395 . . . . 0.0 110.874 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.462 ' O ' HG23 ' A' ' 101' ' ' THR . 57.7 m80 -68.62 158.42 34.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.588 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.442 ' CB ' ' H ' ' A' ' 131' ' ' ALA . . . -71.21 -15.59 62.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.697 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.543 ' OD1' ' CG ' ' A' ' 130' ' ' ASP . 75.2 m-20 -97.47 8.49 44.51 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.697 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -78.4 87.7 4.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.986 0.422 . . . . 0.0 110.322 -179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.858 ' O ' HG23 ' A' ' 110' ' ' ILE . 10.9 ptp85 -65.63 -32.28 73.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.368 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.534 ' O ' HD12 ' A' ' 110' ' ' ILE . 6.9 p -42.94 -17.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.375 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.767 ' CG1' HG21 ' A' ' 118' ' ' THR . 48.4 t -106.42 -16.78 8.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.002 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.821 ' O ' HG22 ' A' ' 109' ' ' ILE . 45.4 mm -110.08 20.19 6.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.163 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.858 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -86.92 -165.36 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.941 179.601 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -97.02 151.37 19.79 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.44 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 98.4 mttt -135.99 134.99 39.15 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.571 178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -83.7 14.21 4.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.084 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.15 159.61 70.25 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.992 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.93 92.9 1.09 Allowed 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 123.126 2.551 . . . . 0.0 112.031 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.4 mm -124.73 137.34 57.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.189 -179.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.735 HD23 ' C ' ' A' ' 117' ' ' LEU . 6.8 tt -109.78 118.0 35.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.203 0.525 . . . . 0.0 110.436 179.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.767 HG21 ' CG1' ' A' ' 108' ' ' VAL . 68.3 m -114.16 123.0 48.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.825 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.816 HD23 ' N ' ' A' ' 120' ' ' THR . 4.0 tt -107.79 120.77 43.18 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.346 -0.541 . . . . 0.0 110.558 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.816 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -115.87 114.68 25.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.154 0.502 . . . . 0.0 110.523 179.083 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.68 ' OG1' ' N ' ' A' ' 122' ' ' CYS . 0.0 OUTLIER -133.43 -166.07 1.72 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.172 -178.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.68 ' N ' ' OG1' ' A' ' 121' ' ' THR . 3.5 t 94.42 -63.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.342 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.701 ' O ' ' CG ' ' A' ' 123' ' ' TYR . 9.1 p90 -32.58 96.27 0.09 OUTLIER Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.43 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.479 ' N ' ' O ' ' A' ' 122' ' ' CYS . 58.5 Cg_endo -82.22 -100.26 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.618 2.212 . . . . 0.0 112.191 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -118.06 -8.9 10.64 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.566 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.536 ' C ' ' OD1' ' A' ' 126' ' ' ASP . 40.1 p30 -89.84 11.12 21.16 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.514 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.68 ' CZ ' ' O ' ' A' ' 129' ' ' GLY . 35.2 t80 -51.41 -39.87 58.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.694 179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.589 ' C ' ' O ' ' A' ' 127' ' ' TYR . 84.4 mt 21.43 78.05 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.381 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.68 ' O ' ' CZ ' ' A' ' 127' ' ' TYR . . . 67.95 -46.97 0.34 Allowed Glycine 0 CA--C 1.522 0.502 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.545 ' OD1' ' O ' ' A' ' 129' ' ' GLY . 85.8 m-20 -141.45 126.02 17.84 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.634 -0.426 . . . . 0.0 110.791 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.52 ' HB3' ' CG ' ' A' ' 134' ' ' ARG . . . -77.42 135.19 65.56 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.45 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -44.66 -37.09 11.03 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.446 2.097 . . . . 0.0 111.784 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.562 ' OD1' ' O ' ' A' ' 133' ' ' ASP . 27.3 p30 -167.29 114.69 0.78 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.486 179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.52 ' CG ' ' HB3' ' A' ' 131' ' ' ALA . 77.5 mtp180 -100.89 139.43 36.6 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.951 0.405 . . . . 0.0 110.341 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.524 ' CD1' HG12 ' A' ' 100' ' ' ILE . 1.9 t80 -76.42 136.22 39.44 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.172 -179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.539 ' CG1' HG22 ' A' ' 101' ' ' THR . 5.9 mm -122.55 113.54 38.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 C-N-CA 120.579 -0.449 . . . . 0.0 111.696 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.581 HG22 ' O ' ' A' ' 137' ' ' ILE . 0.6 OUTLIER -107.18 112.88 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 177.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.439 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 44.7 tt0 -93.63 139.81 30.35 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.508 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.58 148.77 31.49 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.974 179.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 33.1 tttm -119.12 152.22 36.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.384 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.485 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 18.0 tp -77.45 119.21 20.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.25 179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 1.2 p -95.43 -41.55 8.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.673 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.466 ' O ' HD11 ' A' ' 141' ' ' LEU . . . -144.78 179.93 21.6 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.1 p -154.03 161.42 41.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.731 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.408 ' N ' ' O ' ' A' ' 90' ' ' THR . 94.5 m-85 -144.03 159.37 42.73 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.773 -179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.8 p -144.57 128.17 17.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.654 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 46.3 tttp . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.967 -1.015 . . . . 0.0 110.579 179.92 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.8 p -61.15 -36.34 79.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.748 0.309 . . . . 0.0 110.642 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.444 ' O ' ' O ' ' A' ' 4' ' ' MET . 96.9 m-70 -82.88 -149.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.327 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.444 ' O ' ' O ' ' A' ' 3' ' ' HIS . 92.0 mtp 59.13 123.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.463 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.434 ' O ' ' OG ' ' A' ' 5' ' ' SER . 10.8 t 60.23 44.12 13.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.36 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.4 t -133.88 151.32 51.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.607 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -109.79 178.63 4.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.041 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.493 ' O ' ' C ' ' A' ' 9' ' ' GLU . 74.3 m -62.3 -48.55 79.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.991 -179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.493 ' C ' ' O ' ' A' ' 8' ' ' THR . 36.7 tt0 31.8 -116.45 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.201 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.483 ' N ' ' HG2' ' A' ' 9' ' ' GLU . 50.1 m-70 -136.23 26.53 3.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.53 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -79.55 142.6 35.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.133 0.492 . . . . 0.0 110.613 -179.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -69.24 142.18 54.26 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.341 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 86.57 15.8 63.13 Favored Glycine 0 CA--C 1.521 0.433 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -119.61 137.01 54.13 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-O 121.014 0.435 . . . . 0.0 110.375 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.05 106.81 0.77 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.46 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.409 HG23 ' N ' ' A' ' 17' ' ' ALA . 15.9 m -109.81 -40.53 4.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.971 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' N ' HG23 ' A' ' 16' ' ' VAL . . . -135.09 164.56 27.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.695 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.0 ttt -131.75 128.21 38.37 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.635 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.3 tt -98.11 116.79 31.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.069 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.497 ' ND2' ' HE3' ' A' ' 27' ' ' LYS . 48.5 t-20 -110.76 137.33 48.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.022 0.439 . . . . 0.0 111.235 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.57 HD12 ' HG3' ' A' ' 26' ' ' LYS . 9.3 mt -116.67 115.87 39.03 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.286 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.94 -39.0 0.69 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.677 2.251 . . . . 0.0 112.847 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.581 ' C ' HD22 ' A' ' 24' ' ' LEU . 47.5 tptt -64.1 -35.62 81.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.007 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.723 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.4 mm? -101.9 7.14 41.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.918 -179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp 40.78 59.35 2.21 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.131 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.57 ' HG3' HD12 ' A' ' 21' ' ' ILE . 15.3 ptpt -150.33 166.52 29.75 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.668 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.497 ' HE3' ' ND2' ' A' ' 20' ' ' ASN . 27.6 mtpt -139.82 146.49 39.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.144 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.454 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 49.4 m-85 -132.13 138.68 48.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.717 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 p -89.57 112.24 23.4 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.544 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.9 mm -84.09 120.72 35.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.395 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -100.69 140.37 35.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.024 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.5 ' CE2' HG22 ' A' ' 47' ' ' VAL . 58.6 t-105 -59.46 132.1 52.96 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.276 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.658 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 76.55 140.2 1.03 Allowed Glycine 0 N--CA 1.463 0.445 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -111.33 78.64 1.13 Allowed 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.469 -0.492 . . . . 0.0 110.857 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 82.5 m-20 -90.19 134.26 34.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.78 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.517 ' O ' ' OD1' ' A' ' 36' ' ' ASP . 56.7 t0 -85.0 -8.09 58.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.494 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -67.63 -38.61 84.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.778 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.29 133.47 37.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.765 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 90.3 mt -101.76 6.19 41.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.318 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -62.34 -51.53 67.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.034 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -154.68 166.79 32.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.517 -179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 63' ' ' SER . . . -104.18 -12.22 29.89 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.38 98.31 5.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.314 0.578 . . . . 0.0 110.982 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.85 152.98 20.48 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.615 ' SD ' HD21 ' A' ' 62' ' ' LEU . 2.4 tpp -87.93 145.65 25.93 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.705 0.288 . . . . 0.0 110.433 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.449 ' CD1' HG21 ' A' ' 51' ' ' THR . 2.4 t80 -77.13 139.13 39.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.853 0.359 . . . . 0.0 110.973 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.658 HG23 ' HA2' ' A' ' 33' ' ' GLY . 94.2 t -117.24 120.76 65.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.401 179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.659 ' CB ' ' HG1' ' A' ' 51' ' ' THR . 4.9 p -170.64 176.3 4.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.54 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -72.98 -18.76 61.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.682 179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.734 HG21 ' O ' ' A' ' 109' ' ' ILE . 2.3 m -107.9 -21.28 5.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-O 120.9 0.381 . . . . 0.0 110.843 -179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.659 ' HG1' ' CB ' ' A' ' 48' ' ' SER . 17.3 p -89.49 127.95 35.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.288 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.442 ' O ' ' O ' ' A' ' 59' ' ' HIS . 1.3 t -136.02 166.83 22.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.505 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.56 157.75 55.13 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.684 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.87 80.68 2.89 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.589 2.193 . . . . 0.0 112.528 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 35.4 p -113.02 -5.33 13.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.946 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 148.46 91.48 0.1 OUTLIER Glycine 0 CA--C 1.525 0.696 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 59.69 91.36 0.01 OUTLIER Glycine 0 CA--C 1.528 0.867 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -170.25 162.43 35.65 Favored Glycine 0 CA--C 1.524 0.6 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.66 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 17.0 t-160 -83.35 117.19 22.85 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 86.6 m -112.77 108.02 16.87 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.533 HG11 HD12 ' A' ' 109' ' ' ILE . 78.4 t -106.24 129.03 60.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.943 0.401 . . . . 0.0 110.011 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.615 HD21 ' SD ' ' A' ' 45' ' ' MET . 27.1 mt -120.53 158.63 26.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.939 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 120' ' ' THR . 7.8 p -139.0 150.58 46.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.261 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -167.17 177.94 41.55 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.484 ' HA ' ' CD1' ' A' ' 123' ' ' TYR . 3.2 p-80 -97.43 132.99 42.61 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 122.523 -0.398 . . . . 0.0 110.789 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.721 ' O ' ' CG ' ' A' ' 125' ' ' PHE . 60.6 ttt85 -84.83 77.25 10.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.159 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.51 ' O ' ' O ' ' A' ' 68' ' ' THR . 1.0 OUTLIER -107.9 157.43 18.2 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.718 -179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.51 ' O ' ' O ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER 57.15 128.96 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.642 -179.931 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.492 ' O ' HG12 ' A' ' 69' ' ' VAL . 34.8 t -77.78 -10.53 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.627 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.482 ' O ' ' CB ' ' A' ' 71' ' ' THR . 44.5 t80 -72.17 159.83 33.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.441 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' A' ' 70' ' ' PHE . 2.1 m 80.74 -11.98 1.08 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.546 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -62.54 -38.48 90.17 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.076 0.465 . . . . 0.0 110.429 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.634 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . 29.6 mt -62.07 -38.7 89.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.362 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.19 -29.26 37.92 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.432 ' HG3' HG22 ' A' ' 71' ' ' THR . 84.1 mt-30 -78.72 -41.91 29.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.832 0.348 . . . . 0.0 111.035 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.678 HD22 ' OH ' ' A' ' 135' ' ' TYR . 20.8 mt -89.83 80.92 6.41 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.085 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.634 ' NZ ' ' O ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -172.69 142.38 1.18 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.462 179.587 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -77.83 -16.5 58.27 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.596 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.3 mtmm -79.2 -15.19 58.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.143 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.423 ' OD1' ' C ' ' A' ' 80' ' ' ASP . 0.0 OUTLIER -70.57 153.67 42.65 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.419 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.5 p -136.08 142.42 44.33 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.044 0.45 . . . . 0.0 110.002 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 79.1 mt -119.12 123.54 44.66 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.878 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.664 HG12 HG22 ' A' ' 90' ' ' THR . 2.2 t -107.12 124.73 63.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.35 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.638 HD22 ' C ' ' A' ' 83' ' ' VAL . 3.4 mm? -110.39 129.61 55.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.377 -179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.419 ' HG2' HG23 ' A' ' 90' ' ' THR . 80.6 mt-10 -101.0 124.25 46.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.216 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.418 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 1.8 t80 -149.8 130.37 13.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.992 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 55.46 43.29 28.86 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.136 179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 65.27 8.17 4.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.458 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 52.1 mtmt -107.02 150.98 25.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.383 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.664 HG22 HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -117.29 121.97 42.64 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.798 -179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -104.12 130.53 51.84 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.457 ' OG1' ' C ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -99.75 114.98 28.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.13 -179.713 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.428 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 81.7 m-85 -110.69 155.49 22.37 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.725 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.3 tt0 -130.73 140.13 50.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.156 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.456 HD13 HG23 ' A' ' 137' ' ' ILE . 1.1 mm -62.38 119.69 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 C-N-CA 119.989 -0.684 . . . . 0.0 110.203 -179.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.68 -64.1 1.12 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.885 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -146.98 133.01 19.21 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 121.172 0.51 . . . . 0.0 110.452 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.498 HG23 HG13 ' A' ' 137' ' ' ILE . 1.6 mp -111.04 131.13 63.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.608 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.402 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 18.9 p90 -153.72 -178.16 6.86 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.511 -0.475 . . . . 0.0 111.092 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.427 HG12 ' CD1' ' A' ' 135' ' ' TYR . 2.7 mt -127.13 134.08 66.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.258 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.542 HG22 ' CD1' ' A' ' 136' ' ' ILE . 2.9 t -146.06 172.49 13.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.91 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.429 ' O ' HG23 ' A' ' 101' ' ' THR . 4.9 m-70 -61.77 156.48 20.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.48 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.528 ' HB2' ' HG3' ' A' ' 134' ' ' ARG . . . -74.5 -25.97 59.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.831 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 47.5 p30 -89.46 2.17 54.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.565 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -65.36 90.16 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.526 -179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.983 ' O ' HG23 ' A' ' 110' ' ' ILE . 22.9 ptt85 -56.11 -35.91 67.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.51 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.536 ' C ' HD12 ' A' ' 110' ' ' ILE . 2.5 p -40.64 -17.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.536 179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.787 ' CG1' HG21 ' A' ' 118' ' ' THR . 6.5 t -110.61 -15.58 9.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.005 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.734 ' O ' HG21 ' A' ' 50' ' ' VAL . 48.2 mm -113.74 21.91 5.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.036 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.983 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.1 OUTLIER -88.19 -169.2 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.858 179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 24.0 ttmt -94.03 147.44 23.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.496 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.4 mttt -133.22 147.95 52.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.449 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -97.58 11.66 36.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.847 0.356 . . . . 0.0 110.067 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -133.66 159.48 72.34 Favored Pre-proline 0 C--N 1.332 -0.153 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.73 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.49 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 46.7 Cg_endo -76.02 89.79 1.21 Allowed 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.043 2.495 . . . . 0.0 111.959 179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.0 mm -121.46 134.99 63.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.437 -179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.517 HD23 ' C ' ' A' ' 117' ' ' LEU . 9.2 tt -109.34 120.85 43.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.653 179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.787 HG21 ' CG1' ' A' ' 108' ' ' VAL . 71.7 m -116.36 119.78 36.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.109 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.716 HD23 ' N ' ' A' ' 120' ' ' THR . 0.7 OUTLIER -110.67 114.65 28.2 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.462 -179.759 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.716 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -106.63 127.86 53.69 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.071 0.462 . . . . 0.0 110.762 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.631 HG23 ' CD2' ' A' ' 119' ' ' LEU . 27.4 p -135.76 162.39 32.9 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.129 0.49 . . . . 0.0 111.56 -179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.612 ' O ' ' O ' ' A' ' 123' ' ' TYR . 0.5 OUTLIER 179.61 -79.76 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.937 179.509 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.612 ' O ' ' O ' ' A' ' 122' ' ' CYS . 5.8 m-85 50.64 151.9 0.04 OUTLIER Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.732 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -66.22 56.77 0.43 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.717 2.278 . . . . 0.0 112.244 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.721 ' CG ' ' O ' ' A' ' 66' ' ' ARG . 3.2 p90 -87.01 -31.49 20.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.575 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.703 ' OD2' ' CE2' ' A' ' 125' ' ' PHE . 62.1 m-20 -128.96 -17.56 3.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.757 179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.687 ' CE2' ' O ' ' A' ' 128' ' ' ILE . 71.6 t80 -109.71 155.33 21.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.607 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.687 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 87.2 mt -93.44 119.71 41.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.237 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 97.89 -115.37 5.25 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 110.778 -0.929 . . . . 0.0 110.778 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -121.2 108.0 13.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.734 0.302 . . . . 0.0 110.682 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.577 ' O ' ' NH1' ' A' ' 134' ' ' ARG . . . -45.79 111.45 1.4 Allowed Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.695 -179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -50.85 -42.06 52.91 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.552 2.168 . . . . 0.0 112.022 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -104.82 150.42 24.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.25 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.577 ' NH1' ' O ' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -126.4 137.96 53.49 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.9 0.381 . . . . 0.0 110.95 -179.62 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.678 ' OH ' HD22 ' A' ' 76' ' ' LEU . 5.2 t80 -79.57 126.39 30.82 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.542 ' CD1' HG22 ' A' ' 101' ' ' THR . 1.1 mt -122.02 126.51 74.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 CA-C-O 121.218 0.532 . . . . 0.0 111.943 -179.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.594 HD11 ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp -108.17 112.76 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.287 178.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -95.4 136.65 35.5 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.548 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -139.87 153.53 47.04 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.905 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.549 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 8.4 tptt -116.55 146.72 42.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.948 -179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.549 ' H ' ' HD2' ' A' ' 140' ' ' LYS . 16.4 tp -69.69 124.09 23.08 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.107 0.479 . . . . 0.0 110.109 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 4.9 p -99.04 -47.94 5.05 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.629 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.457 ' C ' ' OG1' ' A' ' 92' ' ' THR . . . -141.97 172.05 24.26 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 -179.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.2 p -144.9 134.76 23.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 110.614 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -122.93 146.29 47.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.196 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 97.9 p -134.14 123.99 25.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.485 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.221 -0.442 0 CA-C-O 117.988 -1.006 . . . . 0.0 110.419 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 55.87 -165.17 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.79 0.329 . . . . 0.0 110.488 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.589 ' O ' ' OG ' ' A' ' 5' ' ' SER . 78.0 t60 -102.95 106.54 17.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.365 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.419 ' CG ' ' H ' ' A' ' 5' ' ' SER . 0.4 OUTLIER 42.81 -123.66 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.576 -179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.589 ' OG ' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER 52.86 77.53 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.615 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.586 ' O ' ' OE1' ' A' ' 14' ' ' GLU . 67.7 m -72.05 145.54 48.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.471 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -126.46 41.5 3.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.656 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.54 -41.77 2.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.572 179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.63 158.12 34.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.612 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.625 ' N ' ' ND1' ' A' ' 10' ' ' HIS . 0.1 OUTLIER -82.54 18.28 1.54 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.568 -179.944 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -55.28 145.58 21.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.208 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 12' ' ' GLU . 2.1 pt-20 -58.22 135.87 57.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.073 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.39 2.68 61.77 Favored Glycine 0 CA--C 1.522 0.473 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 -179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.586 ' OE1' ' O ' ' A' ' 6' ' ' SER . 76.2 mm-40 -115.32 140.45 49.1 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 120.793 0.33 . . . . 0.0 110.512 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.8 ttpt -63.1 121.52 13.83 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.216 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.3 m -120.55 -39.47 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.96 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -130.3 156.95 43.81 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.628 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.5 ttm -119.68 141.77 49.08 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.161 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.465 HD11 ' HB3' ' A' ' 82' ' ' LEU . 29.0 tp -108.4 121.81 45.71 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.644 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 58.4 t-20 -118.38 127.8 54.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.902 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.515 HG22 ' H ' ' A' ' 24' ' ' LEU . 6.0 mt -104.56 115.53 62.62 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.389 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.62 ' CD ' ' O ' ' A' ' 81' ' ' THR . 56.9 Cg_endo -77.11 -45.78 0.16 Allowed 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.846 2.364 . . . . 0.0 112.52 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.632 ' C ' HD22 ' A' ' 24' ' ' LEU . 0.1 OUTLIER -60.3 -40.25 89.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.489 -179.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.771 ' N ' HD22 ' A' ' 24' ' ' LEU . 2.9 mm? -102.56 8.97 39.72 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.562 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 24' ' ' LEU . 0.1 OUTLIER 40.42 40.21 0.83 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.519 179.635 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.42 ' CB ' HD12 ' A' ' 21' ' ' ILE . 0.0 OUTLIER -112.07 157.91 20.21 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.519 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -138.71 139.89 38.56 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.584 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -137.06 159.09 42.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.855 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.6 m -101.99 122.38 43.95 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.001 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.4 mm -94.08 118.71 40.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.319 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -101.16 136.76 40.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.323 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.592 ' CD1' ' O ' ' A' ' 10' ' ' HIS . 55.8 t-105 -60.41 133.05 55.72 Favored 'General case' 0 C--O 1.226 -0.17 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.616 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.568 ' HA2' HG23 ' A' ' 47' ' ' VAL . . . 77.62 163.98 21.63 Favored Glycine 0 C--N 1.331 0.258 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -163.52 93.21 0.74 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.745 -0.382 . . . . 0.0 110.868 179.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -78.46 134.07 37.38 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.763 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -70.84 -40.39 72.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.642 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -60.13 -24.77 64.96 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.557 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 48.5 p -101.86 144.16 30.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.542 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 12.0 mt -110.83 131.31 55.16 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.527 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -130.75 -160.55 1.05 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.624 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mmtm -61.65 -42.08 98.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.489 -179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.91 -4.59 4.65 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.77 92.45 2.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.935 0.398 . . . . 0.0 110.49 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.35 148.68 19.44 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.703 ' CE ' ' H ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -95.46 134.45 38.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.627 0.251 . . . . 0.0 110.325 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.673 ' O ' ' SD ' ' A' ' 45' ' ' MET . 18.6 t80 -75.43 139.45 42.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.535 -179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.568 HG23 ' HA2' ' A' ' 33' ' ' GLY . 40.2 t -111.02 124.58 67.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.962 0.41 . . . . 0.0 110.433 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.538 ' OG ' ' CE2' ' A' ' 46' ' ' PHE . 18.8 m -160.92 165.38 30.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.604 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -69.0 -24.22 64.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.704 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.583 HG21 ' HA ' ' A' ' 110' ' ' ILE . 4.6 m -94.18 -40.52 11.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.161 0.505 . . . . 0.0 110.742 -179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.51 ' N ' HG23 ' A' ' 50' ' ' VAL . 81.7 p -76.18 155.56 34.44 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.056 -0.658 . . . . 0.0 110.716 -179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -148.97 171.6 16.08 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.606 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.466 HG22 ' CH2' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -87.41 156.75 53.68 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.754 -179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.452 ' HG3' HD23 ' A' ' 84' ' ' LEU . 68.0 Cg_endo -80.03 83.46 2.23 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.581 2.188 . . . . 0.0 112.445 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 52.0 p -113.85 -9.47 13.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.569 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 149.73 90.41 0.08 OUTLIER Glycine 0 CA--C 1.526 0.726 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.85 85.75 0.08 OUTLIER Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.503 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -167.22 160.64 34.37 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 110.691 -0.963 . . . . 0.0 110.691 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.702 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 13.6 t-160 -83.65 116.66 22.74 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 90.7 m -111.81 127.19 55.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.234 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.703 ' H ' ' CE ' ' A' ' 45' ' ' MET . 54.6 t -117.29 129.75 73.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.85 0.357 . . . . 0.0 110.354 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.538 HD22 ' O ' ' A' ' 61' ' ' VAL . 1.9 mm? -112.7 145.49 40.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.632 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 120' ' ' THR . 47.2 t -126.73 144.12 51.03 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.086 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.47 ' O ' ' OG1' ' A' ' 121' ' ' THR . . . -164.16 166.58 37.73 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.531 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.57 ' N ' ' ND1' ' A' ' 65' ' ' HIS . 0.5 OUTLIER -116.87 145.18 43.74 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 122.554 -0.38 . . . . 0.0 110.536 -179.987 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 24.0 ttp180 -96.18 135.09 38.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.5 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -156.7 -50.74 0.08 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.621 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 68' ' ' THR . 5.7 t -127.47 129.32 47.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.495 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.92 135.69 52.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.647 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -122.35 -17.41 7.09 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.64 179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.3 t -134.65 75.84 1.6 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.595 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -64.12 -40.67 96.69 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.58 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.668 ' O ' ' NZ ' ' A' ' 77' ' ' LYS . 0.0 OUTLIER -62.48 -44.34 96.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.921 -179.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -65.64 -32.46 83.21 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -40.35 94.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.918 0.39 . . . . 0.0 110.165 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -120.33 111.4 17.72 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.888 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.668 ' NZ ' ' O ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -174.23 141.12 0.71 Allowed 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 179.417 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -77.84 -12.36 59.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.052 0.454 . . . . 0.0 110.507 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -84.95 -15.51 44.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.137 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.401 ' HB2' ' CD ' ' A' ' 77' ' ' LYS . 1.2 t70 -69.5 152.76 44.45 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.951 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.62 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.1 OUTLIER -142.04 115.01 8.7 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.304 179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.465 ' HB3' HD11 ' A' ' 19' ' ' LEU . 67.2 mt -90.47 132.21 35.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.629 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.548 HG12 HG22 ' A' ' 90' ' ' THR . 2.1 t -109.85 115.54 49.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.994 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.851 HD21 HD12 ' A' ' 117' ' ' LEU . 6.0 mp -94.98 123.47 38.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.196 -179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.457 ' HG2' HG23 ' A' ' 90' ' ' THR . 96.7 mt-10 -99.73 117.61 34.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.374 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -149.6 133.26 16.8 Favored 'General case' 0 C--O 1.225 -0.216 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.936 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 56.23 43.67 26.21 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.321 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 61.5 9.31 2.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.337 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -107.44 150.21 27.04 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.518 179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.548 HG22 HG12 ' A' ' 83' ' ' VAL . 0.1 OUTLIER -118.03 123.85 46.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.709 -179.658 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.441 ' O ' ' HA ' ' A' ' 83' ' ' VAL . 15.4 m-85 -107.31 132.63 52.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.271 179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.18 112.37 24.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.9 0.381 . . . . 0.0 111.634 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.703 ' CE2' HD22 ' A' ' 84' ' ' LEU . 75.6 m-85 -109.85 147.58 33.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.775 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.645 ' OE2' ' NE2' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -124.71 139.83 53.5 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 179.682 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.583 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 1.3 mm -63.5 117.13 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.286 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.645 ' NE2' ' OE2' ' A' ' 94' ' ' GLU . 55.9 mm-40 -84.27 -67.97 0.75 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.844 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -145.83 139.66 26.51 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.109 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 137' ' ' ILE . 4.4 mt -112.81 127.78 69.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.61 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.469 ' CH2' ' HB2' ' A' ' 138' ' ' GLU . 25.8 p90 -150.89 -177.98 6.32 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.777 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.461 ' N ' HD12 ' A' ' 100' ' ' ILE . 3.6 mp -127.25 131.52 70.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.641 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.449 HG22 HD11 ' A' ' 136' ' ' ILE . 1.6 t -132.31 165.95 23.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.673 -179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -70.6 153.8 42.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.408 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -67.56 -13.32 61.96 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.697 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -92.67 8.02 40.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.76 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.599 ' OD1' ' OG1' ' A' ' 107' ' ' THR . 68.1 t0 -85.98 89.91 7.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.581 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.849 ' O ' HG23 ' A' ' 110' ' ' ILE . 11.5 ptm180 -70.15 -24.19 63.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.429 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.599 ' OG1' ' OD1' ' A' ' 105' ' ' ASP . 12.9 p -49.56 -12.85 0.07 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.357 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.851 ' CG1' HG21 ' A' ' 118' ' ' THR . 43.9 t -111.02 -8.77 11.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.992 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.718 ' O ' HG22 ' A' ' 109' ' ' ILE . 29.9 mm -111.91 7.03 8.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.828 0.347 . . . . 0.0 111.022 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.849 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -79.03 -161.26 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.629 179.83 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 14.1 ptpt -109.89 155.25 21.95 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.784 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.491 ' H ' ' HB2' ' A' ' 59' ' ' HIS . 99.3 mttt -138.54 144.06 39.74 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.451 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -85.74 10.88 12.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.999 0.428 . . . . 0.0 110.051 179.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -127.04 156.72 73.89 Favored Pre-proline 0 CA--C 1.53 0.194 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.135 -179.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.503 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 51.4 Cg_endo -76.89 88.48 1.39 Allowed 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.975 2.45 . . . . 0.0 111.609 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.4 mm -124.07 131.43 72.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.916 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.851 HD12 HD21 ' A' ' 84' ' ' LEU . 5.3 tt -105.28 122.41 45.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.201 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.851 HG21 ' CG1' ' A' ' 108' ' ' VAL . 89.8 m -118.99 126.08 50.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.134 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.885 HD23 ' N ' ' A' ' 120' ' ' THR . 3.2 tt -107.7 124.55 50.17 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.599 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.885 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -120.99 113.97 20.85 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.448 0.642 . . . . 0.0 110.719 179.04 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.682 ' O ' ' SG ' ' A' ' 122' ' ' CYS . 1.7 t -144.81 169.79 17.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.229 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.682 ' SG ' ' O ' ' A' ' 121' ' ' THR . 1.3 m 153.99 -71.31 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.503 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.503 ' C ' ' O ' ' A' ' 122' ' ' CYS . 51.5 m-85 28.6 70.77 0.5 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.896 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.517 ' O ' ' N ' ' A' ' 127' ' ' TYR . 62.3 Cg_endo -77.79 160.36 31.01 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.889 2.392 . . . . 0.0 112.115 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.635 ' CE2' ' OD1' ' A' ' 126' ' ' ASP . 50.6 p90 -48.54 -13.71 0.05 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.872 0.368 . . . . 0.0 110.393 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.635 ' OD1' ' CE2' ' A' ' 125' ' ' PHE . 78.2 m-20 -102.7 12.11 36.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.861 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.659 ' CZ ' ' O ' ' A' ' 129' ' ' GLY . 39.3 t80 -51.3 -51.78 51.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.252 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.646 ' C ' ' O ' ' A' ' 127' ' ' TYR . 30.0 mm 9.92 94.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 O-C-N 123.508 0.505 . . . . 0.0 110.723 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.659 ' O ' ' CZ ' ' A' ' 127' ' ' TYR . . . 96.6 -95.52 1.77 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 -179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 131' ' ' ALA . 3.5 m-20 -132.82 113.17 12.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.634 0.254 . . . . 0.0 110.703 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 130' ' ' ASP . . . -37.26 140.49 0.47 Allowed Pre-proline 0 C--O 1.233 0.199 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.683 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.15 -20.12 56.57 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.693 2.262 . . . . 0.0 111.724 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -167.07 124.91 1.28 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.766 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -105.26 136.23 45.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.556 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.719 ' CD2' HD11 ' A' ' 137' ' ' ILE . 3.6 t80 -74.58 130.68 40.01 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.78 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.453 HD12 HG11 ' A' ' 108' ' ' VAL . 5.3 mm -115.21 117.22 54.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 120.591 -0.443 . . . . 0.0 111.936 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.719 HD11 ' CD2' ' A' ' 135' ' ' TYR . 12.8 mm -107.04 109.97 30.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.469 ' HB2' ' CH2' ' A' ' 99' ' ' TRP . 41.8 tt0 -92.06 137.0 32.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.054 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.532 ' HB3' ' HB3' ' A' ' 117' ' ' LEU . . . -138.65 149.03 44.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.199 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.47 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 26.6 tptt -123.44 142.1 51.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.837 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.47 ' H ' ' HD2' ' A' ' 140' ' ' LYS . 21.3 tp -69.5 122.88 19.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.382 178.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.577 HG21 ' HB3' ' A' ' 94' ' ' GLU . 7.4 p -99.06 -46.82 5.45 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.734 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -142.04 -177.67 17.37 Favored Glycine 0 CA--C 1.523 0.538 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 95.9 p -151.05 152.4 33.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.945 0.403 . . . . 0.0 110.713 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.508 ' N ' ' O ' ' A' ' 90' ' ' THR . 90.5 m-85 -140.02 149.56 43.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.427 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 19.1 p -139.18 119.39 13.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.334 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.8 tttm . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.484 -179.835 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.471 ' O ' ' O ' ' A' ' 1' ' ' GLY . 4.4 p 36.25 -158.51 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.872 0.368 . . . . 0.0 110.567 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.0 m80 -111.33 167.01 10.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.675 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 34.4 tpp -61.03 -85.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.641 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.665 ' O ' ' N ' ' A' ' 7' ' ' GLN . 77.3 p -165.98 128.41 1.98 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.528 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 47.26 -79.11 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.843 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.665 ' N ' ' O ' ' A' ' 5' ' ' SER . 93.2 mm-40 60.31 50.8 5.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.627 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 44.8 p -118.54 139.15 51.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.286 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.429 ' HG3' ' N ' ' A' ' 10' ' ' HIS . 36.5 tp10 -162.57 -118.06 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.446 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.429 ' N ' ' HG3' ' A' ' 9' ' ' GLU . 62.8 m170 -72.92 -12.39 60.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.414 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.5 mmtp -62.29 127.4 31.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.26 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -78.6 154.35 30.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.88 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.603 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 76.7 18.79 78.62 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -125.75 147.6 49.34 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-O 120.835 0.35 . . . . 0.0 110.548 -179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -63.21 119.52 9.74 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.236 179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.571 HG11 ' HB2' ' A' ' 32' ' ' TRP . 4.6 m -119.64 -20.94 4.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.226 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.516 ' HB2' ' CD2' ' A' ' 86' ' ' TYR . . . -149.19 161.38 42.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.709 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.5 ttt -116.51 141.23 48.45 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.627 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.608 ' HB2' HD11 ' A' ' 30' ' ' ILE . 4.0 tp -109.81 121.86 46.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.567 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -117.76 129.67 55.84 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.706 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.579 HG21 HD23 ' A' ' 24' ' ' LEU . 13.3 mt -113.84 109.17 50.35 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.2 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -77.92 -41.72 0.29 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.679 2.253 . . . . 0.0 113.208 -179.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.575 ' HB3' HD22 ' A' ' 24' ' ' LEU . 6.6 tptp -58.78 -43.98 90.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.175 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.579 HD23 HG21 ' A' ' 21' ' ' ILE . 1.4 mm? -101.24 2.93 40.4 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.022 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.8 mttt 50.4 56.75 7.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.953 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 15.1 mtmt -134.44 155.23 50.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.788 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.04 138.86 42.6 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.772 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -137.92 157.8 45.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.762 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.4 t -99.86 134.03 43.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.831 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 19' ' ' LEU . 36.4 mm -99.24 127.28 52.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.331 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.5 m-85 -106.37 139.51 40.74 Favored 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.222 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.603 ' O ' ' N ' ' A' ' 13' ' ' GLY . 41.6 t-105 -70.29 131.78 44.69 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.861 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.449 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 71.57 173.24 17.1 Favored Glycine 0 C--O 1.23 -0.122 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -149.65 78.89 1.37 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.836 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -94.74 149.19 21.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.757 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -72.26 -17.21 61.91 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.604 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.561 ' O ' ' CD2' ' A' ' 39' ' ' LEU . . . -62.95 -38.0 89.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.685 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.474 ' C ' HD22 ' A' ' 39' ' ' LEU . 31.9 m -62.53 133.77 55.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.607 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.561 ' CD2' ' O ' ' A' ' 37' ' ' ALA . 4.4 mm? -100.13 134.01 43.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.654 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.5 tttp 69.57 63.05 0.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.52 -179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.457 ' HG3' ' N ' ' A' ' 42' ' ' GLY . 4.3 tptm -89.82 -120.82 0.06 Allowed 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.41 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.457 ' N ' ' HG3' ' A' ' 41' ' ' LYS . . . 122.79 -54.79 0.7 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.329 -0.708 . . . . 0.0 111.329 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 32.5 t -125.06 92.32 2.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 120.944 0.402 . . . . 0.0 110.661 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -113.96 143.07 17.83 Favored Glycine 0 CA--C 1.523 0.55 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.449 ' O ' ' CA ' ' A' ' 33' ' ' GLY . 30.6 ttm -90.92 128.64 36.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -70.97 132.48 45.26 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.494 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 47' ' ' VAL . 2.3 p -115.46 109.88 29.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.171 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 47.3 t -150.5 172.06 16.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.471 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -63.49 -37.62 88.01 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.537 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.834 HG21 ' O ' ' A' ' 109' ' ' ILE . 13.0 m -83.92 -38.95 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.898 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.613 HG23 HG23 ' A' ' 50' ' ' VAL . 30.6 p -85.89 158.08 20.02 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.63 -0.428 . . . . 0.0 110.459 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.6 t -160.08 173.56 15.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.6 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.547 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -84.52 158.46 60.13 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.736 -179.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.552 ' HG3' HD23 ' A' ' 84' ' ' LEU . 74.4 Cg_endo -82.65 83.62 1.95 Allowed 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.501 2.134 . . . . 0.0 112.654 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.9 p -119.7 -5.65 10.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.735 179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 152.24 87.4 0.06 OUTLIER Glycine 0 CA--C 1.527 0.812 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 63.6 96.49 0.02 OUTLIER Glycine 0 CA--C 1.526 0.735 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.54 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -172.65 150.74 12.96 Favored Glycine 0 CA--C 1.525 0.714 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.657 ' CE1' HD12 ' A' ' 110' ' ' ILE . 22.3 t-160 -76.4 102.47 5.97 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 29.4 m -96.36 125.1 40.62 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.013 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.561 HG11 ' CD1' ' A' ' 109' ' ' ILE . 55.2 t -117.75 130.54 72.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.042 0.449 . . . . 0.0 109.975 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.559 HD22 ' O ' ' A' ' 61' ' ' VAL . 2.1 mm? -114.18 139.65 49.19 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.16 179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.8 t -112.89 134.11 54.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.846 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 120' ' ' THR . . . -131.35 71.77 0.49 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.648 -0.981 . . . . 0.0 110.648 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.595 ' H ' ' CD2' ' A' ' 65' ' ' HIS . 0.0 OUTLIER -54.12 137.24 40.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.602 0.239 . . . . 0.0 110.528 -179.668 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.0 mtm-85 71.97 174.49 0.29 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.941 0.401 . . . . 0.0 110.621 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -94.45 122.76 37.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.78 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 4.8 t -146.86 46.88 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.557 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 2.4 t -105.92 118.58 53.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.444 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -75.25 -61.91 1.74 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.73 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.42 ' O ' ' OE1' ' A' ' 75' ' ' GLN . 0.3 OUTLIER -113.72 98.62 7.15 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 0.0 109.937 179.729 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.499 ' O ' HD23 ' A' ' 76' ' ' LEU . 26.2 m-20 -60.1 -42.3 94.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.569 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.41 ' O ' ' HE3' ' A' ' 77' ' ' LYS . 46.0 mt -62.92 -41.55 99.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.587 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -66.33 -42.51 93.97 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.624 ' OE1' ' N ' ' A' ' 75' ' ' GLN . 0.1 OUTLIER -69.99 -42.52 72.97 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.462 -179.264 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.857 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.9 pp -92.56 108.64 20.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.21 0.529 . . . . 0.0 110.88 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.596 ' O ' HG21 ' A' ' 95' ' ' ILE . 16.6 ptpt 177.15 150.38 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.284 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -80.02 -12.4 59.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.497 179.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 mtmt -87.98 -14.84 38.09 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.572 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.573 ' H ' ' HG3' ' A' ' 77' ' ' LYS . 3.5 t70 -66.96 153.3 43.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.862 -179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.486 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 1.3 p -141.49 135.7 30.48 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-O 121.147 0.499 . . . . 0.0 109.69 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.47 HD21 ' OD2' ' A' ' 80' ' ' ASP . 7.2 mt -114.42 128.1 56.17 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.714 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.541 ' C ' HD12 ' A' ' 84' ' ' LEU . 2.4 t -106.77 121.47 59.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 120.954 0.407 . . . . 0.0 110.249 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.897 HD21 HD12 ' A' ' 117' ' ' LEU . 6.1 mp -105.1 121.59 44.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.208 -179.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.434 ' HG2' HG23 ' A' ' 90' ' ' THR . 92.8 mt-10 -101.71 113.7 27.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.108 179.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.516 ' CD2' ' HB2' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -147.86 132.76 18.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.843 -179.579 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 t0 60.35 40.39 17.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.833 0.349 . . . . 0.0 111.404 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 63.71 11.13 5.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.178 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.673 ' NZ ' ' OH ' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -110.61 149.66 30.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.566 179.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.532 ' O ' ' N ' ' A' ' 145' ' ' TYR . 0.0 OUTLIER -115.18 113.31 23.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.747 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.673 ' OH ' ' NZ ' ' A' ' 89' ' ' LYS . 9.4 m-85 -100.77 129.01 46.6 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.477 ' N ' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -100.86 119.95 39.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.045 0.45 . . . . 0.0 111.637 -178.154 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.756 ' CE1' HD22 ' A' ' 84' ' ' LEU . 72.6 m-85 -111.55 158.16 19.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.248 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -133.79 139.69 46.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.262 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.775 HD12 HD11 ' A' ' 98' ' ' ILE . 7.0 mm -67.64 120.72 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 120.285 -0.566 . . . . 0.0 110.13 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.477 ' NE2' ' HB2' ' A' ' 140' ' ' LYS . 44.5 mt-30 -90.89 -62.68 1.4 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.613 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.541 ' O ' HD13 ' A' ' 98' ' ' ILE . 58.6 tttp -148.98 143.35 26.07 Favored 'General case' 0 C--O 1.239 0.501 0 CA-C-O 121.143 0.497 . . . . 0.0 110.247 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.775 HD11 HD12 ' A' ' 95' ' ' ILE . 14.8 mm -117.67 129.72 73.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.792 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.425 ' CZ2' HG21 ' A' ' 136' ' ' ILE . 19.7 p90 -150.35 -176.71 5.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.031 0.443 . . . . 0.0 111.352 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.547 HG22 ' HB3' ' A' ' 133' ' ' ASP . 4.9 mt -126.04 132.63 70.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.4 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.584 ' OG1' ' OD2' ' A' ' 105' ' ' ASP . 3.1 t -131.84 171.32 13.68 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.839 -179.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.502 ' CD2' ' OD1' ' A' ' 133' ' ' ASP . 26.7 m170 -72.97 162.1 29.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.728 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -72.13 -11.37 60.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.62 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -104.14 16.6 25.88 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.686 ' OD1' HG23 ' A' ' 107' ' ' THR . 31.6 t0 -86.31 101.42 13.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.905 0.383 . . . . 0.0 110.377 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.613 ' O ' ' N ' ' A' ' 109' ' ' ILE . 33.7 ptt180 -72.62 -21.32 61.13 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.799 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.686 HG23 ' OD1' ' A' ' 105' ' ' ASP . 21.3 p -45.73 -20.12 0.07 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.884 -179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.66 HG22 ' O ' ' A' ' 105' ' ' ASP . 10.6 m -101.42 -17.2 6.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.047 0.451 . . . . 0.0 110.291 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.834 ' O ' HG21 ' A' ' 50' ' ' VAL . 47.8 mm -109.89 23.36 4.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.905 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.657 HD12 ' CE1' ' A' ' 59' ' ' HIS . 0.9 OUTLIER -89.01 -162.18 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.863 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -111.46 143.15 42.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.724 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -131.07 145.39 52.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.575 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 51.4 tt0 -87.48 12.62 11.83 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.109 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.75 165.72 26.33 Favored Pre-proline 0 C--N 1.331 -0.236 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.966 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.54 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 52.6 Cg_endo -78.87 98.52 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.854 2.369 . . . . 0.0 111.605 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . . . . . . . . . 50.3 mm -126.02 131.66 71.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-N 114.643 -1.162 . . . . 0.0 110.331 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.897 HD12 HD21 ' A' ' 84' ' ' LEU . 9.6 tt -102.4 121.3 42.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.368 0.604 . . . . 0.0 110.203 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.8 m -117.52 106.18 12.88 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.223 -0.898 . . . . 0.0 109.491 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.995 HD12 ' N ' ' A' ' 120' ' ' THR . 0.1 OUTLIER -100.85 127.41 47.32 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.046 -179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.995 ' N ' HD12 ' A' ' 119' ' ' LEU . 0.6 OUTLIER -119.69 137.35 53.96 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.451 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.721 ' CG2' HD11 ' A' ' 119' ' ' LEU . 5.8 p -134.01 169.96 16.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.046 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.687 ' SG ' ' O ' ' A' ' 121' ' ' THR . 5.4 m 95.01 -73.62 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.337 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.631 ' CE2' ' CZ ' ' A' ' 134' ' ' ARG . 53.0 m-85 56.3 111.9 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.013 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.549 ' HA ' ' H ' ' A' ' 131' ' ' ALA . 50.2 Cg_exo -49.58 -43.11 40.62 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.368 2.046 . . . . 0.0 112.776 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.7 ' CG ' ' N ' ' A' ' 126' ' ' ASP . 0.8 OUTLIER -65.77 -50.77 63.53 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.993 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.7 ' N ' ' CG ' ' A' ' 125' ' ' PHE . 0.7 OUTLIER -70.62 -43.76 68.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.208 -179.308 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.701 ' CE2' ' O ' ' A' ' 128' ' ' ILE . 17.7 t80 -55.15 141.63 34.17 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.555 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.701 ' O ' ' CE2' ' A' ' 127' ' ' TYR . 8.8 mm -54.87 108.01 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.412 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.93 -113.76 4.25 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 42.1 t0 -141.54 106.38 4.92 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.615 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.549 ' H ' ' HA ' ' A' ' 124' ' ' PRO . . . -72.14 119.24 73.51 Favored Pre-proline 0 CA--C 1.53 0.185 0 C-N-CA 120.684 -0.406 . . . . 0.0 110.188 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.576 ' O ' ' OD1' ' A' ' 133' ' ' ASP . 59.3 Cg_exo -47.49 -31.55 13.82 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.278 1.985 . . . . 0.0 111.909 179.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.576 ' OD1' ' O ' ' A' ' 132' ' ' PRO . 78.0 m-20 -155.84 178.53 10.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.502 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.631 ' CZ ' ' CE2' ' A' ' 123' ' ' TYR . 41.4 ttm180 -117.36 133.11 56.35 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.52 ' CE2' HD11 ' A' ' 137' ' ' ILE . 2.8 t80 -70.12 135.41 49.15 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.2 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.528 ' CG1' HG22 ' A' ' 101' ' ' THR . 43.5 mm -121.84 116.03 48.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 C-N-CA 120.641 -0.424 . . . . 0.0 111.455 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.721 HD13 HG23 ' A' ' 98' ' ' ILE . 40.4 mm -101.76 108.42 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 30.2 tp10 -97.65 138.36 35.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.107 0.479 . . . . 0.0 111.1 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.15 148.45 28.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.862 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.536 ' CG ' ' N ' ' A' ' 141' ' ' LEU . 28.2 ttpt -121.97 157.59 30.95 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.024 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.804 HD23 ' N ' ' A' ' 142' ' ' THR . 3.9 tt -81.67 122.09 27.19 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.536 -0.465 . . . . 0.0 110.64 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.804 ' N ' HD23 ' A' ' 141' ' ' LEU . 0.1 OUTLIER -98.47 -40.37 8.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.709 179.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.477 ' O ' ' N ' ' A' ' 92' ' ' THR . . . -150.76 155.13 26.01 Favored Glycine 0 CA--C 1.522 0.498 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -135.14 158.19 45.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.079 0.466 . . . . 0.0 111.277 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' A' ' 90' ' ' THR . 95.2 m-85 -135.07 146.47 48.95 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.688 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.577 ' O ' ' O ' ' A' ' 147' ' ' LYS . 96.2 p -129.57 114.37 15.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.19 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.577 ' O ' ' O ' ' A' ' 146' ' ' SER . 55.0 tttt . . . . . 0 C--O 1.22 -0.468 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.592 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 2.223 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.563 ' O ' ' O ' ' A' ' 1' ' ' GLY . 1.4 p 29.96 99.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 0.0 110.558 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.557 ' O ' ' O ' ' A' ' 4' ' ' MET . 86.4 t60 32.97 90.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.496 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.557 ' O ' ' O ' ' A' ' 3' ' ' HIS . 77.2 mtm -30.2 151.96 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.439 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.3 p -72.02 158.99 34.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.505 -179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.6 p -132.43 147.77 52.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.512 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.452 ' NE2' ' HA ' ' A' ' 7' ' ' GLN . 8.0 mm100 -58.37 -113.42 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.535 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.46 116.06 29.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.346 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.452 ' O ' ' OE2' ' A' ' 14' ' ' GLU . 95.8 mt-10 -148.6 -160.75 1.22 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.523 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 72.9 m-70 -91.15 1.24 57.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.512 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.694 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 0.8 OUTLIER -70.18 150.88 46.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.565 -179.538 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.559 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 54.1 mp0 -86.61 147.01 26.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.292 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.83 18.69 55.86 Favored Glycine 0 CA--C 1.521 0.448 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.694 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 1.0 OUTLIER -123.65 131.13 53.54 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-O 120.842 0.354 . . . . 0.0 110.449 179.829 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.585 ' N ' ' CD2' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.4 100.97 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.023 179.929 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.446 HG11 ' HB2' ' A' ' 32' ' ' TRP . 13.0 m -100.34 -30.49 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.092 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -143.4 158.34 43.72 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.723 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.9 ttm -119.47 139.61 51.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.448 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 7.9 tp -105.53 113.84 27.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.475 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -107.13 126.04 51.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.245 0.545 . . . . 0.0 110.726 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.426 HG22 ' H ' ' A' ' 24' ' ' LEU . 10.3 mt -103.95 114.08 64.82 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.138 179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.511 ' CD ' ' O ' ' A' ' 81' ' ' THR . 58.4 Cg_endo -77.33 -47.51 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.984 2.456 . . . . 0.0 112.871 -178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.573 ' C ' HD22 ' A' ' 24' ' ' LEU . 50.5 tptt -59.47 -40.51 87.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.574 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.798 ' N ' HD22 ' A' ' 24' ' ' LEU . 2.8 mm? -98.43 -3.57 36.48 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.582 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt 52.87 39.77 29.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.972 0.415 . . . . 0.0 110.642 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.83 152.44 37.3 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.832 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.4 mtmt -128.96 142.31 50.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.853 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -135.67 150.41 49.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.801 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 47.1 m -98.96 115.78 29.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.583 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.48 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.3 mp -93.14 127.03 45.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.969 0.414 . . . . 0.0 110.63 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD2' ' N ' ' A' ' 15' ' ' LYS . 33.6 m-85 -107.55 143.1 36.43 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.869 -179.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.598 ' HZ2' HG23 ' A' ' 47' ' ' VAL . 47.3 t-105 -61.84 127.29 30.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.736 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 45' ' ' MET . . . 89.1 168.21 43.59 Favored Glycine 0 N--CA 1.461 0.31 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -165.17 110.85 0.93 Allowed 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.915 179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -101.8 125.77 48.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 0.0 110.716 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.472 ' C ' ' OD1' ' A' ' 36' ' ' ASP . 51.5 p30 -81.12 -3.83 53.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.511 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -70.94 -64.58 0.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.614 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 8.3 p -86.32 168.02 14.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.517 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.8 tp -98.36 86.53 3.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.413 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.5 mtpt -80.96 -171.97 3.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.458 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 29.9 mttp -51.78 -28.63 16.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.371 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 63' ' ' SER . . . 108.52 -36.3 4.45 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.5 96.87 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.152 0.501 . . . . 0.0 110.355 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -132.04 161.02 23.79 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.766 ' SD ' ' N ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -104.27 139.25 39.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.72 0.295 . . . . 0.0 110.587 -179.875 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.766 ' N ' ' SD ' ' A' ' 45' ' ' MET . 40.5 t80 -76.7 120.59 22.09 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.127 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.598 HG23 ' HZ2' ' A' ' 32' ' ' TRP . 2.2 p -97.53 120.37 46.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.661 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.21 166.53 32.17 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.414 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.51 ' O ' ' OD1' ' A' ' 49' ' ' ASP . 41.0 t0 -64.07 -33.98 77.0 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.548 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.595 HG21 ' HA ' ' A' ' 110' ' ' ILE . 4.1 m -84.82 -41.62 16.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.144 0.497 . . . . 0.0 110.863 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.52 ' N ' HG23 ' A' ' 50' ' ' VAL . 44.2 p -77.5 161.47 27.9 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.277 -0.569 . . . . 0.0 110.724 -179.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.508 ' O ' ' CE ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -156.22 169.75 23.82 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.905 0.383 . . . . 0.0 110.587 179.721 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.402 ' H ' HG23 ' A' ' 53' ' ' THR . 0.1 OUTLIER -88.89 153.86 49.73 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.587 179.849 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.689 ' HG3' HD23 ' A' ' 84' ' ' LEU . 56.6 Cg_endo -73.23 85.56 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.874 2.383 . . . . 0.0 112.314 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.7 t -118.95 4.41 11.43 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.62 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.94 89.95 0.26 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 62.5 85.58 0.05 OUTLIER Glycine 0 CA--C 1.532 1.096 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.44 161.91 35.31 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.714 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 12.3 t-160 -81.36 121.03 25.7 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 36.2 m -114.9 122.9 47.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.188 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.552 ' O ' HD22 ' A' ' 62' ' ' LEU . 39.9 t -115.98 128.61 73.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.338 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.552 HD22 ' O ' ' A' ' 61' ' ' VAL . 1.9 mm? -113.82 145.64 41.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.232 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 42' ' ' GLY . 35.7 t -130.82 135.63 47.92 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.647 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.651 ' O ' ' CB ' ' A' ' 121' ' ' THR . . . -157.27 164.54 32.96 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 111.464 -0.654 . . . . 0.0 111.464 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.466 ' ND1' ' N ' ' A' ' 65' ' ' HIS . 0.0 OUTLIER -123.05 153.53 39.74 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.836 -0.346 . . . . 0.0 110.864 -179.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 72.8 mtp85 61.8 101.53 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.471 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -65.15 -31.68 72.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.214 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 70.63 107.03 0.06 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.592 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 69' ' ' VAL . 2.5 m -45.15 -26.7 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.49 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.553 ' C ' ' H ' ' A' ' 72' ' ' ASP . 3.1 m-85 -73.93 143.57 45.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.669 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 70' ' ' PHE . 53.8 p 50.33 6.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.479 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 70' ' ' PHE . 25.5 t0 -59.36 -47.04 86.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.538 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 73' ' ' LEU . 15.3 tp -60.64 -42.49 97.04 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.902 0.382 . . . . 0.0 110.814 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.404 ' HA3' HD21 ' A' ' 24' ' ' LEU . . . -63.26 -30.12 76.55 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.22 -0.752 . . . . 0.0 111.22 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 86.1 mt-30 -70.06 -39.44 75.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.935 0.398 . . . . 0.0 110.792 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.452 ' CD2' ' O ' ' A' ' 72' ' ' ASP . 0.0 OUTLIER -101.44 98.02 8.42 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.772 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.523 ' O ' HG21 ' A' ' 95' ' ' ILE . 0.0 OUTLIER 178.01 148.71 0.18 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.116 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -78.13 -13.83 59.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.54 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -83.17 -15.69 49.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.414 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.55 153.16 41.44 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.652 -179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.511 ' O ' ' CD ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -141.95 121.53 13.34 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.088 0.471 . . . . 0.0 109.8 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 24.2 mt -98.39 133.34 42.91 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.545 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.463 ' C ' HD12 ' A' ' 84' ' ' LEU . 3.1 t -111.92 122.62 66.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.927 0.394 . . . . 0.0 110.25 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.689 HD23 ' HG3' ' A' ' 54' ' ' PRO . 8.5 mp -102.33 124.45 47.92 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.105 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -101.22 115.22 29.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.093 179.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.632 ' O ' ' N ' ' A' ' 89' ' ' LYS . 5.6 t80 -144.55 143.07 30.64 Favored 'General case' 0 C--O 1.223 -0.322 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.812 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 86' ' ' TYR . 38.9 t70 38.05 52.64 1.57 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.738 0.304 . . . . 0.0 111.407 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 63.8 m-80 58.1 9.87 1.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.395 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.632 ' N ' ' O ' ' A' ' 86' ' ' TYR . 53.4 mtmt -104.57 143.72 32.66 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.55 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.438 HG22 HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -116.85 122.56 44.71 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.844 -179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -109.88 127.95 55.04 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 110.094 -0.335 . . . . 0.0 110.094 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.533 ' OG1' ' O ' ' A' ' 143' ' ' GLY . 0.2 OUTLIER -96.47 109.25 21.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.393 -179.65 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.606 ' CE1' HD22 ' A' ' 84' ' ' LEU . 52.9 m-85 -99.06 155.15 17.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.991 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -131.38 130.02 42.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.194 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.526 ' CD1' ' CG2' ' A' ' 137' ' ' ILE . 4.9 mm -61.11 119.32 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 120.239 -0.585 . . . . 0.0 110.648 -179.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -89.79 -65.8 0.98 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.757 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 24.9 tptt -147.16 138.15 23.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.454 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.459 HG23 HG13 ' A' ' 137' ' ' ILE . 1.3 mp -113.62 133.27 60.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.491 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.404 ' CD1' ' C ' ' A' ' 99' ' ' TRP . 18.6 p90 -153.48 -178.68 7.16 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.929 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.475 ' N ' HD12 ' A' ' 100' ' ' ILE . 1.8 mp -125.27 129.67 73.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.491 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.539 HG22 ' CG1' ' A' ' 136' ' ' ILE . 4.8 t -128.85 172.94 10.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.673 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -73.9 153.41 39.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.69 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -61.95 -34.51 76.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.524 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -78.98 18.75 0.59 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.677 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -89.22 99.09 12.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.326 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.945 ' O ' HG23 ' A' ' 110' ' ' ILE . 23.1 ptt85 -80.15 -19.42 47.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.779 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.445 ' O ' HD12 ' A' ' 110' ' ' ILE . 6.8 p -48.1 -18.25 0.18 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.957 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.554 ' HB ' HG21 ' A' ' 118' ' ' THR . 4.1 m -110.52 -9.35 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.287 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.689 ' O ' HG22 ' A' ' 109' ' ' ILE . 39.2 mm -104.95 1.33 10.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.033 179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.945 HG23 ' O ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER -77.72 -167.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.442 179.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 50' ' ' VAL . 12.6 ptmt -99.88 151.66 21.05 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.774 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.605 ' H ' ' HB2' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -125.45 134.94 51.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.303 -179.781 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -78.31 6.96 7.17 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.221 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.09 164.16 33.4 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.559 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.429 ' O ' HD13 ' A' ' 116' ' ' ILE . 36.4 Cg_endo -71.41 96.17 0.72 Allowed 'Trans proline' 0 C--N 1.302 -1.874 0 C-N-CA 123.192 2.595 . . . . 0.0 112.155 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 115' ' ' PRO . 50.9 mm -128.98 133.13 66.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.46 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.834 HD23 ' C ' ' A' ' 117' ' ' LEU . 5.7 tt -106.69 120.36 41.77 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.161 0.505 . . . . 0.0 110.316 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.554 HG21 ' HB ' ' A' ' 108' ' ' VAL . 91.1 m -118.34 119.09 33.58 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.158 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.868 HD23 ' N ' ' A' ' 120' ' ' THR . 5.6 tt -105.73 127.81 53.31 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.609 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.868 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.1 OUTLIER -120.83 117.76 28.24 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.817 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.651 ' CB ' ' O ' ' A' ' 64' ' ' GLY . 1.7 t -151.5 -170.04 3.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.729 -179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.632 ' SG ' ' O ' ' A' ' 121' ' ' THR . 1.6 p 152.46 -85.18 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.593 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.487 ' N ' ' CD1' ' A' ' 123' ' ' TYR . 11.4 m-85 44.2 66.95 4.35 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.05 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -82.75 178.4 6.09 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 123.151 2.567 . . . . 0.0 112.304 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -54.09 -24.77 18.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.315 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.51 ' C ' ' OD1' ' A' ' 126' ' ' ASP . 2.0 p30 -93.64 13.11 23.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.556 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.681 ' CZ ' ' O ' ' A' ' 129' ' ' GLY . 53.0 t80 -58.47 -48.44 80.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.29 -179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.644 ' C ' ' O ' ' A' ' 127' ' ' TYR . 96.2 mt 4.03 78.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 O-C-N 123.918 0.761 . . . . 0.0 110.516 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.681 ' O ' ' CZ ' ' A' ' 127' ' ' TYR . . . 112.0 -100.69 1.19 Allowed Glycine 0 CA--C 1.526 0.775 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 131' ' ' ALA . 20.1 t70 -133.35 104.89 6.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.741 0.305 . . . . 0.0 110.574 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' A' ' 130' ' ' ASP . . . -38.21 139.39 0.65 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.757 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -68.93 -21.34 37.61 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.797 2.332 . . . . 0.0 112.0 179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -138.95 143.54 38.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.554 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.474 ' HG3' ' SG ' ' A' ' 122' ' ' CYS . 4.9 ttt180 -117.22 132.87 56.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.922 0.391 . . . . 0.0 110.411 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.621 ' HD2' HD11 ' A' ' 137' ' ' ILE . 5.3 t80 -75.79 125.96 30.08 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.595 -0.442 . . . . 0.0 109.915 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.675 ' C ' HD12 ' A' ' 137' ' ' ILE . 4.2 mm -112.91 118.59 58.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.91 0.386 . . . . 0.0 111.94 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.943 ' N ' HD12 ' A' ' 137' ' ' ILE . 1.3 mp -110.42 107.04 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -90.98 136.58 32.98 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.382 0.611 . . . . 0.0 111.344 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -141.33 146.2 36.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.911 179.587 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.522 ' HD2' ' H ' ' A' ' 141' ' ' LEU . 50.9 tptt -111.69 139.85 46.8 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.352 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.711 ' C ' HD13 ' A' ' 141' ' ' LEU . 2.2 tm? -75.5 114.87 14.55 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 119.974 -0.691 . . . . 0.0 109.707 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.605 ' OG1' ' N ' ' A' ' 143' ' ' GLY . 0.0 OUTLIER -97.74 -65.39 0.97 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.273 -179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.605 ' N ' ' OG1' ' A' ' 142' ' ' THR . . . -101.41 151.19 18.66 Favored Glycine 0 CA--C 1.524 0.608 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.257 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 89.9 p -137.35 126.91 25.16 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.93 0.395 . . . . 0.0 110.428 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -118.74 146.48 44.73 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.677 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.2 p -133.94 130.1 37.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.574 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 88.0 tttt . . . . . 0 C--O 1.221 -0.416 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.609 -179.962 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.587 ' O ' ' O ' ' A' ' 1' ' ' GLY . 8.7 m 26.35 100.33 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.818 0.342 . . . . 0.0 110.592 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 46.4 m80 -98.26 -101.31 0.21 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.798 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.489 ' O ' ' CG ' ' A' ' 4' ' ' MET . 7.9 ptp -129.83 128.57 42.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.842 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 4' ' ' MET . 1.3 m -169.33 -152.12 0.1 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.469 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 71.43 84.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.598 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -128.38 8.08 5.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.492 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 2.5 m 64.34 -129.87 0.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.531 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 52.6 -106.07 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.571 -179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.553 ' O ' ' OE2' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -127.55 43.93 3.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.694 -179.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.607 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 12.5 tmtt? -68.43 127.28 32.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.531 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.553 ' OE2' ' O ' ' A' ' 10' ' ' HIS . 9.0 mp0 -81.38 109.28 15.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.141 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 32' ' ' TRP . . . 129.05 24.69 1.04 Allowed Glycine 0 CA--C 1.522 0.476 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.607 ' CG ' ' O ' ' A' ' 11' ' ' LYS . 0.3 OUTLIER -127.29 131.8 50.44 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.801 0.334 . . . . 0.0 110.458 179.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.64 96.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.986 0.422 . . . . 0.0 110.285 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 14' ' ' GLU . 5.6 m -100.71 -38.31 6.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.921 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.95 157.85 45.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.596 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 32.0 ttm -125.35 136.16 53.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.441 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.409 HD12 HD21 ' A' ' 84' ' ' LEU . 1.9 tt -101.72 119.05 38.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.19 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -111.89 137.73 49.46 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.367 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 10.2 mt -119.26 112.96 35.59 Favored Pre-proline 0 N--CA 1.451 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.892 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.477 ' HD2' ' O ' ' A' ' 81' ' ' THR . 56.3 Cg_endo -75.16 -40.26 0.91 Allowed 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.882 2.388 . . . . 0.0 112.929 -178.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.507 ' HB3' HD22 ' A' ' 24' ' ' LEU . 4.5 tmtt? -65.06 -37.57 88.0 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.716 -179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.62 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.7 mm? -96.24 3.02 53.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.738 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.537 ' HD3' ' N ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER 45.69 57.12 5.26 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.898 179.102 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.455 ' HD3' ' CE2' ' A' ' 28' ' ' PHE . 18.1 ptpt -157.26 173.91 16.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.969 0.414 . . . . 0.0 110.629 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.01 158.09 43.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.619 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.455 ' CE2' ' HD3' ' A' ' 26' ' ' LYS . 87.7 m-85 -133.37 154.22 50.92 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.738 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.1 m -95.21 112.48 24.18 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.835 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.546 ' N ' ' CD1' ' A' ' 30' ' ' ILE . 1.2 mp -93.79 122.04 44.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.425 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.481 ' CD1' ' HE2' ' A' ' 41' ' ' LYS . 86.3 m-85 -102.71 146.1 28.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.864 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TRP . . . . . 0.469 ' O ' ' N ' ' A' ' 13' ' ' GLY . 51.6 t-105 -62.56 125.08 22.72 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.557 -179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 82.67 142.98 4.58 Favored Glycine 0 N--CA 1.46 0.291 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -133.74 94.36 3.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.675 -0.41 . . . . 0.0 110.623 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -99.38 108.09 20.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.861 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -67.22 -32.97 74.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.509 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.39 90.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.646 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 50.0 m -66.81 127.64 33.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.345 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.401 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 5.1 mp -96.61 85.96 3.99 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.586 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.401 ' HG2' ' O ' ' A' ' 39' ' ' LEU . 12.5 mmtt 175.63 -5.93 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.604 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.481 ' HE2' ' CD1' ' A' ' 31' ' ' TYR . 3.4 tptt -125.41 166.87 15.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.46 -179.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.33 -51.72 0.03 OUTLIER Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.019 -0.833 . . . . 0.0 111.019 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.7 m -110.69 117.76 55.65 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-O 121.418 0.627 . . . . 0.0 110.546 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -152.99 167.28 31.68 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.114 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.504 ' HE2' ' O ' ' A' ' 46' ' ' PHE . 2.1 ttp -98.74 129.09 45.17 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.504 ' O ' ' HE2' ' A' ' 45' ' ' MET . 19.3 t80 -65.12 131.12 45.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.393 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.469 ' HB ' ' CZ2' ' A' ' 32' ' ' TRP . 2.0 p -113.7 124.18 70.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.667 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.65 ' N ' ' OG1' ' A' ' 51' ' ' THR . 36.3 t -158.02 174.31 15.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.563 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -67.65 -13.75 62.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.602 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.71 HG21 ' O ' ' A' ' 109' ' ' ILE . 3.5 m -111.17 -14.1 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.892 0.377 . . . . 0.0 110.556 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.65 ' OG1' ' N ' ' A' ' 48' ' ' SER . 29.3 p -104.32 141.22 36.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.2 t -142.18 167.48 22.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.473 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.406 HG22 ' CZ3' ' A' ' 32' ' ' TRP . 0.1 OUTLIER -83.11 162.65 53.81 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.917 -179.515 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -82.58 83.08 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.681 2.254 . . . . 0.0 112.437 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 55' ' ' SER . 0.9 OUTLIER -117.77 7.71 12.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.654 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 132.16 87.28 0.36 Allowed Glycine 0 CA--C 1.526 0.772 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.76 92.64 0.04 OUTLIER Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.905 -0.878 . . . . 0.0 110.905 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.526 ' H ' ' HA ' ' A' ' 115' ' ' PRO . . . -170.25 160.09 32.78 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.689 ' ND1' ' O ' ' A' ' 110' ' ' ILE . 19.2 t-160 -82.61 114.2 20.83 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.458 HG22 ' CD2' ' A' ' 62' ' ' LEU . 21.6 m -111.47 120.87 43.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.253 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.893 HG11 ' CD1' ' A' ' 109' ' ' ILE . 65.2 t -114.6 125.66 71.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.044 0.45 . . . . 0.0 109.806 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.621 HD22 ' C ' ' A' ' 61' ' ' VAL . 2.7 mm? -108.55 143.26 37.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.567 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 32.3 t -126.87 138.28 53.3 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.712 -179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.458 ' O ' ' CD1' ' A' ' 123' ' ' TYR . . . -160.26 -179.0 34.75 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.68 ' O ' ' N ' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -84.68 154.22 22.62 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 122.402 -0.469 . . . . 0.0 110.86 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.639 ' NH1' ' O ' ' A' ' 126' ' ' ASP . 29.0 ptt180 -36.41 -21.11 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.586 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.68 ' N ' ' O ' ' A' ' 65' ' ' HIS . 23.1 t70 -25.84 97.95 0.01 OUTLIER 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.539 -179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.42 ' N ' ' O ' ' A' ' 66' ' ' ARG . 54.7 m -156.34 -23.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.528 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 7.2 p -62.44 -30.95 50.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.623 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -60.02 -44.06 94.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.626 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 41.5 p -135.33 51.47 2.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.532 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.448 ' OD1' ' N ' ' A' ' 73' ' ' LEU . 30.3 p-10 -55.56 -44.41 76.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.452 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.458 ' HA ' HD13 ' A' ' 73' ' ' LEU . 3.9 mm? -62.01 -41.95 98.63 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.079 179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.474 ' HA3' HD11 ' A' ' 24' ' ' LEU . . . -79.55 -15.55 79.49 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 111.021 -0.832 . . . . 0.0 111.021 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 61.3 mm-40 -87.17 -43.42 12.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.782 0.325 . . . . 0.0 110.68 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.823 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.6 pp -108.47 103.99 13.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.034 0.445 . . . . 0.0 111.218 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.546 ' HG3' ' H ' ' A' ' 80' ' ' ASP . 2.3 ptmt 177.91 137.02 0.08 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.246 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.31 -17.62 62.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.058 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.7 mmmt -79.49 -13.94 59.23 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.367 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.657 ' OD1' ' N ' ' A' ' 81' ' ' THR . 1.0 OUTLIER -70.65 155.35 40.85 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.935 -179.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.657 ' N ' ' OD1' ' A' ' 80' ' ' ASP . 0.1 OUTLIER -142.64 119.16 10.99 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.025 0.441 . . . . 0.0 109.981 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 46.9 mt -95.66 129.05 42.98 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.837 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.516 ' C ' HD22 ' A' ' 84' ' ' LEU . 21.3 t -113.43 118.1 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.033 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.516 HD22 ' C ' ' A' ' 83' ' ' VAL . 4.1 mm? -105.45 135.36 46.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.458 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.481 ' HG2' HG23 ' A' ' 90' ' ' THR . 95.9 mt-10 -106.48 123.73 48.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.946 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 87' ' ' ASP . 21.9 t80 -143.4 131.03 21.25 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.261 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 86' ' ' TYR . 8.6 t0 49.45 49.02 20.54 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.315 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 63.43 11.27 5.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.471 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 86' ' ' TYR . 44.3 mtmt -109.94 145.24 37.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.987 0.423 . . . . 0.0 110.288 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.507 HG22 ' CG1' ' A' ' 83' ' ' VAL . 0.2 OUTLIER -112.33 123.64 50.73 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.909 -179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -104.48 132.87 50.24 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.295 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.97 111.1 23.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.164 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 141' ' ' LEU . 80.4 m-85 -109.6 150.36 28.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.48 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -131.18 140.38 49.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.827 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.471 HD13 ' HA ' ' A' ' 95' ' ' ILE . 14.4 mm -60.76 122.23 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 120.054 -0.658 . . . . 0.0 110.557 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 60.7 mm-40 -104.02 -50.48 3.37 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.859 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.421 ' O ' ' HB3' ' A' ' 138' ' ' GLU . 15.3 tptm -154.27 132.51 11.86 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 121.192 0.52 . . . . 0.0 110.611 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.449 ' CD1' ' HA ' ' A' ' 76' ' ' LEU . 71.9 mt -122.04 132.84 70.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.475 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 30.2 p90 -153.73 -176.06 5.66 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.797 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.729 ' N ' HD12 ' A' ' 100' ' ' ILE . 1.8 mp -127.75 129.61 70.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.432 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 9.4 t -134.39 -171.12 2.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.694 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' HIS . . . . . 0.404 ' O ' ' HB2' ' A' ' 105' ' ' ASP . 93.2 m-70 -78.31 153.89 31.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.902 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -64.14 -30.8 71.84 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.609 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -88.63 14.22 10.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.731 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.896 ' O ' HG22 ' A' ' 108' ' ' VAL . 3.8 t70 -75.58 94.34 3.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.039 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.728 ' O ' ' N ' ' A' ' 109' ' ' ILE . 30.6 ptt-85 -64.78 -34.28 77.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.664 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.652 ' O ' HD11 ' A' ' 110' ' ' ILE . 3.1 p -35.63 -25.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.93 -179.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 105' ' ' ASP . 28.6 m -98.15 -24.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 110.801 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.893 ' CD1' HG11 ' A' ' 61' ' ' VAL . 8.1 mm -104.89 27.34 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.637 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.689 ' O ' ' ND1' ' A' ' 59' ' ' HIS . 0.8 OUTLIER -90.85 -162.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.408 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 12.8 ttpt -107.39 137.9 44.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.769 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.495 ' HD2' ' CD2' ' A' ' 59' ' ' HIS . 99.2 mttt -126.36 143.4 51.18 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.18 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.6 ' N ' ' OE2' ' A' ' 114' ' ' GLU . 15.0 mt-10 -90.97 11.4 22.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.569 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.6 ' OE2' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -136.7 168.68 15.91 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 120.994 0.426 . . . . 0.0 110.589 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.526 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 51.7 Cg_endo -78.44 90.46 1.27 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.164 2.576 . . . . 0.0 112.251 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.484 HG21 ' HZ3' ' A' ' 112' ' ' LYS . 50.8 mm -122.57 129.42 75.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.757 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.806 HD23 ' C ' ' A' ' 117' ' ' LEU . 6.5 tt -104.08 122.26 44.92 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.71 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.639 HG21 ' HB ' ' A' ' 108' ' ' VAL . 19.6 m -114.27 113.61 24.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.13 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 120' ' ' THR . 1.8 tt -104.27 116.23 31.8 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.699 -179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.734 ' N ' HD23 ' A' ' 119' ' ' LEU . 0.0 OUTLIER -112.52 129.29 56.4 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.42 0.45 . . . . 0.0 110.196 179.714 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.616 HG23 ' CD2' ' A' ' 119' ' ' LEU . 71.4 p -134.43 156.38 48.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.397 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' CYS . . . . . 0.548 ' O ' ' O ' ' A' ' 123' ' ' TYR . 1.0 OUTLIER 158.01 -62.15 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.676 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.548 ' O ' ' O ' ' A' ' 122' ' ' CYS . 8.2 m-85 54.46 144.59 0.04 OUTLIER Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.757 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.423 ' O ' ' O ' ' A' ' 127' ' ' TYR . 45.8 Cg_endo -71.54 -57.02 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.759 2.306 . . . . 0.0 112.475 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.639 ' CE2' ' OD2' ' A' ' 126' ' ' ASP . 1.6 p90 -56.99 -33.71 67.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.277 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.639 ' O ' ' NH1' ' A' ' 66' ' ' ARG . 4.0 m-20 -63.09 -37.73 88.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.444 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.609 ' O ' ' N ' ' A' ' 129' ' ' GLY . 4.0 t80 -110.7 118.55 36.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.445 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.505 ' C ' ' O ' ' A' ' 127' ' ' TYR . 88.1 mt -32.13 89.56 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.298 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 127' ' ' TYR . . . 104.2 -159.58 16.29 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.884 -0.886 . . . . 0.0 110.884 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -91.77 106.07 18.19 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.476 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -45.02 103.67 0.35 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.626 -179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.62 -40.92 63.46 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.695 2.264 . . . . 0.0 112.018 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -118.11 158.81 24.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.543 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.524 ' HA ' ' SG ' ' A' ' 122' ' ' CYS . 0.8 OUTLIER -123.53 134.61 53.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.209 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.578 ' CD2' HD11 ' A' ' 137' ' ' ILE . 4.2 t80 -87.43 125.14 34.1 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.496 ' HA ' ' O ' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -122.16 128.52 75.57 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 CA-C-N 116.217 -0.447 . . . . 0.0 112.016 -179.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.578 HD11 ' CD2' ' A' ' 135' ' ' TYR . 7.2 mm -106.87 111.76 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.036 179.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 97' ' ' LYS . 67.5 tt0 -94.27 138.48 32.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.507 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -148.75 149.02 30.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.655 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -114.43 152.66 31.21 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.188 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.469 ' HB2' ' CE1' ' A' ' 93' ' ' TYR . 11.2 tp -77.07 115.61 17.01 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.444 -0.502 . . . . 0.0 110.702 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.63 -42.18 12.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.123 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.404 ' O ' HD11 ' A' ' 141' ' ' LEU . . . -142.73 171.6 24.74 Favored Glycine 0 CA--C 1.526 0.778 0 N-CA-C 110.941 -0.864 . . . . 0.0 110.941 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 56.4 p -147.08 151.39 36.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.781 0.324 . . . . 0.0 110.41 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -136.58 160.75 37.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.688 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.588 ' O ' ' C ' ' A' ' 147' ' ' LYS . 7.9 p -150.74 125.56 9.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.45 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.588 ' C ' ' O ' ' A' ' 146' ' ' SER . 17.4 tttm . . . . . 0 C--O 1.22 -0.45 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.471 -179.851 . . . . . . . . 1 1 . 1 stop_ save_